Citrus Sinensis ID: 022401
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 298 | 2.2.26 [Sep-21-2011] | |||||||
| Q39193 | 361 | Serine/threonine-protein | yes | no | 0.889 | 0.734 | 0.902 | 1e-142 | |
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.892 | 0.734 | 0.898 | 1e-142 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.885 | 0.711 | 0.875 | 1e-138 | |
| Q940H6 | 362 | Serine/threonine-protein | no | no | 0.882 | 0.726 | 0.886 | 1e-138 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.892 | 0.734 | 0.868 | 1e-137 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.885 | 0.731 | 0.842 | 1e-134 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.818 | 0.719 | 0.856 | 1e-124 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.818 | 0.719 | 0.852 | 1e-124 | |
| P43291 | 363 | Serine/threonine-protein | no | no | 0.815 | 0.669 | 0.827 | 1e-123 | |
| Q7XQP4 | 359 | Serine/threonine-protein | no | no | 0.822 | 0.682 | 0.824 | 1e-123 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 505 bits (1300), Expect = e-142, Method: Compositional matrix adjust.
Identities = 240/266 (90%), Positives = 254/266 (95%), Gaps = 1/266 (0%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQRILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 243 SVPDTNPISQECRDLISRIFVADPAA 268
S+PD IS EC LISRIFVADPA
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPAT 265
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1298), Expect = e-142, Method: Compositional matrix adjust.
Identities = 239/266 (89%), Positives = 250/266 (93%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA+LTVGP MDMPIMHD DRY+ VRDIGSGNFGVARLMR + +LVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPK+FRKTIQRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRILGVQY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPAA 268
S+PD IS ECRDLI+RIFVA+PA
Sbjct: 241 SIPDYVHISPECRDLIARIFVANPAT 266
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 490 bits (1262), Expect = e-138, Method: Compositional matrix adjust.
Identities = 231/264 (87%), Positives = 248/264 (93%)
Query: 4 DRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
DRA+LTVGP MDMPIMHDSDRY+ VRDIGSGNFGVARLMRD+ T ELVAVKYIERG+KID
Sbjct: 12 DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71
Query: 64 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 123
+NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC RFSEDEAR+
Sbjct: 72 DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191
Query: 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243
PAYIAPEVLL+ EYDGK ADVWSCGVTLYVM+VG YPFEDP+EPK+FRKTIQRIL+VQYS
Sbjct: 192 PAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQRILNVQYS 251
Query: 244 VPDTNPISQECRDLISRIFVADPA 267
+P+ IS ECR LISRIFV DP+
Sbjct: 252 IPENVDISPECRHLISRIFVGDPS 275
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 490 bits (1261), Expect = e-138, Method: Compositional matrix adjust.
Identities = 235/265 (88%), Positives = 251/265 (94%), Gaps = 2/265 (0%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 243 SVPDTNPISQECRDLISRIFVADPA 267
++PD IS ECR LISRIFVADPA
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPA 263
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1256), Expect = e-137, Method: Compositional matrix adjust.
Identities = 231/266 (86%), Positives = 249/266 (93%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MD A+ + +D+PIMHDSDRYDFV+DIGSGNFGVARLM D+VTKELVAVKYIERG+KI
Sbjct: 1 MDPATNSPIMPIDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPE+LLR EYDGK+ADVWSCGVTLYVMLVG YPFEDP EP+D+RKTIQRILSV Y
Sbjct: 181 TPAYIAPEILLRQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRILSVTY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPAA 268
S+P+ +S ECR LISRIFVADPA
Sbjct: 241 SIPEDLHLSPECRHLISRIFVADPAT 266
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 476 bits (1225), Expect = e-134, Method: Compositional matrix adjust.
Identities = 225/267 (84%), Positives = 249/267 (93%), Gaps = 3/267 (1%)
Query: 3 MDRASLTVGP-AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK 61
M+RA+ GP M+MPIMHD DRY+ V++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1 MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58
Query: 62 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 121
IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59 IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181
RFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241
GTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP++PK+FRKTIQ+IL VQ
Sbjct: 179 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILGVQ 238
Query: 242 YSVPDTNPISQECRDLISRIFVADPAA 268
YS+PD IS ECRDLI+RIFV +PA+
Sbjct: 239 YSIPDYVHISPECRDLITRIFVGNPAS 265
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 445 bits (1145), Expect = e-124, Method: Compositional matrix adjust.
Identities = 209/244 (85%), Positives = 228/244 (93%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RY+ ++DIGSGNFGVA+L+RD TKEL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
DVWSCGVTLYVMLVG YPFEDPDEP++FRKTI RILSVQY VPD +S ECR L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241
Query: 263 VADP 266
VA+P
Sbjct: 242 VANP 245
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 208/244 (85%), Positives = 228/244 (93%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RY+ ++DIGSGNFGVA+L+RD TKEL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
DVWSCGVTLYVMLVG YPFEDPDEP++FRKTI RILSVQY VPD +S ECR L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241
Query: 263 VADP 266
VA+P
Sbjct: 242 VANP 245
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1132), Expect = e-123, Method: Compositional matrix adjust.
Identities = 201/243 (82%), Positives = 229/243 (94%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+DIG+GNFGVARLM+ K +KELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHLAI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKMA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
DVWSCGVTLYVMLVG YPFED ++PK+FRKTIQ+I++VQY +PD ISQ+C++L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIQKIMAVQYKIPDYVHISQDCKNLLSRIF 241
Query: 263 VAD 265
VA+
Sbjct: 242 VAN 244
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-123, Method: Compositional matrix adjust.
Identities = 202/245 (82%), Positives = 228/245 (93%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RY+ ++DIG+GNFGVARLMR+K TKELVA+KYI RG KIDENV REIINHRSLRHPNI+
Sbjct: 2 ERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV++TPTHLAIVMEYA+GGELF+RICNAGRFSEDEAR+FFQQLI GVSYCH MQ+CH
Sbjct: 62 RFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKTA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
DVWSCGVTLYVMLVG YPFEDPD+PK+FRKTI RI+S+QY +P+ +SQ+CR L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIMSIQYKIPEYVHVSQDCRQLLSRIF 241
Query: 263 VADPA 267
VA+PA
Sbjct: 242 VANPA 246
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 298 | ||||||
| 255562649 | 362 | Serine/threonine-protein kinase SAPK10, | 0.892 | 0.734 | 0.936 | 1e-145 | |
| 449460610 | 363 | PREDICTED: serine/threonine-protein kina | 0.892 | 0.732 | 0.939 | 1e-144 | |
| 356563656 | 360 | PREDICTED: serine/threonine-protein kina | 0.889 | 0.736 | 0.920 | 1e-144 | |
| 225470483 | 361 | PREDICTED: serine/threonine-protein kina | 0.892 | 0.736 | 0.909 | 1e-143 | |
| 356511732 | 360 | PREDICTED: serine/threonine-protein kina | 0.889 | 0.736 | 0.913 | 1e-142 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.892 | 0.732 | 0.909 | 1e-142 | |
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 0.889 | 0.728 | 0.916 | 1e-142 | |
| 356521207 | 364 | PREDICTED: serine/threonine-protein kina | 0.889 | 0.728 | 0.909 | 1e-142 | |
| 356563658 | 367 | PREDICTED: serine/threonine-protein kina | 0.889 | 0.722 | 0.897 | 1e-142 | |
| 357518557 | 363 | Serine/threonine protein kinase SAPK3 [M | 0.889 | 0.730 | 0.909 | 1e-141 |
| >gi|255562649|ref|XP_002522330.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538408|gb|EEF40014.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1343), Expect = e-145, Method: Compositional matrix adjust.
Identities = 249/266 (93%), Positives = 256/266 (96%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
M+R+++TVGP MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI
Sbjct: 1 MNRSAITVGPGMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICN GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNGGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPKDFRKTIQRILSVQY
Sbjct: 181 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKDFRKTIQRILSVQY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPAA 268
S+PD IS EC DLISRIF+ DPAA
Sbjct: 241 SIPDVVQISPECCDLISRIFIFDPAA 266
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460610|ref|XP_004148038.1| PREDICTED: serine/threonine-protein kinase SRK2I-like [Cucumis sativus] gi|449502711|ref|XP_004161721.1| PREDICTED: serine/threonine-protein kinase SRK2I-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1334), Expect = e-144, Method: Compositional matrix adjust.
Identities = 250/266 (93%), Positives = 253/266 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA++TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDK TKELVAVKYIERGDKI
Sbjct: 1 MDRATITVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKHTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILT THLAIVMEYASGGELFERI NAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTTTHLAIVMEYASGGELFERISNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPKDFRKTIQRIL VQY
Sbjct: 181 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKDFRKTIQRILGVQY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPAA 268
S+PD IS ECR LISRIF ADPA
Sbjct: 241 SIPDCVQISLECRHLISRIFEADPAT 266
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563656|ref|XP_003550077.1| PREDICTED: serine/threonine-protein kinase SRK2I-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 515 bits (1327), Expect = e-144, Method: Compositional matrix adjust.
Identities = 244/265 (92%), Positives = 254/265 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA+LTVGP MDMPIMHDSDRYD VRDIGSGNFGVARLM+DK TKELVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMQDKQTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICNAGRF+EDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNAGRFTEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQR+LSVQY
Sbjct: 181 TPAYIAPEVLLKQEYDGKLADVWSCGVTLYVMLVGAYPFEDPNEPKDFRKTIQRVLSVQY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPA 267
S+PD IS ECR LISRIFV DPA
Sbjct: 241 SIPDGVQISPECRHLISRIFVFDPA 265
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470483|ref|XP_002264172.1| PREDICTED: serine/threonine-protein kinase SRK2I isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1320), Expect = e-143, Method: Compositional matrix adjust.
Identities = 242/266 (90%), Positives = 253/266 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR++L +GP MD+PIMHDSDRYDFVRDIGSGNFG+ARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRSTLALGPIMDLPIMHDSDRYDFVRDIGSGNFGIARLMRDKLTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA+GGELFERIC AGRF EDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAAGGELFERICKAGRFIEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVL+R EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPKDFRKTIQRILSVQY
Sbjct: 181 TPAYIAPEVLMRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKDFRKTIQRILSVQY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPAA 268
S+P + IS EC LISRIFVADP A
Sbjct: 241 SIPSSVQISTECHHLISRIFVADPGA 266
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511732|ref|XP_003524577.1| PREDICTED: serine/threonine-protein kinase SAPK10-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 510 bits (1313), Expect = e-142, Method: Compositional matrix adjust.
Identities = 242/265 (91%), Positives = 252/265 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA+LTVGP MDMPIMHDSDRYD VRDIGSGNFGVARLM+DK TKELVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMQDKQTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICNAGRF+EDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNAGRFTEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSSAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQR+LSVQY
Sbjct: 181 TPAYIAPEVLLKQEYDGKLADVWSCGVTLYVMLVGAYPFEDPNEPKDFRKTIQRVLSVQY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPA 267
S+PD IS EC LISRIFV DPA
Sbjct: 241 SIPDGVQISPECGHLISRIFVFDPA 265
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1312), Expect = e-142, Method: Compositional matrix adjust.
Identities = 242/266 (90%), Positives = 253/266 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR+++TVGPAMD+PIMHDSDRY+ VRDIGSGNFGVARLMRDK T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+F KTIQRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPAA 268
S+PD IS ECR LISRIFVADPA
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPAT 266
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1312), Expect = e-142, Method: Compositional matrix adjust.
Identities = 243/265 (91%), Positives = 253/265 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR+++TVGP MDMPIMHDSDRY+ VRDIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPA 267
S+PD IS ECR LISRIFVADPA
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPA 265
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521207|ref|XP_003529248.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1312), Expect = e-142, Method: Compositional matrix adjust.
Identities = 241/265 (90%), Positives = 253/265 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR+++TVGP MDMPIMHDSD+Y+ VRDIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPA 267
S+PD IS ECR LISRIFVADPA
Sbjct: 241 SIPDYVHISSECRHLISRIFVADPA 265
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563658|ref|XP_003550078.1| PREDICTED: serine/threonine-protein kinase SRK2I-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1310), Expect = e-142, Method: Compositional matrix adjust.
Identities = 244/272 (89%), Positives = 254/272 (93%), Gaps = 7/272 (2%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA+LTVGP MDMPIMHDSDRYD VRDIGSGNFGVARLM+DK TKELVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMQDKQTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICNAGRF+EDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNAGRFTEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHS 175
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVLHS
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVSFLVLLSSVLHS 180
Query: 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
QPKSTVGTPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQ
Sbjct: 181 QPKSTVGTPAYIAPEVLLKQEYDGKLADVWSCGVTLYVMLVGAYPFEDPNEPKDFRKTIQ 240
Query: 236 RILSVQYSVPDTNPISQECRDLISRIFVADPA 267
R+LSVQYS+PD IS ECR LISRIFV DPA
Sbjct: 241 RVLSVQYSIPDGVQISPECRHLISRIFVFDPA 272
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357518557|ref|XP_003629567.1| Serine/threonine protein kinase SAPK3 [Medicago truncatula] gi|355523589|gb|AET04043.1| Serine/threonine protein kinase SAPK3 [Medicago truncatula] gi|388521379|gb|AFK48751.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1307), Expect = e-141, Method: Compositional matrix adjust.
Identities = 241/265 (90%), Positives = 251/265 (94%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA++TVGP MD+PIMHDSDRYD VRDIGSGNFG+ARLM+DK TKELVAVKYIERGDKI
Sbjct: 1 MDRAAMTVGPGMDLPIMHDSDRYDLVRDIGSGNFGIARLMQDKQTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI NAG FSEDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERISNAGHFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP PRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPTPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQR+LSVQY
Sbjct: 181 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGSYPFEDPNEPKDFRKTIQRVLSVQY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPA 267
S+PD I+ ECR LISRIFV DPA
Sbjct: 241 SIPDNVQITPECRHLISRIFVFDPA 265
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 298 | ||||||
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.899 | 0.742 | 0.896 | 7.3e-130 | |
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.895 | 0.737 | 0.877 | 1.6e-125 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.822 | 0.680 | 0.832 | 5.3e-111 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.815 | 0.673 | 0.818 | 2.1e-109 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.822 | 0.694 | 0.816 | 4.3e-109 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.818 | 0.697 | 0.799 | 1.7e-107 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.818 | 0.711 | 0.803 | 2.1e-107 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.818 | 0.719 | 0.762 | 6.9e-102 | |
| RGD|69407 | 776 | Sik1 "salt-inducible kinase 1" | 0.781 | 0.300 | 0.423 | 3.4e-46 | |
| MGI|MGI:104754 | 779 | Sik1 "salt inducible kinase 1" | 0.781 | 0.299 | 0.423 | 1.3e-45 |
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1274 (453.5 bits), Expect = 7.3e-130, P = 7.3e-130
Identities = 242/270 (89%), Positives = 257/270 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQRILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 243 SVPDTNPISQECRDLISRIFVADPAA-VSI 271
S+PD IS EC LISRIFVADPA +SI
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISI 269
|
|
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1233 (439.1 bits), Expect = 1.6e-125, P = 1.6e-125
Identities = 237/270 (87%), Positives = 254/270 (94%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 243 SVPDTNPISQECRDLISRIFVADPAA-VSI 271
++PD IS ECR LISRIFVADPA +SI
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISI 268
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1096 (390.9 bits), Expect = 5.3e-111, P = 5.3e-111
Identities = 204/245 (83%), Positives = 226/245 (92%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+D+G+GNFGVARL+R K TKELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCH++Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
DVWSCGVTLYVMLVGGYPFEDPD+P++FRKTIQRI++VQY +PD ISQECR L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRIF 241
Query: 263 VADPA 267
V + A
Sbjct: 242 VTNSA 246
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 2.1e-109, P = 2.1e-109
Identities = 199/243 (81%), Positives = 226/243 (93%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+DIG+GNFGVARLMR K +KELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
DVWSCGVTLYVMLVG YPFED ++PK+F+KTIQRI++V+Y +PD ISQ+C+ L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIF 241
Query: 263 VAD 265
V +
Sbjct: 242 VTN 244
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
Identities = 200/245 (81%), Positives = 224/245 (91%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+YD V+D+G+GNFGVARL+R K TKELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct: 2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCH++Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
DVWSCGVTLYVMLVG YPFEDP++PK+FRKTIQRI++VQY +PD ISQEC+ L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRIF 241
Query: 263 VADPA 267
V + A
Sbjct: 242 VTNSA 246
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1063 (379.3 bits), Expect = 1.7e-107, P = 1.7e-107
Identities = 195/244 (79%), Positives = 221/244 (90%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RYD +RD+GSGNFGVA+L+R+K E AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct: 2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL R EY+GKIA
Sbjct: 122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
DVWSCGVTLYVMLVG YPFEDP++P++ R TIQRILSV Y++PD IS EC+ L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRIF 241
Query: 263 VADP 266
VADP
Sbjct: 242 VADP 245
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1062 (378.9 bits), Expect = 2.1e-107, P = 2.1e-107
Identities = 196/244 (80%), Positives = 222/244 (90%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RY+ V+DIGSGNFGVA+L+RDK +KEL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCH++Q+CH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL EYDGKIA
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
DVWSCGVTLYVMLVG YPFEDP +PKDFRKTI RIL QY++PD +S ECR L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIF 241
Query: 263 VADP 266
VA+P
Sbjct: 242 VANP 245
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1010 (360.6 bits), Expect = 6.9e-102, P = 6.9e-102
Identities = 186/244 (76%), Positives = 214/244 (87%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
++Y+ V+D+G GNFG+ARLMR+K T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct: 2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y HA+Q+CH
Sbjct: 62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV R EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
DVWSCGV LYVMLVG YPFEDP +P++FRKT+Q+I++V Y +P IS++CR L+SRIF
Sbjct: 182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRIF 241
Query: 263 VADP 266
VA+P
Sbjct: 242 VANP 245
|
|
| RGD|69407 Sik1 "salt-inducible kinase 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 470 (170.5 bits), Expect = 3.4e-46, Sum P(2) = 3.4e-46
Identities = 105/248 (42%), Positives = 149/248 (60%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPN 80
YD R +G GNF V +L R +VTK VA+K I++ ++D E + RE+ + L HPN
Sbjct: 27 YDVERTLGKGNFAVVKLARHRVTKTQVAIKIIDK-TRLDSSNLEKIYREVQLMKLLNHPN 85
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
I++ +V+ T L IV E+A GE+F+ + + G SE+EAR F Q++S V YCH +
Sbjct: 86 IIKLYQVMETKDMLYIVTEFAKNGEMFDYLTSNGHLSENEARKKFWQILSAVEYCHNHHI 145
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
HRDLK EN LLDG+ +K+ DFG+ + +P ST G+P Y APEV EY+G
Sbjct: 146 VHRDLKTENLLLDGNMD--IKLADFGFG-NFYKPGEPLSTWCGSPPYAAPEVFEGKEYEG 202
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
D+WS GV LYV++ G PF+ P+ P R QR+L ++ +P +SQ+C LI
Sbjct: 203 PQLDIWSLGVVLYVLVCGSLPFDGPNLPT-LR---QRVLEGRFRIPFF--MSQDCETLIR 256
Query: 260 RIFVADPA 267
R+ V DPA
Sbjct: 257 RMLVVDPA 264
|
|
| MGI|MGI:104754 Sik1 "salt inducible kinase 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 465 (168.7 bits), Expect = 1.3e-45, Sum P(2) = 1.3e-45
Identities = 105/248 (42%), Positives = 148/248 (59%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPN 80
YD R +G GNF V +L R +VTK VA+K I++ ++D E + RE+ + L HPN
Sbjct: 27 YDVERTLGKGNFAVVKLARHRVTKTQVAIKIIDK-TRLDSSNLEKIYREVQLMKLLNHPN 85
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
I++ +V+ T L IV E+A GE+F+ + + G SE+EAR F Q++S V YCH +
Sbjct: 86 IIKLYQVMETKDMLYIVTEFAKNGEMFDYLTSNGHLSENEARQKFWQILSAVEYCHNHHI 145
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
HRDLK EN LLD + +K+ DFG+ + +P ST G+P Y APEV EY+G
Sbjct: 146 VHRDLKTENLLLDSNMD--IKLADFGFG-NFYKPGEPLSTWCGSPPYAAPEVFEGKEYEG 202
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
DVWS GV LYV++ G PF+ P+ P R QR+L ++ +P +SQ+C LI
Sbjct: 203 PQLDVWSLGVVLYVLVCGSLPFDGPNLPT-LR---QRVLEGRFRIPFF--MSQDCETLIR 256
Query: 260 RIFVADPA 267
R+ V DPA
Sbjct: 257 RMLVVDPA 264
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2ZAB5 | SAPK3_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8040 | 0.8221 | 0.7335 | N/A | no |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.8510 | 0.7885 | 0.7078 | N/A | no |
| Q39193 | SRK2I_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9022 | 0.8892 | 0.7340 | yes | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8565 | 0.8187 | 0.7197 | N/A | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8984 | 0.8926 | 0.7348 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00009710001 | SubName- Full=Chromosome undetermined scaffold_245, whole genome shotgun sequence; (361 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | GSVIVG00017286001 | SubName- Full=Chromosome chr6 scaffold_15, whole genome shotgun sequence; (208 aa) | • | 0.414 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 298 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-93 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-81 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-62 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-61 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-57 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-53 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-49 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-44 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-44 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-43 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-42 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-42 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-41 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-41 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-39 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-39 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-38 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-38 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-37 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-37 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-37 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-37 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-37 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-37 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-37 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-36 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-36 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-36 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-36 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-35 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-35 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-35 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-35 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-34 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-34 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-34 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-34 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-33 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-33 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-33 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-33 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-33 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-33 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-32 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-32 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-32 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-32 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-31 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-30 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-30 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-29 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-29 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-28 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-28 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-27 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-27 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-27 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-25 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-25 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-25 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-25 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-25 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-24 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-24 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-24 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-22 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-22 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-21 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-20 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-19 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 275 bits (707), Expect = 4e-93
Identities = 99/246 (40%), Positives = 140/246 (56%), Gaps = 9/246 (3%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 82
Y+ + +G G+FG L RDK T +LVA+K I ++ K E + REI + L+HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
R +V L +VMEY GG+LF+ + GR SEDEARF+ +Q++S + Y H+ + H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVLL Y +
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPISQECRDLISRI 261
D+WS GV LY +L G PF D+ + ++I + P IS E +DLI ++
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 262 FVADPA 267
V DP
Sbjct: 235 LVKDPE 240
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 6e-81
Identities = 101/249 (40%), Positives = 140/249 (56%), Gaps = 9/249 (3%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 81
Y+ +R +GSG+FG + K T ++VAVK + K D+ +REI R L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR + HL +VMEY GG+LF+ + G SEDEA+ Q++ G+ Y H+ +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGK 200
HRDLK EN LLD + +KI DFG +K + S +T VGTP Y+APEVLL G
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTNPISQECRDLI 258
DVWS GV LY +L G PF + D + I+RIL +++ P + S+E +DLI
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENIL-DQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 259 SRIFVADPA 267
+ DP+
Sbjct: 238 KKCLNKDPS 246
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 1e-62
Identities = 85/214 (39%), Positives = 117/214 (54%), Gaps = 18/214 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 88
+G G FG L RDK T + VA+K I++ D E + REI + L HPNIV+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 89 LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
HL +VMEY GG L + + N G+ SEDE Q++ G+ Y H+ + HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 148 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVLL Y + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
GV LY + + + I+++L
Sbjct: 180 LGVILYEL-------------PELKDLIRKMLQK 200
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 193 bits (494), Expect = 7e-61
Identities = 84/254 (33%), Positives = 133/254 (52%), Gaps = 20/254 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
+Y+ ++ IG G+FG L+R K +L +K I +K E+ E+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 136
I+++ E L IVMEYA GG+L ++I + F E++ +F QL + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
+ ++ HRD+K +N L +K+ DFG SK S+V + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
Y+ K +D+WS G LY + +PFE ++ + +IL QY P + S E
Sbjct: 177 NKPYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILKGQYP-PIPSQYSSE 230
Query: 254 CRDLISRIFVADPA 267
R+L+S + DP
Sbjct: 231 LRNLVSSLLQKDPE 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 5e-58
Identities = 92/244 (37%), Positives = 129/244 (52%), Gaps = 18/244 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
+G G+FG L+R K T +L A+K +++ I + R+ + HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T L +V+EYA GGELF + GRFSE+ ARF+ +++ + Y H++ + +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 147 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL Y GK D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263
WS GV LY ML G PF D + ++IL P+ +S E RDLIS +
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFPEF--LSPEARDLISGLLQ 229
Query: 264 ADPA 267
DP
Sbjct: 230 KDPT 233
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 6e-57
Identities = 83/247 (33%), Positives = 125/247 (50%), Gaps = 18/247 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRFK-- 85
+G G+FG L DK T EL+AVK +E +E + +REI SL+HPNIVR+
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
E L I +EY SGG L + G+ E R + +Q++ G++Y H+ + HRD+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127
Query: 146 KLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
K N L+D +K+ DFG +K S GTP ++APEV +R E G+ A
Sbjct: 128 KGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRGEEYGRAA 184
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISR 260
D+WS G T+ M G P+ + P + +I S +P+ +S+E +D + +
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNPMAA---LYKIGSSGEPPEIPEH--LSEEAKDFLRK 239
Query: 261 IFVADPA 267
DP
Sbjct: 240 CLRRDPK 246
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 7e-53
Identities = 89/256 (34%), Positives = 143/256 (55%), Gaps = 29/256 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQRE-IINHR----SLR 77
D ++F++ +G+G+FG L+R K + + A+K + + KI + Q E ++N + S+R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59
Query: 78 HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
HP +V F++ ++L +VMEY GGELF + +GRF E ARF+ Q++ +
Sbjct: 60 HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
Y H++ + +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
+L Y GK D W+ G+ +Y ML G PF D D P + ++IL + P + S
Sbjct: 170 ILSKGY-GKAVDWWALGILIYEMLAGYPPFFD-DNP---IQIYEKILEGKVRFP--SFFS 222
Query: 252 QECRDLISRIFVADPA 267
+ +DLI + D
Sbjct: 223 PDAKDLIRNLLQVDLT 238
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 4e-51
Identities = 83/273 (30%), Positives = 130/273 (47%), Gaps = 45/273 (16%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 78
+ F + IG G+F L ++K T + A+K + + K+ +++E++ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61
Query: 79 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
P I++ F++ +L V+EYA GEL + I G E RF+ +++ + Y
Sbjct: 62 PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 173
H+ + HRDLK EN LLD +KI DFG +K
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233
+ S VGT Y++PE LL + GK +D+W+ G +Y ML G PF +E T
Sbjct: 176 RRRFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LT 230
Query: 234 IQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
Q+IL ++YS P P + +DLI ++ V DP
Sbjct: 231 FQKILKLEYSFPPNFP--PDAKDLIEKLLVLDP 261
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 2e-49
Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 12/247 (4%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 83
++ + IG G FG R K T + VA+K I + E + EI + +HPNIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCH 142
+ L L IVME+ SGG L + + + + +E + + ++L+ G+ Y H+ + H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
RD+K N LL DG +K+ DFG S + VGTP ++APEV+ YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
AD+WS G+T + G P+ + K K + + + S E +D + +
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKK 233
Query: 261 IFVADPA 267
+P
Sbjct: 234 CLQKNPE 240
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 3e-49
Identities = 84/249 (33%), Positives = 125/249 (50%), Gaps = 20/249 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 86
I G +G L + K T ++ A+K I++ D I +N +++ R + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+L +VMEY GG+L + N G ED AR + +++ + Y H+ + HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 147 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+N L+D + LK+ DFG SK + + K VGTP YIAPEV+L +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
K D WS G LY LVG PF + P + Q IL+ + P+ +S E DL
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHG-ETP---EEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 258 ISRIFVADP 266
IS++ V DP
Sbjct: 234 ISKLLVPDP 242
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 1e-44
Identities = 91/267 (34%), Positives = 133/267 (49%), Gaps = 28/267 (10%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 79
Y +R +G G+FG L RD+ +LVA+K + + + REI SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 136
NIV+ + L +VMEY GG L + + G SE EA F Q++S + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 189
+ + HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 190 EVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------- 240
EVLL Y +D+WS G+TLY +L G PFE +T++ IL +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 241 QYSVPDTNPISQECRDLISRIFVADPA 267
S + IS+ DL+ ++ DP
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPK 264
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-44
Identities = 79/252 (31%), Positives = 128/252 (50%), Gaps = 16/252 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ Y + IG G G D+ T + VA+K + + E + EI+ + +HPNI
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V + + L L +VMEY GG L + I N R +E + + ++++ G+ Y H+ V
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K +N LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+ R +Y
Sbjct: 138 IHRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 198 DGKIADVWSCGVTLYVMLVGGYP--FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
K+ D+WS G+ M G P +P F T + I ++ + S E +
Sbjct: 194 GPKV-DIWSLGIMCIEM-AEGEPPYLREPPLRALFLITTKGIPPLK----NPEKWSPEFK 247
Query: 256 DLISRIFVADPA 267
D +++ V DP
Sbjct: 248 DFLNKCLVKDPE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 6e-43
Identities = 84/280 (30%), Positives = 129/280 (46%), Gaps = 43/280 (15%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
+ ++ +G G+ G L+R K T +L A+K +++ + I N ++EI+ +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 134
HP + T T+L +VM+Y GGELF + SE+ ARF+ +++ + Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 135 CHAMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 177
H + + +RDLK EN LL S P P K G +SSV
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 178 -----------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
S VGT YIAPEV+ + + D W+ G+ LY ML G PF+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG--- 234
Query: 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
+ +T IL + + P + P+S RDLI ++ V DP
Sbjct: 235 -SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDP 273
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 88/245 (35%), Positives = 128/245 (52%), Gaps = 22/245 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 82
+G G FG L+R+K T + A+K I + + I + ++ + H ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
K T L VMEYA+GGELF + FSED ARF+ +++S + Y H+ V +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKI 201
RDLKLEN +LD +KI DFG K + T GTP Y+APEVL ++Y G+
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRA 175
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
D W GV +Y M+ G PF + D K F + IL + P T +S E + L++ +
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEAKSLLAGL 229
Query: 262 FVADP 266
DP
Sbjct: 230 LKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 5e-42
Identities = 80/256 (31%), Positives = 123/256 (48%), Gaps = 34/256 (13%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGD-KIDENVQREIINHRSLRHPNIVRFKEV 87
IG G FG + T EL+AVK I + D K + + E+ L+HPN+V++ V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHAMQVCHRDL 145
+ + I MEY SGG L E + GR DE R + QL+ G++Y H+ + HRD+
Sbjct: 68 EVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 146 KLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
K N LD + +K+ DFG + ++ + + +S GTPAY+APEV+ + G
Sbjct: 126 KPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183
Query: 201 I--ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--------PDTNPI 250
AD+WS G + M G P+ + D + + V PD+ +
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWSELDNE----------FQIMFHVGAGHKPPIPDSLQL 233
Query: 251 SQECRDLISRIFVADP 266
S E +D + R +DP
Sbjct: 234 SPEGKDFLDRCLESDP 249
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 9e-42
Identities = 86/289 (29%), Positives = 128/289 (44%), Gaps = 67/289 (23%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y+ + +G G +GV RDK T E+VA+K I R D +E + REI + L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQ 139
IV+ +VI T L +V EY +L + + G S + + QL+ G++YCH+ +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLR- 194
+ HRDLK +N L++ LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 195 HEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED--PD------- 225
Y + D+WS G M+ G G P E+ P
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 226 -------EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
PKD K + R + E DL+S++ +PA
Sbjct: 233 KPTFPKFPPKDLEKVLPR-------------LDPEGIDLLSKMLQYNPA 268
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 73/234 (31%), Positives = 115/234 (49%), Gaps = 9/234 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
+G G FG L++ K A+K +++ ++ Q I + + HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
++ ++MEY GGEL+ + + G F E ARF+ ++ Y H + +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
EN LLD + +K+ DFG++K + + GTP Y+APE++L YD D WS
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
G+ LY +L G PF + DE D + IL + N I + +DLI +
Sbjct: 178 LGILLYELLTGRPPFGEDDE--DPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 88/242 (36%), Positives = 125/242 (51%), Gaps = 15/242 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 85
+G G+FG L K T EL AVK +++ + D++V+ + R L +HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L VMEY +GG+L I +GRF E ARF+ +++ G+ + H + +RDL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
KL+N LLD +KI DFG K +L ST GTP YIAPE+L Y G D
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264
W+ GV LY ML G PFE DE + F Q IL + P +S+E + ++
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYPRW--LSKEAKSILKSFLTK 233
Query: 265 DP 266
+P
Sbjct: 234 NP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 7e-40
Identities = 90/282 (31%), Positives = 128/282 (45%), Gaps = 48/282 (17%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RH 78
D ++ ++ IG G FG L+RDK T ++ A+K + + D I N + R +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 79 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
P IV+ F++ HL +VMEY GG+L + F E+ ARF+ +L+ +
Sbjct: 61 PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 169
H + HRD+K +N L+D +K+ DFG K
Sbjct: 117 VHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 170 -SSVLHSQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
H Q + STVGTP YIAPEVL Y + D WS GV LY ML G PF
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD 233
Query: 225 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
+ + K I S+++ P P+S E DLI R + DP
Sbjct: 234 TLQETYNKIINWKESLRF--PPDPPVSPEAIDLICR-LLCDP 272
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 78/247 (31%), Positives = 116/247 (46%), Gaps = 14/247 (5%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 85
V+ +G G+ GV +R K T ++ A+K I + Q RE+ RS P +V+
Sbjct: 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRD 144
++IV+EY GG L + + G+ E + +Q++ G+ Y H + HRD
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRD 125
Query: 145 LKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKI 201
+K N L+ G KI DFG SK +T VGT Y++PE ++ E
Sbjct: 126 IKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYA 180
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTNPISQECRDLISR 260
AD+WS G+TL +G +PF P +P F + +Q I S+P S E RD IS
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPA-EEFSPEFRDFISA 238
Query: 261 IFVADPA 267
DP
Sbjct: 239 CLQKDPK 245
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 79/248 (31%), Positives = 131/248 (52%), Gaps = 17/248 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
D + ++ +G+G FG L+RD++++ A+K + + I ++V E + + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P I+R L ++MEY GGELF + N+GRFS F+ +++ + Y H+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
++ +RDLK EN LLD +K+ DFG++K L + + GTP Y+APEV+ +
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT-NPISQECRDL 257
K D W+ G+ +Y MLVG PF D D P ++IL+ + P + + +DL
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD-DNPFGI---YEKILAGKLEFPRHLDLYA---KDL 228
Query: 258 ISRIFVAD 265
I ++ V D
Sbjct: 229 IKKLLVVD 236
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-39
Identities = 77/258 (29%), Positives = 122/258 (47%), Gaps = 31/258 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
+ + + IG G+FG DK T ++VA+K I E D+I++ +Q+EI R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
I ++ L + L I+MEY GG + + G+ E F ++++ G+ Y H
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ +
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------PKDFRKTIQRILSVQYSVPDTNP 249
YD K AD+WS G+T + G P D PK+ +++ N
Sbjct: 175 YDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG-----------NK 222
Query: 250 ISQECRDLISRIFVADPA 267
S+ +D +S DP
Sbjct: 223 FSKPFKDFVSLCLNKDPK 240
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-39
Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPN 80
Y+ + IG G+FG R +R K +++ K I+ G + E ++++++ R L+HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60
Query: 81 IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 134
IVR+ + + + L IVMEY GG+L + I E+ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 135 CH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 188
CH V HRDLK N LD + +K+ DFG +K S T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
PE L YD K +D+WS G +Y + PF
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-38
Identities = 82/248 (33%), Positives = 120/248 (48%), Gaps = 28/248 (11%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEV 87
IG G FGV + T + VA+K I +E + +EI ++L+HPNIV++
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
I T L I++EYA G L + I G F E + Q++ G++Y H V HRD+K
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKA 127
Query: 148 ENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
N L DG +K+ DFG + K + + S VGTP ++APEV+ +D+
Sbjct: 128 ANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA-SDI 182
Query: 205 WSCGVTLYVMLVGGYPFEDPDE-PKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLI 258
WS G T+ +L G P+ D + FR I V D +P IS E +D +
Sbjct: 183 WSLGCTVIELLTGNPPYYDLNPMAALFR--I---------VQDDHPPLPEGISPELKDFL 231
Query: 259 SRIFVADP 266
+ F DP
Sbjct: 232 MQCFQKDP 239
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-38
Identities = 72/248 (29%), Positives = 121/248 (48%), Gaps = 14/248 (5%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPN 80
++ +R IG G FG +++ + TK++ A+KY+ + +++ R ++N R L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V ++ +V++ GG+L + +FSE++ +F+ +++ + Y H+ +
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
HRD+K +N LLD + I DF + + ST GTP Y+APEVL R Y
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SV 178
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI--SQECRDLI 258
D WS GVT Y L G P+ R +I + Q + P S E D I
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHS-----RTIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 259 SRIFVADP 266
+++ DP
Sbjct: 234 NKLLERDP 241
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-38
Identities = 84/252 (33%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPN 80
+ + +G G +G L + K T E+VA+K +++ N R ++ R + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V+ +L + MEY GG+ + N G SED ARF+ ++ V H +
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
HRDLK EN L+D S +K+ DFG SK V + S VG+P Y+APEVL YD
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 201 IADVWSCGVTLYVMLVGGYPF--EDPDEP----KDFRKTIQRILSVQYSVPDTNPISQEC 254
+ D WS G LY L G PF P+E K +++T+QR + P N +S E
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD---PRFN-LSDEA 233
Query: 255 RDLISRIFVADP 266
DLI+++ + DP
Sbjct: 234 WDLITKL-INDP 244
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 36/275 (13%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 81
Y + IG G +GV RDK+T E+VA+K I+ + I + REI + L HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQV 140
++ +V L +V E+ +L++ I + R E + + QL+ G+++CH+ +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLRHEY 197
HRDLK EN L++ LK+ DFG ++S S + V T Y APE+LL +
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------PKDFRKTIQRILSVQY 242
D+WS G +L F E P+ + K + ++
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 243 SVPDTNPI---------SQECRDLISRIFVADPAA 268
S P + S + DL+S++ DP
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 78/234 (33%), Positives = 117/234 (50%), Gaps = 15/234 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 85
IG G+FG L + K + AVK +++ + + Q+ I+ R+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
K EN LLD L DFG K + HS+ ST GTP Y+APEVL + YD + D
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
W G LY ML G PF D + + + + L ++ + IS R L+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN------ISVSARHLL 227
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
RY + IG G G+ +D+ T E VA+K + I REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
+V+ +V + +VMEY +L E + + R E + + + + L+ GV+Y HA
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-RHE 196
+ HRDLK N L+ S LKI DFG ++ S V T Y APE+L +
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 197 YDGKIADVWSCGVTLYVMLVGG 218
YD + D+W+ G +L G
Sbjct: 178 YDPGV-DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 90/248 (36%), Positives = 131/248 (52%), Gaps = 27/248 (10%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 84
+G G+FG L K T E A+K +++ D + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
T HL VMEY +GG+L I ++GRF E ARF+ ++I G+ + H + +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIAD 203
LKL+N LLD +KI DFG K ++ ST GTP YIAPE+L +Y+ + D
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-D 178
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLI 258
WS GV LY ML+G PF DE + F S+ + P IS+E +D +
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELF-----------DSILNDRPHFPRWISKEAKDCL 227
Query: 259 SRIFVADP 266
S++F DP
Sbjct: 228 SKLFERDP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 85/241 (35%), Positives = 126/241 (52%), Gaps = 14/241 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
+G G FG L+R+K T A+K + + I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T L VMEYA+GGELF + F+E+ ARF+ +++S + Y H+ V +RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 205
LEN +LD +KI DFG K + + K+ GTP Y+APEVL ++Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
GV +Y M+ G PF + D + F + IL + P T +S E + L++ + D
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPRT--LSPEAKSLLAGLLKKD 233
Query: 266 P 266
P
Sbjct: 234 P 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 4e-37
Identities = 85/241 (35%), Positives = 127/241 (52%), Gaps = 14/241 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
+G G FG L+R+K + + A+K +++ I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T L VMEY +GGELF + FSED RF+ +++S + Y H+ ++ +RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVW 205
LEN +LD +KI DFG K + + K+ GTP Y+APEVL ++Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
GV +Y M+ G PF + D K F + IL P T +S + + L+S + + D
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEDIKFPRT--LSADAKSLLSGLLIKD 233
Query: 266 P 266
P
Sbjct: 234 P 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-37
Identities = 81/241 (33%), Positives = 121/241 (50%), Gaps = 14/241 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 86
IG G+FG +R + T+ + A+K I + + + + R++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+P L +V+ + +GGELF + GRF ARF+ +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVW 205
EN LLD + +CDFG K ++ +T GTP Y+APE+LL H Y K D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
+ GV LY ML G PF D + + +RK +Q L PD ++ +DL+ + D
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL----RFPDG--FDRDAKDLLIGLLSRD 231
Query: 266 P 266
P
Sbjct: 232 P 232
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-36
Identities = 86/249 (34%), Positives = 126/249 (50%), Gaps = 12/249 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 80
+Y+ +R +G G FG+ L R K ++LV +K I E+ K + Q E + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM 138
I+ + E L L IVMEYA GG L E I ED FF Q++ + + H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
K +D+W+ G LY + FE + P + +I+S ++ P ++ S + R LI
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFEAANLP----ALVLKIMSGTFA-PISDRYSPDLRQLI 233
Query: 259 SRIFVADPA 267
+ DP+
Sbjct: 234 LSMLNLDPS 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 88/242 (36%), Positives = 128/242 (52%), Gaps = 15/242 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
+G G FG L+++K T A+K +++ + + V + +R L RHP + K
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDL 145
T L VMEYA+GGELF + FSED ARF+ +++S + Y H+ V +RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
KLEN +LD +KI DFG K + + K+ GTP Y+APEVL ++Y G+ D
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264
W GV +Y M+ G PF + D K F + IL + P T +S E + L+S +
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEAKSLLSGLLKK 233
Query: 265 DP 266
DP
Sbjct: 234 DP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-36
Identities = 86/268 (32%), Positives = 130/268 (48%), Gaps = 33/268 (12%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 80
IGSG+FG L + + EL+AVK +E R + + + REI + L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV++ L HL I +EY GG + + N G F E R F +Q++ G++Y H +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 193
HRD+K N L+D +KI DFG SK S+ + S G+ ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPD-TNPIS 251
+ Y K AD+WS G + ML G +PF D + +Q I + + + P+ + IS
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQ-------LQAIFKIGENASPEIPSNIS 237
Query: 252 QECRDLISRIFVAD----PAAVSIFFFP 275
E D + + F D P A + P
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHP 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 6e-36
Identities = 78/240 (32%), Positives = 123/240 (51%), Gaps = 15/240 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
+G+G+FG R+ + K T E A+K +++ + + + + +S L HP IV
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+ ++E+ GGELF + AGRF D A+F+ +L+ Y H+ + +RDLK
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLK 145
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
EN LLD +K+ DFG++K + + + GTP Y+APEV ++ + GK D W+
Sbjct: 146 PENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEV-IQSKGHGKAVDWWT 200
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
GV LY + G PF D D P FR ++IL+ + P N RDL+ + D
Sbjct: 201 MGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFP--NWFDGRARDLVKGLLQTDH 254
|
Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-35
Identities = 83/243 (34%), Positives = 126/243 (51%), Gaps = 17/243 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 85
+G G+FG L K E AVK +++ ID++V+ ++ R L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T HL VME+ +GG+L I + GRF A F+ +++ G+ + H+ + +RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
KL+N +LD +KI DFG K +V ST GTP YIAPE+L +Y + D
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFV 263
WS GV LY ML+G PF DE + F S++ P I++E +D++ ++F
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFE-------SIRVDTPHYPRWITKESKDILEKLFE 232
Query: 264 ADP 266
DP
Sbjct: 233 RDP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-35
Identities = 74/200 (37%), Positives = 108/200 (54%), Gaps = 19/200 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+ Y+ ++ IGSG +G RD T ELVA+K I E GD + +Q+EI + RHPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQ 139
IV + L L IVMEY GG L + G SE + + ++ + G++Y H
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 192
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175
Query: 193 -LRHEYDGKIADVWSCGVTL 211
+ YDGK D+W+ G+T
Sbjct: 176 ERKGGYDGK-CDIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 71/204 (34%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKY---IERGDKIDENVQREIINHRSLRHP 79
++Y+ + +G G +GV R+K T E+VA+K E + + + RE+ R LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV KE L +V EY EL E + G D R + QL+ ++YCH+
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 193
+ HRD+K EN L+ S + LK+CDFG++++ L ++P S V T Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174
Query: 194 RHEYDGKIADVWSCGVTLYVMLVG 217
GK DVW+ G + +L G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 80/208 (38%), Positives = 109/208 (52%), Gaps = 12/208 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 83
+G G+FG L K T EL A+K +++GD I + V+ + R S RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T H+ VMEYA+GG+L I + FSE A F+ ++ G+ Y H ++ +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
DLKL+N LLD +KI DFG K + ST GTP ++APEVL Y +
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDF 230
D W GV +Y MLVG PF DE + F
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVF 210
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 85/250 (34%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RH 78
++F+ +G G+FG L K T EL A+K I + D I D++V+ ++ R L +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + + T L VMEY +GG+L I G+F E A F+ ++ G+ + H+
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
+ +RDLKL+N +LD +KI DFG K ++ + T GTP YIAPE++ Y
Sbjct: 121 GIIYRDLKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
GK D W+ GV LY ML G PF+ DE + F Q I+ S P + +S+E +
Sbjct: 179 -GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYPKS--LSKEAVSI 231
Query: 258 ISRIFVADPA 267
+ PA
Sbjct: 232 CKGLLTKHPA 241
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 9e-35
Identities = 82/247 (33%), Positives = 130/247 (52%), Gaps = 25/247 (10%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 85
+G G+FG L K T + A+K +++ + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T +L VMEY +GG+L I + +F A F+ ++I G+ + H+ + +RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
KL+N LLD +KI DFG K ++L T GTP YIAPE+LL +Y+ + D
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLIS 259
WS GV LY ML+G PF DE + F+ S+ NP +++E +D++
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQ-----------SIRMDNPCYPRWLTREAKDILV 228
Query: 260 RIFVADP 266
++FV +P
Sbjct: 229 KLFVREP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 1e-34
Identities = 74/209 (35%), Positives = 112/209 (53%), Gaps = 10/209 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 83
IG G FG +R K T+ + A+K + + + + + +R I+ L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
K T + L +V +Y SGGELF + GRFSED A+F+ +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
DLK EN LLD + + +CDFG SK+++ ++ +T GT Y+APEVLL + K
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
D WS GV ++ M G PF D + +R
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 79/254 (31%), Positives = 141/254 (55%), Gaps = 24/254 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
+Y V+ IG G+FG A L++ K + +K I + K E ++E+ +++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA 137
IV+++E +L IVM+Y GG+L+++I NA R F ED+ +F Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 192
++ HRD+K +N L DG+ +K+ DFG ++ VL+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEIC 173
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
Y+ K +D+W+ G LY M + F E + + + +I+ Y P ++ S
Sbjct: 174 ENRPYNNK-SDIWALGCVLYEMCTLKHAF----EAGNMKNLVLKIIRGSYP-PVSSHYSY 227
Query: 253 ECRDLISRIFVADP 266
+ R+L+S++F +P
Sbjct: 228 DLRNLVSQLFKRNP 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 71/195 (36%), Positives = 102/195 (52%), Gaps = 20/195 (10%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 78
Y ++ +G G FG L R+K T ELVA+K +++ +E + RE+ +SLR H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 136
PNIV+ KEV L V EY G L++ + FSE R Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 194
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+LLR
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172
Query: 195 H-EYDGKIADVWSCG 208
Y + D+W+ G
Sbjct: 173 STSYSSPV-DIWALG 186
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 84/246 (34%), Positives = 131/246 (53%), Gaps = 19/246 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
++F+ +G G+FG L K T EL A+K +++ I D++V+ ++ R L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + T L VMEY +GG+L +I GRF E A F+ ++ G+ + H+
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYD 198
+ +RDLKL+N +LD +KI DFG K ++ K+ GTP YIAPE++ Y
Sbjct: 122 IIYRDLKLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY- 178
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE----C 254
GK D W+ GV LY ML G PFE DE + F Q I+ + P + +S+E C
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYPKS--MSKEAVAIC 232
Query: 255 RDLISR 260
+ L+++
Sbjct: 233 KGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-34
Identities = 81/250 (32%), Positives = 127/250 (50%), Gaps = 22/250 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRS 75
++ +D ++ IG G FG +L+R K +K++ A+K + + + I + +R+I+ H +
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
IV+ +L +VMEY GG+L + N E ARF+ +++ +
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 191
H+M HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214
Query: 192 LLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
L Y G+ D WS GV LY MLVG PF + K + S+ + PD
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDI 272
Query: 249 PISQECRDLI 258
IS++ +DLI
Sbjct: 273 EISKQAKDLI 282
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 66/255 (25%), Positives = 103/255 (40%), Gaps = 25/255 (9%)
Query: 27 FVRDIGSGNFGVARL----MRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
+ +G G FG + + VAVK + + D ++ ++ RE R L HP
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV+ V L IVMEY GG+L + R S + F Q+ G+ Y +
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 192
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 122 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESL 176
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
++ K +DVWS GV L+ + G + + +++ Y +P
Sbjct: 177 KEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG----YRLPKPPNCPP 231
Query: 253 ECRDLISRIFVADPA 267
E L+ + + DP
Sbjct: 232 ELYKLMLQCWAEDPE 246
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 75/221 (33%), Positives = 107/221 (48%), Gaps = 13/221 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 85
IG G+FG L + K AVK +++ + + Q I+ R +L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
K EN LLD + + DFG K V + ST GTP Y+APEVL + YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
W G LY ML G PF +D + IL +P
Sbjct: 180 WCLGAVLYEMLYGLPPFYS----RDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 75/245 (30%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 84
+G G FG L D T +AVK + + ++ EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
+ L+I MEY GG + +++ G +E R + +Q++ GV Y H+ + HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGK 200
+K N L D A +K+ DFG SK + S KS GTP +++PEV+ Y G+
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GR 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKD--FRKTIQRILSVQYSVPDTNPISQECRDLI 258
ADVWS G T+ ML P+ + E F+ Q +P +S + R+ +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIATQ---PTNPQLPSH--VSPDARNFL 240
Query: 259 SRIFV 263
R FV
Sbjct: 241 RRTFV 245
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 36/270 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
+ ++ ++ I +G +G L+R K T++ A+K I + + I N V+R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
+P +V T HL +VMEY GG+ + N G D AR +F + + + Y H
Sbjct: 60 -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 180
+ HRDLK +N L+ + +K+ DFG SK ++ K
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRIL 238
GTP YIAPEV+LR Y GK D W+ G+ LY LVG PF + P+E F + I
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI---- 229
Query: 239 SVQYSVPDTN-PISQECRDLISRIFVADPA 267
S P+ + + + +DLISR+ +P
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPL 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 77/245 (31%), Positives = 110/245 (44%), Gaps = 15/245 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 84
+G G FG + K T ++ A K ++ R + +++I+ S R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCH 142
T L +VM +GG+L I N G F E A F+ Q+I G+ + H ++ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLK EN LLD R I D G + + K GTP Y+APEVL YD
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
D ++ G TLY M+ G PF E + + +R L + PD S E +DL +
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF--SPEAKDLCEALL 233
Query: 263 VADPA 267
DP
Sbjct: 234 QKDPE 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 83/246 (33%), Positives = 129/246 (52%), Gaps = 19/246 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
++F+ +G G+FG L K T EL A+K +++ I D++V+ ++ R L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + T L VMEY +GG+L I G+F E +A F+ ++ G+ + H
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
+ +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ Y
Sbjct: 122 IIYRDLKLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY- 178
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE----C 254
GK D W+ GV LY ML G PF+ DE + F Q I+ S P + +S+E C
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYPKS--LSKEAVSIC 232
Query: 255 RDLISR 260
+ L+++
Sbjct: 233 KGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 5e-33
Identities = 86/246 (34%), Positives = 125/246 (50%), Gaps = 17/246 (6%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 82
R +G G+FG L R K + L AVK +++ D I D++V+ + R L HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ TP L VME+ +GG+L I + RF E ARF+ ++ S + + H + +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKI 201
RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L Y G
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPS 176
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
D W+ GV LY ML G PFE +E F + IL+ + P +SQ+ D++
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYPTW--LSQDAVDILKAF 230
Query: 262 FVADPA 267
+P
Sbjct: 231 MTKNPT 236
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-33
Identities = 79/252 (31%), Positives = 123/252 (48%), Gaps = 27/252 (10%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR--------HP 79
++ I G FG L + + T + A+K +++ D I +N ++ N ++ R P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN---QVTNVKAERAIMMIQGESP 57
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + + +L +VMEY +GG+ I G ED A+ + +++ GV H
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ HRD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L D
Sbjct: 118 IIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DD 171
Query: 200 KIADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECR 255
K++D WS G ++ L G PF E PD ILS + + P+ S E
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRRINWPEEVKEFCSPEAV 225
Query: 256 DLISRIFVADPA 267
DLI+R+ DPA
Sbjct: 226 DLINRLLCMDPA 237
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 86/294 (29%), Positives = 134/294 (45%), Gaps = 67/294 (22%)
Query: 26 DF--VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLR----- 77
DF ++ IG G FG RL++ K T + A+K + + + + ++E + H R+ R
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILAE 57
Query: 78 --HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
+P +V+ +L ++MEY GG++ + F+E+E RF+ + I +
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVLH 174
H + HRD+K +N LLD +K+ DFG
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 175 SQPK------------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216
S+P STVGTP YIAPEV L+ Y K D WS GV +Y MLV
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLV 234
Query: 217 GGYPF--EDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADP 266
G PF ++P E T ++I++ + ++ PD P+S E +DLI R +
Sbjct: 235 GYPPFCSDNPQE------TYRKIINWKETLQFPDEVPLSPEAKDLIKR-LCCEA 281
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 76/253 (30%), Positives = 120/253 (47%), Gaps = 20/253 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHP 79
Y +R +G G FG A L R LV K + + E +R+ +N L+HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHA 137
NI+ + + L I MEYA+GG L+++I F E+ ++ Q++S VSY H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLR 194
+ HRD+K N L + A +K+ DFG SK S ++ + VGTP Y++PE+
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
+Y+ K +D+W+ G LY +L F+ + K +Q + P + S E
Sbjct: 176 VKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-----PVVSVYSSEL 229
Query: 255 RDLISRIFVADPA 267
L+ + DP
Sbjct: 230 ISLVHSLLQQDPE 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 67/254 (26%), Positives = 105/254 (41%), Gaps = 24/254 (9%)
Query: 27 FVRDIGSGNFGVARL----MRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
+ +G G FG + K VAVK + + D ++ ++ RE R L HP
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
N+V+ V L IVMEY GG+L + N + S + F Q+ G+ Y +
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 122 NFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESLK 176
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
++ K +DVWS GV L+ + G ++ + ++ Y +P E
Sbjct: 177 EGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG----YRLPQPPNCPPE 231
Query: 254 CRDLISRIFVADPA 267
DL+ + + DP
Sbjct: 232 LYDLMLQCWAEDPE 245
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 79/285 (27%), Positives = 124/285 (43%), Gaps = 54/285 (18%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 80
Y+ + IG G +G R+K T ELVA+K I R + E REI + LRHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 81 IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
IVR KE++ + +I V EY +G L + +F+E + + + +QL+ G+ Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
H+ + HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 193 L-RHEYDGKIADVWSCGVTLYVMLVG--------------------GYP----FEDPDEP 227
L Y ++ D+WS G L + +G G P + +
Sbjct: 174 LGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232
Query: 228 KDF-----RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
F +K +R L + + I DL+ ++ DP
Sbjct: 233 PWFENLKPKKPYKRRLREFFK----HLIDPSALDLLDKLLTLDPK 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 83/254 (32%), Positives = 130/254 (51%), Gaps = 23/254 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
RY+ ++ IG G+FG L + K E +K I + K E ++E+I ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA 137
IV F L IVMEY GG+L +RI N R FSED+ +F Q+ G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 192
++ HRD+K +N L +G A K+ DFG ++ L+ + VGTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
Y+ K D+WS G LY + +PFE + + + +I ++ P + S+
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKICQGYFA-PISPNFSR 228
Query: 253 ECRDLISRIFVADP 266
+ R LIS++F P
Sbjct: 229 DLRSLISQLFKVSP 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-32
Identities = 82/251 (32%), Positives = 132/251 (52%), Gaps = 19/251 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
+Y+ +R +G G+FG A L++ + + A+K I + E+ ++E + ++HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
V FKE HL IVMEY GG+L ++I G+ F ED +F Q+ GV + H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLRH 195
V HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
Y+ K +D+WS G LY + +PF + ++ I ++ Y P + S E R
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYK-PLPSHYSYELR 229
Query: 256 DLISRIFVADP 266
LI ++F +P
Sbjct: 230 SLIKQMFKRNP 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 79/247 (31%), Positives = 135/247 (54%), Gaps = 22/247 (8%)
Query: 31 IGSGNFGVARLMRDKVTKE----LVAVKYIERG-----DKIDENVQREIINHRSLRHPNI 81
+G G+FG L+R K+T L A+K +++ D++ ++R+I+ + HP I
Sbjct: 4 LGQGSFGKVFLVR-KITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ T L +++++ GG+LF R+ F+E++ +F+ +L + + H++ +
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGK 200
+RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV+ R + +
Sbjct: 121 YRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 177
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
AD WS GV ++ ML G PF+ KD ++T+ IL + +P +S E + L+
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLLRA 231
Query: 261 IFVADPA 267
+F +PA
Sbjct: 232 LFKRNPA 238
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-32
Identities = 73/207 (35%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 84
+G G+FG L K T E+ A+K +++ D I D++V + R L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
T L VMEY +GG+L +I + +F E +RF+ ++ + + H V +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIAD 203
LKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L EY + D
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-D 178
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDF 230
W+ GV +Y M+ G PFE +E F
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-32
Identities = 76/256 (29%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGD-----KIDENV--QREIINH 73
++ +R +G+G +G L+R KV +L A+K +++ K E+ +R+++
Sbjct: 2 FELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
R P +V T T L ++++Y +GGELF + F+E E R + +++ +
Sbjct: 61 VR-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
+ H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV
Sbjct: 120 HLHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 192 LLRHEYD-GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
+ K D WS GV + +L G PF E + +RIL + P T +
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT--M 235
Query: 251 SQECRDLISRIFVADP 266
S E RD I ++ DP
Sbjct: 236 SAEARDFIQKLLEKDP 251
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-32
Identities = 74/248 (29%), Positives = 116/248 (46%), Gaps = 22/248 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 84
+GSG+FG + + AVK + G E V+ +EI L+HPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
+L I +E GG L + + G F E R + +Q++ G+ Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
+K N L+D + +K+ DFG +K V S KS G+P ++APEV+ + G AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-----VPDTNPISQECRDLIS 259
WS G T+ M G P+ + + + + S +PD +S E +D I
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPIPDH--LSDEAKDFIL 236
Query: 260 RIFVADPA 267
+ DP+
Sbjct: 237 KCLQRDPS 244
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 78/246 (31%), Positives = 114/246 (46%), Gaps = 20/246 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEV 87
+G G++G ++ + A+K ++ G K E+ EI S+ HPNI+ +KE
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHR 143
L L IVMEYA G+L + I + E E F QL+ G+ H ++ HR
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIA 202
DLK N LL +KI D G SK VL K+ +GTP Y+APEV Y K +
Sbjct: 128 DLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRPYSYK-S 182
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDTNPISQECRDLISRI 261
D+WS G LY M PF E + + ++ +Y +P SQ+ ++ I +
Sbjct: 183 DIWSLGCLLYEMATFAPPF----EARSMQDLRYKVQRGKYPPIPPIY--SQDLQNFIRSM 236
Query: 262 FVADPA 267
P
Sbjct: 237 LQVKPK 242
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 8/205 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ +D + +G G++G K T ++VA+K + + + + + +EI + P I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
V++ T L IVMEY G + + +I N +E+E Q + G+ Y H+ +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
HRD+K N LL+ K+ DFG S + + ++ + +GTP ++APEV+ Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 199 GKIADVWSCGVTLYVMLVGGYPFED 223
K AD+WS G+T M G P+ D
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 75/251 (29%), Positives = 117/251 (46%), Gaps = 29/251 (11%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRH---PNIVRFK 85
IG G +G + T +VA+K I D+ ++QRE+ LR PNI ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
L L I+MEYA GG + + AG +E ++++ + Y H + V HRD+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDI 127
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR-HEYDGKIAD 203
K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ YD K AD
Sbjct: 128 KAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK-AD 184
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------ISQECRD 256
+WS G+T+Y M G P+ D D +P + P S+ R+
Sbjct: 185 IWSLGITIYEMATGNPPYSDVDA-----------FRAMMLIPKSKPPRLEDNGYSKLLRE 233
Query: 257 LISRIFVADPA 267
++ +P
Sbjct: 234 FVAACLDEEPK 244
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-31
Identities = 66/212 (31%), Positives = 113/212 (53%), Gaps = 16/212 (7%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 80
+++ ++G+GN GV + + T +++AVK I I+E +Q++I I H+ P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH-A 137
IV F ++I MEY GG L + GR E ++ G++Y H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
++ HRD+K N L++ ++K+CDFG S V +S K+ VGT +Y+APE + ++Y
Sbjct: 120 HKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY 176
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 229
K +D+WS G++L + G +P+ ++P D
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-31
Identities = 77/251 (30%), Positives = 123/251 (49%), Gaps = 20/251 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPN 80
++ + IG G+FGV + K K + A+K I+ K++ + E I+ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHAM 138
I+R+ E L L IVMEYA G+L + + GR ED+ FF Q++ G+++ H+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRH 195
++ HRD+K N LD +KI D G +K +L + VGTP Y++PE+
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
Y+ K +DVW+ GV LY G +PF+ ++ K I+ + P + SQ+
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-----PVSQMYSQQLA 230
Query: 256 DLISRIFVADP 266
LI + D
Sbjct: 231 QLIDQCLTKDY 241
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-30
Identities = 70/197 (35%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 85
IG G+FG L R K ++ AVK +++ + + ++ I++ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
K EN LLD + + DFG K ++ H+ ST GTP Y+APEVL + YD + D
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179
Query: 205 WSCGVTLYVMLVGGYPF 221
W G LY ML G PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 70/203 (34%), Positives = 108/203 (53%), Gaps = 12/203 (5%)
Query: 67 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 126
+R I+ +++HP IV T L +++EY SGGELF + G F ED A F+
Sbjct: 50 ERNIL--EAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPA 185
++ + + H + +RDLK EN LLD +K+ DFG K S+ T GT
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIE 165
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
Y+APE+L+R + GK D WS G +Y ML G PF + +KTI +IL + ++P
Sbjct: 166 YMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENR----KKTIDKILKGKLNLP 220
Query: 246 DTNPISQECRDLISRIFVADPAA 268
++ E RDL+ ++ +P++
Sbjct: 221 PY--LTPEARDLLKKLLKRNPSS 241
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 79/259 (30%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 79
IG G +G L + T E++AVK +E I ++ EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV++ T +L+I +EY GG + + GRF E RFF +Q++ G++Y H+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLR 194
+ HRDLK +N L+D KI DFG SK S + Q S G+ ++APEV
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--LSVQYSVP----DTN 248
Y K+ D+WS G + M G P+ D + I + L + S P D +
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSD-------EEAIAAMFKLGNKRSAPPIPPDVS 238
Query: 249 P-ISQECRDLISRIFVADP 266
+S D ++ F +P
Sbjct: 239 MNLSPVALDFLNACFTINP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 83/294 (28%), Positives = 120/294 (40%), Gaps = 66/294 (22%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 80
RY+ ++ IGSG +GV DK T VA+K I D ID + + REI R LRH N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 81 IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 126
I+ +++ P+ + IV E S L ++D ++F
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 182
Q++ G+ Y H+ V HRDLK N L++ + LKICDFG ++ K V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 183 TPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG--------------------GYPF 221
T Y APE+LL Y I D+WS G +L G P
Sbjct: 169 TRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227
Query: 222 EDPDEPKDFRKTIQRILSVQYS--------VPDTNPISQECRDLISRIFVADPA 267
E+ + K + S+ P +P E DL+ ++ V DP
Sbjct: 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP---EAIDLLEKMLVFDPK 278
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-30
Identities = 76/255 (29%), Positives = 128/255 (50%), Gaps = 19/255 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERG-----DKIDENV--QREIINH 73
++ ++ +G+G +G L+R KVT +L A+K +++ K E+ +R ++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVR-KVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ P +V T L ++++Y SGGE+F + FSEDE RF+ ++I +
Sbjct: 61 VR-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
+ H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APE+
Sbjct: 120 HLHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
+ GK D WS G+ ++ +L G PF E + +RIL P I
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF--IG 235
Query: 252 QECRDLISRIFVADP 266
E +DL+ ++ DP
Sbjct: 236 PEAQDLLHKLLRKDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV------QREIINHRSL 76
+D +G G+FG +++R+K T ++ A+K +++ + + +R+I++ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 135
P I + + +L +VMEY GG+L + +F ED A+F+ +L+ +
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 193
H M HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 194 RHEYDGKIA-----DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PD 246
DGK D WS GV Y M+ G PF + KT I++ Q + P+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE----GTSAKTYNNIMNFQRFLKFPE 232
Query: 247 TNPISQECRDLI 258
+S + DLI
Sbjct: 233 DPKVSSDFLDLI 244
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 82/261 (31%), Positives = 132/261 (50%), Gaps = 15/261 (5%)
Query: 13 AMDMPIMHDSDRYDFVR--DIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQRE 69
A+ + + R IG G+ G+ + DK T VAVK ++ R + E + E
Sbjct: 7 ALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNE 66
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
++ R +HPNIV L L +VME+ GG L + I R +E++ ++
Sbjct: 67 VVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVL 125
Query: 130 SGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAY 186
+S+ HA V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP +
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
+APEV+ R Y G D+WS G+ + M+ G P+ + + P K I+ L + + +
Sbjct: 182 MAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPK--LKN 237
Query: 247 TNPISQECRDLISRIFVADPA 267
+ +S R + R+ V DPA
Sbjct: 238 LHKVSPRLRSFLDRMLVRDPA 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 8e-30
Identities = 74/203 (36%), Positives = 102/203 (50%), Gaps = 30/203 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ-------REIINHRS 75
D Y+ + I G +GV RDK T E+VA+K + K+++ + REI
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60
Query: 76 LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 128
L+HPNIV KEV++ + +VMEY E L E + F + E + QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 186
+SGV++ H + HRDLK N LL + LKICDFG ++ S L + V T Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 187 IAPEVLL-RHEYDGKIADVWSCG 208
APE+LL EY I D+WS G
Sbjct: 173 RAPELLLGAKEYSTAI-DMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 79/259 (30%), Positives = 114/259 (44%), Gaps = 20/259 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
D Y+ + IG G V E VA+K I+ +K +V +E+ HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 136
N+V++ + L +VM Y SGG L + G E ++++ G+ Y H
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 137 AMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 189
+ HRD+K N LL DGS +KI DFG S S K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 190 EVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
EV+ H YD K AD+WS G+T + G P+ K T+Q + D
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 249 PISQECRDLISRIFVADPA 267
S+ R +IS DP+
Sbjct: 235 KYSKSFRKMISLCLQKDPS 253
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 9e-29
Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 85
IG G+FG L + K+ + AVK +++ ++ Q+ I+ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V+++ +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
K EN LLD + + DFG K + S +T GTP Y+APEV+ + YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPD 225
W G LY ML G PF D
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 14/244 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G +G+ RD T+ +A+K I ER + + + EI H L+H NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 90 TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 147 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYD-GKIADV 204
+N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+ + G AD+
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADI 194
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKD--FRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
WS G T+ M G PF + EP+ F+ + +I +P++ +S E ++ I R F
Sbjct: 195 WSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI---HPEIPES--LSAEAKNFILRCF 249
Query: 263 VADP 266
DP
Sbjct: 250 EPDP 253
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 31 IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 85
+G G FG +L VAVK ++ +E +E + L HPN+VR
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 86 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 136
V L +V+EY GG+L + R S +++ + L+S G+ Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 193
+ + HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ K +DVWS GV L+ + +G P+
Sbjct: 181 DGIFTSK-SDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 84/278 (30%), Positives = 124/278 (44%), Gaps = 48/278 (17%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVR 83
V IG G +GV R+K+T E+VA+K I R D E V REI + L HPNIV+
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 84 FKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+VI T L +V E+ + F + + QL+ G+++CH+ +V H
Sbjct: 64 LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLRHEYD 198
RDLK +N L++ A +K+ DFG +++ + P T V T Y APE+LL +Y
Sbjct: 124 RDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 199 GKIADVWSCGVTLYVML--------------------VGGYPFED--------PDEPKDF 230
D+WS G M+ G P E PD F
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238
Query: 231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 268
K ++ VP P+ ++ RDL+S++ DP
Sbjct: 239 PKWARQ--DFSKVVP---PLDEDGRDLLSQMLHYDPNK 271
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 73/252 (28%), Positives = 118/252 (46%), Gaps = 19/252 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 83
+G+G F RD T L+AVK + +++ E +++EI L HP+I+R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+H + +E+ +GG + + G F E + +QL+ G+SY H Q+ HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLRHE 196
D+K N L+D S RL+I DFG ++ L ++ +GT A++APEV LR E
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEV-LRGE 183
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
G+ DVWS G + M P+ + ++ + I +I S + +S RD
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPEHLSPGLRD 242
Query: 257 LISRIFVADPAA 268
+ R P
Sbjct: 243 VTLRCLELQPED 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 5e-28
Identities = 76/248 (30%), Positives = 128/248 (51%), Gaps = 20/248 (8%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKIDEN------VQREIINHRSLR 77
++F+R +G+G+FG L K VA+K E+ I + +R+I+N+ +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HP V ++L +V+E+ GGE F + RF D F+ Q++ Y +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ + +RDLK EN LLD +K+ DFG++K V+ ++ + GTP YIAPE+LL +
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH 205
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
GK AD W+ G+ +Y +LVG PF + ++K ++ I+ + D N C+ L
Sbjct: 206 -GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFL-DNN-----CKHL 258
Query: 258 ISRIFVAD 265
+ ++ D
Sbjct: 259 MKKLLSHD 266
|
Length = 340 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 71/197 (36%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRHPNIVRFKE 86
IG G +G+ RD + E+VA+K + ER D I + REI +LRHPNIV KE
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKE 73
Query: 87 VILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ HL +VMEY L + + FSE + + QL+ G+ Y H +
Sbjct: 74 VV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFII 130
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRHEYDGK 200
HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+LL
Sbjct: 131 HRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188
Query: 201 IADVWSCGVTLYVMLVG 217
D+W+ G L +L
Sbjct: 189 AIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 84/286 (29%), Positives = 125/286 (43%), Gaps = 61/286 (21%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
++ IG G FG L+R T L A+K + + D + N +R+I+ + +
Sbjct: 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--NEWV 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ +L VM+Y GG++ + G F ED ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 142 HRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------SSVL 173
HRD+K +N L+D +K+ DFG Y K S +
Sbjct: 124 HRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 174 HSQPK----------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+ K S VGTP YIAPEVLLR Y ++ D WS GV LY MLVG
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVG 240
Query: 218 GYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRI 261
PF P + T ++++ + + +P +S+E DLI R+
Sbjct: 241 QPPFLAD-TPAE---TQLKVINWETTLHIPSQAKLSREASDLILRL 282
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 3e-27
Identities = 70/258 (27%), Positives = 132/258 (51%), Gaps = 24/258 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDKIDE-------NVQREIINH 73
++ ++ +G+G +G L+R KV + +L A+K +++ + + +R+++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVR-KVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ P +V T T L ++++Y +GGELF + RF E E + + +++ +
Sbjct: 61 IR-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
+ H + + +RD+KLEN LLD + + + DFG SK + S GT Y+AP++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 192 LLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTN 248
+ + +D K D WS GV +Y +L G PF E + +RIL + P + +
Sbjct: 178 VRGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236
Query: 249 PISQECRDLISRIFVADP 266
++ +D+I R+ + DP
Sbjct: 237 ALA---KDIIQRLLMKDP 251
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 7e-27
Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 30/260 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
D ++ + ++G G FG + K T A K I+ + D V+ +I++ +HP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAM 138
NIV E L I++E+ GG L + R +E + R+ +Q++ +++ H+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 193
+V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APEV+
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 194 ---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--- 247
+ YD K AD+WS G+TL + P + + ++ +L + S P T
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELN-------PMRVLLKILKSEPPTLDQ 230
Query: 248 -NPISQECRDLISRIFVADP 266
+ S D + V DP
Sbjct: 231 PSKWSSSFNDFLKSCLVKDP 250
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 76/223 (34%), Positives = 112/223 (50%), Gaps = 13/223 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
++++ + +G G +GV R K TKE+VA+K E +++ E RE+ R+L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV KE L +V EY EL E + N ++ R + QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRH 195
+ HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+LL
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 238
Y GK D+WS G L L G P + D TIQ++L
Sbjct: 177 PY-GKAVDMWSVGCILG-ELSDGQPLFPGESEIDQLFTIQKVL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-27
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 21/224 (9%)
Query: 27 FVRDIGSGNFGV---ARL-MRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPN 80
+ +G G FG L + T+ VAVK ++ G ++ E E + L HPN
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
IVR V L IV EY GG+L F R + + + + Q+ G+ Y +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 193
HRDL N L+ + +KI DFG S+ ++ + APE L
Sbjct: 122 NFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRKTIQR 236
++ K +DVWS GV L+ + G P+ ++ + ++
Sbjct: 178 DGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-26
Identities = 82/248 (33%), Positives = 125/248 (50%), Gaps = 18/248 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
++ Y+ V+ IG G FG +L+R K T+++ A+K + + + I + R +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P +V+ +L +VMEY GG+L + N E ARF+ +++ + H+
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
M HRD+K +N LLD S LK+ DFG +K ++ + VGTP YI+PEVL
Sbjct: 161 MGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216
Query: 194 RHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
Y G+ D WS GV LY MLVG PF + K + S+ + PD N I
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 274
Query: 251 SQECRDLI 258
S+E ++LI
Sbjct: 275 SKEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 80/249 (32%), Positives = 120/249 (48%), Gaps = 19/249 (7%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVRFK 85
V IGSG G + + T L A+K Y D + + REI R + HPN+V+
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
++ + +++E+ GG L +F D AR Q++SG++Y H + HRD+
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHRDI 194
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVL---LRH-EYDGK 200
K N L++ A +KI DFG S+ P S+VGT AY++PE + L H YDG
Sbjct: 195 KPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY 252
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLI 258
D+WS GV++ +G +PF + D+ + I S P P S+E R I
Sbjct: 253 AGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLMCAIC---MSQPPEAPATASREFRHFI 308
Query: 259 SRIFVADPA 267
S +PA
Sbjct: 309 SCCLQREPA 317
|
Length = 353 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLR 77
RY+ + +G G + V RDK T +VA+K I+ G++ I+ REI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 135
HPNI+ +V +++ +V E+ +L E++ + + + + + G+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 191
H+ + HRDLK N L+ LK+ DFG ++S P V T Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173
Query: 192 LLRHEYDGKIADVWSCGV 209
L + G D+WS G
Sbjct: 174 LFGARHYGVGVDMWSVGC 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 85/278 (30%), Positives = 135/278 (48%), Gaps = 41/278 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
D+Y+ V IG G +GV RD+VT E +A+K I R ++ DE V REI + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 136
NIVR ++V+ + L +V EY +L + + ++ F+++ + + Q++ G++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 192
+ +V HRDLK +N L+D LK+ DFG +++ + P T V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------SV 244
L + D+WS G ++ +V P D D I RIL S+
Sbjct: 176 LGSRHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234
Query: 245 PD---TNP-------------ISQECRDLISRIFVADP 266
PD P + DL+S++ DP
Sbjct: 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDP 272
|
Length = 294 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 70/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
+ + IG G F V + +VA+K ++ + +D ++ +EI + L H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 134
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 189
H+ ++ HRD+K N + + +K+ D G SK++ HS VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
E + + Y+ K +D+WS G LY M PF + + ++I Y +
Sbjct: 176 ERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADH 232
Query: 250 ISQECRDLISRIFVADPA 267
S+E RDL+SR DP
Sbjct: 233 YSEELRDLVSRCINPDPE 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 85/292 (29%), Positives = 126/292 (43%), Gaps = 28/292 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHP 79
RY + +IGSG +GV D + + VA+K I + +R E+ R +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 80 NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
NI+ ++++ P + +VM+ +L I + +E+ R+F QL+ G+ Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 190
H+ V HRDLK N L++ L+I DFG S S H V T Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 191 VLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSVQYSVPDTN 248
+LL EY I D+WS G ML F P K++ ++ ILSV S P
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLF-----PGKNYVHQLKLILSVLGS-PSEE 234
Query: 249 PISQ----ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296
+++ R I + P S F + L L S + FD E
Sbjct: 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI 286
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 69/201 (34%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 20 HDSD-RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----R 74
D + + +R+IG G+FG RD T E+VA+K + K ++II +
Sbjct: 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV 132
LRHPN + +K L +VMEY S ++ E + E E + G+
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGL 128
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+Y H+ + HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV+
Sbjct: 129 AYLHSHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVI 183
Query: 193 L---RHEYDGKIADVWSCGVT 210
L +YDGK DVWS G+T
Sbjct: 184 LAMDEGQYDGK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 68/230 (29%), Positives = 107/230 (46%), Gaps = 42/230 (18%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---- 77
+ ++ V IG G +G R K T +LVA+K ++ + +E ++ E LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61
Query: 78 HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 127
HPNI F + L +VME GG +L + + G R E+ + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 128 LISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 180
+ G++Y H +V HRD+K +N LL + +K+ DFG S +Q ST
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171
Query: 181 --VGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
+GTP ++APEV+ YD + +DVWS G+T + G P D
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 81
Y + IG G F + + T + A+K + +++ N REI R L HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 82 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAM 138
+R EV+ LA+V E L+E I R E + + QL+ + + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHE 196
+ HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE LL
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 197 YDGKIADVWSCGVTLYVML 215
Y G D+W+ G + +L
Sbjct: 175 YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHP 79
+Y+ + IG G +G +++ T E+VA+K + R D DE V REI + L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHA 137
NIVR +V+ + L +V EY + ++ ++ G + + F QL+ G+++CH+
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
V HRDLK +N L++ + LK+ DFG +++ + + V T Y P+VL +
Sbjct: 118 HNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 197 -YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSVPDT 247
Y I D+WS G + G P ++ D K I R+L +PD
Sbjct: 176 LYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234
Query: 248 NP----------------ISQECRDLISRIFVADPA 267
P ++ RDL+ + V +P
Sbjct: 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPV 270
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 79/256 (30%), Positives = 120/256 (46%), Gaps = 22/256 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGD-KIDENVQREIINH--RSLR 77
RY + +G G+FG L++DK L +K I G+ +E VQ L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 133
HP IV+F L I+ EY G +L ++ SE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
Y H ++ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTNPIS 251
YD K +D+WS G LY M + FE ++F + RI+ S+P+T
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPETYS-- 230
Query: 252 QECRDLISRIFVADPA 267
++ ++ + DP+
Sbjct: 231 RQLNSIMQSMLNKDPS 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 71/230 (30%), Positives = 116/230 (50%), Gaps = 18/230 (7%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 83
R IG G++ L+ K T+ + A+K I++ D+ VQ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T + L V+E+ SGG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +Y +
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 203 DVWSCGVTLYVMLVGGYPF------EDPDE-PKDFRKTIQRILSVQYSVP 245
D W+ GV ++ M+ G PF ++PD+ +D+ Q IL Q +P
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY--LFQVILEKQIRIP 225
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA+K + + E + EI+ R +HPNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ + L L +VMEY +GG L + + E + ++ + + + H+ QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 200 KIADVWSCGVTLYVMLVGGYPF--EDP 224
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 75/248 (30%), Positives = 123/248 (49%), Gaps = 18/248 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
++ YD V+ IG G FG +L+R K ++++ A+K + + + I + R +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P +V+ +L +VMEY GG+L + N E A+F+ +++ + H+
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
M + HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216
Query: 194 RH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
Y G+ D WS GV L+ MLVG PF + K + S+ + P+ I
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PEDVEI 274
Query: 251 SQECRDLI 258
S+ ++LI
Sbjct: 275 SKHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 77
Y+ + +IG G +G RD T VA+K + E G I + REI + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 78 -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 130
HPNIVR +V P L +V E+ + C + + +QL+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 131 GVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
GV + H+ ++ HRDLK +N L+ DG ++KI DFG ++ S V T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVM 214
PEVLL+ Y + D+WS G +
Sbjct: 175 PEVLLQSSYATPV-DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-25
Identities = 77/246 (31%), Positives = 123/246 (50%), Gaps = 21/246 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 84
+G G FG L D T +AVK ++ + E + EI ++L H IV++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 85 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ P L+I ME+ GG + +++ + G +E+ R + +Q++ GVSY H+ + H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
RD+K N L D +K+ DFG SK + + KS GTP +++PEV+ Y
Sbjct: 130 RDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY- 186
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDL 257
G+ AD+WS G T+ ML P+ + + K ++ Q + P P +S CRD
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----IATQPTNPVLPPHVSDHCRDF 241
Query: 258 ISRIFV 263
+ RIFV
Sbjct: 242 LKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 37/275 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRH 78
++RY ++ +G G FG+ RD++T + VA+K I + + + RE+ + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 79 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NI+ ++ ++P + V E G R+ + + ++F Q++ G+ Y H+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HE 196
V HRDLK N L++ + LKICDFG ++ + Q V T Y APE++L +
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 197 YDGKIADVWSCGVTLYVMLVGG--YPFEDP------------DEPKDFRKTI--QRILSV 240
YD ++ D+WS G ML G +P +D P D TI + L
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241
Query: 241 QYSVPDTN--PISQ-------ECRDLISRIFVADP 266
S+P P S+ DL+ ++ V DP
Sbjct: 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDP 276
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 74/245 (30%), Positives = 129/245 (52%), Gaps = 23/245 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
IG G+ G+ + R+K + VAVK ++ R + E + E++ R +H N+V + L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
L ++ME+ GG L + I + R +E++ + ++ + Y H+ V HRD+K ++
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 150 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
L LDG R+K+ DFG+ ++ S + KS VGTP ++APEV+ R Y ++ D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWS 202
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKT-IQRILSVQYSVP----DTNPISQECRDLISRI 261
G+ + M+ G EP F + +Q + ++ S P + + IS RD + R+
Sbjct: 203 LGIMVIEMVDG--------EPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254
Query: 262 FVADP 266
+P
Sbjct: 255 LTREP 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-25
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 45/278 (16%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 80
D ++ ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ +L ++ME+ GG++ + SE+ +F+ + + + H +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 178
HRD+K +N LLD +K+ DFG ++ H+ P
Sbjct: 121 GFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 179 ----------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
+ +RK + ++ + P PIS++ +DLI R
Sbjct: 238 SETPQETYRKVMNWKETLVF--PPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 9e-25
Identities = 82/245 (33%), Positives = 117/245 (47%), Gaps = 41/245 (16%)
Query: 16 MPIMHDS-----DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQR- 68
MP +D + Y+ ++ IG+G FG L++ K T+E K I RG K E Q
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 69 -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 121
E+ R L+H NIVR+ + L + L I+ME+ G+L I G+ E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 122 RFFFQQLISGVSYCHAMQ-------VCHRDLKLENTLLDG---------------SPAPR 159
+QL+ ++YCH ++ V HRDLK +N L + P
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLV 216
KI DFG SK+ + S S VGTP Y +PE+LL HE YD K +D+W+ G +Y +
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL-HETKSYDDK-SDMWALGCIIYELCS 238
Query: 217 GGYPF 221
G PF
Sbjct: 239 GKTPF 243
|
Length = 1021 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 71/194 (36%), Positives = 101/194 (52%), Gaps = 17/194 (8%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y V IG G +GV RDK+T E+VA+K I R + DE V REI + L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAM 138
IVR +V+ + L +V E+ +L + + ++ D + QL+ G++YCH+
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLR 194
+V HRDLK +N L+D A LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLG 173
Query: 195 HEYDGKIADVWSCG 208
D+WS G
Sbjct: 174 SRQYSTPVDIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 1e-24
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 9/174 (5%)
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
+PN ++ + T ++M+Y G+LF+ + G+ SE E + +QL+ ++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + H Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFE-DPDE---PKDFRKTIQRILSVQYSVPDT 247
D D W+ GV Y +L G +PF+ D DE + K Q+ L +V
Sbjct: 184 DVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236
|
Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 76/209 (36%), Positives = 99/209 (47%), Gaps = 27/209 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
D++D + IG G +G RDK T ELVA+K + R D E REI R L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65
Query: 79 PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 124
NIV KE I+T A +V EY G L + + FSED + F
Sbjct: 66 RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 182
+QL+ G++YCH HRD+K N LL+ ++K+ DFG ++ T V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTL 211
T Y PE+LL E G DVWSCG L
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 2e-24
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 8/201 (3%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIIN 72
D+ + + ++ ++ IGSG +G R+ T EL A+K I E G+ VQ+EII
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ +H NIV + L L I ME+ GG L + G SE + + ++ + G+
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 191
Y H+ HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 192 LLRHEYDG--KIADVWSCGVT 210
G ++ D+W+ G+T
Sbjct: 178 AAVERKGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 14/209 (6%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFK 85
+ +G G G R K T + A+K I + + + RE+ ++S + P IV++
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 86 EVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVSYCHAM 138
L + + I MEY GG L + I GR E + ++ G+SY H+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
++ HRD+K N LL +K+CDFG S V S + GT Y+APE + Y
Sbjct: 125 KIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQGKPYS 181
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
+DVWS G+TL + +PF EP
Sbjct: 182 IT-SDVWSLGLTLLEVAQNRFPFPPEGEP 209
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-24
Identities = 63/195 (32%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRHPNIVRFKE 86
+G G + R++ T E+VA+K I E G REI + L+H NIVR +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHENIVRLHD 65
Query: 87 VILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
VI T L +V EY + + G + + F QL+ G+++CH +V HRD
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-RHEYDGKIA 202
LK +N L++ LK+ DFG +++ + + + V T Y AP+VLL Y I
Sbjct: 126 LKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI- 182
Query: 203 DVWSCGVTLYVMLVG 217
D+WS G + M+ G
Sbjct: 183 DIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 3e-24
Identities = 76/247 (30%), Positives = 121/247 (48%), Gaps = 26/247 (10%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
IG G+FG D T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L T L I+MEY GG + + AG F E + ++++ G+ Y H+ + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKIADVWS 206
N LL S +K+ DFG + + +Q K + VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWS 186
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDLISR 260
G+T + L G P P + V + +P NP S+ ++ I
Sbjct: 187 LGITA-IELAKGEPPNSDMHP----------MRVLFLIPKNNPPTLTGEFSKPFKEFIDA 235
Query: 261 IFVADPA 267
DP+
Sbjct: 236 CLNKDPS 242
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-24
Identities = 78/245 (31%), Positives = 122/245 (49%), Gaps = 19/245 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 84
+G G FG L D T +AVK + + K ++ EI ++LRH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 85 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ P L+I +EY GG + +++ G +E+ R + +Q++ GVSY H+ + H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLRHEYD 198
RD+K N L D A +K+ DFG SK ++ S KS GTP +++PEV+ Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY- 186
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
G+ ADVWS T+ ML P+ + + K + +PD +S CRD +
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM--LPDG--VSDACRDFL 242
Query: 259 SRIFV 263
+IFV
Sbjct: 243 KQIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-24
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 16/211 (7%)
Query: 27 FVRDIGSGNFGVARLMR----DKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPN 80
F++ +G G+FG L R T E VAVK + ++ + +REI R+L H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K V P L ++MEY G L + + + + + F Q+ G+ Y +
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLL 193
+ HRDL N L++ +KI DFG +K K +P + APE L
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
++ +DVWS GVTLY + G P + P
Sbjct: 186 TSKFSSA-SDVWSFGVTLYELFTYGDPSQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-24
Identities = 74/251 (29%), Positives = 125/251 (49%), Gaps = 20/251 (7%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 83
R IG G++ L+R K T+ + A+K +++ + ID + + ++ HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T + L V+EY +GG+L + + E+ ARF+ ++ ++Y H + +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +Y G
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 203 DVWSCGVTLYVMLVGGYPF------EDPDE-PKDFRKTIQRILSVQYSVPDTNPISQECR 255
D W+ GV ++ M+ G PF ++PD+ +D+ Q IL Q +P + +S +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY--LFQVILEKQIRIPRS--LSVKAA 233
Query: 256 DLISRIFVADP 266
++ DP
Sbjct: 234 SVLKSFLNKDP 244
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 75/234 (32%), Positives = 114/234 (48%), Gaps = 16/234 (6%)
Query: 42 MRDKVTKELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100
R KE V K++ D+ R E+ + H IV+ + + L ++MEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 101 ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156
SGG+L ++I + F E E F Q++ + H+ ++ HRDLK N L P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204
Query: 157 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 213
+K+ DFG+SK SV S GTP Y+APE+ R Y K AD+WS GV LY
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263
Query: 214 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
+L PF+ P + R+ +Q++L +Y P P+S + L+ + +PA
Sbjct: 264 LLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPA 312
|
Length = 478 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-24
Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 45/276 (16%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 80
++ ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V+ +L ++ME+ GG++ + +E+E +F+ + + + H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 178
HRD+K +N LLD +K+ DFG ++ HS P
Sbjct: 123 IHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 179 --------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 225 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
+ ++K + ++ + P PIS++ +DLI R
Sbjct: 240 TPQETYKKVMNWKETLIF--PPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 6e-24
Identities = 68/196 (34%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
IG G+FG D TKE+VA+K I+ + DE ++Q+EI P I R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L T L I+MEY GG + + G E ++++ G+ Y H+ + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSC 207
N LL S +K+ DFG + ++T VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSL 187
Query: 208 GVTLYVMLVGGYPFED 223
G+T + G P D
Sbjct: 188 GITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 7e-24
Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 14/245 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 86
+G G FG + + T +L A K + + K + + ++ R L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCH 142
T T L +VM +GG+L I N F E A F+ Q+ISG+ + H ++ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
RDLK EN LLD ++I D G + + S+ K GTP ++APE+L EYD +
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
D ++ GVTLY M+ PF E + ++ QRIL+ + PD S + +
Sbjct: 179 -DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK--FSPASKSFCEAL 235
Query: 262 FVADP 266
DP
Sbjct: 236 LAKDP 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 7e-24
Identities = 71/227 (31%), Positives = 112/227 (49%), Gaps = 20/227 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
IG G+FG D T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L T L I+MEY GG + + G E + ++++ G+ Y H+ + HRD+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWS 206
N LL S +K+ DFG + + +Q K VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWS 186
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
G+T + L G P P + V + +P NP + E
Sbjct: 187 LGITA-IELAKGEPPHSELHP----------MKVLFLIPKNNPPTLE 222
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-23
Identities = 77/262 (29%), Positives = 113/262 (43%), Gaps = 25/262 (9%)
Query: 25 YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI------------ERGDKIDENVQREII 71
Y + +GSG FG V ++ + + L+A+K I ER I + V I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 127
LRHPNIVR+ + L L IVM+ G L E + RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 128 LISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
++ + Y H ++ HRDL N +L ++ I DFG +K S+ S VGT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
PE++ Y G+ ADVW+ G LY M PF + +I+ Y
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYS----TNMLSLATKIVEAVYEPLP 234
Query: 247 TNPISQECRDLISRIFVADPAA 268
S++ D+I+ D A
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEA 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-23
Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA+K I + E + EI+ + L++PNIV
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQV 140
F + L L +VMEY +GG L + + DEA+ ++ + + + HA QV
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 198 DGKIADVWSCGVTLYVMLVGGYPF--EDP 224
K+ D+WS G+ M+ G P+ E+P
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-23
Identities = 74/245 (30%), Positives = 119/245 (48%), Gaps = 19/245 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 84
+G G FG L D T +A K ++ + E + EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 85 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ L I MEY GG + +++ G +E R + +Q++ G+SY H+ + H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLRHEYD 198
RD+K N L D A +K+ DFG SK ++ S +S GTP +++PEV+ Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY- 186
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
G+ ADVWS G T+ ML P+ + + I +I + + + IS+ RD +
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 259 SRIFV 263
IFV
Sbjct: 243 GCIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-23
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 83
+G G +G +L+AVK +E +K E +Q E+ +SL+H NIV+
Sbjct: 8 LGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+ L ++I ME+ GG + + G E + +Q++ GV+Y H V HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLRHE 196
D+K N +L P +K+ DFG ++ HS KS GTP ++APEV+
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPD 225
Y G+ +D+WS G T++ M G P D
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 5e-23
Identities = 64/191 (33%), Positives = 102/191 (53%), Gaps = 8/191 (4%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 82
Y+ ++ +GSG +G R+ T EL AVK I E GD +Q+EI + +H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ L+ L I MEY GG L + G SE + + ++ + G++Y H+ H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG-- 199
RD+K N LL + +K+ DFG +K + ++ KS +GTP ++APEV + G
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 200 KIADVWSCGVT 210
++ D+W+ G+T
Sbjct: 188 QLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-23
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 83
R IG G++ L+R K ++ A+K +++ + ID + + ++ +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T + L +V+EY +GG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L EY G
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 203 DVWSCGVTLYVMLVGGYPF----EDPD 225
D W+ GV ++ M+ G PF ++PD
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-23
Identities = 79/264 (29%), Positives = 122/264 (46%), Gaps = 41/264 (15%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
+R+IG G+FG RD T E+VA+K + K ++II + ++HPN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 84 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+K L +VMEY S +L E + E E + G++Y H+ +
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV+L +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 199 GKIADVWSCGVT-------------------LYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
GK+ DVWS G+T LY + P +E D+ + + S
Sbjct: 203 GKV-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF--VDS 259
Query: 240 VQYSVPDTNPISQECRDLISRIFV 263
+P P S+E L+ +FV
Sbjct: 260 CLQKIPQDRPTSEE---LLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 1e-22
Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA+K + + E + EI+ R ++PNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ + L L +VMEY +GG L + + E + ++ + + + H+ QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 200 KIADVWSCGVTLYVMLVGGYPF--EDP 224
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 65/192 (33%), Positives = 98/192 (51%), Gaps = 17/192 (8%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
+R+IG G+FG RD E+VA+K + K ++II + LRHPN ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 84 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
++ L +VMEY S +L E + E E + G++Y H+ +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV+L +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 199 GKIADVWSCGVT 210
GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-22
Identities = 77/242 (31%), Positives = 126/242 (52%), Gaps = 15/242 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
IG G+ G+ + K + +LVAVK ++ R + E + E++ R +H N+V L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
L +VME+ GG L + I R +E++ ++ +S HA V HRD+K ++
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 150 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
LL DG R+K+ DFG+ ++ S + KS VGTP ++APE++ R Y G D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 207 CGVTLYVMLVGGYP-FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
G+ + M+ G P F +P P K I+ L + + + + +S + + R+ V D
Sbjct: 202 LGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPK--LKNLHKVSPSLKGFLDRLLVRD 257
Query: 266 PA 267
PA
Sbjct: 258 PA 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-YIERGDK--IDENVQREIINHRSLRHP 79
++Y+ + IG G++GV R++ T ++VA+K ++E D I + REI + L+HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
N+V EV L +V EY L E N E + Q + V++CH
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLRHE 196
HRD+K EN L+ + ++K+CDFG+++ +L V T Y APE+L+
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 197 YDGKIADVWSCGVTLYVMLVG 217
G DVW+ G +L G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-22
Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA++ + + E + EI+ R ++PNIV
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ + L L +VMEY +GG L + + E + ++ + + + H+ QV H
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
RD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV+ R Y
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 200 KIADVWSCGVTLYVMLVGGYPF--EDP 224
K+ D+WS G+ M+ G P+ E+P
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-22
Identities = 64/252 (25%), Positives = 119/252 (47%), Gaps = 18/252 (7%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 83
+ D+G+GN G ++ T ++A K + G K +V+++I+ + H P IV
Sbjct: 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVS 67
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCH 142
F L ++ + ME+ G L G + ++ G++Y + ++ H
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RD+K N L++ ++K+CDFG S +++S + VGT Y++PE + +Y K +
Sbjct: 128 RDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYTVK-S 183
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-VQYSVPDTNP------ISQECR 255
DVWS G+++ + +G +PF + D + IL +Q V + P ++ R
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 256 DLISRIFVADPA 267
D + + DP
Sbjct: 244 DFVDACLLKDPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-22
Identities = 75/245 (30%), Positives = 127/245 (51%), Gaps = 21/245 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
IG G+ G+ + +K T + VAVK ++ R + E + E++ R H N+V L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
L +VME+ GG L + I R +E++ ++ +SY H V HRD+K ++
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 150 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ R Y G D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP----DTNPISQECRDLISRIF 262
G+ + M+ G P+ +EP +Q + ++ ++P D++ +S R + +
Sbjct: 204 LGIMVIEMIDGEPPYF--NEPP-----LQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256
Query: 263 VADPA 267
V +P+
Sbjct: 257 VREPS 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-22
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 17/192 (8%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 83
+ +IG G+FG + T E+VAVK + G + +E Q +E+ + L+HPN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 84 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+K L +VMEY S +L E + E E + G++Y H+ +
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV+L +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 199 GKIADVWSCGVT 210
GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------ 67
+ P + +Y+ + IG G FG R K TK++VA+K + + EN +
Sbjct: 3 YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFPIT 57
Query: 68 --REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG-RF 116
REI + L+H N+V E+ T +V E+ +L + N +F
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKF 116
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLH 174
+ E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++ L
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLS 172
Query: 175 SQPKST-----VGTPAYIAPEVLLRHEYDGKIADVWSCG 208
K V T Y PE+LL G D+W G
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-22
Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 61/293 (20%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDE----NVQREIINHRSL 76
+ + V+ IG G FG RL++ K T ++ A+K + + + K D+ +R+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
P +V +L ++ME+ GG+L + FSED RF+ + + + H
Sbjct: 60 -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 169
+ HRD+K +N L+D +K+ DFG Y K
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 170 --------SSVLHSQPK-------------STVGTPAYIAPEVLLRHEYDGKIADVWSCG 208
+ + S+ + STVGTP YIAPE+ L+ Y G+ D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLG 235
Query: 209 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
++ L+G PF + + +RK I ++ + PD +S E DLI R+
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYF--PDDIHLSVEAEDLIRRL 286
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 8e-22
Identities = 69/230 (30%), Positives = 98/230 (42%), Gaps = 19/230 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHP 79
RY + IG G +G+ K T VA+K I + + REI R +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 135
NI+ + I+ P + EL E ++ S D ++F Q++ G+ Y
Sbjct: 64 NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 191
H+ V HRDLK N LL+ LKICDFG ++ + V T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSV 240
+L + K D+WS G L ML F P KD+ + IL V
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLSNRPLF-----PGKDYLHQLNLILGV 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 18/203 (8%)
Query: 94 LAIVMEYASGGELFERICN---AGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
+A+V++YA+ G+L + I + R F E EA F Q++ V + H+ + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 150 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
LL + +K+ DFG+SK ++V ++ GTP Y+APE+ R Y K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDTNPISQECRDLISRIFVAD 265
GV LY +L PF+ ++ + + + L+ +Y +P + IS E +++++ + +D
Sbjct: 231 LGVLLYELLTLKRPFDG----ENMEEVMHKTLAGRYDPLPPS--ISPEMQEIVTALLSSD 284
Query: 266 PAAVSIFFFPLNM-SCLLLFSFV 287
P LNM C L S +
Sbjct: 285 PKRRPSSSKLLNMPICKLFISGL 307
|
Length = 496 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 81
+ ++ + ++G G FG ++K T L A K I+ + ++ E+ EI S HPNI
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQV 140
V+ + +L I++E+ +GG + + R +E + R +Q + ++Y H ++
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 141 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 193
HRDLK N L LDG +K+ DFG S + Q + S +GTP ++APEV++
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 194 -RHEYDGKIADVWSCGVTLYVM 214
YD K ADVWS G+TL M
Sbjct: 181 KDRPYDYK-ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 81/290 (27%), Positives = 120/290 (41%), Gaps = 65/290 (22%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
++ +G G FG L T L A+K + + D ++ N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ +L VM+Y GG++ + F E ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 142 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 178
HRD+K +N L LDG +K+ DFG Y K S + +P
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 179 ---------------------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 211
S VGTP YIAPEVLLR Y ++ D WS GV L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL 238
Query: 212 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
+ MLVG PF P + K I ++ +P +S E DLI+++
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH--IPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-21
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-YIERGDKIDENVQ----REIINHRSLR 77
++Y+ + +G G++G+ + K T ++VA+K ++E D D+ V+ REI + LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 135
H N+V EV L +V E+ L E+ N E R + Q++ G+ +C
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 193
H+ + HRD+K EN L+ S + +K+CDFG+++ ++ T V T Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 194 RHEYDGKIADVWSCGVTLYVMLVG 217
G+ D+W+ G + ML G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-21
Identities = 68/243 (27%), Positives = 115/243 (47%), Gaps = 17/243 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 83
+G G FG ++ K T ++ A K +++ G+K+ +++EI+ + P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHAMQVC 141
+ THL +VM +GG+L I N G + R + Q+ G+ + H+M +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
+RD+K EN LLD RL D G + GT Y+APE+L Y +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
D ++ G ++Y M+ G PF+D E + +R L + N ++E +D+ R+
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQN-FTEESKDIC-RL 232
Query: 262 FVA 264
F+A
Sbjct: 233 FLA 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-21
Identities = 73/248 (29%), Positives = 113/248 (45%), Gaps = 21/248 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 83
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
TP L +++ +GG+L + G FSE E RF+ ++I G+ + H V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 144 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
DLK N LLD R+ CDF K P ++VGT Y+APEVL +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
AD +S G L+ +L G PF + KD + + L+V +PD+ S E + L+
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTVNVELPDS--FSPELKSLLE 231
Query: 260 RIFVADPA 267
+ D +
Sbjct: 232 GLLQRDVS 239
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 70/196 (35%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 80
+Y ++ IG G +G+ ++ T E VA+K I ++ID + REI R L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 81 IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++ K+ I+ P H + IV E +L + I ++ S+D ++F QL+ G+ Y
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 193
H+ V HRDLK N LL+ + LKICDFG ++ +S V T Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 194 R-HEYDGKIADVWSCG 208
EY I DVWS G
Sbjct: 182 NCSEYTTAI-DVWSVG 196
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-21
Identities = 74/240 (30%), Positives = 113/240 (47%), Gaps = 23/240 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 83
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
TP L+ +++ +GG+L + G FSE E RF+ ++I G+ + H V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 144 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYD 198
DLK N LLD R+ CDF K P ++VGT Y+APEVL + YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
AD +S G L+ +L G PF + KD + + L++ +PD+ S E R L+
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-21
Identities = 68/251 (27%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRF 84
+ IG G F + ++ VA+K ++ + +D +++ + + L HPN++++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQV 140
+ + L IV+E A G+L + I + E +F QL S V + H+ +V
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
HRD+K N + + +K+ D G SK++ H S VGTP Y++PE + +
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHEN 181
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
Y+ K +D+WS G LY M PF + + Q+I Y T S++ R
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238
Query: 256 DLISRIFVADP 266
+L+S DP
Sbjct: 239 ELVSMCIYPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-21
Identities = 84/290 (28%), Positives = 121/290 (41%), Gaps = 65/290 (22%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
++ +G G FG L R TK L A+K + + D + N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--NEWV 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR +L VM+Y GG++ + G F ED ARF+ +L V H M
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123
Query: 142 HRDLKLENTLLD--------------------------GSPAPRLKICDFGYS------- 168
HRD+K +N L+D R DF
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 169 -----------KSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
+++ H + S VGTP YIAPEVLLR Y ++ D WS GV LY ML
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEML 242
Query: 216 VGGYPF--EDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRI 261
VG PF + P E T ++++ Q S +P +S E DLI ++
Sbjct: 243 VGQPPFLAQTPLE------TQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-21
Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 49/281 (17%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y + IG G +GV R+K T ++VA+K I R + +E V REI + L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
IV ++V++ + L ++ E+ S + + + + + + Q++ G+ +CH+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVL 192
+V HRDLK +N L+D +K+ DFG +++ H V T Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE-----VVTLWYRAPEVL 173
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--FRKTIQRILSVQ--------Y 242
L D+WS G T++ + P D D FR I RIL
Sbjct: 174 LGSPRYSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTEDVWPGVT 230
Query: 243 SVPD---TNP-------------ISQECRDLISRIFVADPA 267
S+PD T P + ++ DL+ ++ + DPA
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPA 271
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
++ ++ + ++G G FG ++K T L A K IE + + E+ EI + HP
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
IV+ L I++E+ GG + + R +E + + +Q++ + Y H+M+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 193
+ HRDLK N LL DG +K+ DFG S +V Q + S +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 194 --RHEYDGKIADVWSCGVTLYVM 214
YD K AD+WS G+TL M
Sbjct: 187 MKDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 66/192 (34%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G + R K+T+ LVA+K I E + RE+ ++L+H NIV ++I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
T L +V EY +L + + N G S + F QL+ G+SYCH ++ HRDLK
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVW 205
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY I D+W
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI-DMW 188
Query: 206 SCGVTLYVMLVG 217
G LY M G
Sbjct: 189 GVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-20
Identities = 72/257 (28%), Positives = 119/257 (46%), Gaps = 28/257 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIINHRSL 76
D ++ ++ IG G FG +++ K T+ + A+K + + + + +R ++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 135
+ I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
H + HRD+K +N LLD + R LK+ G +SSV VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171
Query: 189 PEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
PE+L E G D WS GV +Y ML G PF + + K + Q+
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS 231
Query: 245 PDTNPISQECRDLISRI 261
T+ +S+E +DLI R+
Sbjct: 232 HITD-VSEEAKDLIQRL 247
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 6e-20
Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-D--ENVQ------REI 70
H +Y+ ++ +G G +G+ D+ TKE+VA+K KI D N REI
Sbjct: 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------KIFDAFRNATDAQRTFREI 57
Query: 71 INHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFF 125
+ + L HPNIV+ VI I + + E E + A + R+
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIM 113
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----- 180
QL+ + Y H+ V HRDLK N LL+ R+K+ DFG ++S +
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 181 -VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
V T Y APE+LL K D+WS G L ML+G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-20
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
D ++ + ++G+GN GV ++ K + ++A K I +I ++ +II + H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
P IV F + ++I ME+ GG L + + A R E+ ++ G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
Q+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPD 225
+ +D+WS G++L + +G YP PD
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-20
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
D ++ + ++G+GN GV + K + ++A K I +I ++ +II + H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPD 225
+ +D+WS G++L M +G YP PD
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 68/215 (31%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
RY +R +G G+ G+ D + VAVK I D ++ REI R L H N
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 81 IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 126
IV+ EV+ T L IV EY + G SE+ AR F
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 182
QL+ G+ Y H+ V HRDLK N ++ + LKI DFG ++ H K +
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
T Y +P +LL K D+W+ G ML G
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 78/257 (30%), Positives = 121/257 (47%), Gaps = 28/257 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK------YIERGDKIDENVQREIINHRSL 76
D ++ ++ IG G FG +++ K T ++ A+K ++R + +R+++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 135
R I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 189
H + HRD+K +N LLD + RL DFG S L T VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 190 EVLLRHEYDGK-----IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
E+L E DGK D WS GV +Y ML G PF + + K + Q+
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP- 230
Query: 245 PDTNPISQECRDLISRI 261
PD +S+E +DLI R+
Sbjct: 231 PDVTDVSEEAKDLIRRL 247
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 68/211 (32%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------REIINHRSLR 77
RY IG G++GV D T E VA+K I + + E+V REI R LR
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57
Query: 78 HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
HP+IV K ++L P+ + +V E +L + I + + +FF QL+ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 188
Y H V HRDLK +N L + +LKICDFG ++ + + V T Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 189 PEVL--LRHEYDGKIADVWSCGVTLYVMLVG 217
PE+ +Y I D+WS G +L G
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-19
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN 80
SD ++ + IG G +G + +K AVK ++ IDE ++ E ++L HPN
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 81 IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 131
+V+F K+ + L +V+E +GG +L + G R E + + + G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 189
+ + H + HRD+K N LL + +K+ DFG S +S + ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193
Query: 190 EVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
EV+ L YD + DVWS G+T + G P D
Sbjct: 194 EVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 19/218 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPN 80
+D ++ + IG G +G + +K L AVK ++ +DE ++ E +SL HPN
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 81 IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 131
+V+F + L +V+E +GG EL + + G R E + + G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 190
+ + H ++ HRD+K N LL +K+ DFG S + + ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 191 VL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
V+ + YD + DVWS G+T + G P D
Sbjct: 199 VIACEQQYDYSYDAR-CDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-19
Identities = 73/251 (29%), Positives = 119/251 (47%), Gaps = 19/251 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDKIDEN--VQREIINHRSLRHPNI 81
Y FVR +G G++G L+R + K+ V K R E ++E L+HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 82 VRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHAM 138
V ++E L IVM + GG+L+ ++ G+ E++ +F Q+ + Y H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRH 195
+ HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++PE+
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
Y+ K +DVW+ G +Y M + F KD + RI+ + P S E
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRIIEGKLP-PMPKDYSPELG 231
Query: 256 DLISRIFVADP 266
+LI+ + P
Sbjct: 232 ELIATMLSKRP 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-19
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 12/224 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLR 77
+D Y+ + +G G++ + KV +LVA+K I E G RE + L+
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLK 61
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
H NIV ++I T L +V EY + G + + F QL+ G+SY H
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE 196
+ HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+VLL
Sbjct: 122 RYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
D+W G M+ G F KD + ++RI V
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPG---MKDIQDQLERIFLV 220
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-19
Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 18/219 (8%)
Query: 28 VRDIGSGNFGVARLMR----DKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNI 81
+R +G G+FG L + T E+VAVK ++R G + ++EI ++L H NI
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 82 VRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
V++K L ++MEY G L + + + + + F QQ+ G++Y H+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPEVLLRH 195
HRDL N LLD +KI DFG +K+ + + + +P + A E L +
Sbjct: 128 YIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
++ +DVWS GVTLY +L + P PK F + I
Sbjct: 186 KF-SYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-19
Identities = 67/251 (26%), Positives = 113/251 (45%), Gaps = 22/251 (8%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRF 84
+ IG G F + VA+K ++ D +D + + I + L HPN++++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQV 140
+ L IV+E A G+L I + + E +F QL S + + H+ +V
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
HRD+K N + + +K+ D G SK++ H S VGTP Y++PE + +
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHEN 181
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
Y+ K +D+WS G LY M PF + + ++I Y ++ S+E R
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 256 DLISRIFVADP 266
L++ DP
Sbjct: 239 QLVNMCINPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-19
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
F++++G+G FGV + + + + VA+K I+ G ++ E L H +V+
Sbjct: 8 FLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
V + IV EY S G C E RF QL+ G++Y + Q
Sbjct: 67 VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
HRDL N L+D +K+ DFG S+ VL + S+VG+ + PEVLL +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ 235
+ K +DVW+ GV ++ V +G P+E + + K Q
Sbjct: 178 FSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-19
Identities = 69/254 (27%), Positives = 121/254 (47%), Gaps = 20/254 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIINHRSLRH 78
++ ++ IG G FG +++ K ++ A+K + + + + +R+++ + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA 137
I +L +VM+Y GG+L + R ED ARF+ +++ + H
Sbjct: 63 --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRH 195
+ HRD+K +N L+D + RL DFG + +S+ VGTP YI+PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 196 EYDGK-----IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
E DGK D WS GV +Y ML G PF + + K + Q+ T+ +
Sbjct: 179 E-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD-V 236
Query: 251 SQECRDLISRIFVA 264
S++ +DLI R+ +
Sbjct: 237 SEDAKDLIRRLICS 250
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-19
Identities = 73/223 (32%), Positives = 108/223 (48%), Gaps = 13/223 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
+ Y + +G G++ R K+T +LVA+K I E G RE + L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 137
NIV ++I T L +V EY +L + + + G S R F QL+ G++YCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RH 195
+V HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VLL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 238
EY + D+W G Y M G F + +D I R+L
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-19
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 24 RYDFVRDIGSGNFGVARLMRDK--VTKELVAVKYIE----RGDKIDENVQREIINHRSLR 77
+Y+ IG G +G + K + A+K + + I ++ REI R L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 78 HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 131
H N+V EV L ++ + +YA F R + Q+++G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 132 VSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 183
V Y H+ V HRDLK N L+ +G +KI D G ++ + ++ K V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178
Query: 184 PAYIAPEVLL--RHEYDGKIADVWSCG 208
Y APE+LL RH Y I D+W+ G
Sbjct: 179 IWYRAPELLLGARH-YTKAI-DIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-19
Identities = 61/192 (31%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G + R K+T LVA+K I E + RE+ + L+H NIV ++I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 89 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
T L +V EY +L + + + G + + F QL+ G++YCH +V HRDLK
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVW 205
+N L++ LK+ DFG +++ + ++ S V T Y P++LL +Y +I D+W
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI-DMW 189
Query: 206 SCGVTLYVMLVG 217
G Y M G
Sbjct: 190 GVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 22/216 (10%)
Query: 26 DFVRDIGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPN 80
+ + IG + L + K T LVAVK I E++ Q+EII R L+HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 81 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
I+ + + + L +V M Y S +L + G E F + +++ + Y H+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 189
HR +K + LL G ++ + YS + V+H PKS+V +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 190 EVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFED 223
EVL + Y+ K D++S G+T + G PF+D
Sbjct: 178 EVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G + R K+T+ LVA+K I E + RE+ + L+H NIV +++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 89 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
T L +V EY +L + + + G S + F Q++ G++YCH +V HRDLK
Sbjct: 74 HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKP 132
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVW 205
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY +I D+W
Sbjct: 133 QNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI-DMW 189
Query: 206 SCGVTLYVMLVG 217
G + M G
Sbjct: 190 GVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 28 VRDIGSGNFGVARLMR-----DKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+RD+G G+FG L R D T E VAVK + E G ++++EI R+L H N
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 81 IVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K + + ++ME+ G L E + N + + + + Q+ G+ Y +
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLL 193
Q HRDL N L++ ++KI DFG +K+ + K + +P + APE L+
Sbjct: 128 RQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
+ ++ +DVWS GVTLY +L
Sbjct: 186 QSKF-YIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 83
++ V +G+G +G R T +L A+K ++ + +E ++ EI + + H NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 84 FKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 135
+ + P H L +VME+ G + + + N ED + ++++ G+++
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 194
HA +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 138 HAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 195 HE-----YDGKIADVWSCGVTLYVMLVGGYPFED 223
E YD + +D+WS G+T M G P D
Sbjct: 196 DENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 73/233 (31%), Positives = 115/233 (49%), Gaps = 26/233 (11%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR--SLRH 78
D + + + +IGSG G MR K T ++AVK + R +EN +R +++ H
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71
Query: 79 --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 134
P IV+ +T + + I ME S +L +RI G ED ++ + Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129
Query: 135 C---HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPE 190
H V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPE 184
Query: 191 VL----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
+ +YD + ADVWS G++L + G +P+++ +F + + +IL
Sbjct: 185 RIDPPDPNPKYDIR-ADVWSLGISLVELATGQFPYKNCK--TEF-EVLTKILQ 233
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-17
Identities = 63/260 (24%), Positives = 119/260 (45%), Gaps = 24/260 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
D + + ++G GN+G + + T +A+K I ++DE+ +II + H
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 135
P IV F + + MEY G +L+ ED R ++ G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 136 -HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 195 HEYDGKI-----ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
+ +DVWS G+++ M +G YP+ P+ + ++ ++ P T P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIVDGDPPTLP 231
Query: 250 --ISQECRDLISRIFVADPA 267
S + +D +++ P
Sbjct: 232 SGYSDDAQDFVAKCLNKIPN 251
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-17
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 22/199 (11%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 86
+G GN G +T+ ++AVK I I +Q++I++ + + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 87 VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCH 142
++I E+ GG L + +I GR + ++ G++Y ++++ H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RD+K N L++ ++K+CDFG S V +S K+ VGT AY+APE + +Y G +
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHS 174
Query: 203 DVWSCGVTLYVMLVGGYPF 221
DVWS G++ + +G +P+
Sbjct: 175 DVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 48/156 (30%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGV 132
+++ HP+++R K+ +++ +V+ + S +L+ + + D+A +Q++ G+
Sbjct: 112 QNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGL 170
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
Y HA ++ HRD+K EN ++ ++ I D G ++ V+ GT APEVL
Sbjct: 171 RYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL 228
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYP---FEDPD 225
R +Y+ K AD+WS G+ L+ ML YP FEDP
Sbjct: 229 ARDKYNSK-ADIWSAGIVLFEML--AYPSTIFEDPP 261
|
Length = 357 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 73/242 (30%), Positives = 111/242 (45%), Gaps = 42/242 (17%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTK--ELVAVKYIERGDKIDENVQREIINHRSLR---- 77
RY+ ++++G G +G+ R+ T E VA+K KI ++I+ R+LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54
Query: 78 ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 125
H NI ++ I+ P + + Y EL E +I +G ++ + F
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 180
Q++ G+ Y H+ V HRDLK N L D LKICDFG ++ S + T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167
Query: 181 --VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 238
V T Y APE++L + K DVWS G L L+G P + KD+ + +IL
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPVF---KGKDYVDQLNQIL 223
Query: 239 SV 240
V
Sbjct: 224 QV 225
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 27 FVRDIGSGNFGVARLMR-DKV---TKELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 81
F++ +G GNFG L R D + T E+VAVK ++ + +REI +SL+H NI
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 82 VRFKEVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHAM 138
V++K V + +L +VMEY G L + + R + + Q+ G+ Y +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEV 191
+ HRDL N L++ R+KI DFG +K + Q K V P + APE
Sbjct: 128 RYVHRDLATRNILVESE--NRVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPES 182
Query: 192 LLRHEYDGKIADVWSCGVTLY 212
L ++ +DVWS GV LY
Sbjct: 183 LTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR----- 77
DRY + +GSG +G D T VA+K K+ Q I R+ R
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68
Query: 78 ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 127
H N++ +V + L +V G +L I + S+D +F Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 185
++ G+ Y H+ + HRDLK N ++ LKI DFG ++ H+ + T V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
Y APE++L + + D+WS G + +L G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPN 80
RY ++ +GSG +G DK T E VA+K + R + + RE+ + ++H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 81 IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++ +V + +VM Y ++I SED+ ++ Q++ G+ Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
H+ + HRDLK N L + LKI DFG ++ + ++ V T Y APEV+L
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILN 188
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
+ + D+WS G + ML G F+ KD+ + +IL V
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKV 230
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFK 85
++G+GN GV + + + ++A K I +I ++ +II + H P IV F
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNSPYIVGFY 65
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRD 144
+ ++I ME+ GG L + + AGR E+ ++ G++Y ++ HRD
Sbjct: 66 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRD 125
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y + +D+
Sbjct: 126 VKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYTVQ-SDI 181
Query: 205 WSCGVTLYVMLVGGYPFEDPDE 226
WS G++L M +G YP PD
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-17
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
F++++GSG FGV L + + + VA+K I G +E+ E L HP +V+
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 87 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V L IV E+ G L + G+ S+D Q + G+ Y HRDL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIA 202
N L+ S +K+ DFG ++ VL + S+ G + PEV +Y K +
Sbjct: 127 AARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-S 182
Query: 203 DVWSCGVTLY-VMLVGGYPFE 222
DVWS GV ++ V G PFE
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-17
Identities = 73/275 (26%), Positives = 120/275 (43%), Gaps = 36/275 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
DRY ++ +GSG +G D+ T VA+K + R + + RE+ + ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 80 NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
N++ +V L +VM + G ++ + SED +F Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y HA + HRDLK N L + LKI DFG ++ + S+ V T Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQRILS 239
+ + D+WS G + ML G F+ D K+F + +Q +
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248
Query: 240 VQY--SVPDTNPISQECRDLISRIFVADPAAVSIF 272
Y +P +D S + A+P AV++
Sbjct: 249 KNYVKKLPRF-----RKKDFRSLLPNANPLAVNVL 278
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
V++IGSG FG+ L + K VA+K I G +E+ E L HP
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPK 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+V+ V + + +V E+ G L + + G+FS++ + G++Y +
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV +
Sbjct: 121 VIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
Y K +DVWS GV ++ V G P+E+
Sbjct: 178 YSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-16
Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 18/214 (8%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 83
++ V +G+G +G R T +L A+K ++ +E +++EI + + H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 84 FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 135
+ + L +VME+ G + + I N E+ + ++++ G+S+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 194
H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 195 HE-----YDGKIADVWSCGVTLYVMLVGGYPFED 223
E YD K +D+WS G+T M G P D
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
F++++GSG FGV L + + K VA+K I G +++ E L HPN+V+
Sbjct: 8 FLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 87 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V + IV EY + G L + G+ + + + Y + HRDL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIA 202
N L+ +K+ DFG ++ VL Q S+ GT + PEV + K +
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182
Query: 203 DVWSCGVTLYVMLVGG-YPFE 222
DVWS GV ++ + G P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y + +G G++ ++ +LVA+K I K +E V RE + L+H N
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISM--KTEEGVPFTAIREASLLKGLKHAN 64
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV ++I T L V EY I + G R F QL+ G++Y H +
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYD 198
HRDLK +N L+ S LK+ DFG +++ + SQ S+ V T Y P+VLL +Y
Sbjct: 125 LHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 199 GKIADVWSCGVTLYVMLVG 217
+ D+W G ML G
Sbjct: 183 SAL-DIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-16
Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 21/250 (8%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 81
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ 139
V T L +V+ +GG+L I + G F E A F+ ++ G+ H +
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ Y
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDL 257
D W+ G LY M+ G PF+ + K R+ ++R++ V + + S + R L
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVK---EVQEEYSEKFSPDARSL 235
Query: 258 ISRIFVADPA 267
+ DP
Sbjct: 236 CKMLLCKDPK 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-16
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 30 DIGSGNFGVARLMRDKVTKEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
+G G+FGV R R + + VAVK + DK+ + + +E SL H N+
Sbjct: 2 KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHAMQ 139
+R V+LT L +V E A G L +R+ +A G F + Q+ +G+ Y + +
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLL 193
HRDL N LL + ++KI DFG ++ + + V P A+ APE L
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES-L 172
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
R +DVW GVTL+ M G E+P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYG---EEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-16
Identities = 65/247 (26%), Positives = 108/247 (43%), Gaps = 17/247 (6%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 81
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ 139
V T L +V+ +GG+L I N G F E+ A F+ +++ G+ H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+RDLK EN LLD ++I D G + + VGT Y+APEVL Y
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-T 179
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
D W G +Y M+ G PF E + +R+L + + S+E + +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY--SAKFSEEAKSICK 237
Query: 260 RIFVADP 266
+ DP
Sbjct: 238 MLLTKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 8e-16
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 29 RDIGSGNFGVAR--LMRDKVTKEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 81
+++G GNFG + K KE+ VAVK +++ + I ++E + S L HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR V L +VME A G L + + + + Q+ G++Y +
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLRHEY 197
HRDL N LL + KI DFG S++ ++T P + APE + ++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 198 DGKIADVWSCGVTLYVML-VGGYPFED 223
K +DVWS GVTL+ G P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-16
Identities = 80/293 (27%), Positives = 116/293 (39%), Gaps = 61/293 (20%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
D Y+ + IG G +G RDK T +LVA+K R + +E + REI + L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59
Query: 79 -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 127
IVR +V L +V EY +L + + + GR + F Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 186
L+ GV++CH V HRDLK +N L+D LKI D G ++ S+ + T Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------ 240
APEVLL + D+WS G M F E +Q++L +
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-------LQQLLHIFKLLGT 230
Query: 241 --------------------------QYSVPDTNPISQECRDLISRIFVADPA 267
+VPD +S E DL+ ++ DPA
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPA 280
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 55/185 (29%), Positives = 82/185 (44%), Gaps = 11/185 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
IG G FG +M + VAVK ++ + E +LRHPN+V+ V+L
Sbjct: 14 IGKGEFG--DVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 91 PTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L IV EY + G L + + + GR + + F + G+ Y HRDL
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR 131
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSC 207
N L+ K+ DFG +K + K V + APE L ++ K +DVWS
Sbjct: 132 NVLVSEDLVA--KVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKFSTK-SDVWSF 185
Query: 208 GVTLY 212
G+ L+
Sbjct: 186 GILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-15
Identities = 68/253 (26%), Positives = 110/253 (43%), Gaps = 27/253 (10%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 79
R +G G FG + + T ++ A K +E+ G+ + N ++ E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF---- 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
+V T L +V+ +GG+L I N G F E+ A F+ ++ G+ H
Sbjct: 62 -VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHE 196
++ +RDLK EN LLD ++I D G + + + + VGT Y+APEV+
Sbjct: 121 ERIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNER 177
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPDTNPISQEC 254
Y D W G +Y M+ G PF E + +R+ Q YS S+
Sbjct: 178 Y-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS----EKFSEAA 232
Query: 255 RDLISRIFVADPA 267
R + ++ DP
Sbjct: 233 RSICRQLLTKDPG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 6/146 (4%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
V+ I G FG L R K +L AVK +++ D I++N+ ++ R + P IV
Sbjct: 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVH 68
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+ + ++ +VMEY GG++ + G F E+ A + ++ + Y H + HR
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHR 128
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK 169
DLK +N L+ S +K+ DFG SK
Sbjct: 129 DLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 21/226 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
RY ++ IGSG G+ D + + VA+K + R + + +R E++ + + H N
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 131
I+ V TP + IVME +C + D R + Q++ G
Sbjct: 85 IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ + H+ + HRDLK N ++ LKI DFG ++++ V T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 237
+L Y + D+WS G + M+ GG F D + K I+++
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 86
IG G FG M K + ++AVK I R ++ +R +++ RS P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 87 VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 135
+ I ME S + ++ + + ++++ ++
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 193
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181
Query: 194 --RHEYDGKIADVWSCGVTLYVMLVGGYPF 221
R YD + +DVWS G+TLY + G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREIINHRSLR--- 77
+Y+ V +IG G +G RD + VA+K + D + + RE+ + L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 78 HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 130
HPNIVR +V T T + +V E+ +++ G + + +Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
G+ + HA + HRDLK EN L+ + ++K+ DFG ++ V T Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 191 VLLRHEYDGKIADVWSCGVTLYVML 215
VLL+ Y + D+WS G M
Sbjct: 178 VLLQSTYATPV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 21/226 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
RY ++ IGSG G+ D V VAVK + R + + +R E++ + + H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 81 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 131
I+ V TP + +VME +C D R + Q++ G
Sbjct: 82 IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ + H+ + HRDLK N ++ LKI DFG ++++ + V T Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 237
+L Y + D+WS G + ++ G F+ D + K I+++
Sbjct: 194 ILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 21/249 (8%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 79
R +G G FG + + T ++ A K +E+ G+ + N +R E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
+V T L +V+ +GG+L I N G F E A F+ +L G+
Sbjct: 62 -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
++ +RDLK EN LLD ++I D G + + VGT Y+APEV+ +Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
D W G +Y M+ G PF E + +R+ Q + S++ + +
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY--SEKFSEDAKSI 235
Query: 258 ISRIFVADP 266
+ +P
Sbjct: 236 CRMLLTKNP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 17/226 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
+RY + +GSG +G D ++ VAVK + R + RE+ + ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 80 NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
N++ +V T + E G +L I + S++ +F QL+ G+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
H+ + HRDLK N ++ L+I DFG ++ + + V T Y APE++L
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
+ + D+WS G + +L G F D+ ++RI+ V
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPG----NDYIDQLKRIMEV 231
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 18/194 (9%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
R + S N G + + L+A K ++ G + ++ EI+ L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHAMQVCHR 143
+ + ++ + +L+ + + +D + R +QL+ V Y H ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKI 201
D+KLEN L+ L DFG + + VGT A +PE+L Y +I
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEI 348
Query: 202 ADVWSCGVTLYVML 215
D+WSCG+ L ML
Sbjct: 349 TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 67/261 (25%), Positives = 119/261 (45%), Gaps = 25/261 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLR 77
D + + ++G G +GV MR T ++AVK I E Q+ + I+ RS+
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58
Query: 78 HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 133
P V F + + I ME S + ++++ + G ++ + ++ +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-IVKALE 117
Query: 134 YCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE- 190
Y H+ + V HRD+K N L++ ++K+CDFG S V S K+ G Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPER 174
Query: 191 ---VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
L + YD K +DVWS G+T+ + G +P++ P F++ Q + +P
Sbjct: 175 INPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLPA- 230
Query: 248 NPISQECRDLISRIFVADPAA 268
S E +D +++ +
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKE 251
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 65/249 (26%), Positives = 110/249 (44%), Gaps = 18/249 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
+RY + +GSG +G D T VAVK + R + + RE+ + ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 80 NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
N++ +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
H+ + HRDLK N L + LKI DFG ++ H+ + T V T Y APE++
Sbjct: 136 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
L + + D+WS G + +L G F D D K I R++ + S+
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLKKISSE 248
Query: 253 ECRDLISRI 261
R+ I +
Sbjct: 249 SARNYIQSL 257
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
IG+G+FGV T E VA+K + + + RE++ ++L H NI+ K+ T
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINIIFLKDYYYT 130
Query: 91 PT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
L +VME+ + + R N + + QL ++Y H+
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 138 MQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
+CHRDLK +N L+D P LK+CDFG +K+ + + S + + Y APE++L
Sbjct: 189 KFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
D+WS G + M++ GYP
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMIL-GYP 269
|
Length = 440 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 76/289 (26%), Positives = 113/289 (39%), Gaps = 62/289 (21%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR------ 77
RYD +R IG G G L D V VA+K I R D + ++ R LR
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57
Query: 78 ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 124
HP IV + + M Y G L + + S++ A F
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 125 -FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 167
F ++ + + Y H+ V HRDLK +N LL + I D+G
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 168 SKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
+ ++ +S P VGTP Y+APE LL D+++ GV LY ML +P+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR- 233
Query: 225 DEPKDFRKTIQRILSVQYSVPDTNPIS--QECRDLISRI----FVADPA 267
K RK +S + + ++ +E +S+I DPA
Sbjct: 234 ---KKGRK-----ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPA 274
|
Length = 932 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 53/236 (22%), Positives = 94/236 (39%), Gaps = 34/236 (14%)
Query: 22 SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDE-----N 65
S+RY +G G +G D +T ++VA+K + + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 66 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 125
RE+ ++H NI+ +V + + +VM+ + +L + + R +E + +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 174
Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183
Query: 175 SQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
Q + S V T Y APE+L+ E D+WS G +L G F +E
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239
|
Length = 335 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 73/280 (26%), Positives = 110/280 (39%), Gaps = 51/280 (18%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNIV 82
R IG G FGV + D + VA+K + + +N V RE+ +H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 83 RFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSYCHA 137
+ IL P H+ E EL + I + S D + F Q++ G+ Y H+
Sbjct: 63 SALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL-- 193
+ HRD+K N L++ + LKICDFG ++ T V T Y APE+L+
Sbjct: 122 AGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFE----------------DPDEPKDFRK----T 233
RH Y + D+WS G +L F+ P + R
Sbjct: 180 RH-YTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL-EAMRSACEGA 236
Query: 234 IQRILSVQYSVPDTN-------PISQECRDLISRIFVADP 266
IL + P + E L+ R+ V DP
Sbjct: 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDP 276
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 29 RDIGSGNFG-VAR-LMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 85
R +GSG FG V L +++V VA+K ++ D + ++ Q+E+ + LRH +++
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVR---VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLF 68
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHR 143
V + I+ E G L + + A Q+ G++Y HR
Sbjct: 69 AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128
Query: 144 DLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDG 199
DL N L+ K+ DFG + K V L S K + APE +
Sbjct: 129 DLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGTFST 183
Query: 200 KIADVWSCGVTLY-VMLVGGYPFE 222
K +DVWS G+ LY + G P+
Sbjct: 184 K-SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-13
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 28 VRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
R +G+G FG V + TK VAVK ++ G E +E + LRH +V+
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHAM 138
V + IV EY S G L + + E + QL+ G++Y +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLLR 194
HRDL N L+ + KI DFG ++ ++ + P + APE
Sbjct: 123 NYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 195 HEYDGKIADVWSCGVTLYVMLVGG---YP 220
+ K +DVWS G+ L ++ G YP
Sbjct: 179 GRFTIK-SDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYI-----ERGDKIDENVQREIINH-RSL 76
+Y+ V +IG G +G RD K VA+K + E G + + ++ H +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 77 RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 129
HPN+VR +V T L +V E+ +++ G +E FQ L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML 215
EVLL+ Y + D+WS G M
Sbjct: 179 EVLLQSSYATPV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 64/295 (21%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------REIINHRSLR 77
RY ++ IGSG G+ D VT + VA+K + R +NV RE++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73
Query: 78 HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 128
H NI+ V TP + +VME A+ ++ + + R S + Q+
Sbjct: 74 HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
+ G+ + H+ + HRDLK N ++ LKI DFG ++++ V T Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR--------ILSV 240
PEV+L Y + D+WS G + M+ G F D + K I++ + +
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244
Query: 241 QYSV-------------------PDTN-PISQE---------CRDLISRIFVADP 266
Q +V PD P E RDL+S++ V DP
Sbjct: 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 43/227 (18%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
Y+ + +G G FG R T +VA+K I E+ D REI + L+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66
Query: 79 PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 124
PN+V ++ + + +V Y SG L E + + +E + + +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------ 178
QL+ G++Y H + HRD+K N L+D LKI DFG ++ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGG 176
Query: 179 --------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+ V T Y PE+LL D+W G M
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-13
Identities = 70/286 (24%), Positives = 117/286 (40%), Gaps = 45/286 (15%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
RY ++ IGSG G+ D V VA+K + R + + +R E++ + + H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
I+ V L + EL + +C + D R + Q++ G+ + H+
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
+ D+WS G + M+ F D + K I+++
Sbjct: 196 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPA 267
L+ PD+ N + + + RDL+S++ V DPA
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR 77
D+ + IG+G FG R K+ +E+ VA+K ++ G E +R+ ++ S+
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59
Query: 78 ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 131
HPNI+ + V+ + IV EY G L F R + G+F+ + + + SG
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 185
+ Y M HRDL N L++ + K+ DFG S+ VL P++ T
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ APE + ++ +DVWS G+ ++ VM G P+ +
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 31 IGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
+G G +G A+ K KE A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEY-ALKQIE-GTGISMSACREIALLRELKHPNVIALQKV 66
Query: 88 ILTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHA 137
L+ + + ++ +YA F R A + + Q++ G+ Y HA
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIA 188
V HRDLK N L+ +G R+KI D G+++ L + P V T Y A
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRA 183
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVML 215
PE+LL + K D+W+ G +L
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 66/223 (29%), Positives = 95/223 (42%), Gaps = 39/223 (17%)
Query: 27 FVRDIGSGNFGVARL-----MRDKVTKE-----------LVAVKYIERG--DKIDENVQR 68
FV +G G FG L ++D K LVAVK + D E+ +
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 69 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRFS 117
E+ L PNI R V L ++MEY G+L F + CN+ S
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177
+ Q+ SG+ Y ++ HRDL N L+ +KI DFG S++ L+S
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSSD 184
Query: 178 KSTVG--TPAYI---APEVLLRHEYDGKIADVWSCGVTLYVML 215
V P I A E +L ++ K +DVW+ GVTL+ +L
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 64/199 (32%), Positives = 88/199 (44%), Gaps = 22/199 (11%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
IG G FG +++ + T + VAVK I K D Q E L H N+VR V
Sbjct: 14 IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHRDL 145
IL L IVME S G L + GR + F + G+ Y + ++ HRDL
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADV 204
N L+ S K+ DFG ++ + S P + APE L ++ K +DV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180
Query: 205 WSCGVTLYVMLVGG---YP 220
WS GV L+ + G YP
Sbjct: 181 WSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 35/214 (16%)
Query: 31 IGSGNFG---VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
IG G FG RL + VA+K ++ G DK + E HPNI+R +
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 86 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGVSYCH 136
V+ + I+ EY G L F R E++ +F QL+ SG+ Y
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-----PA-YIAPE 190
M HRDL N L++ + K+ DFG S+ L ++T T P + APE
Sbjct: 124 EMNYVHRDLAARNILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKIPIRWTAPE 178
Query: 191 VLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ + +DVWS G+ ++ VM G P+ D
Sbjct: 179 A-IAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 53/186 (28%), Positives = 75/186 (40%), Gaps = 17/186 (9%)
Query: 47 TKELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 100
T VA+K + R D +E +RE L HPNIV P L V EY
Sbjct: 2 TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APR 159
G L E + G E Q++ ++ H + HRDLK +N ++ + P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 160 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 211
K+ DFG + T +GTP Y APE LR E +D+++ G+
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGLIF 179
Query: 212 YVMLVG 217
L G
Sbjct: 180 LECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 31 IGSGNFGVARLMRDKVTKEL--VAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G +G + K K+ A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 89 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHAM 138
L+ + ++ +YA F R A + + Q++ G+ Y HA
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 189
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML 215
E+LL + K D+W+ G +L
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-12
Identities = 65/245 (26%), Positives = 102/245 (41%), Gaps = 19/245 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 86
IG GNFG R + VAVK + + +++ + + + HPNIVR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V + IVME GG+ + G R E + +G+ Y + HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLRHEYDGKIA 202
N L+ LKI DFG S+ +++ P + APE L Y + +
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-S 177
Query: 203 DVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
DVWS G+ L+ +G P+ + + R+ I++ V+ P+ P L+ R
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQ--GVRLPCPELCP--DAVYRLMERC 232
Query: 262 FVADP 266
+ DP
Sbjct: 233 WEYDP 237
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-12
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 24 RYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----R 74
+ ++ +GSG FG V +KV K VA+K + ++ +EI++
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKV-KIPVAIKVLR--EETSPKANKEILDEAYVMA 64
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 133
S+ HP++VR + L+ ++ + G L + + + + Q+ G+S
Sbjct: 65 SVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPE 190
Y ++ HRDL N L+ +P +KI DFG +K V + + G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 191 VLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+L Y K +DVWS GVT++ +M G P+E
Sbjct: 182 SILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-12
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 15/193 (7%)
Query: 30 DIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
++GSGNFG + + + K +++ VAVK I + D D ++ E++ + L +P IVR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
I +VME A G L + + +E Q+ G+ Y HR
Sbjct: 61 MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLRHEYDG 199
DL N LL KI DFG SK + + + K+ P + APE + +++
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 200 KIADVWSCGVTLY 212
K +DVWS GV ++
Sbjct: 178 K-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-12
Identities = 62/215 (28%), Positives = 85/215 (39%), Gaps = 41/215 (19%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFK 85
IG GNFG K VAVK R + ++ + L HPNIV+
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAM 138
V + + IVME GG L + + + R ++L+ +G+ Y +
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPAYIA 188
HRDL N L+ + LKI DFG Y+ S L P K T A
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT-------A 163
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
PE L Y + +DVWS G+ L+ G YP
Sbjct: 164 PEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-12
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 31 IGSGNFG-VAR-LMRDKVTKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
IG+G FG V R +++ KE+ VA+K ++ G E +++ ++ S+ H NI+R
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 84 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ V+ I+ EY G L + + + G FS + + + +G+ Y M H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRHE 196
RDL N L++ + K+ DFG S+ VL P+ T T + APE + +
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS G+ ++ VM G P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 31 IGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
IG+G FG RL + VA+K ++ G E +R+ ++ S+ HPNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 84 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+ V+ + I+ E+ G L F R N G+F+ + + + +G+ Y M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 193
HRDL N L++ + K+ DFG S+ L T + + APE +
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
++ +DVWS G+ ++ VM G P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 33/212 (15%)
Query: 29 RDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHP 79
R++G G+FG +A+ + + VA+K + + E E +N S
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCH 69
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF--------FFQ--- 126
++VR V+ T +VME + G+L + R R + F Q
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQKFIQMAA 126
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P 184
++ G++Y A + HRDL N ++ +KI DFG ++ + P
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 185 A-YIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
++APE L + K +DVWS GV L+ M
Sbjct: 185 VRWMAPESLKDGVFTTK-SDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-11
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 30 DIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 83
++GSGNFG + K+ K+ VA+K ++ + +++V+ E++ + H P IVR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 84 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V L +VME ASGG L + + + Q+ G+ Y H
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLRHEYD 198
RDL N LL KI DFG SK+ + + +S P + APE + ++
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 199 GKIADVWSCGVTLYVML-VGGYPFE 222
+ +DVWS G+T++ G P++
Sbjct: 177 SR-SDVWSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 8e-11
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 31 IGSG--NFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRFK 85
IG G + L R K T E V V+ I +E V Q E+ + HPNIV ++
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65
Query: 86 EVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+ L +V + + G + IC SE + Q ++ + Y H M HR
Sbjct: 66 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHR 125
Query: 144 DLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAYIAPEV 191
+K + L +DG K+ G + V+H PK +V +++PEV
Sbjct: 126 SVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEV 179
Query: 192 LLRH--EYDGKIADVWSCGVTLYVMLVGGYPFED 223
L ++ YD K +D++S G+T + G PF+D
Sbjct: 180 LQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-11
Identities = 60/186 (32%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
IG G FG L + K VAVK I + D + E LRH N+V+ VI+
Sbjct: 14 IGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 91 P-THLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
L IV EY + G L + + + GR D F + + Y A HRDL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWS 206
N L+ S K+ DFG +K + S + T P + APE L ++ K +DVWS
Sbjct: 131 RNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SDVWS 184
Query: 207 CGVTLY 212
G+ L+
Sbjct: 185 FGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 31 IGSGNFG------VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPN 80
+GSG FG ++ VAVK + +G E ++E + L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 133
IV+ V L I+ME GG+L + +A ++L+ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTPAYI 187
Y M HRDL N L+ G A R +KI DFG ++ S + + + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 188 APEVLLRHEYDGKI---ADVWSCGVTLY-VMLVGGYPF 221
APE LL DGK +DVWS GV ++ ++ +G P+
Sbjct: 181 APESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 21 DSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP 79
D +R +G+G FG V + + T VAVK ++ G ++ E + LRHP
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
+++ V + IV E G L E + QLI SG+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 189
+Y A HRDL N L+ + K+ DFG ++ + ++ G I AP
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
E L + + K +DVWS G+ L ++ G YP
Sbjct: 174 EAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYP 206
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 71/249 (28%), Positives = 104/249 (41%), Gaps = 42/249 (16%)
Query: 31 IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 85
+G GNFG ++DK VAVK + D E + + R L+ HPNIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAM 138
V + IVME GG+ + R +DE + +QL+ +G++Y +
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 190
HRDL N L+ + LKI DFG S+ SS L P + APE
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPE 164
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
L Y + +DVWS G+ L+ G YP + ++ + R+ Q D
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDV 223
Query: 248 NPISQECRD 256
+ Q C D
Sbjct: 224 YKVMQRCWD 232
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 27 FVRDIGSGNFGVARL-----MRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
R++G G FG L + + KELVAVK ++ + ++ +RE + +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 125
NIV+F V +V EY G+L + + G + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
Q+ SG+ Y + HRDL N L+ +KI DFG S+ +++ VG
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHT 184
Query: 186 -----YIAPEVLLRHEYDGKIADVWSCGVTLY 212
++ PE ++ ++ + +DVWS GV L+
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 43/229 (18%)
Query: 23 DRYDFVRDIGSGNFGVARL-----MRDKVTKE-----------LVAVKYIERGDKIDENV 66
R F +G G FG L M + K+ LVAVK + R D ++N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62
Query: 67 Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 111
+ +EI L+ PNI+R V +T L ++ EY G+L + +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 112 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171
+ S F Q+ SG+ Y ++ HRDL N L+ + +KI DFG S++
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179
Query: 172 VLHSQPKSTVGTPA-----YIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
L+S + A +++ E +L ++ +DVW+ GVTL+ +L
Sbjct: 180 -LYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 13/169 (7%)
Query: 51 VAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 110
VAVK ++ E +E + ++HPN+V+ V I+ E+ + G L + +
Sbjct: 34 VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 93
Query: 111 CNAGRFSEDEARFFFQ--QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168
R + + Q+ S + Y HRDL N L+ +K+ DFG S
Sbjct: 94 RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLS 151
Query: 169 K-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 212
+ + H+ K + + APE L +++ K +DVW+ GV L+
Sbjct: 152 RLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SDVWAFGVLLW 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ V+ +G+G FG V + TK VAVK ++ G + E ++L+H +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
VR V+ + I+ EY + G L F + G+ + F Q+ G++Y
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
HRDL+ N L+ S + KI DFG ++ + ++ + G + APE +
Sbjct: 124 YIHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 197 YDGKIADVWSCGVTLYVMLVGG---YP 220
+ K +DVWS G+ LY ++ G YP
Sbjct: 181 FTIK-SDVWSFGILLYEIVTYGKIPYP 206
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 23 DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKY--IERGDKIDENVQREIINHRSLR 77
+ R IG G FG M + K VAVK + E +E R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 136
HP+IV+ VI T + IVME A GEL + N + QL + ++Y
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPEVLLR 194
+ + HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE +
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ +DVW GV ++ ++++G PF
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 44/229 (19%)
Query: 31 IGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 83
+G G FG A ++ + VAVK ++ E ++ E + + HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 84 FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 126
L +++EYA G L F R ++ + DE
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 127 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 173
LIS G+ Y M++ HRDL N L+ + ++KI DFG S+ S V
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
S+ + V ++A E L H Y + +DVWS GV L+ ++ +GG P+
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 24 RYDFV--RDIGSGNFGVARLM--------RDKVTKELVAVKYI-ERGDKIDENVQREIIN 72
R++ V R++G G FG L +DK+ LVAVK + + D ++ RE
Sbjct: 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKI---LVAVKTLKDASDNARKDFHREAEL 60
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSED 119
+L+H +IV+F V + L +V EY G+L + + G ++
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 176
+ QQ+ +G+ Y + HRDL N L+ + +KI DFG S+ S+ +
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRV 178
Query: 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
T+ ++ PE ++ ++ + +DVWS GV L+ + G
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYG 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 35/225 (15%)
Query: 20 HDSDRYDFVRDIGSGNFGV---ARLMRDKVTKE--LVAVKYIERG--DKIDENVQREIIN 72
+ + ++VRDIG G FG AR + +VAVK ++ + + QRE
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 112
HPNIV+ V + ++ EY + G+L E R C
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 113 AGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 169
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRN 179
Query: 170 --SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 212
S+ + ++ ++ PE + + Y + +DVW+ GV L+
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 61/247 (24%), Positives = 106/247 (42%), Gaps = 23/247 (9%)
Query: 29 RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
+ +G+G FG V +K TK VAVK ++ G E E ++L+H +V+ V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 88 ILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
+ T + I+ E+ + G L F + + + F Q+ G+++ HRDL
Sbjct: 70 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 146 KLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
+ N L+ S + KI DFG ++ K + + APE + + K
Sbjct: 129 RAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSFTIK 183
Query: 201 IADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
+DVWS G+ L ++ G P+ P+ + R L Y +P +E +++
Sbjct: 184 -SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELYNIMM 237
Query: 260 RIFVADP 266
R + P
Sbjct: 238 RCWKNRP 244
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-09
Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 29 RDIGSGNFG-VAR-LMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPNIVR 83
R +G+G FG + R ++ +EL VA+ + G DK E + H NIVR
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 84 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+ VI + IV EY S G L F R + G+ + L SG+ Y M
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129
Query: 142 HRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIAPEVLLRHE 196
H+ L L++ KI F KS +++ KS V + APE + H
Sbjct: 130 HKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAAPEAIQYHH 184
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS G+ ++ VM G P+ D
Sbjct: 185 FSSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 31 IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 83
IG GNFG + ++ + A+K ++ + ++ R+ + HPNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 127
+L + +EYA G L + R+ A S + F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 185
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++A E L Y +DVWS GV L+ ++ +GG P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 31 IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 83
IG GNFG + +++ K A+K ++ + EN R+ + HPNI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 129
+L I +EYA G L + + + D A QQL+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 130 --SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 185
+G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T+G P
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++A E L Y K +DVWS GV L+ ++ +GG P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 24/186 (12%)
Query: 50 LVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105
LVAVK + R D + + + +EI L++PNI+R V ++ L ++ EY G+
Sbjct: 46 LVAVKML-RAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 106 L------------FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153
L F N S + Q+ SG+ Y ++ HRDL N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 154 GSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210
+KI DFG S+ S + V ++A E +L ++ +DVW+ GVT
Sbjct: 164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVT 220
Query: 211 LYVMLV 216
L+ M
Sbjct: 221 LWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 21/240 (8%)
Query: 30 DIGSG--NFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRF 84
+IG G N L R T LV V+ + + +E++ Q E++ RHPNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 85 KEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V T + L ++ M Y S L + G SE + G++Y H
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYI 123
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEVLLR- 194
HR++K + L+ G L YS K+ V++ P+ + +++PE+L +
Sbjct: 124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183
Query: 195 -HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
+ Y+ K +D++S G+T + G PF+D + +Q++ YS D E
Sbjct: 184 LYGYNVK-SDIYSVGITACELATGRVPFQDMLRTQ---MLLQKLKGPPYSPLDITTFPCE 239
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 44/237 (18%)
Query: 24 RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
R++F RD +G G FG + +DK KE V V D E ++
Sbjct: 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 67
Query: 71 INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDE 120
++ + +H NI+ L +++EYAS G L E + A R +S D
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDI 126
Query: 121 AR-----FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168
AR F+ L+S G+ Y + + HRDL N L+ + +KI DFG +
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLA 184
Query: 169 K--SSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ +++ + + + P ++APE L Y + +DVWS GV ++ + +GG P+
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 34/221 (15%)
Query: 29 RDIGSGNFG------VARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+IG+G FG R M V KEL A + + VQ +R L HPN
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQ----PYRELNHPN 56
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 135
+++ + +V+E+ G+L R A +D + ++ SG+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVL 192
H H DL L N L + +KI D+G + + K P ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 193 LRHEYDGKIAD------VWSCGVTLYVMLVGGYPFEDPDEP 227
D D +WS GVT++ + F D+P
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL------FTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 27 FVRDIGSGNFG-VAR----LMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHP 79
F+ ++G G FG V + ++++ VA+K ++ K+ + ++E L+HP
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFFQ 126
NIV V ++ EY + G+L E + G S D + F
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 127 ---QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 180
Q+ +G+ Y + HRDL N L+ +KI DFG S+ S+ + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 212
+ ++ PE +L ++ + +D+WS GV L+
Sbjct: 187 LLPVRWMPPEAILYGKFTTE-SDIWSFGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 34/231 (14%)
Query: 17 PIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVK----YIERGDKIDENVQRE 69
P++ +D F IG GNFG AR+ +D + + A+K Y + D D + E
Sbjct: 2 PVLEWND-IKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELE 59
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNA 113
++ + HPNI+ +L + +EYA G L + + A
Sbjct: 60 VLC-KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
S + F + G+ Y Q HRDL N L+ + KI DFG S+ +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEV 176
Query: 174 HSQPKSTVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ K T+G P ++A E L Y +DVWS GV L+ ++ +GG P+
Sbjct: 177 YV--KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 30 DIGSGNFG------VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIV 82
++G G FG L+ ++ K LVAVK + E + ++ QRE L+H +IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQ-DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV 70
Query: 83 RFKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQ 127
RF V L +V EY G+L F R G+ + + Q
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-- 185
+ SG+ Y ++ HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTML 186
Query: 186 ---YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
++ PE +L ++ + +D+WS GV L+ + G
Sbjct: 187 PIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYG 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ ++ +G+G FG V + TK VAVK ++ G E+ E + LRH +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 135
V+ V+ + + IV EY S G L + + + GR + D A Q+ +G++Y
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 190
M HRDL+ N L+ KI DFG ++ L + T A + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
L + K +DVWS G+ L ++ G YP
Sbjct: 174 AALYGRFTIK-SDVWSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 30/222 (13%)
Query: 24 RYDFV--RDIGSGNFGVARL-----MRDKVTKELVAVKYIERGD-KIDENVQREIINHRS 75
R D V R++G G FG L + K LVAVK ++ ++ QRE +
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 63
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSED 119
L+H +IV+F V L +V EY G+L F R G
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 176
+ Q+ SG+ Y + HRDL N L+ + +KI DFG S+ S+ +
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRV 181
Query: 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
T+ ++ PE ++ ++ + +DVWS GV L+ + G
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYG 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 8e-08
Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 30/172 (17%)
Query: 74 RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 117
L H NI L H+ I + Y + G L F + C N S
Sbjct: 63 YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 174
+ Q+ G+SY H V H+D+ N ++D ++KI D S+ H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYH 173
Query: 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPD 225
+ ++A E L+ EY +DVWS GV L+ +M +G P+ + D
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEID 224
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 67/237 (28%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 29 RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 83
R IG G+FG L+ K AVK + R ++E Q +E I + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 84 FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVC 141
+ L +V+ Y G+L I + + + F Q+ G+ Y + +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 142 HRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
HRDL N +LD S +K+ DFG Y K S H+ K V ++A E L
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQ 175
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
++ K +DVWS GV L+ ++ G YP D + + +R+L +Y PD
Sbjct: 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY-CPDP 230
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 28 VRDIGSGNFGVAR----LMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNI 81
V+ +GSG FG + + K VA+K + G K + E + S+ HP++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
VR V L+PT + +V + G L + + + + Q+ G+ Y ++
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRH 195
HRDL N L+ SP +KI DFG ++ +L K ++A E +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFE 222
++ + +DVWS GVT++ +M GG P++
Sbjct: 187 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 31 IGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G FG V + T+ VA+K ++ G E +E + LRH +V+ V+
Sbjct: 14 LGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 70
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGVSYCHAMQVCHRDL 145
+ + IV EY S G L + + G + + Q+ SG++Y M HRDL
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRHEYDGK 200
+ N L+ + K+ DFG ++ L + T A + APE L + K
Sbjct: 129 RAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 201 IADVWSCGVTLYVMLVGG---YP 220
+DVWS G+ L + G YP
Sbjct: 184 -SDVWSFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 29 RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREI-------INHRSLRH 78
+ +G G FG +L +D ++ VAVK + K+D + EI + H
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI--- 129
PN+++ V + L +++ + G+L + R + Q L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFM 119
Query: 130 ----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKST 180
G+ Y HRDL N +L + +C DFG SK S + Q +
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
+IA E L Y K +DVW+ GVT++ + G YP
Sbjct: 176 KMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYP 217
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 34/262 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDEN----VQRE 69
+ F + +G+G FG +++ D V K VAVK ++ E + +
Sbjct: 35 NNLSFGKTLGAGAFG--KVVEATAYGLSKSDAVMK--VAVKMLKPTAHSSEREALMSELK 90
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQ 127
I++H H NIV + ++ EY G+L F R + ++ F Q
Sbjct: 91 IMSHLG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 185
+ G+++ + HRDL N LL + +KICDFG ++ + S K P
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 186 -YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKD--FRKTIQ---RIL 238
++APE + Y + +DVWS G+ L+ + +G P+ P P D F K I+ R+
Sbjct: 208 KWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPY--PGMPVDSKFYKLIKEGYRMA 264
Query: 239 SVQYSVPDTNPISQECRDLISR 260
+++ + I + C D
Sbjct: 265 QPEHAPAEIYDIMKTCWDADPL 286
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 23/212 (10%)
Query: 28 VRDIGSGNFG-----VARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
+R +G G FG + R + VAVK + D+ D ++ I++ H
Sbjct: 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS--KFNH 68
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQQLISG 131
NIVR V I++E +GG+L F R R S + F + + G
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SVLHSQPKSTVGTPAYI 187
Y HRD+ N LL R+ KI DFG ++ + + + + ++
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219
PE L + K DVWS GV L+ + GY
Sbjct: 189 PPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGY 219
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 59/253 (23%), Positives = 109/253 (43%), Gaps = 17/253 (6%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
V+ +G+G FG + + VA+K +++G E E + L+HP +VR V
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 88 ILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
+ T + I+ EY G L F + + + ++ Q+ G+++ HRDL
Sbjct: 70 V-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIA 202
+ N L+ S KI DFG ++ + ++ + G + APE + + K +
Sbjct: 129 RAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-S 184
Query: 203 DVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
DVWS G+ L ++ G P+ P+ + + L Y +P + +E +L+
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQNLERGYRMPRPDNCPEELYELMRLC 239
Query: 262 FVADPAAVSIFFF 274
+ P F +
Sbjct: 240 WKEKPEERPTFEY 252
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 11/182 (6%)
Query: 43 RDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102
++ V VK + G + REI +++ H I+ + + +VM
Sbjct: 114 HGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169
Query: 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162
+LF + +G ++A ++L+ ++Y H + HRD+K EN LD L
Sbjct: 170 C-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG- 227
Query: 163 CDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219
DFG + H P+ GT +PE+L Y K D+WS G+ L+ M V
Sbjct: 228 -DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNV 285
Query: 220 PF 221
Sbjct: 286 TL 287
|
Length = 392 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 39/226 (17%)
Query: 29 RDIGSGNFGVARLM------RDKVTKEL-VAVKYIERGDKIDENVQREIINHRSL----- 76
+ +G G FG + +DK K + VAVK + + D D+++ ++++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLS-DLVSEMEMMKMIG 75
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EARFFFQ 126
+H NI+ L +++EYAS G L E + A R +S D E + F+
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 127 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPK 178
L+S G+ Y + + HRDL N L+ +KI DFG ++ + K
Sbjct: 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKK 192
Query: 179 STVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+T G P ++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 25/241 (10%)
Query: 31 IGSGNFGVAR----LMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNIV 82
+GSG FG + K VA+K I+ D+ +EI +H SL H IV
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
R + + L +V + + G L + + + + Q+ G+ Y ++
Sbjct: 73 RLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV 131
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTP-AYIAPEVLLRHE 196
HR+L N LL S + ++I DFG + +L+ K S TP ++A E +L
Sbjct: 132 HRNLAARNILLK-SDS-IVQIADFGVA--DLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 197 YDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
Y + +DVWS GVT++ M+ G Y P E D + +R+ Q D + +
Sbjct: 188 YTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVK 246
Query: 254 C 254
C
Sbjct: 247 C 247
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 40/246 (16%)
Query: 31 IGSGNFGVARLMRDKVTKE-----LVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 81
+G G FG L + K +E LV VK +++ DEN+Q RE+ R L H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 132
VR + +++EY G+L F R + +Q ++ G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 133 SYCHAMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 187
+ + HRDL N L+ L Y+ + ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185
Query: 188 APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED-PDEPKDFRKTIQRILS--VQYS 243
APE + ++ K +DVWS GV ++ V G PF DE + + R+ + ++
Sbjct: 186 APEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLNRLQAGKLELP 239
Query: 244 VPDTNP 249
VP+ P
Sbjct: 240 VPEGCP 245
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 45/234 (19%)
Query: 23 DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDENVQREI 70
DR + +G G FG A + + VAVK + + D + E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 71 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------- 123
I +H NI+ V L +V+EYA+ G L + + A R + A
Sbjct: 72 IG----KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126
Query: 124 ----------FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
F Q+ G+ + + + HRDL N L+ + +KI DFG ++ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182
Query: 174 HSQP---KSTVG-TPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
H K+T G P ++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 44/146 (30%), Positives = 62/146 (42%), Gaps = 20/146 (13%)
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 177
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK--DFRKTI 234
TV T APEVL Y + D+WS G+ ++ V F + + I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378
Query: 235 QRILSVQYSVPDTNPISQECRDLISR 260
RI+ D P R L+S+
Sbjct: 379 LRIIRQAQVHVDEFPQHAGSR-LVSQ 403
|
Length = 461 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 19/227 (8%)
Query: 41 LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100
L+ D T++ +K + + + + II H PN+V + I++ + +V+++
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66
Query: 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160
A GG+L+ I E+ + + +++ + H + RDL N LLD +L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 220
+S+ S + Y APEV E + + D WS G L+ +L G
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTL 181
Query: 221 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
E P I ++P+ +S+E R L+ ++ +P
Sbjct: 182 VE--CHPSG----INT--HTTLNIPEW--VSEEARSLLQQLLQFNPT 218
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 45/235 (19%)
Query: 23 DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIER-------GDKIDENV 66
DR + +G G FG + ++VTK VAVK ++ D I E
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTK--VAVKMLKSDATEKDLSDLISEME 75
Query: 67 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED--- 119
++I +H NI+ L +++EYAS G L E R + +
Sbjct: 76 MMKMIG----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 120 --EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
E + F+ L+S G+ Y + + HRDL N L+ +KI DFG ++
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARD 189
Query: 171 -SVLHSQPKSTVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ K+T G P ++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 17/179 (9%)
Query: 44 DKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM-EYAS 102
D T E V +K +RG E I+ R++ HP+I++ K +++ Y +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162
+L+ + + + + ++ + Y H ++ HRD+K EN ++ P +
Sbjct: 168 --DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DV 221
Query: 163 C--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
C DFG + V + K GT A APE+L R Y G D+WS G+ L+ M
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 34/236 (14%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-------ENVQREIINHRSLRHPNI 81
+ +G G FG +M ++ ++ +K + KI E+ E + + HPN+
Sbjct: 5 KTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 82 VRFKEVILTPTHL------AIVMEYASGGEL-----FERICNAGRFSEDEARF-FFQQLI 129
+R V L +++ + G+L + R+ + ++ + F +
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVGTP 184
SG+ Y + HRDL N +L+ + + +C DFG SK + + Q +
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRI 237
+IA E L Y K +DVWS GVT++ + G YP + E D+ + R+
Sbjct: 179 KWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 180
F Q+ +G+ + + HRDL N L+ +KICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQR 236
++APE + + Y ++DVWS G+ L+ + +GG P+ + + F I+R
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 25/166 (15%)
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EARFFFQ 126
+H NI+ V L +++EYA+ G L E + A R ++ D E + F+
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPEEQLSFK 134
Query: 127 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQP 177
L+S G+ Y + + HRDL N L+ +KI DFG ++ + + +
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKK 192
Query: 178 KSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
S P ++APE L Y + +DVWS G+ ++ + +GG P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 29 RDIGSGNFGVARL--MRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 84
++IG+G FG L + T V VK + + E ++ E +RSL+H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHAMQ 139
T +VME+ G+L + R C + + ++ G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEV 191
H DL L N LL +KI D+G S H++ K +IAPE+
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 192 LLRHEYDG--------KIADVWSCGVTLYVML-VGGYPF 221
+ E G K ++VWS GVT++ + +G P+
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
F Q+ G+ + + HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 184 P----AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRIL 238
++APE + + Y ++DVWS G+ L+ + +GG P+ F I+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-- 355
Query: 239 SVQYSVPDTNPISQECRDLISRIFVADP 266
+ + PD QE D++ + + ++P
Sbjct: 356 GYRMAKPDHAT--QEVYDIMVKCWNSEP 381
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 34/222 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ R+ + +G G FG D+ KE AVK + K + + EI +R +
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187
Query: 82 V-RFKEVILT------PTHLAIVM-EYASGGELFERICNAGRFSEDE-ARFFFQQLISGV 132
RF + + H+ IVM +Y G L + I G FS A+ FQ +GV
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQ---TGV 242
Query: 133 S--YCHA-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHS 175
+ Y H + + H DLK EN L++ S P P R++ICD G HS
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHS 301
Query: 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+ + V T Y +PEV+L + D+WS G +Y + G
Sbjct: 302 R-TAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 28 VRDIGSGNFGVAR----LMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
++ +GSG FG + + K VA+K + K ++ + E S+ +P++
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 71
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
R + LT T + ++ + G L + + + + Q+ G++Y ++
Sbjct: 72 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRH 195
HRDL N L+ +KI DFG +K +L + K ++A E +L
Sbjct: 131 VHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFE 222
Y + +DVWS GVT++ +M G P++
Sbjct: 187 IYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 28 VRDIGSGNFGVAR----LMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHP 79
V+ +GSG FG + + K VA+K + N +EI++ + P
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAM 138
+ R + LT T + +V + G L + + N R + + Q+ G+SY +
Sbjct: 70 YVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLRH 195
++ HRDL N L+ SP +KI DFG ++ + G ++A E +L
Sbjct: 129 RLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFE 222
+ + +DVWS GVT++ +M G P++
Sbjct: 187 RFTHQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 14/137 (10%)
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 182
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 183 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 237
P ++APE + Y + +DVWS GV L+ + +G P+ ++F + ++ R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 238 LSVQYSVPDTNPISQEC 254
+ + + P+ I C
Sbjct: 297 RAPENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 27/223 (12%)
Query: 43 RDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102
+ V +K + + L H ++V+ V + ++ +V EY
Sbjct: 25 VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83
Query: 103 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL----- 152
G L E+ + + D A +QL S + Y ++ H ++ +N L+
Sbjct: 84 FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139
Query: 153 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA-DVWSCGVTL 211
+ P +K+ D G + + + + +IAPE + + IA D WS G TL
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTL 196
Query: 212 YVMLVGG-YPFE--DPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
+ G P E + F + R+ +PD ++
Sbjct: 197 LEICSNGEEPLSTLSSSEKERFYQDQHRL-----PMPDCAELA 234
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 14/137 (10%)
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 182
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 183 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 237
P ++APE + Y + +DVWS GV L+ + +G P+ ++F + ++ R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 238 LSVQYSVPDTNPISQEC 254
+ +Y+ P+ I +C
Sbjct: 296 RAPEYATPEIYSIMLDC 312
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 21/152 (13%)
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 181
F Q+ G+S+ + HRDL N LL + KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 182 GTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKD--FRKTIQ-- 235
P ++APE + Y + +DVWS G+ L+ + +G P+ P P D F K I+
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPY--PGMPVDSKFYKMIKEG 333
Query: 236 -RILSVQYSVPDTNPISQECRDLISRIFVADP 266
R+LS + + + I + C D ADP
Sbjct: 334 YRMLSPECAPSEMYDIMKSCWD-------ADP 358
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 176
+D RF Q + G+ + + HRD+ N LL DG A KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267
Query: 177 --PKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRK 232
K P ++APE + Y + +DVWS G+ L+ + +G P+ F K
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
Query: 233 TIQRILSVQYSVPDTNP-----ISQECRDL 257
++R Q S PD P I + C +L
Sbjct: 327 MVKR--GYQMSRPDFAPPEIYSIMKMCWNL 354
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 45/226 (19%)
Query: 29 RDIGSGNFG------------VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL 76
++IG+G FG VAR+ V KEL A K ++ +R L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARV----VVKELKA----NASSKEQNEFLQQGDPYRIL 52
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QLISGV 132
+HPNI++ + +V EY G+L + + Q ++ +GV
Sbjct: 53 QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTPAYIA 188
++ H H DL L N L +K+ D+G K + ++ V ++A
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL-RWLA 169
Query: 189 PEVLLRHEYDG-------KIADVWSCGVTLYVMLVGGYPFEDPDEP 227
PE L+ + G K ++VW+ GVTL+ + FE+ +P
Sbjct: 170 PE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 31 IGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G FG + + TK VA+K ++ G + E +E + LRH +V V+
Sbjct: 14 LGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV- 70
Query: 90 TPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
+ + IV E+ G L F + + + Q+ G++Y M HRDL+
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRHEYDGKIA 202
N L+ + KI DFG ++ L + T A + APE L + K +
Sbjct: 131 ANILVGDNLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 184
Query: 203 DVWSCGVTLYVMLVGG---YP 220
DVWS G+ L ++ G YP
Sbjct: 185 DVWSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 22/56 (39%), Positives = 31/56 (55%), Gaps = 1/56 (1%)
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 236
+GTP Y+APE+LL + G D W+ GV L+ L G PF D + F+ + R
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR 595
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 37/137 (27%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 182
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 183 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 237
P ++APE + Y + +DVWS GV L+ + +G P+ ++F + ++ R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 238 LSVQYSVPDTNPISQEC 254
+ Y+ P+ +C
Sbjct: 302 RAPDYTTPEMYQTMLDC 318
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 29 RDIGSGNFGVAR---LMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIV 82
R +G G FG R L + + + VAVK ++ +++ RE + HPN++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 83 RFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFSEDEARFFFQQLI------- 129
+ V L L I M + G+L + R E+ Q L+
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVGTP 184
SG+ Y + HRDL N +L+ + + +C DFG SK S + Q ++
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++A E L + Y +DVW+ GVT++ +M G P+
Sbjct: 180 KWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 37/195 (18%)
Query: 50 LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105
LVAVK I R D ++N + + + L+ PNI+R V + L ++ EY G+
Sbjct: 48 LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 106 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHAMQVCHRDL 145
L + ++ + E Q+ SG+ Y ++ HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRHEYDGK 200
N L+ + +KI DFG S++ L++ + A ++A E +L ++
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAVLPIRWMAWECILMGKFT-T 219
Query: 201 IADVWSCGVTLYVML 215
+DVW+ GVTL+ +L
Sbjct: 220 ASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 27/187 (14%)
Query: 49 ELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106
+LVA+K ++ + + Q+E L HPNIV V+ + ++ EY + G+L
Sbjct: 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 107 FERI----------CNAG-----RFSEDEARFFFQ--QLISGVSYCHAMQVCHRDLKLEN 149
E + C++ + S D F Q+ +G+ Y + H+DL N
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154
Query: 150 TLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 205
L+ +KI D G S+ + QPKS + ++ PE ++ ++ +D+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210
Query: 206 SCGVTLY 212
S GV L+
Sbjct: 211 SFGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 43/187 (22%), Positives = 85/187 (45%), Gaps = 28/187 (14%)
Query: 49 ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104
+ VA+K ++ DK + E + E + L+HPNIV V+ L+++ Y S
Sbjct: 36 QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 105 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHAMQVCHRDLKLE 148
+L E + + G +D+ A F Q+ +G+ + + V H+DL
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153
Query: 149 NTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 205
N L+ +KI D G + ++ + +++ +++PE ++ ++ +D+W
Sbjct: 154 NVLV--FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIW 210
Query: 206 SCGVTLY 212
S GV L+
Sbjct: 211 SYGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 29/92 (31%), Positives = 41/92 (44%), Gaps = 13/92 (14%)
Query: 135 CHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
A++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
Y K AD++S G+TLY L P+ +
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEALDYELPYNEE 107
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 33/215 (15%)
Query: 23 DRYDFVRDIGSGNFGVAR--LMRDKVTKEL---VAVKYIERGDKIDENVQREIINHRSLR 77
++ +R++G G+FG+ RD + E VAVK + + E + E +N S+
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 78 HP----NIVRFKEVILTPTHLAIVMEYASGGEL--FERIC------NAGRFSE--DEARF 123
++VR V+ +VME + G+L + R N GR E
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 180
++ G++Y +A + HRDL N ++ +KI DFG ++ + + +
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKG 181
Query: 181 VGTPAYIAPEVLLRHEYDGKI---ADVWSCGVTLY 212
+ ++APE L DG +D+WS GV L+
Sbjct: 182 LLPVRWMAPESL----KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 24/175 (13%)
Query: 53 VKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 112
VK I + I + EI + L+HPNIV+ + + ++ EY G L E + N
Sbjct: 720 VKEINDVNSIPSS---EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776
Query: 113 AGRFSEDEARFFFQQLISGVS------YCH-AMQVCHRDLKLENTLLDGSPAPRLKICDF 165
E R +++ G++ +C + V +L E ++DG P L++
Sbjct: 777 LSW----ERR---RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRL--- 826
Query: 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 220
S +L + K + + AY+APE + K +D++ G+ L +L G P
Sbjct: 827 --SLPGLLCTDTKCFISS-AYVAPETRETKDITEK-SDIYGFGLILIELLTGKSP 877
|
Length = 968 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 298 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.35 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.17 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.94 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.8 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.34 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.3 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.24 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.22 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.22 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.1 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.03 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.98 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.89 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.81 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.76 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.65 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.64 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.63 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.44 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.29 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.24 | |
| PLN02236 | 344 | choline kinase | 97.12 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.04 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.04 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.0 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.76 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.59 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.55 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.53 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.47 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.39 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.37 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.29 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.9 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.6 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.14 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.13 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.04 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.79 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.64 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-55 Score=360.27 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=229.4
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeec--CCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-eEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAI 96 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 96 (298)
...++.+.++.||+|..|+||+++|+.+++.+|+|++.. +.....++.+|+++++..+||+|++++|+|.++. .+++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 344589999999999999999999999999999999943 4555678899999999999999999999999998 5999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+||||++|||...+...+.+++..+-.++.++++||.|||+ ++|+||||||+|||++..|+ +||+|||.+......
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-
Confidence 99999999999999988999999999999999999999995 99999999999999999998 999999998766555
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCC-CCchhHHHHHHHHhhcCC-CCCCCCCCCHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-DEPKDFRKTIQRILSVQY-SVPDTNPISQE 253 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 253 (298)
...+..||..|||||.+.+..|+.+ +||||||+.++|+++|+.||... .......+++..|+..+. ..|.. .++++
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~e 310 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPE 310 (364)
T ss_pred hcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHH
Confidence 5677889999999999999999888 99999999999999999999886 334566777888877554 44443 58999
Q ss_pred HHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
+++||..||.+||.+|||+ .++++|||+.
T Consensus 311 f~~FV~~CL~Kdp~~R~s~--------~qLl~Hpfi~ 339 (364)
T KOG0581|consen 311 FRSFVSCCLRKDPSERPSA--------KQLLQHPFIK 339 (364)
T ss_pred HHHHHHHHhcCCcccCCCH--------HHHhcCHHHh
Confidence 9999999999999999987 6666888887
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-55 Score=365.20 Aligned_cols=271 Identities=35% Similarity=0.548 Sum_probs=229.1
Q ss_pred CCCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc--------hHHHHHHHHHHhcCCCCCee
Q 022401 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--------DENVQREIINHRSLRHPNIV 82 (298)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~ 82 (298)
+.++..| -...+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+.... .....+|+++|++|+||||+
T Consensus 161 d~~~~~p-ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV 239 (475)
T KOG0615|consen 161 DSSKVPP-KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIV 239 (475)
T ss_pred hhccCcc-chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEE
Confidence 4444433 34788999999999999999999999999999999999763211 12357999999999999999
Q ss_pred eeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC-CCCCEE
Q 022401 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLK 161 (298)
Q Consensus 83 ~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~-~~~~~~ 161 (298)
++++++..+...|+|+||++||.|.+.+-.+..+.+...+.+++|++.|+.|||++||+||||||+|||++.+ ....+|
T Consensus 240 ~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 240 RIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred EEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEE
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999776 444599
Q ss_pred EeecCccccccCCCCCCCCCCCCcccCccccccccC--CCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 022401 162 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239 (298)
Q Consensus 162 l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 239 (298)
|.|||+|........-.+.+|++.|.|||++.+.+. ++.+.|+||+||++|.+++|.+||........+.+. +..
T Consensus 320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ---I~~ 396 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ---ILK 396 (475)
T ss_pred ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH---Hhc
Confidence 999999997777777788999999999999987653 454589999999999999999999987665434333 333
Q ss_pred cCCC--CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 240 VQYS--VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 240 ~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+.+. .+....++++..+||.+||..||++|||+ .++++|||+.+.+
T Consensus 397 G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~--------~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 397 GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSA--------DEALNHPWFKDAP 444 (475)
T ss_pred CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCH--------HHHhcChhhhccc
Confidence 4432 22344589999999999999999999987 5556899988543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=366.42 Aligned_cols=250 Identities=36% Similarity=0.598 Sum_probs=229.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeec----CCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.+|..++.||+|||+.||.+++..+|..||+|++.+ .....+...+|++++++|+|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 679999999999999999999988999999999987 5667788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~ 177 (298)
|.|..++|-.++....++++.++..+++||+.|+.|||+++|+|||||..|+|++++-+ +||+|||+|...... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence 99999999999999999999999999999999999999999999999999999999888 999999999876655 555
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
.+.+|||.|+|||++...+.... +||||+||++|.|+.|.+||.. +.+.+...++...++..|. .++.+..+|
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dL 248 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDL 248 (592)
T ss_pred ceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHH
Confidence 77889999999999998888777 9999999999999999999987 4457777887777777666 489999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
|.+||+.||.+|||+ .+++.|+|+
T Consensus 249 I~~lL~~~P~~Rpsl--------~~vL~h~Ff 272 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSL--------DEVLDHPFF 272 (592)
T ss_pred HHHHhcCCcccCCCH--------HHHhcCHhh
Confidence 999999999999988 555578888
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-52 Score=343.15 Aligned_cols=263 Identities=32% Similarity=0.525 Sum_probs=230.3
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
.....++|+++++||.|+||.||.++.+.+++.||+|++.+.. ......++|..+|.+++||.||+++..|.+.+.
T Consensus 20 ~~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 20 EMVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred ccCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 3566789999999999999999999999999999999987642 334567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+|++|+.||.|...+++.+.+++..++.++..|+.||.|||+.||+||||||+|||+|.+|+ ++|+|||+|.....
T Consensus 100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999 99999999984443
Q ss_pred C-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 174 H-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 174 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
. ......+||+.|||||++.+.+++.. +|.||||+++|+|++|..||...+. .+..+++..+... ..+..++.
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~----~~~~~~I~~~k~~-~~p~~ls~ 251 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDV----KKMYDKILKGKLP-LPPGYLSE 251 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccH----HHHHHHHhcCcCC-CCCccCCH
Confidence 3 44556689999999999999988766 9999999999999999999999765 5556666555522 22223799
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.+++++.+|+.||++|.. .......+-.|||+.++
T Consensus 252 ~ardll~~LL~rdp~~RLg----~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 252 EARDLLKKLLKRDPRQRLG----GPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHHHHHHhccCHHHhcC----CCCChHHhhcCcccccC
Confidence 9999999999999999986 23356778999999865
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=340.39 Aligned_cols=260 Identities=35% Similarity=0.565 Sum_probs=225.1
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
+...++|.+.+.||.|+|++||+++++.++..||||.+.+.. +..+.+.+|+.+|+.++||||+.+++++++++.+|
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 445689999999999999999999999999999999997653 34456778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC-CC---CCEEEeecCccccc
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSS 171 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~-~~---~~~~l~d~~~~~~~ 171 (298)
+|||||+||+|.+++...+.+++.+++.++.||+.|+++||+++|+||||||.|||++.. +. +.+||.|||+++..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999764 32 56999999999988
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC-CCCC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPI 250 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 250 (298)
.........+|++.|||||++....|+.+ +|+||+|+++|+|++|..||......+.+. .+..+....+. +...
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~----~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL----YIKKGNEIVPVLPAEL 240 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhccccccCchhhhc
Confidence 87788888899999999999999999888 999999999999999999999876543332 22222222222 2235
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+..+.+++...++.||.+|.++ .+.+.|+++..
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~--------~~~~~~~~l~~ 273 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISF--------EDFFDHPFLAA 273 (429)
T ss_pred cCchhhhhhHHHhcCccccCch--------HHhhhhhhccc
Confidence 6678899999999999999965 77778888763
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=343.89 Aligned_cols=258 Identities=47% Similarity=0.769 Sum_probs=228.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC-----C-cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----D-KIDENVQREIINHRSLR-HPNIVRFKEVILTP 91 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~-----~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 91 (298)
....++|++++.||+|+||.|+.|++..++..||+|++.+. . ...+.+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 35568999999999999999999999999999999976653 1 23556778999999998 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC-CCCCEEEeecCcccc
Q 022401 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKS 170 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~-~~~~~~l~d~~~~~~ 170 (298)
..+++||||+.||.|.+.+.+.+++.+.++..+++|++.|++|+|++|++||||||+|++++.+ ++ +||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccc
Confidence 9999999999999999999998999999999999999999999999999999999999999988 66 99999999986
Q ss_pred c-cCCCCCCCCCCCCcccCcccccccc-CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 171 S-VLHSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 171 ~-~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
. ..........|++.|+|||.+.+.. |..+++||||+|+++|.|++|..||...+. .....++..+.+..+..-
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----~~l~~ki~~~~~~~p~~~ 246 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----PNLYRKIRKGEFKIPSYL 246 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH----HHHHHHHhcCCccCCCCc
Confidence 6 4566778889999999999999988 988889999999999999999999998443 555666777887777663
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
. +.++.+++++||..||.+|+|+.+++ .|||++.
T Consensus 247 ~-S~~~~~Li~~mL~~~P~~R~t~~~i~--------~h~w~~~ 280 (370)
T KOG0583|consen 247 L-SPEARSLIEKMLVPDPSTRITLLEIL--------EHPWFQK 280 (370)
T ss_pred C-CHHHHHHHHHHcCCCcccCCCHHHHh--------hChhhcc
Confidence 3 99999999999999999999875444 6777764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=343.16 Aligned_cols=257 Identities=31% Similarity=0.516 Sum_probs=222.6
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (298)
.-...+|.+++.||+|+|++|++|+.+.+++.||||++.+.. +..+.+..|-..|.+| .||+|++++-.|.|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 356789999999999999999999999999999999987642 2234466788899999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+|++|+++|.|.+++...+.+++.-.+.++.+|+.||+|||++|||||||||+|||++.+++ ++|.|||.+.....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSP 226 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCCh
Confidence 9999999999999999999999999999999999999999999999999999999999999998 99999999863322
Q ss_pred CCC--------------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 022401 174 HSQ--------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239 (298)
Q Consensus 174 ~~~--------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 239 (298)
... .....|+..|.+||++..+..+.. +|||+|||++|+|+.|.+||.+.++. ...++|+.
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~Ney----liFqkI~~ 301 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEY----LIFQKIQA 301 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHH----HHHHHHHH
Confidence 111 133568999999999977766555 99999999999999999999998884 45556666
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 240 VQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..+.++.. .|+...+||.++|..||.+|+|+ .++-+|||+.+.
T Consensus 302 l~y~fp~~--fp~~a~dLv~KLLv~dp~~Rlt~--------~qIk~HpFF~~V 344 (604)
T KOG0592|consen 302 LDYEFPEG--FPEDARDLIKKLLVRDPSDRLTS--------QQIKAHPFFEGV 344 (604)
T ss_pred hcccCCCC--CCHHHHHHHHHHHccCccccccH--------HHHhhCcccccC
Confidence 66665554 78999999999999999999988 666688888754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-50 Score=322.67 Aligned_cols=258 Identities=25% Similarity=0.450 Sum_probs=216.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|+.+.++|+|++|+||+++++.+|+.||||.+..+.. ..+...+|+.+|++|+|+|+|.++++|.....+++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 689999999999999999999999999999999976433 34556799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCC
Q 022401 100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~ 177 (298)
||+. ++.+.++..+ .++...++.++.|++.|+.|+|+++++||||||+||+++.+|. +||||||+|+.... ....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchh
Confidence 9987 4555555544 5899999999999999999999999999999999999999998 99999999986663 3333
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------CC
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------QY 242 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~ 242 (298)
.....+.+|.|||.+.+...+.+..|||++||++.||++|...|.+..+.+++....+.+... ..
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 445578899999999998777777999999999999999999999998888766554443211 11
Q ss_pred CCCCCC----------CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 243 SVPDTN----------PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 243 ~~~~~~----------~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
++|.+. +++.-+.+|+..||+.||.+|+ +|.+++.|||+++
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~--------sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL--------SCEQLLHHPYFDG 289 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc--------cHHHHhcChHHHH
Confidence 223222 3556799999999999999999 5577778888854
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=343.66 Aligned_cols=254 Identities=36% Similarity=0.692 Sum_probs=234.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
.+-|++++.||.|+.|.|-+|++..+|+.+|||++.+.. .....+.+|+.+++-+.|||++.++++++....+|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 457999999999999999999999999999999997652 2335578999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
.||++||-|.+++-..+++++.+...+++||+.|+.|+|..+|+||||||+|++++..++ +||+|||+|.....+...
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccc
Confidence 999999999999999999999999999999999999999999999999999999999988 999999999988888888
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
.+.+|.+.|.+||++.+.+|...++||||-|+++|.|++|.+||++ +.+..+..+++.+.+..|.. ++.+.++|
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs~--Is~eaQdL 242 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPSN--ISSEAQDL 242 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCCc--CCHHHHHH
Confidence 9999999999999999999999999999999999999999999995 55688888889999988744 89999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
|++||..||++|+|. .+++.|||++.
T Consensus 243 Lr~ml~VDp~~RiT~--------~eI~kHP~l~g 268 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITT--------EEILKHPFLSG 268 (786)
T ss_pred HHHHhccCccccccH--------HHHhhCchhhc
Confidence 999999999999988 55557888864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=312.06 Aligned_cols=258 Identities=30% Similarity=0.539 Sum_probs=232.3
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++++.||.|+||.|-+++++.+|..||+|+..+.. +..+...+|..+|+.+.||.++++.+.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 66789999999999999999999999999999999988753 33355778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+||+|.+||.|.+++...+++++...+.++.+|+.|++|||+++|++|||||+||++|.+|+ +|+.|||++......
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc-
Confidence 99999999999999999999999999999999999999999999999999999999999999 999999999855433
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
....+|+|.|+|||.+..+++... +|-|+||+++|||+.|..||...+. .+..++|+.+....|.. .+.+++
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~~--fs~~~k 269 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPSY--FSSDAK 269 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCcc--cCHHHH
Confidence 567889999999999998888665 9999999999999999999998765 67788888888877665 799999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+||+.+|+.|-.+|..- +.+=..++-+|||+.+
T Consensus 270 dLl~~LL~vD~t~R~gn---lknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKRFGN---LKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHHHHHhhhhHhhhcC---cCCCccccccCccccc
Confidence 99999999999999432 2333678889999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=320.74 Aligned_cols=253 Identities=29% Similarity=0.439 Sum_probs=216.2
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeE-EEEeC-C
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKE-VILTP-T 92 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~-~ 92 (298)
+.....+|++.++||.|.||.||++++..+|..+|.|.+..+ .+..+...+|+.+|++|+||||++.++ .+..+ +
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 556668899999999999999999999999999999998754 344566889999999999999999998 34444 4
Q ss_pred eEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhh--cC--cEEecCCCCceEeeCCCCCCEEEee
Q 022401 93 HLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHA--MQ--VCHRDLKLENTLLDGSPAPRLKICD 164 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~----~~~~~~~~~~~~i~~~l~~~l~~Lh~--~~--i~H~dl~p~nilv~~~~~~~~~l~d 164 (298)
.+++|||+|++|+|...+. +...+++.++|.++.|++.||.++|+ .. ++||||||.||+++.+|. +||+|
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGD 171 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGD 171 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeecc
Confidence 5899999999999988874 34469999999999999999999998 55 999999999999999998 99999
Q ss_pred cCccccccCCCC-CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 022401 165 FGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243 (298)
Q Consensus 165 ~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
||+++....... ..+..|||.|||||.+.+.+|+.+ +||||+||++|||...+.||.+. .+..+.++|..+++.
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYP 246 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCC
Confidence 999985554433 345579999999999999999888 99999999999999999999985 567777888887664
Q ss_pred CCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 244 VPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 244 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
.-....++.++.++|..|+..||+.||+...++.
T Consensus 247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 247 PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 2222448899999999999999999998654443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=325.08 Aligned_cols=259 Identities=31% Similarity=0.458 Sum_probs=212.4
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--eEEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVM 98 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 98 (298)
..+|..++.||+|+||.||.+.+..+|...|+|........ .+.+.+|+.+|.+++|||||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 56799999999999999999999988999999998775221 456889999999999999999999854444 699999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-CCCCCEEEeecCccccccC---
Q 022401 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL--- 173 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~~~~~--- 173 (298)
||+++|+|.+++.+.+ .+++..+..+.+|+++||.|||++|++||||||+|||++. ++. +||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccc
Confidence 9999999999998877 8999999999999999999999999999999999999998 577 99999999875553
Q ss_pred -CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
........|++.|||||++.......+++|||||||++.||+||..||.... ....... .+.........+..+++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~~~~~~~-~ig~~~~~P~ip~~ls~ 250 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--EEAEALL-LIGREDSLPEIPDSLSD 250 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--chHHHHH-HHhccCCCCCCCcccCH
Confidence 2223456799999999999864333445999999999999999999998741 1112222 22222212244555899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+.++||+.||+.||++|||+ .++++|||+....
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta--------~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTA--------EELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHHHhhcCcccCcCH--------HHHhhChhhhccc
Confidence 99999999999999999988 6666888887543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=336.53 Aligned_cols=264 Identities=30% Similarity=0.433 Sum_probs=222.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHH--HHHHHHHHhcCC-CCCeeeeeEEEEeCC-eE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--VQREIINHRSLR-HPNIVRFKEVILTPT-HL 94 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~ 94 (298)
....++|.++++||.|.||.||+|+...++..||||..++.-..-++ -.+|+..|+++. ||||+++.+++.+.. .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 34557999999999999999999999999999999987765433333 458999999998 999999999999887 99
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++|||||+. +|.+++..+ ..+++..+..|+.||++||+|+|++|+.|||+||+|||+..... +||+|||+|+....
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEeccccccccccc
Confidence 999999954 899988655 46999999999999999999999999999999999999987665 99999999998777
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC------------
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------ 241 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 241 (298)
.........|.+|.|||++....+++.+.|+|++||+++|+.+.+..|.+.++.+++-++..-+....
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 77777777899999999998888877779999999999999999999999988777666554432221
Q ss_pred ---CCCCCC---------CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 242 ---YSVPDT---------NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 242 ---~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+++|.. .+.+.+..++|.+||++||.+|||+. ++++|||++...
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~--------~al~~pffq~~~ 298 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTAS--------QALQHPFFQVGR 298 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHH--------HHhcCccccccc
Confidence 122211 13678999999999999999999994 555788887543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=330.19 Aligned_cols=255 Identities=31% Similarity=0.433 Sum_probs=217.0
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcE-EEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL-VAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~-~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
.....+..+..+.+.+|.|+||+||.+.++ |+. +|+|++...... ...|.+|+.++.+++||||++++|++.++
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 334555677788888999999999999997 444 999998765433 45899999999999999999999999888
Q ss_pred C-eEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcC-cEEecCCCCceEeeCCC-CCCEEEeecC
Q 022401 92 T-HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSP-APRLKICDFG 166 (298)
Q Consensus 92 ~-~~~lv~~~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~-i~H~dl~p~nilv~~~~-~~~~~l~d~~ 166 (298)
. .+++|+||+++|+|.+++.. ...++...+..++.+|+.|++|||+.+ |+|+||||+|||++.++ + +||+|||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~--~KI~DFG 189 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKT--LKIADFG 189 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCE--EEECCCc
Confidence 7 79999999999999999987 678999999999999999999999999 99999999999999887 6 9999999
Q ss_pred ccccccCC-CCCCCCCCCCcccCccccc--cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 022401 167 YSKSSVLH-SQPKSTVGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243 (298)
Q Consensus 167 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
+++..... .......|++.|||||.+. ...++.+ +||||||+++|||+||..||..... ......+.....+
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAP----VQVASAVVVGGLR 264 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcCCC
Confidence 99755543 3333468999999999998 4567666 9999999999999999999998765 3444445445555
Q ss_pred CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 244 VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 244 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
...+..+++.+.+++.+||+.||.+||++.+++.+.
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 555555899999999999999999999999999644
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=337.65 Aligned_cols=251 Identities=33% Similarity=0.581 Sum_probs=225.7
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch---HHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|-+.+.||+|+||.||+++++.+.+.||+|.+.+..+.. ..+.+|++|+++++||||+.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 68999999999999999999999999999999998765554 456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC-C
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~-~ 178 (298)
|+.| +|...++..+.+++..+..++.+++.||.|||+.+|.|+|+||.||+++.++. +|++|||+++........ .
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence 9977 99999999999999999999999999999999999999999999999999988 999999999866655433 3
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
.-.|+|.|||||...+..|+.. +|+|||||++||++.|++||-.. .+...++.|...+..+|.. .+.++..|+
T Consensus 159 sikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~d~v~~p~~--~S~~f~nfl 231 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYAR----SITQLVKSILKDPVKPPST--ASSSFVNFL 231 (808)
T ss_pred eccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhcCCCCCccc--ccHHHHHHH
Confidence 3459999999999998888777 99999999999999999999873 4567777777777766663 799999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..+|.+||.+|. .|-++++|||..+
T Consensus 232 ~gLL~kdP~~Rl--------tW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 232 QGLLIKDPAQRL--------TWTDLLGHPFWKG 256 (808)
T ss_pred HHHhhcChhhcc--------cHHHHhcChHHhh
Confidence 999999999999 4688889999764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=330.49 Aligned_cols=261 Identities=34% Similarity=0.566 Sum_probs=222.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---------------chHHHHHHHHHHhcCCCCCee
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------------IDENVQREIINHRSLRHPNIV 82 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~ 82 (298)
.....++|++++.||+|.||.|-+|++..+++.||+|++.+... ..+...+|+.++++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 35567899999999999999999999999999999999865321 125788999999999999999
Q ss_pred eeeEEEEeC--CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCE
Q 022401 83 RFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (298)
Q Consensus 83 ~~~~~~~~~--~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~ 160 (298)
+++++.-+. ..+|+|+|||..|.+...-.....+++.+.+.++++++.||+|||.+||+||||||+|+|++++|. +
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--V 249 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--V 249 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--E
Confidence 999998765 579999999998877554433444899999999999999999999999999999999999999987 9
Q ss_pred EEeecCccccccCC------CCCCCCCCCCcccCcccccc---ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 022401 161 KICDFGYSKSSVLH------SQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231 (298)
Q Consensus 161 ~l~d~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~ 231 (298)
||+|||.+...... .+.....|+|.|+|||.+.+ ..+..++.||||+|++||.|+.|+.||.+... .
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~ 325 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----L 325 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----H
Confidence 99999988644222 12234569999999999887 45667789999999999999999999998554 6
Q ss_pred HHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 232 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+...+|.+.....|......++++++|.+||.+||.+|++. -.+-.|||++.+
T Consensus 326 ~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l--------~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 326 ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL--------PDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeeh--------hhheecceeccC
Confidence 77888888888888887789999999999999999999987 555589999854
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=335.29 Aligned_cols=253 Identities=29% Similarity=0.480 Sum_probs=225.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch-HHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
..|...+.||+|+.|.||.|....++..||||++....... +-+.+|+.+++..+|+||+++++.+...+.+++||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 47999999999999999999999999999999998765544 45779999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCCC
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 180 (298)
+||+|.+.+... .+++.++..+.+.+++||+|||.+||+|+|||.+||+++.+|. +||+|||+|....... .....
T Consensus 353 ~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred CCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccc
Confidence 999999988554 4899999999999999999999999999999999999999998 9999999987555544 66777
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 260 (298)
.|+++|||||....+.|..+ .||||||++++||+.|++||-.. ..++++..-..++.+.+..+..++.++++|+.+
T Consensus 430 VGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE---~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNE---NPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred cCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCC---ChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 89999999999999999888 99999999999999999999863 445555555667788888888899999999999
Q ss_pred hhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 261 IFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 261 ~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
||+.|+.+|+++ .++|+||||.
T Consensus 506 cL~~dv~~RasA--------~eLL~HpFl~ 527 (550)
T KOG0578|consen 506 CLVVDVEQRASA--------KELLEHPFLK 527 (550)
T ss_pred HhhcchhcCCCH--------HHHhcChhhh
Confidence 999999999988 5555777773
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=326.89 Aligned_cols=263 Identities=31% Similarity=0.489 Sum_probs=223.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
....++|+++++||+|+||.||+|+.+.+|..||+|++.++. ...+.++.|-.+|....+|.||+++..|.+...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 447789999999999999999999999999999999998753 3335577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~- 173 (298)
|+||||.+||++..+|...+.+++..+..++.+++.||+.||+.|++||||||+|+|+|..|+ +||+|||+|.....
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999999 99999999841110
Q ss_pred --------------------CCCCC---------------------------CCCCCCcccCccccccccCCCCccchHH
Q 022401 174 --------------------HSQPK---------------------------STVGTPAYIAPEVLLRHEYDGKIADVWS 206 (298)
Q Consensus 174 --------------------~~~~~---------------------------~~~~~~~~~aPE~~~~~~~~~~~~Di~s 206 (298)
..... ...|+|.|+|||++.+.+|... +|.||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHH
Confidence 00000 0127899999999999998766 99999
Q ss_pred HHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhh
Q 022401 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSF 286 (298)
Q Consensus 207 lG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~h 286 (298)
|||++|||+.|.+||......+.+.+++..-.. +..|.....+++.++||.+||. ||++|... ....++-.|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~-----~G~~EIK~H 445 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--LKFPEEVDLSDEAKDLITRLLC-DPENRLGS-----KGAEEIKKH 445 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--ccCCCcCcccHHHHHHHHHHhc-CHHHhcCc-----ccHHHHhcC
Confidence 999999999999999997765554444444222 3445555578999999999998 99999973 245788999
Q ss_pred hhhhhh
Q 022401 287 VWMFDA 292 (298)
Q Consensus 287 p~~~~~ 292 (298)
||+.+.
T Consensus 446 PfF~~v 451 (550)
T KOG0605|consen 446 PFFKGV 451 (550)
T ss_pred CccccC
Confidence 999764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=319.56 Aligned_cols=263 Identities=23% Similarity=0.304 Sum_probs=217.0
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.++++++|++++++.+++.+.+.+++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3889999999999999999999999999999987532 222456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|+++++|...+... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence 99999998877543 35899999999999999999999999999999999999998887 999999998754333333
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....++..|+|||.+.+..++.+ +||||+|+++|+|++|..||...............+...... ....++.++.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l 235 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE--YSEKFSEDAKSI 235 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccccc--CCccCCHHHHHH
Confidence 44568899999999988877766 999999999999999999998766543333333333333222 334478999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
+++||+.||.+||++.+. ...++++|||+.+...
T Consensus 236 i~~~l~~~P~~R~~~~~~---~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 236 CRMLLTKNPKERLGCRGN---GAAGVKQHPIFKNINF 269 (285)
T ss_pred HHHHhhcCHHHhcCCCCC---CHHHHhcCHhhcCCCH
Confidence 999999999999985443 3578889999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=324.76 Aligned_cols=256 Identities=30% Similarity=0.513 Sum_probs=215.7
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++.+..+++.+|+|++.... +..+.+.+|+.++++++||||+++++++.++..+++|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999899999999987532 23456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
||+++++|.+++.....+++..+..++.|++.||+|||++|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--RTW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--Ccc
Confidence 99999999999988888999999999999999999999999999999999999998887 99999998864432 223
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
...+++.|+|||.+.+..++.+ +||||||+++|+|++|..||..... ......+......++. ..+.++.++|
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~~~~li 229 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNP----FGIYEKILAGKLEFPR--HLDLYAKDLI 229 (291)
T ss_pred cccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCcCCCc--cCCHHHHHHH
Confidence 3457899999999887777655 9999999999999999999987554 2334444444444433 3689999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++||+.||.+||+... ....+++.|||+.+.
T Consensus 230 ~~~l~~dp~~R~~~~~---~~~~~~l~h~~~~~~ 260 (291)
T cd05612 230 KKLLVVDRTRRLGNMK---NGADDVKNHRWFKSV 260 (291)
T ss_pred HHHcCCCHHHccCCcc---CCHHHHhcCccccCC
Confidence 9999999999996321 124677799998753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=326.81 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=218.7
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
..++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 4578999999999999999999999999999999987532 233567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
|+||+.+++|.+.+.....+++..+..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++..... .
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--R 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--C
Confidence 9999999999999988888999999999999999999999999999999999999998887 99999999864432 2
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....+++.|+|||.+.+..++.+ +|||||||++|+|++|..||..... ......+..+....+ ..++.++.+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~p--~~~~~~~~~ 244 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTP----FRIYEKILAGRLKFP--NWFDGRARD 244 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCcCCC--CCCCHHHHH
Confidence 234468899999999988777655 9999999999999999999976543 333444555544433 347899999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
||.+||+.||.+|++... ....+++.|||+.+
T Consensus 245 li~~~L~~dP~~R~~~~~---~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 245 LVKGLLQTDHTKRLGTLK---GGVADVKNHPYFHG 276 (329)
T ss_pred HHHHHhhcCHHHcCCCCC---CCHHHHhcCCccCC
Confidence 999999999999997422 23578889999975
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=325.90 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=214.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch---HHHHHHHHHHhcCCCCCeeeeeEEEEeC--CeE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 94 (298)
...+.|+.+++||+|.||.||+|++..+|+.||+|.+..+.... .-..+|+.||++|.||||+++.+...+. ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 34578999999999999999999999999999999998765332 2346899999999999999999998876 699
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
|+|||||+. +|.-++... -.+++.+++-+++||+.||+|+|++|++|||||.+|||+|.+|. +||+|||+|+....
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTP 270 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccC
Confidence 999999977 676676553 37999999999999999999999999999999999999999998 99999999984444
Q ss_pred CC--CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC-CC-----
Q 022401 174 HS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VP----- 245 (298)
Q Consensus 174 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~----- 245 (298)
.. ..-....+.+|.|||.+.+...++.+.|+||.||++.||++|...|.+..+.+++..+.+-....... |+
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 33 33455578899999999998877777999999999999999999999998877766555433222111 11
Q ss_pred C-----------------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 246 D-----------------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 246 ~-----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
. ....+++..+|+..||..||.+|.|+.++| +|+|+
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL--------~seyF 403 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL--------QSEYF 403 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh--------cCccc
Confidence 0 014678899999999999999999995554 66676
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=296.60 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=217.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.+|...++||+|.||+||+|++..+|+.||||.+...... .-...+|+..|+.++|+||+.++++|.+.+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 5799999999999999999999999999999999876443 4567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
|++ .+|...+.... .++...++.++.++++|++|||++.|+||||||.|++++++|. +|++|||+++.........
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence 995 48888886544 6899999999999999999999999999999999999999998 9999999998655444332
Q ss_pred C-CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CCCC----------
Q 022401 179 S-TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPD---------- 246 (298)
Q Consensus 179 ~-~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~---------- 246 (298)
. ...+.+|.|||.+.+...+....|+||.||++.||+-|.+-|.+.++.+++....+.+..... .+|.
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 2 357888999999999887777799999999999999998888888887777776666533221 1111
Q ss_pred -----------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 247 -----------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 247 -----------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
-...+++..+|+..||..||.+|+|+.| ++.|+|+.+
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q--------aL~~~yf~~ 286 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ--------ALKHPYFKS 286 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH--------Hhcchhhhc
Confidence 1134678899999999999999998754 556777764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=312.39 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=217.6
Q ss_pred CcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 14 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
....+.+..++|++.++||.|..++||+|+...++..||||++..+. ...+.+.+|+..++.++||||++.+..|..+
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 34456677899999999999999999999999999999999997653 3346789999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 92 THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+.+++||++|.+||+.+.+...- .+++..+..|++++++||.|||.+|.+|||||+.|||++++|. |+|+|||.+-
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa 174 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSA 174 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeee
Confidence 99999999999999999997543 3899999999999999999999999999999999999999998 9999999764
Q ss_pred cccCCCCC-----CCCCCCCcccCcccccc--ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 170 SSVLHSQP-----KSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 170 ~~~~~~~~-----~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
.....+.. ....+++.|||||.+.. .+|+.+ +||||||++..|+.+|+.||.....- .-++.++.+..+
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPm---kvLl~tLqn~pp 250 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPM---KVLLLTLQNDPP 250 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChH---HHHHHHhcCCCC
Confidence 33332222 33468999999999443 356666 99999999999999999999987653 334444444443
Q ss_pred -------CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 243 -------SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
+.......+.+++++|..||.+||.+|||++++| .|+|+.
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl--------kh~FFk 297 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL--------KHAFFK 297 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh--------ccHHHh
Confidence 1222234567899999999999999999985555 566665
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=321.94 Aligned_cols=251 Identities=33% Similarity=0.519 Sum_probs=208.9
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (298)
+.||+|+||.||++++..+|+.||+|++.... .....+.+|+.++++++||||+++++++...+.+++|+||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987532 22345678999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCCC
Q 022401 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 183 (298)
Q Consensus 105 sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~ 183 (298)
+|.+.+.....+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence 99999988888999999999999999999999999999999999999998887 99999998864322 2222344589
Q ss_pred CcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhh
Q 022401 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263 (298)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 263 (298)
+.|+|||.+.+..++.+ +||||+||++|+|++|..||...+. ......+.......+ ..+++++.++|++||+
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~ 231 (323)
T cd05571 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILMEEIRFP--RTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCH----HHHHHHHHcCCCCCC--CCCCHHHHHHHHHHcc
Confidence 99999999988777665 9999999999999999999987543 233334444444333 4489999999999999
Q ss_pred hCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 264 ADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 264 ~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.||++||+... ....++++|||+.+
T Consensus 232 ~dP~~R~~~~~---~~~~~ll~h~~f~~ 256 (323)
T cd05571 232 KDPKQRLGGGP---EDAKEIMEHRFFAS 256 (323)
T ss_pred CCHHHcCCCCC---CCHHHHHcCCCcCC
Confidence 99999994322 12466778888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=315.34 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=205.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.++|++.+.||+|+||.||++++..+++.+|+|++.... .....+.+|+.+++.++||||+++++++.++...++|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999999899999999987543 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCC
Q 022401 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~ 177 (298)
|+. ++|.+.+.. ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++...... ...
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCccC
Confidence 996 467766654 356899999999999999999999999999999999999998887 999999988643222 222
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC---------------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------------- 242 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 242 (298)
....+++.|+|||++.+......++||||+||++|+|++|..||....+.....+..........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 34557889999999876554455599999999999999999999876543222222211111100
Q ss_pred ---CCC---------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 243 ---SVP---------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 243 ---~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
... .....++++.+|+.+||+.||.+|||+ .++++|||+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~--------~~~l~h~~f~~~~ 295 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA--------QAALSHEYFSDLP 295 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH--------HHHhcCcccccCC
Confidence 000 001245789999999999999999987 5666899998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=304.00 Aligned_cols=257 Identities=34% Similarity=0.590 Sum_probs=221.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeec---CCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.+.|++.++||+|.|++|+.+.+..+|+.+++|++.. ....-+.+.+|+.|.+.|+||||+++++.+......|+||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3689999999999999999999999999999998864 3445577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-CCCCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|++.|+.|...+-...-+++..+...++||+.+++|.|.+||+|||+||+|+++.+ +..+.+||+|||++.........
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 99999999877766667888999999999999999999999999999999999953 33345999999999866644444
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCCCCCHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECR 255 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 255 (298)
....|+|.|+|||++...++..+ +|||+-|+++|-++.|.+||.+.+. ..+.+++..+.++.+ ..+.++++.+
T Consensus 170 ~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~----~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQ----HRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred ccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhccccCCCCcccCcCCHHHH
Confidence 55679999999999988888777 9999999999999999999998665 455666666666543 4566899999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+||++||..||.+|+|+.|+| +|||+.+
T Consensus 245 ~LvrrML~~dP~kRIta~EAL--------~HpWi~~ 272 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEAL--------KHPWICN 272 (355)
T ss_pred HHHHHHhccChhhhccHHHHh--------CCchhcc
Confidence 999999999999999985555 7888875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=312.19 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=205.9
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
..++|++.+.||.|+||.||++++..++..||+|.+.... .....+.+|+.++++++||||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 4578999999999999999999999999999999986542 23356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-C
Q 022401 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~ 176 (298)
|++++ +|.+.+.... .++...+..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++....... .
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence 99975 8888876544 5789999999999999999999999999999999999998887 9999999886433222 2
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC---------------
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------- 241 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 241 (298)
.....+++.|+|||.+.+......++||||+|+++|+|++|..||...+..+.+....+......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 23345788999999987654444559999999999999999999987655443332222111000
Q ss_pred CCCC---------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 242 YSVP---------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 242 ~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
...+ ....+++++.+||++||+.||.+|||+ .++++|||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~--------~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA--------EAALRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH--------HHHhcCCCC
Confidence 0000 112367899999999999999999987 555578885
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=319.82 Aligned_cols=262 Identities=28% Similarity=0.437 Sum_probs=217.5
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCC-cEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
.......++|++.+.||.|+||.||+|.+..++ ..+|+|.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD 102 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence 345567789999999999999999999876554 68999998653 2334567789999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
+..+++|+||+.+++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~ 180 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKV 180 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCee
Confidence 9999999999999999999988888999999999999999999999999999999999999998887 99999999864
Q ss_pred ccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
... ......+++.|+|||++.+..++.+ +||||+||++|+|++|..||...+. ....+.+.......+ ..+
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~ 251 (340)
T PTZ00426 181 VDT--RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP----LLIYQKILEGIIYFP--KFL 251 (340)
T ss_pred cCC--CcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCH----HHHHHHHhcCCCCCC--CCC
Confidence 332 2234568899999999987777655 9999999999999999999987554 233444444444433 347
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
++++.+++++||+.||.+|++... -...++++|||+.+
T Consensus 252 ~~~~~~li~~~l~~dp~~R~~~~~---~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 252 DNNCKHLMKKLLSHDLTKRYGNLK---KGAQNVKEHPWFGN 289 (340)
T ss_pred CHHHHHHHHHHcccCHHHcCCCCC---CCHHHHHcCCCcCC
Confidence 899999999999999999974211 13467779999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=315.53 Aligned_cols=259 Identities=25% Similarity=0.446 Sum_probs=211.0
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
..++|++.+.||+|+||.||++++..++..+|+|.+.... .....+.+|+.++++++||||+++++++..++.+++|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3578999999999999999999999999999999987642 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc-CcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
||+++++|.+++.....+++..+..++.+++.|+.|||+. +++|+||||+||+++.++. ++|+|||++...... ..
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MA 159 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCccccccccc-cc
Confidence 9999999999998888899999999999999999999986 6999999999999998887 999999988644322 22
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHH------------------------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT------------------------ 233 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~------------------------ 233 (298)
....++..|+|||.+.+..++.+ +||||||+++|+|++|..||...+..+ +...
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCccccccc
Confidence 34467889999999987777665 999999999999999999997644311 1111
Q ss_pred -------------------HHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 234 -------------------IQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 234 -------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...+............+++++.+||.+||+.||++|||+. ++++|||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~--------ell~h~~~~~~ 307 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLK--------MLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHH--------HHhcChHHhhc
Confidence 1111111111111223688999999999999999999884 55578887654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=319.00 Aligned_cols=262 Identities=36% Similarity=0.578 Sum_probs=227.3
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCC-CCCeeeeeEEEEeCC
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLR-HPNIVRFKEVILTPT 92 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 92 (298)
.......|++.+.||.|.||.||.++.+.+|+.+|+|++.+... ..+.+.+|+.+++++. ||||+.+.+.+++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 34456789999999999999999999999999999999976533 3467899999999998 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC--CCCEEEeecCcccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKS 170 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~--~~~~~l~d~~~~~~ 170 (298)
.+++|+|++.||.|.+.+... .+++.....++.|++.+++|||+.|++|+||||+|+++.... .+.++++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999998776 499999999999999999999999999999999999996543 24699999999987
Q ss_pred ccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC--CCCCCC
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTN 248 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 248 (298)
...........|++.|+|||.+...++... +|+||+|+++|.|++|..||....+...+. .+..+.+ ..+...
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~i~~~~~~f~~~~w~ 263 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFL----AILRGDFDFTSEPWD 263 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHH----HHHcCCCCCCCCCcc
Confidence 776556677789999999999987788776 999999999999999999999987655444 4444444 444555
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.++..+.+||+.|+..||..|+|+ .++++|||++++.
T Consensus 264 ~is~~akd~i~~ll~~dp~~R~ta--------~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 264 DISESAKDFIRKLLEFDPRKRLTA--------AQALQHPWIKSIG 300 (382)
T ss_pred ccCHHHHHHHHHhcccCcccCCCH--------HHHhcCccccCCc
Confidence 689999999999999999999987 5555799998753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=320.60 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=216.6
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
.-++....+.+++++.||+|-||.||.+.+..+ ..+|+|.+....-..+.|.+|++++++|+|++|++++++|..++.+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 344455556778899999999999999999854 3699999998877778999999999999999999999999998899
Q ss_pred EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 95 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
|+|+||+..|+|.++|.. +..++..+.+.++.|||.|++||+++++|||||...||||+.+.. +||+|||+++...
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIG 354 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccC
Confidence 999999999999999976 557999999999999999999999999999999999999998887 9999999998322
Q ss_pred C--CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 173 L--HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 173 ~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
. +...........|+|||.+..+.++.+ |||||||++|+|++| |+.||.+-... +.+ +......+.+.+..
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~----ev~-~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNE----EVL-ELLERGYRLPRPEG 428 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHH----HHH-HHHhccCcCCCCCC
Confidence 1 222233345678999999999999888 999999999999999 78888876643 333 33456678888999
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccc
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFF 274 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~ 274 (298)
+|+++.+++..||..+|++|||+..
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHH
Confidence 9999999999999999999999963
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=324.14 Aligned_cols=254 Identities=34% Similarity=0.536 Sum_probs=215.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.++..++||||+++++++.+++.+++|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999899999999987532 33456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--- 175 (298)
||+.+++|.+++.....+++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999986443322
Q ss_pred ---------------------------CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch
Q 022401 176 ---------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (298)
Q Consensus 176 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 228 (298)
......+++.|+|||.+.+..++.+ +|||||||++|+|++|..||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~- 236 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQ- 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHH-
Confidence 2233457889999999988877666 99999999999999999999886642
Q ss_pred hHHHHHHHHhh--cCCCCCCCCCCCHHHHHHHHHhhhhCCCCccc-ccccchhhhHHHhhhhhhhhh
Q 022401 229 DFRKTIQRILS--VQYSVPDTNPISQECRDLISRIFVADPAAVSI-FFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 229 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~~l~~~~~~~~~hp~~~~~ 292 (298)
....++.. .....+....+++++.++|.+||. ||.+||+ + .++++|||+.+.
T Consensus 237 ---~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~--------~~ll~hp~~~~~ 291 (350)
T cd05573 237 ---ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSF--------EEIKSHPFFKGI 291 (350)
T ss_pred ---HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCH--------HHHhcCCCcCCC
Confidence 23333433 333444444579999999999997 9999998 6 566678888654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=318.57 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=211.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.++..++||||+++++++.+....|+|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999899999999987542 23345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence 99999999999988888999999999999999999999999999999999999998887 99999998864433 234
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC----CCCCCHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD----TNPISQEC 254 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l 254 (298)
...+++.|+|||.+.+..++.+ +|||||||++|+|++|..||...+..+........ .. ....+. ...+++++
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~-~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-KE-TLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-cc-cccCCCCCccccccCHHH
Confidence 4568899999999988877665 99999999999999999999876543332222211 10 111111 12468999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.++|.+||+.+|.+||++ .+++.|||+.+
T Consensus 234 ~~li~~~l~~~~~rr~s~--------~~ll~h~~~~~ 262 (333)
T cd05600 234 WDLITKLINDPSRRFGSL--------EDIKNHPFFKE 262 (333)
T ss_pred HHHHHHHhhChhhhcCCH--------HHHHhCcccCC
Confidence 999999999999999987 55567777764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=311.64 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=205.7
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++.+.||+|+||.||+++++.+++.+|+|++.... ...+.+.+|+.++++++||||+++++++..+..+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999987542 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--CC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--~~ 177 (298)
|+.++++.........+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence 9998777665555567899999999999999999999999999999999999998887 9999999987543222 12
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh----------cC-----C
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS----------VQ-----Y 242 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~~-----~ 242 (298)
....+++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...+..+........... .. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23457889999999987777655 99999999999999999999876543332221111000 00 0
Q ss_pred CCCC-----------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 243 SVPD-----------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 243 ~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
..+. ...++.++.+|+.+||+.||++|||+ .++++|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~--------~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT--------EQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH--------HHHhcCCCC
Confidence 0110 11267889999999999999999987 455578885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=315.97 Aligned_cols=248 Identities=31% Similarity=0.514 Sum_probs=208.9
Q ss_pred eccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 31 IGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 31 lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
||+|+||.||++++..+++.||+|++... ......+.+|+.++++++||||+++++++..+...++|+||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999989999999998753 22335567899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCCCCCCCc
Q 022401 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 185 (298)
Q Consensus 107 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~ 185 (298)
.+.+.....+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++...... .......+++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence 999988888999999999999999999999999999999999999998887 999999988643222 22233458899
Q ss_pred ccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhC
Q 022401 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265 (298)
Q Consensus 186 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 265 (298)
|+|||.+.+..++.+ +||||+|+++|+|++|..||...+. .+....+.......+ ..+++++.++|.+||+.|
T Consensus 159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENV----NEMYRKILQEPLRFP--DGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCH----HHHHHHHHcCCCCCC--CcCCHHHHHHHHHHcCCC
Confidence 999999988777665 9999999999999999999987543 334444555444443 347899999999999999
Q ss_pred CCCcccccccchhhhHHHhhhhhhhhh
Q 022401 266 PAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 266 p~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
|.+||++.. ..++++|||+...
T Consensus 232 p~~R~~~~~-----~~e~l~hp~~~~~ 253 (312)
T cd05585 232 PTRRLGYNG-----AQEIKNHPFFSQL 253 (312)
T ss_pred HHHcCCCCC-----HHHHHcCCCcCCC
Confidence 999997532 4678899998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=317.46 Aligned_cols=262 Identities=27% Similarity=0.452 Sum_probs=214.3
Q ss_pred CeeEEeeeccCCeEEEEEEEEc---cCCcEEEEEEeecC-----CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERG-----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~-----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (298)
+|++++.||+|+||.||++++. .+++.||+|++.+. ....+.+.+|+.+++.+ +|++|+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998874 46889999998753 22234577899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++|+||+.+++|.+.+.....+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999998887 999999998643222
Q ss_pred CC--CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 175 SQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
.. .....+++.|+|||.+.+......++||||||+++|+|++|..||...............+....... +..++.
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF--PSFIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCH
Confidence 21 22345889999999987665445559999999999999999999976554444444444554444433 334799
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++.+++.+||+.||.+||++... ...++++|||+.+.
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~---~~~~~l~h~~~~~~ 273 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQ---GASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCC---CHHHHHcCCCcCCC
Confidence 99999999999999999966432 24678899998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=323.23 Aligned_cols=263 Identities=31% Similarity=0.468 Sum_probs=228.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (298)
.....++|.++++||.|.||.|+++..+.+++.||||+++++. ...+....|..++... +||.++.++.+|..++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4678899999999999999999999999999999999998753 3345666777777766 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
++|+||||..||++ ..+...+.+++..+..++..|+.||+|||++||+|||||.+|||+|.+|+ +||+|||+|...-
T Consensus 443 ~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccC
Confidence 99999999999983 34446678999999999999999999999999999999999999999999 9999999998554
Q ss_pred -CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 173 -LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 173 -~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
......+..|||.|+|||++.+..|+.. .|-|+||++||||+.|+.||.+.++++ ....|.+..+.+|.. ++
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee----~FdsI~~d~~~yP~~--ls 592 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEE----VFDSIVNDEVRYPRF--LS 592 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCCCCCCc--cc
Confidence 4556678889999999999999999776 999999999999999999999987744 445566666666555 89
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.+..++++++|..||++|..+- +.....+-.|||+.+++
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~---e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSG---ERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHHHHHHHHHhccCcccccCCC---CCCchhhhhCCccccCC
Confidence 9999999999999999999874 44467778999998764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=290.04 Aligned_cols=256 Identities=34% Similarity=0.583 Sum_probs=227.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
..-..++|++++.||.|.||.||.|+.+.++..+|+|+..++. ....++.+|+++...|+||||++++++|-++..
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 4556789999999999999999999999999999999988753 344678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 94 LAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
.|+++||...+++...+. ...++++...+.++.|++.|+.|+|..+++||||||+|+|++..+. +|++|||-+...
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeec
Confidence 999999999999999998 5567999999999999999999999999999999999999999888 999999987655
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
+ .+...+.+|+..|.+||+..+...+.+ .|+|++|++.||++.|..||..... .+..+++.......| ..++
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~----~etYkrI~k~~~~~p--~~is 246 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSH----SETYKRIRKVDLKFP--STIS 246 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhh----HHHHHHHHHccccCC--cccC
Confidence 5 566677889999999999999998887 9999999999999999999988663 556666666666655 5589
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+..++|++|+.++|.+|.+. -++..|||+.-
T Consensus 247 ~~a~dlI~~ll~~~p~~r~~l--------~~v~~hpwI~a 278 (281)
T KOG0580|consen 247 GGAADLISRLLVKNPIERLAL--------TEVMDHPWIVA 278 (281)
T ss_pred hhHHHHHHHHhccCccccccH--------HHHhhhHHHHh
Confidence 999999999999999999965 66778999864
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=315.68 Aligned_cols=251 Identities=31% Similarity=0.521 Sum_probs=207.5
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (298)
+.||+|+||.||++++..+|+.||+|++.... .....+.+|+.++++++||||+++++++..+..+|+|+||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987532 23345678999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCCCCCC
Q 022401 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 183 (298)
Q Consensus 105 sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~ 183 (298)
+|...+.....+++..++.++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++...... .......++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence 99999988888999999999999999999999999999999999999998887 999999987643222 222334588
Q ss_pred CcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhh
Q 022401 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263 (298)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 263 (298)
+.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.. .....+.......+ ..+++++.++|.+||+
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~ 231 (323)
T cd05595 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIRFP--RTLSPEAKSLLAGLLK 231 (323)
T ss_pred cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCCCCC--CCCCHHHHHHHHHHcc
Confidence 99999999987777665 99999999999999999999875542 23333333444333 3479999999999999
Q ss_pred hCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 264 ADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 264 ~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.||.+|++.... ...++++|||+.+
T Consensus 232 ~dP~~R~~~~~~---~~~~~l~h~~~~~ 256 (323)
T cd05595 232 KDPKQRLGGGPS---DAKEVMEHRFFLS 256 (323)
T ss_pred CCHHHhCCCCCC---CHHHHHcCCCcCC
Confidence 999999843221 2466778888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=322.53 Aligned_cols=257 Identities=31% Similarity=0.504 Sum_probs=212.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++++..+++.||+|++... ......+.+|+.+++.++||||+++++++.++..+++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999999999999999998753 223345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-- 176 (298)
||+.+++|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 99999998753221100
Q ss_pred -------------------------------------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCC
Q 022401 177 -------------------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219 (298)
Q Consensus 177 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~ 219 (298)
.....|++.|+|||++....++.+ +|||||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence 012347889999999988777665 999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhhcCC--CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 220 PFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 220 pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
||...+.. .....+..... ..+....+++++.++|.+|+. +|.+|++. ....++++|||+.+.
T Consensus 238 Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~-----~~~~~ll~h~~~~~~ 302 (364)
T cd05599 238 PFCSDNPQ----ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN-----NGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCHH----HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC-----CCHHHHhcCCCcCCC
Confidence 99876542 23333433322 233333578999999999996 99999973 134777889998643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=316.38 Aligned_cols=252 Identities=31% Similarity=0.517 Sum_probs=207.0
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (298)
+.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.++||||+++.+++..+..+++|+||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987532 23356778999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCCC
Q 022401 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 183 (298)
Q Consensus 105 sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~ 183 (298)
+|...+.....+++.++..++.||+.||+|||++|++|+||||+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence 99999988888999999999999999999999999999999999999998887 99999998764322 1222334588
Q ss_pred CcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhh
Q 022401 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263 (298)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 263 (298)
+.|+|||.+.+..++.+ +||||||+++|+|++|..||...+. .+....+.......+ ..+++++.++|++||+
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~----~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~ 231 (328)
T cd05593 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILMEDIKFP--RTLSADAKSLLSGLLI 231 (328)
T ss_pred cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCH----HHHHHHhccCCccCC--CCCCHHHHHHHHHHcC
Confidence 99999999987777665 9999999999999999999987543 233333434444333 3479999999999999
Q ss_pred hCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 264 ADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 264 ~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.||.+|++... -...++++|||+.+.
T Consensus 232 ~dP~~R~~~~~---~~~~~il~h~~~~~~ 257 (328)
T cd05593 232 KDPNKRLGGGP---DDAKEIMRHSFFTGV 257 (328)
T ss_pred CCHHHcCCCCC---CCHHHHhcCCCcCCC
Confidence 99999983211 023566678887653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=318.90 Aligned_cols=254 Identities=27% Similarity=0.450 Sum_probs=208.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.++.+++|+||+++++.+.+...+|+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987532 23356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--- 175 (298)
||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999998887 9999999986332110
Q ss_pred ---------------------------------CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCC
Q 022401 176 ---------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (298)
Q Consensus 176 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 222 (298)
......|++.|+|||++.+..++.+ +|||||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence 0012358899999999988877665 999999999999999999998
Q ss_pred CCCCchhHHHHHHHHhhc--CCCCCCCCCCCHHHHHHHHHhhhhCCCC---cccccccchhhhHHHhhhhhhhhh
Q 022401 223 DPDEPKDFRKTIQRILSV--QYSVPDTNPISQECRDLISRIFVADPAA---VSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~---Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..... +...++... ....+....+++++.++|.+|+. +|.+ ||++ .++++|||+.+.
T Consensus 238 ~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~--------~ei~~hp~f~~~ 299 (363)
T cd05628 238 SETPQ----ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGV--------EEIKTNPFFEGV 299 (363)
T ss_pred CCCHH----HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCH--------HHHhCCCCCCCC
Confidence 76543 333334332 22333333478999999999774 4554 4655 666789998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=312.68 Aligned_cols=257 Identities=30% Similarity=0.480 Sum_probs=213.6
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCC-CCeeeeeEEEEeCCeEEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 98 (298)
+|++.+.||+|+||.||++++..+++.||+|++... ....+.+..|..++..+.| ++++++++++...+.+|+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999989999999998753 2233556778888888876 56888999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~ 177 (298)
||+++++|...+.....+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence 99999999999988888999999999999999999999999999999999999998887 99999998763221 2222
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||++.+..++.+ +||||+|+++|+|++|..||..... ......+.......+ ..++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~~~--~~~~~~~~~l 231 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSIMEHNVSYP--KSLSKEAVSI 231 (324)
T ss_pred eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCC--CCCCHHHHHH
Confidence 34458899999999988777665 9999999999999999999987654 333444444444433 3479999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.+||..||.+|++.... ...++++|||+...
T Consensus 232 i~~~l~~~P~~R~~~~~~---~~~~~~~hp~~~~~ 263 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPT---GERDIREHAFFRRI 263 (324)
T ss_pred HHHHhhcCHHHcCCCCCC---CHHHHhcCCCcCCC
Confidence 999999999999987542 24678899998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=313.96 Aligned_cols=253 Identities=31% Similarity=0.473 Sum_probs=210.8
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||+++++.+++.||+|++... ......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999998753 22334566788888766 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
++|...+.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence 999999988888999999999999999999999999999999999999998887 99999998764322 222234458
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+. ......+.......+ ..+++++.+++++||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~~--~~~~~~~~~li~~~L 231 (320)
T cd05590 159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAILNDEVVYP--TWLSQDAVDILKAFM 231 (320)
T ss_pred CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHHhcCCCCCC--CCCCHHHHHHHHHHc
Confidence 899999999987777665 9999999999999999999987654 233444444444333 347999999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.||.+||++.+.. ...+++.|||+.+.
T Consensus 232 ~~dP~~R~~~~~~~--~~~~~~~h~~f~~~ 259 (320)
T cd05590 232 TKNPTMRLGSLTLG--GEEAILRHPFFKEL 259 (320)
T ss_pred ccCHHHCCCCCCCC--CHHHHHcCCCcCCC
Confidence 99999999987642 45778899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=319.78 Aligned_cols=263 Identities=30% Similarity=0.444 Sum_probs=214.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
.....++|++.+.||+|+||.||++++..+++.||+|++... ......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 345568999999999999999999999999999999998653 1223456789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+++|+||+++++|.+++... .+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~ 194 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDA 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccC
Confidence 99999999999999988654 5889999999999999999999999999999999999998887 99999999865432
Q ss_pred CC--CCCCCCCCCcccCcccccccc---CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC--CCCCC
Q 022401 174 HS--QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPD 246 (298)
Q Consensus 174 ~~--~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 246 (298)
.. ......+++.|+|||.+.+.. ....++|||||||++|+|++|..||...+.. .....+.... ...+.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYSKIMDHKNSLTFPD 270 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----HHHHHHHcCCCcCCCCC
Confidence 22 123456899999999986543 2344599999999999999999999876543 3334443332 33444
Q ss_pred CCCCCHHHHHHHHHhhhhCCCC--cccccccchhhhHHHhhhhhhhhhhhh
Q 022401 247 TNPISQECRDLISRIFVADPAA--VSIFFFPLNMSCLLLFSFVWMFDATEN 295 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~~~~~~~~hp~~~~~~~~ 295 (298)
...++.++.++|.+||+.+|.+ |+|+ .++++|||+.+...+
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~--------~ell~h~~~~~~~~~ 313 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGV--------DEIKSHPFFKNDQWT 313 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCH--------HHHhcCcccCCCChh
Confidence 4457999999999999999987 8876 666788888764433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=312.90 Aligned_cols=255 Identities=33% Similarity=0.491 Sum_probs=209.5
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHH---hcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
|++.+.||+|++|.||++++..+++.||+|++.... ...+.+..|..++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999987532 2234455665554 567899999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~ 176 (298)
+||+++++|...+.. ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++...... ..
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 999999999887744 56899999999999999999999999999999999999998887 999999987643222 22
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.. .....+.......+ ..++.++.+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~----~~~~~i~~~~~~~p--~~~~~~~~~ 230 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEE----EVFDSIVNDEVRYP--RFLSREAIS 230 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCC--CCCCHHHHH
Confidence 234568899999999987777655 99999999999999999999876542 33334444444333 347999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+|.+||+.||.+||++.+. ...++++|||+.+.
T Consensus 231 li~~~L~~dP~~R~~~~~~---~~~~l~~~~~f~~~ 263 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEK---DAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHhhcCHhHcCCCCCC---CHHHHhhCCCcCCC
Confidence 9999999999999987654 35788899998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.09 Aligned_cols=256 Identities=28% Similarity=0.454 Sum_probs=208.7
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++++.||+|+||.||++++..+++.||+|++.+.. .....+.+|+.++++++||||+++++++.++..+|+|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986532 23356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-- 176 (298)
||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 99999998852211000
Q ss_pred ----------------------------------------------CCCCCCCCcccCccccccccCCCCccchHHHHHH
Q 022401 177 ----------------------------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210 (298)
Q Consensus 177 ----------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~l 210 (298)
.....|++.|+|||.+.+..++.+ +|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence 001347889999999988777665 999999999
Q ss_pred HHHHHhCCCCCCCCCCchhHHHHHHHHhhc--CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhh
Q 022401 211 LYVMLVGGYPFEDPDEPKDFRKTIQRILSV--QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVW 288 (298)
Q Consensus 211 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~ 288 (298)
+|+|++|..||......+. ...+... ....+....++.++.+||.+||. +|.+|+.. ....++++|||
T Consensus 238 l~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r-----~~~~~~l~hp~ 307 (377)
T cd05629 238 MFECLIGWPPFCSENSHET----YRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR-----GGAHEIKSHPF 307 (377)
T ss_pred hhhhhcCCCCCCCCCHHHH----HHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC-----CCHHHHhcCCC
Confidence 9999999999987654332 2333322 22334444578999999999997 77776521 13367778888
Q ss_pred hhh
Q 022401 289 MFD 291 (298)
Q Consensus 289 ~~~ 291 (298)
+.+
T Consensus 308 ~~~ 310 (377)
T cd05629 308 FRG 310 (377)
T ss_pred cCC
Confidence 864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=303.85 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=207.9
Q ss_pred eccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 31 lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
||+|+||.||+++...+|+.||+|.+.... .....+..|++++++++||||+++.+++..+..+++|+||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999999999999886432 1223455699999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCC
Q 022401 107 FERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184 (298)
Q Consensus 107 ~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 184 (298)
.+.+.... .++...+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||++.............++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence 88875443 5888999999999999999999999999999999999998887 9999999886554333333456788
Q ss_pred cccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhh
Q 022401 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264 (298)
Q Consensus 185 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 264 (298)
.|+|||++.+..++.+ +|+||+|+++|+|++|..||........................ ...+++++.+++++||+.
T Consensus 159 ~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 159 GYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAK 236 (277)
T ss_pred CccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhcc
Confidence 9999999987776555 99999999999999999999865443333334444443333322 234799999999999999
Q ss_pred CCCCcccccccchhhhHHHhhhhhhhh
Q 022401 265 DPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 265 dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
||.+||++.+++ .+++.|||+.+
T Consensus 237 ~P~~R~~~~~~~----~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKN----DDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccch----hhhhcChhhcC
Confidence 999999998876 57778999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=305.46 Aligned_cols=260 Identities=24% Similarity=0.332 Sum_probs=214.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++.+++..+..+++|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4899999999999999999998889999999987532 122446789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|+.+++|.+.+... ..+++..+..++.|++.|+.|||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence 99999999887543 35899999999999999999999999999999999999998877 999999998754433333
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||.+.+..++.+ +||||+|+++|++++|..||...............+....... +..++..+.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 235 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--SEKFSEAARSI 235 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc--CcccCHHHHHH
Confidence 34467889999999987777665 9999999999999999999987665443333333333333222 33478999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.+||+.||.+||+..+. ...++++|||+..
T Consensus 236 i~~~l~~~P~~R~~~~~~---~~~~l~~~~~~~~ 266 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGE---GAEEVKAHPFFRT 266 (285)
T ss_pred HHHHccCCHHHhcCCCCC---CHHHHhcCcCccC
Confidence 999999999999966532 3467889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=312.62 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=209.5
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+++.||+|++.... .....+..|..++.++ +||||+++++++..++.+++|+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47899999999999999999999999987532 2234577889999888 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
++|...+.....+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999998864221 222234467
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch-----hHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----DFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
++.|+|||++.+..++.+ +|+||||+++|+|++|..||......+ ......+.+.......+ ..++.++.++
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l 235 (329)
T cd05588 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKASSV 235 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC--CCCCHHHHHH
Confidence 899999999988777665 999999999999999999996432111 11222333444444433 3478999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
|.+||+.||.+|+++.... ...++++|||+.+
T Consensus 236 i~~~L~~dP~~R~~~~~~~--~~~~i~~hp~~~~ 267 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQT--GFRDIKSHPFFRN 267 (329)
T ss_pred HHHHhccCHHHcCCCCCCC--CHHHHhcCCCCCC
Confidence 9999999999999864332 4678889999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=304.52 Aligned_cols=253 Identities=29% Similarity=0.377 Sum_probs=207.5
Q ss_pred eccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 31 lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
||+|+||.||.+.+..+++.+|+|.+..... ..+.+..|+.++++++|+|++++.+++..+..+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999999999999999875322 224567899999999999999999999999999999999999999
Q ss_pred HHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCCCC
Q 022401 107 FERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 181 (298)
Q Consensus 107 ~~~l~----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 181 (298)
...+. ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence 88774 3346899999999999999999999999999999999999988776 9999999886433222 222345
Q ss_pred CCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHh
Q 022401 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261 (298)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 261 (298)
+++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...............+..... ..+..+++++.+++.+|
T Consensus 159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV--TYPDKFSPASKSFCEAL 235 (280)
T ss_pred CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC--CCcccCCHHHHHHHHHH
Confidence 7889999999988877665 99999999999999999999876543333333444433332 23344799999999999
Q ss_pred hhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 262 FVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 262 l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
|+.||++||++.+.. ..++++|||+.+
T Consensus 236 l~~~P~~R~~~~~~~---~~~~l~h~~~~~ 262 (280)
T cd05608 236 LAKDPEKRLGFRDGN---CDGLRTHPLFRD 262 (280)
T ss_pred hcCCHHHhcCCCCCC---HHHHhcChhhhc
Confidence 999999999776543 478889999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=317.44 Aligned_cols=254 Identities=29% Similarity=0.479 Sum_probs=209.9
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++++..+++.||+|++..... ....+.+|+.+++.++|+||+++++++.++..+++|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999876422 3455778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-
Q 022401 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~- 176 (298)
||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence 999999999999776 67999999999999999999999999999999999999998887 99999999864433221
Q ss_pred -CCCCCCCCcccCcccccc------ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC--CCCCCC
Q 022401 177 -PKSTVGTPAYIAPEVLLR------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPDT 247 (298)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~ 247 (298)
.....+++.|+|||++.. ..+ ..++||||||+++|+|++|..||........ ..++.... ...+..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTY-GVECDWWSLGVIAYEMIYGRSPFHEGTSAKT----YNNIMNFQRFLKFPED 233 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCC-CCcceeecccceeeeeccCCCCCCCCCHHHH----HHHHHcCCCccCCCCC
Confidence 223457889999999863 233 3449999999999999999999987665333 33333322 233444
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..+++++.+++..||+ ||.+|||+ .++++|||+...
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~--------~~l~~h~~~~~~ 269 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGY--------EGLCCHPFFSKI 269 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCH--------HHHhCCCCcCCC
Confidence 4579999999999997 99999987 556688887653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=318.23 Aligned_cols=254 Identities=28% Similarity=0.430 Sum_probs=207.6
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
+.|++++.||+|+||.||++++..+++.||+|++.... .....+.+|+.++++++||||+++++++.+...+++|+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999987532 23356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--- 175 (298)
||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998877 9999999864211000
Q ss_pred ---------------------------------------------CCCCCCCCCcccCccccccccCCCCccchHHHHHH
Q 022401 176 ---------------------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210 (298)
Q Consensus 176 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~l 210 (298)
......|++.|+|||.+.+..++.+ +|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhH
Confidence 0012357889999999988777665 999999999
Q ss_pred HHHHHhCCCCCCCCCCchhHHHHHHHHhh--cCCCCCCCCCCCHHHHHHHHHhh--hhCCCCcccccccchhhhHHHhhh
Q 022401 211 LYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTNPISQECRDLISRIF--VADPAAVSIFFFPLNMSCLLLFSF 286 (298)
Q Consensus 211 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l--~~dp~~Rps~~~~l~~~~~~~~~h 286 (298)
+|+|++|..||......... .++.. .....+....+++++.+||.+|+ ..+|..|+++ .+++.|
T Consensus 238 l~elltG~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~--------~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQ----LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA--------DDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHH----HHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH--------HHHhcC
Confidence 99999999999876543222 22222 22334444457899999999955 4556669977 555678
Q ss_pred hhhhh
Q 022401 287 VWMFD 291 (298)
Q Consensus 287 p~~~~ 291 (298)
||+.+
T Consensus 306 p~f~~ 310 (381)
T cd05626 306 PFFSE 310 (381)
T ss_pred cccCC
Confidence 88764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=312.42 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=208.9
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+++.+|+|++.+.. .....+..|+.++.++ +||||+++++++..++.+++|+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999987632 2234566788888776 899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
++|...+.....+++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999998864322 222234467
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCC-----chhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----PKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
++.|+|||++.+..++.+ +|+||||+++|+|++|..||..... ........+.+.......+ ..++.++.++
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~l 235 (329)
T cd05618 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASV 235 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC--CCCCHHHHHH
Confidence 899999999988777665 9999999999999999999963221 1111223333444444443 3478999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.+||+.||.+||++.... ...++++|||+.+.
T Consensus 236 l~~~L~~dP~~R~~~~~~~--~~~~i~~hp~f~~~ 268 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQT--GFADIQGHPFFRNV 268 (329)
T ss_pred HHHHhcCCHHHcCCCCCCC--CHHHHhcCCCCCCC
Confidence 9999999999999964332 35788899999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=296.00 Aligned_cols=270 Identities=27% Similarity=0.354 Sum_probs=223.2
Q ss_pred CCCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch---HHHHHHHHHHhcCCCCCeeeeeEE
Q 022401 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEV 87 (298)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~ 87 (298)
-++...-.+-+.+.|+.+..|++|.||.||.|+++.+++.||+|++.-+.... -.-.+|+++|.+++|||||.+.++
T Consensus 64 ~~~~~l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEV 143 (419)
T KOG0663|consen 64 LKQELLGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEV 143 (419)
T ss_pred cccccccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEE
Confidence 44444677888999999999999999999999999999999999987654322 235689999999999999999999
Q ss_pred EEeC--CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEee
Q 022401 88 ILTP--THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (298)
Q Consensus 88 ~~~~--~~~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d 164 (298)
.... +.+|+||+|++. +|.+++.+-+ ++...+++-++.|++.|++|||.+.|+||||||+|+|++..|. +|++|
T Consensus 144 VvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaD 220 (419)
T KOG0663|consen 144 VVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIAD 220 (419)
T ss_pred EeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecc
Confidence 8754 479999999976 8999997765 7999999999999999999999999999999999999999998 99999
Q ss_pred cCccccccCCCCC-CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-
Q 022401 165 FGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY- 242 (298)
Q Consensus 165 ~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 242 (298)
||+|+........ .....+.+|.|||.+.+.+-++.+.|+||+||++.|++++.+.|.+..+.+++....+-+....-
T Consensus 221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred cchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 9999866554332 33446889999999999877777799999999999999999999998887777666655422110
Q ss_pred ------CCCCC------------------C-CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 243 ------SVPDT------------------N-PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 243 ------~~~~~------------------~-~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.++.- . .+++.-.+|+..+|.+||.+|.|+.++| .|.|+.+
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L--------~h~~F~e 366 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL--------KHEYFRE 366 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh--------ccccccc
Confidence 00000 0 1568899999999999999999995555 7777775
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=318.13 Aligned_cols=264 Identities=28% Similarity=0.430 Sum_probs=213.7
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
.....++|++.+.||+|+||.||++++..+++.+|+|++.+. ......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 345568999999999999999999999999999999998652 2233457789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+++|+||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceeccc
Confidence 99999999999999988654 5899999999999999999999999999999999999998887 99999999875432
Q ss_pred CCC--CCCCCCCCcccCcccccccc---CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC--CCCCC
Q 022401 174 HSQ--PKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPD 246 (298)
Q Consensus 174 ~~~--~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 246 (298)
... .....+++.|+|||++.+.. ....++|+||+|+++|+|++|..||...+... ...++.... ...+.
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG----TYSKIMDHKNSLNFPE 270 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCcccCCCC
Confidence 221 23456899999999987543 23445999999999999999999998765433 333443322 33444
Q ss_pred CCCCCHHHHHHHHHhhhhCCCC--cccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 247 TNPISQECRDLISRIFVADPAA--VSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
...++..+.+++..||+.++.+ |+++ .++++|||+.....+|
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~--------~e~l~hp~~~~~~~~~ 314 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGV--------EEIKQHPFFKNDQWNW 314 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCH--------HHHhcCcccCCCCcCh
Confidence 4457899999999999754443 6765 6677899998765555
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=312.18 Aligned_cols=250 Identities=30% Similarity=0.489 Sum_probs=206.3
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHH-HHhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+++.||+|++.... .....+..|.. +++.++||||+++++++...+.+++|+||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999987532 11223344443 56789999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
++|...+.....+++..+..++.||+.||+|||++|++||||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999998864322 222234458
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||++.+..++.+ +||||||+++|+|++|..||...+. ......+....... ...++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l 231 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDT----AEMYDNILNKPLRL--KPNISVSARHLLEGLL 231 (323)
T ss_pred ChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCH----HHHHHHHHcCCCCC--CCCCCHHHHHHHHHHh
Confidence 899999999988777665 9999999999999999999987543 33344444444433 3347999999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.||.+||++.+.+ .++++|||+.+
T Consensus 232 ~~~p~~R~~~~~~~----~~il~~~~~~~ 256 (323)
T cd05575 232 QKDRTKRLGAKDDF----LEIKNHVFFSS 256 (323)
T ss_pred hcCHHhCCCCCCCH----HHHHcCCCcCC
Confidence 99999999987544 57889999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=323.50 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=202.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--------C
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------T 92 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~ 92 (298)
...+|++++.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 4568999999999999999999999899999999886543 2345799999999999999999886432 2
Q ss_pred eEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 93 HLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
.+++|+||+++ ++.+.+. ....+++..++.++.|++.||+|||+.|++||||||+||+++.++. .+||+|||++
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla 218 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSA 218 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccc
Confidence 57799999975 6666553 3567899999999999999999999999999999999999986553 4999999999
Q ss_pred ccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc--------
Q 022401 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-------- 240 (298)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 240 (298)
.............+++.|+|||++.+....+.++|||||||++|+|++|..||.+....+.+....+.+...
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 765544444455678999999998765444445999999999999999999998876655544443322110
Q ss_pred -----CCCCC----------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 241 -----QYSVP----------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 241 -----~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...++ .+...++++.+||.+||+.||.+|||+ .++++|||+.+.
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta--------~e~l~hp~f~~~ 357 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP--------IEALADPFFDDL 357 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH--------HHHhCChhHHhh
Confidence 00011 122367899999999999999999988 455577777643
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.30 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=208.2
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.++|++.+.||+|+||.||++.+..++..+++|.+.... .....+.+|+.++++++||||+++++++..++.+++|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999999899999999887543 233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc-CcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
|+.+++|.+++.....+++..+..++.+++.|+.|||+. +++|+||||+||+++.++. ++|+|||++...... ...
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~-~~~ 160 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MAN 160 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhhh-ccc
Confidence 999999999998888899999999999999999999975 7999999999999998887 999999987643221 122
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHH-------------------------
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT------------------------- 233 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~------------------------- 233 (298)
...++..|+|||.+.+..++.+ +|+|||||++|++++|..||........ ...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCccchh
Confidence 3457889999999987776655 9999999999999999999976443111 110
Q ss_pred ----------------HHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 234 ----------------IQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 234 ----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...+.............+.++.+|+.+||+.||++|||+ .+++.|||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~--------~ell~h~~~~~~ 305 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL--------KQLMVHAFIKRS 305 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH--------HHHhhCHHHhcC
Confidence 011111111111112357899999999999999999987 455578888654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=306.79 Aligned_cols=245 Identities=37% Similarity=0.644 Sum_probs=223.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch----HHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.+|++.+.||.|.+|.|-+|..+..|+.||||.+.++.-.. -.+.+|++|+..|.||||+.++++|+....+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 47999999999999999999999999999999998764333 34779999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
||..+|.|.+++++.+.+++.+...+++||..|+.|+|+++++|+|||.+|||+|.+++ +||.|||++..........
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHH
Confidence 99999999999999999999999999999999999999999999999999999999998 9999999987666667778
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
+.+|++.|.+||+..+.+|.....|-||||+++|-++.|.+||.+.+. ..+++.+..+.+..|.. |.+..-||
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrEP~~---PSdA~gLI 283 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYREPET---PSDASGLI 283 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccCCCC---CchHHHHH
Confidence 889999999999999999998889999999999999999999999664 66777777777776654 77899999
Q ss_pred HHhhhhCCCCcccccccc
Q 022401 259 SRIFVADPAAVSIFFFPL 276 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l 276 (298)
++||-.||.+|.|+++|-
T Consensus 284 RwmLmVNP~RRATieDiA 301 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIA 301 (668)
T ss_pred HHHHhcCcccchhHHHHh
Confidence 999999999999985444
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=319.24 Aligned_cols=256 Identities=30% Similarity=0.452 Sum_probs=208.6
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++++.||+|+||.||++++..+++.||+|++... ......+.+|+.++++++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999998653 223356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC----
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 174 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~---- 174 (298)
||+++++|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 999999987421100
Q ss_pred ----------------------------------------CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHH
Q 022401 175 ----------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 214 (298)
Q Consensus 175 ----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l 214 (298)
.......|++.|+|||++.+..++.+ +|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence 00012357889999999988777665 9999999999999
Q ss_pred HhCCCCCCCCCCchhHHHHHHHHhhc--CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 215 LVGGYPFEDPDEPKDFRKTIQRILSV--QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 215 ~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
++|..||......+.. ..+... ....+....++.++.++|.+|+ .+|.+|+... ...++++|||+..
T Consensus 238 l~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~-----t~~ell~h~~~~~ 306 (376)
T cd05598 238 LVGQPPFLADTPAETQ----LKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN-----GADEIKAHPFFKG 306 (376)
T ss_pred hhCCCCCCCCCHHHHH----HHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC-----CHHHHhCCCCcCC
Confidence 9999999876543322 222222 2233334457899999999987 5999999321 2366667888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=318.83 Aligned_cols=256 Identities=31% Similarity=0.461 Sum_probs=209.9
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
+.|++++.||+|+||.||++++..+++.+|+|++.... .....+.+|+.++++++||||+++++++.++..+++|+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999987532 23356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC----
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 174 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~---- 174 (298)
||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 999999986421100
Q ss_pred --------------------------------------------CCCCCCCCCCcccCccccccccCCCCccchHHHHHH
Q 022401 175 --------------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210 (298)
Q Consensus 175 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~l 210 (298)
.......|++.|+|||++.+..++.+ +||||+||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHH
Confidence 00012347889999999988887765 999999999
Q ss_pred HHHHHhCCCCCCCCCCchhHHHHHHHHhhc--CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhh
Q 022401 211 LYVMLVGGYPFEDPDEPKDFRKTIQRILSV--QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVW 288 (298)
Q Consensus 211 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~ 288 (298)
+|+|++|..||...+..+ ...++... ....+....+++++.++|.+|+ .||.+|++. ....++++|||
T Consensus 238 l~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~-----~~~~ei~~hp~ 307 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLE----TQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK-----NGADEIKAHPF 307 (382)
T ss_pred HHHHHhCCCCCCCCCHHH----HHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC-----CCHHHHhcCCC
Confidence 999999999998765432 22233332 2233444557999999999987 599999972 12467778998
Q ss_pred hhh
Q 022401 289 MFD 291 (298)
Q Consensus 289 ~~~ 291 (298)
+.+
T Consensus 308 f~~ 310 (382)
T cd05625 308 FKT 310 (382)
T ss_pred cCC
Confidence 864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.94 Aligned_cols=260 Identities=21% Similarity=0.298 Sum_probs=204.7
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
...++|++++.||+|+||.||++.+..+++.||+|.... ..+.+|+.++++++||||+++++++..+...+++++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 345689999999999999999999999999999996432 356789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC--CCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~--~~~ 177 (298)
++. ++|...+.....++..+++.++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++...... ...
T Consensus 164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKY 240 (391)
T ss_pred cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCccccccccccccc
Confidence 995 588888877788999999999999999999999999999999999999998887 999999998632221 122
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCC-------chhHHHHHHHH-------------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------PKDFRKTIQRI------------- 237 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-------~~~~~~~~~~~------------- 237 (298)
....+++.|+|||++.+..++.+ +||||||+++|+|++|..||-.... ...+.......
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 23468899999999987777655 9999999999999999987644221 11111111111
Q ss_pred ---------hhcCCCCCC-------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 238 ---------LSVQYSVPD-------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 238 ---------~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
.......+. ...++.++.++|.+||+.||.+|||+ .++++|||+++...-|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta--------~elL~hp~f~~~~~~~ 386 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA--------EALLDFAAFQDIPDPY 386 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH--------HHHhcChhhccCCCCC
Confidence 000000000 11246789999999999999999988 4555788888755444
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.43 Aligned_cols=265 Identities=23% Similarity=0.377 Sum_probs=209.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
..++|++.+.||+|+||.||++++..+++.+|+|.+.... .....+.+|+.++++++|||++++++++..+...++|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 3478999999999999999999999899999999987542 22345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-C
Q 022401 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~ 176 (298)
||+++ +|.+.+... ..++...+..++.|++.||+|||++|++||||+|+||+++.++. ++|+|||++....... .
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccc
Confidence 99975 777777554 45889999999999999999999999999999999999998887 9999999886433222 2
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC---------------
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------- 241 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 241 (298)
.....+++.|+|||.+.+......++||||+|+++|+|++|..||...+..+.+......+....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 23345688999999987655445559999999999999999999987665444333322111000
Q ss_pred CCC---------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 242 YSV---------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 242 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
... .....+++++.++|.+||+.||.+|||+ .++++|||+.+...-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~--------~e~l~h~~~~~~~~~~ 296 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA--------EEAMKHAYFRSLGTRI 296 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH--------HHHhcChhhhhccccc
Confidence 000 1112468899999999999999999987 5555788888655433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=312.98 Aligned_cols=251 Identities=33% Similarity=0.514 Sum_probs=206.2
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (298)
+.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.++||||+++++++..+..+++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987532 22345678899999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 105 sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
+|...+.....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence 999999888889999999999999999999997 79999999999999998887 99999998764322 222234458
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||++.+..++.+ +||||||+++|+|++|..||...+.. .....+.......+ ..+++++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~----~~~~~i~~~~~~~p--~~~~~~~~~li~~~L 231 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFP--RTLSPEAKSLLSGLL 231 (325)
T ss_pred CcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHH----HHHHHHhcCCCCCC--CCCCHHHHHHHHHHh
Confidence 899999999987777665 99999999999999999999875542 33333444444433 347899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.||.+|++.... ...++++|||+.+
T Consensus 232 ~~dP~~R~~~~~~---~~~~il~h~~~~~ 257 (325)
T cd05594 232 KKDPKQRLGGGPD---DAKEIMQHKFFAG 257 (325)
T ss_pred hcCHHHhCCCCCC---CHHHHhcCCCcCC
Confidence 9999999732211 1366668888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=309.63 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=208.1
Q ss_pred EeeeccCCeEEEEEEEEc---cCCcEEEEEEeecCC-----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 28 VRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++.||+|+||.||.+++. .+++.||+|++.... .....+.+|+.++++++||||+++++++..++.+|+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 468899999987532 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~ 178 (298)
|+.+++|.+.+.....+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence 9999999999988888999999999999999999999999999999999999998887 999999987633222 2223
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
...+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+.. .....+....... +..+++++.++|
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~~li 231 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRK----KTIDKILKGKLNL--PPYLTPEARDLL 231 (323)
T ss_pred ccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCC--CCCCCHHHHHHH
Confidence 3458899999999987777655 99999999999999999999876542 3344444444433 334789999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+||+.||.+||+.... ...++++|||+..
T Consensus 232 ~~~l~~~p~~R~~~~~~---~~~~l~~h~~~~~ 261 (323)
T cd05584 232 KKLLKRNPSSRLGAGPG---DAAEVQSHPFFRH 261 (323)
T ss_pred HHHcccCHhHcCCCCCC---CHHHHhcCCCcCC
Confidence 99999999999954332 3477888999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=311.30 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=201.6
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CeEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA 95 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 95 (298)
+|++.+.||+|+||.||++++..++..||+|.+... ......+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999988643 22234578899999999999999999988643 3589
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+|+||+. ++|.+.+.....+++..+..++.|++.||.|||++|++|+||||+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence 9999995 589999988888999999999999999999999999999999999999998887 9999999986432221
Q ss_pred C----CCCCCCCCcccCcccccc--ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH-----------HHh
Q 022401 176 Q----PKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ-----------RIL 238 (298)
Q Consensus 176 ~----~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~-----------~~~ 238 (298)
. .....+++.|+|||.+.+ ..++. ++||||||+++|+|++|..||...+....+..... .+.
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCc-hhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 123457889999998765 34444 49999999999999999999977554222111100 000
Q ss_pred -----------hcCCCC---CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 239 -----------SVQYSV---PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 239 -----------~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
...... .....+++++.+++.+||+.||++|||+ .++++|||+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--------~e~l~hp~f~~~~ 297 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA--------EEALADPYFKGLA 297 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH--------HHHhcCchhhhcC
Confidence 000000 0112367889999999999999999987 5555788886543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=301.11 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=216.8
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.|+..+.||+|+||.||.+.+..+++.+|+|.+.... .....+.+|+.++++++|+|++++.+++..++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4889999999999999999999999999999987542 222446789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|+.+++|...+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence 99999998888543 36899999999999999999999999999999999999988876 999999988654433333
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....++..|+|||.+.+..++.+ +|+||+|+++|++++|..||...............+....... ...++.++.+|
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 235 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY--SAKFSEEAKSI 235 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc--CccCCHHHHHH
Confidence 44568899999999987777665 9999999999999999999987654333333333333333222 33478999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+..||+.||++||++.+.. ..+++.|||+.+..
T Consensus 236 i~~~l~~~P~~R~~~~~~~---~~~l~~~~~~~~~~ 268 (285)
T cd05632 236 CKMLLTKDPKQRLGCQEEG---AGEVKRHPFFRNMN 268 (285)
T ss_pred HHHHccCCHhHcCCCcccC---hHHHHcChhhhcCC
Confidence 9999999999999975443 58889999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=307.83 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=211.8
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
+|++.+.||+|+||.||++++..+++.+|+|++.+.. .....+..|..++..+ +|++++++++++...+.+++|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999899999999987542 1223455677777766 5799999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~ 177 (298)
||+++++|...+.....+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence 99999999999988888999999999999999999999999999999999999998887 99999998864322 2222
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||++.+..++.+ +|||||||++|+|++|..||...+. ......+.......+ ..++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~s~~~~~l 231 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYP--KSMSKEAVAI 231 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCC--CcCCHHHHHH
Confidence 34568899999999988777665 9999999999999999999987654 333444444444443 3479999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.+||+.||.+|++..... ..++.+|||+..
T Consensus 232 i~~~l~~~p~~R~~~~~~~---~~~i~~h~~~~~ 262 (323)
T cd05616 232 CKGLMTKHPGKRLGCGPEG---ERDIKEHAFFRY 262 (323)
T ss_pred HHHHcccCHHhcCCCCCCC---HHHHhcCCCcCC
Confidence 9999999999999864332 356778888764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=312.97 Aligned_cols=253 Identities=29% Similarity=0.464 Sum_probs=210.2
Q ss_pred EeeeccCCeEEEEEEEEc---cCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 28 VRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
++.||+|+||.||++++. .+|+.+|+|++.... .....+.+|+.++++++||||+++++++..+..+|+|+||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999873 578899999987532 22345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCCC
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~~ 180 (298)
.+++|.+.+.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... ......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence 99999999988888999999999999999999999999999999999999998887 999999988644332 222344
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 260 (298)
.+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+. ......+....... +..+++++.++|++
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~----~~~~~~i~~~~~~~--p~~~~~~~~~li~~ 231 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDR----KETMTMILKAKLGM--PQFLSPEAQSLLRA 231 (318)
T ss_pred cCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCH----HHHHHHHHcCCCCC--CCCCCHHHHHHHHH
Confidence 57889999999887777655 9999999999999999999987543 23333444444333 33478999999999
Q ss_pred hhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 261 IFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 261 ~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
||+.||.+||++.+.+ ..+++.|||+...
T Consensus 232 ~l~~~P~~R~~a~~~~---~~~~~~~~~~~~~ 260 (318)
T cd05582 232 LFKRNPANRLGAGPDG---VEEIKRHPFFSTI 260 (318)
T ss_pred HhhcCHhHcCCCCCCC---HHHHhCCCCcCCC
Confidence 9999999999987654 4778899998653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=309.56 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=208.6
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+++.||+|++.... .....+..|..++..+ +||||+++++++..++.+|+|+||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999899999999987532 2234466788888765 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~ 182 (298)
++|...+.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999988888999999999999999999999999999999999999998887 999999988643222 22233457
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||.+.+..++.+ +||||+|+++|+|++|..||...+. ......+.......+ ..++.++.+++.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~~~~~~~ll~~~L 231 (321)
T cd05591 159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNE----DDLFESILHDDVLYP--VWLSKEAVSILKAFM 231 (321)
T ss_pred CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCC--CCCCHHHHHHHHHHh
Confidence 899999999987777666 9999999999999999999987654 333444555444333 337899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.||.+||+..+.. ....++++|||+.+
T Consensus 232 ~~dp~~R~~~~~~~-~~~~~~~~hp~~~~ 259 (321)
T cd05591 232 TKNPNKRLGCVASQ-GGEDAIKQHPFFKE 259 (321)
T ss_pred ccCHHHcCCCCCCC-CCHHHHhcCCccCC
Confidence 99999999654432 14577789999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=300.07 Aligned_cols=263 Identities=27% Similarity=0.420 Sum_probs=223.5
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
+.+..+.|++++.||.|.-|.||+++.+.++..+|+|++.+.. +...+...|.+||..++||.+.+++..++.++.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 4556678999999999999999999999999999999998753 233456679999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
.|++||||+||+|..+++.++ .+++..++.++..++.||+|||..|||+|||||+||||.++|+ +.|+||+++...
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~ 229 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRC 229 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccC
Confidence 999999999999999887655 5999999999999999999999999999999999999999999 999999987421
Q ss_pred cC--------------------------------CCCC-------------------------CCCCCCCcccCcccccc
Q 022401 172 VL--------------------------------HSQP-------------------------KSTVGTPAYIAPEVLLR 194 (298)
Q Consensus 172 ~~--------------------------------~~~~-------------------------~~~~~~~~~~aPE~~~~ 194 (298)
.. .... ....||-+|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 0000 00125668999999999
Q ss_pred ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccc
Q 022401 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFF 274 (298)
Q Consensus 195 ~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 274 (298)
.+.... .|.|+||+++|||+.|..||.+.+. .+....+...+...+....++.++++||+++|.+||.+|....
T Consensus 310 ~GHgsA-VDWWtfGIflYEmLyG~TPFKG~~~----~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~- 383 (459)
T KOG0610|consen 310 EGHGSA-VDWWTFGIFLYEMLYGTTPFKGSNN----KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK- 383 (459)
T ss_pred CCCCch-hhHHHHHHHHHHHHhCCCCcCCCCc----hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc-
Confidence 988666 9999999999999999999999887 4555666777777787777899999999999999999999741
Q ss_pred cchhhhHHHhhhhhhhh
Q 022401 275 PLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 275 ~l~~~~~~~~~hp~~~~ 291 (298)
+=..++-+|||+.+
T Consensus 384 ---rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 384 ---RGAAEIKRHPFFEG 397 (459)
T ss_pred ---cchHHhhcCccccC
Confidence 12367778999865
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=308.77 Aligned_cols=252 Identities=33% Similarity=0.506 Sum_probs=209.6
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++.+..++..||+|++.... .....+..|..+++.+ +||||+++++++...+.+++|+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999899999999987532 2334566788888877 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
++|...+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999988888999999999999999999999999999999999999998887 99999998763222 222233457
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+. ......+.......+ ..++.++.++|.+||
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~----~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l 231 (318)
T cd05570 159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDE----DELFQSILEDEVRYP--RWLSKEAKSILKSFL 231 (318)
T ss_pred CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCH----HHHHHHHHcCCCCCC--CcCCHHHHHHHHHHc
Confidence 889999999988777665 9999999999999999999987553 233344444444333 347999999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..||.+|||+.+. ...+++.|||+.+.
T Consensus 232 ~~dP~~R~s~~~~---~~~~ll~~~~~~~~ 258 (318)
T cd05570 232 TKNPEKRLGCLPT---GEQDIKGHPFFREI 258 (318)
T ss_pred cCCHHHcCCCCCC---CHHHHhcCCCcCCC
Confidence 9999999998552 34778899998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=315.40 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=212.6
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++++..+++.||+|++... ......+.+|+.++..++||+++++++.+.+++.+++|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999998742 233456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--- 175 (298)
||+++++|.+++.+...+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999875322110
Q ss_pred ---------------------------------CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCC
Q 022401 176 ---------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (298)
Q Consensus 176 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 222 (298)
......|++.|+|||++.+..++.+ +|||||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence 0012357889999999988887765 999999999999999999998
Q ss_pred CCCCchhHHHHHHHHhhcC--CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 223 DPDEPKDFRKTIQRILSVQ--YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...... ...++.... ...+....+++++.++|.+|+ .||.+|++. ....++++|||+.+.
T Consensus 238 ~~~~~~----~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~-----~~~~ei~~hp~f~~~ 299 (360)
T cd05627 238 SETPQE----TYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS-----NGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCHHH----HHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCC-----CCHHHHhcCCCCCCC
Confidence 765432 233333322 223333347899999999987 499999974 235788899999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=295.73 Aligned_cols=252 Identities=29% Similarity=0.430 Sum_probs=209.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
+.|++.+.||+|++|.||.+.+..++..+++|.+..... ....+.+|+.++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 469999999999999999999988899999998875422 22457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
++|++++++|.+.+.....+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence 9999999999999988888999999999999999999999999999999999999998877 99999998864432211
Q ss_pred C----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 177 P----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 177 ~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
. ....++..|+|||.+.+..++.+ +||||+|+++|++++|..||...+... ...+..........+..++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 234 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMA----AIFKIATQPTNPQLPSHVSP 234 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHH----HHHHHhccCCCCCCCccCCH
Confidence 1 22346778999999988776555 999999999999999999998754422 22223333333334445789
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
++.+++.+||..||.+|||+ .++++|||+
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~--------~~ll~~~~~ 263 (263)
T cd06625 235 DARNFLRRTFVENAKKRPSA--------EELLRHFFV 263 (263)
T ss_pred HHHHHHHHHhhcCcccCCCH--------HHHhhCCCC
Confidence 99999999999999999987 555577775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=307.18 Aligned_cols=257 Identities=29% Similarity=0.458 Sum_probs=213.2
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 98 (298)
+|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|..++..+. |++++++.+++...+.+++|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999987532 22344667888888775 577888999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~ 177 (298)
||+++++|.+.+.....+++.++..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++...... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence 99999999999988888999999999999999999999999999999999999998887 999999988643222 222
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||++.+..++.+ +|+||+|+++|+|++|..||..... ......+.......+ ..++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~~p--~~~~~~~~~l 231 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSIMEHNVSYP--KSLSKEAVSI 231 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCC--ccCCHHHHHH
Confidence 34457899999999987777655 9999999999999999999987654 233444444444433 3478999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.+||+.||.+|++..+.. ..++.+|||+...
T Consensus 232 i~~~l~~~p~~R~~~~~~~---~~~i~~h~~f~~~ 263 (323)
T cd05615 232 CKGLMTKHPSKRLGCGPEG---ERDIREHAFFRRI 263 (323)
T ss_pred HHHHcccCHhhCCCCCCCC---HHHHhcCcccCCC
Confidence 9999999999999876543 3677899998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=302.54 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=200.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEcc-CCcEEEEEEeecCCc---chHHHHHHHHHHhcC---CCCCeeeeeEEEEe-----
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILT----- 90 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----- 90 (298)
++|++.+.||+|+||.||++++.. +++.+|+|.+..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 468899998865322 223455677766655 69999999998852
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 91 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
...+++|+|+++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence 356899999996 5888888653 35899999999999999999999999999999999999998887 999999998
Q ss_pred ccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CCC--
Q 022401 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVP-- 245 (298)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-- 245 (298)
.............+++.|+|||.+.+..++.+ +||||+|+++|+|++|..||......+.+............ .++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 75544433445567899999999877777665 99999999999999999999987765554444332211000 000
Q ss_pred ------------------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 246 ------------------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 246 ------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
....+++.+.+++.+||+.||++|||+ .++++|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~--------~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA--------YSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH--------HHHhcCCCC
Confidence 012467889999999999999999987 455578885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=307.70 Aligned_cols=248 Identities=31% Similarity=0.475 Sum_probs=203.5
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhc-CCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+++.||+|++.... ........|..++.. ++||||+++++++.+++.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999987532 223445667777765 4899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~ 182 (298)
++|...+.....+++..+..++.|++.||+|||++|++||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence 999999988888999999999999999999999999999999999999998887 999999987633221 22234457
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||++.+..++.+ +||||+|+++|+|++|..||...+.. .....+.......+ ..++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~~li~~~l 231 (316)
T cd05620 159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDED----ELFESIRVDTPHYP--RWITKESKDILEKLF 231 (316)
T ss_pred CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCC--CCCCHHHHHHHHHHc
Confidence 899999999988777665 99999999999999999999875542 23333333333333 347899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.||.+||++. ..+.+|||+.+.
T Consensus 232 ~~dP~~R~~~~-------~~~~~h~~f~~~ 254 (316)
T cd05620 232 ERDPTRRLGVV-------GNIRGHPFFKTI 254 (316)
T ss_pred cCCHHHcCCCh-------HHHHcCCCcCCC
Confidence 99999999873 245678888654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=299.39 Aligned_cols=256 Identities=29% Similarity=0.424 Sum_probs=214.9
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--C---eEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--T---HLAIV 97 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~---~~~lv 97 (298)
-.|.-.+++|.|+||+||.+....++..+|||..-.+.+. ...|+++++.+.||||+++.-+|... . ...+|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4689999999999999999999989999999988765542 23589999999999999999998643 2 45799
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 98 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+||++. +|.+.+.. +..++.-.++-+.+||++||.|||+.||+||||||.|+|+|.+.. .+||+|||.|.....
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVLVK 178 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC-eEEeccCCcceeecc
Confidence 999965 88888763 577899999999999999999999999999999999999998754 599999999998888
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC--------C---
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------Y--- 242 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~--- 242 (298)
.....+..++..|.|||.+.+...++.+.||||.||++.||+-|+..|.+.+..+++...++-+.... .
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 88888888999999999999987777779999999999999999999999888777766555432111 0
Q ss_pred --CC----------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 243 --SV----------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 243 --~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.. -.....+++..+|+.++|+.+|.+|.++ .+++.|||+++
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~--------~~~l~h~fFde 311 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA--------LEALAHPFFDE 311 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH--------HHHhcchhhHH
Confidence 00 0223478999999999999999999988 56667777764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=311.68 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=205.8
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
....++|++++.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.++|+||+++++++..++.+++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 334578999999999999999999999899999999986543 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~- 175 (298)
|+||+.+++|... ...++..+..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++.......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMD 223 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccc
Confidence 9999999988543 34567888999999999999999999999999999999998887 9999999986443222
Q ss_pred CCCCCCCCCcccCccccccc----cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 176 QPKSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
......++..|+|||.+... .+...++|||||||++|+|++|..||......+ .......+.... .......++
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~ 301 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAICMSQ-PPEAPATAS 301 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhccC-CCCCCCccC
Confidence 12344688999999987432 333445999999999999999999998543322 223333322211 222334578
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.++.+||.+||+.||++|||+ .++++|||+...
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~--------~ell~hp~~~~~ 334 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSA--------MQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHHHccCChhhCcCH--------HHHhcCcccccC
Confidence 999999999999999999987 556689998754
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=317.73 Aligned_cols=261 Identities=28% Similarity=0.374 Sum_probs=216.0
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-C-----CCeeeeeEEEEeC
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-H-----PNIVRFKEVILTP 91 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~ 91 (298)
......+|.+.+.||+|.||.|.+|.+..+++.||||+++.......+...|+.+|..++ | -|+++++++|...
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 334445899999999999999999999999999999999998888888889999999886 3 4799999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 92 THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+++|+|+|.. ..+|.+++.++. .++...+..++.||+.||..||+.||+|+||||+|||+.+.+.+.+||+|||+++
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999999999 559999997654 5889999999999999999999999999999999999987777789999999987
Q ss_pred cccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------
Q 022401 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------- 240 (298)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 240 (298)
......- ....+..|.|||++.+.+|+.+ .|||||||++.||++|.+.|.+.++.+++..++.-+...
T Consensus 340 ~~~q~vy--tYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 340 FESQRVY--TYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred ccCCcce--eeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 4433322 5556778999999999999888 999999999999999999998888766655443322100
Q ss_pred ---------------------------------------CCCCC-CCC--------CCCHHHHHHHHHhhhhCCCCcccc
Q 022401 241 ---------------------------------------QYSVP-DTN--------PISQECRDLISRIFVADPAAVSIF 272 (298)
Q Consensus 241 ---------------------------------------~~~~~-~~~--------~~~~~l~~li~~~l~~dp~~Rps~ 272 (298)
....| ... .-...+.+||.+||.+||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 00001 000 012468999999999999999988
Q ss_pred cccchhhhHHHhhhhhhh
Q 022401 273 FFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 273 ~~~l~~~~~~~~~hp~~~ 290 (298)
.+.++|||+.
T Consensus 497 --------~qal~Hpfl~ 506 (586)
T KOG0667|consen 497 --------AQALNHPFLT 506 (586)
T ss_pred --------HHHhcCcccc
Confidence 5555888887
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=307.47 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=211.7
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+++.+|+|++.... .....+.+|..++.++ +||+|+++++++...+.+++|+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999998642 2234567888888888 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
++|...+.....+++..++.++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence 999999888888999999999999999999999999999999999999998887 99999998864222 222234558
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc---hhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .......+.+....... +..++..+.+++.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~li~ 235 (327)
T cd05617 159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI--PRFLSVKASHVLK 235 (327)
T ss_pred CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC--CCCCCHHHHHHHH
Confidence 899999999988777665 99999999999999999999643221 11122333334444333 3447899999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+||+.||.+|+++.... ...++.+|||+.+..
T Consensus 236 ~~L~~dP~~R~~~~~~~--~~~~i~~h~~f~~~~ 267 (327)
T cd05617 236 GFLNKDPKERLGCQPQT--GFSDIKSHTFFRSID 267 (327)
T ss_pred HHhccCHHHcCCCCCCC--CHHHHHcCCCCCCCC
Confidence 99999999999976543 567889999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=311.49 Aligned_cols=253 Identities=32% Similarity=0.477 Sum_probs=223.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe-EEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIV 97 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 97 (298)
.++|..++++|.|+||.++.++++..++.|++|.+.... .......+|+.++.+++||||+.+.+.|..++. +++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 478999999999999999999999999999999987643 333467899999999999999999999999887 9999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 98 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
|+|++||++.+.+.... .+++..+..++.|++.|++|||++.|+|||||+.|||++.++. ++|+|||++.......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence 99999999999986543 5899999999999999999999999999999999999999998 9999999998777665
Q ss_pred -CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 176 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 176 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
......|++.|++||.+.+.+|..+ +|||||||++|||.+-..+|...+- ..++.++..+. -.|.+..++.++
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m----~~Li~ki~~~~-~~Plp~~ys~el 234 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNM----SELILKINRGL-YSPLPSMYSSEL 234 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccch----HHHHHHHhhcc-CCCCCccccHHH
Confidence 6677889999999999999999888 9999999999999999999998665 45555555555 335666689999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHH
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLL 282 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~ 282 (298)
+.+|+.||..+|+.||++.++|.++.+.
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 9999999999999999998888874444
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=309.30 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=202.5
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 92 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 92 (298)
...++|++.+.||+|+||.||.+.+..++..+|+|.+... ......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3468999999999999999999999989999999998653 233456778999999999999999999986543
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 93 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 93 --~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
.+|+|+||+++ ++...+.. .++...+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~ 172 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART 172 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccc
Confidence 57999999976 56555533 4788999999999999999999999999999999999998887 99999999875
Q ss_pred ccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH-------------
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI------------- 237 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~------------- 237 (298)
...........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+..+.+.......
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 443333344567889999999988777766 999999999999999999998766543332222111
Q ss_pred -----hhcCCCC------------------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 238 -----LSVQYSV------------------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 238 -----~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
....... ......++++.+||.+||..||++|||+. ++++|||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~--------e~l~hp~~~ 319 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD--------EALRHPYIT 319 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHH--------HHhcCchhh
Confidence 0000000 01112457899999999999999999884 555777775
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=305.54 Aligned_cols=248 Identities=34% Similarity=0.511 Sum_probs=202.7
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhc-CCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+++.||+|++.... ...+....|..++.. .+||||+++++++..+..+++|+||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987532 222334456666654 4899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
++|...+.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999999864322 222234458
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||++.+..++.+ +||||||+++|+|++|..||...+.. .....+....... +..++.++.+++.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~--~~~~~~~~~~ll~~~l 231 (316)
T cd05592 159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDED----ELFDSILNDRPHF--PRWISKEAKDCLSKLF 231 (316)
T ss_pred CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCC--CCCCCHHHHHHHHHHc
Confidence 899999999988777666 99999999999999999999876542 3333343333333 3347899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.||.+||++. ..+++|||+.+.
T Consensus 232 ~~~P~~R~~~~-------~~l~~h~~~~~~ 254 (316)
T cd05592 232 ERDPTKRLGVD-------GDIRQHPFFRGI 254 (316)
T ss_pred cCCHHHcCCCh-------HHHHcCcccCCC
Confidence 99999999863 355678888653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=300.87 Aligned_cols=253 Identities=36% Similarity=0.583 Sum_probs=207.3
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHH---HHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~---~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
|++++.||+|+||.||++++..++..+|+|++......... ..+|+.++++++||||+++.+++.+....+++++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999887544433 345999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc-cCCCCCCCC
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~-~~~~~~~~~ 180 (298)
.+++|.+++.....++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999999987888999999999999999999999999999999999999998887 999999987642 233334456
Q ss_pred CCCCcccCccccc-cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC--CCCCCCCCCHHHHHH
Q 022401 181 VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQECRDL 257 (298)
Q Consensus 181 ~~~~~~~aPE~~~-~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l 257 (298)
.++..|+|||.+. +... ..++|+||+|+++++|++|..||......+. .....+...... ........+.++.++
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccccchhh-hhhhhhcccccccccccccchhHHHHHHH
Confidence 6788999999987 4455 4449999999999999999999998732222 222222222111 111111124899999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+.+||+.||.+|||+ .++++|||+
T Consensus 237 i~~~l~~~p~~R~~~--------~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSA--------EELLKHPWF 260 (260)
T ss_dssp HHHHSSSSGGGSTTH--------HHHHTSGGG
T ss_pred HHHHccCChhHCcCH--------HHHhcCCCC
Confidence 999999999999987 666688885
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=305.02 Aligned_cols=247 Identities=32% Similarity=0.496 Sum_probs=202.9
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhc-CCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+++.||+|++.... ........|..++.. ++||||+++++++..++.+++|+||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999899999999987642 223445567777765 5899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~ 182 (298)
++|...+.....+++.++..++.|++.||.|||++|++|+||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence 999999988788999999999999999999999999999999999999998887 999999987633221 22234457
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||++.+..++.+ +||||+||++|+|++|..||...+. ....+.+.......+ ..++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~----~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l 231 (316)
T cd05619 159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIRMDNPCYP--RWLTREAKDILVKLF 231 (316)
T ss_pred CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCC--ccCCHHHHHHHHHHh
Confidence 899999999987777665 9999999999999999999987553 233333333333332 347899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.||.+||++. .++.+|||+.+
T Consensus 232 ~~~P~~R~~~~-------~~l~~h~~~~~ 253 (316)
T cd05619 232 VREPERRLGVK-------GDIRQHPFFRE 253 (316)
T ss_pred ccCHhhcCCCh-------HHHHcCcccCC
Confidence 99999999874 25568888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=308.70 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=206.6
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHH-HHhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+|+.+|+|++.... .....+..|.. +++.++||||+++++++..++.+++|+||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 22233444443 56778999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
++|...+.....+++..+..++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999998864322 222234458
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.. +....+....... ....+.++.+++.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~~ll~~ll 231 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVA----EMYDNILHKPLVL--RPGASLTAWSILEELL 231 (325)
T ss_pred ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHH----HHHHHHHcCCccC--CCCCCHHHHHHHHHHh
Confidence 899999999988777665 99999999999999999999875542 3334444433332 2347899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..||.+||++.+.+ .+++.|||+.+
T Consensus 232 ~~~p~~R~~~~~~~----~~i~~h~~f~~ 256 (325)
T cd05604 232 EKDRQRRLGAKEDF----LEIQEHPFFES 256 (325)
T ss_pred ccCHHhcCCCCCCH----HHHhcCCCcCC
Confidence 99999999986554 67889999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=302.44 Aligned_cols=266 Identities=24% Similarity=0.399 Sum_probs=211.9
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
..++|++.+.||.|++|.||++.+..++..||+|.+.... .....+.+|+.++++++||||+++++++..+..+++|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 3478999999999999999999999899999999987543 22345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-C
Q 022401 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~ 176 (298)
||+++ +|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 160 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence 99974 88887765 346899999999999999999999999999999999999998887 9999999886433222 2
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------C
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------Q 241 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 241 (298)
.....+++.|+|||.+.+......++||||||+++|+|++|..||...+..+........+... .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 2234567889999998765544555999999999999999999998765433322221111000 0
Q ss_pred CCCC---------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcC
Q 022401 242 YSVP---------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYH 297 (298)
Q Consensus 242 ~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~ 297 (298)
...+ ....+++++.++|.+||+.||.+|||+ .++++|||+..-.|.+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~--------~eil~h~~f~~~~~~~~ 297 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA--------EEAMKHPYFHCLGERIH 297 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH--------HHHhcCcccccccchhh
Confidence 0011 112468899999999999999999987 66668999988777765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=293.39 Aligned_cols=260 Identities=27% Similarity=0.376 Sum_probs=214.1
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCC-eeeeeEEEEeCC-----
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT----- 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 92 (298)
...|+.+++||+|.+|+||+|+.+.+|+.||+|.+..+.. .-....+|+.+++.++|+| |+.+.+++-.++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4679999999999999999999999999999999987654 3355789999999999999 999999998877
Q ss_pred -eEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 93 -HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 93 -~~~lv~~~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
.+++|+||.+ .+|..++...+ .++...++.+++||+.|++|||+++|+||||||.||+++++|. +||+|||+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGL 166 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--Eeeeccch
Confidence 8999999995 48888887655 4777899999999999999999999999999999999999887 99999999
Q ss_pred cccccCCC-CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CCC
Q 022401 168 SKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVP 245 (298)
Q Consensus 168 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 245 (298)
++...... .......+..|.|||.+.+...+....||||+||++.||+++...|.+..+.+++....+-+..... .+|
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 98555333 3566678889999999999865555599999999999999999999998886665555444322210 011
Q ss_pred C----------------CC-------CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 246 D----------------TN-------PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 246 ~----------------~~-------~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
. .. ..+++..+++.+||+.+|..|.|+ ...++|||+++.
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa--------~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA--------KGALTHPYFSEL 308 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH--------HHHhcChhhccc
Confidence 0 00 123589999999999999999988 455577887754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.79 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=205.3
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----eEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 95 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 95 (298)
+|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4889999999999999999998899999999886432 22356788999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+|+||+. ++|...+.....+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence 9999996 578888877788999999999999999999999999999999999999998887 9999999986433221
Q ss_pred --CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH-----------------
Q 022401 176 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR----------------- 236 (298)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~----------------- 236 (298)
......+++.|+|||.+.+......++||||+||++|+|++|..||...+..+.+......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 1223356788999999877654455599999999999999999999876654433222111
Q ss_pred --HhhcCCCC-------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 237 --ILSVQYSV-------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 237 --~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+....... ......++++.+||.+||+.||.+|||+ .++++|||+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~--------~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA--------ADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH--------HHHhcCHhhCCC
Confidence 11111110 1123357899999999999999999988 555678888763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=306.64 Aligned_cols=249 Identities=29% Similarity=0.496 Sum_probs=204.9
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHH-HHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQRE-IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+++.||+|++.... .....+..| ..+++.++||||+++++++...+.+++|+||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999899999999987532 112233333 3456788999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
++|.+.+.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999998864322 222334458
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||++.+..++.+ +|||||||++|+|++|..||...+.. +....+...... ....++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~~--~~~~~~~~~~~li~~~l 231 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDNILNKPLQ--LKPNITNSARHLLEGLL 231 (325)
T ss_pred CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHH----HHHHHHHhCCcC--CCCCCCHHHHHHHHHHc
Confidence 899999999988777665 99999999999999999999875543 333344333333 23357999999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
+.||.+|+++.+.+ .++.+|+|+.
T Consensus 232 ~~~p~~R~~~~~~~----~~i~~~~~~~ 255 (325)
T cd05602 232 QKDRTKRLGAKDDF----MEIKNHIFFS 255 (325)
T ss_pred ccCHHHCCCCCCCH----HHHhcCcccC
Confidence 99999999998765 5788999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=311.72 Aligned_cols=266 Identities=30% Similarity=0.450 Sum_probs=212.6
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
.....++|++.+.||+|+||.||++++..+++.+|+|++... ......+.+|..+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 345568999999999999999999999999999999998642 2223456789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+++|+||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++. ++|+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~ 194 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNK 194 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCc
Confidence 99999999999999988654 5789999999999999999999999999999999999998887 99999999864432
Q ss_pred CC--CCCCCCCCCcccCcccccccc---CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC--CCCCC
Q 022401 174 HS--QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPD 246 (298)
Q Consensus 174 ~~--~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 246 (298)
.. ......+++.|+|||++.... ..+.++|||||||++|+|++|..||...+.. .....+.... ...+.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYSKIMNHKNSLTFPD 270 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCcccCCC
Confidence 22 223456899999999987543 2344599999999999999999999876543 3334443322 33455
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
...++.++.++|..||. +|..|++. ....++++|||+.+....|
T Consensus 271 ~~~~s~~~~~li~~~L~-~~~~r~~r-----~~~~ei~~h~~~~~~~~~~ 314 (371)
T cd05622 271 DNDISKEAKNLICAFLT-DREVRLGR-----NGVEEIKRHLFFKNDQWAW 314 (371)
T ss_pred cCCCCHHHHHHHHHHcC-ChhhhcCC-----CCHHHHhcCcccCCCChhH
Confidence 55689999999999997 55554321 1236677888887655444
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=307.54 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=201.8
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCC--cchHHHHHHHHHHhcC-CCCCeeeeeEEEEe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (298)
.+..++|++.+.||.|+||.||+|.+. .+++.||+|++.... .....+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 345689999999999999999999752 345689999987533 2235678999999999 89999999998876
Q ss_pred C-CeEEEEEeccCCCCHHHHHHhC--------------------------------------------------------
Q 022401 91 P-THLAIVMEYASGGELFERICNA-------------------------------------------------------- 113 (298)
Q Consensus 91 ~-~~~~lv~~~~~~~sL~~~l~~~-------------------------------------------------------- 113 (298)
. ..+++++||+++++|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 5 4689999999999999888642
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---CCCCCCCCC
Q 022401 114 ------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTP 184 (298)
Q Consensus 114 ------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 184 (298)
.+++..++..++.|++.||.|||++|++|+||||+||+++.++. ++|+|||++....... ......++.
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCc
Confidence 23677888999999999999999999999999999999998876 9999999986432211 112234557
Q ss_pred cccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhh
Q 022401 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263 (298)
Q Consensus 185 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 263 (298)
.|+|||++.+..++.+ +||||||+++|+|++ |..||........+.. .+..+ .....+...++++.+++.+||+
T Consensus 241 ~y~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 241 KWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ---RLKDG-TRMRAPENATPEIYRIMLACWQ 315 (338)
T ss_pred cccCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHhcC-CCCCCCCCCCHHHHHHHHHHcc
Confidence 8999999987777666 999999999999997 9999987554333222 22222 2223344578999999999999
Q ss_pred hCCCCcccccccchhh
Q 022401 264 ADPAAVSIFFFPLNMS 279 (298)
Q Consensus 264 ~dp~~Rps~~~~l~~~ 279 (298)
.||.+|||+.+++...
T Consensus 316 ~dp~~RPs~~el~~~l 331 (338)
T cd05102 316 GDPKERPTFSALVEIL 331 (338)
T ss_pred CChhhCcCHHHHHHHH
Confidence 9999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=305.74 Aligned_cols=250 Identities=30% Similarity=0.475 Sum_probs=205.2
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHH-HHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++++..+++.||+|++.+.. .....+..|. .+++.++||||+++++++.+.+..++|+||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987532 1222344444 467889999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc-CCCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~ 182 (298)
++|...+.....+++..+..++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++.... .........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence 999998888888999999999999999999999999999999999999998887 9999999876422 2222334457
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||.+.+..++.+ +|||||||++|+|++|..||...+. ......+....... +...+.++.+++.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l 231 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDV----SQMYDNILHKPLQL--PGGKTVAACDLLVGLL 231 (321)
T ss_pred CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCH----HHHHHHHhcCCCCC--CCCCCHHHHHHHHHHc
Confidence 889999999987777666 9999999999999999999987653 23344444444333 3346899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.||.+|+++...+ .++++|||+.+
T Consensus 232 ~~~p~~R~~~~~~~----~~~~~~~~~~~ 256 (321)
T cd05603 232 HKDQRRRLGAKADF----LEIKNHVFFSP 256 (321)
T ss_pred cCCHhhcCCCCCCH----HHHhCCCCcCC
Confidence 99999999875443 57889999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=297.55 Aligned_cols=260 Identities=24% Similarity=0.333 Sum_probs=209.2
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.|++.+.||+|+||.||.+.+..+++.+|+|.+..... ....+.+|+.++++++|++++++.+.+.+.+.+++|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999998875422 22446789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|+.+++|.+.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence 999999998885433 5899999999999999999999999999999999999998877 999999988654433333
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....++..|+|||.+.+..++.+ +||||+|+++|+|++|..||......... .....+.... ........++++.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~l 235 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEV-QEEYSEKFSPDARSL 235 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhhh-hhhcCccCCHHHHHH
Confidence 34568899999999988777665 99999999999999999999875432211 1111111111 111234478999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.+||+.||.+|||+... ...++++|||+..
T Consensus 236 i~~~l~~~p~~R~s~~~~---~~~~~~~h~~~~~ 266 (285)
T cd05630 236 CKMLLCKDPKERLGCQGG---GAREVKEHPLFKQ 266 (285)
T ss_pred HHHHhhcCHHHccCCCCC---chHHHHcChhhhc
Confidence 999999999999984321 2467778888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=285.77 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=214.0
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT- 92 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 92 (298)
.-.+.+.+++|+|.+.||+|||+.||++++-.+++.||+|.+.... +..+...+|+...++++|||+++.+++...+.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 4456678899999999999999999999999999999999998766 56677889999999999999999999876543
Q ss_pred ----eEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEeeCCCCCCEEE
Q 022401 93 ----HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKI 162 (298)
Q Consensus 93 ----~~~lv~~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~~~~~~~~~l 162 (298)
..|++++|...|||.+.+.. +..+++.+++.|+.++++||++||+.. ++|+||||.||++++++. +++
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl 170 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVL 170 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEE
Confidence 58999999999999988853 336899999999999999999999998 999999999999998777 999
Q ss_pred eecCccccccCCCCCC----------CCCCCCcccCccccccccC--CCCccchHHHHHHHHHHHhCCCCCCCCCCchhH
Q 022401 163 CDFGYSKSSVLHSQPK----------STVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230 (298)
Q Consensus 163 ~d~~~~~~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 230 (298)
.|||.++......... ...++.-|.|||.+.-... .+.++|||||||++|.|+.|..||...-+.-
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-- 248 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-- 248 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--
Confidence 9999987444433222 2347888999998753322 2444999999999999999999996532100
Q ss_pred HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
-...-.+++++..+|....+++.+.++|++||+.||.+||++.+++..
T Consensus 249 gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 011112456677788877799999999999999999999999888754
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=289.86 Aligned_cols=255 Identities=31% Similarity=0.494 Sum_probs=219.7
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---------chHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (298)
++|.-.+.||.|..++|-.+.++.+|..+|+|++..... ..+.-.+|+.||+++ .||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 368888999999999999999999999999999864321 123345799999998 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+++|++.|+.|.|.+++...-.+++.+...|++|++.|+.|||.++|||+||||+||+++++.+ ++|+|||+++...
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence 99999999999999999998888999999999999999999999999999999999999998887 9999999999888
Q ss_pred CCCCCCCCCCCCcccCccccccc-----cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC--CCC
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVP 245 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~ 245 (298)
.+......+|+|.|+|||.+... +.+++..|+|+.|+++|-++.|-.||+-... .-+.+-++.+.+ ..+
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----mlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----MLMLRMIMEGKYQFRSP 250 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----HHHHHHHHhcccccCCc
Confidence 88888888999999999997643 2334559999999999999999999987543 234445555554 455
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...+.+++..++|++||+.||.+|.|+.++ +.|||++-
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~--------LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEA--------LAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHH--------hcChHHHH
Confidence 666789999999999999999999998555 57888753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=297.90 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=200.1
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcC---CCCCeeeeeEEEEeC-----C
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILTP-----T 92 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~-----~ 92 (298)
+|++.+.||+|++|.||++++..+++.+|+|.+.... .......+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5999999999999999999999999999999886532 1223455677777655 699999999998642 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
.+++++|++.+ +|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence 58999999975 788887654 34899999999999999999999999999999999999998887 99999998875
Q ss_pred ccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-------CC
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------YS 243 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~ 243 (298)
...........++..|+|||.+.+..++.+ +||||+|+++|+|++|..||......+.+.+......... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 543333344557888999999987777665 9999999999999999999987665544444333221100 00
Q ss_pred C--------------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 244 V--------------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 244 ~--------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
. .....+++++.+++.+||+.||++|||+ .+++.|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--------~~~l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA--------FRALQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH--------HHHhcCCCC
Confidence 0 0012467889999999999999999987 555578885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=309.42 Aligned_cols=251 Identities=31% Similarity=0.463 Sum_probs=204.4
Q ss_pred eccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcC---CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 31 lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
||+|+||.||++++..+++.||+|++..... .......|..++... +||||+++++++.....+++|+||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999999999999999865321 122334455666554 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 182 (298)
++|...+.....+++..++.++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence 999999988888999999999999999999999999999999999999998887 99999999864322 222334568
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
++.|+|||++.+......++||||+|+++|+|++|..||...+. ....+.+.......+.. .+++++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~-~~~~~~~~li~~~L 233 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----QQMYRNIAFGKVRFPKN-VLSDEGRQFVKGLL 233 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH----HHHHHHHHcCCCCCCCc-cCCHHHHHHHHHHc
Confidence 89999999987655444559999999999999999999987543 33344454454444432 37899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.||.+||++.+.+ .++++|||+.+.
T Consensus 234 ~~~P~~R~~~~~~~----~~ll~h~~~~~~ 259 (330)
T cd05586 234 NRNPQHRLGAHRDA----VELKEHPFFADI 259 (330)
T ss_pred CCCHHHCCCCCCCH----HHHhcCccccCC
Confidence 99999999765443 678899998753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=295.31 Aligned_cols=257 Identities=29% Similarity=0.414 Sum_probs=207.4
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeec---CCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe-----CCeE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHL 94 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 94 (298)
.+|..++.||.|++|.|..|.++.+|+.||||.+.. .....++-.+|+.+++.++|+||+.+.+++.. -+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 456668999999999999999999999999999873 23334667799999999999999999999865 3578
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
|+|+|+| +.+|...+..++.+++..+..++.|++.||.|+|+.|++||||||.|++++.+-. +|++|||+|+.....
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKF 178 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeecccc
Confidence 9999999 6689999988888999999999999999999999999999999999999987776 999999999866543
Q ss_pred ---CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH--------------
Q 022401 175 ---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237 (298)
Q Consensus 175 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~-------------- 237 (298)
..-.....|.+|.|||.+.....++++.||||+||++.||++|...|.+.+..+++.....-+
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 111233467889999998777666777999999999999999999998866654443222111
Q ss_pred -----hhcCCCCC------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 238 -----LSVQYSVP------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 238 -----~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
.......+ ...+.++...+|+++||..||.+|+|+. +++.|||+.
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~--------eAL~hPYl~ 314 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE--------EALAHPYLA 314 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH--------HHhcChhhh
Confidence 11111111 1125789999999999999999999885 555777775
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=295.81 Aligned_cols=255 Identities=33% Similarity=0.563 Sum_probs=214.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|++|.||.+.+..+++.+++|++.... ...+.+.+|++++++++||||+++++++.+...+++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999899999999987532 33456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|.||+++.++. ++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence 99999999999988888999999999999999999999999999999999999998887 999999988654333 33
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
...+++.|+|||.+.+...+.+ +|+||||+++|+|++|..||...+. ....+.+..+....+ ...+..+.++|
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~--~~~~~~l~~li 229 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNP----IQIYEKILEGKVRFP--SFFSPDAKDLI 229 (290)
T ss_pred CCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCccCC--ccCCHHHHHHH
Confidence 4457889999999877766554 9999999999999999999987553 233333444443333 34689999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+||+.||.+|++.. .....++++|||+.+
T Consensus 230 ~~~l~~~p~~R~~~~---~~~~~~l~~~~~~~~ 259 (290)
T cd05580 230 RNLLQVDLTKRLGNL---KNGVNDIKNHPWFAG 259 (290)
T ss_pred HHHccCCHHHccCcc---cCCHHHHHcCccccc
Confidence 999999999999442 234577788999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=307.19 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=201.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 91 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 91 (298)
..++|++.+.||+|+||.||.+.+..+++.+|+|.+.... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4579999999999999999999998889999999887532 2335677899999999999999999998643
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
...++|+|++++ ++...+.. .++...+..++.|++.||+|||++|++||||||+||+++.++. ++|+|||++...
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccC
Confidence 357999999976 56665543 4788999999999999999999999999999999999998887 999999998755
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh------------
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS------------ 239 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 239 (298)
..........++..|+|||.+.+..++.+ +||||||+++|+|++|..||...+..+.+......+..
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 44433445567899999999988777666 99999999999999999999876544333332222110
Q ss_pred ------cCCC------------------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 240 ------VQYS------------------VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 240 ------~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
.... .......+.++.+||.+||+.||++|||+.+++ +|||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell--------~hp~~~ 315 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL--------QHPYIN 315 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh--------cCcchh
Confidence 0000 001112356889999999999999999885555 667664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=303.68 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=203.4
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++++..+++.||+|++.+. ......+.+|..++..++|+||+++++++.+++.+|+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999999989999999998752 222345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-
Q 022401 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~- 176 (298)
||+.+++|.+++.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence 99999999999976 457899999999999999999999999999999999999998887 99999998864433222
Q ss_pred -CCCCCCCCcccCcccccc----ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC--CCC-CCC
Q 022401 177 -PKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVP-DTN 248 (298)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~-~~~ 248 (298)
.....+++.|+|||++.. ......++||||+||++|+|++|..||...+..+ ....+..... ..+ ...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCcccCCCccC
Confidence 122458899999999863 2223445999999999999999999998755432 2333332221 222 223
Q ss_pred CCCHHHHHHHHHhhhhCCCC--cccccccchhhhHHHhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAA--VSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+++++.+++++||..++.+ |+++ .++++|||+.+
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~--------~~~l~hp~~~~ 271 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGL--------QDFKDHPFFEG 271 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCH--------HHHhcCCCCCC
Confidence 47899999999998653333 6655 67778888864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=291.53 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=214.2
Q ss_pred eccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 31 lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
||.|++|.||++.+..+++.+++|++.... ...+.+.+|+.++++++|||++++++.+.+++.+++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999999889999999987543 3345688999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCCcc
Q 022401 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186 (298)
Q Consensus 107 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 186 (298)
.+.+.....++...+..++.+++.||++||++|++|+||+|+||+++.++. ++|+|||++.............++..|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence 999988888999999999999999999999999999999999999998887 999999988755443333344578889
Q ss_pred cCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCC
Q 022401 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266 (298)
Q Consensus 187 ~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 266 (298)
++||.+....++.+ +|+||+|+++|++++|..||...... ..+....+..+......+...++++.+++.+||+.||
T Consensus 159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 99999877777665 99999999999999999999876531 1333444443333334444468999999999999999
Q ss_pred CCcccccccchhhhHHHhhhhhhhhhhhhcC
Q 022401 267 AAVSIFFFPLNMSCLLLFSFVWMFDATENYH 297 (298)
Q Consensus 267 ~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~ 297 (298)
++||+..+. ...++++|||+.+ .+|+
T Consensus 236 ~~R~~~~~~---~~~~l~~~~~~~~--~~~~ 261 (262)
T cd05572 236 EERLGNLKG---GIKDIKKHKWFNG--FDWE 261 (262)
T ss_pred hhCcCCccc---CHHHHhcChhhhC--CCCC
Confidence 999985442 3588889999986 4775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=293.51 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=214.2
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
+|++.+.||.|++|.||.+.+..++..+++|.+.... .....+.+|++++++++|||++++++++..+...++|++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999889999999987542 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~ 179 (298)
|+.+++|...+....++++.++..++.+++.+|.|||++|++|+||+|+||+++.++. ++|+|||++...........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence 9999999999988788999999999999999999999999999999999999998887 99999998875554444445
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
..++..|+|||.+.+..++.+ +|+||+|+++|++++|..||...... ........... .....+..++.++.++|.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET--ADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc--ccccCcccCcHHHHHHHH
Confidence 667888999999877776555 99999999999999999999876642 11222222221 222333447899999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+||+.||.+||++. ..++++|||+
T Consensus 235 ~~l~~~p~~R~~~~------~~~l~~~~~~ 258 (258)
T cd05578 235 KLLERDPQKRLGDN------LKDLKNHPYF 258 (258)
T ss_pred HHccCChhHcCCcc------HHHHhcCCCC
Confidence 99999999999884 4667788885
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=307.07 Aligned_cols=256 Identities=28% Similarity=0.416 Sum_probs=216.7
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
...|...+.||.|.||.||+|.+..+++.||+|++..+. ...+.+.+|+.++.+++++||.+.++.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 346888999999999999999999999999999998754 334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCCCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~~~ 178 (298)
|+.||++.+++..+..+++..+..++++++.|+.|||..+.+|+|||+.||++..+|. +||+|||++..... .....
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhccc
Confidence 9999999999988888899999999999999999999999999999999999998887 99999998853333 23336
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh-hcCCCCCCCCCCCHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL-SVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 257 (298)
...|++.|||||++....|+.+ +||||||++.+||++|.+|+........ +.-|- +.++.+ ...++..+++|
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrv----lflIpk~~PP~L--~~~~S~~~kEF 242 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRV----LFLIPKSAPPRL--DGDFSPPFKEF 242 (467)
T ss_pred cccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceE----EEeccCCCCCcc--ccccCHHHHHH
Confidence 7789999999999998889888 9999999999999999999987654110 00011 112222 22588999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
|..||++||+.||++. .++.|+|+....|
T Consensus 243 V~~CL~k~P~~RpsA~--------~LLKh~FIk~a~k 271 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAK--------ELLKHKFIKRAKK 271 (467)
T ss_pred HHHHhhcCcccCcCHH--------HHhhhHHHHhcCC
Confidence 9999999999999884 4556777765443
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=305.63 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=203.2
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP----- 91 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 91 (298)
...++|++.+.||+|+||.||.+.+..+++.+|+|++... ......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3468999999999999999999999989999999998653 23345677899999999999999999987543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 92 -THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 92 -~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
..+|+|+||+++ +|...+.. .++...+..++.|++.||+|||++|++||||||+||+++.++. ++|+|||++..
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~ 175 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART 175 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccc
Confidence 357999999965 67666643 4788999999999999999999999999999999999998887 99999999875
Q ss_pred ccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh-----------
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS----------- 239 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------- 239 (298)
...........++..|+|||++.+..++.+ +|||||||++|+|++|..||...+..+........+..
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 544433344567899999999988777666 99999999999999999999876654443333221110
Q ss_pred -------cCC------------------CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 240 -------VQY------------------SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 240 -------~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
... ........+.++++||.+||+.||.+|||+ .++++|||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~--------~e~L~hp~~~ 322 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV--------DEALQHPYIN 322 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH--------HHHhcCcccc
Confidence 000 000011134678999999999999999988 4555777775
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=317.02 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=199.1
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCC------CCeeeeeEEEEeC-Ce
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-TH 93 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~ 93 (298)
..++|++.+.||+|+||.||++.+..+++.||||++............|+.+++.++| .+++++++++..+ ..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 4578999999999999999999999899999999987654444556667777776654 4588999988765 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCC--------------C
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPA--------------P 158 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~--------------~ 158 (298)
+|+|++++ +++|.+++...+.+++..+..++.|++.||+|||+ .||+||||||+||+++.++. .
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 89999988 66888888888889999999999999999999997 59999999999999986552 2
Q ss_pred CEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 022401 159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 238 (298)
Q Consensus 159 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 238 (298)
.+||+|||.+.... .......+++.|+|||++.+..++.+ +|||||||++|||++|..||...+..+.+... .+..
T Consensus 286 ~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i-~~~~ 361 (467)
T PTZ00284 286 RVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM-EKTL 361 (467)
T ss_pred eEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHc
Confidence 48999999875322 22234568899999999988887666 99999999999999999999876653332221 1111
Q ss_pred hcC----------------------CC--C------------CC-CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 239 SVQ----------------------YS--V------------PD-TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 239 ~~~----------------------~~--~------------~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
... .. . +. ....++.+.+||.+||..||.+|||+.|
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e------- 434 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ------- 434 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH-------
Confidence 100 00 0 00 0001356889999999999999998854
Q ss_pred HHhhhhhhhh
Q 022401 282 LLFSFVWMFD 291 (298)
Q Consensus 282 ~~~~hp~~~~ 291 (298)
+++|||+..
T Consensus 435 -~L~Hp~~~~ 443 (467)
T PTZ00284 435 -MTTHPYVLK 443 (467)
T ss_pred -HhcCccccc
Confidence 557777764
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=312.95 Aligned_cols=252 Identities=30% Similarity=0.447 Sum_probs=207.1
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccC-CcEEEEEEeecCCcc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~-~~~~aiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
...|.+.+.||.|++|.||.|.+..+ +..+++|.+...... ...+.+|+.+++.++||||+++++++..++.+++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 44599999999999999999998776 778899977554322 3456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 100 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 100 ~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
|+++++|.+.+.. ..++++.++..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++.......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCcc
Confidence 9999999887743 446899999999999999999999999999999999999998887 9999999987543222
Q ss_pred ---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 176 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 176 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
......|++.|+|||++.+..++.+ +|||||||++|+|++|..||..... .+....+..+... +.+..++.
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~----~~~~~~~~~~~~~-~~~~~~s~ 297 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSS 297 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCC-CCCccCCH
Confidence 1233458899999999887777655 9999999999999999999977543 2334444433332 23345789
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
++.++|.+||+.||++||++.+++.+.+.
T Consensus 298 ~~~~li~~~L~~dP~~Rps~~~~l~~~~~ 326 (478)
T PTZ00267 298 GMKALLDPLLSKNPALRPTTQQLLHTEFL 326 (478)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHhCHHH
Confidence 99999999999999999998777654443
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=292.35 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=204.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
++|++.+.||+|++|.||++.+..++..+++|.+..+. .....+.+|+.++++++|||++++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46899999999999999999998899999999987642 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 180 (298)
+++++|... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCC
Confidence 999988644 35688899999999999999999999999999999999998887 999999988644322 22334
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchh---HHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---FRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
.++..|+|||.+.+..++.+ +|+||||+++|+|++|..||........ .......+.............++++.++
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 67889999999987777665 9999999999999999999975432111 1122222222222211223368899999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+.+||+.||++||++ .++++|||++.-.
T Consensus 233 i~~~l~~~P~~Rp~~--------~eil~~~~~~~~~ 260 (279)
T cd06619 233 ITQCMRKQPKERPAP--------ENLMDHPFIVQYN 260 (279)
T ss_pred HHHHhhCChhhCCCH--------HHHhcCccccccc
Confidence 999999999999987 4555677776443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=297.96 Aligned_cols=259 Identities=31% Similarity=0.476 Sum_probs=213.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|++|.||.+.+..+++.+++|.+..... ....+.+|+++++.++|+||+++++.+.+....++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 479999999999999999999998899999999876532 3345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 99 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence 999999999998754 46899999999999999999999999999999999999998877 99999998753322111
Q ss_pred ------------------------------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 022401 177 ------------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (298)
Q Consensus 177 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 226 (298)
.....++..|+|||.+.+..++.+ +||||||+++|++++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCch
Confidence 012246778999999987776555 9999999999999999999987665
Q ss_pred chhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...+ .++.......+.....+.++.+++.+||..||++|||.... ..++++|||+++.
T Consensus 238 ~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~----~~~ll~~~~~~~~ 295 (316)
T cd05574 238 DETF----SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG----AAEIKQHPFFRGV 295 (316)
T ss_pred HHHH----HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhh----HHHHHcCchhhcC
Confidence 3333 33334444444444478999999999999999999984333 2677789998874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=293.05 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=206.4
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++.+.||+|++|.||+++++.+++.+++|.+.... ...+.+.+|+.++++++|+|++++++++.....+++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999999889999999886542 233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~ 178 (298)
|+++++|.........+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence 9999888888777778999999999999999999999999999999999999998887 9999999887543332 222
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------CCC
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------QYS 243 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~ 243 (298)
...++..|+|||.+.+......++|+||+|+++++|++|..||......+............ ...
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 33467789999998765443445999999999999999999998766544332222211000 000
Q ss_pred CCC----------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 244 VPD----------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 244 ~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.+. ...++..+.+|+.+||+.||++|||+ .+++.|||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~--------~eil~~~~f 286 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC--------EELLEHPYF 286 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH--------HHHhcCCCC
Confidence 000 12467889999999999999999987 556678875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=292.84 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=211.4
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .....+.+|+.+++.++|+|++++.+++.++..+++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999999899999999987643 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~ 179 (298)
+.+++|.+++... ++++..++.++.|++.++.+||+.+++|+||+|+||++++++. ++|+|||++...... .....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence 9999999998765 7899999999999999999999999999999999999998887 999999998655433 22334
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
..++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.. .....+............++.++.+++.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPM----RVLFLIPKNNPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchH----HHHHHhhhcCCCCCcccccCHHHHHHHH
Confidence 457778999999988776655 99999999999999999999765432 2222222222221122227899999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
+||..||++|||+ .++++|||+.+..+
T Consensus 233 ~~l~~~p~~Rpt~--------~~il~~~~~~~~~~ 259 (274)
T cd06609 233 LCLNKDPKERPSA--------KELLKHKFIKKAKK 259 (274)
T ss_pred HHhhCChhhCcCH--------HHHhhChhhcCCCc
Confidence 9999999999987 55667999886544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=295.07 Aligned_cols=245 Identities=20% Similarity=0.169 Sum_probs=201.4
Q ss_pred CCeeEE--eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch----HHHHHHHHHHhcCCCCCeeeeeEEEEe----CC
Q 022401 23 DRYDFV--RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT----PT 92 (298)
Q Consensus 23 ~~y~~~--~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 92 (298)
++++.. ..+++|+++.||++.. +|+.||+|.+....... +.+.+|+.++++++||||+++++++.+ ..
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 334444 6789999999999988 58899999987654333 566799999999999999999999877 34
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
.+++|+||+++++|.+++.....++......++.+++.|+.+||+ .+++|+||+|+||+++.++. +||+|||++...
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~ 173 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKIL 173 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhh
Confidence 789999999999999999888889999999999999999999998 49999999999999998887 999999987643
Q ss_pred cCCCCCCCCCCCCcccCcccccc--ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
.. ......++..|+|||.+.+ ..++.+ +||||||+++|+|++|..||...+.. .....+.......+.+..
T Consensus 174 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~ 246 (283)
T PHA02988 174 SS--PPFKNVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTTK----EIYDLIINKNNSLKLPLD 246 (283)
T ss_pred cc--ccccccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCCCCCCCc
Confidence 22 2234457788999999875 455555 99999999999999999999876542 333334334444444445
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.++++.+++.+||+.||.+|||+.+++..
T Consensus 247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 247 CPLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred CcHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 79999999999999999999999999853
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=287.46 Aligned_cols=250 Identities=30% Similarity=0.457 Sum_probs=207.3
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||+|++|.||++.+..+++.+++|.+... ......+.+|+.++++++|||++++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 589999999999999999999989999999988653 33456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-C
Q 022401 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-~ 177 (298)
+++++|.+++... ..++...++.++.+++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence 9999999998764 56899999999999999999999999999999999999998887 99999998764433222 2
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||...+..++.+ +|+||||+++++|++|..||...+.. ....++...... +....++.++.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQG----ALILKIIRGVFP-PVSQMYSQQLAQL 232 (256)
T ss_pred hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCC-CCccccCHHHHHH
Confidence 23457788999999988777665 99999999999999999999876532 223333333222 2222578999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+.+||+.+|++||++ .+++.|||+
T Consensus 233 i~~~l~~~p~~Rp~~--------~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDT--------FQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCH--------HHHhhCCCC
Confidence 999999999999988 455566764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=290.52 Aligned_cols=250 Identities=33% Similarity=0.467 Sum_probs=205.8
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----------hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
+|.+.+.||+|++|.||.|.+..+++.+++|.+...... .+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999888899999988653221 2457789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
.++++||+++++|.+++.....+++..+..++.+++.|+++||+.|++|+||+|+||++++++. ++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence 9999999999999999988888999999999999999999999999999999999999998877 99999998864432
Q ss_pred CCC-------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 174 HSQ-------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 174 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
... .....++..|+|||.+.+..++.+ +|+||+|+++|++++|..||........ ...+... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~-~~~~~ 232 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQA----IFKIGEN-ASPEI 232 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHH----HHHHhcc-CCCcC
Confidence 111 112346778999999887777655 9999999999999999999987654222 2222221 11222
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+..++.++.++|.+||+.||.+||++ .++++|||+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~--------~~il~~~~~ 267 (267)
T cd06628 233 PSNISSEAIDFLEKTFEIDHNKRPTA--------AELLKHPFL 267 (267)
T ss_pred CcccCHHHHHHHHHHccCCchhCcCH--------HHHhhCCCC
Confidence 34478999999999999999999987 555577775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=303.55 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=198.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
....+|++++.||+|+||.||++.+..++..||+|+.... ....|+.++++++||||+++++++......++|++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3445799999999999999999999988999999975433 23568999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
++.+ +|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..........
T Consensus 138 ~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 138 HYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred ccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccc
Confidence 9965 67777654 457899999999999999999999999999999999999998887 9999999886443333333
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCC-CCCCCCc---------hhHHHHHHHHhhcCCCCC---
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPDEP---------KDFRKTIQRILSVQYSVP--- 245 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~---------~~~~~~~~~~~~~~~~~~--- 245 (298)
...++..|+|||++.+..++.+ +|||||||++|+|+++..| |...... ..+.............++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred cccccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 4568899999999988877666 9999999999999986544 3332221 111111111110000000
Q ss_pred -------------------------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 246 -------------------------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 246 -------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...+++.++.+||.+||+.||.+|||+ .++++|||+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta--------~e~l~hp~f~~ 356 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA--------EEILNYPMFAQ 356 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH--------HHHhcCchhcc
Confidence 112356778889999999999999988 56668999875
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=311.64 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=206.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 92 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 92 (298)
...++|++.+.||+|+||.||.+++..+++.||+|++.... .....+.+|+..+..++|+|++++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 44589999999999999999999999999999999987543 22345778999999999999999988775432
Q ss_pred ----eEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEee
Q 022401 93 ----HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (298)
Q Consensus 93 ----~~~lv~~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d 164 (298)
.+++|+||+++++|.+.+.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~D 186 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGD 186 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEe
Confidence 36899999999999998854 346899999999999999999999999999999999999998887 99999
Q ss_pred cCccccccCC---CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC
Q 022401 165 FGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241 (298)
Q Consensus 165 ~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (298)
||++...... .......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+. ......+....
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~----~~~~~~~~~~~ 261 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENM----EEVMHKTLAGR 261 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcCC
Confidence 9998643321 22234568899999999988777665 9999999999999999999987543 33344444433
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 242 YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
.. +.+..+++++.+++.+||+.||.+||++.+++++++
T Consensus 262 ~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 262 YD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred CC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 32 334558999999999999999999999866665543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=294.23 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=205.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
++|++.+.||+|+||.||++.+..++..+++|.+..... ....+.+|++++++++||||+++++++..++.+++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 479999999999999999999998999999998865422 235577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~ 179 (298)
+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCccccccc-cccc
Confidence 9999999999888889999999999999999999997 59999999999999998887 999999987643222 2234
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH------------------------
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ------------------------ 235 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~------------------------ 235 (298)
..++..|+|||.+.+..++.+ +|+||||++++++++|..||...+. ........
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 457889999999877666555 9999999999999999999865432 11111111
Q ss_pred ---------HHhhcC-CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 236 ---------RILSVQ-YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 236 ---------~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+.... ...+ ...++.++.+++.+||+.||++|||+ .++++|||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~--------~~ll~~~~~~~ 292 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADL--------KELTKHPFIKR 292 (308)
T ss_pred hhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCH--------HHHhcChhhhh
Confidence 000000 1111 11267899999999999999999987 55557777764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=323.33 Aligned_cols=262 Identities=29% Similarity=0.468 Sum_probs=208.0
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP- 91 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 91 (298)
-+.....++|++++.||+|+||.||++++..++..+++|.+.... .....+..|+.++++++||||+++++++...
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 344455679999999999999999999999999999999887532 3345678899999999999999999998653
Q ss_pred -CeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc-------CcEEecCCCCceEeeCC----
Q 022401 92 -THLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAM-------QVCHRDLKLENTLLDGS---- 155 (298)
Q Consensus 92 -~~~~lv~~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~-------~i~H~dl~p~nilv~~~---- 155 (298)
..+|+||||+++++|.+++.. ...+++..++.|+.||+.||.|||+. +|+|+||||+|||++.+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 578999999999999998864 35699999999999999999999984 49999999999999642
Q ss_pred -----------CCCCEEEeecCccccccCCCCCCCCCCCCcccCccccccc--cCCCCccchHHHHHHHHHHHhCCCCCC
Q 022401 156 -----------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFE 222 (298)
Q Consensus 156 -----------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 222 (298)
+...++|+|||++.............+++.|+|||++.+. .++. ++|||||||++|+|++|..||.
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~-KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCc-hhHHHHHHHHHHHHHHCCCCCC
Confidence 2334899999998755444434455689999999998643 3444 4999999999999999999998
Q ss_pred CCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.......+. ..+.. ....+. ...+.++.+||..||+.+|.+||++.++ +.|||+..
T Consensus 245 ~~~~~~qli---~~lk~-~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~Ql--------L~h~~ik~ 300 (1021)
T PTZ00266 245 KANNFSQLI---SELKR-GPDLPI-KGKSKELNILIKNLLNLSAKERPSALQC--------LGYQIIKN 300 (1021)
T ss_pred cCCcHHHHH---HHHhc-CCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHH--------hccHHHhh
Confidence 765433322 22222 222222 2368999999999999999999988554 56777653
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=292.01 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=201.7
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+.++++++|||++++++++.++..+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5899999999999999999999899999999886532 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-C
Q 022401 101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (298)
Q Consensus 101 ~~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~ 176 (298)
+. ++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence 97 5787777542 46899999999999999999999999999999999999998887 9999999886433221 1
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc----------------
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------- 240 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 240 (298)
.....+++.|+|||.+.+......++|+||||+++++|++|..||......+............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2233567889999988765544445999999999999999999998765433322222111000
Q ss_pred -------CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 241 -------QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 241 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.........+++++.++|.+||+.||.+|||+ .+++.|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~--------~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA--------KKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH--------HHHhcCCCC
Confidence 00000122378999999999999999999987 555577875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=288.43 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=209.4
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
.++|++.+.||+|++|.||++....++..+++|.+..... .+.+.+|+.++++++|+|++++++++.....+++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 3689999999999999999999988889999999876543 678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCC
Q 022401 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (298)
Q Consensus 102 ~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 179 (298)
++++|.+.+.. ...+++..+..++.+++.|+.|||+.+++|+||+|.||++++++. ++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence 99999999865 456899999999999999999999999999999999999998887 9999999887544332 2233
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
..++..|+|||++.+..++.+ +||||+|+++++|++|..||........... ...........+..++.++.+++.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---IPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred ccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhh---hccCCCCCCCchhhcCHHHHHHHH
Confidence 446788999999887777655 9999999999999999999986543221111 111111222333457889999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+||+.||.+|||+ .+++.|||+
T Consensus 235 ~~l~~~P~~Rps~--------~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSA--------IQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCH--------HHHhcCCCC
Confidence 9999999999987 556678875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=293.68 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=199.8
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||.|++|.||++++..+|+.+++|.+.... .....+.+|+.++++++|||++++++++.+...+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5899999999999999999999899999999986532 2235577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCC
Q 022401 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (298)
Q Consensus 101 ~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~ 178 (298)
+++ +|.+.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence 975 77776654 567899999999999999999999999999999999999998887 9999999886433221 122
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC----------------C
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------------Y 242 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~ 242 (298)
...++..|+|||.+.+....+.++||||||+++|+|++|..|+....+.........+..... .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 345678899999987765445559999999999999999988654443222211111111000 0
Q ss_pred -C-------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 243 -S-------VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 243 -~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
. ......+++++.++|.+||+.||.+|||+. +++.|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~--------~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE--------EALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHH--------HHhcCCCC
Confidence 0 011124678999999999999999999884 55578885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=292.78 Aligned_cols=257 Identities=29% Similarity=0.485 Sum_probs=210.8
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++.+..+++.|++|.+.... .....+.+|+.+++.++||||+++++++..+..+++|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999887643 22345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--- 175 (298)
|++++++|.+++.....+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence 99999999999988888999999999999999999999999999999999999998877 9999999875311110
Q ss_pred -------------CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 176 -------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 176 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
......++..|+|||.+.+..++.+ +|+||||+++|++++|..||.+... .+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~----~~~~~~~~~~~~ 233 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTP----EELFGQVISDDI 233 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccc
Confidence 0011235678999999877777655 9999999999999999999976543 233333333332
Q ss_pred CCCC-CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 243 SVPD-TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 243 ~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..+. ...+++++.+++.+||+.||++||++. ..+++++|||+..
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~-----~~~~ll~~~~~~~ 278 (305)
T cd05609 234 EWPEGDEALPADAQDLISRLLRQNPLERLGTG-----GAFEVKQHRFFLG 278 (305)
T ss_pred CCCCccccCCHHHHHHHHHHhccChhhccCcc-----CHHHHHhCccccC
Confidence 2222 224789999999999999999999873 3467889999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=290.72 Aligned_cols=254 Identities=29% Similarity=0.373 Sum_probs=208.1
Q ss_pred eccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 31 lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
||+|+||.||.+.+..+|+.+++|.+.... .....+.+|+.++++++|||++++++++...+.+|+|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999999899999999986532 2234567899999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCC
Q 022401 107 FERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184 (298)
Q Consensus 107 ~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 184 (298)
.+.+.... .+++..+..++.|++.++.|||+.|++|+||+|+||+++.++. ++|+|||.+.............+..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence 99987665 6899999999999999999999999999999999999998887 9999999886544433334455778
Q ss_pred cccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhh
Q 022401 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264 (298)
Q Consensus 185 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 264 (298)
.|++||.+.+..++.+ +|+||+|+++++|++|..||...................... .+...++++.++|.+||+.
T Consensus 159 ~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 159 GYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVE--YPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccccc--CCccCCHHHHHHHHHHccC
Confidence 8999999877776555 999999999999999999998765433333333333332222 2334689999999999999
Q ss_pred CCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 265 DPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 265 dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
||.+||++.+.- ..++++|||+.+.
T Consensus 236 ~p~~R~~~~~~~---~~~ll~h~~~~~~ 260 (277)
T cd05577 236 DPEKRLGCRGGS---ADEVREHPLFKDL 260 (277)
T ss_pred ChhHccCCCccc---HHHHHhChhhhcC
Confidence 999999776622 3677889999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=311.01 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=207.0
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
-+.+..+...+++.||+|.||+||++++.++ ||||.+... ....+.|++|+..+++-+|.||+-|.|++..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 3445557889999999999999999999854 899998753 4456789999999999999999999999987776
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+|+.+|.|.||..+++... +++..+...|++|+++|+.|||.++|+|+|||..|||+.+++. |||+|||++....
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKT 539 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeee
Confidence 99999999999999997544 6899999999999999999999999999999999999998877 9999999986332
Q ss_pred C---CCCCCCCCCCCcccCccccccc--cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCC
Q 022401 173 L---HSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247 (298)
Q Consensus 173 ~---~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
. ..+.....+...|||||+++-. ...++++||||||+++|||++|..||...+. +...-.+-+-....-.....
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hheEEEecccccCccchhhh
Confidence 2 2333555678889999997632 3335559999999999999999999994433 32211111110011122334
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHH
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLL 282 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~ 282 (298)
.+.+.++.+|+..||++++++||++.++|.+.-+.
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 45788999999999999999999999999754333
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=286.06 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=215.4
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .....+.+|+..+.+++|+|++++.+++...+.+++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36999999999999999999999899999999987654 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC-
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 178 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~- 178 (298)
+++++|.+++.....+++..++.++.+++.++++||+ .|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence 9999999999888889999999999999999999999 99999999999999998887 9999999887544333322
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC-CCHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDL 257 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 257 (298)
...++..|+|||.+.+..++.+ +|+||||+++|++++|..||..... ....+....+..... ...... ++..+.++
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 235 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGPP-PSLPAEEFSPEFRDF 235 (264)
T ss_pred ceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHhcCCC-CCCCcccCCHHHHHH
Confidence 3456788999999877766555 9999999999999999999987653 122334444443222 222333 78999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
|.+||+.+|.+|||+ .++++|||++..
T Consensus 236 i~~~l~~~p~~R~~~--------~~ll~~~~~~~~ 262 (264)
T cd06623 236 ISACLQKDPKKRPSA--------AELLQHPFIKKA 262 (264)
T ss_pred HHHHccCChhhCCCH--------HHHHhCHHHHhc
Confidence 999999999999987 666678988754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=291.53 Aligned_cols=255 Identities=27% Similarity=0.487 Sum_probs=209.8
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .....+.+|++++++++|||++++++++..++.+++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46899999999999999999999899999999987653 3345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 101 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
+.+++|.+++... ..+++..+..++.+++.++++||+ .|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~-~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLA-K 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHh-h
Confidence 9999999999776 788999999999999999999999 99999999999999998876 99999998764432222 1
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCC-chhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-PKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
...++..|+|||.+.+..++.+ +|+||+|++++++++|..||..... ........+.+............++.++.++
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred cccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 2567788999999887777665 9999999999999999999976531 1222333444333322111111278899999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
|.+||+.||.+|||+ .+++.|||+
T Consensus 237 i~~~l~~~p~~Rpt~--------~~ll~~~~~ 260 (265)
T cd06605 237 VNLCLIKDPRERPSY--------KELLEHPFI 260 (265)
T ss_pred HHHHcCCCchhCcCH--------HHHhhCchh
Confidence 999999999999987 556688888
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=290.93 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=207.2
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
.....++|++.+.||+|++|.||.+++..+++.+++|.+..... ....+.+|+.+++.++|||++++++++...+.+++
T Consensus 4 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 4 RRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred ccCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 34455789999999999999999999998999999999876532 23457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-C
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 175 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~ 175 (298)
++||+++++|.+++...+.+++.+++.++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIA 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCccc
Confidence 9999999999999988888999999999999999999999999999999999999998877 999999987643322 2
Q ss_pred CCCCCCCCCcccCccccc---cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 176 QPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
......++..|+|||.+. ...++. ++|+||||+++|+|++|..||............... ............++.
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQ-LCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-NFQPPKLKDKMKWSN 239 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCc-hhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-CCCCCcccccCCCCH
Confidence 223446788999999874 233444 599999999999999999998765432221111111 001111122224788
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVW 288 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~ 288 (298)
.+.+++.+||+.||++|||+ .++++|||
T Consensus 240 ~~~~li~~~l~~~P~~R~~~--------~~ll~~~~ 267 (267)
T cd06645 240 SFHHFVKMALTKNPKKRPTA--------EKLLQHPF 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCH--------HHHhcCCC
Confidence 99999999999999999987 45557776
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=286.12 Aligned_cols=253 Identities=30% Similarity=0.462 Sum_probs=209.1
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||+|++|.||.+....+++.+++|.+..... ....+.+|+.++++++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 59999999999999999999988899999999876544 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC--
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 178 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~-- 178 (298)
+.+++|.+.+.....+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence 999999999988777899999999999999999999999999999999999998877 9999999887544332221
Q ss_pred ---CCCCCCcccCcccccccc---CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 179 ---STVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 179 ---~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
...++..|+|||.+.... ... ++||||+|++++++++|..||......... ............+....+++
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~-~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGR-AADIWSLGCVVLEMATGKRPWSELDNEFQI--MFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCc-ccchHHHHHHHHHHHhCCCCccCCcchHHH--HHHHhcCCCCCCCcccccCH
Confidence 235678899999987665 444 499999999999999999999765432211 11111122333444444689
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.+.+++.+||+.||.+|||+ .+++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~--------~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTA--------SELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCH--------HHHhcCCCC
Confidence 99999999999999999987 555678875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=286.34 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=207.7
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
+|+..+.||+|++|.||++....+++.+++|.+.... ...+.+.+|+.++++++|+|++++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888999999999999999998889999999886543 2345688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
+||+++++|.+++.....+++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 999999999999988888999999999999999999999999999999999999998877 999999988754444333
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....++..|++||.+........++|+||+|+++|++++|..||......... ..+.........+..++.++.++
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----FKIGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH----HHHHhcccCCCcCCCcCHHHHHH
Confidence 44557888999999876652334499999999999999999999876532221 11112111112233478999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+.+||+.||.+||++ .+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~--------~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTA--------AELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCH--------HHHhcCCCC
Confidence 999999999999987 555577775
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=288.60 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=204.0
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEc---cCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
++.++|++.+.||+|+||.||.+... ..+..+|+|.+.... .....+.+|+..+++++||||+++++++..+...
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 46678999999999999999999864 346689999887643 2235678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++||||+++++|.+++... ..+++..++.++.+++.|++|||+.|++|+||+|+||+++.++. ++++|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~ 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKS 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccc
Confidence 9999999999999998764 57899999999999999999999999999999999999998876 99999997653322
Q ss_pred CCC--CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 174 HSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 174 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
... .....++..|+|||.+.+..++.+ +||||||+++|++++ |..||......+. .+.+. .....+.+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~ 233 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDV----IKAVE-DGFRLPAPRNC 233 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHH----HHHHH-CCCCCCCCCCC
Confidence 211 112234567999999877777665 999999999999875 9999987654322 22222 22334455668
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccch
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
|..+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 234 PNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=290.26 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=209.1
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
.....++|++++.||+|++|.||++++..++..+++|.+.... .....+.+|+.+++.++|||++++++++..++.+++
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3445578999999999999999999999899999999987543 334567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-
Q 022401 97 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~- 174 (298)
|+||+++++|...+.+ ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTL 164 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccc
Confidence 9999999999887754 456899999999999999999999999999999999999988777 999999987643222
Q ss_pred CCCCCCCCCCcccCccccccc-----cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-CCCCCCCC
Q 022401 175 SQPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTN 248 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 248 (298)
.......++..|+|||.+.+. .++. ++|+||||+++|+|++|..||...+... ...++... ......+.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~ 239 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMR----VLLKIAKSEPPTLSQPS 239 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCc-hhhhHhHHHHHHHHhcCCCCCccccHHH----HHHHHhcCCCccCCCCc
Confidence 222334577889999987532 2333 4999999999999999999997754322 12222222 22333445
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.++.++.+++.+||+.||++||++ .++++|||+..
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~--------~~il~~~~~~~ 274 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSA--------AQLLEHPFVSS 274 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCH--------HHHhcCccccc
Confidence 578899999999999999999987 55567888864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=293.45 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=208.7
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc------hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
+|++.+.||+|++|.||++.+..+++.|++|.+...... ...+.+|+.++++++|+|++++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999888999999998764322 34567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-
Q 022401 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~- 175 (298)
+||+ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence 9999 889999997766 7999999999999999999999999999999999999998887 9999999886443322
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-------------
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY------------- 242 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 242 (298)
......++..|+|||.+.+......++|+||||+++++|++|..||......+.+......+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2223345678999998866554455699999999999999998888766554433333222110000
Q ss_pred ------CC---CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 243 ------SV---PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 243 ------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
.. ......+.++.++|.+||+.||.+|||+ .++++|||+.+....|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~--------~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA--------RQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH--------HHHhhCccccCCCCCC
Confidence 00 0012346889999999999999999987 5566799998755443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=283.70 Aligned_cols=251 Identities=33% Similarity=0.517 Sum_probs=208.1
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||+|++|.||.+.+..++..+++|.+.... .....+.+|+.++++++|||++++++.+..++..++|+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5999999999999999999998899999999987542 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 101 ~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
+++++|.+++... ..+++..+..++.+++.++++||++|++|+||+|+||+++.++. .++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence 9999999999763 35899999999999999999999999999999999999976553 47999999987655444444
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
...++..|+|||.+.+...+.+ +|+||+|++++++++|..||...+... ....+..... .+....++.++.+++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~l~~li 233 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPA----LVLKIMSGTF-APISDRYSPDLRQLI 233 (256)
T ss_pred ccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHH----HHHHHHhcCC-CCCCCCcCHHHHHHH
Confidence 5567889999999887766555 999999999999999999997765432 2222222222 122334789999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.+||+.||.+|||+ .++++|||+
T Consensus 234 ~~~l~~~p~~Rpt~--------~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQL--------SQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCH--------HHHhhCCCC
Confidence 99999999999988 555577775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=297.11 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=204.7
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||+++.+.+++.+|+|++.+. ......+.+|..++..++|++|+++.+++.+...+++|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4799999999999999999999989999999998642 222344778899999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-
Q 022401 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~- 176 (298)
||+.+++|.+++.. ...+++..+..++.|++.|++|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence 99999999999976 457899999999999999999999999999999999999998887 99999998864322221
Q ss_pred -CCCCCCCCcccCcccccc----ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--CCC-CC
Q 022401 177 -PKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPD-TN 248 (298)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~-~~ 248 (298)
.....+++.|+|||++.. ......++||||||+++|+|++|..||...+. .+...++...... .+. ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH----HHHHHHHhCCCccccCCCccc
Confidence 223468899999998863 22234449999999999999999999987554 3333444333322 221 23
Q ss_pred CCCHHHHHHHHHhhhhCCCC--cccccccchhhhHHHhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAA--VSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.++.++.+++++||..++.+ |++ +.++++|||+.+.
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~--------~~~~~~h~~f~~~ 272 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNG--------IEDFKQHPFFTGI 272 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCC--------HHHHhCCCCcCCC
Confidence 47899999999999765544 454 4777789988753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=287.26 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=207.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
++|++.+.||.|++|.||++....++..+++|++.... .....+.+|+..++.++|+|++++++.+..++.+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999998889999999986543 2446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
+.+++|.+.+... ..+++..+..++.|++.|+.+||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence 9999999998764 45899999999999999999999999999999999999998877 999999987644333222
Q ss_pred -----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC---CCC
Q 022401 178 -----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD---TNP 249 (298)
Q Consensus 178 -----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 249 (298)
....++..|++||.+......+.++|+||||+++++|++|..||...+....+.+.... ....... ...
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 235 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKK 235 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcccccc
Confidence 22346788999999877633344599999999999999999999876553333332221 1112222 125
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+++++.+++.+||..||++||++ .++++|||+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~--------~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTA--------EELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCH--------HHHhhCCCC
Confidence 78999999999999999999987 666678885
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=288.83 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=210.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
..+|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+.+++.++|||++++++++.....+++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 367999999999999999999998899999999887543 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 179 (298)
+.+++|..++... .+++.++..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCC
Confidence 9999999988654 5899999999999999999999999999999999999998877 9999999876433222 1223
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
..++..|+|||.+.+..++.+ +|+||||+++|++++|..||...+........ ..........+..+++.+.++|+
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSPIFRDFLN 250 (296)
T ss_pred cCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCcccCCcccCCHHHHHHHH
Confidence 457788999999887777665 99999999999999999999876543222211 11222233344558899999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+||..||.+|||+ .+++.|||+..
T Consensus 251 ~~l~~dp~~Rpt~--------~~il~~~~~~~ 274 (296)
T cd06655 251 RCLEMDVEKRGSA--------KELLQHPFLKL 274 (296)
T ss_pred HHhhcChhhCCCH--------HHHhhChHhhh
Confidence 9999999999987 56668888875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=303.03 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=202.5
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEEEeC
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 91 (298)
...++|++.+.||+|+||.||++++.. ++..||+|.+..... ..+.+.+|+.+++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 455789999999999999999998643 335799999875432 235678899999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC----------------------------------------------------------
Q 022401 92 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 113 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~---------------------------------------------------------- 113 (298)
..+++|+||+++++|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999887532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC---CC
Q 022401 114 ------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PK 178 (298)
Q Consensus 114 ------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~---~~ 178 (298)
.+++...++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeecc
Confidence 13678889999999999999999999999999999999998776 99999999864332211 11
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
...++..|+|||++.+..++.+ +||||||+++|+|++ |..||............ .........+...+.++.++
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM----VKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred CCCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHH----HHcccCccCCCCCCHHHHHH
Confidence 2234567999999877777665 999999999999997 99999875543322222 22223333344468999999
Q ss_pred HHHhhhhCCCCcccccccchhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~ 279 (298)
+.+||+.||.+|||+.+++++.
T Consensus 348 i~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=288.98 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=204.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC------CeE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------THL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~ 94 (298)
.+.|++.+.||+|+||.||++....+++.+|+|++.........+.+|+.+++++ +|+|++++++++... ..+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 4679999999999999999999998999999999987766667788999999998 699999999998753 468
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 95 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
++++||+.+++|.+++... ..+++..+..++.|++.|++|||+++++|+||+|+||+++.++. ++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~ 162 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceecc
Confidence 9999999999999998763 36889999999999999999999999999999999999998887 9999999986433
Q ss_pred CC-CCCCCCCCCCcccCccccccc-----cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 173 LH-SQPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 173 ~~-~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
.. .......++..|+|||.+... .++. ++|+||+|+++|+|++|..||....... .. ............
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGv~l~el~~g~~p~~~~~~~~---~~-~~~~~~~~~~~~ 237 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMR---AL-FLIPRNPAPRLK 237 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCc-hhhHHHHHHHHHHHHhCCCCccccCHHH---HH-HHHhcCCCCCCC
Confidence 22 223345578889999987632 3444 4999999999999999999997644221 11 111122222223
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
...++.++.+|+.+||..||.+|||+ .+++.|||+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~--------~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTT--------EQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCH--------HHHhhCCCC
Confidence 33578999999999999999999987 555578875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=290.30 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=207.1
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||+|++|.||+|.+..+|+.+++|++.... .....+.+|+.++++++|||++++++++.....+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5999999999999999999998889999999987543 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--CC
Q 022401 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 177 (298)
Q Consensus 101 ~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--~~ 177 (298)
+ +++|.+.+.. ...+++.+++.++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence 9 9999998854 456899999999999999999999999999999999999998877 9999999887544332 12
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC---------------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------------- 242 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 242 (298)
....++..|+|||.+.+......++||||+|++++++++|..||........+......+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 34457888999999876665455699999999999999998888766554433333322111000
Q ss_pred CCC---------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 243 SVP---------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 243 ~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
..+ .....+.++.++|.+||+.||++|||+ .++++|||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~--------~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA--------AEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH--------HHHhhCcCcC
Confidence 000 012357899999999999999999987 5666888873
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=284.26 Aligned_cols=260 Identities=33% Similarity=0.504 Sum_probs=222.7
Q ss_pred CCCCCCeeEE-eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEe----CC
Q 022401 19 MHDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT----PT 92 (298)
Q Consensus 19 ~~~~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~ 92 (298)
...+++|++- ++||-|-.|.|-.+.++.+|..+|+|++... +..++|+++.-.. .|||||.++++++. ..
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3466778775 5789999999999999999999999987754 4567788877655 69999999999864 35
Q ss_pred eEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-CCCCCEEEeecCccc
Q 022401 93 HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSK 169 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~ 169 (298)
.+.+|||.++||.|.+.+++.+. +++.++..|++||+.|++|||+.+|.||||||+|+|+.. ..++.+||+|||++.
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 78999999999999999987775 999999999999999999999999999999999999954 344569999999998
Q ss_pred cccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--C
Q 022401 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--T 247 (298)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 247 (298)
.........+...+++|.|||++-..+|+.. +|+||+|+++|-|++|.+||........-.....+|..+.+.+|. .
T Consensus 213 ~t~~~~~L~TPc~TPyYvaPevlg~eKydks-cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 213 ETQEPGDLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred ccCCCccccCCcccccccCHHHhCchhcCCC-CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 7777777788889999999999977777665 999999999999999999998876655555677788888877665 3
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..++++..++|+.+|..+|.+|.|+ .++.+|||+..
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI--------~~~m~hpwi~~ 327 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTI--------EEVMDHPWINQ 327 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeH--------HHhhcCchhcc
Confidence 4678999999999999999999998 66668999864
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=288.50 Aligned_cols=256 Identities=29% Similarity=0.404 Sum_probs=203.6
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-----------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----------IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
+|.+.+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+.++++++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68999999999999999999988899999998764211 1245778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
..++|+||+++++|.+.+.....++...+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999998887 9999999886433
Q ss_pred CCC---CCCCCCCCCcccCcccccccc-CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 173 LHS---QPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 173 ~~~---~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
... ......++..|+|||.+.... ....++|+||||++++++++|..||..........+................
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 211 112234678899999987654 2344499999999999999999999754432221111111111111111222
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.++.++.+++.+||+.||.+|||+ .++++|||+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~--------~~il~~~~~ 272 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTA--------RELLQHPFI 272 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCH--------HHHhhCCCC
Confidence 468999999999999999999987 666688885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=302.49 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=202.3
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEE-----ccCCcEEEEEEeecCC--cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 91 (298)
...++|++.+.||+|+||.||++.+ ..++..||+|++.... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3456899999999999999999974 3456689999886432 2335678899999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC---------------------------------------------------------
Q 022401 92 THLAIVMEYASGGELFERICNAG--------------------------------------------------------- 114 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~--------------------------------------------------------- 114 (298)
...++||||+++++|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999988885421
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 115 ------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 115 ------------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
.++...+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSN 269 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCccc
Confidence 3677889999999999999999999999999999999998776 99999999864432221
Q ss_pred ---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 177 ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 177 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
.....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||........+.+.+. .......+...+.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 344 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----EGYRMLSPECAPS 344 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH----hCccCCCCCCCCH
Confidence 112234567999999988777665 999999999999998 8889987654433333222 2222223334688
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
++.+++.+||+.||++|||+.+++++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=289.01 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=202.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.++|++.+.||+|+||.||++.+..+++.+++|++.... .....+.+|+.++++++|||++++++++..+..+++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 467999999999999999999998899999999987543 2335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 179 (298)
+++++|.+++....++++..+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCc
Confidence 999999999988888999999999999999999999999999999999999998887 9999999987543222 2233
Q ss_pred CCCCCcccCcccccc---ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 180 TVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
..+++.|+|||.+.. ..++ .++|+||+|+++|+|++|..||............... ............++.++.+
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-NFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred cccCccccCHhHcccccCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-CCCCCCCccccccCHHHHH
Confidence 457788999998753 2343 4599999999999999999998654322111110000 0011112223347899999
Q ss_pred HHHHhhhhCCCCcccccccch
Q 022401 257 LISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~ 277 (298)
++++||+.||++|||+.++++
T Consensus 244 li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhc
Confidence 999999999999999866654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=285.37 Aligned_cols=248 Identities=32% Similarity=0.451 Sum_probs=204.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
++|++.+.||.|++|.||.+.+..+++.+++|.+..... ....+.+|+.++++++|||++++++++.+...+++++|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 689999999999999999999988889999999876432 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCC
Q 022401 102 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (298)
Q Consensus 102 ~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 179 (298)
.+++|.+++... ..+++.++..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhcccc
Confidence 999999988766 68999999999999999999999999999999999999998887 9999999886443322 2233
Q ss_pred CCCCCcccCccccccc---cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC---CCCCCCCCCCHH
Q 022401 180 TVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---YSVPDTNPISQE 253 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 253 (298)
..++..|+|||.+.+. .++.+ +|+||+|+++++|++|..||........... ..... ........++.+
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~-~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFL----ISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccCCccccCchhhcccccCCcCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhccCCCccccchhhhhHH
Confidence 4567789999998766 56554 9999999999999999999987653222211 11121 111223346789
Q ss_pred HHHHHHHhhhhCCCCcccccccch
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+.+++++||+.||.+|||+.++++
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999999999999855553
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=285.81 Aligned_cols=252 Identities=28% Similarity=0.394 Sum_probs=203.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CeE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 94 (298)
.+|++.+.||+|++|.||++.+..+++.+++|.+.... +....+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36999999999999999999999899999999886432 1234577899999999999999999998753 578
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++++|++++++|.+.+.....++....+.++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence 999999999999999988888999999999999999999999999999999999999998877 999999987643221
Q ss_pred ----CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 175 ----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 175 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
.......++..|+|||.+.+..++.+ +|+||+|+++|++++|..||........ .............+..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~ 234 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAA----IFKIATQPTNPQLPSHI 234 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHH----HHHHhcCCCCCCCchhc
Confidence 11122346788999999887777665 9999999999999999999987543222 22222222222223346
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
++.+.+++ +||..+|++||++ .++++|||++
T Consensus 235 ~~~~~~li-~~~~~~p~~Rp~~--------~eil~hp~~~ 265 (266)
T cd06651 235 SEHARDFL-GCIFVEARHRPSA--------EELLRHPFAQ 265 (266)
T ss_pred CHHHHHHH-HHhcCChhhCcCH--------HHHhcCcccc
Confidence 78899998 6888999999987 5555788864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=317.90 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=217.4
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCCcc--hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
...+.++.+.||+|+||.||+++-. .....||||.++..... ..+|++|++++..|+|||||+++|+|..++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 4467889999999999999999864 34568999998875443 5789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCC
Q 022401 94 LAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~--------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~ 159 (298)
+|+|||||..|+|.++|... ++++..+.+.|+.||+.|+.||-++.+|||||-..|.||+++-.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~-- 641 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV-- 641 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--
Confidence 99999999999999998432 23888999999999999999999999999999999999998887
Q ss_pred EEEeecCccccccCC---CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 022401 160 LKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQ 235 (298)
Q Consensus 160 ~~l~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~ 235 (298)
|||+|||+++..... .......-..+|||||.+...+++++ |||||+|+++||+++ |..||.+... .+++.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn----~EVIe 716 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSN----QEVIE 716 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccch----HHHHH
Confidence 999999999744332 22234456789999999999999998 999999999999998 8899988776 56677
Q ss_pred HHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 236 RILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
-+..+.. ++.+.++|.++.+|+..||+.+|.+||++++|-.
T Consensus 717 ~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 717 CIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred HHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 7777887 8888889999999999999999999999988764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=297.47 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=204.8
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++++..+++.||+|++... ......+.+|..++..++|++|+++.+++.+++..|+|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999998652 222344778899999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-
Q 022401 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~- 176 (298)
||+.+++|.+++.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence 99999999999976 467899999999999999999999999999999999999998887 99999999864432221
Q ss_pred -CCCCCCCCcccCcccccc-----ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--CCC-C
Q 022401 177 -PKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPD-T 247 (298)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~-~ 247 (298)
.....+++.|+|||++.+ ..++ .++|+||+|+++|+|++|..||...+.. +...++...... .+. .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYG-PECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCC-CcccEEeeehhhhhhhhCCCCccCCCHH----HHHHHHHcCCCcccCCCcc
Confidence 123458899999998865 2343 4499999999999999999999875542 333333332222 221 2
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..+++++.+++.+||..++ +|+.. ....+++.|||+.+
T Consensus 234 ~~~~~~~~~li~~ll~~~~-~~~~~-----~~~~~~~~h~~f~~ 271 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRE-RRLGQ-----NGIEDFKKHAFFEG 271 (331)
T ss_pred ccCCHHHHHHHHHHccCch-hhcCC-----CCHHHHhcCCCcCC
Confidence 3468999999999998655 44321 24577888998865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=288.69 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=209.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
....+|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+.+++.++|+|++++++.+..+...++|+
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 34468999999999999999999998889999999887643 23456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~ 177 (298)
||+++++|.+++.+ ..++..++..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhcccccccc
Confidence 99999999998854 45789999999999999999999999999999999999998876 9999999876433222 12
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.......... ..........+.+..++..+.++
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred CcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHH---HHhcCCCCCCCCccccCHHHHHH
Confidence 23457788999999877766555 999999999999999999997655322221 11122222333445578999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.+||..||++|||+.+++ +|||+..
T Consensus 250 i~~~l~~~p~~Rpt~~eil--------~~~~~~~ 275 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELL--------QHQFLKI 275 (296)
T ss_pred HHHHCcCCcccCcCHHHHh--------hChhhhc
Confidence 9999999999999885555 6777653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=287.18 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=207.9
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
+|+..+.||+|++|.||.+.+..+++.+++|.+.... .....+.+|+.++++++|+|++++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4889999999999999999998899999999887532 123568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
|++|+.+++|.+++.+..++++..++.++.|++.||.+||++|++|+||+|+||+++.++. .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence 9999999999999988888999999999999999999999999999999999999976653 489999998764433211
Q ss_pred -----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 177 -----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 177 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
.....++..|+|||.+.+..++.+ +|+||+|++++++++|..||......... ....+..........+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHL-ALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchH-HHHHHHhccCCCCCCchhhC
Confidence 122346778999999877666555 99999999999999999999765433222 22222222222223334478
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+++.+++.+||..||.+||++ .++++|||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~--------~~ll~~~~~ 267 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPS--------RELLKHPVF 267 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCH--------HHHhcCccc
Confidence 999999999999999999987 555678886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=296.51 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=197.4
Q ss_pred eEEeeeccC--CeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 26 DFVRDIGSG--NFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 26 ~~~~~lg~g--~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+++++||+| ++++||++.++.+|+.||+|++.... .....+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 78899999999999999999987542 2335577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--
Q 022401 101 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (298)
Q Consensus 101 ~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-- 176 (298)
+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++. +++.||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccc
Confidence 999999999864 345899999999999999999999999999999999999998887 99999975432211111
Q ss_pred ------CCCCCCCCcccCccccccc--cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-------
Q 022401 177 ------PKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------- 241 (298)
Q Consensus 177 ------~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 241 (298)
.....++..|+|||.+.+. .++. ++||||+||++|++++|..||....................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 1122345679999998764 3444 49999999999999999999976543222211111000000
Q ss_pred ---------------------------------CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhh
Q 022401 242 ---------------------------------YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVW 288 (298)
Q Consensus 242 ---------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~ 288 (298)
...+....+++++.+|+.+||+.||++|||+ .++++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~--------~ell~~p~ 309 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA--------STLLNHSF 309 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH--------HHHhcChh
Confidence 0001112356789999999999999999988 56668888
Q ss_pred hhhhh
Q 022401 289 MFDAT 293 (298)
Q Consensus 289 ~~~~~ 293 (298)
+...+
T Consensus 310 f~~~~ 314 (327)
T cd08227 310 FKQIK 314 (327)
T ss_pred hhhcc
Confidence 87543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=285.05 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=203.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+.++|++.+.||+|+||.||++..+. +..+++|.+.........+.+|+.++++++||||+++++++......++++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 34679999999999999999998764 55799998876655567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC--
Q 022401 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (298)
Q Consensus 101 ~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~-- 177 (298)
+++++|.+.+.. ...++...++.++.+++.||.|||++|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceecc
Confidence 999999998865 346899999999999999999999999999999999999998876 999999987643222111
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
....++..|+|||.+.+..++.+ +|+||+|+++|++++ |..||...+..+. ...+.... ....+...+.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~----~~~i~~~~-~~~~~~~~~~~~~~ 232 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEV----VEMISRGF-RLYRPKLASMTVYE 232 (256)
T ss_pred CCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHCCC-CCCCCCCCCHHHHH
Confidence 12234457999999877776655 999999999999999 8899987654332 22333222 22223346889999
Q ss_pred HHHHhhhhCCCCcccccccchh
Q 022401 257 LISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~ 278 (298)
++.+||+.||.+|||+.+++..
T Consensus 233 li~~c~~~~p~~Rps~~~l~~~ 254 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLRA 254 (256)
T ss_pred HHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=284.98 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=207.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
+...+|++.+.||+|++|.||++....+++.+++|.+..+......+.+|+.++++++|+|++++++++..+..+++++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 45578999999999999999999999889999999988765556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|+++++|.+++... ..++...++.++.|++.++.+||++|++|+||+|+||++++++. ++|+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 160 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceee
Confidence 99999999998653 35889999999999999999999999999999999999988877 999999988644332211
Q ss_pred C--CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 178 K--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 178 ~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
. ....+..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+ ....+.. ......+..+|.++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~ 234 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEK-GYRMERPEGCPPKV 234 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHC-CCCCCCCCCCCHHH
Confidence 1 1223457999999877777665 999999999999998 889987654322 2222222 22333445578999
Q ss_pred HHHHHHhhhhCCCCcccccccchh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.+++.+||+.||.+|||+.+++.+
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHH
Confidence 999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=292.09 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=198.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEcc----------------CCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeee
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKV----------------TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR 83 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~----------------~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~ 83 (298)
.++|++.+.||+|+||.||++.+.. ++..||+|.+..... ....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999997532 344799998876432 2356889999999999999999
Q ss_pred eeEEEEeCCeEEEEEeccCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEec
Q 022401 84 FKEVILTPTHLAIVMEYASGGELFERICNAG-------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144 (298)
Q Consensus 84 ~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~-------------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~d 144 (298)
+++++.+.+..++++||+.+++|.+++.... .++...++.++.|++.||.|||+.|++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 9999999999999999999999999885432 356778999999999999999999999999
Q ss_pred CCCCceEeeCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh--CCC
Q 022401 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGY 219 (298)
Q Consensus 145 l~p~nilv~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~ 219 (298)
|||+||+++.++. ++|+|||++....... ......++..|+|||.+....++.+ +||||||+++|+|++ +..
T Consensus 164 lkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 164 LATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCC
Confidence 9999999998877 9999999886432221 1223344678999999877777665 999999999999986 567
Q ss_pred CCCCCCCchhHHHHHHHHhhc--CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 220 PFEDPDEPKDFRKTIQRILSV--QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 220 pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
||................... ......+..+|..+.+++.+||+.||.+|||+.++..
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 887755433322222211111 1112223457899999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=289.43 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=209.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
++|++.+.||.|++|.||.+.+..++..+++|++.... ...+.+.+|+.++++++|||++++++++..+...++|+||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 57999999999999999999998889999999987543 23356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCC
Q 022401 102 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (298)
Q Consensus 102 ~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 179 (298)
++++|.+++... ..+++..+..++.|++.++.|||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccce
Confidence 999999998764 46899999999999999999999999999999999999998887 9999999875432222 2223
Q ss_pred CCCCCcccCcccccc-----ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-CCCCCCCCCCHH
Q 022401 180 TVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVPDTNPISQE 253 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 253 (298)
..+++.|+|||.+.. ..++. ++|+||||+++|+|++|..||....... ....+.... .....+..++.+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~-~sDi~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDY-KADIWSLGITLIELAQMEPPHHELNPMR----VLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCc-cccHHHHHHHHHHHHhCCCCcccCCHHH----HHHHHhcCCCCCcCCcccCCHH
Confidence 457788999998753 22333 4999999999999999999998754322 222232222 233334457899
Q ss_pred HHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+.+++.+||+.||.+||++ .++++|||+.+..
T Consensus 238 ~~~li~~~l~~~p~~Rps~--------~~il~~~~~~~~~ 269 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTA--------AELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHHhccChhhCcCH--------HHHhcChhhcccc
Confidence 9999999999999999987 5666889987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=281.93 Aligned_cols=250 Identities=26% Similarity=0.468 Sum_probs=203.7
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEe-CCeEEEEEe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 99 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~~ 99 (298)
+|++.+.||.|++|.||.+.+..+++.+++|.+.... ...+.+.+|++++++++|+|++++.+.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4999999999999999999999889999999987543 233567889999999999999999998764 446899999
Q ss_pred ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CC
Q 022401 100 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (298)
Q Consensus 100 ~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~ 176 (298)
++++++|.+.+.. ...+++.+++.++.+++.++++||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence 9999999998865 345899999999999999999999999999999999999998887 999999988644322 22
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....+++.|+|||.+.+..++.+ +|+||+|++++++++|..||...+.. .....+..+... +.....++++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMN----SLVYRIIEGKLP-PMPKDYSPELGE 232 (257)
T ss_pred cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhcCCC-CCccccCHHHHH
Confidence 233457888999999888777665 99999999999999999999765432 222233333221 223447899999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
++.+||+.||++|||+ .+++.|||+
T Consensus 233 li~~~l~~~p~~Rp~~--------~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSV--------KSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCH--------HHHhcCCCC
Confidence 9999999999999987 555577775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=300.24 Aligned_cols=255 Identities=21% Similarity=0.307 Sum_probs=202.5
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEc--cCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
...+|++++.||.|+||.||++... .++..+++|.+... ....+|+.++++++||||+++++++.....+|+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3567999999999999999999764 35678999987653 23467999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-- 176 (298)
+++. ++|.+++.....+++.+++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++........
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCcccccc
Confidence 9995 578888877788999999999999999999999999999999999999998887 99999999864433221
Q ss_pred -CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc---hhHHHHHHHHhhcCCC---------
Q 022401 177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQYS--------- 243 (298)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~--------- 243 (298)
.....+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.... ..+....+.+......
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 123458899999999988777666 99999999999999999999765432 2222222211111100
Q ss_pred ----------------CC---CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 244 ----------------VP---DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 244 ----------------~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+ ....++.++.++|++||..||++|||+ .+++.|||+..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa--------~e~l~~p~f~~ 380 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA--------QDILSLPLFTK 380 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH--------HHHhhCchhhc
Confidence 00 012356789999999999999999987 56668888874
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=286.58 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=206.3
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC------e
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT------H 93 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~ 93 (298)
..++|++.+.||+|++|.||.+.+..+++.+++|++.......+.+.+|+.+++++ .|+|++++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 35799999999999999999999988889999999987776667889999999999 6999999999997644 4
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 94 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~ 161 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSA 161 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccce
Confidence 8999999999999988764 357899999999999999999999999999999999999998877 9999999876
Q ss_pred cccCC-CCCCCCCCCCcccCcccccccc----CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-CCC
Q 022401 170 SSVLH-SQPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYS 243 (298)
Q Consensus 170 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~ 243 (298)
..... .......++..|+|||.+.... ....++||||||++++++++|..||.......... .+... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~ 237 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF----KIPRNPPPT 237 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH----HhhccCCCC
Confidence 43222 2223445788899999875322 12334999999999999999999997654322222 22222 222
Q ss_pred CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 244 VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 244 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
......+++++.+++.+||..||.+|||+ .+++.|||+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~--------~~ll~~~~~ 275 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFM--------EELLEHPFI 275 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCH--------HHHhcCCCC
Confidence 33333478899999999999999999987 566678885
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=281.89 Aligned_cols=252 Identities=32% Similarity=0.475 Sum_probs=213.2
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CeEEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 98 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 98 (298)
+|++.+.||+|++|.||.+.+..+++.+++|++.... ...+.+.+|+..+++++|+|++++++.+.+. ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5889999999999999999999889999999987654 3456788999999999999999999999988 8999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-- 176 (298)
|++++++|.+++.....+++..++.++.+++.++.|||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccc
Confidence 99999999999988889999999999999999999999999999999999999998776 99999998875555443
Q ss_pred -CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
.....++..|++||.......+.+ +|+||||++++++++|..||...... ......+.........+...++++.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNP---MAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHhccccCCCcCCCcccCHHHH
Confidence 345567889999999877776555 99999999999999999999886622 2222333322223333445689999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+++.+||+.||.+||++ .++++|||+
T Consensus 235 ~~i~~~l~~~p~~Rp~~--------~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTA--------DELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCH--------HHHhhCCCC
Confidence 99999999999999977 666688885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=289.82 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=205.9
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
++|++++.||+|++|.||++++..++..+|+|.+.... .....+.+|+.++++++|+|++++++++..++.+++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47999999999999999999999899999999886532 2245688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 101 ~~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
+++++|..++... ..+++..+..++.+++.|+.|||+ .|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVAS-L 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccCC-c
Confidence 9999998888663 368999999999999999999996 59999999999999998776 999999987643222 2
Q ss_pred CCCCCCCCcccCccccccccC-----CCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 177 PKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
.....++..|+|||.+.+... ...++|+||+|+++|++++|..||....... .......+...... ..+..++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~ 235 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQLSAIVDGDPP-TLPSGYS 235 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHHHHHhhcCCC-CCCcccC
Confidence 233456778999998755432 2345999999999999999999997654322 22333333333221 2233478
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.++.+++.+||+.+|.+||++ .++++|||+..
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~--------~~l~~~~~~~~ 267 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTY--------AQLLEHPWLVK 267 (286)
T ss_pred HHHHHHHHHHcccCcccCCCH--------HHHhcChhhhh
Confidence 999999999999999999987 45557777653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=287.50 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=205.5
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC-----CeEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP-----THLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~ 95 (298)
.++|++.+.||+|++|.||++....+++.+++|.+.........+.+|+.+++++ +|||++++++++... ..++
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 5789999999999999999999998999999999876655567778899999998 799999999998753 3689
Q ss_pred EEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 96 IVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
+|+||+++++|.+++. ....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~ 178 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQL 178 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhc
Confidence 9999999999998875 3456899999999999999999999999999999999999998877 999999987643
Q ss_pred cCCC-CCCCCCCCCcccCccccccccC----CCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh-hcCCCCC
Q 022401 172 VLHS-QPKSTVGTPAYIAPEVLLRHEY----DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL-SVQYSVP 245 (298)
Q Consensus 172 ~~~~-~~~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~ 245 (298)
.... ......++..|+|||.+..... ...++|+||+|+++|+|++|..||.......... ++. .......
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~ 254 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF----KIPRNPPPTLL 254 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH----HHhcCCCCCCC
Confidence 3222 2233456788999998754321 2344999999999999999999998755432222 222 2222233
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
....++.++.++|.+||+.||++||++ .++++|||++
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~--------~~il~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSV--------THLLEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCH--------HHHhcCcccC
Confidence 344467899999999999999999987 6666888874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=288.86 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=204.4
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEe------CCe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PTH 93 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~ 93 (298)
..+.|++.+.||.|+||.||++++..+++.+++|++.........+..|+.+++++ +|+|++++++++.. ...
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 44789999999999999999999998999999999887665566788899999988 69999999999853 457
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 94 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
+++++||+.+++|.+++... ..+++..++.++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~ 171 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 171 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhh
Confidence 89999999999999988653 35788889999999999999999999999999999999998887 999999987643
Q ss_pred cCC-CCCCCCCCCCcccCcccccc-----ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 172 VLH-SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 172 ~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
... .......+++.|+|||.+.. ..++.+ +|+||||+++|+|++|..||......... ..+........
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~ 246 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRNPPPKL 246 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHHHHhCCCCccccCHHhhh----hhHhhCCCCCC
Confidence 322 22234457888999998753 234444 99999999999999999999765432221 11222222222
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
....++.++.++|.+||+.||.+|||+ .+++.|||+
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~--------~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPST--------EQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCH--------HHHhcCCCC
Confidence 233578999999999999999999987 555678885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=284.41 Aligned_cols=250 Identities=27% Similarity=0.400 Sum_probs=204.0
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
+|++.+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++++++|+|++++.+++.+...+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999874 678899998865321 12457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC---
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 173 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~--- 173 (298)
++||+++++|.+++....++++..+..++.|++.++++||+.+++|+||+|+||++++++. ++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence 9999999999999988788899999999999999999999999999999999999998877 99999998764321
Q ss_pred ----CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-CCCCCCCC
Q 022401 174 ----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTN 248 (298)
Q Consensus 174 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 248 (298)
........++..|+|||.+.+..++.+ +|+||||++++++++|..||...+..... ..+... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~ 232 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAM----FYIGAHRGLMPRLPD 232 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHH----HHhhhccCCCCCCCC
Confidence 111123457788999999887777665 99999999999999999999765432221 111111 11122334
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.++.++.+++.+||+.+|.+||++ .++++|||+
T Consensus 233 ~~~~~~~~~i~~~l~~~p~~Rp~~--------~~~l~~~~~ 265 (265)
T cd06631 233 SFSAAAIDFVTSCLTRDQHERPSA--------LQLLRHDFL 265 (265)
T ss_pred CCCHHHHHHHHHHhcCCcccCCCH--------HHHhcCCCC
Confidence 578999999999999999999987 566678885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=287.90 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=204.5
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
-|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 4789999999999999999999889999999886543 334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCCC
Q 022401 103 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 180 (298)
Q Consensus 103 ~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~~ 180 (298)
+++|...+.. ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... ......
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEccccccccccccccccccc
Confidence 9999888754 457899999999999999999999999999999999999998887 999999987643222 222334
Q ss_pred CCCCcccCcccccc-----ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 181 VGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 181 ~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
.++..|+|||.+.. ..++ .++|+||+|+++|+|++|..||...+..... .............+..++.++.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVL---LKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred cccccccCHhhccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHH---HHHhhcCCCCCCCccccCHHHH
Confidence 57888999998742 2333 3499999999999999999999875432221 1111222223334445789999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
+++.+||+.||.+||++ .++++|||+.
T Consensus 240 ~li~~~l~~~p~~Rp~~--------~~il~~~~~~ 266 (282)
T cd06643 240 DFLKKCLEKNVDARWTT--------TQLLQHPFVT 266 (282)
T ss_pred HHHHHHccCChhhCcCH--------HHHhcCCCEe
Confidence 99999999999999987 4555777765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=282.67 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=217.5
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc-hHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEeccCCCC
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGE 105 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~~s 105 (298)
.+.||+|+++.|-.+....++..||||++.+.... ..++.+|++++.+. .|+||+.++++|+++..+|+|||-+.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 36799999999999999999999999999887544 46788999999888 59999999999999999999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-CCCCCEEEeecCccccccCCC--------C
Q 022401 106 LFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS--------Q 176 (298)
Q Consensus 106 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~~~~~~~--------~ 176 (298)
|.+.+.+...+++.+..++.++|+.||++||++||.||||||+|||... +.-..+||+||++........ .
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 9999999999999999999999999999999999999999999999953 334459999999875332221 1
Q ss_pred CCCCCCCCcccCccccc----cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch-----------hHHHHHHHHhhcC
Q 022401 177 PKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------DFRKTIQRILSVQ 241 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~~~~ 241 (298)
..+..|+..|||||+.. ...++.+++|.||||+++|-|+.|..||.+....+ .-.++...|+.+.
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 13345777899999753 34566777999999999999999999998765432 4567888889998
Q ss_pred CCCCCC--CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 242 YSVPDT--NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 242 ~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+..|.. ..++.+..++++.+|..|+.+|.++ ..+++|||++.
T Consensus 323 YeFPdkdWahIS~eakdlisnLlvrda~~rlsa--------~~vlnhPw~~~ 366 (463)
T KOG0607|consen 323 YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA--------AQVLNHPWVQR 366 (463)
T ss_pred CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh--------hhccCCccccc
Confidence 887753 4689999999999999999999966 77778999874
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=289.56 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=204.3
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCC-----cEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTK-----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
..++|++.+.||+|++|.||.+.....+ ..+++|.+.... .....+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 4468999999999999999999976544 679999876433 234568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC
Q 022401 94 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~ 157 (298)
.++++||+++++|.+++... ..++...++.++.|++.||.|||++|++|+||+|+||++++++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 99999999999999998654 34788899999999999999999999999999999999998877
Q ss_pred CCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 022401 158 PRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKT 233 (298)
Q Consensus 158 ~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~ 233 (298)
++|+|||++....... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...... +.
T Consensus 163 --~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~----~~ 235 (283)
T cd05048 163 --VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQ----EV 235 (283)
T ss_pred --EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHH----HH
Confidence 9999999886432221 1223345678999999877777665 999999999999998 99999875542 22
Q ss_pred HHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 234 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
...+.... ..+.+..+|+++.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33333322 223345689999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=289.09 Aligned_cols=258 Identities=23% Similarity=0.405 Sum_probs=209.9
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
..++|++.+.||+|++|.||++.+..+++.+++|++.... .....+.+|+++++.++|||++++++++.....+++|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4578999999999999999999999889999999876543 33467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
||+++++|.+++...+.++...+..++.+++.++.|||+ .+++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~~-~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELINS-IA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhhh-cc
Confidence 999999999999888889999999999999999999997 68999999999999998876 999999987643222 12
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc-------hhHHHHHHHHhhcCCCCCCCCCC
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------KDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
....++..|+|||.+.+..++.+ +|+||+|+++|++++|..||...... ..+......+.............
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238 (284)
T ss_pred CccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence 23467889999999877766666 99999999999999999999865432 11122333333322211112236
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
+.++.+|+.+||+.||.+|||+.+ ++.|||+.
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e--------~~~~~~~~ 270 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQ--------LCAMPPFI 270 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHH--------HhcCcccc
Confidence 889999999999999999998854 45666664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=280.27 Aligned_cols=246 Identities=30% Similarity=0.481 Sum_probs=205.6
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++++.||.|++|.||.+++..++..+++|.+... ......+.+|+.++++++|+|++++++++.+...+++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 599999999999999999999999999999987653 33345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CC
Q 022401 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~ 177 (298)
+++++|.+.+... ..++..++..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence 9999999999765 46899999999999999999999999999999999999998887 9999999886443332 22
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|.|||.+.+..++.+ +|+||+|+++++|++|..||..... .+....+..+.... .....+.++.++
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNP----LNLVVKIVQGNYTP-VVSVYSSELISL 232 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCCC-CccccCHHHHHH
Confidence 34457889999999877776555 9999999999999999999976543 23333333333332 234578999999
Q ss_pred HHHhhhhCCCCcccccccch
Q 022401 258 ISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~ 277 (298)
+.+||..||.+||++.++++
T Consensus 233 i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred HHHHcccCcccCCCHHHHhh
Confidence 99999999999998855553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=295.14 Aligned_cols=266 Identities=27% Similarity=0.363 Sum_probs=236.0
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
....+.|+..++||.||||.||.++.+.+|+.||+|.+.+. ........+|..++.+++.+.||.+-..++....+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 34557899999999999999999999999999999987653 23334567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 95 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
|+|+..|+||+|.-++.+-+ .+++..+..++.+|+.||++||+.+||+||+||+|||+|++|+ ++|+|+|+|....
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~ 338 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIP 338 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecC
Confidence 99999999999998887765 7999999999999999999999999999999999999999999 9999999999888
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
.........||..|||||++.+..|+.. .|.|||||++|+|+.|+.||....+.....++.+++.+....++ ...++
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS~ 415 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFSE 415 (591)
T ss_pred CCCccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccCH
Confidence 7777777799999999999999998777 99999999999999999999998776666677777777666666 44899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+..++.+.+|++||.+|.....- -...+-+|||+.+.
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~---ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGE---GAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCc---CcchhhhCcccccC
Confidence 99999999999999999987644 46788899999873
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=284.57 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=204.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++++..+++.+++|.+... ......+.+|+.++++++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 6899999999999999999999989999999987542 233345788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 99 ~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
||+++++|.+++.. ...+++..+..++.+++.|+.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence 99999999888753 345789999999999999999999999999999999999998887 999999987643322
Q ss_pred CC-CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 175 SQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 175 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
.. .....+++.|+|||.+.+...+.+ +|+||+|+++|++++|..||...... .......+.............+..
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEK 236 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCHH
Confidence 21 123457788999999887777665 99999999999999999998654321 122333333322221222346789
Q ss_pred HHHHHHHhhhhCCCCcccccccchh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=312.37 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=219.1
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC-CcchHHHHHHHHHHhcCC-CCCeeeeeEE-EEe---C--
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLR-HPNIVRFKEV-ILT---P-- 91 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~---~-- 91 (298)
+...+++|.+.|.+|||+.||+|++...|..||+|+.... ......+++|+.+++.|+ |+|||.+++. ... +
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3456789999999999999999999988789999987654 344567889999999996 9999999994 221 1
Q ss_pred -CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 92 -THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 92 -~~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
-.++++||||.|+.|-+++... ..+++.++++|+.++++|+.+||... ++|||||-+|||++.+++ +||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccc
Confidence 2578999999999999999743 35999999999999999999999888 999999999999999998 9999999
Q ss_pred ccccccCCCCC----------CCCCCCCcccCcccccc--ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 022401 167 YSKSSVLHSQP----------KSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234 (298)
Q Consensus 167 ~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~ 234 (298)
.++........ -....|+.|.|||++.- +....+++|||+|||+||.|.....||......
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 98744333311 12247899999999753 223345599999999999999999999987542
Q ss_pred HHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.|+++.+.+|....+++.+.+||+.||+.||.+||++.|+++..+...--++++.+.
T Consensus 265 -aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 265 -AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred -eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 477889999998889999999999999999999999999998888777777766544
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=282.76 Aligned_cols=250 Identities=22% Similarity=0.363 Sum_probs=205.3
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.+..++|++.+.||+|++|.||++... ++..+++|.+.......+.+.+|+.++++++|+|++++++++...+..++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 345678999999999999999999875 4567999988766555678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 99 EYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
|++.+++|.+++.. ...++...+..++.+++.|++|||+.+++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEY 158 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCce
Confidence 99999999999864 345788999999999999999999999999999999999998887 99999999874432221
Q ss_pred --CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 177 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 177 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
.....++..|+|||.+....++.+ +||||||+++|+|++ |..||....... ....+.. ....+....++.+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~ 232 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSD----VMSALQR-GYRMPRMENCPDE 232 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHH----HHHHHHc-CCCCCCCCCCCHH
Confidence 112234567999999877776555 999999999999998 899997654322 2222222 2333444557899
Q ss_pred HHHHHHHhhhhCCCCcccccccch
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+.+++.+||+.||++||++.++..
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=302.59 Aligned_cols=255 Identities=19% Similarity=0.220 Sum_probs=198.0
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.....|.+.+.||+|+||.||++.+..+++.|++|... ...+.+|+.++++++|+||+++++++..++..+++++
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34568999999999999999999999899999999532 2345789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--
Q 022401 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (298)
Q Consensus 100 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-- 176 (298)
++. ++|..++... ..++..+++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++........
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTP 317 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceecccccccc
Confidence 995 5777777553 46899999999999999999999999999999999999998877 99999999864322211
Q ss_pred -CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCC-CCCCC------chhHHHHHHHHhhcCC------
Q 022401 177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDE------PKDFRKTIQRILSVQY------ 242 (298)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~~------~~~~~~~~~~~~~~~~------ 242 (298)
.....++..|+|||++.+..++.+ +|||||||++|||++|..|+ ..... ...+...++.......
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 123458899999999988777665 99999999999999987654 22211 1122222222110000
Q ss_pred -----------------------CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 243 -----------------------SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 243 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+.....++.++.+||.+||+.||.+|||+ .+++.|||+++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa--------~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA--------AELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH--------HHHhhCcccCC
Confidence 001111345689999999999999999987 56668888864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=281.17 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=204.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
+..++|++.+.||+|++|.||++.... ++.+++|.+.........+.+|+.++++++|||++++++++...+..++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 456789999999999999999998764 5679999987665556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
++.+++|.+++.... .++...+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYE 159 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCccc
Confidence 999999999987654 6899999999999999999999999999999999999998887 999999988644322111
Q ss_pred CC--CCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 178 KS--TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 178 ~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
.. ......|+|||...+..++.+ +|+||||++++++++ |..||........ ...+. .....+.....+.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~ 233 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEV----LQQVD-QGYRMPCPPGCPKEL 233 (261)
T ss_pred ccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHH-cCCCCCCCCcCCHHH
Confidence 11 112357999999877777666 999999999999999 9999976553222 22222 222333444578999
Q ss_pred HHHHHHhhhhCCCCcccccccch
Q 022401 255 RDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
.+++.+||+.||.+||++.+++.
T Consensus 234 ~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 234 YDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=295.01 Aligned_cols=258 Identities=36% Similarity=0.664 Sum_probs=226.1
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
+.+-|.+.+.||+|-|.+|.+|++.-+|..||||++.+... ....+.+|+..++-++||||++++++.-....+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 34679999999999999999999999999999999987532 235678999999999999999999999888899999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe-eCCCCCCEEEeecCccccccCCC
Q 022401 98 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv-~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
.|.-++|+|.+++-.. ..+++....+++.||+.||.|+|+..+|||||||+||.+ ..-|- +||.|||++-...+..
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGl--VKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGL--VKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCc--eEeeeccccccCCCcc
Confidence 9999999999998544 358999999999999999999999999999999999866 55565 9999999998777777
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
.....+|+..|.|||++.+..|+.++.||||||+++|-+++|+.||+..++.+ .+..|+...+..|.. ++.+.+
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----TLTmImDCKYtvPsh--vS~eCr 247 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----TLTMIMDCKYTVPSH--VSKECR 247 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----hhhhhhcccccCchh--hhHHHH
Confidence 77888999999999999999999999999999999999999999999988854 445566666665544 899999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
+||..||..||.+|.+.. .+-.|+|++..+.
T Consensus 248 dLI~sMLvRdPkkRAslE--------eI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 248 DLIQSMLVRDPKKRASLE--------EIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHhcCchhhccHH--------HHhccccccCCCC
Confidence 999999999999999774 4557888886554
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=281.97 Aligned_cols=248 Identities=32% Similarity=0.500 Sum_probs=206.0
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
+|++.+.||.|++|.||.+++..++..+++|.+... ....+.+.+|+.++++++|+|++++.+.+.++..++++++|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 589999999999999999999999999999988643 233466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-CC
Q 022401 102 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 178 (298)
Q Consensus 102 ~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-~~ 178 (298)
++++|.+.+.. ...+++..++.++.+++.|+.+||++|++|+||+|+||++++++. ++++|||.+........ ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence 99999988864 345789999999999999999999999999999999999998877 99999998864433222 22
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
...++..|+|||.+.+..++.+ +|+||+|+++|+|++|..||...+. ......+...... +.+..++.++.+++
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSW----KNLILKVCQGSYK-PLPSHYSYELRSLI 232 (255)
T ss_pred cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCH----HHHHHHHhcCCCC-CCCcccCHHHHHHH
Confidence 3457788999999877776555 9999999999999999999986543 2223333333322 23345789999999
Q ss_pred HHhhhhCCCCcccccccchhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.+||+.||.+|||+.+++...
T Consensus 233 ~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 233 KQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHhCCcccCCCHHHHhhcc
Confidence 999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=290.31 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=201.0
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcE--EEEEEeecC--CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~--~aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (298)
+..++|++.+.||+|+||.||+|.++.++.. +++|..... ......+.+|+.++.++ +|+|++++++++..++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 4557899999999999999999998776654 466665432 22335678899999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC
Q 022401 95 AIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~ 158 (298)
++++||+++++|.+++.... .++..+++.++.|++.|++|||++|++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~- 162 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 162 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc-
Confidence 99999999999999986432 4788999999999999999999999999999999999998876
Q ss_pred CEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 022401 159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 237 (298)
Q Consensus 159 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~ 237 (298)
++|+|||++..............+..|+|||...+..++.+ +||||||++++++++ |..||......+. ...+
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~~ 236 (303)
T cd05088 163 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YEKL 236 (303)
T ss_pred -EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHH----HHHH
Confidence 99999998763322222222334567999998876666555 999999999999998 9999976554322 2222
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
........+...+.++.+++.+||+.+|.+||++.+++.+.
T Consensus 237 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 237 -PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred -hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 22222233344789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=280.83 Aligned_cols=251 Identities=30% Similarity=0.453 Sum_probs=203.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CeE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 94 (298)
.+|++.+.||+|++|.||.+.+..+++.|++|.+.... .....+.+|+.++++++|||++++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999899999999876432 1234677899999999999999999998764 568
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++++||+++++|.+++.....+++..+..++.+++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence 899999999999999988778899999999999999999999999999999999999998887 999999987643221
Q ss_pred ----CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 175 ----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 175 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
.......++..|+|||.+.+...+.+ +|+||||+++|++++|..||....... ...+..........+...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMA----AIFKIATQPTNPVLPPHV 234 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHH----HHHHHhcCCCCCCCchhh
Confidence 11122346778999999877766555 999999999999999999997654322 222222222222233446
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+..+.+++++|+ .+|.+||++ .++++|||+
T Consensus 235 ~~~~~~~i~~~l-~~p~~Rp~~--------~~il~~~~~ 264 (265)
T cd06652 235 SDHCRDFLKRIF-VEAKLRPSA--------DELLRHTFV 264 (265)
T ss_pred CHHHHHHHHHHh-cChhhCCCH--------HHHhcCccc
Confidence 788999999999 599999987 666688886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=299.48 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=199.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------C
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 92 (298)
.++|++++.||.|+||.||++.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 478999999999999999999999899999999987532 2234567899999999999999999987543 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
..+++++++ +++|.+.+. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~ 169 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQAD 169 (343)
T ss_pred cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecC
Confidence 578999988 678887764 456899999999999999999999999999999999999998887 9999999987543
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-----------
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------- 241 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 241 (298)
. ......++..|+|||.+.+......++||||||+++|+|++|..||...+..+.+...........
T Consensus 170 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred C--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 2 223345788999999987754445559999999999999999999987554333322221110000
Q ss_pred --------CCCC------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 242 --------YSVP------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 242 --------~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...+ .....++.+.+||.+||+.||.+|||+. ++++|||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~--------ell~hp~~~~ 303 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS--------EALAHPYFSQ 303 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHH--------HHhcCcchhc
Confidence 0000 0113567789999999999999999884 5556777763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=288.43 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=209.0
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
-...+|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++|+|++++++++..+...++|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 34478999999999999999999998889999999987643 23456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~ 177 (298)
||+++++|.+++.+ ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCc
Confidence 99999999998854 45789999999999999999999999999999999999998887 9999999876433222 12
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||.+.+..++.+ +|+||+|+++|++++|..||...+...... ............+..+++.+.++
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchhee---eeccCCCCCCCCccccCHHHHHH
Confidence 23457788999999877766555 999999999999999999997654322111 11111222233344578999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.+||..||.+||++ .++++|||+..
T Consensus 249 i~~~l~~~p~~Rps~--------~~il~~~~~~~ 274 (297)
T cd06656 249 LNRCLEMDVDRRGSA--------KELLQHPFLKL 274 (297)
T ss_pred HHHHccCChhhCcCH--------HHHhcCchhcc
Confidence 999999999999987 45557777764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=281.46 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=202.9
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+.++|++.+.||+|++|.||.+.... +..+|+|.+.......+.+.+|+.++++++||||+++++++......++++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 45689999999999999999998764 44599998876655567789999999999999999999999988899999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--C
Q 022401 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~--~ 177 (298)
+.+++|.+++... ..+++..++.++.|++.|++|||+.|++|+||+|.||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeec
Confidence 9999999998764 36899999999999999999999999999999999999998776 99999998764322211 1
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
....++..|+|||...+..++.+ +||||||+++|+|++ |..||...+..+ ....+.... ........+.++.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~ 232 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSE----TVEKVSQGL-RLYRPHLASEKVYA 232 (256)
T ss_pred CCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHHHhcCC-CCCCCCCCCHHHHH
Confidence 11234567999999877776665 999999999999998 999998766432 222332222 22223346899999
Q ss_pred HHHHhhhhCCCCcccccccch
Q 022401 257 LISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~ 277 (298)
++.+||+.||.+||++.+++.
T Consensus 233 li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 233 IMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=288.09 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=204.4
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++.+.||+|++|.||++.+..+++.+|+|.+..... ..+.+.+|+.+++.++|||++++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 479999999999999999999988899999998765322 34567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-CC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-~~ 178 (298)
|+++++|..+......++...++.++.|++.++.|||+.|++|+||+|+||++++++. ++|+|||++........ ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence 9999988887776667899999999999999999999999999999999999998887 99999998764333221 12
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------CCC
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------QYS 243 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~ 243 (298)
...++..|+|||.+.+......++||||||+++++|++|..||......+............ ...
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 33467789999998765544455999999999999999999997655433222222111000 000
Q ss_pred CC----------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 244 VP----------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 244 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.+ ....++..+.+++.+||+.||.+||++ .+++.|||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~--------~~il~~~~~ 286 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS--------SQLLHHEFF 286 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH--------HHHhcCCCC
Confidence 00 122468899999999999999999988 455577775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=285.57 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=202.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEE-----eCCeE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----TPTHL 94 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~ 94 (298)
..++|++.+.||+|++|.||++.+..+++.+++|++.........+.+|+.+++++ +|||++++++++. .+..+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 55799999999999999999999998999999998876555556788899999999 6999999999874 34578
Q ss_pred EEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 95 AIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
++++||+++++|.+++. ....+++..++.++.+++.|+.|||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~ 173 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQ 173 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceee
Confidence 99999999999988774 2346888999999999999999999999999999999999998887 99999998864
Q ss_pred ccCCC-CCCCCCCCCcccCccccccc-----cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCC
Q 022401 171 SVLHS-QPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244 (298)
Q Consensus 171 ~~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
..... ......++..|+|||.+... .++. ++|+||+|+++|+|++|..||........... .........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~ 249 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDA-RCDVWSLGITAIELGDGDPPLADLHPMRALFK---IPRNPPPTL 249 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccc-hhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh---ccccCCCcc
Confidence 43222 22344578899999987532 2334 49999999999999999999987543222211 111111222
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 245 PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 245 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
..+..++.++.+++.+||+.||++|||+. ++++|||+
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~--------ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVS--------DLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHH--------HHhhcccC
Confidence 23344678999999999999999999884 45567764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=280.24 Aligned_cols=250 Identities=28% Similarity=0.518 Sum_probs=206.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||+|+||.+|.+++..+++.+++|.+... ......+.+|+.++++++|||++++.+++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 699999999999999999999989999999998753 23335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-C
Q 022401 101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-~ 177 (298)
+.+++|.+.+.... .+++.++..++.|++.++.+||++|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence 99999999886543 5789999999999999999999999999999999999988877 99999998864433221 1
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||.+.+...+.+ +|+||+|++++++++|..||...+.. .....+..+... +.+...+.++.++
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~l 232 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMK----NLVLKIIRGSYP-PVSSHYSYDLRNL 232 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHH----HHHHHHhcCCCC-CCcccCCHHHHHH
Confidence 23346788999999877776655 99999999999999999999865432 223333333322 2334578999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
|.+||+.+|.+||++ .+++.|||+
T Consensus 233 i~~~l~~~p~~Rp~~--------~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSV--------NSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCH--------HHHhhCcCC
Confidence 999999999999987 555578875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=285.85 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=197.9
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc--hHHHHHHHHHHhcCC-CCCeeeeeEEEEeC--CeEEEEEe
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVME 99 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~~ 99 (298)
|++.+.||+|++|.||++.+..+++.+++|.+...... .....+|+..++++. |+|++++++++.++ +.+++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 78899999999999999999989999999988654222 223456888888885 99999999999987 88999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
|+.+ ++.+.+.. ...+++.++..++.|++.||+|||+.|++|+||+|+||+++. +. ++|+|||++..........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI--LKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC--eEEEecccccccccCCCcC
Confidence 9975 77777755 457899999999999999999999999999999999999998 55 9999999987554433333
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh--------------cCCCC
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--------------VQYSV 244 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~ 244 (298)
...++..|+|||.+........++|+||+|+++|+|++|..||...+..+........... .....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 4457788999998765554455699999999999999999999876543332222111100 01111
Q ss_pred CC---------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 245 PD---------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 245 ~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+. ....+.++.++|.+||+.||++|||+ .++++|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~--------~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA--------KQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCH--------HHHhhCCCC
Confidence 11 12467999999999999999999987 566678885
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=285.63 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=205.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++.+.||+|++|.||++.+..+++.|++|.+... ......+.+|++++++++|+|++++++++..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999999988999999988653 3334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--CC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--~~ 177 (298)
|++++++.........+++..++.++.+++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence 9998777766666677999999999999999999999999999999999999998877 9999999886544433 22
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC------------C---
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------Y--- 242 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~--- 242 (298)
....++..|+|||.+.+....+.++|+||+|+++|++++|..||...+..+.+........... .
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 3345678899999988773334459999999999999999999987654433222211110000 0
Q ss_pred CC-----------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 243 SV-----------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 243 ~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.. .....++.++.+|+.+||+.||.+|||+ .+++.|||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--------~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC--------DELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH--------HHHhcCCCC
Confidence 00 0112248899999999999999999987 455567764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=285.67 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=203.1
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||.|++|.||++.+..++..+++|.+..... ....+.+|+.++++++|||++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48999999999999999999998999999998865432 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CC
Q 022401 101 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (298)
Q Consensus 101 ~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~ 177 (298)
+. ++|..++.. ...+++..+..++.+++.|++|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence 96 578888754 346899999999999999999999999999999999999998887 9999999876433221 12
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC--------------CC
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------YS 243 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~ 243 (298)
....++..|+|||.+.+......++|+||||+++|++++|..||...+..+............. ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2334577899999887766545569999999999999999999987665444333332211100 00
Q ss_pred CC---------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 244 VP---------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 244 ~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.+ ....++.++.++|.+||+.||.+|||+ .+++.|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--------~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA--------KAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH--------HHHhcCCCC
Confidence 00 012367899999999999999999988 555578885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.22 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=204.9
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .....+.+|+.++++++|||++++++++.+...+++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999999899999999886542 223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-C
Q 022401 100 YASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~ 176 (298)
|+++ +|.+.+..... .++..++.++.|++.||+|||++|++|+||+|+||+++.++. .++|+|||++....... .
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence 9965 77777755443 578889999999999999999999999999999999985443 38999999886443222 1
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC--------------
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-------------- 242 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 242 (298)
.....+++.|+|||.+.+......++|+||+|+++|++++|..||......+...+..........
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 223346788999998876554455599999999999999999999876544333332221111000
Q ss_pred ---CCC------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 243 ---SVP------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 243 ---~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
... .....++++.+++.+||+.||++||++ .++++|||+.+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~--------~~~l~~~~~~~~~~ 292 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA--------RAALEHEYFKDLGD 292 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH--------HHHhcCchHhHHhc
Confidence 000 012367899999999999999999987 55567999987654
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=283.91 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=198.0
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.++|++.+.||+|++|.||.+.+..+++.+++|.+.... .....+.+|+.+++.++|+|++++.+++..+...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 368999999999999999999999889999999986543 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CC
Q 022401 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~ 177 (298)
|+. +++.+.+.. ...++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCC
Confidence 996 566666543 456788899999999999999999999999999999999998887 9999999886433222 12
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC----------------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------------- 241 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 241 (298)
....+++.|+|||.+.+......++|+||||+++|++++|..||....................
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 3334678899999987654334449999999999999999999976543211111111100000
Q ss_pred --CCC---------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 242 --YSV---------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 242 --~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
... ......+.++.+++.+|+..||.+|||+ .+++.|||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~--------~~~l~h~~~ 291 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA--------QDALLHPYF 291 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH--------HHHhcCCCC
Confidence 000 0001136789999999999999999987 555678875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=276.85 Aligned_cols=251 Identities=30% Similarity=0.479 Sum_probs=208.6
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
+|++.+.||+|++|.||.+.+..++..+++|++..... ....+.+|+.++++++|+|++++++++..+...++++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 58999999999999999999988899999999877544 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCC
Q 022401 103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181 (298)
Q Consensus 103 ~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 181 (298)
+++|.+++... ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence 99999998776 57899999999999999999999999999999999999998877 9999999887554433234556
Q ss_pred CCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHh
Q 022401 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261 (298)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 261 (298)
++..|++||.+.+...+.+ +|+||||++++++++|..||...+....... . ........+....++.++.+++.+|
T Consensus 159 ~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFK-I--ATNGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred cCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-H--HhcCCCCcCcccccCHHHHHHHHHH
Confidence 7888999999877776555 9999999999999999999987543222111 1 1122222333333589999999999
Q ss_pred hhhCCCCcccccccchhhhHHHhhhhh
Q 022401 262 FVADPAAVSIFFFPLNMSCLLLFSFVW 288 (298)
Q Consensus 262 l~~dp~~Rps~~~~l~~~~~~~~~hp~ 288 (298)
|+.||.+|||+ .++++|||
T Consensus 235 l~~~p~~R~t~--------~~~l~~~~ 253 (253)
T cd05122 235 LQKNPEKRPTA--------EQLLKHPF 253 (253)
T ss_pred ccCChhhCCCH--------HHHhcCCC
Confidence 99999999988 45556776
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=280.96 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=203.4
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+..+|++.+.||+|++|.||++.+. ++..+++|.+.........+.+|+.++++++|||++++++++...+..++|+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3457999999999999999999886 456799999876655566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC--
Q 022401 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~-- 177 (298)
+++++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceeccccccccc
Confidence 9999999998653 46899999999999999999999999999999999999998887 999999987643221111
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....+..|+|||.+.+..++.+ +|+||||+++|++++ |..||......+. ...+. .....+.+..++.++.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~ 232 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEV----VESVS-AGYRLYRPKLAPTEVYT 232 (256)
T ss_pred CCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHH----HHHHH-cCCcCCCCCCCCHHHHH
Confidence 11123357999999887777665 999999999999998 7899976544222 22222 22233344457999999
Q ss_pred HHHHhhhhCCCCcccccccchh
Q 022401 257 LISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~ 278 (298)
++.+||+.+|++|||+.++++.
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999888864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=283.09 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=198.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHH-HhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++.+.||+|+||.||++++..+|+.||+|++..... ....+..|+.. ++.++|||++++++++..+...++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999999876432 22344455554 566789999999999999999999999
Q ss_pred ccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc-CcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 100 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 100 ~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
|++ ++|.+++.. ...+++..++.++.|++.||+|||++ +++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 996 577776643 34689999999999999999999997 9999999999999998887 999999998654332
Q ss_pred CCCCCCCCCCcccCccccccc----cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 175 SQPKSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
.......++..|+|||.+.+. .++. ++|+||+|+++|+|++|..||...... ...............+ ...+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~-~~~~ 233 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDV-KSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLP-AEKF 233 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCc-cccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHhcCCCCCC-cccc
Confidence 222334567889999987642 2334 499999999999999999999754321 1122222222222222 2247
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
|.++.+++.+||+.+|.+||++ .++++|||+....
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~--------~~il~~~~~~~~~ 268 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNY--------PELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCH--------HHHhcCchhhhcc
Confidence 8999999999999999999988 5555777776543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=284.52 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=200.1
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.++|++.+.||+|++|.||++.++.+++.|++|.+..... ....+.+|+.++++++|+||+++++++.++...++|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 4789999999999999999999988899999999865432 22456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-C
Q 022401 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-~ 177 (298)
|+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccc
Confidence 9975 888888654 46899999999999999999999999999999999999998887 99999998764332211 1
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC----------------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------------- 241 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 241 (298)
....++..|+|||.+.+......++||||+|+++|+|++|..||..............+.....
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 2234577899999987655444559999999999999999999976553222111111111100
Q ss_pred --CCC-------CCCCCCC--HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 242 --YSV-------PDTNPIS--QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 242 --~~~-------~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
... .....++ .++.+++.+||+.||.+|||+ .++++|||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~--------~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA--------AEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH--------HHHhcCCCC
Confidence 000 0001233 788999999999999999987 455577775
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=287.19 Aligned_cols=244 Identities=31% Similarity=0.474 Sum_probs=195.3
Q ss_pred eEEeeeccCCeEEEEEEEEc----cCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 26 DFVRDIGSGNFGVARLMRDK----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 26 ~~~~~lg~g~~~~vy~~~~~----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.+.+.||.|.||.||.|... ..+..|+||.+..... ..+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57899999999999999998 4567899999965332 35778999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC---
Q 022401 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 174 (298)
Q Consensus 100 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~--- 174 (298)
|+++++|.+++... ..++...+..++.|++.||.|||+++++|++|+++||+++.++. +||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 99999999999876 67999999999999999999999999999999999999998887 999999988654211
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
...........|+|||.+....++.+ +||||||+++||+++ |..||..... ......+ ......+.+..++..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~ 233 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDN----EEIIEKL-KQGQRLPIPDNCPKD 233 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHHHH-HTTEETTSBTTSBHH
T ss_pred cccccccccccccccccccccccccc-cccccccccccccccccccccccccc----ccccccc-cccccceeccchhHH
Confidence 22233446678999999888777555 999999999999999 6789877643 2233333 222333445558999
Q ss_pred HHHHHHHhhhhCCCCcccccccch
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+.+++.+||+.||.+|||+.+++.
T Consensus 234 ~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 234 IYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHh
Confidence 999999999999999999988875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=286.82 Aligned_cols=258 Identities=30% Similarity=0.391 Sum_probs=204.4
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CeEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 95 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 95 (298)
+.++|++.+.||+|++|.||+|.+..+++.+++|.+..... ....+.+|+.++++++|||++++++++... ...+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 34689999999999999999999998899999999875432 223467899999999999999999998877 8999
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+|+||+.+ +|.+.+.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSP 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCC
Confidence 99999975 8888886544 5899999999999999999999999999999999999998887 999999988754433
Q ss_pred -CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-------------
Q 022401 175 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------- 240 (298)
Q Consensus 175 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 240 (298)
.......++..|+|||.+.+......++|+||+|+++++|++|..||......+...+........
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 222334567889999998766544455999999999999999999998766544433332221100
Q ss_pred ----C--------CCCCCCCC-CCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 241 ----Q--------YSVPDTNP-ISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 241 ----~--------~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
. .....+.. +++.+.++|.+||+.||++|||+ .++++|||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~--------~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA--------EDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH--------HHHhcCCCC
Confidence 0 00001111 47889999999999999999987 555577775
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=283.61 Aligned_cols=255 Identities=28% Similarity=0.450 Sum_probs=204.8
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC--CcchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCeEEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+.+|+.++++++ |||++++++++..+...++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588999999999999999999889999999988653 233456788999999886 999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~ 177 (298)
||+++++|.+++.. ..+++..++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCcccc
Confidence 99999999998855 47899999999999999999999999999999999999998776 9999999886443332 22
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....++..|+|||.+.+......++|+||||+++|+|++|..||....... ....+.............+.++.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR----AMMLIPKSKPPRLEDNGYSKLLREF 234 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh----hhhccccCCCCCCCcccCCHHHHHH
Confidence 334577889999998765544445999999999999999999997654321 1111111111111122368899999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+.+||+.||.+||++.++ +.|||+....
T Consensus 235 i~~~l~~~p~~R~~~~~i--------l~~~~~~~~~ 262 (277)
T cd06917 235 VAACLDEEPKERLSAEEL--------LKSKWIKAHS 262 (277)
T ss_pred HHHHcCCCcccCcCHHHH--------hhChHhhccc
Confidence 999999999999987554 5688886544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=283.95 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=205.6
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||.|++|.||++++..+++.+++|.+.... .....+.+|+.+++.++|||++++++++..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999998899999999876422 23356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 99 ~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+++.+++|.+++.. ...+++..++.++.+++.|+.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence 99999999998863 345899999999999999999999999999999999999998877 999999987644332
Q ss_pred CC-CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 175 SQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 175 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
.. .....++..|+|||.+.+..++.+ +|+||+|+++|+|++|..||...... .....+.+.............+.+
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHH
Confidence 22 223457788999999887777665 99999999999999999999764321 123333333333222223347889
Q ss_pred HHHHHHHhhhhCCCCcccccccchh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
+.+++.+||+.||.+|||+.+++++
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHHH
Confidence 9999999999999999999888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=285.68 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=204.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCcc--hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
..++|.+.+.||+|++|.||++.... ++..+++|.+...... .+.+.+|++++++++|+|++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 34679999999999999999998743 3578999998765333 4678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCC
Q 022401 94 LAIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~--------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~ 159 (298)
.++++||+++++|.+++...+ .+++..+..++.+++.++++||++|++|+||+|+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-- 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV-- 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--
Confidence 999999999999999986542 3788899999999999999999999999999999999998877
Q ss_pred EEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 022401 160 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQ 235 (298)
Q Consensus 160 ~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~ 235 (298)
++|+|||++....... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+ ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~----~~~ 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEE----VIE 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHH
Confidence 9999999886432221 1223334678999999988777665 999999999999998 999997765433 223
Q ss_pred HHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 236 RILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.+..+... .....++.++.+++.+||+.||.+||++.++++.
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 277 (280)
T cd05049 236 CITQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277 (280)
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 33333222 2234578999999999999999999999888864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=281.04 Aligned_cols=249 Identities=31% Similarity=0.427 Sum_probs=200.7
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----hHHHHHHHHH-HhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|++|.||+|.+..+++.+|+|.+.+.... ...+..|..+ ....+|+|++++++++..++.+++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 6799999999999999888999999998754221 1223344443 4455899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 183 (298)
++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... .....++
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCC
Confidence 999999988888999999999999999999999999999999999999998876 99999998764332 2334577
Q ss_pred CcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCCCCCHHHHHHHHHh
Q 022401 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDLISRI 261 (298)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 261 (298)
..|++||.+.+..++.+ +|+||+|+++|++++|..||...+... ....+.......+ ....+++++.+++.+|
T Consensus 157 ~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 157 PDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAETPDA----VFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCccChhhhcCCCCcch-hhhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 88999999877765544 999999999999999999998765432 2233333332222 2234789999999999
Q ss_pred hhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 262 FVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 262 l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
|+.||++||++..+ .+++.|||+.+.
T Consensus 232 l~~~p~~R~~~~~~-----~~~l~~~~~~~~ 257 (260)
T cd05611 232 LCMDPAKRLGANGY-----QEIKSHPFFKSI 257 (260)
T ss_pred ccCCHHHccCCCcH-----HHHHcChHhhcC
Confidence 99999999987433 568899999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=279.34 Aligned_cols=250 Identities=32% Similarity=0.501 Sum_probs=205.5
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCeEEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM 98 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 98 (298)
+|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+.++++++|+|++++++++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999899999999886532 234567789999999999999999998764 45789999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHh-----hcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 99 ~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh-----~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
||+++++|.+++.. ..++++..++.++.+++.||.+|| +.+++|+||+|+||+++.++. ++|+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence 99999999998865 457899999999999999999999 899999999999999998877 9999999887
Q ss_pred cccCCCC-CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 170 SSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 170 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
....... .....++..|+|||.+.+...+.+ +|+||||+++++|++|..||...+. ....+.+...... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~-~~~~ 232 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQ----LQLASKIKEGKFR-RIPY 232 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCH----HHHHHHHhcCCCC-CCcc
Confidence 5544332 234457889999999877776555 9999999999999999999987652 2233333333322 2334
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
..+.++.+++.+||+.+|.+||++ .++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~--------~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPST--------EELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCH--------HHHhhCCCC
Confidence 578999999999999999999988 555577875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=282.80 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=205.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 98 (298)
++|+..+.||.|++|.||.+.+..+++.+++|.+..... ....+.+|++++++++||||+++++++... ..+++|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 479999999999999999999988999999999875433 446688999999999999999999998654 4789999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 99 ~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
||+++++|.+++.. ...+++..+..++.+++.+|.|||+.|++|+||+|.||+++.++. ++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence 99999999887642 345889999999999999999999999999999999999998877 999999987644322
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc-hhHHHHHHHHhhcCC-CC----CCCC
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSVQY-SV----PDTN 248 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~-~~----~~~~ 248 (298)
.. ....++..|++||.+.+..++.+ +|+||+|+++|+|++|..||...... ....+....+..... .. ....
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred cc-ccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 22 23446778999999887777666 99999999999999999999876321 111222222222111 11 1112
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.+++++.+|+.+||..||.+|||+ .+++.|||+....
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~--------~eil~~~~~~~~~ 273 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTP--------WDMLEHPWIKAQM 273 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCH--------HHHHhCccccccc
Confidence 356889999999999999999988 5666788886443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.33 Aligned_cols=263 Identities=28% Similarity=0.411 Sum_probs=205.1
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEeC--Ce
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 93 (298)
+...++|++.+.||.|++|.||++.+..+|+.||+|.+...... .....+|+.++++++|+|++++++++... +.
T Consensus 3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 34668999999999999999999999989999999998754322 23456899999999999999999998765 56
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
+++|+||+.+ +|.+++.. ...+++.+++.++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~ 159 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYG 159 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecC
Confidence 8999999965 78877765 356899999999999999999999999999999999999998887 9999999887544
Q ss_pred CCC-CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-----------
Q 022401 173 LHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------- 240 (298)
Q Consensus 173 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 240 (298)
... ......++..|+|||.+.+......++|+||+|+++|+|++|..||...+..+.+..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 322 11223346779999998765544555999999999999999999998766544333333221100
Q ss_pred ----CCCCCC---------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 241 ----QYSVPD---------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 241 ----~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
....+. ....++++.++|.+||+.||++|||+ .+++.|||+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~--------~~il~h~~f~~~ 296 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA--------EEALESSYFKEK 296 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH--------HHHhcChhhccC
Confidence 000000 01247889999999999999999987 455578888754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=277.90 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=205.7
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.+.++|++.+.||.|++|.||.+... ++.+++|.+.........+.+|+.++++++|+|++++++++.+....++|+|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 35678999999999999999999875 7789999998765556778899999999999999999999998899999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
++++++|.+++.... .+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQD- 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccccc-
Confidence 999999999997665 6899999999999999999999999999999999999998887 99999998875532222
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.......|+|||.+....++.+ +|+||||++++++++ |..||......+ ....+.. ......+...++++.+
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPHVEK-GYRMEAPEGCPPEVYK 230 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHhc-CCCCCCccCCCHHHHH
Confidence 3334567999999877666555 999999999999997 999997764322 2222222 2222334457899999
Q ss_pred HHHHhhhhCCCCcccccccchh
Q 022401 257 LISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~ 278 (298)
++++||+.+|.+|||+.++++.
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHHHHhccChhhCcCHHHHHHH
Confidence 9999999999999999888864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=282.48 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=203.2
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
...++|++.+.||+|++|.||.+.+.. ++..+++|.+..... ....+.+|+.++++++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 345789999999999999999999976 678899998764432 2345788999999999999999999999888
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC-CCEEEee
Q 022401 93 HLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICD 164 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~-~~~~l~d 164 (298)
..++++||+.+++|.+++.... .+++..+..++.|++.|++|||+++++|+||+|+||+++.++. ..++|+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999986543 4889999999999999999999999999999999999986552 3489999
Q ss_pred cCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 022401 165 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 240 (298)
Q Consensus 165 ~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 240 (298)
||++........ .........|+|||.+.+..++.+ +||||||+++|+|++ |..||......+ ....+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~- 236 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQE----VMEFVTG- 236 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHc-
Confidence 998874422111 112223467999999987777666 999999999999997 999998755432 2222222
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 241 QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 241 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
......+..++.++.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22223344578999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=282.40 Aligned_cols=252 Identities=18% Similarity=0.279 Sum_probs=200.5
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
....++|++.+.||+|++|.||.+.+.. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3466889999999999999999998642 356799998764322 234577899999999999999999999989
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEE
Q 022401 92 THLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~----------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~ 161 (298)
...++|+||+++++|.+++.... .++...+..++.+++.||.|||+.|++|+||+|+||+++.++. ++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~ 159 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VK 159 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EE
Confidence 99999999999999999886532 3567788999999999999999999999999999999998877 99
Q ss_pred EeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 022401 162 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 237 (298)
Q Consensus 162 l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~ 237 (298)
|+|||++....... ......++..|+|||.+.+..++.+ +||||||+++|++++ |..||....... ....+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~----~~~~~ 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQ----VLRFV 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH
Confidence 99999876332211 1122344678999999887777665 999999999999998 688887655422 22222
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
..... ...+...++++.+++.+||+.||++|||+.+++.+
T Consensus 235 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22222 12234478999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=283.08 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=213.0
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
..+.|++.+.||+|++|.||.+.+..++..+++|++.......+.+.+|+..+++++|+|++++++++......++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 45679999999999999999999988899999999987655567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCC
Q 022401 101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (298)
Q Consensus 101 ~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~ 178 (298)
+++++|.+++.... .++...+..++.+++.+|.+||+.|++|+||+|+||+++.++. ++|+||+++....... ...
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhc
Confidence 99999999998876 8999999999999999999999999999999999999998887 9999999875433222 112
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
...++..|++||.+.+..++.+ +|+||||+++|++++|..||...+....... ..............++.++.+++
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFL---ITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCCCcchhhCCHHHHHHH
Confidence 3346778999999877776655 9999999999999999999986544222211 11122222333344789999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+||+.+|.+|||+ .++++|||+..
T Consensus 251 ~~~l~~~p~~Rpt~--------~~il~~~~~~~ 275 (286)
T cd06614 251 NKCLVKDPEKRPSA--------EELLQHPFLKK 275 (286)
T ss_pred HHHhccChhhCcCH--------HHHhhChHhhc
Confidence 99999999999987 55557888775
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.03 Aligned_cols=253 Identities=27% Similarity=0.357 Sum_probs=203.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++.+..+++.||+|++.... ....++.+|+.++++++|||++++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999899999999986532 22356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 99 EYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~-----------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
||++|++|.+++... ...+...++.++.|++.||+|||+.|++||||||+||+++.++. ++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCc
Confidence 999999999988532 23456778899999999999999999999999999999998887 99999999
Q ss_pred cccccCC-------------------CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch
Q 022401 168 SKSSVLH-------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (298)
Q Consensus 168 ~~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 228 (298)
+...... .......|++.|+|||.+.+..++.+ +||||+||++|+|++|..||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 8644111 01112357899999999887777655 999999999999999999997744322
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
. .................+|+.+.+++.+||+.||++|++..+.+.....
T Consensus 239 i---~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 239 I---SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred h---hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 1111111122222234578999999999999999999988776654433
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=281.48 Aligned_cols=250 Identities=32% Similarity=0.494 Sum_probs=207.7
Q ss_pred eccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 31 lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
||.|++|.||.+++..+++.+++|.+.... .....+.+|+.++++++|||++++++.+..+...+++++++.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999999889999999986543 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---------CC
Q 022401 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QP 177 (298)
Q Consensus 107 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~---------~~ 177 (298)
.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence 999988778999999999999999999999999999999999999998887 9999999876443321 11
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+...|++||.......+.+ +|+||||++++++++|..||..... ......+.......+....++.++.++
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETP----EEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 23346778999999877776555 9999999999999999999987653 233334444444444444468999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.+||+.+|.+|||+..+ .++++|||+.+.
T Consensus 234 i~~~l~~~p~~Rpt~~~~-----~~~l~~~~~~~~ 263 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSI-----EEIKNHPFFKGI 263 (265)
T ss_pred HHHHhcCCHhhcCCCccH-----HHHhcCccccCC
Confidence 999999999999998333 467789999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.79 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=187.2
Q ss_pred EeeeccCCeEEEEEEEEc--cCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCeEEEEEeccCC
Q 022401 28 VRDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 103 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~ 103 (298)
+++||+|+||.||+|++. .+++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +..++++++++.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999975 367889999886543 34567889999999999999999999864 4578999999854
Q ss_pred CCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC--CCCCEEEeecCcccccc
Q 022401 104 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 172 (298)
Q Consensus 104 ~sL~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~--~~~~~~l~d~~~~~~~~ 172 (298)
+|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.+ ....+||+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 777776422 248899999999999999999999999999999999999432 22349999999986543
Q ss_pred CCC----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc---------hhHHHHHHHHh-
Q 022401 173 LHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------KDFRKTIQRIL- 238 (298)
Q Consensus 173 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---------~~~~~~~~~~~- 238 (298)
... ......+++.|+|||.+.+....+.++||||+||++|+|++|..||...... +.+........
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence 222 1223457889999999887655455599999999999999999999754421 11111110000
Q ss_pred -----------------------hcCCCC--------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhh
Q 022401 239 -----------------------SVQYSV--------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFV 287 (298)
Q Consensus 239 -----------------------~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp 287 (298)
...... ......+.++.+||.+||+.||.+|||+ .++++||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~--------~e~l~hp 315 (317)
T cd07868 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS--------EQAMQDP 315 (317)
T ss_pred CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCH--------HHHhcCC
Confidence 000000 0001235678999999999999999988 5555788
Q ss_pred hh
Q 022401 288 WM 289 (298)
Q Consensus 288 ~~ 289 (298)
|+
T Consensus 316 ~f 317 (317)
T cd07868 316 YF 317 (317)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=291.03 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=218.7
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
-|.++++||+|++|.||+|.++.+|..+|||.+..+.. .+++.+|+.++++.+.|++++.+|.+.....+++|||||..
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 48999999999999999999999999999999887653 46778999999999999999999999999999999999999
Q ss_pred CCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc-cCCCCCCCCC
Q 022401 104 GELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV 181 (298)
Q Consensus 104 ~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~-~~~~~~~~~~ 181 (298)
||..+.+. .+.++++.++..+++..++||+|||...-+|||||..||+++.+|+ .||.|||.+... ..-.......
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCccc
Confidence 99999885 4567999999999999999999999999999999999999999998 899999987522 2223345667
Q ss_pred CCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHh
Q 022401 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261 (298)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 261 (298)
|++.|||||++..-+|++. +||||||+...||..|.+||..... .+....-....++.+..+..+++++.+||++|
T Consensus 191 GTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred cCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 9999999999999999998 9999999999999999999987442 11212122334444555566889999999999
Q ss_pred hhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 262 FVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 262 l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
|-++|++|.|+ .++++|||+.+.
T Consensus 267 LiK~PE~R~TA--------~~L~~H~FiknA 289 (502)
T KOG0574|consen 267 LIKKPEERKTA--------LRLCEHTFIKNA 289 (502)
T ss_pred hcCCHHHHHHH--------HHHhhhhhhcCC
Confidence 99999999998 888899998754
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=283.59 Aligned_cols=257 Identities=28% Similarity=0.342 Sum_probs=200.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCe-----
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTH----- 93 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 93 (298)
++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+.+++++. |||++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999998999999998765432 2356788999999995 6999999999887655
Q ss_pred EEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-CCCCCEEEeecCc
Q 022401 94 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGY 167 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-~~~~~~~l~d~~~ 167 (298)
.++++||+++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++. ++|+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeeccc
Confidence 8999999986 787777532 35799999999999999999999999999999999999987 555 99999998
Q ss_pred cccccCC-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-C--
Q 022401 168 SKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-S-- 243 (298)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-- 243 (298)
+...... .......+++.|+|||.+.+......++|+||||+++|+|++|..||...+......+....+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 7643322 22223346778999998866544445599999999999999999999876654444333322111000 0
Q ss_pred ----------C---------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 244 ----------V---------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 244 ----------~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
. .....+++++.+||.+||..||.+||++ .+++.|||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~--------~eil~~~~~~ 295 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA--------KAALTHPYFD 295 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH--------HHHhcCCCcC
Confidence 0 0012468899999999999999999987 5666788873
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=278.38 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=206.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|++|.||++....+++.+++|.+... ....+.+.+|+.++++++|+|++++++++...+..++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 6899999999999999999999989999999987632 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 99 ~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
||+++++|..++.. ...++...++.++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence 99999999988854 345889999999999999999999999999999999999998887 999999987643332
Q ss_pred C-CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 175 S-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 175 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
. ......++..|.|||.+.+..++.+ +|+||+|+++|++++|..||..... ........+.............+.+
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCChhhcCHH
Confidence 2 2233457788999999887777665 9999999999999999999865432 2223333333322221112247889
Q ss_pred HHHHHHHhhhhCCCCcccccccchhh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
+.++|.+||+.+|.+|||+.+++++.
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 99999999999999999998888643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.39 Aligned_cols=261 Identities=25% Similarity=0.353 Sum_probs=224.8
Q ss_pred CCCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCc---E-EEEEEeecC----CcchHHHHHHHHHHhcCCCCCee
Q 022401 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---L-VAVKYIERG----DKIDENVQREIINHRSLRHPNIV 82 (298)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~-~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~ 82 (298)
.|..+-++.+.-++..+.++||+|+||.||.++.+..+. . ||+|....+ ......+.+|.++++.++||||+
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 577777888888999999999999999999999875422 3 899988742 33446688999999999999999
Q ss_pred eeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEE
Q 022401 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (298)
Q Consensus 83 ~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~ 161 (298)
+++|++.++..+++|+|+|+||+|.++|...+. ++..+...++.+.+.||+|||+.+++||||-..|+|++.++. +|
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vK 302 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VK 302 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EE
Confidence 999999999999999999999999999988874 999999999999999999999999999999999999998886 89
Q ss_pred EeecCccccccCCCCCC-CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 022401 162 ICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS 239 (298)
Q Consensus 162 l~d~~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 239 (298)
++|||+++......... .......|+|||.+....++.+ +||||||+++||+++ |..||.+... .....++..
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~----~~v~~kI~~ 377 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKN----YEVKAKIVK 377 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCH----HHHHHHHHh
Confidence 99999988665333333 3346688999999998888777 999999999999998 7889988664 455666656
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 240 VQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
...+.+.+...|.++..++.+||..||++|||+.++.+.
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~ 416 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKK 416 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHH
Confidence 677777777789999999999999999999999888753
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=283.50 Aligned_cols=254 Identities=31% Similarity=0.491 Sum_probs=211.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 97 (298)
++|++.+.||+|++|.||++....++..+++|++... ......+.+|..+++++. ||||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999999989999999998753 223356778999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~- 176 (298)
++++.+++|.+.+...+.++...++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 999999999999988888999999999999999999999999999999999999998887 99999998764332221
Q ss_pred --------------------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 022401 177 --------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 236 (298)
Q Consensus 177 --------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~ 236 (298)
.....++..|+|||.......+.+ +|+||||++++++++|..||........ .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~ 233 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLT----FQK 233 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHH----HHH
Confidence 112235678999998877665554 9999999999999999999998764222 233
Q ss_pred HhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 237 ILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+...... .+..+++.+.+++.+||+.||.+|||+.+ ...++++|||+
T Consensus 234 ~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~----~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYS--FPPNFPPDAKDLIEKLLVLDPQDRLGVNE----GYDELKAHPFF 280 (280)
T ss_pred HHhcCCC--CCCccCHHHHHHHHHHhcCCHhhCCCccc----CHHHHhcCCCC
Confidence 3333333 33447899999999999999999999855 33677889986
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.63 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=199.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCc--EEEEEEeecC--CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~--~~aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 97 (298)
++|++.+.||+|+||.||++..+.++. .+++|.+... ....+.+.+|+.++.++ +||||+++++++.....++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999876654 4678876632 22335678899999999 799999999999998999999
Q ss_pred EeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEE
Q 022401 98 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~ 161 (298)
+||+++++|.+++.... .++...+..++.|++.||+|||++|++|+||+|+||+++.++. ++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence 99999999999986532 4788899999999999999999999999999999999988776 99
Q ss_pred EeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 022401 162 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 240 (298)
Q Consensus 162 l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 240 (298)
|+|||++..............+..|+|||...+..++.+ +||||||+++|+|++ |..||......+ ....+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~----~~~~~~~- 233 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAE----LYEKLPQ- 233 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhc-
Confidence 999998763322222222233457999999877776655 999999999999997 999997755422 2222222
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 241 QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 241 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
......+..++.++.+++.+||+.||.+|||+.+++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 222233445789999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=276.81 Aligned_cols=251 Identities=30% Similarity=0.468 Sum_probs=205.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC------CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CeE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 94 (298)
.+|++.+.||+|++|.||.+.+..++..+++|.+... ......+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999999989999999987542 12234678899999999999999999998764 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++++|++++++|.+.+.....+++..++.++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence 899999999999999988778999999999999999999999999999999999999998876 999999988644321
Q ss_pred C----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 175 S----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 175 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
. ......++..|+|||.+.+..++.+ +|+||||++++++++|..||....... ...+..........+..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~p~~~ 234 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMA----AIFKIATQPTKPMLPDGV 234 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHH----HHHHHHcCCCCCCCCccc
Confidence 1 1122346788999999887776555 999999999999999999998754322 222333333333344558
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
++++.+++.+||+ +|..||++ ..+++|||+
T Consensus 235 ~~~~~~~i~~~l~-~~~~r~~~--------~~~~~~~~~ 264 (264)
T cd06653 235 SDACRDFLKQIFV-EEKRRPTA--------EFLLRHPFV 264 (264)
T ss_pred CHHHHHHHHHHhc-CcccCccH--------HHHhcCCCC
Confidence 8999999999998 68999987 566678874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=281.47 Aligned_cols=253 Identities=27% Similarity=0.434 Sum_probs=205.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+.|+..+.||.|++|.||.+.+..++..+|+|.+.... .....+.+|+.+++++.|||++++++++.++..+++|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46889999999999999999998889999999887543 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 179 (298)
+++++|.+++.. .++++.++..++.+++.|+++||+.+++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence 999999998864 56899999999999999999999999999999999999998877 9999999886443322 1223
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
..++..|+|||.+.+..++.+ +|+||||+++|+|++|..||........ ...+.... ........+..+.+++.
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRV----LFLIPKNN-PPTLTGEFSKPFKEFID 234 (277)
T ss_pred ccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhH----hhhhhcCC-CCCCchhhhHHHHHHHH
Confidence 346778999999887777655 9999999999999999999986543211 11111111 11222346789999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+||+.+|.+||++ .+++.|||+...
T Consensus 235 ~~l~~~p~~Rp~~--------~~il~~~~~~~~ 259 (277)
T cd06640 235 ACLNKDPSFRPTA--------KELLKHKFIVKN 259 (277)
T ss_pred HHcccCcccCcCH--------HHHHhChHhhhc
Confidence 9999999999988 555577777643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=282.60 Aligned_cols=264 Identities=19% Similarity=0.277 Sum_probs=207.3
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
....++|++.+.||+|+||.||++..+. .+..+|+|.+..... ....+.+|+.++++++|||++++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3456899999999999999999987642 355799998764432 224567899999999999999999999988
Q ss_pred CeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEE
Q 022401 92 THLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~ 161 (298)
...++++||+++++|.+++... ...+...+..++.+++.||.|||+++++|+||+|+||+++.++. ++
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~ 159 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VK 159 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EE
Confidence 9999999999999999999642 23466788999999999999999999999999999999998876 99
Q ss_pred EeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 022401 162 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 237 (298)
Q Consensus 162 l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~ 237 (298)
|+|||++....... ......++..|+|||.+.+..++.+ +|+||||+++|++++ |..||......+ ....+
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~~~ 234 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLKFV 234 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH
Confidence 99999876432211 1122234567999999887777665 999999999999998 788987755422 22222
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.... ....+...++++.+++.+||+.||.+|||+.++++ .+.-..|||+.+.
T Consensus 235 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--~l~~~~~~~~~~~ 286 (288)
T cd05061 235 MDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN--LLKDDLHPSFPEV 286 (288)
T ss_pred HcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH--HHHhhcCCCCCCC
Confidence 2222 12223346899999999999999999999999884 3444469988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.95 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=202.5
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEEEe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 90 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (298)
.+..++|++.+.||+|+||.||.|.... +++.||+|++..... ..+.+.+|+.++.++ +|+||+++++++..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 4455799999999999999999997543 457899998875332 234567899999999 79999999998865
Q ss_pred C-CeEEEEEeccCCCCHHHHHHhC--------------------------------------------------------
Q 022401 91 P-THLAIVMEYASGGELFERICNA-------------------------------------------------------- 113 (298)
Q Consensus 91 ~-~~~~lv~~~~~~~sL~~~l~~~-------------------------------------------------------- 113 (298)
. ..++++++|+++++|.+.+...
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 5788999999999999888532
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---CCCCCCCCCc
Q 022401 114 -----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPA 185 (298)
Q Consensus 114 -----~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 185 (298)
.+++...+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++....... ......++..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCcc
Confidence 25788899999999999999999999999999999999998776 9999999987442221 1122344567
Q ss_pred ccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhh
Q 022401 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264 (298)
Q Consensus 186 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 264 (298)
|+|||++.+..++.+ +|||||||++|+|++ |..||......+.+...... ......+...++++.+++.+||+.
T Consensus 241 y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 241 WMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE----GTRMRAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred ccCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc----cCCCCCCccCCHHHHHHHHHHccC
Confidence 999999988888776 999999999999998 99999775443333322221 122223344789999999999999
Q ss_pred CCCCcccccccchhhhH
Q 022401 265 DPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 265 dp~~Rps~~~~l~~~~~ 281 (298)
+|++||++.+++++...
T Consensus 316 ~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 316 NPEDRPTFSELVEILGD 332 (337)
T ss_pred ChhhCcCHHHHHHHHHH
Confidence 99999999999876543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=281.27 Aligned_cols=250 Identities=20% Similarity=0.311 Sum_probs=200.1
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEc----cCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDK----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
+.++|++.+.||+|+||.||++... .++..+++|.+..... ....+.+|+.++++++|||++++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4478999999999999999999853 4567899998874332 224678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC
Q 022401 95 AIVMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~-----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~ 157 (298)
++++||+++++|.+++... ..++...+..++.+++.|+.|||++|++|+||+|+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 9999999999999988532 23678889999999999999999999999999999999998877
Q ss_pred CCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 022401 158 PRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKT 233 (298)
Q Consensus 158 ~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~ 233 (298)
++|+|||++....... ......++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...... ..
T Consensus 163 --~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~----~~ 235 (283)
T cd05090 163 --VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQ----EV 235 (283)
T ss_pred --EEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHH----HH
Confidence 9999999986432221 1122334567999999877776555 999999999999998 88898765431 22
Q ss_pred HHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 234 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
...+.. ....+.+..+++++.+++.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 222222 22233445579999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.08 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=208.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC-CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.++|++.+.||+|+||.||++.+..++..+++|.+... ....+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 47999999999999999999999888899999998643 33345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 179 (298)
+++++|.+++... .++..++..++.+++.|+.+||++|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccccccc
Confidence 9999999988653 5788999999999999999999999999999999999998876 9999999875333222 2223
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
..+++.|++||.+....++.+ +|+||||+++|++++|..||...+....... ..............++.++.++++
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheee---hhcCCCCCCCCccccCHHHHHHHH
Confidence 457788999999877777555 9999999999999999999976543221111 111222233334457889999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+||..+|.+||++ .+++.|||+...
T Consensus 251 ~~l~~~p~~Rp~~--------~~il~h~~~~~~ 275 (293)
T cd06647 251 RCLEMDVEKRGSA--------KELLQHPFLKIA 275 (293)
T ss_pred HHccCChhhCcCH--------HHHhcCHHHhcC
Confidence 9999999999987 566678887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=278.17 Aligned_cols=248 Identities=24% Similarity=0.448 Sum_probs=198.6
Q ss_pred CCeeEEeee--ccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDI--GSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~l--g~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++.+.+ |+|+||.||++.++.++..+++|.+........ |......+ +|||++++++++..++.+++|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 467777777 999999999999999999999999875432211 22222212 79999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
|+++++|.+++.....+++.+++.++.|++.|+.+||+.|++|+||+|+||+++.++ . ++|+|||++..... ..
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~--~~l~dfg~~~~~~~---~~ 164 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDR--IYLCDYGLCKIIGT---PS 164 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCe--EEEecCccceecCC---Cc
Confidence 999999999998887899999999999999999999999999999999999999887 5 99999998764332 22
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchh-HHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
...++..|+|||.+.+..++.+ +|+||+|+++++|++|..||........ ........ . ...+.....++.+.+|
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q--KKLPFIKNVSKNANDF 240 (267)
T ss_pred cCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c--ccCCcccccCHHHHHH
Confidence 3457889999999987777655 9999999999999999999986543321 12222222 2 2223334589999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
|.+||+.||.+||+. ..++++|||+.
T Consensus 241 i~~~l~~~p~~R~~~-------~~~~l~h~~~~ 266 (267)
T PHA03390 241 VQSMLKYNINYRLTN-------YNEIIKHPFLK 266 (267)
T ss_pred HHHHhccChhhCCch-------HHHHhcCCccc
Confidence 999999999999953 36667899975
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=278.22 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=203.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
+.++|++.+.||+|+||.||+|....+ ...+++|.+.... .....+.+|+.++++++||||+++.+++...+..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 356899999999999999999998643 4579999876543 22356788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+++|++++++|.+++... +.++...+..++.+++.|+.|||+++++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccc
Confidence 999999999999998654 46899999999999999999999999999999999999998887 999999998754311
Q ss_pred CC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 175 SQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 175 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
.. .....++..|+|||.+.+..++.+ +||||||+++|++++ |..||...... .....+.. ....+....+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~~~~ 233 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKAVED-GYRLPPPMDC 233 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHHc-CCCCCCCCCC
Confidence 11 112234567999999887777665 999999999999998 99999765432 22223222 2233344567
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
++++.+++.+||+.+|++||++.+++++.
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=278.22 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=200.7
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
...++|++.+.||+|++|.||++.+..++ .+++|.+.......+.+.+|+.++++++|||++++++.+. ....++|+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 34578999999999999999999887554 5999998865555677899999999999999999999874 456789999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-
Q 022401 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (298)
Q Consensus 100 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~- 176 (298)
++++++|.+++... ..++...+..++.+++.||++||+.+++|+||+|+||++++++. ++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT 158 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeeccccccc
Confidence 99999999999653 35788999999999999999999999999999999999998877 99999998864432221
Q ss_pred -CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
.....++..|+|||...+..++.+ +|+||||+++|++++ |..||....... ....+.. ....+....++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~l 232 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVER-GYRMPCPPECPESL 232 (262)
T ss_pred cccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHH----HHHHHhc-CCCCCCccccCHHH
Confidence 112334567999999877777655 999999999999999 788887654322 2222222 22233344578999
Q ss_pred HHHHHHhhhhCCCCcccccccch
Q 022401 255 RDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
.+++.+||+.||++||++.+++.
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 233 HDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=281.58 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=197.5
Q ss_pred CCe-eEEeeeccCCeEEEEEEE----EccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeC--Ce
Q 022401 23 DRY-DFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (298)
Q Consensus 23 ~~y-~~~~~lg~g~~~~vy~~~----~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 93 (298)
++| ++.+.||+|+||.||.+. ...++..+|+|.+..... ....+.+|+.++++++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 456 999999999999998765 335678899999875432 456778999999999999999999987653 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+++++||+++++|.+++... .+++..++.++.+++.|+.|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence 89999999999999998654 5899999999999999999999999999999999999998877 99999998864432
Q ss_pred CCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchh----------HHHHHHHHhh
Q 022401 174 HSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD----------FRKTIQRILS 239 (298)
Q Consensus 174 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~----------~~~~~~~~~~ 239 (298)
... .....++..|+|||.+.+...+.+ +||||||+++++|++|..||........ ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 221 122234567999999877776665 9999999999999999999865432100 0001111111
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 240 VQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
.....+.+...+.++.+++.+||+.||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22233334557899999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=286.53 Aligned_cols=250 Identities=21% Similarity=0.329 Sum_probs=202.1
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCc----EEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
...+|++.+.||+|+||.||++.+..++. .+|+|.+... ......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 45689999999999999999999765554 3899987643 23346788899999999999999999998765 56
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+++++++.+++|.+.+... ..++...++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccC
Confidence 7899999999999998764 35889999999999999999999999999999999999998887 99999999875433
Q ss_pred CCCC---CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 174 HSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 174 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
.... .....+..|++||.+.+..++.+ +||||||+++|++++ |..||....... ...+.......+.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~ 235 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEKGERLPQPPI 235 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHhCCCCCCCCCC
Confidence 2221 11223567999999887777665 999999999999997 999997654321 2223333444455555
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
++.++.+++.+||+.||.+||++.+++...
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l 265 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIEF 265 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=277.70 Aligned_cols=242 Identities=25% Similarity=0.362 Sum_probs=195.6
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
+.||+|+||.||.+.+..+++.+++|.+... ......+.+|++++++++||||+++++++......++|+||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4689999999999999989999999987643 23346688999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC---CCCCC
Q 022401 107 FERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 182 (298)
Q Consensus 107 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~ 182 (298)
.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence 9998654 45899999999999999999999999999999999999998876 999999987643321111 11122
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 261 (298)
...|+|||.+.+..++.+ +|+||||+++|++++ |..||........ ... .......+.....+.++.+++.+|
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~li~~~ 232 (252)
T cd05084 159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT----REA-IEQGVRLPCPELCPDAVYRLMERC 232 (252)
T ss_pred ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHH----HHH-HHcCCCCCCcccCCHHHHHHHHHH
Confidence 456999999877776665 999999999999997 8888876543221 111 112222233445789999999999
Q ss_pred hhhCCCCcccccccchh
Q 022401 262 FVADPAAVSIFFFPLNM 278 (298)
Q Consensus 262 l~~dp~~Rps~~~~l~~ 278 (298)
|+.||++|||+.+++.+
T Consensus 233 l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 233 WEYDPGQRPSFSTVHQE 249 (252)
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999888753
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=293.61 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=202.7
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccC-----CcEEEEEEeecCCc--chHHHHHHHHHHhcCC-CCCeeeeeEEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVIL 89 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 89 (298)
.....++|++++.||.|+||.||++.+... +..||+|++..... ..+.+.+|+.+++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 455678999999999999999999987432 34699999865432 2356889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhC--------------------------------------------------------
Q 022401 90 TPTHLAIVMEYASGGELFERICNA-------------------------------------------------------- 113 (298)
Q Consensus 90 ~~~~~~lv~~~~~~~sL~~~l~~~-------------------------------------------------------- 113 (298)
.....++|+||+++++|.+++...
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999998887542
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEee
Q 022401 114 ----------------------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153 (298)
Q Consensus 114 ----------------------------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~ 153 (298)
..++..++..++.|++.||+|||+.+++|+||+|+||+++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 1367778899999999999999999999999999999999
Q ss_pred CCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchh
Q 022401 154 GSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 229 (298)
Q Consensus 154 ~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~ 229 (298)
.++. ++|+|||++....... ......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||........
T Consensus 272 ~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 272 QGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred CCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 8876 9999999986432221 1122335678999999877777665 999999999999997 8899876543222
Q ss_pred HHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 230 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
+.. . .......+....++.++.+++.+||+.||++|||+.++.++.
T Consensus 349 ~~~---~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 349 FYN---K-IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred HHH---H-HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 222 2 222233344456899999999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=282.38 Aligned_cols=254 Identities=29% Similarity=0.426 Sum_probs=202.0
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
|++.+.||.|++|.||++.+..+|+.|++|++.... .....+.+|+..++.++|||++++++++.+....+++++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678999999999999999998899999999987543 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCC
Q 022401 102 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (298)
Q Consensus 102 ~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~ 178 (298)
+ ++|.+++.... .+++..++.++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccC
Confidence 5 58998887665 6899999999999999999999999999999999999998776 9999999886433222 112
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-----------------
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------------- 241 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 241 (298)
...++..|+|||.+.+......++|+||+|+++|+|++|..||...+..+...+..+......
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 334577899999876654434459999999999999999999987654333333222110000
Q ss_pred C------CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 242 Y------SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 242 ~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
. .......++.++.++|.+||+.||.+|||+. ++++|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~--------~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAK--------AALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHH--------HHhcCCCC
Confidence 0 0011234678999999999999999999884 55577775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=283.90 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=202.1
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
.+++..+.++|++.+.||+|++|.||+|.+..+++.+|+|.+..... ....+.+|+.++++++|||++++++++...
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 45667778899999999999999999999999999999998865322 223456899999999999999999998754
Q ss_pred C--------eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEE
Q 022401 92 T--------HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (298)
Q Consensus 92 ~--------~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l 162 (298)
. ..++|+||+.+ +|.+.+... ..+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl 160 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKL 160 (310)
T ss_pred cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEE
Confidence 3 45999999965 777777554 36899999999999999999999999999999999999998887 999
Q ss_pred eecCccccccCCCCC-----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 022401 163 CDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 237 (298)
Q Consensus 163 ~d~~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 237 (298)
+|||++......... ....++..|+|||.+.+......++|+||+|+++|+|++|..||...+.... ...+..+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-~~~~~~~ 239 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-LTLISQL 239 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH
Confidence 999988644332211 2234567899999887655434559999999999999999999977554322 2222222
Q ss_pred hhcCC----------------CCCC-----------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 238 LSVQY----------------SVPD-----------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 238 ~~~~~----------------~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
..... ..+. ....+..+.++|.+||..||.+|||+ .++++|||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~--------~e~l~h~~f 310 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA--------DTALNHDFF 310 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH--------HHHhcCCCC
Confidence 21100 0000 00124678899999999999999987 555578885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=280.42 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=202.9
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
+|++.+.||.|++|.||++.+..+|..+++|.+..... ..+.+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999998999999999876432 2456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CC
Q 022401 102 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (298)
Q Consensus 102 ~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~ 177 (298)
.+ +|.+++... ..+++..+..++.|++.|++|||+.|++|+||+|+||++++++. ++|+|||++....... ..
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence 75 787777543 35899999999999999999999999999999999999998887 9999999886433221 11
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC--------------CC
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------YS 243 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~ 243 (298)
....++..|++||.+.+......++|+||+|+++|++++|..||...+..+............. ..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 2334677899999887655445559999999999999999999988765544433322210000 00
Q ss_pred CCC---------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 244 VPD---------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 244 ~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.+. ....++++.+++.+||+.||.+||++ .++++|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~--------~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA--------HDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH--------HHHhcCCCC
Confidence 000 11357889999999999999999987 555577875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=281.22 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=205.1
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
..+|++.+.||.|++|.||.+.+.. +..+++|.+..... ....+.+|+.+++.++|+|++++++++.....+++++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3579999999999999999999987 78899999876544 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC-
Q 022401 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~- 177 (298)
+++++|.+++... ..++...+..++.+++.|++|||++|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLS 161 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCccccc
Confidence 9999999999753 35889999999999999999999999999999999999998887 999999988644322211
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
....++..|++||.+....++.+ +|+||||+++|++++ |..||......+.+ ..+. .....+.+...++++.+
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~ 235 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVY----DQIT-AGYRMPCPAKCPQEIYK 235 (261)
T ss_pred cCCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHH----HHHH-hCCcCCCCCCCCHHHHH
Confidence 12234567999999877766655 999999999999998 88999775543222 2222 22333445568999999
Q ss_pred HHHHhhhhCCCCcccccccch
Q 022401 257 LISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~ 277 (298)
++.+||+.||.+|||+.+++.
T Consensus 236 ~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 236 IMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=283.56 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=206.8
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCC--cchHHHHHHHHHHhcC-CCCCeeeeeEE
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEV 87 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 87 (298)
..+....++|++.+.||+|+||.||.+... .++..+|+|.+.... ...+.+.+|+.+++++ +||||++++++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 345677789999999999999999999752 345579999886543 2235688999999999 79999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 88 ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 88 ~~~~~~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
+...+..++++||+.+++|.+++.... .++..++..++.+++.||+|||+++++|+||+|+||+++.++. ++|+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCC
Confidence 999999999999999999999986543 3899999999999999999999999999999999999987776 999999
Q ss_pred CccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcC
Q 022401 166 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQ 241 (298)
Q Consensus 166 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (298)
|++........ .....++..|+|||.+.+..++.+ +||||+|+++|++++ |..||........+.+.. ...
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~----~~~ 260 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI----KEG 260 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH----HcC
Confidence 99864432221 122335678999999887777665 999999999999998 999998765543332222 222
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 242 YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.........++++.+++.+||+.+|++|||+.+++..
T Consensus 261 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 261 YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 2223334578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=313.09 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=215.8
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccC-Cc----EEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVT-KE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~-~~----~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
.+.....++.+.||+|.||.||.+..... +. .||+|.+.+. ......|.+|..+++.+.||||++++|++.+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 35567899999999999999999998643 32 3899988765 44456799999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEee
Q 022401 92 THLAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d 164 (298)
...++++|||.+|+|..++.+. ..++..+++.++.+|++|++||+++++|||||...|+|++.... +|++|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEcc
Confidence 9999999999999999999765 34899999999999999999999999999999999999998865 99999
Q ss_pred cCccccc---cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 022401 165 FGYSKSS---VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 240 (298)
Q Consensus 165 ~~~~~~~---~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 240 (298)
||+|+.. ..+.......-...|||||.+....++++ +||||||+++||+++ |..||...+.. +.+.-...+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~----~v~~~~~~g 920 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNF----EVLLDVLEG 920 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchH----HHHHHHHhC
Confidence 9999822 22223333345578999999999999888 999999999999999 77899987763 333334444
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 241 QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 241 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
. +++.+..+|+.+.+++.+||+.+|++||++..+++..
T Consensus 921 g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~ 958 (1025)
T KOG1095|consen 921 G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQD 958 (1025)
T ss_pred C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhh
Confidence 4 8888888999999999999999999999999998744
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=290.43 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=201.2
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------ 91 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 91 (298)
..++|++.+.||+|++|.||.+.+..+++.+|+|.+... ......+.+|+.++++++|||++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357899999999999999999999989999999988643 22334567899999999999999999998643
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
...|+|+|++.+ +|.+.+... ++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeC
Confidence 357999999965 787777544 889999999999999999999999999999999999998887 999999998754
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-----------
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------- 240 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 240 (298)
..........++..|+|||.+.+..++.+ +||||||+++|+|++|..||...+......+....+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 44333334457788999999988777665 999999999999999999998765433332222111000
Q ss_pred -------CCC--------------CC-----CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 241 -------QYS--------------VP-----DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 241 -------~~~--------------~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
... .+ .....++++.++|.+||+.||++|||+.++| +|||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL--------~~~~~~ 315 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL--------QHPYIN 315 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh--------cChhHh
Confidence 000 00 0112466799999999999999999885555 667664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=296.50 Aligned_cols=240 Identities=31% Similarity=0.438 Sum_probs=208.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
...-++=||.|+.|.||.++-+ ++.||||.+. +....++.-|+.|+||||+.|.|+|...-.+|+|||||..
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred HhhhhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 3445677999999999999886 6679999654 3334578889999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 183 (298)
|.|...|..+.+++...+..|.++|+.|++|||.+.|+|||||.-||||..+.. |||+|||-+.....-...-...|+
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGT 274 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGT 274 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999998887 999999987654444444556799
Q ss_pred CcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhh
Q 022401 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263 (298)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 263 (298)
..|||||++++.+...+ .||||||++||||+||..||...+. ..++-.+......++.+..+|+.+.=|+++||+
T Consensus 275 VaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred HhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccch----heeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 99999999988888777 9999999999999999999988665 233344444556777888899999999999999
Q ss_pred hCCCCcccccccchh
Q 022401 264 ADPAAVSIFFFPLNM 278 (298)
Q Consensus 264 ~dp~~Rps~~~~l~~ 278 (298)
-.|..||+|.+||-|
T Consensus 350 sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLH 364 (904)
T ss_pred cCCCCCccHHHHHHH
Confidence 999999999998854
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=281.55 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=202.4
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
...+|.+.+.||+|+||.||.+... .++..+++|.+.... .....+.+|+.++++++|||++++++++.....+
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3468999999999999999999852 345678999886543 3345688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEE
Q 022401 95 AIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~-------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~ 161 (298)
++++||+++++|.+++...+ .+++..++.++.|++.||+|||+.|++|+||+|+||++++++. ++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~k 160 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VK 160 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EE
Confidence 99999999999999986543 3899999999999999999999999999999999999998887 99
Q ss_pred EeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 022401 162 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 237 (298)
Q Consensus 162 l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~ 237 (298)
|+|||++....... ......++..|+|||.+.+..++.+ +|+||||+++++|++ |..||...... .....+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~----~~~~~i 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIECI 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH
Confidence 99999886433221 1222334668999999877777665 999999999999998 88998776542 233333
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
..+.. .......+.++.+++.+||+.||.+|||+.+++.
T Consensus 236 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 236 TQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 33332 2223347899999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=272.92 Aligned_cols=250 Identities=31% Similarity=0.462 Sum_probs=208.1
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||+|++|.||.+.+..+++.+++|.+..... ..+.+.+|++++++++|+|++++++++.+.+..++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999988899999999877643 446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-CCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 179 (298)
+++++|.+.+.....+++..++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccc
Confidence 999999999988888999999999999999999999999999999999999998776 99999998875443332 233
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
..++..|++||...+...+.+ +|+|++|++++++++|..||....... ......... ....+..+++++.+++.
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~-~Dv~~lG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLNPMA---ALFRIVQDD--HPPLPEGISPELKDFLM 232 (254)
T ss_pred cccchhhcCHhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHhccC--CCCCCCCCCHHHHHHHH
Confidence 457788999999877665444 999999999999999999998655322 111111122 22234457899999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+||+.+|++|||+ .+++.|||+
T Consensus 233 ~~l~~~p~~R~~~--------~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTA--------KQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCH--------HHHhcCCCC
Confidence 9999999999988 455566764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=276.04 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=200.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.+.......||+|+||.||++.+..++..+++|.+.... ...+.+.+|+.++++++|+||+++++++..++..++++|+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 344555578999999999999998889999999887543 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-C
Q 022401 101 ASGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (298)
Q Consensus 101 ~~~~sL~~~l~~~-~~~--~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~ 176 (298)
+++++|.+++... ..+ +...+..++.|++.|+.|||+.|++|+||+|+||+++.+.. .++|+|||++....... .
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-eEEEecchhheecccCCCc
Confidence 9999999998754 445 78889999999999999999999999999999999976332 49999999876443222 1
Q ss_pred CCCCCCCCcccCcccccccc-CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
.....++..|+|||.+.+.. ....++|+||+|+++|++++|..||.......... .......... ..+..+++++.
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~ 242 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-FKVGMFKIHP--EIPESLSAEAK 242 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-hhhhhhccCC--CCCcccCHHHH
Confidence 22334678999999976543 23345999999999999999999997654322111 1111111122 22344789999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+++.+||+.+|.+|||+ .+++.|||+
T Consensus 243 ~li~~~l~~~p~~Rpt~--------~~ll~~~~~ 268 (268)
T cd06624 243 NFILRCFEPDPDKRASA--------HDLLQDPFL 268 (268)
T ss_pred HHHHHHcCCCchhCCCH--------HHHHhCCCC
Confidence 99999999999999988 566688885
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=279.19 Aligned_cols=250 Identities=20% Similarity=0.312 Sum_probs=202.4
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccC-----CcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
+..++|++.+.||+|+||.||.+..... +..+++|.+.... .....+.+|+.+++.++|||++++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 4567999999999999999999998643 4789999976543 22346788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEE
Q 022401 93 HLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l 162 (298)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl 160 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEE
Confidence 999999999999999998542 23677889999999999999999999999999999999998887 999
Q ss_pred eecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 022401 163 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRIL 238 (298)
Q Consensus 163 ~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 238 (298)
+|||++....... ......++..|+|||.+.+..++.+ +||||||+++|++++ |..||....... ..+.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~----~~~~~~ 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEE----VLKFVI 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHH----HHHHHh
Confidence 9999876433221 2223345678999999877776655 999999999999998 889997654322 222222
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 239 SVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
.......+...+.++.+++.+||+.+|.+|||+.+++.
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 -DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22223334457899999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=282.89 Aligned_cols=249 Identities=28% Similarity=0.404 Sum_probs=202.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+.|+..+.||+|++|.||++.+..++..+|+|.+.... ...+.+.+|+.++++++|||++++++++..+..+++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45788899999999999999998889999999887432 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 179 (298)
+++++|.+.+.. ..+++..+..++.+++.|+.|||++|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence 999999988854 56899999999999999999999999999999999999998887 9999999886443322 1122
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
..++..|+|||++.+..++.+ +|+||||++++++++|..||......... ..+... .........+.++.+++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVL----FLIPKN-SPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred ccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHH----hhhhcC-CCCCCCcccCHHHHHHHH
Confidence 346788999999987777655 99999999999999999998765432211 111111 111222346889999999
Q ss_pred HhhhhCCCCcccccccchhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~ 280 (298)
+||+.+|.+||++.+++.+++
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred HHccCCcccCcCHHHHHHhHH
Confidence 999999999999866665443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=275.44 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=204.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
...++|++.+.||.|++|.||++... ++..+++|.+.........+.+|+.++++++|+|++++++++......++++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45689999999999999999999976 45679999988766666789999999999999999999999998899999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--
Q 022401 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 175 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-- 175 (298)
++++++|.+++.... .++...+..++.+++.|+.|||++|++|+||+|+||++++++. ++|+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYT 159 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhh
Confidence 999999999997643 6899999999999999999999999999999999999998877 9999999876443211
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
.......+..|+|||.+.+...+.+ +|+||+|++++++++ |..||....... ....+.. ....+.+...+.++
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~ 233 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNRE----VLEQVER-GYRMPRPPNCPEEL 233 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHc-CCCCCCCCCCCHHH
Confidence 1112223467999999877766555 999999999999998 999997655432 2223222 22334444568999
Q ss_pred HHHHHHhhhhCCCCcccccccc
Q 022401 255 RDLISRIFVADPAAVSIFFFPL 276 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l 276 (298)
.+++.+||+.||.+||++.++.
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 234 YDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred HHHHHHHcccCcccCCCHHHHH
Confidence 9999999999999999997776
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=275.65 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=201.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
..++|+++++||+|+||.||+|... +++.+++|.+.......+.+.+|+.++++++|+|++++++++. .+..++++|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4578999999999999999999875 5678999998876666678899999999999999999999874 4578999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--
Q 022401 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (298)
Q Consensus 101 ~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-- 176 (298)
+.+++|.+.+... ..++..++..++.+++.||+|||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCccc
Confidence 9999999988643 36888999999999999999999999999999999999998887 99999998764432111
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
.....++..|+|||.+....++.+ +||||||+++|++++ |..||...+..+. ...+ ......+.....+.++.
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEV----IQNL-ERGYRMPRPDNCPEELY 233 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHH----HHHH-HcCCCCCCCCCCCHHHH
Confidence 112234568999999877776655 999999999999998 9999987554222 2222 22233344455789999
Q ss_pred HHHHHhhhhCCCCcccccccch
Q 022401 256 DLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+++.+||+.||++|||+.++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999987774
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=276.67 Aligned_cols=242 Identities=26% Similarity=0.412 Sum_probs=202.8
Q ss_pred eeeccCCeEEEEEEEEccC---CcEEEEEEeecCCcc--hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||.+..... +..+++|.+...... ...+.+|+..++.++|+|++++++++.....+++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4789999999999999865 889999998765443 46788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 104 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 104 ~sL~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++|.+++... ..+++.+++.++.+++.|+.+||++|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence 9999999875 77999999999999999999999999999999999999998877 999999998755433
Q ss_pred C---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 175 S---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 175 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
. ......++..|+|||.+....++.+ +||||+|+++|+|++ |..||....... ....+.. ......+..+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~ 232 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEE----VLEYLRK-GYRLPKPEYC 232 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHHc-CCCCCCCccC
Confidence 2 2233446778999999877766555 999999999999999 589998764322 2222222 3333445557
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
+.++.+++.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 233 PDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 8999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=281.94 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=202.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCC----------------cEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCee
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTK----------------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIV 82 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~----------------~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~ 82 (298)
..++|++++.||+|+||.||.+.+...+ ..+++|.+.... ...+.+.+|+.++++++|||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3478999999999999999999876533 457999887543 3346688899999999999999
Q ss_pred eeeEEEEeCCeEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceE
Q 022401 83 RFKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (298)
Q Consensus 83 ~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nil 151 (298)
++++++..+...++++|++.+++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999987665 6899999999999999999999999999999999999
Q ss_pred eeCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh--CCCCCCCCCC
Q 022401 152 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDE 226 (298)
Q Consensus 152 v~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf~~~~~ 226 (298)
++.++. ++|+|||++....... ......++..|+|||.+.+..++.+ +||||||+++|++++ +..||.....
T Consensus 163 i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 163 VGKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ecCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 998876 9999999886433221 1223345678999999877666655 999999999999998 6778876554
Q ss_pred chhHHHHHHHHh--hcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 227 PKDFRKTIQRIL--SVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 227 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
...+........ ......+.+...|.++.+++.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 333222221111 111122333446799999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=273.65 Aligned_cols=250 Identities=33% Similarity=0.549 Sum_probs=208.3
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||.|++|.||.+.+..++..+++|++.... .....+.+|++.++.++|+|++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5899999999999999999998889999999987643 3445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-
Q 022401 101 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (298)
Q Consensus 101 ~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~- 175 (298)
+++++|.+.+... ..++...+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence 9999999998764 67899999999999999999999999999999999999998776 9999999886443332
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
......+++.|+|||......++.+ +|+||+|++++++++|..||...+. ............ .+.+..++.++.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENL----LELALKILKGQY-PPIPSQYSSELR 232 (258)
T ss_pred eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcH----HHHHHHHhcCCC-CCCCCCCCHHHH
Confidence 2233457788999999877776655 9999999999999999999977553 222333322222 223335789999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+++.+||+.+|.+|||+ .++++|||+
T Consensus 233 ~~i~~~l~~~p~~Rp~~--------~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSI--------AQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCH--------HHHhcCCCC
Confidence 99999999999999988 555677875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=278.48 Aligned_cols=249 Identities=20% Similarity=0.344 Sum_probs=199.9
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCc----EEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
...++|++.+.||+|+||.||++.+..++. .||+|...... .....+.+|..+++.++|||++++++++... .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 345789999999999999999999876665 47999876432 2345678899999999999999999998654 5
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+++++++++++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++. ++|+|||++....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~ 160 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLD 160 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecc
Confidence 67899999999999998764 46899999999999999999999999999999999999988777 9999999886443
Q ss_pred CCCCC---CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 173 LHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 173 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
..... ....++..|+|||...+..++.+ +||||||+++||+++ |..||....... . ..........+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~----~~~~~~~~~~~~~~ 234 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-I----PDLLEKGERLPQPP 234 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-H----HHHHHCCCcCCCCc
Confidence 32211 12234567999999877777665 999999999999998 889987654322 1 12222222333444
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
..+.++.+++.+||+.||+.||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 235 ICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 57899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=290.32 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=201.7
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-eEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~~ 99 (298)
+++|.-...||+|+||.||++.-.. ++.+|||+....... ..+|.+|+.++.+++|||+++++|||.+.+ ..++|+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 4677788899999999999999874 478999988765554 566999999999999999999999999988 5999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---cEEecCCCCceEeeCCCCCCEEEeecCccccccC-
Q 022401 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 173 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~---i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~- 173 (298)
|+..|||.+.+.... ++++.....|+.++++||+|||+.. |+|||||++|||+|.+.. .||+|||++.....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEG 230 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCcc
Confidence 999999999997655 8899999999999999999999754 999999999999998888 99999999965544
Q ss_pred CCCCCCC-CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCC--CchhHHHHHHHHhhc-CC----CCC
Q 022401 174 HSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSV-QY----SVP 245 (298)
Q Consensus 174 ~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~-~~----~~~ 245 (298)
....... .|+..|++||+......+.+ +||||||++++|+++|+.|..... ....+.......... .. +..
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~ 309 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR 309 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence 3333333 88999999999988667666 999999999999999998877542 222223322222211 11 111
Q ss_pred CC-CCCC--H---HHHHHHHHhhhhCCCCcccccccchhh
Q 022401 246 DT-NPIS--Q---ECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 246 ~~-~~~~--~---~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.. ...+ . .+..+..+|++.+|..||++.+++.+.
T Consensus 310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 01 1233 2 366777889999999999999876544
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.37 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=200.0
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
....|++.+.||+|++|.||.+....+++.|++|.+..... ....+.+|+.+++.++|||++++.+++.++...++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34679999999999999999999988899999998864322 23457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 97 VMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 97 v~~~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
|+||+.+ ++.+.+. ....+++..+..++.|++.||.|||+.|++|+||+|.||+++.++. ++|+|||++......
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~~- 168 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSPA- 168 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCCC-
Confidence 9999975 6666664 3456899999999999999999999999999999999999998887 999999987643322
Q ss_pred CCCCCCCCCcccCcccccc---ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 176 QPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
....++..|+|||.+.+ ..++. ++||||+|+++|++++|..||...+.... ...+............++.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~-~sDv~s~G~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 241 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNDSPTLSSNDWSD 241 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCc-ccchHHHHHHHHHHHcCCCCCCCccHHHH----HHHHhcCCCCCCCchhhCH
Confidence 23456778999998742 33444 49999999999999999999976543221 1122222221122234688
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
++.+++.+||+.||.+||++.++ +.|||+.
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~i--------l~~~~~~ 271 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEEL--------LKHRFVL 271 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHH--------hcChhhc
Confidence 99999999999999999988555 4677775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.51 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=201.3
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeC--
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-- 91 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 91 (298)
+++...++|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 2 YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred CCCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 556668999999999999999999999998999999998865432 224567899999999999999999987543
Q ss_pred ------CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEee
Q 022401 92 ------THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (298)
Q Consensus 92 ------~~~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d 164 (298)
..+++|++|+.+ ++...+.. ...+++..++.++.|++.||+|||+.|++|+||+|+||++++++. ++|+|
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~d 158 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIAD 158 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECc
Confidence 357999999965 56665543 457999999999999999999999999999999999999998887 99999
Q ss_pred cCccccccCCCCC------------CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 022401 165 FGYSKSSVLHSQP------------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (298)
Q Consensus 165 ~~~~~~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 232 (298)
||++......... ....+++.|+|||.+.+......++||||+|+++|+|++|..||...+.......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9988643322211 1113467799999886655444559999999999999999999987665444333
Q ss_pred HHHHHhhcCC-------------------CCC-----CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhh
Q 022401 233 TIQRILSVQY-------------------SVP-----DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVW 288 (298)
Q Consensus 233 ~~~~~~~~~~-------------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~ 288 (298)
.......... ..+ .....++++.++|.+||+.||.+|||+ .++++|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~--------~ell~~~~ 310 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA--------SDALEHPY 310 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH--------HHHhcCCC
Confidence 2222110000 000 001244789999999999999999987 66668888
Q ss_pred h
Q 022401 289 M 289 (298)
Q Consensus 289 ~ 289 (298)
+
T Consensus 311 f 311 (311)
T cd07866 311 F 311 (311)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=281.02 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=202.9
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccC-----CcEEEEEEeecCC--cchHHHHHHHHHHhcC-CCCCeeeeeEEEEe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (298)
.+..++|++.+.||+|++|.||++.+... ...+++|.+.... .....+.+|+.+++++ +|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 34557999999999999999999997643 3689999887542 2234577899999999 79999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC
Q 022401 91 PTHLAIVMEYASGGELFERICN----------------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~----------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~ 154 (298)
++.+++++||+.+++|..++.. ...+++..++.++.|++.|++|||+.|++|+||+|+||+++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 9999999999999999999854 235889999999999999999999999999999999999998
Q ss_pred CCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhH
Q 022401 155 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 230 (298)
Q Consensus 155 ~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~ 230 (298)
++. ++|+|||++....... ......++..|+|||...+..++.+ +||||||+++|++++ |..||......+.
T Consensus 168 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~- 243 (293)
T cd05053 168 DHV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEEL- 243 (293)
T ss_pred CCe--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHH-
Confidence 876 9999999886433221 1122234567999999877777665 999999999999997 8899976554222
Q ss_pred HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
...+. .......+...+.++.+++.+||..||.+|||+.++++..
T Consensus 244 ---~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 244 ---FKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred ---HHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 22222 2222233445689999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=287.93 Aligned_cols=258 Identities=28% Similarity=0.409 Sum_probs=201.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----Ce
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 93 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 93 (298)
..+|++.+.||.|++|.||.+++..+++.|++|.+... ......+.+|+.+++.++|+|++++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46899999999999999999999999999999988653 22334567899999999999999999987644 35
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
.+++++|+. ++|.+.+....++++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCC
Confidence 899999995 689888888888999999999999999999999999999999999999998877 99999998874433
Q ss_pred C-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc------------
Q 022401 174 H-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------ 240 (298)
Q Consensus 174 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 240 (298)
. .......++..|+|||.+........++|+||||+++|+|++|..||...+......... ...+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT-ELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH-HHhCCCChHHhhhcCch
Confidence 2 122233567789999988654334455999999999999999999997654322111111 10000
Q ss_pred -----------CCC---CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 241 -----------QYS---VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 241 -----------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
... ......+++++.++|++||+.||++|||+ .++++|||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~--------~ell~h~~~~~ 296 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV--------EEALAHPYLAS 296 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH--------HHHHcCcchhh
Confidence 000 00123478899999999999999999987 55557777764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=275.48 Aligned_cols=251 Identities=31% Similarity=0.522 Sum_probs=205.2
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||.|++|.||++....++..+++|.+... ....+.+.+|+.+++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 589999999999999999999999999999998654 23345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-C
Q 022401 101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-~ 177 (298)
+.+++|.+.+.... .+++..+..++.+++.|+.|||+.+++|+||+|+||++++++. .++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence 99999999886543 4789999999999999999999999999999999999987754 369999998864433222 1
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||...+..++.+ +|+||+|++++++++|..||...+.. +........... +.....+.++.++
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLH----QLVLKICQGYFA-PISPNFSRDLRSL 233 (257)
T ss_pred cccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhcccCC-CCCCCCCHHHHHH
Confidence 23357788999999877776655 99999999999999999999765432 222233332222 2233478899999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+.+||..+|++|||+ .+++.|||+
T Consensus 234 i~~~l~~~p~~Rpt~--------~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSI--------TSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCH--------HHHhhCCCC
Confidence 999999999999987 555577775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=278.55 Aligned_cols=253 Identities=27% Similarity=0.375 Sum_probs=196.8
Q ss_pred eeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----hHHHHHHHHHHh---cCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHR---SLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 30 ~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
.||+|+||.||++.+..+++.+|+|.+...... ...+.++..+++ ...||+++.+.+++..++..++|+||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999988999999988653211 122334443333 3479999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCC
Q 022401 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (298)
Q Consensus 103 ~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 182 (298)
+++|...+.....+++..+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence 9999999988888999999999999999999999999999999999999998887 999999988643322 2233457
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
+..|+|||.+.+......++|+||+|+++|++++|..||........ ........... ...+..+++++.++|.+||
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVN--VELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCC--cCCccccCHHHHHHHHHHh
Confidence 88999999986544334449999999999999999999976543221 12222222222 2233447899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..||.+||+.... +..++++|||+.+
T Consensus 235 ~~~p~~R~~~~~~---~~~~~~~h~~~~~ 260 (279)
T cd05633 235 QRDVSKRLGCLGR---GAQEVKEHVFFKG 260 (279)
T ss_pred cCCHHHhcCCCCC---CHHHHHhCccccC
Confidence 9999999963221 3467789999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=281.74 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=201.1
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEcc-------CCcEEEEEEeecCC--cchHHHHHHHHHHhcC-CCCCeeeeeEEEEe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (298)
..++|.+.+.||+|+||.||.+++.. ++..+|+|.+.... .....+.+|+.+++.+ +|||++++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34799999999999999999998643 23469999887542 2334577899999999 79999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC
Q 022401 91 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~ 154 (298)
....++|+||+++++|.+++.... .++..+++.++.|++.||+|||+.|++|+||+|+||+++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 999999999999999999996532 3788899999999999999999999999999999999998
Q ss_pred CCCCCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhH
Q 022401 155 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 230 (298)
Q Consensus 155 ~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~ 230 (298)
++. ++|+|||.+........ .....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+. +
T Consensus 176 ~~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~-~-- 249 (307)
T cd05098 176 DNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-E-- 249 (307)
T ss_pred CCc--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH-H--
Confidence 876 99999998764432111 112223467999999877776655 999999999999998 7888866442 2
Q ss_pred HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
+....+ ........+...+.++.+++.+||..+|.+|||+.++++....
T Consensus 250 -~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 250 -ELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred -HHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 222222 2222333344578999999999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=275.80 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=200.4
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
...++|++.+.||+|++|.||.+... .+..+++|.+.......+.+.+|+.++++++|+|++++++++. ....+++++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 45578999999999999999999876 4556999998776555678899999999999999999999875 456789999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
++++++|.+++... ..++...++.++.+++.|+.|||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYT 158 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccc
Confidence 99999999998653 35899999999999999999999999999999999999998876 999999998643322111
Q ss_pred --CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 178 --KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
....++..|+|||.+.+..++.+ +|+||||+++|++++ |..||...+..+ ....+.. ....+.+...+.++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~ 232 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNRE----VLEQVER-GYRMPCPQDCPISL 232 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHHc-CCCCCCCCcCCHHH
Confidence 12234457999999877776655 999999999999999 888997654322 2222222 22333444578999
Q ss_pred HHHHHHhhhhCCCCcccccccch
Q 022401 255 RDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
.+++.+||+.||.+|||+.++.+
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999976663
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=279.92 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=206.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCCcc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
..+|.+.+.||+|++|.||.+++. .++..+++|.+...... ...+.+|+.++++++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 467999999999999999999864 24556888887654332 356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCC
Q 022401 96 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~ 159 (298)
+|+||+++++|.+++.... .+++..++.++.+++.|++|||++|++|+||+|+||+++.++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~-- 161 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL-- 161 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--
Confidence 9999999999999986542 3788999999999999999999999999999999999998886
Q ss_pred EEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 022401 160 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQ 235 (298)
Q Consensus 160 ~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~ 235 (298)
++|+|||++....... ......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+ ...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~----~~~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTE----VIE 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH
Confidence 9999999886433221 1223345678999999887777665 999999999999998 999987765432 223
Q ss_pred HHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhh
Q 022401 236 RILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFV 287 (298)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp 287 (298)
.+..+... ......|.++.+++.+||+.||.+|||+.+++++.....-..|
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 237 CITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 33332222 2233468999999999999999999999999976655544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=277.70 Aligned_cols=250 Identities=23% Similarity=0.384 Sum_probs=202.5
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCc---EEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
+.++|++.+.||+|+||.||++....+++ .|++|.+... ......+..|+.++++++|||++++.+++..+...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 45679999999999999999999876554 6999988653 233457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+|+||+++++|.+++... +.++..++..++.|++.|++|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccC
Confidence 999999999999998653 46899999999999999999999999999999999999987776 999999987533222
Q ss_pred CCCCC---CC---CCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCC
Q 022401 175 SQPKS---TV---GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247 (298)
Q Consensus 175 ~~~~~---~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
..... .. .+..|+|||.+.+..++.+ +||||+|+++|++++ |..||......+ ....+ ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~----~~~~i-~~~~~~~~~ 233 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQD----VINAI-EQDYRLPPP 233 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHH----HHHHH-HcCCcCCCc
Confidence 11111 11 1346999999877777665 999999999999886 999998755422 22222 223344445
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
..+|.++.+++.+||+.+|.+||++.+++..
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5678999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=274.70 Aligned_cols=239 Identities=26% Similarity=0.329 Sum_probs=192.4
Q ss_pred eeccCCeEEEEEEEE--ccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 022401 30 DIGSGNFGVARLMRD--KVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (298)
Q Consensus 30 ~lg~g~~~~vy~~~~--~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (298)
.||+|+||.||++.+ ..++..+++|++..... ..+.+.+|+.+++.++||||+++++++. ....++|+|+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 45678899998765432 3456788999999999999999999875 45678999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC----CCC
Q 022401 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 180 (298)
Q Consensus 105 sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~----~~~ 180 (298)
+|.+++.....+++..+..++.|++.|+++||++|++|+||+|.||+++.++. ++|+|||++......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCC
Confidence 99999988788999999999999999999999999999999999999998776 999999988644332211 122
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
.++..|+|||.+....++.+ +|+||||+++|++++ |..||...... .....+.... ..+.+..+++++.++|.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~i~~~~-~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGN----EVTQMIESGE-RMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHCCC-CCCCCCCCCHHHHHHHH
Confidence 23468999998876666555 999999999999998 99999875442 2222232222 23344458999999999
Q ss_pred HhhhhCCCCcccccccch
Q 022401 260 RIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~ 277 (298)
+||+.||++||++.+|..
T Consensus 233 ~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhccCchhCcCHHHHHH
Confidence 999999999999977764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=302.28 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=218.9
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeec-CCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
+-|.|+..||.|+||.||+|.++.++-..|-|++.. +....+.+.-|+.||....||+|+++++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 569999999999999999999999998999998875 3445678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc-cccCCCCCCC
Q 022401 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKS 179 (298)
Q Consensus 102 ~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~-~~~~~~~~~~ 179 (298)
.||-....+-. +..+++.++..+.++++.||.|||+++|+|||||..|||++.+|. ++|.|||.+. ..........
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhcc
Confidence 99999887654 447999999999999999999999999999999999999999998 9999999764 2333334466
Q ss_pred CCCCCcccCccccc-----cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 180 TVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 180 ~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
..|+|+|||||+.. ..+|+++ +||||||+.+.+|..+.+|....+.- .-+++---+.++.+..+..++.++
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpM---RVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchH---HHHHHHhhcCCCcccCcchhhhHH
Confidence 78999999999854 3466676 99999999999999999998876542 222222234555677788899999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.+|+..||.+||..||++ .++|.|||+++.+-
T Consensus 266 ~DfLk~cL~Knp~~Rp~a--------aqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPA--------AQLLKHPFVQNAPS 297 (1187)
T ss_pred HHHHHHHHhcCCccCCCH--------HHHhhCcccccCCc
Confidence 999999999999999977 67779999996543
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=281.74 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=201.2
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
...+|++.+.||+|+||.||++.... .+..+|+|++..... ..+.+.+|+.++..++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 45679999999999999999998753 357899999875432 23567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC
Q 022401 94 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~ 157 (298)
.+++++|+.+++|.+++... ..++...+..++.|++.||+|||+.|++|+||||+||++++++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 99999999999999988532 24788889999999999999999999999999999999998776
Q ss_pred CCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 022401 158 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKT 233 (298)
Q Consensus 158 ~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~ 233 (298)
++|+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...... ..
T Consensus 163 --~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~----~~ 235 (283)
T cd05091 163 --VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQ----DV 235 (283)
T ss_pred --eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHH----HH
Confidence 99999998764322211 123335678999999877777665 999999999999998 77888765442 22
Q ss_pred HHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 234 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
...+..... .+.+..+++++.+++.+||+.+|.+||++.+++.
T Consensus 236 ~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 236 IEMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 333333332 2334558999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=278.37 Aligned_cols=254 Identities=29% Similarity=0.447 Sum_probs=202.2
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CeEEEEEe
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME 99 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~~ 99 (298)
|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+.++++++|+|++++++++.+. ...++|++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999889999999998653 3335677899999999999999999999888 89999999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--
Q 022401 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (298)
Q Consensus 100 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-- 176 (298)
|+++ +|.+++... ..+++..++.++.+++.|+++||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence 9975 888888665 57899999999999999999999999999999999999998887 99999998864443321
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CCCC---------
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPD--------- 246 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~--------- 246 (298)
.....++..|+|||.+.+....+.++||||||++++++++|..||...+................. .++.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 223345678999998766544455599999999999999999999876654443333222111000 0000
Q ss_pred --------------CCC-CCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 247 --------------TNP-ISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 247 --------------~~~-~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
... ++.++.+++++||+.||.+||++ .++++|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~--------~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA--------DQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH--------HHHhhCcCC
Confidence 011 37899999999999999999987 555577775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.37 Aligned_cols=252 Identities=29% Similarity=0.472 Sum_probs=205.9
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
.|...+.||+|++|.||.+.+..+++.+++|.+..... ..+.+.+|+.++++++|||++++++++...+..+++++++.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 57778899999999999999988899999998865432 23457889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCCCC
Q 022401 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 181 (298)
Q Consensus 103 ~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 181 (298)
+++|.+.+.. .+++..++..++.+++.++++||+.|++|+||+|+||+++.++. ++|+|||.+....... ......
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCccccccc
Confidence 9999998876 67899999999999999999999999999999999999998887 9999999875433222 222345
Q ss_pred CCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CCCCCCCCCHHHHHHHHH
Q 022401 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTNPISQECRDLISR 260 (298)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 260 (298)
+++.|+|||.+.+..++.+ +|+||+|++++++++|..||...+.. .....+..... .......++.++.+++.+
T Consensus 177 ~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPL----QAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred CCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 7888999999877777665 99999999999999999999765432 22223333222 222233478999999999
Q ss_pred hhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 261 IFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 261 ~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
||+.||.+|||+. ++++|||+..
T Consensus 252 ~l~~~p~~Rpt~~--------~il~~~~~~~ 274 (285)
T cd06648 252 MLVRDPAQRATAA--------ELLNHPFLAK 274 (285)
T ss_pred HcccChhhCcCHH--------HHccCccccc
Confidence 9999999999874 5557788754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=278.01 Aligned_cols=262 Identities=26% Similarity=0.439 Sum_probs=211.1
Q ss_pred CeeEEeeeccCCeEEEEEEEEc---cCCcEEEEEEeecC-----CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERG-----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~-----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (298)
.|++.+.||.|+||.||.+++. .+|..||+|++... ....+.+.+|+.+++++ +|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 47889999998753 22345678899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++|+||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccc
Confidence 999999999999999988888999999999999999999999999999999999999998876 999999988644332
Q ss_pred C--CCCCCCCCCcccCcccccccc-CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 175 S--QPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 175 ~--~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
. ......++..|+|||.+.... ....++||||+|+++|++++|..||...............+....... +..++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC--CccCC
Confidence 1 112344778899999986532 223449999999999999999999976544334444444444433333 33478
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..+.+++++||+.||.+||+.. ...+..++.|||++..
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~---~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCG---PSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCC---CCCHHHHHcCcccccC
Confidence 9999999999999999998542 2245788899998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=279.61 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=209.5
Q ss_pred CeeEEeeeccCCeEEEEEEEEc---cCCcEEEEEEeecC-----CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERG-----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~-----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (298)
+|++.+.||+|++|.||.++.. .+++.+++|++... ......+.+|+.++.++ +|||++++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 45788999988753 22335577899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++|+||+++++|.+.+.....+++..++.++.|++.+|.+||+.|++|+||+|.||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence 999999999999999987778999999999999999999999999999999999999998876 999999987644332
Q ss_pred CC--CCCCCCCCcccCcccccccc-CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 175 SQ--PKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
.. .....++..|++||.+.+.. ....++|+||+|+++++|++|..||.............+.+....... +...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF--PKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC--CcccC
Confidence 21 12234678899999976654 223449999999999999999999975443333334444444443332 33478
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.++.+++.+||+.||++|||+.+ ...+++|||+....
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~-----~~~~l~~~~~~~~~ 273 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANG-----ADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcch-----HHHHhcCcccccCC
Confidence 99999999999999999999753 34678999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=273.76 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=199.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEE-eCCeEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIV 97 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv 97 (298)
..+..+|++.+.||+|++|.||++... +..+++|...... ..+.+.+|+.++++++|+|++++++++. .++..+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 345678999999999999999999775 6779999876543 3467889999999999999999999765 45678999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 98 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+||+++++|.+++.... .+++..++.++.+++.||+|||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQ 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccccC
Confidence 99999999999987644 3788999999999999999999999999999999999998887 9999999876433222
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
.....+..|+|||...+..++.+ +||||||+++|+|++ |..||...+. ......+... ........++..+
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~ 228 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVEKG-YKMDAPDGCPPVV 228 (256)
T ss_pred --CCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHhcC-CCCCCCCCCCHHH
Confidence 23344567999999877776655 999999999999997 8999876443 2223333222 2223344578999
Q ss_pred HHHHHHhhhhCCCCcccccccch
Q 022401 255 RDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
.+++.+||+.||.+|||+.++++
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=282.61 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=200.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.++|+..+.||+|+||.||.+.+..+++.+|+|.+.... .....+.+|+.++.++. |+||+++++++..+...++++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 357888899999999999999999999999999987543 23456778999999996 999999999999999999999
Q ss_pred eccCCCCHHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHhhc-CcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 99 EYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 99 ~~~~~~sL~~~l-----~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
+++.. ++.++. .....+++..+..++.+++.|++|||+. +++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhc
Confidence 99854 554432 1345789999999999999999999974 9999999999999998877 9999999986544
Q ss_pred CCCCCCCCCCCCcccCccccccc---cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CCC--C
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVP--D 246 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--~ 246 (298)
.........++..|+|||.+.+. .++. ++||||+|++++++++|..||..... ......+...... ..+ .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDV-RSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcc-hhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCCCCcCCCcC
Confidence 33333444577889999998766 3444 49999999999999999999976542 2222233322221 111 2
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...++.++.+|+.+||+.||.+|||+ .+++.|||+..
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~--------~~i~~~~~~~~ 272 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKY--------KELLEHPFIKD 272 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCH--------HHHhcChhhhc
Confidence 23478999999999999999999988 45557777753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=282.35 Aligned_cols=257 Identities=30% Similarity=0.463 Sum_probs=202.0
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 92 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 92 (298)
..++|++.+.||+|++|.||++.++.+++.+++|.+.... .....+.+|+.++++++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999999889999999987543 22345678999999999999999999987654
Q ss_pred -----eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 93 -----HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 93 -----~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
.+++++||+++ ++...+... ..+++..+..++.|++.||+|||+.|++|+||+|+||++++++. ++|+|||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg 161 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFG 161 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCccc
Confidence 78999999976 666666543 46899999999999999999999999999999999999998887 9999999
Q ss_pred ccccccCCCC--CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC-
Q 022401 167 YSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS- 243 (298)
Q Consensus 167 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 243 (298)
++........ .....++..|+|||.+.+......++||||+|++++++++|..||...+..+.+..... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~ 240 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR-LCGSPCPA 240 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCChh
Confidence 8864433221 12234567899999886554334459999999999999999999987665444333332 2211100
Q ss_pred -C-----------------------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 244 -V-----------------------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 244 -~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+ .....+|..+.+++.+||+.||.+|||+ .+++.|||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~--------~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA--------EEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH--------HHHhcCCCC
Confidence 0 0112368999999999999999999987 566678885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=277.74 Aligned_cols=250 Identities=21% Similarity=0.366 Sum_probs=204.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
.++|++.+.||.|+||.||+++.+. +.+.+++|.+..... ....+.+|+.++++++|+|++++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 4789999999999999999999753 356799998765433 246788999999999999999999999888999
Q ss_pred EEEEeccCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 95 AIVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~---------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
++|+|++++++|.+++.... .++...+..++.|++.+|+|||+.|++|+||+|+||+++.++. ++++||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~ 161 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLL 161 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEccc
Confidence 99999999999999997655 6899999999999999999999999999999999999998887 999999
Q ss_pred CccccccCC--CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 166 GYSKSSVLH--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 166 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
+++...... .......++..|+|||.+.+.....+ +||||||++++++++ |..||...... ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~----~~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDE----EVLNRLQAGKL 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchH----HHHHHHHcCCc
Confidence 987532211 11222344567999999877766555 999999999999998 78899765442 23334444444
Q ss_pred CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 243 SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 243 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.++.....|.++.+++.+||+.||.+|||+.+++..
T Consensus 237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 444555689999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=277.91 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=199.3
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEE----ccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRD----KVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILT--PTH 93 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~----~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 93 (298)
+..+|++.+.||+|+||.||.+.. ..++..|++|.+..... ....+.+|+.++++++|||++++.+++.. ...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 346899999999999999999984 45688999999865432 34567899999999999999999998754 357
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
+++|+||+++++|.+++... ..++...+..++.+++.||.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCccccccc
Confidence 89999999999999998654 46899999999999999999999999999999999999998887 9999999987543
Q ss_pred CCCCC----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch-----------hHHHHHHHH
Q 022401 173 LHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------DFRKTIQRI 237 (298)
Q Consensus 173 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-----------~~~~~~~~~ 237 (298)
..... ....+...|+|||.+.+..++.+ +||||||+++++|++|..|+....... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 32211 11223446999999877776555 999999999999999877654332110 001111122
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.......+....++.++.+++.+||+.+|++|||+.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 23333344455678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=273.47 Aligned_cols=240 Identities=26% Similarity=0.342 Sum_probs=195.7
Q ss_pred eeeccCCeEEEEEEEEccCC---cEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTK---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~---~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++.....+ ..+++|.+..... ..+.+.+|+.+++++.|+|++++++++. ...++++++++.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999875444 7899998876544 4567889999999999999999999875 4568999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC----CC
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KS 179 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~----~~ 179 (298)
++|.+++.....+++..+..++.|++.++++||+.+++|+||+|+||+++.++. ++|+|||.+......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence 999999988888999999999999999999999999999999999999998887 999999988644332221 11
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
..++..|+|||.+.+..++.+ +||||||+++|++++ |..||...+.. +....+.. ....+.+..++..+.+++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~l~~li 231 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAMLES-GERLPRPEECPQEIYSIM 231 (257)
T ss_pred ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHHc-CCcCCCCCCCCHHHHHHH
Confidence 122457999999877777665 999999999999998 99999876542 22222222 223344556789999999
Q ss_pred HHhhhhCCCCcccccccch
Q 022401 259 SRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~ 277 (298)
.+||+.||.+||++.+++.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 232 LSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 9999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=286.52 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=206.2
Q ss_pred CCCee-EEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch---------------HHHHHHHHHHhcCCCCCeeeee
Q 022401 22 SDRYD-FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRFK 85 (298)
Q Consensus 22 ~~~y~-~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---------------~~~~~e~~~l~~l~h~~i~~~~ 85 (298)
.++|. +.+.||.|++|.||++.+..+++.||+|.+....... ..+.+|+.++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35776 4578999999999999999889999999886543221 1467899999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
+++..++..++++|++. ++|.+.+.....+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCc
Confidence 99999999999999996 589999988788999999999999999999999999999999999999998887 999999
Q ss_pred CccccccCC---------------CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhH
Q 022401 166 GYSKSSVLH---------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230 (298)
Q Consensus 166 ~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 230 (298)
|++...... .......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 988643310 11112235678999999876654455599999999999999999999877654443
Q ss_pred HHHHHHHhhcCCC-CC---------------------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhh
Q 022401 231 RKTIQRILSVQYS-VP---------------------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVW 288 (298)
Q Consensus 231 ~~~~~~~~~~~~~-~~---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~ 288 (298)
............. ++ .....++++.++|.+||+.+|++|||+ .+++.|||
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~--------~~~l~~~~ 315 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA--------KEALKHEY 315 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH--------HHHhcCcc
Confidence 3333221111000 00 012357889999999999999999987 56667888
Q ss_pred hhhhhh
Q 022401 289 MFDATE 294 (298)
Q Consensus 289 ~~~~~~ 294 (298)
+++..+
T Consensus 316 ~~~~~~ 321 (335)
T PTZ00024 316 FKSDPL 321 (335)
T ss_pred cCCCCC
Confidence 875543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=288.31 Aligned_cols=257 Identities=29% Similarity=0.407 Sum_probs=205.6
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----eEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 95 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 95 (298)
+|++.+.||.|++|.||++++..++..+++|.+... ....+.+.+|+.++++++|+|++++.+++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 599999999999999999999888999999988753 233456888999999999999999999988765 789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
++++++. ++|.+.+....++++..++.++.+++.||++||+.|++|+||+|.||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence 9999997 488888888778999999999999999999999999999999999999998876 9999999987554432
Q ss_pred ----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC---------
Q 022401 176 ----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------- 242 (298)
Q Consensus 176 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 242 (298)
......++..|+|||.+.+......++|+||+|+++++|++|..||...+..+..............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 1233456778999999887733344599999999999999999999877654433332221110000
Q ss_pred ---------------C-CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 243 ---------------S-VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 243 ---------------~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
. .......+.++.++|.+||+.||.+|||+.++ ++|||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l--------l~~~~~~~ 294 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA--------LAHPYLAQ 294 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH--------HhCccHHh
Confidence 0 00112367899999999999999999988554 46666653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=287.27 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=202.9
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCeEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLA 95 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 95 (298)
++|++.+.||+|++|.||.+.+..+++.|++|++.... .....+.+|+.++++++||||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 78999999999999999999999999999999987542 334567789999999999999999998763 35789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+|++|+. ++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccC
Confidence 9999995 589998887778999999999999999999999999999999999999998887 9999999886433222
Q ss_pred CC-----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH--------------
Q 022401 176 QP-----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR-------------- 236 (298)
Q Consensus 176 ~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~-------------- 236 (298)
.. ....++..|+|||.+.+......++|+||+|+++|+|++|..||...+...........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 11 22356788999999866444455599999999999999999999765433222111110
Q ss_pred -----Hhh-cCC--CCC---CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 237 -----ILS-VQY--SVP---DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 237 -----~~~-~~~--~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
... ... ..+ .....++++.++|.+||+.||.+|||+ .++++|||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--------~~~l~~~~~~~ 299 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV--------EQALQHPFLAQ 299 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH--------HHHHhChhhhh
Confidence 000 000 000 012368999999999999999999987 55667888863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=276.36 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=202.5
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCC---cEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
+.++|++.+.||+|+||.||++.+..++ ..+++|.+.... .....+.+|+.++++++||||+++++++..++..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 4568999999999999999999876443 368999876532 23456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+++|++++++|.+++... ..++..++..++.+++.|+++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccc
Confidence 999999999999998764 46899999999999999999999999999999999999988876 999999988644332
Q ss_pred CCC----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 175 SQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 175 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
... .....+..|++||.+.+..++.+ +|+||||+++|++++ |..||......+. ...+... ...+....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~ 233 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDV----IKAIEEG-YRLPAPMD 233 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHH----HHHHhCC-CcCCCCCC
Confidence 211 11122457999999977777665 999999999999886 9999987654322 2222222 33444556
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
+++++.+++.+||+.+|.+||++.+++..
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 262 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERPKFEQIVSI 262 (267)
T ss_pred CCHHHHHHHHHHcccCchhCCCHHHHHHH
Confidence 78999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=287.39 Aligned_cols=257 Identities=28% Similarity=0.429 Sum_probs=197.2
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CeE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 94 (298)
.++|++.+.||+|++|.||.+.+..+++.||+|++... ......+.+|+.++++++|+|++++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999999989999999988642 23345677899999999999999999987643 357
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+++++++.+ ++.+.+ ....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPE 159 (336)
T ss_pred EEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccc
Confidence 999999965 777766 4457899999999999999999999999999999999999998887 999999988643322
Q ss_pred CC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH-----------HHhh
Q 022401 175 SQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ-----------RILS 239 (298)
Q Consensus 175 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~-----------~~~~ 239 (298)
.. .....++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......... .+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 12235678899999876554444559999999999999999999976543222111110 0000
Q ss_pred ---------cCC--CCC---CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 240 ---------VQY--SVP---DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 240 ---------~~~--~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
... ..+ .....++++.+++.+||+.||.+|||+. ++++|||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~--------e~l~hp~~~ 296 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE--------EALAHPYLE 296 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHH--------HHhcCcccc
Confidence 000 000 0123578899999999999999999884 555677765
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=278.28 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=198.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
+|++.+.||+|+||.||++.... ....+++|.+..... ....+.+|+.++++++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58999999999999999998753 235688888765432 23567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe
Q 022401 97 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv 152 (298)
++||+.+++|.+++... ..++...++.++.+++.||.|||+.|++|+||+|+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987542 247788999999999999999999999999999999999
Q ss_pred eCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCch
Q 022401 153 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (298)
Q Consensus 153 ~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~ 228 (298)
++++. ++|+|||++....... ......++..|+|||.+.+..++.+ +||||||+++++|++ |..||.......
T Consensus 161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 88876 9999999986432221 1222334568999999877766555 999999999999998 899997654322
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
+.+ ........+.+..++.++.+++.+||+.||.+||++.+++..
T Consensus 238 -~~~----~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 238 -LFN----LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred -HHH----HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 222 222223334445578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=291.09 Aligned_cols=250 Identities=34% Similarity=0.553 Sum_probs=216.3
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeec---CCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (298)
.++||+|-||+||-++++.+|+-||||++.+ ..+..+.+++|+.||+.+.||+|+.+.-.|+..+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4789999999999999999999999999875 3455678999999999999999999999999999999999999776
Q ss_pred CHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-CCCCCEEEeecCccccccCCCCCCCCCC
Q 022401 105 ELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (298)
Q Consensus 105 sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 182 (298)
-|...++ +.+++++...+.++.||+.||+|||-++|+|+||||+||++.+ +.-+.+||+|||+++............|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 6666664 5568999999999999999999999999999999999999954 3345799999999998888888888899
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--CCCCCHHHHHHHHH
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLISR 260 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 260 (298)
++.|+|||++++++|... -|+||+|+++|.-+.|..||+..++ ....+++..+-+|. ...++++..+||..
T Consensus 729 TPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEd------IndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDED------INDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred CccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccc------hhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 999999999999999887 9999999999999999999997543 23344555543332 23478999999999
Q ss_pred hhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 261 IFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 261 ~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+|+..-++|.|. ...+.||||++-
T Consensus 802 LLqVkm~kRysv--------dk~lsh~Wlq~y 825 (888)
T KOG4236|consen 802 LLQVKMRKRYSV--------DKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHhcch--------Hhhccchhhhcc
Confidence 999999999965 677789999863
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=271.89 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=203.1
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+..+|++.+.||+|++|.||++.+. .+..+++|.+.........+.+|++++++++|||++++++++......+++++|
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 3468999999999999999999886 466799998876665667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--C
Q 022401 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~--~ 177 (298)
+.+++|.+++... ..++...++.++.+++.++.+||+.+++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCccccc
Confidence 9999999988654 46889999999999999999999999999999999999998776 99999998764322111 1
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....+..|+|||.+.+..++.+ +|+||+|+++|++++ |..||....... ....+... .....+...++++.+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~ 232 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSE----VVETINAG-FRLYKPRLASQSVYE 232 (256)
T ss_pred CCCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHH----HHHHHhCC-CCCCCCCCCCHHHHH
Confidence 12234567999999877766555 999999999999998 899998755422 22222222 122223346899999
Q ss_pred HHHHhhhhCCCCcccccccchh
Q 022401 257 LISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~ 278 (298)
++.+||+.+|++|||+.+++++
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHh
Confidence 9999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=283.77 Aligned_cols=254 Identities=27% Similarity=0.452 Sum_probs=205.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
+.|.....||+|+||.||++.+..++..+++|.+.... ...+.+.+|+.+++.++|+|++++++.+...+..++|+||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 45677788999999999999998889999999886543 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCCC
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 180 (298)
++++|.+++.. ..+++..+..++.+++.|++|||+.|++|+||+|+||+++.++. ++|+|||++....... .....
T Consensus 102 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 102 EGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCcee
Confidence 99999988744 46899999999999999999999999999999999999998877 9999999876432222 12234
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 260 (298)
.++..|+|||.+.+..++.+ +|+||+|+++|++++|..||........+.. ... ......+.....+..+.+++..
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRD--NLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHh--cCCCccccccccCHHHHHHHHH
Confidence 57788999999877776655 9999999999999999999987554322221 111 1122223333478899999999
Q ss_pred hhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 261 IFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 261 ~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
||..||.+|||+.+ +++|||+..
T Consensus 255 ~l~~~P~~Rpt~~~--------il~~~~~~~ 277 (292)
T cd06658 255 MLVREPSQRATAQE--------LLQHPFLKL 277 (292)
T ss_pred HccCChhHCcCHHH--------HhhChhhhc
Confidence 99999999998854 456777764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=274.75 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=200.5
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
-|++.+.||.|+||.||++.+..++..+|+|.+.... .....+.+|+.++++++|||++++++++..+..+++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4788999999999999999998889999999876432 23356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCCC
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 180 (298)
++++|..++.. ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... .....
T Consensus 85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhccc
Confidence 99999988854 46899999999999999999999999999999999999998877 9999999875433221 11233
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 260 (298)
.++..|+|||.+.+..++.+ +|+||+|++++++++|..||....... ....+..... ......++.++.+++.+
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMK----VLFLIPKNNP-PTLEGNYSKPLKEFVEA 235 (277)
T ss_pred cCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHH----HHHHHhcCCC-CCCCcccCHHHHHHHHH
Confidence 56778999999877766555 999999999999999999997654321 1222222211 12233478999999999
Q ss_pred hhhhCCCCcccccccchhh
Q 022401 261 IFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 261 ~l~~dp~~Rps~~~~l~~~ 279 (298)
||+.+|.+||++.+++++.
T Consensus 236 ~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 236 CLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred HccCChhhCcCHHHHHhCH
Confidence 9999999999886655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.60 Aligned_cols=255 Identities=21% Similarity=0.312 Sum_probs=204.4
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEc-------cCCcEEEEEEeecC--CcchHHHHHHHHHHhcC-CCCCeeeeeE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKE 86 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 86 (298)
.+....++|++.+.||+|+||.||.++.. ..+..+++|..... ......+.+|+.+++.+ +||||+++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 34567899999999999999999999753 23457999987643 23345688999999999 8999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCce
Q 022401 87 VILTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (298)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~ni 150 (298)
++......++++||+.+++|.+++... ..++..++..++.|++.||.|||++|++|+||+|+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999998653 2367788999999999999999999999999999999
Q ss_pred EeeCCCCCCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCC
Q 022401 151 LLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE 226 (298)
Q Consensus 151 lv~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~ 226 (298)
+++.++. ++|+|||++........ .....++..|+|||++.+..++.+ +||||||+++|++++ |..||.....
T Consensus 169 li~~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 169 LVTENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EEcCCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9998876 99999999864432221 122334567999999887777666 999999999999998 7788876543
Q ss_pred chhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.+....+... .....+..++.++.+++.+||..+|.+|||+.+++...
T Consensus 246 ----~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 246 ----EELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred ----HHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 2223333222 22233445789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=280.21 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=198.5
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccC--------------CcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeee
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVT--------------KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFK 85 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~--------------~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~ 85 (298)
.++|++.+.||+|+||.||.+++..+ ...||+|.+.... .....+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 36899999999999999999987543 2358999886542 2335688999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEee
Q 022401 86 EVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153 (298)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~sL~~~l~~~~------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~ 153 (298)
+++...+..++|+||+.+++|.+++.... .++...++.++.+++.|++|||+.|++|+||+|+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999885432 367888999999999999999999999999999999999
Q ss_pred CCCCCCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh--CCCCCCCCCCch
Q 022401 154 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEPK 228 (298)
Q Consensus 154 ~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf~~~~~~~ 228 (298)
.++. ++|+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++++|++ +..||.......
T Consensus 164 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred CCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 8776 99999998864322211 122234568999999887777655 999999999999998 567887765433
Q ss_pred hHHHHHHHHhh--cCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 229 DFRKTIQRILS--VQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 229 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
......+.... ...........|+.+.+++++||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 32222221111 11112233347899999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=272.40 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=198.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
.++|++.+.||+|++|.||.+.+..++ .+++|.+.......+.+.+|+.++++++|+|++++++++. ....++++||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 367999999999999999999887554 5899988766656677889999999999999999999875 45678999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--C
Q 022401 102 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 177 (298)
Q Consensus 102 ~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~--~ 177 (298)
.+++|.+++.... .++...+..++.+++.||.|||+.|++|+||+|+||++++++. ++|+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCccccc
Confidence 9999999986543 4788999999999999999999999999999999999998887 99999998864322211 1
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
....++..|+|||...+...+.+ +|+||||+++|++++ |..||......+. ...+.. ....+.....+..+.+
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREV----LEQVER-GYRMPCPQGCPESLHE 234 (260)
T ss_pred CCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHc-CCCCCCCcccCHHHHH
Confidence 12234567999998877776555 999999999999999 8899987554322 222222 2233334457899999
Q ss_pred HHHHhhhhCCCCcccccccch
Q 022401 257 LISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~ 277 (298)
++++||+.||.+||++.++++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999987774
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=272.40 Aligned_cols=249 Identities=31% Similarity=0.460 Sum_probs=205.8
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+.++++++|+|++++.+++......++|+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999899999999987643 2334567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 101 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 101 ~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
+++++|.+++.. ...+++..++.++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-C
Confidence 999999998865 356899999999999999999999999999999999999998776 999999988654433 2
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....++..|++||...+..++.+ +|+||+|++++++++|..||...+.. .....+...... +.....+.++.+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQ----DLRYKVQRGKYP-PIPPIYSQDLQN 231 (256)
T ss_pred cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCCC-CCchhhCHHHHH
Confidence 334557889999999877776655 99999999999999999999876532 222222222222 222347899999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
++.+||+.+|++|||+ .++++||++
T Consensus 232 li~~~l~~~p~~Rp~~--------~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNC--------DKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCH--------HHHhcCCCC
Confidence 9999999999999987 555577764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=271.79 Aligned_cols=245 Identities=36% Similarity=0.545 Sum_probs=205.9
Q ss_pred eccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 31 lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
||.|++|.||.+.+..+++.+++|++..... ....+..|+.++++++|+|++++++.+..+...+++++++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999988899999999876432 335678899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCCCCCCCc
Q 022401 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 185 (298)
Q Consensus 107 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~ 185 (298)
.+++.....+++..+..++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||++...... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence 999988888999999999999999999999999999999999999998887 999999988654433 22334456778
Q ss_pred ccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhC
Q 022401 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265 (298)
Q Consensus 186 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 265 (298)
|++||...+...+.+ +|+||||+++|++++|..||...+. ......+..... +.+...++++.+++.+||..|
T Consensus 159 ~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~--~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKDPL--RFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred ccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcCCC--CCCCCCCHHHHHHHHHHhcCC
Confidence 999999877776555 9999999999999999999976554 233333333333 334446899999999999999
Q ss_pred CCCcccccccchhhhHHHhhhhhh
Q 022401 266 PAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 266 p~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
|++||++.. ..++++|||+
T Consensus 232 p~~R~~~~~-----~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGG-----AEEIKAHPFF 250 (250)
T ss_pred HhhCCCccc-----HHHHHhCCCC
Confidence 999999855 3677789986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=273.73 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=202.3
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCc---EEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
..++|+..+.||+|++|.||++....++. .+++|.+.... ...+.+.+|+.++++++|||++++.+++.+....+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 45689999999999999999999875544 68999876542 33456888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+|+|++++++|.+++.. .+.++..++..++.+++.|++|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~ 160 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccc
Confidence 99999999999999865 357899999999999999999999999999999999999998776 999999987644322
Q ss_pred CCCC----CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 175 SQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 175 ~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
.... .......|++||.+.+..++.+ +||||||+++|++++ |..||......+ ....+.. ....+....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~----~~~~i~~-~~~~~~~~~ 234 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHE----VMKAIND-GFRLPAPMD 234 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHHHhc-CCCCCCCCC
Confidence 2111 1122357999999877777655 999999999999997 999997765422 2222222 223344445
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
.+.++.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7899999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=274.36 Aligned_cols=255 Identities=26% Similarity=0.353 Sum_probs=197.2
Q ss_pred eeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----hHHHHHHH---HHHhcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREI---INHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 30 ~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
.||+|+||.||++.+..+++.||+|.+...... ...+..|. ..++...||+++.+.+++..+..+++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999888999999988754211 11233333 34445679999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCC
Q 022401 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (298)
Q Consensus 103 ~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 182 (298)
+++|...+.....+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence 9999999988888999999999999999999999999999999999999998876 999999987643322 2234467
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
+..|+|||.+.+....+.++||||+|+++|+|++|..||........ .............. +..++.++.+++.+||
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~--~~~~s~~~~~li~~~l 234 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVEL--PDSFSPELRSLLEGLL 234 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCC--CCcCCHHHHHHHHHHh
Confidence 88999999987553333449999999999999999999987643221 12222222222333 3346899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
..||.+||..... ...++++|||+.+..
T Consensus 235 ~~~p~~R~~~~~~---~~~~ll~~~~~~~~~ 262 (278)
T cd05606 235 QRDVNRRLGCLGR---GAQEVKEHPFFRSLD 262 (278)
T ss_pred hcCHHhccCCCCC---CHHHHHhCccccCCC
Confidence 9999999932110 235667899987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=280.76 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=185.6
Q ss_pred EeeeccCCeEEEEEEEEcc--CCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCeEEEEEeccCC
Q 022401 28 VRDIGSGNFGVARLMRDKV--TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 103 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~ 103 (298)
+..||+|+||.||+|++.. ++..+|+|.+.... ....+.+|+.++++++|||++++++++.. +..++++++|+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 4689999999999999753 56789999886543 34567889999999999999999999854 4578999999865
Q ss_pred CCHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC--CCCCEEEeecCcccccc
Q 022401 104 GELFERICN---------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 172 (298)
Q Consensus 104 ~sL~~~l~~---------~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~--~~~~~~l~d~~~~~~~~ 172 (298)
+|.+.+.. ...+++..++.++.|++.||.|||+.|++|+||||+||++..+ ...+++|+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 67666632 1247889999999999999999999999999999999999432 12349999999987443
Q ss_pred CCCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch---------hHHHHHHHHh-
Q 022401 173 LHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------DFRKTIQRIL- 238 (298)
Q Consensus 173 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---------~~~~~~~~~~- 238 (298)
.... .....+++.|+|||.+.+....+.++||||+|+++|+|++|..||....+.. .+........
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence 3221 1233567889999998776544555999999999999999999997543211 0110000000
Q ss_pred ----------hc--------CCC-------------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhh
Q 022401 239 ----------SV--------QYS-------------VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFV 287 (298)
Q Consensus 239 ----------~~--------~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp 287 (298)
.. ... .......+..+.+++.+||+.||.+|||+ .++++||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~--------~e~l~hp 315 (317)
T cd07867 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS--------EQALQDP 315 (317)
T ss_pred CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCH--------HHHhcCC
Confidence 00 000 00011235678899999999999999988 5556888
Q ss_pred hh
Q 022401 288 WM 289 (298)
Q Consensus 288 ~~ 289 (298)
|+
T Consensus 316 ~f 317 (317)
T cd07867 316 YF 317 (317)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=279.64 Aligned_cols=254 Identities=29% Similarity=0.424 Sum_probs=203.1
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+.++++++|+|++++++++.++...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 6788999999999999999988899999998865432 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCC
Q 022401 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (298)
Q Consensus 102 ~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 179 (298)
.+ ++.+.+.. ...+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence 76 77777755 457899999999999999999999999999999999999998877 9999999876444332 2223
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC---------------CC
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY---------------SV 244 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------~~ 244 (298)
..++..|+|||.+.+....+.++|+||+|+++|++++|..||...+..+........+..... ..
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 456778999999877634445599999999999999999999876654443333222111100 00
Q ss_pred C---------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 245 P---------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 245 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+ ....++.++.++|.+||+.||.+||++ .+++.|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~--------~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA--------EQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH--------HHHhhCCCC
Confidence 0 112367899999999999999999987 566678885
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=313.14 Aligned_cols=262 Identities=29% Similarity=0.438 Sum_probs=223.9
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeec---C-CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---G-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~---~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|.|+++||.|+||.|.+++++.+++.||.|++.+ - .....-|+.|-.++.--..+=|+.++..|.+++++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 445789999999999999999999999999999999876 1 223355778888888777888999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+||+|++||+|..+++...++++.-++.++..++.||+-||+.|+|||||||+|||+|..|+ ++|.|||.|-.....+
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999 9999999886554433
Q ss_pred --CCCCCCCCCcccCccccccc----cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc--CCCCCCC
Q 022401 176 --QPKSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--QYSVPDT 247 (298)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~ 247 (298)
......|||.|+|||++... +.+++.+|.||+|+++|||+.|..||.. +.+.+...+|.+- .+.+|..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa----dslveTY~KIm~hk~~l~FP~~ 305 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA----DSLVETYGKIMNHKESLSFPDE 305 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH----HHHHHHHHHHhchhhhcCCCcc
Confidence 33566799999999998732 3334459999999999999999999997 5567777777765 4555655
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
..+|++..+||.+++ .+|..|.. ++-+.++-+|||+.+++
T Consensus 306 ~~VSeeakdLI~~ll-~~~e~RLg-----rngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALL-CDREVRLG-----RNGIEDIKNHPFFEGID 345 (1317)
T ss_pred cccCHHHHHHHHHHh-cChhhhcc-----cccHHHHHhCccccCCC
Confidence 669999999999999 78999985 23358888999998763
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=279.26 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=200.9
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEc-------cCCcEEEEEEeecCC--cchHHHHHHHHHHhcC-CCCCeeeeeEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVI 88 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 88 (298)
....++|.+.+.||+|++|.||++++. .....+++|.+.... .....+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344579999999999999999999863 234578999877533 2235678899999999 699999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe
Q 022401 89 LTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (298)
Q Consensus 89 ~~~~~~~lv~~~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv 152 (298)
.+...+++++||+++++|.+++... ..++..++..++.|++.||.|||++|++|+||+|+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9989999999999999999998653 247888999999999999999999999999999999999
Q ss_pred eCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCch
Q 022401 153 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (298)
Q Consensus 153 ~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~ 228 (298)
+.++. ++|+|||++....... ......++..|+|||.+.+..++.+ +||||||+++|++++ |..||......
T Consensus 168 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~- 243 (314)
T cd05099 168 TEDNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVE- 243 (314)
T ss_pred cCCCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 98876 9999999986443211 1122233457999999877776655 999999999999999 88898765432
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
+....+... .....+..++.++.+++.+||+.||.+|||+.+++...
T Consensus 244 ---~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 244 ---ELFKLLREG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred ---HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 222222222 22223445789999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.69 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=200.2
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
..+|++.+.||+|+||.||.+... .++..+++|.+.... .....+.+|++++++++|+||+++.+++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 467999999999999999999742 356688999876533 33457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCE
Q 022401 96 IVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~---------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~ 160 (298)
+++||+.+++|.+++.... .+++..+..++.|++.|++|||+.|++|+||+|+||++++++. +
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~--~ 161 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV--V 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--E
Confidence 9999999999999986543 3788999999999999999999999999999999999998776 9
Q ss_pred EEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 022401 161 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR 236 (298)
Q Consensus 161 ~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~ 236 (298)
+|+|||++....... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+. ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEA----IEC 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHH----HHH
Confidence 999999876332221 1122234578999999887777666 999999999999998 8899876554322 222
Q ss_pred HhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 237 ILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+.... ....+..+|+++.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22221 22334457899999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=275.51 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=199.4
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcC---CCCCeeeeeEEEEeCCe-----
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILTPTH----- 93 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 93 (298)
|++.+.||+|++|.||+++++.+++.+++|.+..... ....+.+|+.+++++ .|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999988899999999874322 223455677776655 59999999999988766
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
+++++|++.+ +|.+++.... .+++..++.++.+++.||++||+.+++|+||+|+||+++.++. ++|+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence 9999999975 7888886643 4899999999999999999999999999999999999998876 999999988755
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-CCCC-----
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVP----- 245 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~----- 245 (298)
..........++..|+|||.+.+..++.+ +|+||+|+++|+|++|..||......+............. ..++
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 44433334456788999999987777665 9999999999999999999987665554444433221100 0000
Q ss_pred ---------------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 246 ---------------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 246 ---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
....+++.+.+++.+||+.||.+||++ .++++|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~--------~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA--------FEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH--------HHHhcCcCC
Confidence 011246788999999999999999987 555578885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=299.30 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=187.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccC-CcEEEEE------------------EeecCCcchHHHHHHHHHHhcCCCCCee
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVT-KELVAVK------------------YIERGDKIDENVQREIINHRSLRHPNIV 82 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~-~~~~aiK------------------~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 82 (298)
.++|++++.||+|+||.||++..+.. +...+.| ...........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46899999999999999999876432 2222222 1222223345578899999999999999
Q ss_pred eeeEEEEeCCeEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC
Q 022401 83 RFKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (298)
Q Consensus 83 ~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~ 157 (298)
++++++.+....|++++++.+ ++..++... .......+..++.|++.||+|||++|++|+||||+||+++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999854 666665432 22346678889999999999999999999999999999998887
Q ss_pred CCEEEeecCccccccCCCC--CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCC-CCCCCC--chhHHH
Q 022401 158 PRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPDE--PKDFRK 232 (298)
Q Consensus 158 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~--~~~~~~ 232 (298)
+||+|||++........ .....++..|+|||.+.+..++.+ +|||||||++|+|++|..+ +..... ...+.+
T Consensus 306 --vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 306 --IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred --EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999864433221 123458899999999988877666 9999999999999998754 433221 122222
Q ss_pred HHHHHhhcCCCC--------------------------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhh
Q 022401 233 TIQRILSVQYSV--------------------------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSF 286 (298)
Q Consensus 233 ~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~h 286 (298)
.+..+....... ......+.++.++|.+||+.||.+|||+ .+++.|
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa--------~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA--------AELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH--------HHHhhC
Confidence 221111000000 0111356788899999999999999988 555578
Q ss_pred hhhhh
Q 022401 287 VWMFD 291 (298)
Q Consensus 287 p~~~~ 291 (298)
||+.+
T Consensus 455 p~f~~ 459 (501)
T PHA03210 455 PLFSA 459 (501)
T ss_pred hhhhc
Confidence 88764
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=270.93 Aligned_cols=248 Identities=22% Similarity=0.371 Sum_probs=200.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
+..++|++.+.||+|+||.||++... .+..+++|.+.......+.+.+|+.++++++|+|++++.+++.. ...++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 45689999999999999999999865 45569999887665556778899999999999999999999877 77899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|+++++|.+++... ..++...+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYT 158 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcc
Confidence 99999999998653 35788899999999999999999999999999999999988876 999999987643322111
Q ss_pred --CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 178 --KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
....++..|+|||.+....++.+ +|+||||+++|++++ |..||...+.... ...+ ......+.....+.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~ 232 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEV----IRAL-ERGYRMPRPENCPEEL 232 (260)
T ss_pred cccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHH----HHHH-hCCCCCCCcccCCHHH
Confidence 12234567999999877666555 999999999999998 8999987544222 2222 2223334445578999
Q ss_pred HHHHHHhhhhCCCCcccccccch
Q 022401 255 RDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
.+++.+||..||++||++.+++.
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999877764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=274.76 Aligned_cols=253 Identities=21% Similarity=0.248 Sum_probs=203.4
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEcc----CCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEe-C
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-P 91 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~----~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 91 (298)
.++.++|++.+.||+|+||.||.+.+.. ++..+++|.+.... .....+.+|+.++++++|+|++++++++.. +
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3567899999999999999999999875 35779999876432 224557889999999999999999998776 4
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEe
Q 022401 92 THLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~ 163 (298)
...+++++++.+++|.+++... ..++..+++.++.+++.||+|||+.+++|+||+|+||+++.++. ++|+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~ 159 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKIT 159 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEEC
Confidence 6789999999999999988653 45889999999999999999999999999999999999988876 9999
Q ss_pred ecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 022401 164 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS 239 (298)
Q Consensus 164 d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 239 (298)
|||+++...... ......++..|+|||.+.+..++.+ +||||||+++|++++ |..||...+..+ .. ....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~----~~-~~~~ 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE----MA-AYLK 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH----HH-HHHH
Confidence 999986432211 1122334567999999877777665 999999999999998 999997754322 12 2222
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 240 VQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
..........+|+++.+++.+||..||++|||+.+++...
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 234 DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 2334444455789999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=277.22 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=205.0
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEc----cCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDK----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT--PTH 93 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 93 (298)
..+|++.+.||+|+||.||++... .++..+|+|.+..... ....+.+|+.++++++|+|++++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 357899999999999999999864 3478899999886655 36778999999999999999999999877 557
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.++++||+++++|.+++.... .++...+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccc
Confidence 899999999999999997654 5899999999999999999999999999999999999998876 9999999887544
Q ss_pred CCCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch----------hHHHHHHHHh
Q 022401 173 LHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------DFRKTIQRIL 238 (298)
Q Consensus 173 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~----------~~~~~~~~~~ 238 (298)
.... .........|++||...+..++.+ +|+||||+++++|++|..|+....... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 2211 112234456999999877776655 999999999999999999986543211 0122222233
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 239 SVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
......+.....+.++.+++.+||+.||.+|||+.+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 33334444555789999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=280.78 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=196.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEcc--CCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CeEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKV--TKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 95 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 95 (298)
+|++.+.||+|++|.||++.+.. ++..||+|.+.... ...+.+.+|+.++++++|||++++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999987 78999999987632 3346678899999999999999999999988 7899
Q ss_pred EEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC----CCCCCEEEeecC
Q 022401 96 IVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG----SPAPRLKICDFG 166 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~----~~~~~~~l~d~~ 166 (298)
+|+|++.+ ++.+.+.. ...+++..++.++.|++.||+|||+.+++|+||+|+||+++. ++. ++|+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCc
Confidence 99999965 66666532 136889999999999999999999999999999999999987 555 9999999
Q ss_pred ccccccCCCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch---------hHHHH
Q 022401 167 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------DFRKT 233 (298)
Q Consensus 167 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---------~~~~~ 233 (298)
++........ .....++..|+|||.+.+......++|+||||+++++|++|..||....... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 8864432222 1233467789999988765544555999999999999999999997654322 11111
Q ss_pred HHHHhh--------------------cCCCCCCC-----------CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHH
Q 022401 234 IQRILS--------------------VQYSVPDT-----------NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLL 282 (298)
Q Consensus 234 ~~~~~~--------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~ 282 (298)
...+.. ........ ...+.++.+++.+||+.||++|||+ .+
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~--------~e 309 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA--------EE 309 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH--------HH
Confidence 110000 00000000 1356789999999999999999987 55
Q ss_pred Hhhhhhh
Q 022401 283 LFSFVWM 289 (298)
Q Consensus 283 ~~~hp~~ 289 (298)
+++|||+
T Consensus 310 il~~~~f 316 (316)
T cd07842 310 ALEHPYF 316 (316)
T ss_pred HhcCCCC
Confidence 5678875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.96 Aligned_cols=253 Identities=26% Similarity=0.459 Sum_probs=205.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
.-|+....||+|+||.||++.+..+++.+++|.+.... ...+.+.+|+.+++.++|||++++++++..++..++++||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 44666778999999999999998889999999986532 33456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCCC
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 180 (298)
++++|...+.. ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++....... .....
T Consensus 101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccce
Confidence 99999887744 56899999999999999999999999999999999999998887 9999999876333222 12334
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CCCCCCCCCHHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTNPISQECRDLIS 259 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 259 (298)
.++..|+|||.+.+..++.+ +|+||+|+++++|++|..||........ ...+..... ........+.++.+++.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQA----MKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred ecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhccCCCCccccCCCCHHHHHHHH
Confidence 57789999999977777655 9999999999999999999986543222 222222221 22233347899999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+||+.+|.+||++ .++++|||+..
T Consensus 253 ~~l~~~P~~Rps~--------~~ll~~~~~~~ 276 (297)
T cd06659 253 RMLTREPQERATA--------QELLDHPFLLQ 276 (297)
T ss_pred HHhcCCcccCcCH--------HHHhhChhhcc
Confidence 9999999999987 55557777764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=288.00 Aligned_cols=255 Identities=23% Similarity=0.354 Sum_probs=203.8
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCCcc--hHHHHHHHHHHhcCC-CCCeeeeeEEE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVI 88 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~ 88 (298)
.+....++|.+.+.||+|+||.||++++. .++..||+|++...... ...+.+|+.++.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 45666788999999999999999999964 34568999999754322 346788999999997 99999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhCC------------------------------------------------------
Q 022401 89 LTPTHLAIVMEYASGGELFERICNAG------------------------------------------------------ 114 (298)
Q Consensus 89 ~~~~~~~lv~~~~~~~sL~~~l~~~~------------------------------------------------------ 114 (298)
......++|+||+.+++|.+++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999885431
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCce
Q 022401 115 --------------------------------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (298)
Q Consensus 115 --------------------------------------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~ni 150 (298)
.++...+..++.+++.||+|||+.+++|+||+|+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256667888999999999999999999999999999
Q ss_pred EeeCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCC
Q 022401 151 LLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE 226 (298)
Q Consensus 151 lv~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~ 226 (298)
+++.++. ++|+|||++....... ......++..|+|||.+.+..++.+ +||||||+++++|++ |..||.....
T Consensus 271 Ll~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9998776 9999999986432211 1122345678999999977776555 999999999999998 8889876554
Q ss_pred chhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.+.... ........+.+..++.++.+++.+||..+|.+||++.++++.
T Consensus 348 ~~~~~~----~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYN----AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHH----HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332222 222233333444578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=276.59 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=198.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEE----ccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--Ce
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRD----KVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~----~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 93 (298)
..-|++++.||+|+||.||.++. ..++..|++|.+.... .....+.+|+.++++++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 45589999999999999999984 4568889999986442 2345688999999999999999999998775 57
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.++|+||+++++|.+++.... .++..+++.++.+++.||+|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccc
Confidence 899999999999999986543 5899999999999999999999999999999999999998877 9999999887443
Q ss_pred CCCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCC-----------CchhHHHHHHHH
Q 022401 173 LHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-----------EPKDFRKTIQRI 237 (298)
Q Consensus 173 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-----------~~~~~~~~~~~~ 237 (298)
.... .....++..|+|||.+.+..++.+ +||||||+++|+++++..|+.... ...........+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 3221 122345667999999877776665 999999999999999776543211 111111122221
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
......+....+++++.+|+.+||+.||.+|||+.++++.
T Consensus 240 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 240 -EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2222334445588999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=273.93 Aligned_cols=243 Identities=25% Similarity=0.332 Sum_probs=193.6
Q ss_pred eeeccCCeEEEEEEEEccCCc--EEEEEEeecC--CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~--~~aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|+||.||++....++. .+++|.+... ......+.+|+.++.++ +|||++++++++...+..++++||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999977665 4678877642 23345688899999999 799999999999999999999999999
Q ss_pred CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 104 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 104 ~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
++|.+++.... .++..++..++.+++.|++|||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence 99999986532 3788999999999999999999999999999999999998877 99999998
Q ss_pred cccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
+..............+..|+|||.+....++.+ +|+||||+++++|++ |..||...+.. .....+.. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~~~-~~~~~~ 232 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKLPQ-GYRLEK 232 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHH----HHHHHHhC-CCCCCC
Confidence 753332222222334567999999877666555 999999999999997 99999764432 22222222 222233
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
....+.++.+++.+||+.||.+|||+.+++...
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 344789999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=273.22 Aligned_cols=250 Identities=20% Similarity=0.306 Sum_probs=197.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCc----EEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
+..++|++.+.||+|+||.||++.+..++. .+++|.+.... .....+..|+..+.++.||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 345789999999999999999999876665 46777765332 223456778888899999999999998754 45
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+++++++++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~ 160 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLY 160 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceecc
Confidence 7789999999999999975 456899999999999999999999999999999999999998776 9999999986443
Q ss_pred CCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 173 LHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 173 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
.... .....++..|++||.+.+..++.+ +||||||+++|++++ |..||..... .. ...+.......+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~-~~----~~~~~~~~~~~~~~~ 234 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRP-HE----VPDLLEKGERLAQPQ 234 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCH-HH----HHHHHHCCCcCCCCC
Confidence 2221 122335567999999877777655 999999999999998 9999976543 11 122222233333344
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.++.++.+++.+||..||.+|||+.+++..
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 235 ICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 478899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=274.16 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=194.4
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCc--EEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------Ce
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKE--LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 93 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~--~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 93 (298)
+.+++.||+|+||.||+++...++. .+|+|.+... ....+.+.+|+.++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3578999999999999999876654 5899987654 23345678899999999999999999987532 24
Q ss_pred EEEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 94 LAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~------~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
.+++++|+.+++|.+++.. ...++...+..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence 6899999999999887732 234789999999999999999999999999999999999988877 99999999
Q ss_pred cccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCC
Q 022401 168 SKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYS 243 (298)
Q Consensus 168 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
+....... .......++.|++||...+..++.+ +||||||+++|++++ |..||...... .....+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~~~~-~ 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENS----EIYDYLRQGN-R 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHcCC-C
Confidence 87543222 1223345678999999877777665 999999999999999 78899764432 2222222222 2
Q ss_pred CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 244 VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 244 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.+....+++.+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 23344578999999999999999999999888864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=271.67 Aligned_cols=241 Identities=26% Similarity=0.386 Sum_probs=197.0
Q ss_pred eeeccCCeEEEEEEEEcc-CCc--EEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSGNFGVARLMRDKV-TKE--LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~-~~~--~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||+|++|.||++.+.. +++ .+++|.+..... ....+.+|+.++++++||||+++++++.. ..+++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999864 333 689998876544 45678899999999999999999999988 889999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC----CC
Q 022401 104 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QP 177 (298)
Q Consensus 104 ~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~----~~ 177 (298)
++|.+.+.+.. .++...++.++.|++.||++||++|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence 99999997764 6899999999999999999999999999999999999998876 9999999886443321 11
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
....++..|+|||.+.+..++.+ +||||||+++++|++ |..||......+. ...+.......+.+...|..+.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQI----LKKIDKEGERLERPEACPQDIYN 232 (257)
T ss_pred cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHhcCCcCCCCccCCHHHHH
Confidence 22345678999999877777666 999999999999998 9999976654332 22222223333444457899999
Q ss_pred HHHHhhhhCCCCcccccccch
Q 022401 257 LISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~ 277 (298)
++.+||+.+|.+|||+.++++
T Consensus 233 li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 233 VMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHCCCCcccCCCHHHHHH
Confidence 999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=285.78 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=202.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeec---CCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (298)
-...|++++.||.||.+.||++.....+ .||+|.+.. +.....-+.+|+..|.+| +|.+|+++++|-..++.+|+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 4567999999999999999999987555 456665543 445557799999999999 58999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 97 VMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
|||+- ..+|...|.+... .+...++.+.+|++.++.++|+.||||.||||.|+++-.+. +||+|||.|.......
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~---LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGR---LKLIDFGIANAIQPDT 513 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeee---EEeeeechhcccCccc
Confidence 99975 5689888877665 34468899999999999999999999999999999886433 9999999987555443
Q ss_pred ---CCCCCCCCCcccCccccccccCC----------CCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 176 ---QPKSTVGTPAYIAPEVLLRHEYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 176 ---~~~~~~~~~~~~aPE~~~~~~~~----------~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
......|++.|||||.+.....+ .+++|||||||++|+|+.|..||+... .....+..++..+.
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI~~P~~ 590 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAITDPNH 590 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhhcCCCc
Confidence 33567799999999998754332 334999999999999999999998743 23455666666655
Q ss_pred CCCCCCCC-CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 243 SVPDTNPI-SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 243 ~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.++.+.-- +.++.++++.||+.||.+|||+ -.+|+|||++-
T Consensus 591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si--------~eLLqhpFl~~ 632 (677)
T KOG0596|consen 591 EIEFPDIPENDELIDVMKCCLARDPKKRWSI--------PELLQHPFLQI 632 (677)
T ss_pred cccccCCCCchHHHHHHHHHHhcCcccCCCc--------HHHhcCccccc
Confidence 33332212 3459999999999999999977 55667888774
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=275.67 Aligned_cols=258 Identities=26% Similarity=0.375 Sum_probs=200.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 95 (298)
....++|++.+.||+|++|.||++.+..+++.+|+|.+..... ....+..|+.++.+. .||||+++++++......+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 4556899999999999999999999998899999999875432 233455566655555 5999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+++|++.+ ++.+++.. ...+++..+..++.+++.|++|||+ .|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~ 167 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVD 167 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccC
Confidence 99999854 67666654 4578999999999999999999997 59999999999999998776 99999998865433
Q ss_pred CCCCCCCCCCCcccCcccccccc----CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-CCCCCCCC
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTN 248 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 248 (298)
........++..|+|||.+.+.. ++. ++|+||||+++|+|++|..||...... .+...++... ....+...
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDI-RADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEPPSLPPNE 243 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCcccccc-chhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCCCCCCCCC
Confidence 33333345677899999986543 444 499999999999999999999764321 1222222222 22333333
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.++.++.+|+.+||+.||.+||++ .+++.|||++.
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~--------~~il~~~~~~~ 278 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKY--------RELLQHPFIRR 278 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCH--------HHHhcChhhhc
Confidence 478999999999999999999988 55557777763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=282.60 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=194.5
Q ss_pred eeeccC--CeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 022401 29 RDIGSG--NFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (298)
Q Consensus 29 ~~lg~g--~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (298)
+.||.| ++|.||.+++..+++.||+|+...... ..+.+.+|+.+++.++||||+++++++..+...++|++++.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 899999999998999999999875432 235678899999999999999999999999999999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC----
Q 022401 104 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---- 177 (298)
Q Consensus 104 ~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~---- 177 (298)
+++.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++. +++.||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCcccccc
Confidence 99999887643 4889999999999999999999999999999999999998876 999999754322111111
Q ss_pred ----CCCCCCCcccCccccccccC-CCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh--------------
Q 022401 178 ----KSTVGTPAYIAPEVLLRHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL-------------- 238 (298)
Q Consensus 178 ----~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------- 238 (298)
....+...|+|||++.+... ...++||||+|+++|++++|..||.................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 11223456999999876421 23459999999999999999999987654322211111000
Q ss_pred ---------------------------hcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 239 ---------------------------SVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 239 ---------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
......+.....++.+.+|+++||+.||++|||+ .++++|||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta--------~e~l~~~~~~~ 313 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA--------SSLLSHAFFKQ 313 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH--------HHHhhCHHHHH
Confidence 0000111122356789999999999999999988 55568888876
Q ss_pred hhh
Q 022401 292 ATE 294 (298)
Q Consensus 292 ~~~ 294 (298)
..|
T Consensus 314 ~~~ 316 (328)
T cd08226 314 VKE 316 (328)
T ss_pred HHH
Confidence 554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=276.82 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=198.7
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEcc----------------CCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeee
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKV----------------TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVR 83 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~----------------~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~ 83 (298)
.++|++.+.||+|+||.||.+++.. ++..+|+|.+.... .....+.+|+.+++.++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3679999999999999999986432 34568999887543 23456889999999999999999
Q ss_pred eeEEEEeCCeEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe
Q 022401 84 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (298)
Q Consensus 84 ~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv 152 (298)
+++++......++++||+.+++|.+++.... .++..++..++.|++.|++|||+.|++|+||+|+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999986543 35677899999999999999999999999999999999
Q ss_pred eCCCCCCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh--CCCCCCCCCCc
Q 022401 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEP 227 (298)
Q Consensus 153 ~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf~~~~~~ 227 (298)
+.++. ++|+|||++........ ......+..|++||...+..++.+ +|+||||+++|+|++ |..||......
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 164 GKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred cCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 88776 99999998864332211 122233567999998877776555 999999999999998 77888776543
Q ss_pred hhHHHHHHHHhh--cCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 228 KDFRKTIQRILS--VQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 228 ~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+........... .....+.+..++..+.+++.+||+.||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 332222111111 11123334457899999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=272.96 Aligned_cols=246 Identities=21% Similarity=0.305 Sum_probs=195.8
Q ss_pred eeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe-----
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 93 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 93 (298)
|++.+.||+|+||.||.|....+ +..+|+|.+..... ....+.+|+..++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987643 47899999875432 23567889999999999999999998866543
Q ss_pred -EEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 94 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 94 -~~lv~~~~~~~sL~~~l~~~------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
.+++++|+.+++|...+... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence 79999999999998887432 35889999999999999999999999999999999999998876 9999999
Q ss_pred ccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 167 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 167 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
++........ ......+..|++||.+.+..++.+ +||||||+++|+|++ |..||......+ ....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~----~~~~~~~~~- 232 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHE----IYDYLRHGN- 232 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCC-
Confidence 9864432221 112234567999999876666555 999999999999999 888987655422 222322222
Q ss_pred CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 243 SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 243 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
....+...+.++.+++.+||+.||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 223344578999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=265.03 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=208.5
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc--hHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (298)
.+.++.+++..||.|..|+|++++.+.+|...|||+..+.... .+++...+.++..- .+|+|+++.|+|..+..+++
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 4567788999999999999999999999999999998775432 34455555555444 58999999999999999999
Q ss_pred EEeccCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHh-hcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 97 VMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 97 v~~~~~~~sL~~~l-~~~~~~~~~~~~~i~~~l~~~l~~Lh-~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
.||.|.. -+..++ ....++++..+-.+...++.||.||- +.|++|||+||+|||+|..|+ +||+|||.+.+....
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecc
Confidence 9998843 344444 34567899999999999999999997 568999999999999999998 999999999888877
Q ss_pred CCCCCCCCCCcccCccccccc---cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh-hcCCCCCCCCCC
Q 022401 175 SQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL-SVQYSVPDTNPI 250 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 250 (298)
.......|++-|||||.+.-. .|+.+ +||||||+.++|++||+.||...+.+ + +.+.++. +.++.++.....
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~td--F-e~ltkvln~ePP~L~~~~gF 321 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTD--F-EVLTKVLNEEPPLLPGHMGF 321 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCcc--H-HHHHHHHhcCCCCCCcccCc
Confidence 777888899999999988643 56666 99999999999999999999986543 2 2233333 455566666678
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
++.+++|+..||.+|+.+||.+ .++++|||+.
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y--------~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKY--------NKLLEHPFIK 353 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcch--------HHHhcCccee
Confidence 9999999999999999999977 4555666654
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=269.71 Aligned_cols=245 Identities=27% Similarity=0.390 Sum_probs=201.6
Q ss_pred eeEEeeeccCCeEEEEEEEEccCC----cEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~----~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
+++.+.||.|+||.||.+.+...+ ..+++|.+..... ....+.+|+..+++++|+|++++++++.+.+..++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467899999999999999998655 8899999876543 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 99 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
+++++++|.+.+..... +++..+..++.|++.|+.+||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence 99999999999876554 899999999999999999999999999999999999998886 99999999864443321
Q ss_pred CC--CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 177 PK--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 177 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
.. ...++..|+|||.+.+..++.+ +|+||+|+++++|++ |..||...... .....+.... ........+.+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~ 232 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMSNE----EVLEYLKKGY-RLPKPENCPPE 232 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhcCC-CCCCCCcCCHH
Confidence 11 2235678999999866666555 999999999999998 78888764432 2222332222 22334447899
Q ss_pred HHHHHHHhhhhCCCCcccccccch
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+.+++.+||+.||.+|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999988875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=275.74 Aligned_cols=254 Identities=30% Similarity=0.448 Sum_probs=203.5
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
|++.+.||+|++|.||.+....+++.+++|.+... ....+.+..|+.++++++|+|++++++++.+....++|+|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999988999999998764 333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCC
Q 022401 102 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (298)
Q Consensus 102 ~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 179 (298)
++ +|.+++... ..+++..+..++.+++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence 74 899999776 57999999999999999999999999999999999999998877 9999999886443322 2223
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc--------------CCCC-
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------------QYSV- 244 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~- 244 (298)
...+..|+|||.+.+....+.++|+||||++++++++|..||...+..+.+.......... ....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 3456779999998776333445999999999999999999998866544433322211100 0000
Q ss_pred --------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 245 --------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 245 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
......+.++.+++.+||..||.+||++ .++++|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~--------~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA--------KEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCH--------HHHhhCcCC
Confidence 0011247889999999999999999987 666688885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=282.66 Aligned_cols=260 Identities=29% Similarity=0.402 Sum_probs=201.3
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC--CeE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THL 94 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 94 (298)
..++|++.+.||+|++|.||++.+..+++.+++|.+... ......+.+|+.+++++ +||||+++++++... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 457899999999999999999999888999999987542 22334567899999999 999999999998653 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++|+|++.+ +|...+..+ .+++...+.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSEL 160 (337)
T ss_pred EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccc
Confidence 999999974 888888665 7888999999999999999999999999999999999998887 999999988644332
Q ss_pred CC------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH-----------
Q 022401 175 SQ------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI----------- 237 (298)
Q Consensus 175 ~~------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 237 (298)
.. .....++..|+|||.+.+......++|+||+|+++|+|++|..||......+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 1123467789999988765544556999999999999999999997755443322221111
Q ss_pred --------hh----cCCC--CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 238 --------LS----VQYS--VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 238 --------~~----~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.. .... ......++.++.++|.+||+.||.+|||+.+++ +|||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il--------~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL--------EHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHh--------hChhhhhh
Confidence 00 0000 011123688999999999999999999885554 66776544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=279.43 Aligned_cols=257 Identities=22% Similarity=0.308 Sum_probs=203.1
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccC-------CcEEEEEEeecCC--cchHHHHHHHHHHhcC-CCCCeeeeeEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVT-------KELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVI 88 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~-------~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 88 (298)
.+...+|++++.||+|+||.||.+++... +..+++|.+.... .....+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 34456899999999999999999986432 2368999876532 2345688999999999 799999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe
Q 022401 89 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (298)
Q Consensus 89 ~~~~~~~lv~~~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv 152 (298)
......++++||+++++|.+++.... .++..++..++.|++.||.|||++|++|+||+|+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 99999999999999999999986532 36778889999999999999999999999999999999
Q ss_pred eCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCch
Q 022401 153 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (298)
Q Consensus 153 ~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~ 228 (298)
+.++. ++|+|||++....... ......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..+
T Consensus 168 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 168 TEDNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred cCCCc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 98877 9999999886433221 1122223467999999987777666 999999999999998 888887654322
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHH
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLL 283 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~ 283 (298)
....+... .....+...+.++.+++.+||+.+|.+|||+.++++......
T Consensus 245 ----~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 ----LFKLLKEG-HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----HHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 22222222 222334457899999999999999999999999997654443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=283.05 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=201.5
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 92 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 92 (298)
..++|++.+.||+|++|.||.+.+..++..||+|++.... .....+.+|+.++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3568999999999999999999999899999999886432 22346778999999999999999999987543
Q ss_pred -eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 -~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
.+++|++++ +++|..++. ...+++..++.++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccccccc
Confidence 468999998 678887775 456899999999999999999999999999999999999998877 999999988644
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh------------
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS------------ 239 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 239 (298)
.. ......+++.|++||.+.+....+.++|+||+|++++++++|..||...+......+.......
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 169 DS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred cc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 32 2223456788999999876443455599999999999999999999876543332222211000
Q ss_pred -------cCCCC------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 240 -------VQYSV------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 240 -------~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..... .....++.++.++|.+||+.||.+|||+ .+++.|||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~--------~~~l~~~~~~~~ 304 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA--------AEALAHPYFEEF 304 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH--------HHHhcCccHhhh
Confidence 00000 0112467889999999999999999987 455567777643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=274.99 Aligned_cols=254 Identities=30% Similarity=0.435 Sum_probs=200.7
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc--hHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEEEecc
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
|++.+.||+|++|.||+|....+++.+++|.+...... .....+|+..+++++ |+|++++++++.++...++|+|++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 78899999999999999999888999999988654332 233456889999998 999999999999999999999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCC
Q 022401 102 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (298)
Q Consensus 102 ~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~ 179 (298)
+++|.+.+.... .++..++..++.|++.+|.|||++|++|+||+|.||++++++. ++|+|||.+...........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence 778888887654 7899999999999999999999999999999999999998887 99999998875544433344
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh---------------cCCCC
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS---------------VQYSV 244 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~ 244 (298)
..++..|+|||.+........++|+||||++++++++|..||......+.+......+.. .....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 557788999998865554455599999999999999999999776654433322211000 00000
Q ss_pred C---------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 245 P---------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 245 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+ .....+.++.+++++||+.||++|||+. +++.|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~--------ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS--------QALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHH--------HHhhCCCC
Confidence 0 0112368899999999999999999885 45567775
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=269.26 Aligned_cols=245 Identities=25% Similarity=0.352 Sum_probs=198.2
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
+...++|++.+.||+|+||.||.+.. +++.+++|.+.... ....+.+|+.++++++|||++++.+++..+ ..++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred cccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 34557899999999999999998864 57789999886543 346788999999999999999999998654 478999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 99 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
||+.+++|.+++.... .++...+..++.|++.|+.+||+.|++||||+|+||+++.++. ++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG-- 153 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--
Confidence 9999999999987544 4789999999999999999999999999999999999998876 999999987643221
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
.........|+|||.+.+..++.+ +|+||||+++|+|++ |..||......+ ....+. ..........++.++.
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~ 227 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKE----VKECVE-KGYRMEPPEGCPADVY 227 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHH----HHHHHh-CCCCCCCCCcCCHHHH
Confidence 122334567999999877776655 999999999999997 899997755322 222222 2222233445789999
Q ss_pred HHHHHhhhhCCCCcccccccch
Q 022401 256 DLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+++.+||+.+|..||++.+++.
T Consensus 228 ~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 228 VLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=268.35 Aligned_cols=239 Identities=25% Similarity=0.350 Sum_probs=189.8
Q ss_pred eeccCCeEEEEEEEEc--cCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCC
Q 022401 30 DIGSGNFGVARLMRDK--VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105 (298)
Q Consensus 30 ~lg~g~~~~vy~~~~~--~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~s 105 (298)
.||+|+||.||.+... ..+..+|+|++..... ..+.+.+|+.++++++||||+++++++. ....++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999998764 3455799998865432 2356889999999999999999999875 457899999999999
Q ss_pred HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC----CCCC
Q 022401 106 LFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKST 180 (298)
Q Consensus 106 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~----~~~~ 180 (298)
|.+++.. ...+++..++.++.|++.|+.|||++|++|+||+|+||+++.++. ++|+|||++........ ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9998864 457899999999999999999999999999999999999998877 99999998864322211 1112
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
.++..|+|||.+....++.+ +||||||+++|++++ |..||......+ ....+..+ .....+...++++.+++.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~l~~li~ 232 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPE----VMSFIEQG-KRLDCPAECPPEMYALMK 232 (257)
T ss_pred CCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHHHHCC-CCCCCCCCCCHHHHHHHH
Confidence 23467999999877666555 999999999999996 999998765422 22222222 222334457899999999
Q ss_pred HhhhhCCCCcccccccch
Q 022401 260 RIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~ 277 (298)
+||+.||++||++.++.+
T Consensus 233 ~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 233 DCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=274.74 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=199.5
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.|...+.||+|++|.||++.+..++..+++|.+..... ....+.+|+.+++.++|||++++++++.+....++|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 47778889999999999999988999999999875322 22457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
|+.+ ++.+.+.. ..++++.++..++.|++.++.|||+.|++|+||+|+||+++.++. ++|+|||++.... ...
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---~~~ 175 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---PAN 175 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---CCC
Confidence 9965 66666644 456899999999999999999999999999999999999998877 9999999875322 223
Q ss_pred CCCCCCcccCcccccc---ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 179 STVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
...++..|+|||.+.. ..++. ++|+||||+++|+|++|..||...+...... .+............++.++.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~-~sDv~slGvil~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~ 250 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNDSPTLQSNEWTDSFR 250 (313)
T ss_pred CccccccccChhhccccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhcCCCCCCccccCHHHH
Confidence 4457788999999742 33444 4999999999999999999997755422222 22222222222334678999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+|+.+||+.+|.+||++ .+++.|||+...
T Consensus 251 ~li~~~l~~~P~~Rp~~--------~~~l~~~~~~~~ 279 (313)
T cd06633 251 GFVDYCLQKIPQERPAS--------AELLRHDFVRRD 279 (313)
T ss_pred HHHHHHccCChhhCcCH--------HHHhcCcccCCC
Confidence 99999999999999987 555678887643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.98 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=200.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
...++|.+.+.||+|++|.||.+.+... ...+++|.+.... ...+.+.+|+.++++++|||++++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 3456899999999999999999987543 4468999876543 334578899999999999999999999865 456
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++|+|++++++|.+++.... .++...++.++.+++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~ 159 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLED 159 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeeccc
Confidence 79999999999999997644 5899999999999999999999999999999999999998877 99999998764332
Q ss_pred CCCC--CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 174 HSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 174 ~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
.... ....+...|+|||.+....++.+ +||||||++++++++ |..||......+.. ..+.. ....+.+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~----~~~~~-~~~~~~~~~~ 233 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVI----GRIEN-GERLPMPPNC 233 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHc-CCcCCCCCCC
Confidence 2211 12223457999999877766655 999999999999986 99999876543322 22222 2233444567
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
|.++.+++.+||+.+|.+|||+.+++...
T Consensus 234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 234 PPTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 89999999999999999999998888644
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=274.72 Aligned_cols=243 Identities=28% Similarity=0.418 Sum_probs=195.7
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
..|+..+.||+|+||.||++++..++..+++|.+..... ....+.+|+.++++++|||++++++++..+...++|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 458999999999999999999988899999999875422 2345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
||+.+ ++.+.+. ...++++.++..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.... ..
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PA 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---Cc
Confidence 99976 6666664 4556899999999999999999999999999999999999988877 9999999875332 22
Q ss_pred CCCCCCCcccCcccccc---ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 178 KSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
....++..|+|||.+.. ...+. ++|+||+|+++|+|++|..||........ ...+............+++.+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l 253 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPTLQSNEWSDYF 253 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCc-cccHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHhccCCCCCCccccHHH
Confidence 34457788999998742 33444 49999999999999999999877543222 222222222222333478899
Q ss_pred HHHHHHhhhhCCCCcccccccc
Q 022401 255 RDLISRIFVADPAAVSIFFFPL 276 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l 276 (298)
.+++.+||+.+|.+||++.+++
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHH
Confidence 9999999999999999885554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=270.25 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=200.7
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCc----EEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
..++|++.+.||+|+||.||++....++. .+++|....... ....+.+|+.++++++|||++++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 45789999999999999999999865554 588887765432 34567889999999999999999999877 788
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++++|++.+++|.+.+... ..+++..+..++.|++.|++|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccC
Confidence 9999999999999998764 46899999999999999999999999999999999999988776 99999998864432
Q ss_pred CCCCC---CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 174 HSQPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 174 ~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
..... ....+..|+|||.+....++.+ +|+||+|++++++++ |..||......+ ....+.. ....+.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~ 235 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVE----IPDLLEK-GERLPQPPI 235 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHH----HHHHHhC-CCCCCCCCC
Confidence 22211 1223457999999876666655 999999999999998 999998754322 2222222 223344444
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.+.++.+++.+||..||..||++.++++.
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~ 264 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELINE 264 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78899999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=280.81 Aligned_cols=254 Identities=21% Similarity=0.344 Sum_probs=198.5
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEEEe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 90 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (298)
....++|++.+.||.|+||.||+|.+. .+++.||+|++..... ....+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 345579999999999999999999853 4578899999875432 234577899999999 68999999998765
Q ss_pred C-CeEEEEEeccCCCCHHHHHHhC--------------------------------------------------------
Q 022401 91 P-THLAIVMEYASGGELFERICNA-------------------------------------------------------- 113 (298)
Q Consensus 91 ~-~~~~lv~~~~~~~sL~~~l~~~-------------------------------------------------------- 113 (298)
. ..+++++||+++++|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 5689999999999999888542
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---CCCC
Q 022401 114 -----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKS 179 (298)
Q Consensus 114 -----------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~---~~~~ 179 (298)
..++...+..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++....... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCC
Confidence 12567788889999999999999999999999999999998876 9999999886432221 1122
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
..++..|+|||.+.+..++.+ +||||||+++|++++ |..||........+.... .. ....+.+...++++.+++
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~ 315 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL---KE-GTRMRAPDYTTPEMYQTM 315 (343)
T ss_pred CCCCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH---hc-cCCCCCCCCCCHHHHHHH
Confidence 234567999999877777665 999999999999997 889987654333222222 11 122223334678999999
Q ss_pred HHhhhhCCCCcccccccchhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.+||+.||.+|||+.+++++.
T Consensus 316 ~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred HHHccCChhhCcCHHHHHHHH
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=274.11 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=203.6
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
.|+....||+|++|.||.+....++..+++|.+.... .....+.+|+.+++.++|+|++++++++...+..++++||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3445578999999999999999899999999876433 234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCCCC
Q 022401 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 181 (298)
Q Consensus 103 ~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 181 (298)
+++|.+.+. ...+++..+..++.|++.+++|||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccc
Confidence 999988774 446899999999999999999999999999999999999998877 9999999876443222 223345
Q ss_pred CCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHh
Q 022401 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261 (298)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 261 (298)
++..|++||.+.+..++.+ +|+||+|+++|++++|..||.......... .... ...........++.++.+++.+|
T Consensus 178 ~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~l~~li~~~ 253 (292)
T cd06657 178 GTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRD--NLPPKLKNLHKVSPSLKGFLDRL 253 (292)
T ss_pred cCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh--hCCcccCCcccCCHHHHHHHHHH
Confidence 6788999999877666555 999999999999999999998654432221 1111 11222223345789999999999
Q ss_pred hhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 262 FVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 262 l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
|+.||.+||++ .++++|||+..
T Consensus 254 l~~~P~~R~~~--------~~ll~~~~~~~ 275 (292)
T cd06657 254 LVRDPAQRATA--------AELLKHPFLAK 275 (292)
T ss_pred HhCCcccCcCH--------HHHhcChHHhc
Confidence 99999999987 45567888764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=270.68 Aligned_cols=248 Identities=31% Similarity=0.470 Sum_probs=199.7
Q ss_pred CeeEEeeeccCCeEEEEEEEEcc-CCcEEEEEEeecCC-----------cchHHHHHHHHHHhc-CCCCCeeeeeEEEEe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGD-----------KIDENVQREIINHRS-LRHPNIVRFKEVILT 90 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~-~~~~~aiK~~~~~~-----------~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 90 (298)
.|++.+.||+|++|.||.+.+.. +++.+++|.+.... .....+.+|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 67889999875321 112345667777764 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 91 PTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~----~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
++..++++||+.+++|.+.+. ....+++..++.++.+++.++.+||+ .+++|+||+|+||+++.++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence 999999999999999988874 34468999999999999999999996 78999999999999998887 999999
Q ss_pred CccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
|.+.............++..|++||.+.+..++.+ +|+||||+++|++++|..||...+... ....+........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 233 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLS----LATKIVEAVYEPL 233 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHH----HHHHHhhccCCcC
Confidence 99875444333344557888999999987776555 999999999999999999997654322 2223333333222
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.....++++.+++.+||+.||++||++.++..+
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 223478999999999999999999999887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=273.32 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=200.4
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
..++|++.+.||+|+||.||++.+.. ++..+++|.+..... ....+.+|+.++++++|||++++++++.+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 45789999999999999999998753 577899998875432 23568889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceE
Q 022401 94 LAIVMEYASGGELFERICNA----------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~----------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nil 151 (298)
.++++|++++++|.+++... ..++...++.++.+++.||.+||++|++|+||+|+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 99999999999999998643 23678889999999999999999999999999999999
Q ss_pred eeCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 022401 152 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP 227 (298)
Q Consensus 152 v~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~ 227 (298)
++.++. ++|+|||++....... .......+..|+|||.+.+..++.+ +||||||+++|+|++ |..||......
T Consensus 163 ~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 163 VGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred ecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 988887 9999999876332221 1122234567999999877777665 999999999999997 77888765432
Q ss_pred hhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+....+..... .+.+...+.++.+++.+||+.||.+|||+.+++.
T Consensus 240 ----~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 ----EVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ----HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 23333333322 2233457899999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=266.22 Aligned_cols=241 Identities=27% Similarity=0.358 Sum_probs=196.1
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
+.||+|++|.||.+.+.. ++.+++|.+..... ....+.+|++++++++|+||+++++++.+....++|+|++.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999977 88999998875432 345788999999999999999999999999999999999999999
Q ss_pred HHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC---CCCCC
Q 022401 107 FERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 182 (298)
Q Consensus 107 ~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~ 182 (298)
.+++.. ...++...+..++.+++.++.+||+++++|+||+|+||+++.++. ++|+|||++......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence 999865 346889999999999999999999999999999999999998887 999999988644321111 12223
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 261 (298)
...|+|||.+.+..++.+ +|+||||+++|++++ |..||........ ...+ ......+.+...+.++.+++.+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~li~~~ 231 (251)
T cd05041 158 PIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQT----RERI-ESGYRMPAPQLCPEEIYRLMLQC 231 (251)
T ss_pred eeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHH----HHHH-hcCCCCCCCccCCHHHHHHHHHH
Confidence 456999999877766555 999999999999998 7888876553221 1112 22233344455789999999999
Q ss_pred hhhCCCCcccccccchh
Q 022401 262 FVADPAAVSIFFFPLNM 278 (298)
Q Consensus 262 l~~dp~~Rps~~~~l~~ 278 (298)
|+.+|.+|||+.++++.
T Consensus 232 l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 232 WAYDPENRPSFSEIYNE 248 (251)
T ss_pred hccChhhCcCHHHHHHH
Confidence 99999999999888853
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=286.28 Aligned_cols=250 Identities=38% Similarity=0.650 Sum_probs=227.0
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch---HHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
...+.|.+.+.||.|.|+.|..+++..++..||+|.+.+..... ..+.+|++++..+.||||++++.+.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34578999999999999999999999999999999988754333 346789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
|+||+.++.+.+++.+.+...+.+...++.|+..|++|||+.+++|||||.+|++++.+-+ +||+|||++........
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeeccccc
Confidence 9999999999999999999999999999999999999999999999999999999998887 99999999988888888
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
....+|++-|.|||.+.+..+....+|+||+|+++|.++.|.+||.+..- ..+-.+...+.++++.. ++.+..+
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----k~Lr~rvl~gk~rIp~~--ms~dce~ 284 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----KELRPRVLRGKYRIPFY--MSCDCED 284 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----ccccchheeeeecccce--eechhHH
Confidence 88999999999999999999999999999999999999999999998543 45555666777777776 7899999
Q ss_pred HHHHhhhhCCCCcccccccch
Q 022401 257 LISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~ 277 (298)
+|+++|-.+|.+|++..++..
T Consensus 285 lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 285 LLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred HHHHhhccCccccCCHHHhhh
Confidence 999999999999998766554
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=289.06 Aligned_cols=256 Identities=23% Similarity=0.390 Sum_probs=211.0
Q ss_pred CCCCe-eEEeeeccCCeEEEEEEEEccCCcEEEEEEee-----cCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--
Q 022401 21 DSDRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-- 92 (298)
Q Consensus 21 ~~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 92 (298)
..++| ++.++||.|+|.+||+|.+..+|-.||=-.+. ......+++..|+.+|+.|+||||++++.++.+..
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 33455 56789999999999999999888777644332 34455588999999999999999999999998764
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
.+.+|+|.+..|+|+.++.+...++...++.|++||++||.|||++. |+|||||.+||||+.+.. .|||+|+|+|..
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G-~VKIGDLGLAtl 195 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLG-EVKIGDLGLATL 195 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcC-ceeecchhHHHH
Confidence 58999999999999999999999999999999999999999999876 999999999999986543 599999999975
Q ss_pred ccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
...... ....|||.|||||+.. -.|+.. .||||||++++||+|+..||....... ...+++.++-..-....--
T Consensus 196 ~r~s~a-ksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~A---QIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 196 LRKSHA-KSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPA---QIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred hhcccc-ceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHH---HHHHHHHcCCCHHHhhccC
Confidence 543333 3478999999999875 556555 999999999999999999999987654 4555666655433333334
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+++++||.+||.. ..+|+|+ .++|.||||+..
T Consensus 270 dPevr~fIekCl~~-~~~R~sa--------~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSA--------KELLKDPFFDED 302 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCH--------HHHhhChhhccc
Confidence 78999999999988 9999977 666688888864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=276.33 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=198.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEccC--CcEEEEEEeecCC---cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC----Ce
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVT--KELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH 93 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~--~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~ 93 (298)
+|++.+.||+|+||.||.+++..+ +..+|+|.+.... .....+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 8899999876432 2245677899999999 599999999875432 45
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++++++++. ++|.+.+.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence 788899885 589998888888999999999999999999999999999999999999998887 99999998864332
Q ss_pred CCC-----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc--------
Q 022401 174 HSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-------- 240 (298)
Q Consensus 174 ~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 240 (298)
... .....++..|+|||.+.+......++|+||+|++++++++|..||...+....+..........
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 211 1223577889999987664433455999999999999999999998765433332222211000
Q ss_pred ---------------C-CCCC-CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 241 ---------------Q-YSVP-DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 241 ---------------~-~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
. .... .....+.++.+++.+||+.||.+|||+ .+++.|||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~--------~~ll~~~~~~ 296 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV--------EEALEHPYLA 296 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH--------HHHhcChhhh
Confidence 0 0000 112357899999999999999999987 4556788875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=269.43 Aligned_cols=261 Identities=34% Similarity=0.544 Sum_probs=221.3
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchH----HHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE----NVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|.++++||+|.||.|.+++.+.+++.||+|++.++.-... .-..|-.+|+..+||.+..+...|.....+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 356899999999999999999999999999999999887643322 2235778888899999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~- 174 (298)
+||||.+||.|.-.++....+++.....+-..|+.||.|||+++||+||||.+|+++|.+|+ +|+.|||+|......
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhccccc
Confidence 99999999999999988888999999999999999999999999999999999999999999 999999999755444
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
......+|+|.|+|||++..+-|... .|.|.+|+++|||++|++||...+....+ .-+.-.....| +.++++.
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~kLF----eLIl~ed~kFP--r~ls~eA 395 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHEKLF----ELILMEDLKFP--RTLSPEA 395 (516)
T ss_pred ceeccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchhHHH----HHHHhhhccCC--ccCCHHH
Confidence 44577889999999999988888655 99999999999999999999987764433 33344444444 4489999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..|+..+|.+||.+|..- --....++..|+|+.+.
T Consensus 396 ktLLsGLL~kdP~kRLGg---GpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 396 KTLLSGLLKKDPKKRLGG---GPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHHHHhhcChHhhcCC---CchhHHHHHhhhhhccC
Confidence 999999999999999854 11234667788888654
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=264.59 Aligned_cols=240 Identities=24% Similarity=0.328 Sum_probs=193.6
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
+.||+|++|.||++... +++.+++|.+.... .....+.+|+.++++++|||++++++++......++|+||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999865 67789999876543 2234678899999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC--CCCCCC
Q 022401 107 FERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGT 183 (298)
Q Consensus 107 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~ 183 (298)
.+++... ..+++..+..++.+++.+|.|||++|++|+||+|+||+++.++. ++|+|||++......... ......
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence 9988653 45789999999999999999999999999999999999998877 999999987643322111 122335
Q ss_pred CcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
..|+|||.+.+..++.+ +||||||+++|++++ |..||....... ....+. ..........++.++.+++.+||
T Consensus 158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQ----AREQVE-KGYRMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHH----HHHHHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence 67999999877766555 999999999999998 899997654322 222222 22233334457899999999999
Q ss_pred hhCCCCcccccccch
Q 022401 263 VADPAAVSIFFFPLN 277 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~ 277 (298)
+.+|++||++.+++.
T Consensus 232 ~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 232 DYKPENRPKFSELQK 246 (250)
T ss_pred ccCcccCCCHHHHHH
Confidence 999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=279.82 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=197.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------Ce
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 93 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 93 (298)
++|.+.+.||+|++|.||+|.+..+++.+|+|.+... ......+.+|+.+++.++||||+++.+++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6899999999999999999999888999999988653 22234577899999999999999999998754 34
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+++|++++.. +|.... ...+++..+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 95 ~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~~ 169 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHADA 169 (342)
T ss_pred EEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCCC
Confidence 6999999854 666554 346889999999999999999999999999999999999998877 99999998864322
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH----------------
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI---------------- 237 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~---------------- 237 (298)
......++..|+|||.+.+......++|+||||+++|+|++|..||...+....+.......
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 22233457789999998765444555999999999999999999998765433332222110
Q ss_pred ---hhcCCCCC------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 238 ---LSVQYSVP------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 238 ---~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.......+ .....+.++.++|.+||+.||.+||++ .+++.|||+.+-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~--------~e~l~h~~f~~~ 303 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA--------TEALEHPYFDSF 303 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH--------HHHhcCcchhhc
Confidence 00000000 012357889999999999999999987 555678888654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=282.70 Aligned_cols=256 Identities=23% Similarity=0.376 Sum_probs=199.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe-----
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 93 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 93 (298)
.++|++.+.||+|++|.||.+++..++..|++|++... ......+.+|+.++++++|||++++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46899999999999999999999989999999987653 2233456789999999999999999998766544
Q ss_pred -EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 -~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.++|++++ +++|.+++.. ..+++..++.++.+++.|+++||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~ 169 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTD 169 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccccc
Confidence 89999998 5689888854 56899999999999999999999999999999999999998877 9999999987443
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-----------
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------- 241 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 241 (298)
.. .....++..|+|||.+.+......++||||||+++|++++|..||...+....+...........
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 22 23345677899999886644444559999999999999999999987654333222211100000
Q ss_pred --------CCC------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 242 --------YSV------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 242 --------~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
... ......++++.++|++||+.||.+|||+. ++++|||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~--------ell~h~~~~~ 303 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA--------EALAHPYLAE 303 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH--------HHhcCCCccc
Confidence 000 00113588999999999999999999884 4557777753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=275.01 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=197.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEe-CCeEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAI 96 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 96 (298)
..++|++.+.||.|++|.||++.+..+++.+++|++... ......+.+|+.++++++|||++++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 567899999999999999999999999999999987543 2234667789999999999999999999876 457899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
+++++ +++|...+.. ..+++..+..++.|++.||+|||+.|++|+||+|.||+++.++. ++|+|||.+..... .
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~--~ 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDP--Q 161 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCC--C
Confidence 99998 5588877754 45788889999999999999999999999999999999998777 99999998764322 1
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH-------------------
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI------------------- 237 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~------------------- 237 (298)
.....++..|+|||.+.+......++|+||+|+++|++++|..||........+.......
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 2233467789999987664434455999999999999999999997654322211111100
Q ss_pred -hhcC--CCCC---CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 238 -LSVQ--YSVP---DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 238 -~~~~--~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.... ...+ ....+++++.++|.+||+.+|++|||+.++ +.|||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el--------l~~~~~ 291 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA--------LAHPYL 291 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH--------hcCCcc
Confidence 0000 0001 112467899999999999999999988554 566666
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=279.42 Aligned_cols=256 Identities=29% Similarity=0.381 Sum_probs=195.0
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC---------
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP--------- 91 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 91 (298)
.++|++.+.||.|++|.||++.+..+++.|++|.+.... .....+.+|+.++++++|||++++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 378999999999999999999999999999999886543 3345678899999999999999999876543
Q ss_pred -----CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 92 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 92 -----~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
...++++||++ ++|.+.+.. ..+++..++.++.|++.|++|||+.|++|+||+|+||+++.++. .++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFG 160 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcc
Confidence 35789999996 488887754 46899999999999999999999999999999999999975442 38999999
Q ss_pred ccccccCCCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH-----
Q 022401 167 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI----- 237 (298)
Q Consensus 167 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~----- 237 (298)
++........ .....++..|+|||.+........++|||||||++|+|++|..||...+............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 8864322211 1223467789999987654444555999999999999999999997765433322222110
Q ss_pred -------------hh---cCCCCC---CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 238 -------------LS---VQYSVP---DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 238 -------------~~---~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
.. .....+ ....++.++.+|+.+||+.||.+|||+.+++.+.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~ 302 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence 00 000000 01236789999999999999999998855554333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=267.81 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=187.1
Q ss_pred eeeccCCeEEEEEEEEc--cCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 022401 29 RDIGSGNFGVARLMRDK--VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~--~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (298)
+.||+|+||.||++... .++..+++|.+..... ....+.+|+.++++++|||++++++++.+....++|+||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999864 3456789998765432 2346788999999999999999999999888999999999999
Q ss_pred CHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---C
Q 022401 105 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 176 (298)
Q Consensus 105 sL~~~l~~~~-----~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~---~ 176 (298)
+|.+++.... ..+...+..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeec
Confidence 9999986432 3566778899999999999999999999999999999998776 9999999875332221 1
Q ss_pred CCCCCCCCcccCcccccccc------CCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCC---
Q 022401 177 PKSTVGTPAYIAPEVLLRHE------YDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD--- 246 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 246 (298)
.....++..|+|||.+.... ..+.++|+||+|+++|+|++ |..||......+...... .......+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~ 235 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---REQQLKLPKPRL 235 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---hcccCCCCCCcc
Confidence 12234567899999876432 12345999999999999996 999997765433322221 122222221
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
....++.+.+++..|+ .+|++|||+.+++.
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 2246788999999999 68999999998885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.83 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=191.0
Q ss_pred eEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 26 ~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
.+++.+|.| +.||.++...+++.+|+|++... ......+.+|+.++++++|+||+++++++...+..++++||+.
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 344444444 55666666668999999998754 3334578899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC----
Q 022401 103 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---- 176 (298)
Q Consensus 103 ~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~---- 176 (298)
+++|.+++... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. +++.||+.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeeccccccccc
Confidence 99999998753 45889999999999999999999999999999999999998887 99999998753322111
Q ss_pred ----CCCCCCCCcccCccccccc--cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh-----------
Q 022401 177 ----PKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS----------- 239 (298)
Q Consensus 177 ----~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------- 239 (298)
.....++..|+|||.+... .++. ++|+||+|+++++|++|..||..........+.......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNE-KSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 1223356679999998654 3444 499999999999999999999875543322221111000
Q ss_pred -----------------cCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 240 -----------------VQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 240 -----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..........++.++.+|+.+||+.||++|||+ .+++.|||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--------~~ll~~p~~~~~ 301 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA--------SQLLNHSFFKQC 301 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH--------HHHhcCchHhhh
Confidence 000001111234678999999999999999988 455577887644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=268.20 Aligned_cols=249 Identities=28% Similarity=0.454 Sum_probs=197.3
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeec------CCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER------GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
+|.+.+.||+|++|.||++.+...+..+++|.... .......+..|..+++.++|||++++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 68999999999999999999987666666666543 112223456788999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 98 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+||+++++|.+.+.. ...+++..++.++.|++.|+.+||+.|++|+||+|+||++++ +. ++|+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~--~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL--LKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC--EeecccCceeecCC
Confidence 999999999888753 456899999999999999999999999999999999999975 33 89999998764322
Q ss_pred C-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 174 H-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 174 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
. .......++..|+|||.+.+..++.+ +|+||+|++++++++|..||..... ......+...... ..+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~ 231 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNF----LSVVLRIVEGPTP-SLPETYSR 231 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHcCCCC-CCcchhcH
Confidence 2 22233456788999999877776665 9999999999999999999965432 2223333332221 22334789
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
++.++|.+||..||++||++ .++++|||+
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~--------~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSA--------AEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCH--------HHHhhCCCC
Confidence 99999999999999999987 566678885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=271.90 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=199.7
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCc----EEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
+..++|+..+.||+|++|.||++.+..++. .+++|.+..... ....+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 456789999999999999999999876665 468887764322 233578899999999999999999998654 4
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+++++++++++|.+.+.... .++...++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLE 160 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEcccccccccc
Confidence 678999999999999986644 5889999999999999999999999999999999999988776 9999999987443
Q ss_pred CCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 173 LHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 173 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
.... .....++..|++||.+.+..++.+ +||||||+++|++++ |..||..... ... ..+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~----~~~~~~~~~~~~~~ 234 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REI----PDLLEKGERLPQPP 234 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHH----HHHHHCCCCCCCCC
Confidence 2221 112234568999999877776555 999999999999997 8899976542 112 22223333334445
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
..+..+.+++.+||..||++||++.+++....
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 57889999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=290.84 Aligned_cols=252 Identities=30% Similarity=0.469 Sum_probs=207.6
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeec-CCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCHH
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 107 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~ 107 (298)
-+||.|.+|+||.+++..+...+|||-+.. ..+..+-++.|+.+.++|+|.||++.+|.+..++++-+.||-.+||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999999999999999998764 4445566889999999999999999999999999999999999999999
Q ss_pred HHHHhC-CCC--CHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc-CCCCCCCCCCC
Q 022401 108 ERICNA-GRF--SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGT 183 (298)
Q Consensus 108 ~~l~~~-~~~--~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~ 183 (298)
+++... +++ ++.++-.+-+||++||.|||++.|||||||-+||+|+.-.. .+||+|||-+.+.. ......+..|+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySG-vlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSG-VLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccc-eEEecccccchhhccCCccccccccc
Confidence 999654 456 88999999999999999999999999999999999975332 49999999876433 33344566799
Q ss_pred CcccCccccccc-cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 184 PAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 184 ~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
..|||||++..+ ..+.+++|||||||.+.||.||.+||....++. ..+-++.-.....+.+..++++.+.||.+|+
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---HhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 999999998654 445777999999999999999999999877643 2222222222333445557899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+||.+||++ .++++-||++..
T Consensus 817 epd~~~R~sA--------~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 817 EPDPCDRPSA--------KDLLQDPFLQHN 838 (1226)
T ss_pred CCCcccCccH--------HHhccCcccccC
Confidence 9999999988 555577888755
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.65 Aligned_cols=244 Identities=24% Similarity=0.369 Sum_probs=193.8
Q ss_pred eeeccCCeEEEEEEEEccCC------cEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 29 RDIGSGNFGVARLMRDKVTK------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~------~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+.||+|++|.||.++..... ..+++|.+.... .....+.+|+.++++++||||+++++++......++++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999986433 679999876543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC---CCCEEEeecCcccc
Q 022401 101 ASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 170 (298)
Q Consensus 101 ~~~~sL~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~---~~~~~l~d~~~~~~ 170 (298)
+++++|.+++... ..++..++..++.+++.|++|||+.+++|+||+|+||+++.++ ...++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999998642 3378899999999999999999999999999999999998766 12499999998864
Q ss_pred ccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 171 SVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 171 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
..... .......+..|+|||.+.+...+.+ +||||||+++|+|++ |..||...+..+ ....+.. ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~-~~~~~~ 234 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQE----VLQHVTA-GGRLQK 234 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHH----HHHHHhc-CCccCC
Confidence 33221 1122344678999999887777555 999999999999998 999997654422 2222222 222233
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
....|.++.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 266 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEI 266 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 44578999999999999999999999887753
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=277.12 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=196.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------C
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 92 (298)
.++|++.+.||+|+||.||.+.+..++..||+|++.... .....+.+|+.++++++||||+++.+++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 478999999999999999999998889999999887532 2235677899999999999999999988643 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
..+++++++ +++|.+.+.. ..+++..++.++.|++.|++|||+.|++|+||+|+||++++++. ++|+|||++....
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~ 171 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD 171 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccc
Confidence 468888877 6788877754 46899999999999999999999999999999999999998887 9999999886432
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh--------------
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL-------------- 238 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------- 238 (298)
. ......++..|+|||.+.+......++||||+|+++|+|++|..||...+....+........
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 172 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred c--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 2 222345677899999876643334459999999999999999999976554333322211110
Q ss_pred -----hcCCCCCC------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 239 -----SVQYSVPD------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 239 -----~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
......+. ....+.++.++|.+||+.||.+||++.++ ++|||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~--------l~h~~f~ 304 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA--------LAHAYFA 304 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH--------hcChhhh
Confidence 00000000 11357889999999999999999987544 4666665
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=267.59 Aligned_cols=244 Identities=20% Similarity=0.314 Sum_probs=186.7
Q ss_pred eeeccCCeEEEEEEEEcc--CCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 022401 29 RDIGSGNFGVARLMRDKV--TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~--~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (298)
+.||+|+||.||++.... ....+++|.+..... ....+.+|+..++.++|+||+++++.+.....+++|+||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999996532 345688887654322 2345778999999999999999999999999999999999999
Q ss_pred CHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---C
Q 022401 105 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 176 (298)
Q Consensus 105 sL~~~l~~~~-----~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~---~ 176 (298)
+|.+++.... ..+...+..++.|++.|++|||++|++|+||||+||+++.++. ++|+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence 9999986543 2457788999999999999999999999999999999998887 9999999875332211 1
Q ss_pred CCCCCCCCcccCccccccc------cCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCC---C
Q 022401 177 PKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP---D 246 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~ 246 (298)
.....++..|+|||..... ...+.++||||||+++|+|++ |..||......+.+..... ......+ .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 235 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR---EQDIKLPKPQL 235 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh---ccCccCCCCcc
Confidence 1233455679999987532 223445999999999999999 7788877654333322222 2222222 2
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
...++..+.+++..|| .||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred cccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 3357889999999998 599999999988864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=272.20 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=197.4
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
..|+..+.||+|++|.||.+++..++..+++|.+.... .....+.+|+.+++.++|+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45888999999999999999998889999999886432 22345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
||+.+ ++.+.+. ...++++.++..++.+++.++.|||+.+++|+||+|+||+++.++. ++|+|||++..... .
T Consensus 95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~---~ 168 (308)
T cd06634 95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---A 168 (308)
T ss_pred EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC---c
Confidence 99964 7766664 4556899999999999999999999999999999999999988876 99999998764322 2
Q ss_pred CCCCCCCcccCcccccc---ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 178 KSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
....++..|+|||.+.+ ...+. ++||||||+++|++++|..||...+..... ..+.............+..+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 243 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNESPALQSGHWSEYF 243 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCc-ccchHHHHHHHHHHHcCCCCCccccHHHHH----HHHhhcCCCCcCcccccHHH
Confidence 23456788999998753 23434 499999999999999999998765432221 12222222222233478899
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
.++|.+||+.+|.+||++.+ ++.|||+.
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~--------ll~~~~~~ 271 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEV--------LLKHRFVL 271 (308)
T ss_pred HHHHHHHhhCCcccCCCHHH--------HhhCcccc
Confidence 99999999999999998844 44666654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=265.58 Aligned_cols=239 Identities=21% Similarity=0.193 Sum_probs=189.6
Q ss_pred eeeccCCeEEEEEEEEccCC----------cEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 29 RDIGSGNFGVARLMRDKVTK----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~----------~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
+.||+|+||.||++.+..++ ..+++|.+.........+.+|+.++++++|||++++++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999998666 357888776554446778899999999999999999999988 7789999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC-----CEEEeecCcccccc
Q 022401 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV 172 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~-----~~~l~d~~~~~~~~ 172 (298)
||+++++|.+++.... .++...+..++.|++.||+|||+.|++|+||+|+||+++.++.. .++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999997666 78999999999999999999999999999999999999877621 49999999886433
Q ss_pred CCCCCCCCCCCCcccCccccccc-cCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
. .....+...|+|||++... .....++|+||||++++++++ |..||....... ..... ......+.. .
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~----~~~~~~~~~--~ 229 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFY----QDQHRLPMP--D 229 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHH----hcCCCCCCC--C
Confidence 2 2233456679999998766 233444999999999999999 577887654221 11111 112222222 2
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
...+.+++.+||+.||.+|||+.++++.
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 4789999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=262.73 Aligned_cols=234 Identities=20% Similarity=0.243 Sum_probs=189.9
Q ss_pred CCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhC
Q 022401 34 GNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 113 (298)
Q Consensus 34 g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~ 113 (298)
|.++.||++++..+++.+|+|.+..... ..+|...+....|||++++++++......++++||+++++|.+.+...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 8899999999999999999999876532 233444444567999999999999999999999999999999999887
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCCcccCccccc
Q 022401 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193 (298)
Q Consensus 114 ~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 193 (298)
..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++++|||.+...... .....++..|+|||...
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccC
Confidence 78999999999999999999999999999999999999998887 999999976533222 22334566799999987
Q ss_pred cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCccccc
Q 022401 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFF 273 (298)
Q Consensus 194 ~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 273 (298)
+..++.+ +|+||+|+++|++++|..|+...... .........+..++..+.++|.+||+.||++||++.
T Consensus 156 ~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 156 ISEETEA-CDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CCCCCch-hhHHHHHHHHHHHHHCcchhhcCchh----------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 6666555 99999999999999999887643211 011111223344789999999999999999999975
Q ss_pred ccchhhhHHHhhhhhh
Q 022401 274 FPLNMSCLLLFSFVWM 289 (298)
Q Consensus 274 ~~l~~~~~~~~~hp~~ 289 (298)
+.. ..++++|||+
T Consensus 225 ~~~---~~~~~~h~~~ 237 (237)
T cd05576 225 VAG---VEDIKSHPFF 237 (237)
T ss_pred ccc---hHHHHcCCCC
Confidence 553 5788999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=264.36 Aligned_cols=240 Identities=21% Similarity=0.238 Sum_probs=185.9
Q ss_pred eeeccCCeEEEEEEEEcc------------CCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 29 RDIGSGNFGVARLMRDKV------------TKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~------------~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
+.||.|+||.||++.... ....+++|.+..... ....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 233588887655432 2346778899999999999999999999988999
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC-----CCEEEeecCccc
Q 022401 96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-----PRLKICDFGYSK 169 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~-----~~~~l~d~~~~~ 169 (298)
+++||+++++|..++.. ...+++..++.++.|++.|++|||++|++|+||+|+||+++.++. ..++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999888865 456899999999999999999999999999999999999976543 138999999875
Q ss_pred cccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHH-hCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
.... .....++..|+|||.+......+.++||||||+++|+|+ +|..||......+ ...+........ .
T Consensus 161 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~~~~~~--~ 230 (262)
T cd05077 161 TVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----KERFYEGQCMLV--T 230 (262)
T ss_pred cccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----HHHHHhcCccCC--C
Confidence 3321 123346678999998865444445599999999999997 5788877643211 112222222222 2
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
..++++.+++.+||+.||.+||++.++++.
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 246889999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.77 Aligned_cols=251 Identities=15% Similarity=0.140 Sum_probs=188.2
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecCCcch--H----------HHHHHHHHHhcCCCCCeeee
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKID--E----------NVQREIINHRSLRHPNIVRF 84 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~~~~--~----------~~~~e~~~l~~l~h~~i~~~ 84 (298)
...++|++.+.||+|+||.||++.+..+ +..+++|......... + ....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457999999999999999999998776 6677777644332211 1 11223344566789999999
Q ss_pred eEEEEeCC----eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCE
Q 022401 85 KEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (298)
Q Consensus 85 ~~~~~~~~----~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~ 160 (298)
++++.... ..++++++.. .++.+.+......++..+..++.|++.|++|||+.+++||||||+||+++.++. +
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--G 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--E
Confidence 99866543 3467777763 467777766656788899999999999999999999999999999999988776 9
Q ss_pred EEeecCccccccCCC--------CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 022401 161 KICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (298)
Q Consensus 161 ~l~d~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 232 (298)
+|+|||+++...... ......+++.|+|||.+.+..++.+ +||||||+++++|++|..||...........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999986442211 1122358899999999887777655 9999999999999999999987743332221
Q ss_pred -----HHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 233 -----TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 233 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
...++...... ....+.++.+++..|++.+|++||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 12222222222 2346899999999999999999999988764
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=262.52 Aligned_cols=243 Identities=23% Similarity=0.293 Sum_probs=188.4
Q ss_pred eeeccCCeEEEEEEEEcc---CCcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEE-eCCeEEEEEeccC
Q 022401 29 RDIGSGNFGVARLMRDKV---TKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYAS 102 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~---~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~~~~~ 102 (298)
+.||+|+||.||++.... .+..+|+|.+... ......+.+|+.+++.++|||++++++++. .+...+++++|+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 3457999987542 223456778999999999999999999875 4556889999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-----CC
Q 022401 103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQ 176 (298)
Q Consensus 103 ~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-----~~ 176 (298)
+++|.+++... ...+...+..++.+++.||.|||+.+++|+||+|+||++++++. ++|+|||++...... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence 99999998754 34677888999999999999999999999999999999998877 999999988633221 11
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhC-CCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
.....++..|+|||.+.+..++.+ +||||||+++|+|++| ..||...+.. .....+..+ ...+.....|+.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~ 232 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSF----DITVYLLQG-RRLLQPEYCPDPLY 232 (262)
T ss_pred cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHhcC-CCCCCCCcCCHHHH
Confidence 122334668999999877777665 9999999999999995 5566543322 222222222 22233344689999
Q ss_pred HHHHHhhhhCCCCcccccccchhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
+++.+||+.+|++||++.+++.+.
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHHHH
Confidence 999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=267.02 Aligned_cols=240 Identities=19% Similarity=0.221 Sum_probs=188.6
Q ss_pred eeeccCCeEEEEEEEEccCCc-------EEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 29 RDIGSGNFGVARLMRDKVTKE-------LVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~-------~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+.||.|+||.||++.+...+. .+++|...... ...+.+.+|..+++.++|||++++++++..+...++|+||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999999865443 38888775443 2345678899999999999999999999998899999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC------CEEEeecCccccccC
Q 022401 101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL 173 (298)
Q Consensus 101 ~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~------~~~l~d~~~~~~~~~ 173 (298)
+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.. .++++|||.+.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 99999999997644 58999999999999999999999999999999999999877652 269999998753322
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCC-CCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
.....++..|+|||.+.+......++||||||+++|++++|. .||........ ..+.......+. ..+.
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-----~~~~~~~~~~~~--~~~~ 230 (258)
T cd05078 161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-----LQFYEDRHQLPA--PKWT 230 (258)
T ss_pred ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-----HHHHHccccCCC--CCcH
Confidence 223456778999999876544344599999999999999985 56554332211 112222222222 3568
Q ss_pred HHHHHHHHhhhhCCCCcccccccchh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
++.+++.+||+.||++|||+.++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999888863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=265.78 Aligned_cols=239 Identities=22% Similarity=0.263 Sum_probs=185.6
Q ss_pred eeccCCeEEEEEEEEcc------------------------CCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeee
Q 022401 30 DIGSGNFGVARLMRDKV------------------------TKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF 84 (298)
Q Consensus 30 ~lg~g~~~~vy~~~~~~------------------------~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~ 84 (298)
.||+|+||.||++.... ....+++|.+..... ....+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999987532 123588888765432 23467788999999999999999
Q ss_pred eEEEEeCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC-----C
Q 022401 85 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-----P 158 (298)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~-----~ 158 (298)
++++..+...++|+||+++++|...+.. .+.+++..+..++.|++.||+|||++|++|+||+|+||+++..+. .
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999988865 557899999999999999999999999999999999999975432 2
Q ss_pred CEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHH-hCCCCCCCCCCchhHHHHHHHH
Q 022401 159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRKTIQRI 237 (298)
Q Consensus 159 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~~~~~~ 237 (298)
.++++|||.+..... .....++..|+|||.+.+......++||||||+++|+++ +|..||........ .. .
T Consensus 162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~----~ 233 (274)
T cd05076 162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ER----F 233 (274)
T ss_pred eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HH----H
Confidence 489999997643221 122345677999998876443345599999999999984 68899976543221 11 1
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.......+. ..++++.+++.+||+.+|.+|||+.++++.
T Consensus 234 ~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 122222222 246789999999999999999999888864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=282.17 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=206.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch----HHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.|.-++.||.|+||.||.|++..+...||||....+.+.. .++.+|+..|+++.|||.+...||+..+...++|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4788899999999999999999999999999987654333 457799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
||- ||-.+++.- ..++.+.++..|..+.+.||.|||+.+.+|||||..||+++..|. |||+|||.+... .+..
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~---~PAn 180 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIM---APAN 180 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhc---Cchh
Confidence 994 477777753 457899999999999999999999999999999999999999998 999999987533 4556
Q ss_pred CCCCCCcccCccccc---cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH-hhcCCCCCCCCCCCHHH
Q 022401 179 STVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-LSVQYSVPDTNPISQEC 254 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 254 (298)
...|+|+|||||++. .+.|+.+ +||||||++..|+....+|+-.-+. -.....| .+..+.++ .+.+++.+
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNA----MSALYHIAQNesPtLq-s~eWS~~F 254 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPTLQ-SNEWSDYF 254 (948)
T ss_pred cccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchH----HHHHHHHHhcCCCCCC-CchhHHHH
Confidence 788999999999875 4567787 9999999999999999988655333 2222233 33333333 55589999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
+.||..||++=|.+|||. ..+|-|+|+.
T Consensus 255 ~~Fvd~CLqKipqeRpts--------e~ll~H~fv~ 282 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTS--------EELLKHRFVL 282 (948)
T ss_pred HHHHHHHHhhCcccCCcH--------HHHhhcchhc
Confidence 999999999999999987 5556778775
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=260.86 Aligned_cols=247 Identities=20% Similarity=0.267 Sum_probs=186.4
Q ss_pred eeeccCCeEEEEEEEEccC--CcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 022401 29 RDIGSGNFGVARLMRDKVT--KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~--~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (298)
+.||+|+||.||+++.... ...+++|.+.... ...+.+.+|+.+++.++|||++++++.+......++|+||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3589999999999976433 3346677665432 23457889999999999999999999999999999999999999
Q ss_pred CHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC---CCC
Q 022401 105 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 177 (298)
Q Consensus 105 sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~---~~~ 177 (298)
+|.+++.+. ...+...++.++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence 999998754 23567778899999999999999999999999999999998887 999999987532211 112
Q ss_pred CCCCCCCcccCcccccccc------CCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 178 KSTVGTPAYIAPEVLLRHE------YDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
....++..|+|||.+.... ..+.++||||||+++|+|++ |..||......+..............+......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 2345678899999875321 11345999999999999997 4668876554443333332222111222223347
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
++.+.+++..|| .+|.+||++.++++.
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRL 265 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence 889999999999 789999999988753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=262.06 Aligned_cols=245 Identities=21% Similarity=0.353 Sum_probs=192.0
Q ss_pred eeEEeeeccCCeEEEEEEEEc---cCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC------
Q 022401 25 YDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 92 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 92 (298)
|.+.+.||+|++|.||++... .++..+|+|++.... ...+.+.+|+.++++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 356889999887543 23456788999999999999999999886532
Q ss_pred eEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 93 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
..+++++|+.+++|..++... ..++...++.++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence 347889999999998776422 24788999999999999999999999999999999999988776 9999999
Q ss_pred ccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 167 YSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 167 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
.+....... ......+.+.|++||.+....++.+ +||||||+++|++++ |..||...+.. +....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~----~~~~~~~~~~- 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENS----EIYNYLIKGN- 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHH----HHHHHHHcCC-
Confidence 887443221 1122334567999999877766655 999999999999999 78888765432 2222222222
Q ss_pred CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 243 SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 243 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
........+.++.+++.+||+.+|.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22223346899999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=289.07 Aligned_cols=147 Identities=30% Similarity=0.454 Sum_probs=134.2
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
..++|++++.||+|+||.||++.+..+++.||+|++..... ....+..|+.++..++||||+++++++.....+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 35789999999999999999999998999999999875422 23567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
||||+.+++|.+++.....+++..++.++.||+.||+|||+.||+|+||||+||+++.++. ++|+|||++.
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 9999999999999988888999999999999999999999999999999999999998876 9999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=279.28 Aligned_cols=252 Identities=31% Similarity=0.426 Sum_probs=208.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhc-CCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.+.|++...+|.|+|+.|-.+.+..++...++|++.+.. ....+|+.++.. -+|||+++..+.+.+....|+|+|.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 478999999999999999999999999999999998762 223445544443 4799999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe-eCCCCCCEEEeecCccccccCCCCCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv-~~~~~~~~~l~d~~~~~~~~~~~~~~~ 179 (298)
+.|+-+.+.+...+... .++..|+.+|+.++.|||++|++||||||+|||+ ++.++ ++|+|||.++..... ...
T Consensus 398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~--~~t 472 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS--CDT 472 (612)
T ss_pred ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh--hcc
Confidence 99988888886666555 7888899999999999999999999999999999 56666 999999987644333 335
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
..-+..|.|||.+...+++.. +|+||||+++|+|++|..||...... .+...++..+.+. ..+|++.++||+
T Consensus 473 p~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLLQ 544 (612)
T ss_pred cchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHHH
Confidence 566788999999987777666 99999999999999999999987765 4455555555544 458999999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+||+.||.+|+++.+++.++|+ ++||++..
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~--~~~~t~p~ 574 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF--LSHPTFPP 574 (612)
T ss_pred HhccCChhhCcChhhhccCcch--hcCCCCCc
Confidence 9999999999999888866666 55555443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=266.80 Aligned_cols=263 Identities=29% Similarity=0.404 Sum_probs=212.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-C-CC----eeeeeEEEEeCC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-H-PN----IVRFKEVILTPT 92 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-h-~~----i~~~~~~~~~~~ 92 (298)
....++|++++.+|+|.||.|-.+.++.++..+|+|++..-.+..+...-|+++++++. + |+ ++.+.++|...+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34468999999999999999999999989999999999887777888888999999993 2 33 677888899999
Q ss_pred eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC--------------
Q 022401 93 HLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-------------- 156 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-------------- 156 (298)
+.|+|+|.+ |.|+.+++.++. +++...+..+++|++.++++||+.+++|.||||+||++.++.
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999998 679999997654 688999999999999999999999999999999999984221
Q ss_pred ----CCCEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 022401 157 ----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (298)
Q Consensus 157 ----~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 232 (298)
...++|+|||.++..... ...-..|..|.|||++.+-+++.+ +||||+||+|.|+.+|...|+..++.+.+ +
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-a 319 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-A 319 (415)
T ss_pred ccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-H
Confidence 125899999988633322 244457889999999999999888 99999999999999999999988876655 5
Q ss_pred HHHHHhhcCC------------------CCCCCC--------------------CCC---HHHHHHHHHhhhhCCCCccc
Q 022401 233 TIQRILSVQY------------------SVPDTN--------------------PIS---QECRDLISRIFVADPAAVSI 271 (298)
Q Consensus 233 ~~~~~~~~~~------------------~~~~~~--------------------~~~---~~l~~li~~~l~~dp~~Rps 271 (298)
+++++++.-+ +++... ..+ ..|.+|++.||..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 5555544211 111100 001 35999999999999999999
Q ss_pred ccccchhhhHHHhhhhhhhhhhh
Q 022401 272 FFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 272 ~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
+.|+ ++|||+...++
T Consensus 400 l~EA--------L~HpFF~~~~~ 414 (415)
T KOG0671|consen 400 LREA--------LSHPFFARLTP 414 (415)
T ss_pred HHHH--------hcCHHhhcCCC
Confidence 9555 58999875543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=260.76 Aligned_cols=281 Identities=25% Similarity=0.348 Sum_probs=213.1
Q ss_pred cCCCCCccCCCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCc----EEEEEEeecCC---cchHHHHHHHHHHhc
Q 022401 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGD---KIDENVQREIINHRS 75 (298)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~aiK~~~~~~---~~~~~~~~e~~~l~~ 75 (298)
+.+.+...+.....+..-+...|++++.||+|.+|.||+|....++. .+|||.++-+. ......-+|+.+++.
T Consensus 4 ~~~~~~~~~~~ser~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~RE 83 (438)
T KOG0666|consen 4 SMDYDFKSKLASERERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRE 83 (438)
T ss_pred cccccchhhhhhhhhhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHH
Confidence 34555555666666666778899999999999999999997654432 68999887542 334667899999999
Q ss_pred CCCCCeeeeeEEEEe-CCeEEEEEeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCc
Q 022401 76 LRHPNIVRFKEVILT-PTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149 (298)
Q Consensus 76 l~h~~i~~~~~~~~~-~~~~~lv~~~~~~~sL~~~l~-----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~n 149 (298)
++|||++.+..++.. +..++++++|.+. +|...+. ....++...++.|+.||+.|+.|||++=++||||||.|
T Consensus 84 l~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaN 162 (438)
T KOG0666|consen 84 LKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPAN 162 (438)
T ss_pred hcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcce
Confidence 999999999999987 7899999999977 6766663 22358999999999999999999999999999999999
Q ss_pred eEeeCCCC--CCEEEeecCccccccCCCCC----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCC
Q 022401 150 TLLDGSPA--PRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (298)
Q Consensus 150 ilv~~~~~--~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 223 (298)
|++..++. +++||+|+|+++........ .....+..|.|||.+.+...++++.|+|++||++.||++..+.|..
T Consensus 163 IlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 163 ILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred EEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99976632 35999999999855443322 2334577899999999999889999999999999999998887765
Q ss_pred CCCchhH-----HHHHHHHh---hcC--CCCCCCC------------------------------CCCHHHHHHHHHhhh
Q 022401 224 PDEPKDF-----RKTIQRIL---SVQ--YSVPDTN------------------------------PISQECRDLISRIFV 263 (298)
Q Consensus 224 ~~~~~~~-----~~~~~~~~---~~~--~~~~~~~------------------------------~~~~~l~~li~~~l~ 263 (298)
.++.... ...+.+|. +.+ .++|... .-++...+|+..||+
T Consensus 243 ~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~ 322 (438)
T KOG0666|consen 243 REEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLT 322 (438)
T ss_pred hhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhc
Confidence 4321100 11222221 111 0111111 123558899999999
Q ss_pred hCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 264 ADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 264 ~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.||.+|+|+ .+.++|+|+.++
T Consensus 323 yDP~kRIta--------~qAleh~yF~~d 343 (438)
T KOG0666|consen 323 YDPIKRITA--------EQALEHPYFTED 343 (438)
T ss_pred cCchhhccH--------HHHhcccccccC
Confidence 999999988 555688888765
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=280.01 Aligned_cols=250 Identities=30% Similarity=0.417 Sum_probs=201.7
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------C
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP------T 92 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 92 (298)
.+.-|...+.||+|+||.||.++++.+|+.+|||.+... .+..+..-+|++++++++|+|||+..++-+.. .
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 346788999999999999999999999999999998764 34456677999999999999999999885543 3
Q ss_pred eEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEee--CCCCCCEEEeecCc
Q 022401 93 HLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGY 167 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~--~~~~~~~~l~d~~~ 167 (298)
...++||||.||+|...+.. ...+++.+++.++.++..||.|||++||+||||||.||++- .+|..-.||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 45899999999999999953 34699999999999999999999999999999999999884 33444589999999
Q ss_pred cccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC------
Q 022401 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------ 241 (298)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------ 241 (298)
|+....+..-.+..||..|.+||.....++++..+|.||+||++|+++||..||..........+....+...+
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 99888888778888999999999988655555559999999999999999999987666544333333332211
Q ss_pred -------------CCCCCCCCCCH----HHHHHHHHhhhhCCCCcc
Q 022401 242 -------------YSVPDTNPISQ----ECRDLISRIFVADPAAVS 270 (298)
Q Consensus 242 -------------~~~~~~~~~~~----~l~~li~~~l~~dp~~Rp 270 (298)
..+|.+...+. -+...+-.+|..||++|=
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 12333333333 355667778889999886
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=261.42 Aligned_cols=262 Identities=30% Similarity=0.467 Sum_probs=221.3
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch----HHHHHHHHHHhcC-CCCCeeeeeEEEEeCCe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (298)
++-..+|.++.+||.|+||.|-++.++.+...||||++.++.-.. +--..|..+|.-. +.|.+++++.+|..-..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 556678999999999999999999999999999999987653221 1123455566544 46889999999998999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+||||+.||+|-..+.+-+.+.+..+..++..|+.||-+||++||++||||.+||+++.+|+ +||.|||++.....
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeeccccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999998 99999999974443
Q ss_pred C-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 174 H-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 174 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
. ....+..|+|.|+|||++...+|... .|.||+|+++|||+.|+.||.+.++.+ +.+.+......+|.. ++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeDE~e----lF~aI~ehnvsyPKs--lSk 575 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQAIMEHNVSYPKS--LSK 575 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHccCcCccc--ccH
Confidence 3 44467789999999999988888665 999999999999999999999988744 445555666665555 799
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+..++....|.+.|.+|...----+ .++-+|||+...
T Consensus 576 EAv~ickg~ltK~P~kRLGcg~~ge---~di~~H~FFR~i 612 (683)
T KOG0696|consen 576 EAVAICKGLLTKHPGKRLGCGPEGE---RDIREHPFFRRI 612 (683)
T ss_pred HHHHHHHHHhhcCCccccCCCCccc---cchhhCcchhhc
Confidence 9999999999999999987644443 567789998754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=234.99 Aligned_cols=259 Identities=26% Similarity=0.450 Sum_probs=210.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.+|.-.++||+|.+|+||+++++.+++.||+|.+..+.. .-....+|+-+++.++|.||+++++..-.++.+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 467788999999999999999999999999999886533 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CC
Q 022401 100 YASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (298)
Q Consensus 100 ~~~~~sL~~~l-~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~ 177 (298)
+|+. .|..+. +-++.++...+..++.|+++|+.+.|+.++.|+|+||.|.+++.+|. +||.|||+++...... -.
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence 9954 666665 34677999999999999999999999999999999999999999998 9999999998544332 33
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCC-CCCCCC-------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTN------- 248 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~------- 248 (298)
+....+..|.+|.++.+.+.+....|+||-||++.|+.. |.+.|.+.+..+++....+-+..... .+|...
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 455678899999999998876666999999999999997 55667776666665554444322111 111111
Q ss_pred ---------------CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 249 ---------------PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 249 ---------------~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+++..-++++..+|.-+|.+|+++ ...++|||+.+-
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisa--------eaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISA--------EAALQHPYFSDF 289 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCH--------HHHhcCcccccc
Confidence 234567899999999999999987 556689998763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=282.46 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=218.7
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCC---cEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
.-.++.+...|.++||.|.||.|+.++-+..| ..||||.++.. .+...+|..|..|+-+++||||+++.|+....
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 34566778999999999999999999987544 47999998865 44456799999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
+.+.+|.|||++|+|..+|.++ ++++.-++..+++.|+.|++||.+.|+|||||-..||||+++-- ||++|||+++.
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRv 780 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRV 780 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceee
Confidence 9999999999999999999755 47999999999999999999999999999999999999998776 99999999984
Q ss_pred ccCCCCC----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 171 SVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 171 ~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
....... .-..-..+|+|||.+...++++. +||||+|+++||.++ |..||+.-.+ .+.++. ++..+++|
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSN----QdVIka-Ie~gyRLP 854 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSN----QDVIKA-IEQGYRLP 854 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccch----HHHHHH-HHhccCCC
Confidence 4333311 11113478999999999999777 999999999999876 8999998665 344433 35677889
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
.+.++|..|.+|+.+||++|-.+||.+.||+.+.-.
T Consensus 855 pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 855 PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 999999999999999999999999999999975533
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=301.59 Aligned_cols=255 Identities=29% Similarity=0.420 Sum_probs=213.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
-+|+-+..||.|.||.||.|.+..+|...|+|-+... .+..+.+.+|..++..+.|||+++.+|+-.+.+.+++.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 4789999999999999999999999999999976543 3445667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC----
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 175 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~---- 175 (298)
||.+|+|.+++..+.-.++.-...+-.|++.|+.|||+.|||||||||+||+++.+|. +|++|||.|.......
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCC
Confidence 9999999999988888888888889999999999999999999999999999999997 9999999987554443
Q ss_pred -CCCCCCCCCcccCcccccccc--CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-CCCCCCCCCC
Q 022401 176 -QPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVPDTNPIS 251 (298)
Q Consensus 176 -~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 251 (298)
......|++.|||||.+.+.+ ....++|||||||++.||+||..||...+..- ..+-++..+. +..|.. ++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~~gh~Pq~P~~--ls 1467 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVAAGHKPQIPER--LS 1467 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHhccCCCCCchh--hh
Confidence 223456999999999988654 23445999999999999999999998876432 2233333333 334444 89
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++-.+||.+||..||..|-++ .++++|-|..+.
T Consensus 1468 ~~g~dFle~Cl~~dP~~Rw~~--------~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTA--------SQLLEHAFGKSC 1500 (1509)
T ss_pred HhHHHHHHHHHhcCchhhhHH--------HHHHHhhccccc
Confidence 999999999999999999665 366677776543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=276.35 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=218.6
Q ss_pred CCCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEcc-CC--cEEEEEEeecCCcc--hHHHHHHHHHHhcCCCCCeeeee
Q 022401 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKV-TK--ELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFK 85 (298)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-~~--~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~ 85 (298)
+|+....-.+-.++..+.+.||+|+||+|+.+.+.. +| -.||||++..+... ..+|.+|+.++.+|+|+|+++++
T Consensus 98 ~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 98 NPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred CcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEe
Confidence 777777778888999999999999999999999863 23 35899998876443 57899999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEe
Q 022401 86 EVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (298)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~ 163 (298)
|+..+ ....+|+|.+..|||.+.|.. .+.+-...+..++.||+.|+.||.++++|||||-..|+++-.... +||+
T Consensus 178 GvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~ 254 (1039)
T KOG0199|consen 178 GVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKIC 254 (1039)
T ss_pred eeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeee
Confidence 99987 778899999999999999976 345888999999999999999999999999999999999987655 9999
Q ss_pred ecCccccccCCCCC----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 022401 164 DFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRIL 238 (298)
Q Consensus 164 d~~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 238 (298)
|||+.+........ ........|+|||.+...+++.. +|+|++|+++|||++ |..||.+...... ++++-
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qI----L~~iD 329 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQI----LKNID 329 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHH----HHhcc
Confidence 99998744433332 22234456999999999999887 999999999999998 6789998876433 33333
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 239 SVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
...+++.+..+++++.+++..||+.+|++||||.+|.+..
T Consensus 330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 5556777777999999999999999999999998886533
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=269.84 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=220.2
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
.+..+..+.....+||.|-+|.||.+.++.-.-.||||.++.+.-..++|.+|..+++.++|||+++++|+|..+-.+|+
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 45556677888899999999999999998888889999998877777899999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-
Q 022401 97 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 173 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~- 173 (298)
|+|||..|+|.+++.+.. .++.--+++++-||..|+.||..++++||||-..|.||..+-. +|+.|||+++....
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGD 418 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCC
Confidence 999999999999997543 4777788999999999999999999999999999999987776 99999999984432
Q ss_pred -CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
+...........|+|||.+..+.++.+ +|||+||+++||+.| |..||.+.+ ...+..+++..++...+..+|
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGid-----lSqVY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGID-----LSQVYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred ceecccCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCcc-----HHHHHHHHhccccccCCCCCC
Confidence 233333445678999999999999888 999999999999998 777888765 445666777888888888899
Q ss_pred HHHHHHHHHhhhhCCCCcccccccc
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPL 276 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l 276 (298)
+.+.+|+++||+++|.+||+++++-
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHH
Confidence 9999999999999999999998765
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=268.94 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=206.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEcc----CCcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~----~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
.+...+.+.||.|-||.||.+.... ..--||||..+.+ ....+.|..|..+++.++||||++++|+| .+...+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~-~e~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC-VEQPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee-ecccee
Confidence 3445566789999999999998742 2335889988763 44467899999999999999999999998 456889
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+|||.++.|-|+.++..+. .++..++..++.||+.+|.|||+.++|||||-..||+|.+..- +||+|||+++-....
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDD 544 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhcccc
Confidence 9999999999999997654 6899999999999999999999999999999999999998876 999999999744332
Q ss_pred --CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 175 --SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 175 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
.......-...|||||.+.-..+++. +|||.||+++||++. |..||.+....+.+- .++..-++|.+.++|
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-----~iEnGeRlP~P~nCP 618 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-----HIENGERLPCPPNCP 618 (974)
T ss_pred chhhccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEE-----EecCCCCCCCCCCCC
Confidence 33334445678999999988888776 999999999999886 889999876644321 123445778888899
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
+.+..+.++||.++|.+||.+.++...
T Consensus 619 p~LYslmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHHHH
Confidence 999999999999999999999888763
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=253.37 Aligned_cols=262 Identities=26% Similarity=0.367 Sum_probs=208.8
Q ss_pred CCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEE
Q 022401 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVIL 89 (298)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (298)
++..|.+.+.++|+-..++|+|.||.||+|+.+.+|+.|++|++..+++ .-....+|+.+|..++|+|++.++++|.
T Consensus 7 s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 7 SMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred cccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 5678999999999999999999999999999999999999987644222 2245678999999999999999999885
Q ss_pred e--------CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCE
Q 022401 90 T--------PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (298)
Q Consensus 90 ~--------~~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~ 160 (298)
. ...+|+||++|.. +|..++++. ..++..++..+++++..||.|+|...|+|||+|++|++++.+|. +
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--l 163 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--L 163 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--E
Confidence 3 2458999999966 788888766 57999999999999999999999999999999999999999988 9
Q ss_pred EEeecCccccccCCCCCCCC-----CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 022401 161 KICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235 (298)
Q Consensus 161 ~l~d~~~~~~~~~~~~~~~~-----~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 235 (298)
+|.|||+++..+........ ..+..|.+||.+.+...+++..|||.-||++.+|+++..-+++..+... ...+.
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq-l~~Is 242 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ-LHLIS 242 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH-HHHHH
Confidence 99999999755544333222 2477899999999988777779999999999999999988877655333 23333
Q ss_pred HHhhcCC--CCCCCC----------------------------CCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 236 RILSVQY--SVPDTN----------------------------PISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 236 ~~~~~~~--~~~~~~----------------------------~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.+++.-. .+|.-. .-+++..+++..+|..||.+|+++.+++++
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 3332110 011111 123688999999999999999988666543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=268.23 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=208.1
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc--hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.+...++++||+|.||.|-++.... +.+||+|....+... ..+|.+|+.+|.+++||||+.+.++|..++.+++++|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3678899999999999999998863 689999998865443 3579999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--
Q 022401 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 175 (298)
Q Consensus 100 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-- 175 (298)
|+..|.|.+++... +.........|+.||+.|++||.+.++|||||.+.|+|++.+.+ +|++|||+++......
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCce
Confidence 99999999999766 33456677889999999999999999999999999999998887 9999999998443322
Q ss_pred -CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh--CCCCCCCCCCchhHHHHHHHHhhc---CCCCCCCCC
Q 022401 176 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEPKDFRKTIQRILSV---QYSVPDTNP 249 (298)
Q Consensus 176 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 249 (298)
.........+|||+|.+..++++++ +|+|+||+++||+++ ...||....+++.... ...+... ...++.+..
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhcCCCCcceeccCCCc
Confidence 2233445689999999999999887 999999999999874 7789988776443332 2222222 223556667
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+|.++.+++.+||..+..+||+++++-.
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 8999999999999999999999977653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=247.44 Aligned_cols=241 Identities=40% Similarity=0.627 Sum_probs=199.4
Q ss_pred CeEEEEEEEEccCCcEEEEEEeecCCcc--hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCHHHHHHh
Q 022401 35 NFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 112 (298)
Q Consensus 35 ~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~ 112 (298)
++|.||.+....++..+++|++...... .+.+.+|+..+++++|+|++++.+++......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5789999999988999999998765433 47888999999999999999999999999999999999999999999977
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCCcccCcccc
Q 022401 113 AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192 (298)
Q Consensus 113 ~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 192 (298)
...++...++.++.+++.++.+||+.+++|+||+|.||+++.++. ++++|||.+.............+...|++||..
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 766899999999999999999999999999999999999998876 999999998765554444556678889999998
Q ss_pred ccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC-CCHHHHHHHHHhhhhCCCCccc
Q 022401 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDLISRIFVADPAAVSI 271 (298)
Q Consensus 193 ~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps 271 (298)
.....+.+ +|+|++|++++++++|..||........ ................. ++.++.+++.+||..||++||+
T Consensus 159 ~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 159 LGKGYGKA-VDVWSLGVILYELLTGKPPFPGDDQLLE---LFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred ccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 77777664 9999999999999999999977433322 22222223322222222 7899999999999999999998
Q ss_pred ccccchhhhHHHhhhhhh
Q 022401 272 FFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 272 ~~~~l~~~~~~~~~hp~~ 289 (298)
+.+++ +|||+
T Consensus 235 ~~~~~--------~~~~~ 244 (244)
T smart00220 235 AEEAL--------QHPFF 244 (244)
T ss_pred HHHHh--------hCCCC
Confidence 85544 67774
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=269.34 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=227.4
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
....++.+++..||-||||.|=+++.+.....+|+|++.+. .+..+.+..|-+++...+.|.|++++-.|.+++.+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34457889999999999999999988766666899988763 34446677899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
|++||.|-||.+...+...+.+++.+...++..++.|++|||++||++|||||+|.+++.+|. +||.|||++......
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccC
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999988888
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
....+.+|+|.|.|||++.+++.+.. +|.|+||+++||+++|.+||.+.+.-.......+.+ -.+..+..++...
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi----d~i~~Pr~I~k~a 648 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI----DKIEFPRRITKTA 648 (732)
T ss_pred CceeeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh----hhhhcccccchhH
Confidence 89999999999999999999998777 999999999999999999999987644444433333 2333345578899
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.++|++++..+|.+|... +..-+.++--|-|+.+
T Consensus 649 ~~Lik~LCr~~P~ERLG~---~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGY---QKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHHHHHhcCcHhhhcc---ccCChHHHHhhhhhhc
Confidence 999999999999999974 2223456667777753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=286.84 Aligned_cols=251 Identities=31% Similarity=0.445 Sum_probs=193.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEe----------
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT---------- 90 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 90 (298)
.+|+.++.||+||||.||+++++-+|+.||||++... ......+.+|+..+.+|+|||+++.+..+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 5789999999999999999999999999999999876 4555678899999999999999865443310
Q ss_pred --------------------------------------------------------------------------------
Q 022401 91 -------------------------------------------------------------------------------- 90 (298)
Q Consensus 91 -------------------------------------------------------------------------------- 90 (298)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------C--------CeEEEEEeccCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHhhcCc
Q 022401 91 ---------------------P--------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQV 140 (298)
Q Consensus 91 ---------------------~--------~~~~lv~~~~~~~sL~~~l~~~~~~-~~~~~~~i~~~l~~~l~~Lh~~~i 140 (298)
+ ..+|+-||||+..++.+.+..+-.. .....|+++++|+.|+.|+|+.|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 0 2368899999887777777655443 477899999999999999999999
Q ss_pred EEecCCCCceEeeCCCCCCEEEeecCcccccc-------------------CCCCCCCCCCCCcccCcccccccc---CC
Q 022401 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLLRHE---YD 198 (298)
Q Consensus 141 ~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~---~~ 198 (298)
+||||||.|||++++++ |||+|||+++... .........||..|+|||.+.+.. |+
T Consensus 719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999998887 9999999987411 001112234788899999987665 55
Q ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCCCCCHHHHHHHHHhhhhCCCCcccccccc
Q 022401 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDLISRIFVADPAAVSIFFFPL 276 (298)
Q Consensus 199 ~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l 276 (298)
.+ +|+||||++++||+ .||...=+ -...+..+..+....+ ....--+.-.++|++|++.||.+|||+.++|
T Consensus 797 ~K-iDmYSLGIVlFEM~---yPF~TsME---Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 797 SK-IDMYSLGIVLFEML---YPFGTSME---RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ch-hhhHHHHHHHHHHh---ccCCchHH---HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 55 99999999999999 56665322 2333444444443333 0111235678899999999999999998888
Q ss_pred hhhhHH
Q 022401 277 NMSCLL 282 (298)
Q Consensus 277 ~~~~~~ 282 (298)
+.-++.
T Consensus 870 ~s~llp 875 (1351)
T KOG1035|consen 870 NSELLP 875 (1351)
T ss_pred hccCCC
Confidence 765554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=269.40 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=220.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEe-----CCeEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT-----PTHLAI 96 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~~l 96 (298)
+.|+|.+++|.|.+|.||+++++.+++..|+|+........+++..|.++++.+ .|||++.+++++.. ++.+++
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 469999999999999999999999999999999988888889999999999988 58999999999864 457999
Q ss_pred EEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc-cccC
Q 022401 97 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVL 173 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~-~~~~ 173 (298)
|||||.+||..+++.+ +..+.+.-+..|++.++.|+.+||++.++|+|+|-.||+++.++. +||+|||++. ..+.
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST 176 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc
Confidence 9999999999999864 446888899999999999999999999999999999999999988 9999999874 4555
Q ss_pred CCCCCCCCCCCcccCccccccc-----cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
.....+..|++.|||||++... .++.. +|+||||++..||.-|.+|+-... ....+.....+.++.+..+.
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmH---PmraLF~IpRNPPPkLkrp~ 252 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMH---PMRALFLIPRNPPPKLKRPK 252 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcc---hhhhhccCCCCCCccccchh
Confidence 5666788899999999997643 34455 999999999999999999976532 33555555556666666677
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+++++.+||+.||.+|-.+||+. ..++.|||+.+
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~--------~~ll~hpFi~e 287 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPST--------EELLKHPFITE 287 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcch--------hhhccCCcccc
Confidence 899999999999999999999976 66668999873
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=249.34 Aligned_cols=132 Identities=27% Similarity=0.405 Sum_probs=115.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-----C---CCeeeeeEEEEeC-
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----H---PNIVRFKEVILTP- 91 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~~- 91 (298)
..++|-+.++||+|-|++||+|.+..+.+.||+|+.+......+....|+.+|++++ | .+|+++++.|...
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 348999999999999999999999999999999988877666777889999999883 2 4699999999864
Q ss_pred ---CeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHh-hcCcEEecCCCCceEee
Q 022401 92 ---THLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLD 153 (298)
Q Consensus 92 ---~~~~lv~~~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh-~~~i~H~dl~p~nilv~ 153 (298)
.++|+|+|+. |.+|..++.. ...++...+++|++||+.||.||| +.||+|.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 5899999999 6688888754 346899999999999999999999 57999999999999994
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=258.34 Aligned_cols=260 Identities=30% Similarity=0.436 Sum_probs=213.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
+-|..++.||-|+||.|.+++...+...||.|.+.+.. ......+.|-.||..-..+-+|+++..|.++..+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34889999999999999999999999999999887632 22344678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc-----cC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-----VL 173 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~-----~~ 173 (298)
+|++||++-++|-..+-+.+.....++..+..|+++.|+.|++||||||+|||||.+|+ +||.|||+|+.. ..
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccc
Confidence 99999999999999999999999999999999999999999999999999999999999 999999998511 00
Q ss_pred C-------CCC-------------------------------CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHH
Q 022401 174 H-------SQP-------------------------------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 215 (298)
Q Consensus 174 ~-------~~~-------------------------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~ 215 (298)
+ .+. ....|++.|+|||++...+++-. +|.||.|++||||+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHh
Confidence 0 000 00126788999999998888777 99999999999999
Q ss_pred hCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 216 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 216 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.|+.||......+.-.+++.+ .....++...+++.+..++|.+++ -+++.|..- +--.++-.|||+..++
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw--~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGk-----ng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINW--RNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGK-----NGADQVKAHPFFKGID 935 (1034)
T ss_pred hCCCCccCCCCCcceeeeeeh--hhccccccccccCHHHHHHHHHHh-cChhhhhcc-----cchhhhhcCccccccc
Confidence 999999876543332332222 223355666778999999999976 577788754 2234688999998653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=240.63 Aligned_cols=270 Identities=26% Similarity=0.415 Sum_probs=223.3
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEe
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (298)
.......++|.++++||.|++..|..++.+.+.+.||+|+++++ .+...-...|.....+- .||.++-++.+|..
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 44556788999999999999999999999999999999998763 33344456666666655 68999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
++.+++|.||.+||.|--.+.++.++++.....+...|+.||.|||++||+++|||..||+++..|+ +||.|+|++..
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKE 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhc
Confidence 9999999999999999888888889999999999999999999999999999999999999999998 99999999974
Q ss_pred c-cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCC---CchhHHH-HHHHHhhcCCCCC
Q 022401 171 S-VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD---EPKDFRK-TIQRILSVQYSVP 245 (298)
Q Consensus 171 ~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~---~~~~~~~-~~~~~~~~~~~~~ 245 (298)
. ......++..|+|.|.|||++++..|... .|.|+||++++||+.|+.||.-.. .+..-.+ +.+-+.+.+.++|
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip 479 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP 479 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc
Confidence 4 33445577889999999999999998777 999999999999999999995432 1111122 3334455555555
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.. ++-....+++..|++||.+|....--. -..++-.|+|+...
T Consensus 480 rs--lsvkas~vlkgflnkdp~erlgc~~~~--g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 480 RS--LSVKASHVLKGFLNKDPKERLGCRPQT--GFSDIKSHAFFRSI 522 (593)
T ss_pred ce--eehhhHHHHHHhhcCCcHHhcCCCccc--chhhhhcchhhhhC
Confidence 44 677888999999999999998763222 46788899999854
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=269.98 Aligned_cols=259 Identities=16% Similarity=0.176 Sum_probs=171.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccC----CcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEE------
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV------ 87 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~----~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------ 87 (298)
.....++|++.+.||+|+||.||++.+..+ +..||+|.+...... +...++ .++...+.++..+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 345678999999999999999999999888 889999987543221 111111 1111122222221111
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCC
Q 022401 88 ILTPTHLAIVMEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147 (298)
Q Consensus 88 ~~~~~~~~lv~~~~~~~sL~~~l~~~~~--------------------~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p 147 (298)
...+..+++|++|+.+++|.+++..... .....+..++.|++.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 2345678999999999999988864321 12334667999999999999999999999999
Q ss_pred CceEeeC-CCCCCEEEeecCccccccC--CCCCCCCCCCCcccCccccccccCC---------------------CCccc
Q 022401 148 ENTLLDG-SPAPRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLLRHEYD---------------------GKIAD 203 (298)
Q Consensus 148 ~nilv~~-~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~---------------------~~~~D 203 (298)
+||+++. ++. +||+|||++..... ........+++.|+|||.+...... ..++|
T Consensus 284 ~NILl~~~~~~--~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGS--FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCc--EEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999985 344 99999999864322 2223445678899999975432211 12369
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH----------HhhcCCC------CCCCCCCCHHHHHHHHHhhhhCCC
Q 022401 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR----------ILSVQYS------VPDTNPISQECRDLISRIFVADPA 267 (298)
Q Consensus 204 i~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~ 267 (298)
|||+||++|+|+++..|+.. ....+...+.. ....... .......+.+..+||.+||+.||+
T Consensus 362 VwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999987766432 11111111111 0000000 000011234567999999999999
Q ss_pred CcccccccchhhhHHHhhhhhhhh
Q 022401 268 AVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 268 ~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+|||+ .++++|||++.
T Consensus 440 kR~ta--------~e~L~Hpff~~ 455 (566)
T PLN03225 440 QRISA--------KAALAHPYFDR 455 (566)
T ss_pred cCCCH--------HHHhCCcCcCC
Confidence 99987 55557888864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=253.11 Aligned_cols=263 Identities=26% Similarity=0.364 Sum_probs=211.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHH--------HHHHHHHHhcCCCCCeeeeeEEEE-e
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--------VQREIINHRSLRHPNIVRFKEVIL-T 90 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~--------~~~e~~~l~~l~h~~i~~~~~~~~-~ 90 (298)
+-+++|-++..||.|||+.||+|-+...+++||+|+-.....+.++ .-+|..|.+.|.||.||++++++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3467899999999999999999999988999999987655444332 236899999999999999999986 5
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc--CcEEecCCCCceEeeCCC-CCCEEEeecCc
Q 022401 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSP-APRLKICDFGY 167 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~--~i~H~dl~p~nilv~~~~-~~~~~l~d~~~ 167 (298)
...+|-|.|||+|.+|.-++.+...+++.+...|+.||+.||.||.+. -|+|-||||.|||+.+.. .+.+||.|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 578999999999999999999999999999999999999999999965 599999999999985433 33599999999
Q ss_pred cccccCCCCC--------CCCCCCCcccCcccccccc---CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 022401 168 SKSSVLHSQP--------KSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 236 (298)
Q Consensus 168 ~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~ 236 (298)
+......... ....|+.+|++||.+.-.. -.+.+.||||+|+++|.++.|..||+....-..+.....-
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9754433222 3345888999999865331 2244599999999999999999999886554433333333
Q ss_pred HhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 237 ILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
+......+|..+.++.+..+||++||++--++|... .++-.|||+-
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV--------~qLA~dpyll 745 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDV--------QQLACDPYLL 745 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhH--------HHHccCcccc
Confidence 344556677777799999999999999999999954 6666677664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=232.91 Aligned_cols=260 Identities=21% Similarity=0.402 Sum_probs=207.4
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-CCCeeeeeEEEEeC--CeEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIV 97 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv 97 (298)
.+++|++.+++|.|.++.||.+....++..++||+++.-. .+.+.+|+.||+.|. ||||+++.++..+. ....++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 5689999999999999999999998888999999887532 367889999999996 99999999999876 467899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
||+.+..+...+ .+.++...+..++.+++.||.|+|+.||+|||+||+|++++.... .++|+|+|++.........
T Consensus 114 FE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 114 FEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred hhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCcee
Confidence 999988665543 355788999999999999999999999999999999999985543 5999999999877777766
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCC-CCCCCchhHHHHHHHHh------------------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEPKDFRKTIQRIL------------------ 238 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~~~~~~~~~~~~~~------------------ 238 (298)
.....+..|--||.+.........-|+|||||++..|+....|| .+.+..+++.+..+-+.
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence 77777888999999887765555499999999999999999886 45455555443322210
Q ss_pred -----hcC----C----CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 239 -----SVQ----Y----SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 239 -----~~~----~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
... + ......-++++..+|+..+|-.|-.+|+|+.|++ .|||+....+
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam--------~HpyF~~~~~ 330 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM--------AHPYFAPVRE 330 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh--------cCchHHHHHH
Confidence 000 0 0011112569999999999999999999996666 6777765444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=256.12 Aligned_cols=262 Identities=18% Similarity=0.198 Sum_probs=186.2
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEc----------------cCCcEEEEEEeecCCcc-hH--------------HHH
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDK----------------VTKELVAVKYIERGDKI-DE--------------NVQ 67 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~----------------~~~~~~aiK~~~~~~~~-~~--------------~~~ 67 (298)
....++|++.++||+|+||.||++... ..++.||||.+...... .+ ...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 356889999999999999999998642 24567999998643221 11 223
Q ss_pred HHHHHHhcCCCCCe-----eeeeEEEEe--------CCeEEEEEeccCCCCHHHHHHhCC--------------------
Q 022401 68 REIINHRSLRHPNI-----VRFKEVILT--------PTHLAIVMEYASGGELFERICNAG-------------------- 114 (298)
Q Consensus 68 ~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~~~~~~~sL~~~l~~~~-------------------- 114 (298)
.|+.++.+++|.++ +++++++.. ....++|+||+.+++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46666667766543 567777643 356899999999999998885321
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC--CCCCCCCcccC
Q 022401 115 ----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIA 188 (298)
Q Consensus 115 ----~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~a 188 (298)
.++...++.++.+++.++.|||+.+++|+||||+||+++.++. ++|+|||++......... ....+++.|++
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeC
Confidence 2355678889999999999999999999999999999998876 999999998643322211 22334789999
Q ss_pred ccccccccC--------------------C-CCccchHHHHHHHHHHHhCCC-CCCCCCCch-------hHHHHHHHHhh
Q 022401 189 PEVLLRHEY--------------------D-GKIADVWSCGVTLYVMLVGGY-PFEDPDEPK-------DFRKTIQRILS 239 (298)
Q Consensus 189 PE~~~~~~~--------------------~-~~~~Di~slG~ll~~l~~g~~-pf~~~~~~~-------~~~~~~~~~~~ 239 (298)
||.+..... . ....|+||+||++++|++|.. ||....... ......+....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 1 122699999999999999875 665321110 11112222333
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhhhhCC---CCcccccccchhhhHHHhhhhhhh
Q 022401 240 VQYSVPDTNPISQECRDLISRIFVADP---AAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
...+.+.....+++.++|+.+||..+| .+|+|+ .++++|||+.
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa--------~eaL~Hp~f~ 504 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV--------GQALSHRFFL 504 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCH--------HHHhCCCCcC
Confidence 444555555578999999999999866 689977 5666888885
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=282.68 Aligned_cols=244 Identities=20% Similarity=0.211 Sum_probs=185.4
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
..+...+.||+|+||.||++++..++..||+|.+...... ..+|+..+++++||||+++++++.++...++||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 3466778999999999999999888999999988654322 2346888999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---hcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCC
Q 022401 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (298)
Q Consensus 103 ~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh---~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~ 179 (298)
+++|.+++.. ++...+..++.+++.|++||| +.+++||||||+||+++.++. .++. ++...... ....
T Consensus 767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~ 837 (968)
T PLN00113 767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTK 837 (968)
T ss_pred CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCC
Confidence 9999999853 788899999999999999999 679999999999999998776 4443 44332111 1123
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc-hhHHHHHHHHhhc-------CCCCCC----C
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSV-------QYSVPD----T 247 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~-------~~~~~~----~ 247 (298)
..+++.|+|||++.+..++.+ +||||+|+++|||++|..||...... ....+..+..... ...... .
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred ccccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 356789999999988777666 99999999999999999998543221 1111111111100 000100 0
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.....++.+++.+||+.||++|||+.+++++.
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 01123578899999999999999999998754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=239.88 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=203.0
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (298)
..+..++.+-+..||.|+||+|+++.++.+|+..|||++..... ...++..|.....+- .+|||++++|.+..++.-
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 34455667778899999999999999999999999999987543 345566677655444 689999999999999999
Q ss_pred EEEEeccCCCCHHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHh-hcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 95 AIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l-----~~~~~~~~~~~~~i~~~l~~~l~~Lh-~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
++.||.|+ .|+..+- -+...+++..+-.|....+.||+||- +..++|||+||+|||++..|. +||+|||.+
T Consensus 139 WiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIc 215 (361)
T KOG1006|consen 139 WICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGIC 215 (361)
T ss_pred eeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--Eeeecccch
Confidence 99999994 4664332 24456899988899999999999997 568999999999999999998 999999998
Q ss_pred ccccCCCCCCCCCCCCcccCccccccc--cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 169 KSSVLHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
.....+.......|+.-|+|||.+... +++.+ +|+||||+++||+.||..||.. ++...+.+..+..+.+....
T Consensus 216 GqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~---w~svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 216 GQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRK---WDSVFEQLCQVVIGDPPILL 291 (361)
T ss_pred HhHHHHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcch---HHHHHHHHHHHHcCCCCeec
Confidence 755555555566788899999998643 46676 9999999999999999999986 34455556666666554222
Q ss_pred ----CCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 247 ----TNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 247 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
...++..+..||.-||.+|-..||.+.+++.+
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22478999999999999999999977555543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=253.09 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=204.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC------CCCeeeeeEEEEeCCeEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR------HPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 95 (298)
-++|.+....|+|-||+|..|.++..|..||||++.........=..|+++|++|. --+++.+.-.|.+.+++|
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 36899999999999999999999988889999999987766677788999999995 347889999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 96 IVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
+|||.. ..+|.+++...+. +....+..++.|++.||.+|-+.|++|+||||.||||+.+.. .+||||||.|....
T Consensus 511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFAS 588 (752)
T ss_pred EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccc
Confidence 999988 5589999987663 778889999999999999999999999999999999987665 58999999876433
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHH-----------HHH--hh
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI-----------QRI--LS 239 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~-----------~~~--~~ 239 (298)
.+. ......+-.|.|||++.+..|+.. .|+||+||+|||+.||...|.+...-..+.-.+ .+- ..
T Consensus 589 ene-itPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~d 666 (752)
T KOG0670|consen 589 ENE-ITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKD 666 (752)
T ss_pred ccc-ccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhh
Confidence 221 122334557999999999999988 999999999999999999998876544332111 110 00
Q ss_pred cCCCC-------------------------C---------CCCCCC-------HHHHHHHHHhhhhCCCCcccccccchh
Q 022401 240 VQYSV-------------------------P---------DTNPIS-------QECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 240 ~~~~~-------------------------~---------~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
..++. | ....+| ..|.+|+..||..||++|.|.
T Consensus 667 qHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~------ 740 (752)
T KOG0670|consen 667 QHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV------ 740 (752)
T ss_pred hhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH------
Confidence 00000 0 000122 569999999999999999966
Q ss_pred hhHHHhhhhhhhh
Q 022401 279 SCLLLFSFVWMFD 291 (298)
Q Consensus 279 ~~~~~~~hp~~~~ 291 (298)
.++|.|||++.
T Consensus 741 --nqAL~HpFi~~ 751 (752)
T KOG0670|consen 741 --NQALKHPFITE 751 (752)
T ss_pred --HHHhcCCcccC
Confidence 67778999874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=259.53 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=208.1
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEcc-------CCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKE 86 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~ 86 (298)
.+....++..+.+.||+|.||.|+++.-.. ....||+|....... ..+.+..|+++++.+ +|+|++.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 455566667888899999999999998431 145799998876443 356788999999999 5999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCce
Q 022401 87 VILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (298)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~ni 150 (298)
++...+.+++|.||+..|+|..++.... .++..+++.++.||+.|++||++..++||||-..||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999997655 488999999999999999999999999999999999
Q ss_pred EeeCCCCCCEEEeecCccccccCCCCCC--CC--CCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 022401 151 LLDGSPAPRLKICDFGYSKSSVLHSQPK--ST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPD 225 (298)
Q Consensus 151 lv~~~~~~~~~l~d~~~~~~~~~~~~~~--~~--~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~ 225 (298)
++..+.. +|++|||+++......... .. .-...|||||.+....++.+ +||||+|+++||+++ |..||.+..
T Consensus 450 Li~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 450 LITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred EecCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9998876 9999999998433222221 11 14567999999999888777 999999999999998 678887633
Q ss_pred CchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 226 EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.. .+..+ ......+...+..+++++.++++.||+.+|++||++.++.+.
T Consensus 527 ~~---~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 527 PT---EELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred cH---HHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 22 23333 445555666677789999999999999999999999988863
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=235.09 Aligned_cols=246 Identities=24% Similarity=0.304 Sum_probs=191.3
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC--CCCCeeeeeEEEEeCC----e
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL--RHPNIVRFKEVILTPT----H 93 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~ 93 (298)
+...+.++.+.||+|.||.||.++++ |..||||+|... ....+.+|.+|++.. +|+||+.+++.-..++ .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc--CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 45678999999999999999999997 678999998754 346778888888765 9999999999854432 5
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh--------cCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------MQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~--------~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
+++|++|.+.|||.++|.. ..++....+.++..++.||+|||. ..|+|||||..||+|..++. +-|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeec
Confidence 7999999999999999966 678999999999999999999993 23999999999999999998 999999
Q ss_pred CccccccCC-----CCCCCCCCCCcccCcccccccc----C-CCCccchHHHHHHHHHHHh----------CCCCCCCCC
Q 022401 166 GYSKSSVLH-----SQPKSTVGTPAYIAPEVLLRHE----Y-DGKIADVWSCGVTLYVMLV----------GGYPFEDPD 225 (298)
Q Consensus 166 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~----~-~~~~~Di~slG~ll~~l~~----------g~~pf~~~~ 225 (298)
|+|-+-... .......|+.+|||||++...- + +.+.+||||||.++||++- -++||.+--
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 998644333 2334566999999999986542 1 2445899999999999974 246776543
Q ss_pred Cch-hHHHHHHHHhhcCCCCCCCCCCC-----HHHHHHHHHhhhhCCCCcccc
Q 022401 226 EPK-DFRKTIQRILSVQYSVPDTNPIS-----QECRDLISRIFVADPAAVSIF 272 (298)
Q Consensus 226 ~~~-~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~ 272 (298)
..+ .+.++.+=++....+...++.+. ..+..+++.||..||..|.|+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 333 33333333344444433333332 247778999999999999987
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=249.98 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=207.9
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCc----EEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
.....+..++||+|+||+||++.+-..|+ +||+|++.... +...++..|.-++.+++|||++++++++..+. +
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 33445667899999999999999865444 67888776543 34677889999999999999999999996655 8
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
-+|++|+++|+|.+++.. .+.+.....+-|..||++|+.|||+++++||||-..||||....+ +|+.|||+++....
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCc
Confidence 889999999999999864 457899999999999999999999999999999999999998887 99999999985554
Q ss_pred CCCCCC---CCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 174 HSQPKS---TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 174 ~~~~~~---~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
....-. ....+-|+|-|.+....++.. +||||+|+++||++| |..|+.+... +.+.++.....+++.+..
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~-----~eI~dlle~geRLsqPpi 924 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPA-----EEIPDLLEKGERLSQPPI 924 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCH-----HHhhHHHhccccCCCCCC
Confidence 443322 224567999998888888776 999999999999998 8899988663 445666666777888888
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
++.++.-++.+||..|+..||+++++..
T Consensus 925 CtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 925 CTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999999987765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=235.90 Aligned_cols=253 Identities=22% Similarity=0.247 Sum_probs=188.5
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhc--CCCCCeeeeeEEEEeCC----
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT---- 92 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~---- 92 (298)
..+....++.+.+|+|.||.||+|+-. ++.||||++.... .+.+.+|-+|... ++|+||++++++-+...
T Consensus 206 l~~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 206 LLELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred cccCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 344678899999999999999999885 5899999998653 4677777777764 48999999999866443
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh---------cCcEEecCCCCceEeeCCCCCCEEEe
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---------MQVCHRDLKLENTLLDGSPAPRLKIC 163 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~---------~~i~H~dl~p~nilv~~~~~~~~~l~ 163 (298)
.+++|++|.+.|+|.++|..+ .++..+..+++..+++||+|||+ ..|+|||||..||||.+|.. +.|+
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIa 358 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIA 358 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEee
Confidence 789999999999999999554 67999999999999999999995 34999999999999999998 9999
Q ss_pred ecCccccccCCC---CCCCCCCCCcccCccccccccCC-----CCccchHHHHHHHHHHHhCCC------------CCCC
Q 022401 164 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVGGY------------PFED 223 (298)
Q Consensus 164 d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~ll~~l~~g~~------------pf~~ 223 (298)
|||++-+..... ......|+.+|||||++.+..-- -++.||||+|.++||++++-. ||..
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999996554332 22335689999999998765322 345899999999999997532 3321
Q ss_pred -CCCchhHHHHHHHHhhcCCCCCCCC-----CCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 224 -PDEPKDFRKTIQRILSVQYSVPDTN-----PISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
......+.++..-+.....+...+. ....-+.+.++.||..||+.|.|+.=+-++
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 1111111111111111111111111 134569999999999999999998554443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=227.41 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=202.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC---
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP--- 91 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 91 (298)
..+...+|.-++.+|.|.- .|..|-+...++.+++|..... ....++..+|...+..+.|+|+++++.++.-.
T Consensus 12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 3556679999999999998 7778888888999999987653 22235567899999999999999999998643
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 92 ---THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 92 ---~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
...|+|+|+++. +|...+. -.++-.++..++.|++.|++|||+.||+||||||+||++..+.. +|+.|||++
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~a 165 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLA 165 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhh
Confidence 357999999954 7877776 34677899999999999999999999999999999999988877 999999999
Q ss_pred ccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-------
Q 022401 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------- 241 (298)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 241 (298)
......-.-.....+..|.|||++.+.++..+ +||||+||++.||++|...|.+.+..+++.+.........
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 86555433334456778999999999997777 9999999999999999999988766555544443322111
Q ss_pred ------------------C--CCCC---------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 242 ------------------Y--SVPD---------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 242 ------------------~--~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
+ ..++ +..-+.-+++++.+||..||++|.|+ .++|.|||+.
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv--------~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV--------DDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH--------HHHhcCCeee
Confidence 0 0010 00123568999999999999999976 5666788775
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=231.57 Aligned_cols=265 Identities=24% Similarity=0.379 Sum_probs=202.5
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----e
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----H 93 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 93 (298)
..+.+-.+.||.|+||+||.+.+..+|+.|++|.+..-. ...+.+.+|+.++..++|.|++..+++..-.. .
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 345677789999999999999999999999999876421 22356789999999999999999888865442 4
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+++|.+. .+|...+-..+.++...++-++.||++||.|||+.||.||||||.|.+++++-. +|++|||+++....
T Consensus 132 iYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~ 208 (449)
T KOG0664|consen 132 LYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccch
Confidence 577888773 356666656677999999999999999999999999999999999999986654 99999999974433
Q ss_pred CCCC--CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh-------------
Q 022401 174 HSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL------------- 238 (298)
Q Consensus 174 ~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~------------- 238 (298)
.... .....+.+|.|||++.+...++.+.||||+||++.|++..+..|+..+....+.- +-.+.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l-ItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM-IIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH-HHHHhCCCcHHHHHHHhh
Confidence 2211 2233567899999999998888889999999999999999999988765444322 11111
Q ss_pred -------hcCCC---------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcCC
Q 022401 239 -------SVQYS---------VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYHS 298 (298)
Q Consensus 239 -------~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~~ 298 (298)
..... +.....-..+...++..+|..||+.|.+. .+.+.|+++.+.+.-+||
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~--------~~A~~~~~~~e~R~r~~s 355 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV--------EEALQHRYLEEGRLRFHS 355 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH--------hhhcccccccccceeeee
Confidence 11111 11111234568888899999999999954 667788888877766654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=253.00 Aligned_cols=248 Identities=28% Similarity=0.359 Sum_probs=190.8
Q ss_pred EeeeccCCeE-EEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEeccCCCC
Q 022401 28 VRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGE 105 (298)
Q Consensus 28 ~~~lg~g~~~-~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~~s 105 (298)
.+.+|.|+.| .||.+.. .|+.||||++-.+ ......+|+..|+.- +||||+++++.-.+....|+..|.|. .+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 3567899998 6788776 4789999987643 234567899999877 69999999999888899999999994 59
Q ss_pred HHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC---CCCCCEEEeecCccccccCCCC--
Q 022401 106 LFERICNAG-R---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQ-- 176 (298)
Q Consensus 106 L~~~l~~~~-~---~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~---~~~~~~~l~d~~~~~~~~~~~~-- 176 (298)
|.+++.... . ......+..+.|++.|+++||+.+|+||||||.||||+. ++..+++|+|||+|........
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 999997641 1 111345778999999999999999999999999999976 5656799999999975544333
Q ss_pred --CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhC-CCCCCCCCCchhHHHHHHHHhhcCCCCCCCC-CCCH
Q 022401 177 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDFRKTIQRILSVQYSVPDTN-PISQ 252 (298)
Q Consensus 177 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 252 (298)
.....|+-.|+|||++........ +||||+||++|+.++| ..||+..-+ ....|..+...+-.-. ....
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~a-vDiFslGCvfyYvltgG~HpFGd~~~------R~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQA-VDIFSLGCVFYYVLTGGSHPFGDSLE------RQANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCcc-cchhhcCceEEEEecCCccCCCchHH------hhhhhhcCccceeeeccCchH
Confidence 344568899999999987776554 9999999999999996 689987432 2233444444322211 1122
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATEN 295 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~ 295 (298)
+..+||.+|++.+|..||++ .+++.|||+=+..|.
T Consensus 742 eA~dLI~~ml~~dP~~RPsa--------~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSA--------TDVLNHPLFWDSEKR 776 (903)
T ss_pred HHHHHHHHhcCCCcccCCCH--------HHHhCCCccCChHHH
Confidence 89999999999999999988 566678887655553
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=241.22 Aligned_cols=199 Identities=29% Similarity=0.461 Sum_probs=176.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchH---------HHHHHHHHHhcCC---CCCeeeeeEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE---------NVQREIINHRSLR---HPNIVRFKEVIL 89 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~---------~~~~e~~~l~~l~---h~~i~~~~~~~~ 89 (298)
-.+|..++.+|+|+||.|+.|.++.+...|++|.+.++.-..+ .+-.|++||.+++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3569999999999999999999999999999999876532222 2336999999996 999999999999
Q ss_pred eCCeEEEEEecc-CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 90 TPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 90 ~~~~~~lv~~~~-~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
+++.+|+++|-. +|-+|.+++.-.+.+++.+.+.|++|++.|+++||+.||+|||||-+||.++++|- +||+|||.+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccch
Confidence 999999999977 57889999999999999999999999999999999999999999999999999987 999999986
Q ss_pred ccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCC
Q 022401 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (298)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 223 (298)
.. ..+++-....|+..|.|||.+.+.+|-.+.-|||++|+++|-++....||..
T Consensus 718 a~-~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AY-TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hh-hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 42 3345556778999999999999999999989999999999999999888753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-30 Score=210.85 Aligned_cols=208 Identities=42% Similarity=0.637 Sum_probs=180.0
Q ss_pred eccCCeEEEEEEEEccCCcEEEEEEeecCCcc--hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCHHH
Q 022401 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 108 (298)
Q Consensus 31 lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~ 108 (298)
||+|.+|.||++....+++.+++|++...... .+.+.+|+..++.++|++++++++++......+++++++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999878999999998876542 5678999999999999999999999999999999999999899999
Q ss_pred HHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-CCCCCEEEeecCccccccCCC-CCCCCCCCCc
Q 022401 109 RICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 185 (298)
Q Consensus 109 ~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 185 (298)
++... ..++...++.++.+++.++++||+.|++|+||+|.||+++. ++. ++|+||+.+....... ......+...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCC
Confidence 98766 57899999999999999999999999999999999999998 665 9999999876443332 1234557788
Q ss_pred ccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhC
Q 022401 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265 (298)
Q Consensus 186 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 265 (298)
|++||..........++|+|++|++++++ .++.+++.+|++.|
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence 99999987662334449999999999999 67999999999999
Q ss_pred CCCcccccccch
Q 022401 266 PAAVSIFFFPLN 277 (298)
Q Consensus 266 p~~Rps~~~~l~ 277 (298)
|.+||++.++++
T Consensus 202 p~~R~~~~~l~~ 213 (215)
T cd00180 202 PEKRPSAKEILE 213 (215)
T ss_pred cccCcCHHHHhh
Confidence 999999877765
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-33 Score=246.08 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=212.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
++|+++..+|.|.+|.||+|+++.++++.|+|++...... ..-+.+|+.+++..+||||+.+++.+.....+++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 5899999999999999999999999999999999876543 456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc-cccCCCCCCCC
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~-~~~~~~~~~~~ 180 (298)
.+++|.+.-+-.+++++.++....+..++++.|||+.|-+|||||-.||++++.|+ +++.|||.+. ...........
T Consensus 95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred CCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhcc
Confidence 99999998888889999999999999999999999999999999999999999998 9999999875 33334555777
Q ss_pred CCCCcccCccccc---cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 181 VGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 181 ~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
.|+++|+|||+.. ..+|.. .+|||++|+...|+-..+.|--... ......++.+=......+.+...+++.+-+|
T Consensus 173 iGtpywmapEvaaverkggynq-lcdiwa~gitAiel~eLqpplfdlh-pmr~l~LmTkS~~qpp~lkDk~kws~~fh~f 250 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQ-LCDIWALGITAIELGELQPPLFDLH-PMRALFLMTKSGFQPPTLKDKTKWSEFFHNF 250 (829)
T ss_pred cCCccccchhHHHHHhcccccc-cccccccccchhhhhhcCCcccccc-hHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence 8999999999743 334444 4999999999999988776643322 1222233333222333455566689999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
++.+|.++|.+||++ ..+++|||++
T Consensus 251 vK~altknpKkRpta--------eklL~h~fvs 275 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTA--------EKLLQHPFVS 275 (829)
T ss_pred HHHHhcCCCccCCCh--------hhheeceeec
Confidence 999999999999988 5555788876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=203.10 Aligned_cols=203 Identities=26% Similarity=0.399 Sum_probs=168.5
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC--CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (298)
...++..-+..||.|++|.|=+.++..+|...|+|.+... .+...+..+|+.+..+- .||.++.++|....+..+++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3445566678899999999999999999999999998753 34445566788776655 79999999999999999999
Q ss_pred EEeccCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 97 VMEYASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 97 v~~~~~~~sL~~~----l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
.||.|+ .||..+ +..++.+++.-+-+|+..++.||.|||+ ..++|||+||+|||++.+|. +|++|||.+...
T Consensus 123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYL 199 (282)
T ss_pred eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceee
Confidence 999994 477443 4567889999999999999999999996 47999999999999999998 999999988655
Q ss_pred cCCCCCCCCCCCCcccCccccc----cccCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 226 (298)
..+.......|+.-|+|||.+. ..+|+.+ +||||||+.+.||.+++.||..-..
T Consensus 200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred hhhhHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCC
Confidence 4444444467888899999865 3366666 9999999999999999999876543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=222.87 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=202.3
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEcc---CCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (298)
.....+.|.++++||+|.|+.||++.... ..+.||+|.+...... ..+.+|+++|.++ .+.||+++.+++..++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 34456789999999999999999999876 7889999998765433 5688999999999 58999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
.++|+||+++....++... ++..++..+++.++.||.++|++||+||||||.|++.+.... +-.|+|||++.....
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDG 185 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHh
Confidence 9999999999888887755 568999999999999999999999999999999999987665 578999999851000
Q ss_pred --------------CCC-------------------------------CCCCCCCCcccCccccccccCCCCccchHHHH
Q 022401 174 --------------HSQ-------------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 208 (298)
Q Consensus 174 --------------~~~-------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG 208 (298)
... .....|+++|.|||++...+--+.+.||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 000 01113788999999998887767779999999
Q ss_pred HHHHHHHhCCCCCCCCCCc-hhHHHHHHH---------------------------------Hhhc--------CC---C
Q 022401 209 VTLYVMLVGGYPFEDPDEP-KDFRKTIQR---------------------------------ILSV--------QY---S 243 (298)
Q Consensus 209 ~ll~~l~~g~~pf~~~~~~-~~~~~~~~~---------------------------------~~~~--------~~---~ 243 (298)
++++.++++..||-...+. +.+.+...- +... .. .
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999997443321 111111000 0000 00 0
Q ss_pred -CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 244 -VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 244 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
..-....|..+.+|+.+||..||.+|.|+ ...|.|||+.+..+
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitA--------EeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITA--------EDALKHPFFDEADR 389 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccH--------HHHhcCcCCcchhh
Confidence 00011245689999999999999999998 45557888876543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=207.32 Aligned_cols=196 Identities=42% Similarity=0.700 Sum_probs=171.2
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
|.+.+.||.|++|.||++....+++.+++|.+..... ....+.+|+..+++++|+|++++++++......++++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6788999999999999999988889999999886543 35678899999999999999999999998899999999999
Q ss_pred CCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--CCCC
Q 022401 103 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 179 (298)
Q Consensus 103 ~~sL~~~l~~~~~-~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 179 (298)
+++|.+++..... ++...+..++.+++.++.+||+.+++|+|++|.||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccc
Confidence 9999999987766 899999999999999999999999999999999999998866 9999999887554432 2344
Q ss_pred CCCCCcccCcccc-ccccCCCCccchHHHHHHHHHHHhCCCCCCC
Q 022401 180 TVGTPAYIAPEVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (298)
Q Consensus 180 ~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 223 (298)
..+...|++||.+ ....++. ++|+|+||++++++++|..||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 4567789999998 4445555 49999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=209.53 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=192.8
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEE-EEeCC
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEV-ILTPT 92 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~ 92 (298)
-++-+.-.+.|.|.+.||+|.||.+-+++++.+++.+++|.+........+|.+|...---| .|.||+.-++. |...+
T Consensus 16 el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 16 ELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 34455566789999999999999999999999999999999999888888899988765555 47899887766 45566
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+++++||++.|+|.+-+... .+.+...+.++.|++.||.|+|+.++||||||.+||||-...-.++||+|||..+...
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 888999999999999888554 4688889999999999999999999999999999999944444489999999876332
Q ss_pred CCCCCCCCCCCCcccCcccccccc-----CCCCccchHHHHHHHHHHHhCCCCCCCCCCchh-HHHHHHHHhhcCCCCCC
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSVQYSVPD 246 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 246 (298)
. ..........|.+||.+.... ..+. +|+|+||++++.++||..||+.....+. ..+..+.........|.
T Consensus 175 ~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps-~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 175 T--TVKYLEYVNNYHAPELCDTVVNEKLVVNPS-TDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred c--eehhhhhhcccCCcHHHhhccccceEeccc-ccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 2 112222345578888764321 2233 8999999999999999999996543332 22333333333333332
Q ss_pred -CCCCCHHHHHHHHHhhhhCCCCc
Q 022401 247 -TNPISQECRDLISRIFVADPAAV 269 (298)
Q Consensus 247 -~~~~~~~l~~li~~~l~~dp~~R 269 (298)
.+..++.+..+.++-|+.+|++|
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hhcccCHHHHHHHHHhcCCccccc
Confidence 33478899999999999999999
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=214.80 Aligned_cols=249 Identities=18% Similarity=0.218 Sum_probs=199.2
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCC-----cEEEEEEeecCCcc--hHHHHHHHHHHhcCCCCCeeeeeEEEEe-C
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTK-----ELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILT-P 91 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 91 (298)
....++++.-.+.+|.||.||.+.++... +.+.+|.+...... ...+..|--.+..+.|||+..+.+++.. .
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 44567888899999999999999765332 23455554433322 2346678888888899999999998765 4
Q ss_pred CeEEEEEeccCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEe
Q 022401 92 THLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~--------~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~ 163 (298)
...++++.+..-++|..++.. .+.++..++..++.|++.|++|||+.|++|.||-..|.++++.-. +||+
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--Vklt 438 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--VKLT 438 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--EEec
Confidence 578999999999999999861 124777888999999999999999999999999999999987654 9999
Q ss_pred ecCccccc---cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 022401 164 DFGYSKSS---VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS 239 (298)
Q Consensus 164 d~~~~~~~---~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 239 (298)
|-.+++.. ..............|||||.+.+..++.. +|+||||+++|||+| |+.|+...+.. .+.....
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPf-----Em~~ylk 512 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPF-----EMEHYLK 512 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHH-----HHHHHHh
Confidence 99988632 22344455566778999999999988776 999999999999998 78898876542 2344555
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccc
Q 022401 240 VQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPL 276 (298)
Q Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l 276 (298)
...++..+.++|+++..++--||..+|++||+++|+.
T Consensus 513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 6778888888999999999999999999999997765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=239.22 Aligned_cols=201 Identities=14% Similarity=0.156 Sum_probs=141.0
Q ss_pred CCC-CCeeeeeEEE-------EeCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCC
Q 022401 76 LRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146 (298)
Q Consensus 76 l~h-~~i~~~~~~~-------~~~~~~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~ 146 (298)
++| +||+++.+++ .....++.++|++ +++|.+++.. ...+++.+++.+++||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 344 5777777766 2334677888887 5699999965 3468999999999999999999999999999999
Q ss_pred CCceEeeCCCC-----------------CCEEEeecCccccccCCC-----------------CCCCCCCCCcccCcccc
Q 022401 147 LENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEVL 192 (298)
Q Consensus 147 p~nilv~~~~~-----------------~~~~l~d~~~~~~~~~~~-----------------~~~~~~~~~~~~aPE~~ 192 (298)
|+|||++..+. ..+|++|||+++...... ......+++.|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999965332 236666776664321100 00112467789999999
Q ss_pred ccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccc
Q 022401 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIF 272 (298)
Q Consensus 193 ~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 272 (298)
.+..++.+ +|||||||++|||++|..|+..... ......... .. +.......+...++.+||..||.+||++
T Consensus 188 ~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 188 NGSSSNCA-SDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV----LP-PQILLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred ccCCCCch-hhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh----cC-hhhhhcCHHHHHHHHHhCCCChhhCcCh
Confidence 88888665 9999999999999998887653211 111111111 11 1111124567789999999999999988
Q ss_pred cccchhhhHHHhhhhhhhhhh
Q 022401 273 FFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 273 ~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.++++|||+.+..
T Consensus 260 --------~eil~h~~~~~~~ 272 (793)
T PLN00181 260 --------SELLQSEFINEPR 272 (793)
T ss_pred --------HHHhhchhhhhhh
Confidence 4555788887643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-27 Score=201.73 Aligned_cols=252 Identities=23% Similarity=0.200 Sum_probs=195.8
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCC-cEEEEEEeecCCcch-HHHHHHHHHHhcCC----CCCeeeeeEEE-EeCCeEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKID-ENVQREIINHRSLR----HPNIVRFKEVI-LTPTHLAI 96 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~-~~~aiK~~~~~~~~~-~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l 96 (298)
+|.+.+.||+|+||.||.+.+..++ ..+|+|......... ..+..|..++..+. .+++..+++.+ ..+..-++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999997664 578888776643222 26788888888886 36899999998 47778899
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-C--CCEEEeecCccc--
Q 022401 97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK-- 169 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~--~~~~l~d~~~~~-- 169 (298)
||+.. |.+|.++.... ..++..++..++.|++.+|++||+.|++||||||.|+.+...+ . ..++|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99988 77999988544 4799999999999999999999999999999999999997654 1 359999999998
Q ss_pred cccCCCC---------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 022401 170 SSVLHSQ---------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240 (298)
Q Consensus 170 ~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (298)
....... .....|+.+|.|+..+.+...... .|+||+++++.+++.|.+||..........+..+.....
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 3211111 122348999999999988888776 999999999999999999997766543322222222111
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 241 QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 241 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.... .....+.++.++...+-+.+...+|.+..+.+.
T Consensus 257 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 257 LTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred cccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1111 222356789999888888999999999777764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=185.91 Aligned_cols=165 Identities=19% Similarity=0.202 Sum_probs=122.8
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCC
Q 022401 104 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (298)
Q Consensus 104 ~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 182 (298)
|+|.+++.. +..+++.+++.++.|++.||+|||+.+ ||+||+++.++. +++ ||++...... ...+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence 588888876 456999999999999999999999998 999999998887 777 9987643322 2257
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchh-HHHHHHHHhhcCCC-CCCCCCCCH--HHHHHH
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSVQYS-VPDTNPISQ--ECRDLI 258 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~--~l~~li 258 (298)
++.|+|||++.+..++.+ +||||+|+++|+|++|..||........ +............. .+....++. ++.+++
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999988887665 9999999999999999999976543222 22222221111110 011112333 699999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+||+.||.+||++ .+++.|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~--------~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAA--------NHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCH--------HHHHHHHHHHH
Confidence 99999999999987 45556777663
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=180.16 Aligned_cols=253 Identities=21% Similarity=0.245 Sum_probs=200.8
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCC-CCeeeeeEEEEeCCeEE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLA 95 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 95 (298)
+-.+..++|.++++||+|+||.+|.+..-.+|..||||.-... ...+.+.-|..+.+.|++ .+|..+..+......-.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 4456678999999999999999999999999999999965443 344667788899998865 78888888888888889
Q ss_pred EEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC-CEEEeecCccccccC
Q 022401 96 IVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVL 173 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~-~~~l~d~~~~~~~~~ 173 (298)
+||+.. |-||.+++. -...++..+++-++-|++.-++|+|.++++||||||+|.+..-+.++ ++.|+|||++.....
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999998 679988875 33468999999999999999999999999999999999999765554 489999999964332
Q ss_pred --------CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 174 --------HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 174 --------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
........|+.+|.|-..+.+...+.. .|+-|+|+++.++--|.+||++..... ......++.+.....+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~t-k~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAAT-KKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhh-HHHHHHHHHHhhcCCC
Confidence 223344558889999888777776666 999999999999999999999876433 2334445554444433
Q ss_pred C---CCCCCHHHHHHHHHhhhhCCCCccccc
Q 022401 246 D---TNPISQECRDLISRIFVADPAAVSIFF 273 (298)
Q Consensus 246 ~---~~~~~~~l~~li~~~l~~dp~~Rps~~ 273 (298)
. ....|.|+.-.+.-|-..-=++-|.+.
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 2 445789999999999888777777763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=183.58 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=204.4
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 97 (298)
....-.|+++++||+|.||+.+.+.+-.++.+||||. +.-.....+++.|....+.| ..++|...+.+.....+-.+|
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKf-EPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKF-EPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEe-ccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 3445679999999999999999999999999999995 44445568889999999888 569999998887777777899
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC---CEEEeecCccccccC
Q 022401 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSKSSVL 173 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~---~~~l~d~~~~~~~~~ 173 (298)
++.. |-||.+++.--+ .++..++..++.|++.-++++|++++|+|||||+|.||...+.. .+.++|||++.....
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9988 679999886544 69999999999999999999999999999999999999754443 489999999963322
Q ss_pred --------CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 174 --------HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 174 --------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
+.......|+.+|||--.+.+...+.+ .|+-|||=++.+++-|.+||++... +...+..++|.......+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA-~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA-DTNKEKYEKIGETKRSTP 259 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC-cchHHHHHHhccccccCC
Confidence 334456679999999999988888777 9999999999999999999999876 444666667665544333
Q ss_pred C---CCCCCHHHHHHHHHhhhhCCCCcccccc
Q 022401 246 D---TNPISQECRDLISRIFVADPAAVSIFFF 274 (298)
Q Consensus 246 ~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ 274 (298)
. ..+.|.++..-++-.-..+=.+-|.+.-
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 2 2347788888888777777777777643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=210.42 Aligned_cols=256 Identities=30% Similarity=0.472 Sum_probs=194.0
Q ss_pred eEEeeeccCCeEEEEEEEEccCCcEEEEEEeec---CC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 26 ~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~---~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.....+|.|++|.++.+........+..|.+.. .. .....+..|.-+-.+++|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 567889999999888888776666566664431 11 11122456777778889999988877776665555559
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC-
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~- 177 (298)
||+++ +|..++.....++..++--+++|++.|++|+|+.|+.|+|+|++|+++..++. +|++|||.+.........
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchh
Confidence 99999 99999988888999999999999999999999999999999999999999987 999999987644333322
Q ss_pred ----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH---HHhhcCCCCCCCCCC
Q 022401 178 ----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ---RILSVQYSVPDTNPI 250 (298)
Q Consensus 178 ----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 250 (298)
....|+.-|+|||.+.+..|++...||||.|+++..|.+|+.||......+.-..... ..............+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 3345778899999999999999999999999999999999999988765443210000 000000111122247
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
|.+-+.+|.+||+.||.+|.|+.+|+ +-+|+++.
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~--------~d~W~~~i 591 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQIL--------NDEWIRSI 591 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHh--------hChHhhhc
Confidence 88999999999999999999986665 55666544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-22 Score=174.99 Aligned_cols=250 Identities=36% Similarity=0.578 Sum_probs=196.1
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCC-CeeeeeEEEEeCCeEEEEEe
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~~ 99 (298)
|.+.+.||.|+|+.||.+.+. ..+++|.+..... ....+.+|..++..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999997 6789998876433 345688899999999988 79999999977778899999
Q ss_pred ccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-
Q 022401 100 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~- 175 (298)
++.++++.+.+.... .++......++.+++.++.++|+.+++|+|++|+||+++..+. .+++.|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence 999999997776665 7899999999999999999999999999999999999987772 28999999886333222
Q ss_pred ------CCCCCCCCCcccCccccccc--cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC-C--
Q 022401 176 ------QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-V-- 244 (298)
Q Consensus 176 ------~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-- 244 (298)
......++..|++||...+. .......|+|++|++++++++|..||...............+...... .
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 23566789999999998874 344555999999999999999999977765421122222222222222 1
Q ss_pred CCCCCC----CHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 245 PDTNPI----SQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 245 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
...... ...+.+++..++..+|..|.+..+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111 2579999999999999999988665543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-25 Score=176.55 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=198.2
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeec---CCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
++.++..++.+|.+.-.|..|+++++++ -++.|++.. ..+....|..|.-.++.+.||||+++++.|..+-.+.+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 4556677888999999999999999754 466676543 44555678888888999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 97 VMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
+..|++.+||...++++.. .+-.+..+++.++++|+.|||+.. +.-.-|+..+|++|.+-..++-.+|-.++.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---
Confidence 9999999999999987654 678899999999999999999865 555678899999999888777667655433
Q ss_pred CCCCCCCCCCCCcccCccccccccCC--CCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
+.....-+|.|++||.++.+..+ .+++|+|||++++||+.|...||.....-+ --.++.-...+...++..
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme----cgmkialeglrv~ippgi 414 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME----CGMKIALEGLRVHIPPGI 414 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh----hhhhhhhccccccCCCCc
Confidence 22334457889999999877654 445999999999999999999998876532 222334445566677778
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccc
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPL 276 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l 276 (298)
+.....++.-|++.||.+||.+..++
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999999998776
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=182.63 Aligned_cols=164 Identities=16% Similarity=0.101 Sum_probs=125.3
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEcc-CCcEEEEEEeecC------CcchHHHHHHHHHHhcCCCCCeee-eeEEEEe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR-FKEVILT 90 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~aiK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~ 90 (298)
..-.++|++.+.||+|+||.||+|.+.. +++.+|+|+.... ......+.+|+.++++++|+|+++ +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 3456789999999999999999999875 6777899986532 112456889999999999999985 433
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecC-CCCceEeeCCCCCCEEEeecCccc
Q 022401 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl-~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
....++||||++|++|.. .. +.. ...++.+++.+|.|||+.|++|||| ||+||+++.++. ++|+|||++.
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~ 160 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLAS 160 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccce
Confidence 245799999999999963 21 111 1467889999999999999999999 999999987776 9999999987
Q ss_pred cccCCCCC---------CCCCCCCcccCccccccc
Q 022401 170 SSVLHSQP---------KSTVGTPAYIAPEVLLRH 195 (298)
Q Consensus 170 ~~~~~~~~---------~~~~~~~~~~aPE~~~~~ 195 (298)
........ ....++..|.+||.+...
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 44332211 122356678888876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-25 Score=193.56 Aligned_cols=245 Identities=27% Similarity=0.429 Sum_probs=200.5
Q ss_pred eeccCCeEEEEEEEE---ccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 30 DIGSGNFGVARLMRD---KVTKELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 30 ~lg~g~~~~vy~~~~---~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
++|+|.+|.|++++. ...+..|++|+..+.. +.......|..++...+ ||.+++++..+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 478999999887764 3457788999876532 11223445667777776 9999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCC
Q 022401 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (298)
Q Consensus 103 ~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 182 (298)
++.+...+.+...+++.....+...++.+++++|+.+++|+|+|++||+++.+|+ +++.|||.++........ +|
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CG 155 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---cc
Confidence 9999999988888999999999999999999999999999999999999999998 999999988754433332 88
Q ss_pred CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhh
Q 022401 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262 (298)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (298)
+..|+|||+.. +... ++|-||+|++++++++|..||.. +....|....+..|. .++.+.++++..++
T Consensus 156 t~eymApEI~~--gh~~-a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLS-AADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLF 222 (612)
T ss_pred chhhhhhHhhh--ccCC-cccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHH
Confidence 99999999987 3333 48999999999999999999998 445555555554443 37899999999999
Q ss_pred hhCCCCcccccccchhhhHHHhhhhhhhhhhhh
Q 022401 263 VADPAAVSIFFFPLNMSCLLLFSFVWMFDATEN 295 (298)
Q Consensus 263 ~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~ 295 (298)
..+|..|.-..-- ...+..+|+|++...+|
T Consensus 223 ~r~p~nrLg~~~~---~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 223 KRNPENRLGAGPD---GVDEIKQHEFFQSIDWN 252 (612)
T ss_pred hhCHHHHhccCcc---hhHHHhccchheeeeHh
Confidence 9999999866321 24788999999987765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=171.03 Aligned_cols=231 Identities=21% Similarity=0.223 Sum_probs=148.6
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCC----------CCCeeeeeEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLR----------HPNIVRFKEVIL 89 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~----------h~~i~~~~~~~~ 89 (298)
....++.||.|+++.||.+.+..+++.+++|++....+ ..+++++|......+. |-.++...+...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 47889999999999999999999999999999875432 2345666665555432 223444444432
Q ss_pred e------------CCe-----EEEEEeccCCCCHHHHHH---hCCCC----CHHHHHHHHHHHHHHHHHHhhcCcEEecC
Q 022401 90 T------------PTH-----LAIVMEYASGGELFERIC---NAGRF----SEDEARFFFQQLISGVSYCHAMQVCHRDL 145 (298)
Q Consensus 90 ~------------~~~-----~~lv~~~~~~~sL~~~l~---~~~~~----~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl 145 (298)
. .+. .+++|+.+ .++|..++. ..... ...-...+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 112 36778877 457877753 22222 22233445689999999999999999999
Q ss_pred CCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCCcccCccccccc-------cCCCCccchHHHHHHHHHHHhCC
Q 022401 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-------EYDGKIADVWSCGVTLYVMLVGG 218 (298)
Q Consensus 146 ~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~ll~~l~~g~ 218 (298)
+|+|++++.+|. ++|+||+...+....... ...+..|.+||..... ...+.+.|.|+||+++|.+.++.
T Consensus 172 ~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999998 999999876543332221 3445778889865432 11233489999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCc
Q 022401 219 YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAV 269 (298)
Q Consensus 219 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 269 (298)
.||........ ....+....++|+.++++|+.+|+.||++|
T Consensus 248 lPf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99987543211 111233334689999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=164.04 Aligned_cols=170 Identities=15% Similarity=0.160 Sum_probs=128.4
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHH----------HHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
..++|++.+.+|.|+||.||.+.. ++..+|+|.+.......+. +.+|+..+.++.|++|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 358999999999999999999766 3557999998754322222 5788889999999999999988664
Q ss_pred C--------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEE
Q 022401 91 P--------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (298)
Q Consensus 91 ~--------~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l 162 (298)
. ...+++|||++|.+|.+... +++ ....+++.++..+|+.|++|||++|.|+++++++ ++|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~l 175 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRI 175 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEE
Confidence 3 35789999999999977632 233 2466999999999999999999999999998766 899
Q ss_pred eecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHH
Q 022401 163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 215 (298)
Q Consensus 163 ~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~ 215 (298)
+|||.......... . ........+..+ +|+|+||+.+..+.
T Consensus 176 iDfg~~~~~~e~~a------~-----d~~vler~y~~~-~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKA------K-----DRIDLERHYGIK-NEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhh------H-----HHHHHHhHhccc-ccccceeEeehHHH
Confidence 99997643311110 0 012333445544 99999999876654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=160.55 Aligned_cols=137 Identities=20% Similarity=0.181 Sum_probs=107.7
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----------hH-----------------HHHHHHHHHhcCCCCC
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------DE-----------------NVQREIINHRSLRHPN 80 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----------~~-----------------~~~~e~~~l~~l~h~~ 80 (298)
...||+|++|.||.|.+. +|+.||+|++..+... .. ...+|..++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999998754211 01 1234889999998777
Q ss_pred eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-hhcCcEEecCCCCceEeeCCCCCC
Q 022401 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPR 159 (298)
Q Consensus 81 i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~L-h~~~i~H~dl~p~nilv~~~~~~~ 159 (298)
+.....+... ..++||||++++++.........++..++..++.|++.+|.++ |+.|++|+||||+||+++. +.
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~-- 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GK-- 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-Cc--
Confidence 6443333222 2379999999877765544556789999999999999999999 7999999999999999984 44
Q ss_pred EEEeecCcccc
Q 022401 160 LKICDFGYSKS 170 (298)
Q Consensus 160 ~~l~d~~~~~~ 170 (298)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999998763
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-23 Score=192.57 Aligned_cols=237 Identities=24% Similarity=0.350 Sum_probs=178.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc--hHHHH---HHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQ---REIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.|...+.||++.|=.|.+|++.. | .+++|++.+.... ...+. .+++ ....++||.+++.-..+.++..|+|.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78999999999999999999863 3 4999998765322 23333 3333 44458999999999887888889999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC-
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~- 177 (298)
+|... +|.+.++.++-+..-+.+.|+.|++.|+..+|+.|++|||||.+|||+++=.. +.|.||............
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCc
Confidence 99854 89999998888899999999999999999999999999999999999987766 999999865422221111
Q ss_pred -------CCCCCCCcccCcccccccc---------C-CCCccchHHHHHHHHHHHh-CCCCCCCC-------CCchhHHH
Q 022401 178 -------KSTVGTPAYIAPEVLLRHE---------Y-DGKIADVWSCGVTLYVMLV-GGYPFEDP-------DEPKDFRK 232 (298)
Q Consensus 178 -------~~~~~~~~~~aPE~~~~~~---------~-~~~~~Di~slG~ll~~l~~-g~~pf~~~-------~~~~~~~~ 232 (298)
.+......|+|||.+.... + -.++-||||+||++.|+++ |.+||.-. .+......
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 2223455799999876532 1 2344799999999999998 67787531 00111111
Q ss_pred HHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.+.+ . -+..++.+|..|++.||.+|.++.+.|..
T Consensus 258 ~Le~----------I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEK----------I--EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHh----------C--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111 1 13469999999999999999999998876
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=155.29 Aligned_cols=139 Identities=18% Similarity=0.139 Sum_probs=109.6
Q ss_pred EEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---------------------------hHHHHHHHHHHhcCCCC
Q 022401 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHP 79 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~ 79 (298)
+.+.||+|++|.||.|.+. +|+.||+|++..+... ......|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999998754211 11235788889999998
Q ss_pred CeeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCC
Q 022401 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP 158 (298)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~ 158 (298)
++.....+.... .++||||++|+++.........++......++.+++.++.++|+ .|++|+||||+||+++ ++.
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~- 155 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK- 155 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC-
Confidence 875544443332 47999999887554433344567888999999999999999999 9999999999999998 555
Q ss_pred CEEEeecCccccc
Q 022401 159 RLKICDFGYSKSS 171 (298)
Q Consensus 159 ~~~l~d~~~~~~~ 171 (298)
++|+|||++...
T Consensus 156 -~~liDFG~a~~~ 167 (190)
T cd05145 156 -PYIIDVSQAVEL 167 (190)
T ss_pred -EEEEEcccceec
Confidence 999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=153.55 Aligned_cols=186 Identities=16% Similarity=0.145 Sum_probs=138.9
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchH-----HHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEEE
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-----NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 98 (298)
..+...|+.|+||+||.+.. .+..++.+.+........ .+.+|++++++++ ++++.+++++ +..++++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45678999999999997766 567788787776655433 5789999999995 5889999886 3468999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecC-CCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl-~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
+|+.|.+|...... ....++.+++.++.++|+.|++|+|| +|+||+++.++. ++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchH
Confidence 99999888654321 12357789999999999999999999 799999988776 999999998744332210
Q ss_pred --------------CCCCCCCcccCccccccc-cCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 022401 178 --------------KSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (298)
Q Consensus 178 --------------~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 225 (298)
.....++.+++|+...-- ..+-...+.++.|+-+|.++|+..|+...+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 001146667777754322 222233688999999999999998876644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=162.98 Aligned_cols=195 Identities=27% Similarity=0.366 Sum_probs=145.6
Q ss_pred CCCCeeeeeEEEEe---------------------------CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 022401 77 RHPNIVRFKEVILT---------------------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129 (298)
Q Consensus 77 ~h~~i~~~~~~~~~---------------------------~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~ 129 (298)
+||||+.+.+.|.+ +..+|+||..++. +|..++-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999888754 3468999999855 898888544 447778888999999
Q ss_pred HHHHHHhhcCcEEecCCCCceEe--eCCCCCCEEEeecCccccccC-------CCCCCCCCCCCcccCcccccccc----
Q 022401 130 SGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL-------HSQPKSTVGTPAYIAPEVLLRHE---- 196 (298)
Q Consensus 130 ~~l~~Lh~~~i~H~dl~p~nilv--~~~~~~~~~l~d~~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~---- 196 (298)
+|+.|||++|+.|+|+|.+||++ ++|+.+.+++.|||+|-.... .+..-...|+...+|||+...-+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999999 667777899999998742222 22223344677789999875432
Q ss_pred -CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCccccccc
Q 022401 197 -YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFP 275 (298)
Q Consensus 197 -~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~ 275 (298)
.+..++|.|+.|.+.||+++...||....+...-... ..+.+. .+.+..+|+.+++++..+|+.||.+|++..-+
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~qL-Palp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQL-PALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhhC-CCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 2234599999999999999999999885532111111 111111 23345589999999999999999999998544
Q ss_pred ch
Q 022401 276 LN 277 (298)
Q Consensus 276 l~ 277 (298)
-+
T Consensus 508 AN 509 (598)
T KOG4158|consen 508 AN 509 (598)
T ss_pred Hh
Confidence 43
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.2e-21 Score=167.57 Aligned_cols=203 Identities=23% Similarity=0.287 Sum_probs=157.6
Q ss_pred HhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCc-EEecCCCCce
Q 022401 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQV-CHRDLKLENT 150 (298)
Q Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i-~H~dl~p~ni 150 (298)
|+.+.|.|+.+++|.+.++...++|.++|.-|+|.+.+.. ...++......++++++.|+.|||+..+ .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3568999999999999999999999999999999999987 4468888999999999999999997765 9999999999
Q ss_pred EeeCCCCCCEEEeecCccccccCC---CCCCCCCCCCcccCccccccccC------CCCccchHHHHHHHHHHHhCCCCC
Q 022401 151 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEY------DGKIADVWSCGVTLYVMLVGGYPF 221 (298)
Q Consensus 151 lv~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Di~slG~ll~~l~~g~~pf 221 (298)
+++.... +|+.|||+....... ...........|.|||.+..... .+++.|+||+|++++|+++...||
T Consensus 81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9998887 999999986543221 11111123456999999876421 244599999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhh-cC----CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 222 EDPDEPKDFRKTIQRILS-VQ----YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
..........+.+..+.. +. +........++++..++.+||..+|..||++.++-.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 886544432444444333 11 122222246678999999999999999999977654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.6e-21 Score=176.10 Aligned_cols=229 Identities=29% Similarity=0.469 Sum_probs=168.2
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
...+..++|..++.+..|++|.||.++++.+.+.+|+| +.++... .++ ++.....|.++
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li---lRn---ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI---LRN---ILTFAGNPFVV-------------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh---hhc---cccccCCccee--------------
Confidence 34556789999999999999999999999888889995 3333211 111 23333334333
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~- 175 (298)
++=...+.+-++++..- +.+++|||+.||+|+|+||+|.+|..-|+ +|+.|||++..+....
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhcc
Confidence 22234444545544432 78899999999999999999999999998 9999999986332211
Q ss_pred ---------------CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 022401 176 ---------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240 (298)
Q Consensus 176 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (298)
..+...+++.|.|||++...+|... .|.|++|+++|+++-|..||.+...++.+...+..
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd---- 273 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD---- 273 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh----
Confidence 1133368999999999988888655 99999999999999999999987665544444443
Q ss_pred CCCCCC-CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 241 QYSVPD-TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 241 ~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
...++. ...+++|.+++++++|..+|..|.-.. ..+++-+|+|++..+
T Consensus 274 ~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~-----ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 274 DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG-----GALEVKQHGFFQLLD 322 (1205)
T ss_pred hccccccCcCCCHHHHHHHHHHHHhChHhhcccc-----hhhhhhhccceeecc
Confidence 333332 233789999999999999999998664 345778899988654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=176.33 Aligned_cols=198 Identities=24% Similarity=0.317 Sum_probs=159.1
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCeE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHL 94 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~ 94 (298)
....+.+|.|-+.+|+|++|.||.|.... |+.+|+|+-....-+. |---.+++.||+ -+.|+.+..+..-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34567899999999999999999999976 9999999766543322 111224444554 35677777777777888
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEee-----CCCCCCEEEeecCccc
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-----GSPAPRLKICDFGYSK 169 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~-----~~~~~~~~l~d~~~~~ 169 (298)
++|.+|.+.|||.++++....+++..+..++.|++..+++||..+||||||||+|.++. +.+..-++|+|||.+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 89999999999999999888899999999999999999999999999999999999994 2233459999999875
Q ss_pred cccCC---CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCC
Q 022401 170 SSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219 (298)
Q Consensus 170 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~ 219 (298)
..... ..-.....+..+-++|+..+..++.. +|.|.++-+++.|+.|..
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 33222 22244557888999999999999887 999999999999999873
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=147.92 Aligned_cols=139 Identities=17% Similarity=0.091 Sum_probs=109.9
Q ss_pred CeeEEeeeccCCeEEEEEEE-EccCCcEEEEEEeecCCcc-------------------------hHHHHHHHHHHhcCC
Q 022401 24 RYDFVRDIGSGNFGVARLMR-DKVTKELVAVKYIERGDKI-------------------------DENVQREIINHRSLR 77 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~-~~~~~~~~aiK~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 77 (298)
-|++.+.||+|++|.||.|. +..+|+.||+|++...... ...+..|...+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 6678999999998754210 122457899998886
Q ss_pred CCC--eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC-cEEecCCCCceEeeC
Q 022401 78 HPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDG 154 (298)
Q Consensus 78 h~~--i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-i~H~dl~p~nilv~~ 154 (298)
+.+ +.++++. ...++|||++++.++.............+...++.+++.++.+||+.| ++|+||+|+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 3344432 234799999999888665544556677778899999999999999999 99999999999998
Q ss_pred CCCCCEEEeecCccc
Q 022401 155 SPAPRLKICDFGYSK 169 (298)
Q Consensus 155 ~~~~~~~l~d~~~~~ 169 (298)
++. ++|+|||.+.
T Consensus 184 ~~~--i~LiDFg~a~ 196 (237)
T smart00090 184 DGK--VVIIDVSQSV 196 (237)
T ss_pred CCC--EEEEEChhhh
Confidence 554 9999999765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-18 Score=140.87 Aligned_cols=134 Identities=19% Similarity=0.229 Sum_probs=105.3
Q ss_pred EEeeeccCCeEEEEEEEEccCCcEEEEEEeecC-CcchHHHHHHHHHHhcC-----CCCCeeeeeEEEEeCC---eEE-E
Q 022401 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---HLA-I 96 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-l 96 (298)
-.+.||+|++|.||. +..++.. +||+.... ....+.+.+|+.+++.+ .||||++++++++.+. .++ +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999995 6556655 68887654 23446789999999999 5799999999998874 333 7
Q ss_pred EEec--cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHhhcCcEEecCCCCceEeeCC--CCCCEEEeecC
Q 022401 97 VMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFG 166 (298)
Q Consensus 97 v~~~--~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l-~~Lh~~~i~H~dl~p~nilv~~~--~~~~~~l~d~~ 166 (298)
|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+.+|+|+||||+||+++.. +..+++|+|++
T Consensus 83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 4478999999664 45555 35678888777 99999999999999999999753 33369999954
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.8e-18 Score=139.05 Aligned_cols=132 Identities=22% Similarity=0.215 Sum_probs=110.6
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---------hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
+.||+|++|.||.+.. .+..+++|........ ...+.+|+.++..+.|+++.....++.+....++++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 5667899976532211 1346689999999999998887778777888899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
|++|.+|.+.+..... ....++.+++.++.++|+.|++|+|++|.||+++ ++. ++|+|||.+.
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCccc
Confidence 9999999998865432 7889999999999999999999999999999998 444 9999999765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=134.76 Aligned_cols=128 Identities=21% Similarity=0.183 Sum_probs=104.1
Q ss_pred eeccCCeEEEEEEEEccCCcEEEEEEeecCCc---------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 30 ~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.||+|++|.||.+.. ++..+++|....... ....+.+|+.+++.+.++++.....++......++++|+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999985 467799998653211 124466899999999988876666666677778899999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++. ++++|||++.
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~--~~liDfg~a~ 137 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK--LYLIDFGLGK 137 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc--EEEEECCCCc
Confidence 999999988754321 7899999999999999999999999999998 554 9999999765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-18 Score=152.29 Aligned_cols=178 Identities=22% Similarity=0.275 Sum_probs=132.0
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 92 THLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
.++|+.|++|...+|.+++.... ..+....+.++.|++.+++| ++.+|+|++|.||+...+.. ++|+|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhe
Confidence 46899999999999999996443 36778899999999999999 99999999999999988776 999999987
Q ss_pred ccccCCC-------CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC
Q 022401 169 KSSVLHS-------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241 (298)
Q Consensus 169 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (298)
....... ......++..||+||++.+..+..+ +|||+||++++|++. +|.... .-......+..+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~---~f~T~~---er~~t~~d~r~g~ 476 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLI---QFSTQF---ERIATLTDIRDGI 476 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHH---HhccHH---HHHHhhhhhhcCC
Confidence 6443333 2234458899999999999999777 999999999999996 121111 1122233333333
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 242 YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
++.....+ .++-..|+.+|+...|.+||++ ....-|+|++
T Consensus 477 ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~--------~~~~~~~~~~ 516 (516)
T KOG1033|consen 477 IPPEFLQD-YPEEYTLLQQLLSPSPEERPSA--------IEVALHEFLQ 516 (516)
T ss_pred CChHHhhc-CcHHHHHHHHhcCCCcccCchH--------HHHhhhhhcC
Confidence 32111111 2455689999999999999944 6666677653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=133.31 Aligned_cols=133 Identities=21% Similarity=0.246 Sum_probs=104.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-----------------------chHHHHHHHHHHhcCCCCC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----------------------IDENVQREIINHRSLRHPN 80 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~~ 80 (298)
.|.+.+.||+|++|.||.+... +|+.+++|++..+.. .......|..++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999875 789999998764321 0122566888888887764
Q ss_pred --eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC
Q 022401 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (298)
Q Consensus 81 --i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~ 158 (298)
+...++ ....++++||++|.+|...... .....++.+++.++.++|+.|++|+||+|+||+++.++.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~- 163 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK- 163 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence 333333 3455899999999988765421 345678899999999999999999999999999988776
Q ss_pred CEEEeecCccc
Q 022401 159 RLKICDFGYSK 169 (298)
Q Consensus 159 ~~~l~d~~~~~ 169 (298)
++|+|||++.
T Consensus 164 -~~liDfg~~~ 173 (198)
T cd05144 164 -IYIIDWPQMV 173 (198)
T ss_pred -EEEEECCccc
Confidence 9999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-17 Score=149.92 Aligned_cols=135 Identities=20% Similarity=0.122 Sum_probs=108.7
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC-C--------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-D--------KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~-~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
..|...+.||+|+||.||++..... .+++|..... . ...+.+.+|+.+++.++|+++.....+..+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3456689999999999999887543 3444433211 1 112457789999999999999988888777778
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
.++|+||+++++|.+.+. ....++.+++.++.+||+.|++|||+||+||+++ ++. ++|+|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~--~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR--LYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc--EEEEeCccccc
Confidence 899999999999998884 4577899999999999999999999999999994 444 99999998763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-18 Score=159.14 Aligned_cols=261 Identities=30% Similarity=0.456 Sum_probs=200.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEcc-CCcEEEEEEeecCC---cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 95 (298)
....|.+.+.||+|.++.|-.+.... ....++.|.+.... ...+....|..+...+. |+|++.+++...+.+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 46789999999999999988887743 34556666554432 23344556777777776 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHh-hcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 96 IVMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 96 lv~~~~~~~sL~~~l-~~~~-~~~~~~~~~i~~~l~~~l~~Lh-~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
+..++..|+++...+ .... ..+....-.++.|+..++.|+| ..++.|+|++|+|.+++..+. ..++.||+++....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYR 176 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccc
Confidence 999999999998888 4444 5777888999999999999999 999999999999999998882 38999999987444
Q ss_pred C-CC---CCCCCCC-CCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCC
Q 022401 173 L-HS---QPKSTVG-TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247 (298)
Q Consensus 173 ~-~~---~~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
. .+ ......+ ++.|.+||...+..+..+..|+||.|+++..+++|..|+......+.......... ..+.....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 255 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPW 255 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCcc
Confidence 4 22 2233446 89999999998877777779999999999999999999987665442211111111 12223344
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...+....+++.+++..+|..|.+..+ +-.+||+.+
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~--------~~~d~~~~~ 291 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEE--------LKLDNWLSS 291 (601)
T ss_pred ccCChhhhhcccccccCCchhcccccc--------ccccccccc
Confidence 457889999999999999999998744 446677665
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-16 Score=126.12 Aligned_cols=132 Identities=21% Similarity=0.263 Sum_probs=93.1
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHH-------------------------HHHHHHHHhcCCCCC--
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-------------------------VQREIINHRSLRHPN-- 80 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~-------------------------~~~e~~~l~~l~h~~-- 80 (298)
.+.||+|++|.||.+.+. +++.||+|++......... ...|...+.++.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999987 7889999988754321111 123444444443332
Q ss_pred eeeeeEEEEeCCeEEEEEeccCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCC
Q 022401 81 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP 158 (298)
Q Consensus 81 i~~~~~~~~~~~~~~lv~~~~~~~sL~~-~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~ 158 (298)
+.+.+++ ...++++||++++++.. .+.... . ......++.+++.++.++|+ .|++|+||+|+||+++ ++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~- 152 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK- 152 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc-
Confidence 3333332 24589999998843321 111111 1 16678899999999999999 9999999999999999 555
Q ss_pred CEEEeecCccc
Q 022401 159 RLKICDFGYSK 169 (298)
Q Consensus 159 ~~~l~d~~~~~ 169 (298)
++++|||.+.
T Consensus 153 -~~liDfg~a~ 162 (187)
T cd05119 153 -VYIIDVPQAV 162 (187)
T ss_pred -EEEEECcccc
Confidence 9999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.4e-15 Score=125.72 Aligned_cols=132 Identities=20% Similarity=0.237 Sum_probs=100.2
Q ss_pred eeec-cCCeEEEEEEEEccCCcEEEEEEeecCC--------------cchHHHHHHHHHHhcCCCCCe--eeeeEEEEeC
Q 022401 29 RDIG-SGNFGVARLMRDKVTKELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI--VRFKEVILTP 91 (298)
Q Consensus 29 ~~lg-~g~~~~vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 91 (298)
..|| .||.|+||.+... +..+++|.+.... .....+.+|+.++.++.|+++ ...+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4566 7888888888774 6679999886421 122457789999999998775 5666654332
Q ss_pred C----eEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 92 T----HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 92 ~----~~~lv~~~~~~-~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
. ..++|+++++| .+|.+.+.. .++++.. +.+++.++.+||+.|++|+||+|.||+++.++. ++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECC
Confidence 2 23599999987 688888754 3455543 568999999999999999999999999988775 9999999
Q ss_pred ccc
Q 022401 167 YSK 169 (298)
Q Consensus 167 ~~~ 169 (298)
.+.
T Consensus 188 ~~~ 190 (239)
T PRK01723 188 RGE 190 (239)
T ss_pred Ccc
Confidence 765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2e-15 Score=115.91 Aligned_cols=131 Identities=24% Similarity=0.265 Sum_probs=110.0
Q ss_pred EEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCC--CCeeeeeEEEEeCCeEEEEEeccCCC
Q 022401 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 104 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (298)
+++.|++|.++.||++.... ..+++|....... ...+.+|...++.+++ .++.+++.+....+..+++++++.+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999853 6799998866544 5678899999999976 58889988887778899999999887
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 105 sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~---~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
++... +......++.+++.++..||.. +++|+|++|.||+++..+. +++.||+.+.
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAG 137 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEeccccc
Confidence 77543 5566778899999999999984 6999999999999997655 9999999765
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.5e-14 Score=127.65 Aligned_cols=167 Identities=19% Similarity=0.262 Sum_probs=130.8
Q ss_pred EEEEccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHH
Q 022401 41 LMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 119 (298)
Q Consensus 41 ~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~ 119 (298)
.+..+.++.++.+..+..... ..+...+.+.-++.++||||+++++.++.+...|+|+|.+. .|...+.+.+ ..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~ 104 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KE 104 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HH
Confidence 455666788888888876554 33557788899999999999999999999999999999984 5677776643 66
Q ss_pred HHHHHHHHHHHHHHHHh-hcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC-CCCCCCCCcccCccccccccC
Q 022401 120 EARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEY 197 (298)
Q Consensus 120 ~~~~i~~~l~~~l~~Lh-~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~ 197 (298)
.+...+.||+.||.+|| +.+++|+||.-..|+|+..|+ .||++|.++........ .........|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence 78888999999999997 678999999999999999998 99999998764433332 11222233467777654433
Q ss_pred CCCccchHHHHHHHHHHHhC
Q 022401 198 DGKIADVWSCGVTLYVMLVG 217 (298)
Q Consensus 198 ~~~~~Di~slG~ll~~l~~g 217 (298)
.. .|.|.|||++++++.|
T Consensus 182 -~s-~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WS-IDSWGLGCLIEELFNG 199 (690)
T ss_pred -cc-hhhhhHHHHHHHHhCc
Confidence 22 6999999999999988
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=8e-15 Score=121.29 Aligned_cols=195 Identities=16% Similarity=0.254 Sum_probs=136.5
Q ss_pred hcCCCCCeeeeeEEEEeCC-----eEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC--cEE
Q 022401 74 RSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ--VCH 142 (298)
Q Consensus 74 ~~l~h~~i~~~~~~~~~~~-----~~~lv~~~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~Lh~~~--i~H 142 (298)
-++-|.||++++.|+.+.+ ...++.+|+..+++..+|.+. ..+......+|+-||+.||.|||+.. ++|
T Consensus 122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih 201 (458)
T KOG1266|consen 122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH 201 (458)
T ss_pred HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence 3456999999999986543 478899999999999998643 34788889999999999999999875 999
Q ss_pred ecCCCCceEeeCCCCCCEEEeecCcccccc-----CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhC
Q 022401 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSV-----LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217 (298)
Q Consensus 143 ~dl~p~nilv~~~~~~~~~l~d~~~~~~~~-----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g 217 (298)
+++....|++..+|- +|++--.....-. .........+.++|.+||.=....-+.. +|||++|....+|..+
T Consensus 202 gnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 202 GNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEMAIL 278 (458)
T ss_pred CCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHHHHh
Confidence 999999999997776 6665433221000 0111233446788999997544444454 9999999999999887
Q ss_pred CCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 218 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 218 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
..--................+-+.. ++.-+.++..|++-.|..||++...++|+
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~le--------n~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLE--------NGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeccCCCcceeehhhhhhhheeecc--------CccccCcCcccccCCCCCCcchhhhhcCc
Confidence 7433332222222222222221111 12345689999999999999997777654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.2e-15 Score=130.23 Aligned_cols=244 Identities=20% Similarity=0.160 Sum_probs=183.2
Q ss_pred CCCCeeEEeeecc--CCeEEEEEEEE--ccCCcEEEEEEeec---CCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 022401 21 DSDRYDFVRDIGS--GNFGVARLMRD--KVTKELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (298)
Q Consensus 21 ~~~~y~~~~~lg~--g~~~~vy~~~~--~~~~~~~aiK~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (298)
....+.+.+.+|. |.+|.+|.++. ..++..+++|.-.. .......-.+|+...+++ .|++.++....++..+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456788889999 99999999998 78889999997432 223333445666666667 4899999888898999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHhhcCcEEecCCCCceEeeCC-CCCCEEEeecC
Q 022401 93 HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFG 166 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~----~l~~Lh~~~i~H~dl~p~nilv~~~-~~~~~~l~d~~ 166 (298)
..++-+|.+. .+|..+...-.. ++...++..+.+... |+.++|+.+++|-|++|.||+...+ .. ++++||+
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s--~~~~df~ 268 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS--CKLTDFG 268 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccce--eecCCcc
Confidence 9999999995 577777665554 788899999999999 9999999999999999999999888 44 8999999
Q ss_pred ccccccCCCCC------CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCC--CCchhHHHHHHHHh
Q 022401 167 YSKSSVLHSQP------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP--DEPKDFRKTIQRIL 238 (298)
Q Consensus 167 ~~~~~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~--~~~~~~~~~~~~~~ 238 (298)
+.......... ....+...|++||...+ .+ ....|+|++|.++.+..++..++..+ ..+..+....
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~-~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LA-TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---- 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc-cc-chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----
Confidence 88654443322 22256778999998633 33 34489999999999999888766655 3333222111
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccc
Q 022401 239 SVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPL 276 (298)
Q Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l 276 (298)
.........+.++...+.+|+..+|..|++++.+.
T Consensus 343 ---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 343 ---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11222333567888899999999999999874444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.2e-13 Score=104.82 Aligned_cols=127 Identities=19% Similarity=0.237 Sum_probs=94.5
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCee-eeeEEEEeCCeEEEEEeccCCCCH
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
++.++.|.++.||.++.. +..+++|...........+.+|..+++.+.+.+++ +++.+. ....++|+|+++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467889999999999875 67899998765543334567888999888655544 344432 3345789999999877
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCc-----EEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 107 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i-----~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
... . .....++.+++.++..||+.++ +|+|++|.||+++ ++. ++++||+.+.
T Consensus 79 ~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~--~~liDf~~a~ 135 (170)
T cd05151 79 LTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR--LWLIDWEYAG 135 (170)
T ss_pred ccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe--EEEEeccccc
Confidence 543 0 1123456889999999999885 9999999999998 444 8999999654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=4e-12 Score=100.98 Aligned_cols=134 Identities=15% Similarity=0.197 Sum_probs=94.8
Q ss_pred EeeeccCCeEEEEEEEEcc------CCcEEEEEEeecC-------------C-c---------chHHH----HHHHHHHh
Q 022401 28 VRDIGSGNFGVARLMRDKV------TKELVAVKYIERG-------------D-K---------IDENV----QREIINHR 74 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~------~~~~~aiK~~~~~-------------~-~---------~~~~~----~~e~~~l~ 74 (298)
...||.|..+.||.|.... .+..+|+|++..+ . + ....+ .+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998753 3578999987421 0 0 01222 27888888
Q ss_pred cCCC--CCeeeeeEEEEeCCeEEEEEeccCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHH-hhcCcEEecCCCCce
Q 022401 75 SLRH--PNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENT 150 (298)
Q Consensus 75 ~l~h--~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~-~l~~~~~~~~~~~~~i~~~l~~~l~~L-h~~~i~H~dl~p~ni 150 (298)
++.. -++.+.+++ ..-++|||++.+..+.. .+ ....++..+...+..+++.++..| |+.|++||||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8853 334444443 45678999997643321 22 222455667778889999999998 899999999999999
Q ss_pred EeeCCCCCCEEEeecCccc
Q 022401 151 LLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 151 lv~~~~~~~~~l~d~~~~~ 169 (298)
++.+ +. ++++||+-+.
T Consensus 157 L~~~-~~--v~iIDF~qav 172 (197)
T cd05146 157 LWHD-GK--VWFIDVSQSV 172 (197)
T ss_pred EEEC-Cc--EEEEECCCce
Confidence 9974 33 9999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=3e-12 Score=114.92 Aligned_cols=137 Identities=17% Similarity=0.178 Sum_probs=93.9
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch-------------------------------H----------HHH
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-------------------------------E----------NVQ 67 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-------------------------------~----------~~~ 67 (298)
+.||.|++|.||+|+.+ +|+.||||+...+.... + ++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999976 68899999975431000 0 122
Q ss_pred HHHHHHhcC----C-CCCeeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHhhcCc
Q 022401 68 REIINHRSL----R-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHAMQV 140 (298)
Q Consensus 68 ~e~~~l~~l----~-h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~-~l~~Lh~~~i 140 (298)
+|...+.++ + ++++.-..-+.......++||||++|.+|.+..... ... ....++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 344444433 2 344333222333345678999999999998776432 112 23456666665 4788999999
Q ss_pred EEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 141 ~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
+|+|++|.||+++.++. ++++|||++...
T Consensus 279 ~H~D~hPgNilv~~~g~--i~liDfG~~~~l 307 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK--IIALDFGIVGRL 307 (437)
T ss_pred eeCCCCcccEEECCCCc--EEEEeCCCeeEC
Confidence 99999999999988876 999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.7e-13 Score=126.26 Aligned_cols=262 Identities=25% Similarity=0.321 Sum_probs=194.1
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
..+.+.+.+.+.+..|.++.++.+.-..+|...+.|........ .+....+-+++..-.+|-++.....+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 35778999999999999999999988878866676654432211 12222233333333456666544444456678
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++++++.++++|...+++.+..+..-....+..+.+++++||+..+.|+|++|.|.+...+++ .++.+|+.......-
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLI 957 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccc
Confidence 999999999999999998887777778888889999999999999999999999999998888 788888732100000
Q ss_pred --------------------------------CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCC
Q 022401 175 --------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (298)
Q Consensus 175 --------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 222 (298)
.......+++.|.+||...+...... +|.|+.|+++++.++|..||+
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCC
Confidence 00111236788999999888877665 999999999999999999999
Q ss_pred CCCCchhHHHHHHHHhhcCCCCCC-CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 223 DPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.... .+..+.+.+....++. +...+++.++++...+..+|.+|..+...- .+-.|||+++.
T Consensus 1037 a~tp----q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~-----e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1037 AETP----QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA-----EVKGHPFFQDV 1098 (1205)
T ss_pred Ccch----hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCccccc-----ccccCCccCCC
Confidence 8765 3444556666665554 334688999999999999999999885333 45578877754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.4e-13 Score=117.90 Aligned_cols=249 Identities=18% Similarity=0.148 Sum_probs=174.2
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEc-cCCcEEEEEEeecCCcch-HHH--HHHHHHHhcC-CCCCeeeeeEEEEeCCeEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGDKID-ENV--QREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~-~~~--~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (298)
..+|.++..||.|.|+.|+....+ .++..|++|-........ +++ ..|+.+...+ .|.+.+.....+......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 358999999999999999887755 567788888665432221 221 2455555555 47777777677767777779
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
--||+.++++.....-...+++...+++..+++.++.++|+..++|+|++|+||++..++ ...+++||+...... ..
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~--~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLA--FS 420 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccccc--ee
Confidence 999999988877665555688899999999999999999999999999999999998764 348899999776411 11
Q ss_pred CCCCCCCCcccC-ccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 177 PKSTVGTPAYIA-PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 177 ~~~~~~~~~~~a-PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
........++.+ .|.+........+.|++|||.-+.+.+++...-....... .+..+ ..+........+.
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-------~i~~~--~~p~~~~~~~~~q 491 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-------TIRSG--DTPNLPGLKLQLQ 491 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-------eeecc--cccCCCchHHhhh
Confidence 122233344442 5555555444555999999999999998764322211100 11111 2233333457788
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHH
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLL 282 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~ 282 (298)
.+..-+...++..||.+.+...++-+.
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchhh
Confidence 888999999999999987776655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.7e-12 Score=96.32 Aligned_cols=129 Identities=23% Similarity=0.212 Sum_probs=102.2
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecC----Ccch-----HHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKID-----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
..+++|+-+.+|.+... |..+++|.-... +... ++-.+|..++.++.--++....-+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999988664 445777754321 2222 334578999998887788777778888999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
|.+|..|.+.+... ...+++.+-.-+.-||..||+||||+++||++++++ +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence 99999999888665 255778888888899999999999999999998665 8999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.4e-11 Score=94.58 Aligned_cols=141 Identities=16% Similarity=0.097 Sum_probs=108.8
Q ss_pred EEeeeccCCeEEEEEEEEccCCcEEEEEEeec---------CCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
....+.+|+.+.|+.+... |+.++||.-.. ......+-++|...+.++.--+|....-++.+.+.-.+.
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 6788999999999988774 77788885322 112234566899999888777777777788888888999
Q ss_pred EeccCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC-CEEEeecCccc
Q 022401 98 MEYASG-GELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSK 169 (298)
Q Consensus 98 ~~~~~~-~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~-~~~l~d~~~~~ 169 (298)
|||.+| .++.+++.... .....-...+++.+-..+..||.++++||||..+||++.+++.. .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999977 46666664332 33333447899999999999999999999999999999877764 25899999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.4e-11 Score=104.08 Aligned_cols=212 Identities=18% Similarity=0.224 Sum_probs=149.1
Q ss_pred EEEEEEEEccCCcEEEEEEeecCCcchH-HHHHHHHHHhcCCCCCeeeeeEEEE----eCCeEEEEEeccCC-CCHHHHH
Q 022401 37 GVARLMRDKVTKELVAVKYIERGDKIDE-NVQREIINHRSLRHPNIVRFKEVIL----TPTHLAIVMEYASG-GELFERI 110 (298)
Q Consensus 37 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~~~~~~-~sL~~~l 110 (298)
.+.|++....+|..|++|++.-...... ..-..++.++++.|.|++++.+++. .+..+++|++|.++ .+|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 4889999999999999999843222222 3345678899999999999999986 45689999999975 5565543
Q ss_pred H---------------hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 111 C---------------NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 111 ~---------------~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
. ++...++..+|.++.|+..||.++|+.|+...-|.+.+|+++.+. ++++...|.........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP 447 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCC
Confidence 2 223477899999999999999999999999999999999998665 48877665433211111
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
. +.+.. -.+.|.--||.++..+.||..--...+..... ....+ ...++.+++
T Consensus 448 -----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I---------~~~yS~D~r 499 (655)
T KOG3741|consen 448 -----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS--HLTRI---------TTTYSTDLR 499 (655)
T ss_pred -----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH--HHHHh---------hhhhhHHHH
Confidence 0 11111 22379999999999999997432222221111 01111 112678999
Q ss_pred HHHHHhhhhCCCCcccccccchhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.+|.-+...++++ .++.+++-|.
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHHH
Confidence 9999999999997 5565555444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-12 Score=119.31 Aligned_cols=140 Identities=24% Similarity=0.311 Sum_probs=90.0
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc-----------------------------------hHH---
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-----------------------------------DEN--- 65 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----------------------------------~~~--- 65 (298)
.|+. +.||.|++|.||.|+.+.+|+.||||+...+-.. ...
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4666 7899999999999999877999999998643110 011
Q ss_pred ---HHHHHHHHhcC----CCCCeeeeeEEEE-eCCeEEEEEeccCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHH
Q 022401 66 ---VQREIINHRSL----RHPNIVRFKEVIL-TPTHLAIVMEYASGGELFER--ICNAG----RFSEDEARFFFQQLISG 131 (298)
Q Consensus 66 ---~~~e~~~l~~l----~h~~i~~~~~~~~-~~~~~~lv~~~~~~~sL~~~--l~~~~----~~~~~~~~~i~~~l~~~ 131 (298)
+.+|...+.++ .+.+.+.+=.++. .....++||||++|+++.+. +...+ .+.+..+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 12233333333 2333333223332 24566799999999999764 22222 12233333334443
Q ss_pred HHHHhhcCcEEecCCCCceEeeCCC--CCCEEEeecCccccc
Q 022401 132 VSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 171 (298)
Q Consensus 132 l~~Lh~~~i~H~dl~p~nilv~~~~--~~~~~l~d~~~~~~~ 171 (298)
...|++|+|++|.||+++.++ .+++++.|||++...
T Consensus 277 ----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 468999999999999998776 224999999987533
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.6e-13 Score=120.45 Aligned_cols=231 Identities=18% Similarity=0.247 Sum_probs=143.8
Q ss_pred CCCcCCCCCCCCCeeEEeeeccCCeE---EEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEE
Q 022401 12 PAMDMPIMHDSDRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88 (298)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~g~~~---~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (298)
-.+..++.....+|+..+.+|..+-| ..|.+.....+.....|... .+.+.+....+++++|
T Consensus 26 ~~~~l~~~~~~~~~~~~~~~~~~g~g~~~~ly~~~~~~sk~~~~~~s~~-----~~~ld~~~~~~~~lr~---------- 90 (700)
T KOG2137|consen 26 IVQVLPGPKESQSYRSLNQVGSAGPGDAWKLYAGKKSGSKAPTLKKSAV-----VWMLDKRASSLQQLRG---------- 90 (700)
T ss_pred eeEecCCcccccccccccceeecCCCchhhhhhhhccCccCccccceee-----eeecChhhhHHHHHhc----------
Confidence 34567788888999999999876655 55666555554444233221 1222223334444555
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh-hcCcEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 89 ~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh-~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
.+...+ .-+....=+.+++.|+.++| +.++||++|.|++|.++.++. .|++.|++
T Consensus 91 ---------~~~vs~-------------aTe~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f 146 (700)
T KOG2137|consen 91 ---------LDGVSK-------------ATEDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSF 146 (700)
T ss_pred ---------ccchhh-------------cccHhhhhhhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchh
Confidence 011100 01111222344559999999 568999999999999999988 99999998
Q ss_pred cccccCCCC----------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCC-CCCCCCchhHHHHHHH
Q 022401 168 SKSSVLHSQ----------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTIQR 236 (298)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~~~~~ 236 (298)
+........ .........|.+||.+.+...... +|+||+|+++|-+..|..+ +...+...........
T Consensus 147 ~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~-sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~ 225 (700)
T KOG2137|consen 147 CVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPA-SDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL 225 (700)
T ss_pred hhccCCCCccccccCCCCCChhhccCcccccchhhcccccccc-ccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc
Confidence 753322111 111224567999999988555555 9999999999998855544 3333222211111111
Q ss_pred HhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 237 ILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.........+++|+++++=+.+++..|+..||++ ......||++|+
T Consensus 226 --~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~--------~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 226 --LNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL--------DLLLSIPFFSDP 271 (700)
T ss_pred --cccccccccccCcHHHHHHHHHHhcCCcccCcch--------hhhhcccccCCc
Confidence 1111222335689999999999999999999966 455567777664
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=6.7e-11 Score=101.65 Aligned_cols=239 Identities=13% Similarity=0.088 Sum_probs=154.8
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEE------EEe-CCeEEEE
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV------ILT-PTHLAIV 97 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~-~~~~~lv 97 (298)
...++.||+|+.+.+|......+ .+-|++....--.+ -++-..+.+.-.||-+-.=+.+ .-+ .....++
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred cCCCccccCCccceeeecchhhc---hhheeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34568899999999998766433 46677655332111 1111122222245433221111 011 2236777
Q ss_pred EeccCCCC-HHHHH------HhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 98 MEYASGGE-LFERI------CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 98 ~~~~~~~s-L~~~l------~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
|+...+.- ...+. ...+..+...+++.++.++.+-..||+.|.+-||++++|++|++++. ++|.|-+....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceee
Confidence 87776531 11111 22345778899999999999999999999999999999999998887 99999876655
Q ss_pred ccCCCCCCCCCCCCcccCccccccc-----cCCCCccchHHHHHHHHHHHhC-CCCCCCCCC----chhHHHHHHHHhhc
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVG-GYPFEDPDE----PKDFRKTIQRILSV 240 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~----~~~~~~~~~~~~~~ 240 (298)
...........+..+|++||...-. ..+.+ +|.|.||+++++++.| ..||.+... ....+. .|..+
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia~g 242 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIAHG 242 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhhcc
Confidence 5556666777889999999976522 33455 8999999999999987 789876421 111111 11111
Q ss_pred CC--------------CCCCCCCCCHHHHHHHHHhhhh--CCCCccccc
Q 022401 241 QY--------------SVPDTNPISQECRDLISRIFVA--DPAAVSIFF 273 (298)
Q Consensus 241 ~~--------------~~~~~~~~~~~l~~li~~~l~~--dp~~Rps~~ 273 (298)
.+ .......+++++..+..+|+.. ++.-|||++
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 11 1111123679999999999965 456899874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-10 Score=94.06 Aligned_cols=139 Identities=19% Similarity=0.261 Sum_probs=101.4
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCC--eeeeeEEEEeC---CeEEEEEecc
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPN--IVRFKEVILTP---THLAIVMEYA 101 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~---~~~~lv~~~~ 101 (298)
+.|+.|..+.+|++.... |..+++|....... ....+.+|..+++.+.+.+ +.+++.+.... +..++|++++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999998753 57899998765433 3557789999999886533 56666665543 2568999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------------
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-------------------------------------------- 137 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-------------------------------------------- 137 (298)
+|.++...+.. ..++......++.++++++..||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 99888665422 345666666777777777777763
Q ss_pred ------------cCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 138 ------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 138 ------------~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
..++|+|++|.||+++.++...+.++||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23589999999999987422237899998654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-09 Score=91.50 Aligned_cols=130 Identities=14% Similarity=0.034 Sum_probs=91.9
Q ss_pred EEEEEEEccCCcEEEEEEeecCCcc------------hHHHHHHHHHHhcCCCCCee--eeeEEEEe-----CCeEEEEE
Q 022401 38 VARLMRDKVTKELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIV--RFKEVILT-----PTHLAIVM 98 (298)
Q Consensus 38 ~vy~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~--~~~~~~~~-----~~~~~lv~ 98 (298)
.|+.... .|+.|.+|........ ...+.+|...+.++...+|. +.+.+.+. ...-++|+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3444433 5678999976432211 11367888888877544432 33445443 23467999
Q ss_pred eccCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-----CCCCCEEEeecCccc
Q 022401 99 EYASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 169 (298)
Q Consensus 99 ~~~~~~-sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-----~~~~~~~l~d~~~~~ 169 (298)
|++++. +|.+++.. ..+.+......++.+++..+..||..|++|+|+++.||+++. ++...+.|+||+-+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999875 78888753 334566778899999999999999999999999999999975 334569999999653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.8e-09 Score=85.85 Aligned_cols=130 Identities=21% Similarity=0.226 Sum_probs=96.2
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-----------------------cchHHHHHHHHHHhcCCCC--
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------------------KIDENVQREIINHRSLRHP-- 79 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-----------------------~~~~~~~~e~~~l~~l~h~-- 79 (298)
+.++..||-|.-|.||.+.+. .|..+++|.=..+. .......+|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467899999999999999997 67889999532110 0112356788999988655
Q ss_pred CeeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCC
Q 022401 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (298)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~ 159 (298)
.+.+.++ .+.-.+|||+.+|..|...- ++......++..|+..+..+=..|++|||+++-||+++.+|.
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 5555544 45668899999987664332 134455556666777666666999999999999999999987
Q ss_pred EEEeecC
Q 022401 160 LKICDFG 166 (298)
Q Consensus 160 ~~l~d~~ 166 (298)
++++||-
T Consensus 241 ~~vIDwP 247 (304)
T COG0478 241 IVVIDWP 247 (304)
T ss_pred EEEEeCc
Confidence 9999995
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.3e-08 Score=80.67 Aligned_cols=122 Identities=25% Similarity=0.284 Sum_probs=76.8
Q ss_pred EEEEEEEccCCcEEEEEEeecC--------------Cc--------c-----hHHHHHHHHHHhcCCCCC--eeeeeEEE
Q 022401 38 VARLMRDKVTKELVAVKYIERG--------------DK--------I-----DENVQREIINHRSLRHPN--IVRFKEVI 88 (298)
Q Consensus 38 ~vy~~~~~~~~~~~aiK~~~~~--------------~~--------~-----~~~~~~e~~~l~~l~h~~--i~~~~~~~ 88 (298)
.||.|... +|..+|+|+...+ .+ . .....+|...|.++..-+ +.+.+++
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 37888774 5678999986421 00 0 123567999999997654 4455443
Q ss_pred EeCCeEEEEEeccC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 89 LTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 89 ~~~~~~~lv~~~~~--~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~-Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
.. -++||||++ |..+..+.... ++......++.+++..+.. +|+.|++||||++.||+++.+ . ++++||
T Consensus 79 -~~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf 150 (188)
T PF01163_consen 79 -NR--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDF 150 (188)
T ss_dssp -ET--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--G
T ss_pred -eC--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEec
Confidence 22 358999998 76665544322 1133456677777774444 689999999999999999877 3 999999
Q ss_pred Cccc
Q 022401 166 GYSK 169 (298)
Q Consensus 166 ~~~~ 169 (298)
+.+.
T Consensus 151 ~qav 154 (188)
T PF01163_consen 151 GQAV 154 (188)
T ss_dssp TTEE
T ss_pred Ccce
Confidence 9654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.6e-08 Score=79.51 Aligned_cols=136 Identities=9% Similarity=0.051 Sum_probs=99.9
Q ss_pred ccCCeEEEEEEEEccCCcEEEEEEeecC-------CcchHHHHHHHHHHhcCCCCC--eeeeeEEEEe--C--CeEEEEE
Q 022401 32 GSGNFGVARLMRDKVTKELVAVKYIERG-------DKIDENVQREIINHRSLRHPN--IVRFKEVILT--P--THLAIVM 98 (298)
Q Consensus 32 g~g~~~~vy~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~--~--~~~~lv~ 98 (298)
+.||-|-|+..... |..+-+|+.... +.....+.+|...++++..-+ +.+++..... . ..-++|+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 34888888887764 446888886521 345678999999998885322 4444422111 1 2357888
Q ss_pred eccC-CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 99 EYAS-GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 99 ~~~~-~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+..+ ..+|.+++.+. .+.+......++.+++.++..||+.|+.|+|+.+.||+++.++...+.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 8664 36888877553 34577888899999999999999999999999999999986665569999998543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.9e-08 Score=79.63 Aligned_cols=107 Identities=19% Similarity=0.200 Sum_probs=82.7
Q ss_pred hHHHHHHHHHHhcCCCCCe--eeeeEEEEeC----CeEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 022401 63 DENVQREIINHRSLRHPNI--VRFKEVILTP----THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYC 135 (298)
Q Consensus 63 ~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~----~~~~lv~~~~~~-~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~L 135 (298)
.....+|...+.++...+| .+.+++.+.. ...++|++++++ .+|.+++......+......++.+++..+..|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3567788888877754333 3444554442 245889999987 47888887755577788899999999999999
Q ss_pred hhcCcEEecCCCCceEeeCCC-CCCEEEeecCccc
Q 022401 136 HAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 169 (298)
Q Consensus 136 h~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~ 169 (298)
|+.|++|+|+++.|||++.++ ...+.++||+-+.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 999999999999999998775 4459999998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.8e-07 Score=75.12 Aligned_cols=135 Identities=16% Similarity=0.145 Sum_probs=90.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHH----------HHHHHHHHhcC---CCCCeeeeeEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----------VQREIINHRSL---RHPNIVRFKEV 87 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~e~~~l~~l---~h~~i~~~~~~ 87 (298)
..++|.+.+++-......|-+..- +|+.+++|.........++ ..+++....++ ..-....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 357899999999888777776665 4678999987653322222 12233333333 22333333333
Q ss_pred EE-----eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEE
Q 022401 88 IL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (298)
Q Consensus 88 ~~-----~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l 162 (298)
.+ .....++++||++|..|.+... +++ .+...+.+++.-||+.|++|||.+|.|++++.++ +++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~i 175 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRI 175 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEE
Confidence 22 2345678999999988765432 222 2456677889999999999999999999998655 899
Q ss_pred eecCcc
Q 022401 163 CDFGYS 168 (298)
Q Consensus 163 ~d~~~~ 168 (298)
.|++..
T Consensus 176 ID~~~k 181 (229)
T PF06176_consen 176 IDTQGK 181 (229)
T ss_pred EECccc
Confidence 999754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.9e-06 Score=70.78 Aligned_cols=72 Identities=17% Similarity=0.169 Sum_probs=53.7
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCC--eeeeeEEEEeCCeEEEEEeccCCCC
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGE 105 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~~~~~~~s 105 (298)
..|++|..+.||+. .+..+++|...... ......+|.+.++.+..-+ +.+.+.+..+.+...+||++++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999973 24457889876533 3456788999998886443 4667777777778889999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.54 E-value=6.5e-07 Score=86.30 Aligned_cols=204 Identities=20% Similarity=0.229 Sum_probs=142.8
Q ss_pred HHHHHHHHhcCCCCCeeeeeEEEEeCCeE----EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcE
Q 022401 66 VQREIINHRSLRHPNIVRFKEVILTPTHL----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141 (298)
Q Consensus 66 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~ 141 (298)
...|...+..+.|+|+.....|....... .+..+++.+.++...+..-+..+..+.+.+..++..|+.++|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 34566777888999999999998765443 35567888999999999999999999999999999999999998666
Q ss_pred EecCCCC---ceEeeCCCCCCEEEe--ecCccccccCCCCCCCCCCCCcccCccccccccCCCC-ccchHHHHHHHHHHH
Q 022401 142 HRDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK-IADVWSCGVTLYVML 215 (298)
Q Consensus 142 H~dl~p~---nilv~~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Di~slG~ll~~l~ 215 (298)
|.-+.-. +.-++..+. +..+ ||+.+.................+.++|....+..... ..|+|.+|.+...+.
T Consensus 309 ~v~L~~s~~~~~~~~~e~~--~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGV--VAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred eeEEecccccccccCccce--eecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 6555544 222233333 4444 8877766655555555566667788887765554322 279999999999998
Q ss_pred hCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 216 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 216 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.|..+-..... ...+.. . ....+..+.+..|+..++++|+++ .+++.|||+..+..
T Consensus 387 ~~~~i~~~~~~-------~~~~l~-------~-~~~~~~~d~~~~~~~~~~~~Rl~~--------~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 387 QGEDISEKSAV-------PVSLLD-------V-LSTSELLDALPKCLDEDSEERLSA--------LELLTHPFLRFPTD 442 (1351)
T ss_pred hcCcccccccc-------hhhhhc-------c-ccchhhhhhhhhhcchhhhhccch--------hhhhhchhcccccc
Confidence 77644222111 111111 1 012278889999999999999976 66667888765544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.5e-06 Score=79.14 Aligned_cols=136 Identities=20% Similarity=0.204 Sum_probs=91.3
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch-----------------------------------HH------HH
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----------------------------------EN------VQ 67 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-----------------------------------~~------~~ 67 (298)
+.++.++-|.||.|+-+ +|+.||||+...+-+.. +. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56788999999999998 48999999875321000 11 22
Q ss_pred HHHHHHhcC-----CCCCeeeeeEEEEeCCeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHH-HHHHhhcCc
Q 022401 68 REIINHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISG-VSYCHAMQV 140 (298)
Q Consensus 68 ~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~-l~~Lh~~~i 140 (298)
+|...+.++ ..+++.-..-|.+....-.++|||++|..+.+... .....+...+. ..++++ ++.+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia---~~~~~~f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELA---ELLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHH---HHHHHHHHHHHHhcCc
Confidence 344444444 24555555555555677889999999998877742 22344533333 333322 334445899
Q ss_pred EEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 141 ~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
.|+|.+|-||+++.++. +.+.|||+...
T Consensus 287 fHaDpHpGNi~v~~~g~--i~~lDfGi~g~ 314 (517)
T COG0661 287 FHADPHPGNILVRSDGR--IVLLDFGIVGR 314 (517)
T ss_pred cccCCCccceEEecCCc--EEEEcCcceec
Confidence 99999999999999977 99999998653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.5e-06 Score=64.92 Aligned_cols=130 Identities=18% Similarity=0.153 Sum_probs=93.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeee-eeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~~~~ 101 (298)
..-+..+.|+.|.+|.||++.+. |..+|+|+.. .+.....+..|.+++..+...++-+ ++.|..+ ++.|+|.
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc--CceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 34456788999999999999986 5578999544 4455678899999999998776644 4444322 2339999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCC--CceEeeCCCCCCEEEeecCccc
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL--ENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p--~nilv~~~~~~~~~l~d~~~~~ 169 (298)
.|.+|....... +. +-+..++....-|-..||-|+.|+- .||++++. . +.|+||..++
T Consensus 95 ~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-~--~~iIDFd~At 154 (201)
T COG2112 95 DGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-D--VYIIDFDSAT 154 (201)
T ss_pred cCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC-c--EEEEEccchh
Confidence 998887765332 22 2344566666778889999999975 56666543 4 8999999765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.34 E-value=7.1e-06 Score=66.80 Aligned_cols=133 Identities=17% Similarity=0.147 Sum_probs=83.6
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch-------------------------HHHHHHHHHHhcCCCCCe-
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-------------------------ENVQREIINHRSLRHPNI- 81 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-------------------------~~~~~e~~~l~~l~h~~i- 81 (298)
...|++|.-+.||.|... ++..+|+|++....... .-..+|..-|+++...++
T Consensus 53 ~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 347778888999999874 57889999986321110 012245555555532222
Q ss_pred -eeeeEEEEeCCeEEEEEeccCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCC
Q 022401 82 -VRFKEVILTPTHLAIVMEYASGGE-LFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP 158 (298)
Q Consensus 82 -~~~~~~~~~~~~~~lv~~~~~~~s-L~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~ 158 (298)
.+.+.+ ..-.+|||++.... -.-.|..- ++...+...+..++++.+.-|=. .++||+||+.-|||+. ++.
T Consensus 132 vP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~- 204 (268)
T COG1718 132 VPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE- 204 (268)
T ss_pred CCCceee----cCCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe-
Confidence 222222 13357999985431 11112111 12333677778888888887765 9999999999999999 554
Q ss_pred CEEEeecCccc
Q 022401 159 RLKICDFGYSK 169 (298)
Q Consensus 159 ~~~l~d~~~~~ 169 (298)
++++|++=+.
T Consensus 205 -p~iID~~QaV 214 (268)
T COG1718 205 -PYIIDVSQAV 214 (268)
T ss_pred -EEEEECcccc
Confidence 8999998443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.3e-05 Score=65.91 Aligned_cols=78 Identities=18% Similarity=0.179 Sum_probs=55.4
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCC--CeeeeeEEEE---eCCeEEEEEeccC
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP--NIVRFKEVIL---TPTHLAIVMEYAS 102 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~---~~~~~~lv~~~~~ 102 (298)
++.++.|..+.||.+.... +.+++|..... .....+.+|..+++.+... .+.+++.... .....++++++.+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999864 47999987655 4456677888888777432 2445555332 3346799999999
Q ss_pred CCCHHH
Q 022401 103 GGELFE 108 (298)
Q Consensus 103 ~~sL~~ 108 (298)
|.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.9e-05 Score=65.68 Aligned_cols=76 Identities=12% Similarity=0.039 Sum_probs=52.3
Q ss_pred eeccCCe-EEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEEEeccCCCCHH
Q 022401 30 DIGSGNF-GVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF 107 (298)
Q Consensus 30 ~lg~g~~-~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~ 107 (298)
.|..|.. ..||.+... +..+++|+..... .....+|+.+++.+. +--+.+++++...++..++|+++.+|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4455555 688988764 3568888776543 345677888887773 334556777766666788999999998776
Q ss_pred HH
Q 022401 108 ER 109 (298)
Q Consensus 108 ~~ 109 (298)
..
T Consensus 81 ~~ 82 (244)
T cd05150 81 AL 82 (244)
T ss_pred Hh
Confidence 43
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.6e-05 Score=76.17 Aligned_cols=80 Identities=19% Similarity=0.213 Sum_probs=57.1
Q ss_pred EEeeeccCCeEEEEEEEEccCC--cEEEEEEeecCC--cchHHHHHHHHHHhcCC-CCCe--eeeeEEEEeC---CeEEE
Q 022401 27 FVRDIGSGNFGVARLMRDKVTK--ELVAVKYIERGD--KIDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAI 96 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~~--~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~l 96 (298)
-++.++.|.+..+|.+.....+ ..+++|+..... .....+.+|..+++.+. |.++ .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677888999999998765432 467888765433 22346789999999885 6665 6777777654 45789
Q ss_pred EEeccCCCCH
Q 022401 97 VMEYASGGEL 106 (298)
Q Consensus 97 v~~~~~~~sL 106 (298)
|||+++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999988653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.8e-05 Score=60.85 Aligned_cols=129 Identities=21% Similarity=0.187 Sum_probs=91.1
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCC-----------------cchHHHHHHHHHHhcCC------CCCeeeee
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRFK 85 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~~i~~~~ 85 (298)
..||+|+.-.||.--+. ....||+..... ....+..+|+....++. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP~d---p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDD---PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCCC---CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56899999999965443 235888876554 22345666776666665 78899999
Q ss_pred EEEEeCCeEEEEEeccC------CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC-
Q 022401 86 EVILTPTHLAIVMEYAS------GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP- 158 (298)
Q Consensus 86 ~~~~~~~~~~lv~~~~~------~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~- 158 (298)
|+.+.+....+|+|... .-||.+++.+. .++. .+ ...+-...++|-+.+|+.+|++|.||++......
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 99999999999998773 24677777443 3555 33 3344455667789999999999999999654432
Q ss_pred -CEEEeec
Q 022401 159 -RLKICDF 165 (298)
Q Consensus 159 -~~~l~d~ 165 (298)
+++|+|-
T Consensus 159 ~~lvlIDG 166 (199)
T PF10707_consen 159 FRLVLIDG 166 (199)
T ss_pred eEEEEEeC
Confidence 4777773
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.14 E-value=0.00033 Score=55.81 Aligned_cols=130 Identities=20% Similarity=0.307 Sum_probs=89.5
Q ss_pred CCCCCCCCeeEEeeeccCCe-EEEEEEEEccCCcEEEEEEeec----C----------C--------cchHHHHHHHHHH
Q 022401 17 PIMHDSDRYDFVRDIGSGNF-GVARLMRDKVTKELVAVKYIER----G----------D--------KIDENVQREIINH 73 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~-~~vy~~~~~~~~~~~aiK~~~~----~----------~--------~~~~~~~~e~~~l 73 (298)
|...-..+++.++.||.|.. |.||+++-. |+.||+|.+.. . . ...+-|..|-...
T Consensus 31 ~F~~h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAf 108 (207)
T PF13095_consen 31 PFTHHGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAF 108 (207)
T ss_pred CcCCCCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhh
Confidence 33334589999999999999 999999885 67999999431 0 0 1112355677766
Q ss_pred hcCC---CCCe--eeeeEEEEeC------------------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHH
Q 022401 74 RSLR---HPNI--VRFKEVILTP------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 130 (298)
Q Consensus 74 ~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~ 130 (298)
-+|+ +.++ ++++|+..-. -...+|.|+.+... .++...+. ++.+
T Consensus 109 gRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~~----~~~~ 175 (207)
T PF13095_consen 109 GRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDIP----QMLR 175 (207)
T ss_pred HHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHHH----HHHH
Confidence 6664 4566 8999997422 12467888775533 23344444 4555
Q ss_pred HHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 131 ~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
-+..+|..||+-+|+++.|.. + =+|+||+.+
T Consensus 176 dl~~~~k~gI~~~Dv~~~ny~----~---G~lvDfs~~ 206 (207)
T PF13095_consen 176 DLKILHKLGIVPRDVKPRNYR----G---GKLVDFSSS 206 (207)
T ss_pred HHHHHHHCCeeeccCcccccc----C---CEEEecccC
Confidence 566699999999999999986 2 378999853
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.6e-05 Score=70.16 Aligned_cols=137 Identities=18% Similarity=0.180 Sum_probs=84.6
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch--------------------------------HH------HHHHH
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--------------------------------EN------VQREI 70 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--------------------------------~~------~~~e~ 70 (298)
+.|+..+.+.|+.|+-+. |+.||||+...+-+.. +. |.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568888999999999985 8899999865321110 01 22222
Q ss_pred HHH----hcCCCCC------eeeeeEEEEeCCeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHH-HHHHhhc
Q 022401 71 INH----RSLRHPN------IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISG-VSYCHAM 138 (298)
Q Consensus 71 ~~l----~~l~h~~------i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~-l~~Lh~~ 138 (298)
+-. +.+.|-+ |.+++ ........++|||++|..+.+.-. ....++...+ +..+.++ ++.+=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHHHhc
Confidence 222 2223444 22221 223456789999999987766532 1223455433 3333332 1233368
Q ss_pred CcEEecCCCCceEeeCC--CCCCEEEeecCccccc
Q 022401 139 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSS 171 (298)
Q Consensus 139 ~i~H~dl~p~nilv~~~--~~~~~~l~d~~~~~~~ 171 (298)
|++|+|-+|-||+++.+ +..++.+.|+|+....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 89999999999999853 3557999999987643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.7e-05 Score=63.63 Aligned_cols=72 Identities=11% Similarity=-0.011 Sum_probs=44.6
Q ss_pred eeeccCCeE-EEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCC---CeeeeeEEEEeC---CeEEEEEecc
Q 022401 29 RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEYA 101 (298)
Q Consensus 29 ~~lg~g~~~-~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~~~~ 101 (298)
+.++.|+.. .||.+. ..+++|.... ......+.+|...++.+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777776 588762 2478886554 33345788899888877532 233333333222 2347899999
Q ss_pred CCCCH
Q 022401 102 SGGEL 106 (298)
Q Consensus 102 ~~~sL 106 (298)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 98776
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00011 Score=60.59 Aligned_cols=75 Identities=15% Similarity=0.257 Sum_probs=47.8
Q ss_pred EeeeccCCeEEEEEEEEcc-CCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCee-eeeEEEEeCCeEEEEEeccCCCC
Q 022401 28 VRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGE 105 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~~~~~~~s 105 (298)
++.|..|-...+|++.... .+..|++|+........-...+|..+++.+...++. +++... +. .+++||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--QN--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--CC--cEEEEeeCCCc
Confidence 4667777778999887543 256788997765433323345788888887544443 343332 22 37999998876
Q ss_pred H
Q 022401 106 L 106 (298)
Q Consensus 106 L 106 (298)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.9e-06 Score=69.39 Aligned_cols=130 Identities=15% Similarity=0.157 Sum_probs=89.7
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc-----------------h------HHHHHHHHHHhcCCCCC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-----------------D------ENVQREIINHRSLRHPN 80 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----------------~------~~~~~e~~~l~~l~h~~ 80 (298)
-+.+++.||-|.-+.||.+.+. .|+..++|.=..+... . -...+|...++.|....
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3678899999999999999886 5778899853221100 0 11235677777664322
Q ss_pred --eeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC
Q 022401 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (298)
Q Consensus 81 --i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~ 158 (298)
+.+.+ +.+.-++||+...|.+|...-.-. + ...+...+...|-.|-.+|++|||.+--||++..++.
T Consensus 172 fpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~---d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~- 240 (465)
T KOG2268|consen 172 FPVPKPI----DHNRHCVVMELVDGYPLRQVRHVE---D---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK- 240 (465)
T ss_pred CCCCCcc----cccceeeHHHhhcccceeeeeecC---C---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence 22332 345778999999998886554221 2 2334445555666788999999999999999998776
Q ss_pred CEEEeecC
Q 022401 159 RLKICDFG 166 (298)
Q Consensus 159 ~~~l~d~~ 166 (298)
++++||-
T Consensus 241 -i~vIDFP 247 (465)
T KOG2268|consen 241 -IVVIDFP 247 (465)
T ss_pred -EEEeech
Confidence 9999996
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00051 Score=58.88 Aligned_cols=80 Identities=13% Similarity=0.057 Sum_probs=57.0
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCC---CCeeeeeEEEEe---CCeEEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILT---PTHLAIV 97 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv 97 (298)
+..-.+.||.|..+.||..... ++ .+++|... .......+..|...++.+.. -.+.++++++.. .+..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcC-CC-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3455678999999999998654 23 47778743 32234678889999988843 356777777654 3568999
Q ss_pred EeccCCCCH
Q 022401 98 MEYASGGEL 106 (298)
Q Consensus 98 ~~~~~~~sL 106 (298)
||+.+|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999988654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00014 Score=61.00 Aligned_cols=130 Identities=14% Similarity=0.107 Sum_probs=73.5
Q ss_pred eccCCeEEEEEEEEccCCcEEEEEEeecCCcch-HHHHHHHHHHhcCCCCCee-eeeEEEEeCCeEEEEEeccCCCCHHH
Q 022401 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGELFE 108 (298)
Q Consensus 31 lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~~~~~~~sL~~ 108 (298)
+..|-...+|++.. ++..+++|......... -...+|..+++.+...++. +++... . -++|++|++|.++..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 45566678888863 46678899765443221 2357788888888543332 333332 2 257999998866532
Q ss_pred H-----------------HHhCC----CCCHH-HHHHHHHHH---------HHHHHHHhh--------cCcEEecCCCCc
Q 022401 109 R-----------------ICNAG----RFSED-EARFFFQQL---------ISGVSYCHA--------MQVCHRDLKLEN 149 (298)
Q Consensus 109 ~-----------------l~~~~----~~~~~-~~~~i~~~l---------~~~l~~Lh~--------~~i~H~dl~p~n 149 (298)
. ++..+ +++.. .+..+..++ ...+..+.. ..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 11211 111111111 111222221 248999999999
Q ss_pred eEeeCCCCCCEEEeecCccc
Q 022401 150 TLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 150 ilv~~~~~~~~~l~d~~~~~ 169 (298)
|++++++ +.++||+.+.
T Consensus 158 il~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC---CEEEeccccC
Confidence 9998765 6899998664
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0014 Score=58.17 Aligned_cols=76 Identities=18% Similarity=0.095 Sum_probs=53.0
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecC--------CcchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCeEEE
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERG--------DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 96 (298)
.+.||.|.+..||.+.....++.++||+-... ....++...|.+.|+.+. ...+.+++.+ ++...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46789999999999998644457999985311 123456677888887762 2345666665 5566789
Q ss_pred EEeccCCCC
Q 022401 97 VMEYASGGE 105 (298)
Q Consensus 97 v~~~~~~~s 105 (298)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=5.6e-06 Score=75.43 Aligned_cols=238 Identities=20% Similarity=0.206 Sum_probs=148.3
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCC-eeeeeEEEEeCCeEEEEEeccC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
.+......+.++++.+++.+...+.-. ..+.+... ....-++++|.+.+||| .+.-.+-+..+....++++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL-~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLL-QHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhe-eceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 456667788899999999888755443 35544433 44566889999999999 4444444445567788999987
Q ss_pred CC-CHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCC
Q 022401 103 GG-ELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (298)
Q Consensus 103 ~~-sL~~~l-~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 180 (298)
++ +-.... .....+...+...+.+.-.+++++||+.--+|+| ||+..+.. .+..+++..............
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t~ 390 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRTA 390 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccccC
Confidence 65 221111 0111233445555667777889999988667887 67665433 688999977644444455677
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC--CCCCCCCCCCHHHH-HH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPDTNPISQECR-DL 257 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~-~l 257 (298)
.+++.+++||....+.+... .|.|++|.-..++.-|..|-...... ...+..+. +.+.....++.-.. ++
T Consensus 391 ~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~~------~~~~g~~p~s~~L~~~~aw~~~~~~~~ 463 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPAV------LPMIGNGPNSPMLTDKSAWSPVFHRDF 463 (829)
T ss_pred CCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCccc------cCCCCCCCCccccchhhhcCcccccCC
Confidence 78999999999888888777 89999998666777666653321100 00000000 00000001111122 36
Q ss_pred HHHhhhhCCCCcccccccchhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
...|+..-|..|+....++.+..
T Consensus 464 ~~~~~~g~P~~pkv~mgacfsKv 486 (829)
T KOG0576|consen 464 PAPCLNGLPPTPKVHMGACFSKV 486 (829)
T ss_pred cccccCCCCCCCcchhhHHHHHH
Confidence 66778888888887766665443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00078 Score=57.69 Aligned_cols=137 Identities=16% Similarity=0.068 Sum_probs=79.4
Q ss_pred EEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCC--eeeeeEE------EEeCCeEEEEE
Q 022401 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIVM 98 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~ 98 (298)
-++.+..|....+|.+... +..+++|++.. ........|..+++.+...+ +.+++.. ...++..++++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3667777877899988653 34689998764 23455666777777664322 3333331 12345678999
Q ss_pred eccCCCCHHH----HH----------Hh---CCCC-----CHHH-H------------HHHHHHHHHHHHHHhh------
Q 022401 99 EYASGGELFE----RI----------CN---AGRF-----SEDE-A------------RFFFQQLISGVSYCHA------ 137 (298)
Q Consensus 99 ~~~~~~sL~~----~l----------~~---~~~~-----~~~~-~------------~~i~~~l~~~l~~Lh~------ 137 (298)
++.+|.++.. .. +. .... .... . ......+..++..+.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998866521 10 10 0000 0000 0 0011112233444442
Q ss_pred -cCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 138 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 138 -~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
.+++|+|++|.||++++++. +.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 46999999999999987654 6799998654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00028 Score=56.17 Aligned_cols=97 Identities=14% Similarity=0.078 Sum_probs=76.3
Q ss_pred HHHHHHHhcCCC-CCeeeeeEEEEeCCeEEEEEeccCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHhh---cC
Q 022401 67 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCHA---MQ 139 (298)
Q Consensus 67 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~---~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~---~~ 139 (298)
.+|..+++.+++ +++.+++|+| .-+++.|+...+++.. .+.+....+...+..++.+++..+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357788888876 6999999998 3355778887665532 12233345788999999999999999987 34
Q ss_pred cEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 140 i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+.-+|++++|+-+++++. +|+.|.+.+.
T Consensus 83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 889999999999998877 9999999764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0006 Score=58.62 Aligned_cols=76 Identities=13% Similarity=0.144 Sum_probs=47.6
Q ss_pred EeeeccCCeEEEEEEEEcc------CCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCeEEEEEec
Q 022401 28 VRDIGSGNFGVARLMRDKV------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~ 100 (298)
++.+..|-...+|++.... .++.+++|+............+|..+++.+...++ .++++++. + ..|++|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~--~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP--N--GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC--C--Cchhhe
Confidence 3455556666888887643 25789999877654444556778888887754333 34444442 2 247888
Q ss_pred cCCCCHH
Q 022401 101 ASGGELF 107 (298)
Q Consensus 101 ~~~~sL~ 107 (298)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 8876653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0014 Score=56.84 Aligned_cols=136 Identities=18% Similarity=0.191 Sum_probs=87.2
Q ss_pred eEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-----------------------cch----HHHHHHHHHHhcCCC
Q 022401 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------------------KID----ENVQREIINHRSLRH 78 (298)
Q Consensus 26 ~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-----------------------~~~----~~~~~e~~~l~~l~h 78 (298)
.+-..|..|.-+.||.|... +|..+|||++..+- ... -...+|+.-|.++..
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34567888999999998876 57779999875210 000 112356777777754
Q ss_pred CCeeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-hhcCcEEecCCCCceEeeCCCC
Q 022401 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPA 157 (298)
Q Consensus 79 ~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~L-h~~~i~H~dl~p~nilv~~~~~ 157 (298)
.+|.-..-+.. ..-.+||+++....-..-.-....++...+..+-.+++.-+.-| |.+++||.||+=-|+|+-.+.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~- 302 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGK- 302 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCE-
Confidence 44322222211 12357889885322211111334567777777777888777777 578999999999999997443
Q ss_pred CCEEEeecCc
Q 022401 158 PRLKICDFGY 167 (298)
Q Consensus 158 ~~~~l~d~~~ 167 (298)
++++|.+=
T Consensus 303 --lyiIDVSQ 310 (520)
T KOG2270|consen 303 --LYIIDVSQ 310 (520)
T ss_pred --EEEEEccc
Confidence 89999863
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0063 Score=52.45 Aligned_cols=140 Identities=17% Similarity=0.156 Sum_probs=79.0
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCC--eeeeeEE------EEeCCeEEE
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAI 96 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~l 96 (298)
..-++.++.|....+|.+... ++ .+++|+..... .......|.++++.|...+ +.+++.. ....+..++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ceeccccCCccccceEEEEeC-CC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 444667777777899988753 34 58889765432 2334455666666663222 2333321 112456789
Q ss_pred EEeccCCCCHH-----------HHH---HhC-CCC--------CHHHH-----H----------HHHHHHHHHHHHHh--
Q 022401 97 VMEYASGGELF-----------ERI---CNA-GRF--------SEDEA-----R----------FFFQQLISGVSYCH-- 136 (298)
Q Consensus 97 v~~~~~~~sL~-----------~~l---~~~-~~~--------~~~~~-----~----------~i~~~l~~~l~~Lh-- 136 (298)
++++++|.++. ..+ +.. ..+ ..... . .....+...++++.
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999885431 111 110 000 00100 0 00112333455553
Q ss_pred -----hcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 137 -----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 137 -----~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
..+++|+|+++.|++++.++. +.+.||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 267999999999999987764 6899998654
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0042 Score=53.84 Aligned_cols=75 Identities=13% Similarity=0.077 Sum_probs=42.4
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-----CCCCeeeee---EEEEeCCeEEEEEe
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK---EVILTPTHLAIVME 99 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~---~~~~~~~~~~lv~~ 99 (298)
.+.++.|....+|.+... +| .+++|++.. ...+....+...++.| ..|.+++-. .+....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 455667777789988764 33 589998762 1223333444444444 233333210 01123456789999
Q ss_pred ccCCCCH
Q 022401 100 YASGGEL 106 (298)
Q Consensus 100 ~~~~~sL 106 (298)
+.+|..+
T Consensus 103 ~l~G~~~ 109 (319)
T PRK05231 103 FLEGKWP 109 (319)
T ss_pred ecCCCCC
Confidence 9988643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0087 Score=52.24 Aligned_cols=72 Identities=19% Similarity=0.164 Sum_probs=47.3
Q ss_pred eeccCCeEEEEEEEEccCCcEEEEEEeec-----C---CcchHHHHHHHHHHhcCC--CCC-eeeeeEEEEeCCeEEEEE
Q 022401 30 DIGSGNFGVARLMRDKVTKELVAVKYIER-----G---DKIDENVQREIINHRSLR--HPN-IVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 30 ~lg~g~~~~vy~~~~~~~~~~~aiK~~~~-----~---~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~lv~ 98 (298)
.+|.|....||.+.....++.++||+-.. + +...++..-|...|+... .|. +.+++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47999999999999864446799997532 1 233345556777776653 354 4444433 666677899
Q ss_pred eccCC
Q 022401 99 EYASG 103 (298)
Q Consensus 99 ~~~~~ 103 (298)
|+.+.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.006 Score=53.48 Aligned_cols=141 Identities=16% Similarity=0.206 Sum_probs=79.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEcc----CCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCee-eeeEEEEeCCeEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIV 97 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv 97 (298)
+...+. .+..|-...+|++.... .++.+++|+........-...+|..+++.+..-++- ++++.+.. . .|
T Consensus 37 ~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v 111 (344)
T PLN02236 37 EALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RV 111 (344)
T ss_pred CcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence 344444 55557777999987432 246799998866543333346788888888554443 44455422 2 47
Q ss_pred EeccCCCCHHHH----------H-------HhCC-C----CC-HHHHHHHHHH-----------------HHHHHHHH--
Q 022401 98 MEYASGGELFER----------I-------CNAG-R----FS-EDEARFFFQQ-----------------LISGVSYC-- 135 (298)
Q Consensus 98 ~~~~~~~sL~~~----------l-------~~~~-~----~~-~~~~~~i~~~-----------------l~~~l~~L-- 135 (298)
.+|+++.++... + +... + .+ ...+..++.+ +...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 888877665321 0 1111 0 11 1222222211 11112222
Q ss_pred --h----hcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 136 --H----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 136 --h----~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
. ...++|+|+++.||++++.+ ..+.++||..+.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 1 23589999999999998532 239999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0063 Score=53.77 Aligned_cols=78 Identities=18% Similarity=0.140 Sum_probs=51.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeec----C---CcchHHHHHHHHHHhcCC--CCC-eeeeeEEEEeCC
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER----G---DKIDENVQREIINHRSLR--HPN-IVRFKEVILTPT 92 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~----~---~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~ 92 (298)
+.++ .+.||.|....||.+.+...++.++||+-.. . +...++..-|.+.|+.+. .|. +.+++.+ ++.
T Consensus 30 ~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e 106 (409)
T PRK12396 30 KGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSV 106 (409)
T ss_pred ccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcH
Confidence 3444 6788999999999999843356799997532 1 223355666777777663 354 4445443 666
Q ss_pred eEEEEEeccCC
Q 022401 93 HLAIVMEYASG 103 (298)
Q Consensus 93 ~~~lv~~~~~~ 103 (298)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 66778888854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0065 Score=52.96 Aligned_cols=79 Identities=14% Similarity=0.175 Sum_probs=47.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCee-eeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~ 98 (298)
+..++.. +..|=...+|++..... +..|++|+........-...+|..+++.+..-++- ++++++ . +. +|.
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~-~-~G--~i~ 89 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF-G-NG--MIQ 89 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe-C-Cc--Eee
Confidence 3444444 44466668888865432 33789998765543333346788888888655543 455554 2 22 478
Q ss_pred eccCCCCH
Q 022401 99 EYASGGEL 106 (298)
Q Consensus 99 ~~~~~~sL 106 (298)
+|+++.++
T Consensus 90 ~fi~g~~l 97 (330)
T PLN02421 90 SFINARTL 97 (330)
T ss_pred hhhcCCCC
Confidence 88877655
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.022 Score=50.74 Aligned_cols=73 Identities=16% Similarity=0.180 Sum_probs=48.9
Q ss_pred EEeeeccCCeEEEEEEEEccCCcEEEEEEeec-----CC---cchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCeEE
Q 022401 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GD---KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~-----~~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 95 (298)
-.+.+|.|....||.+.+. ++.++||+-.. +. ....+...|...|+.+. ...+.+++.++. ..-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4778899999999999874 44699998652 11 12334445566666553 246777877765 4456
Q ss_pred EEEeccCC
Q 022401 96 IVMEYASG 103 (298)
Q Consensus 96 lv~~~~~~ 103 (298)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 68999966
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.018 Score=49.03 Aligned_cols=76 Identities=11% Similarity=0.065 Sum_probs=48.0
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCeEEEEEecc
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
.+-.+.++.|....+|.+. .+++.+.+|+-. ......+..|..-|+.|. .-.+.+++++....+.-++++||.
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4567788889999999887 467789999877 334466778888887773 455778888877776779999999
Q ss_pred CCC
Q 022401 102 SGG 104 (298)
Q Consensus 102 ~~~ 104 (298)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.018 Score=48.76 Aligned_cols=30 Identities=23% Similarity=0.325 Sum_probs=23.7
Q ss_pred CcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 139 ~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
.++|+|++|.||++++++. ..-|.||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 4899999999999986433 24699998654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.031 Score=48.13 Aligned_cols=139 Identities=16% Similarity=0.104 Sum_probs=78.2
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEee--cCCcchHHHHHHHHHHhcCCC--CCeeeeeEEEEeCC--eEEEEE
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPT--HLAIVM 98 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~--~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~ 98 (298)
..+++....|-...+|..... ++.+++.... ..........+|...++.+.- --....+++|.++. ..+.||
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 445555544444466666554 6678888321 122333455677777777643 22334455555554 668999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHH-HHHHHHHHHhh----------------------------------------
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCHA---------------------------------------- 137 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~-~l~~~l~~Lh~---------------------------------------- 137 (298)
++..|..+.+.+... +.. .+++. .++..|..||+
T Consensus 105 ~~veGe~~~~~~~~~---~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 105 EWVEGEVVWSALPPE---SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred EEecceeccCcCCcc---cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 999883222111000 000 11111 33333333332
Q ss_pred ------------------cCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 138 ------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 138 ------------------~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
..++|||+++.|+++++++. +=|.||+++....
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGD 230 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEeccccccCC
Confidence 22699999999999998887 8899999876433
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.13 Score=44.84 Aligned_cols=70 Identities=13% Similarity=0.069 Sum_probs=42.4
Q ss_pred CeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCC--ee---eeeE--EEEeCCeEEEEEeccCCCC
Q 022401 35 NFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IV---RFKE--VILTPTHLAIVMEYASGGE 105 (298)
Q Consensus 35 ~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~---~~~~--~~~~~~~~~lv~~~~~~~s 105 (298)
....||.+... ++..+++|+...+......+..|+..+..|.... ++ ..-| ....++..+.++++.+|..
T Consensus 37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34578888764 4557999987655445666777777776663211 11 1112 1223456788999988754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.0054 Score=55.44 Aligned_cols=157 Identities=17% Similarity=0.192 Sum_probs=89.9
Q ss_pred HHHHHHHHHhcCCCCCeeeeeEEEEeC-CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEe
Q 022401 65 NVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143 (298)
Q Consensus 65 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~ 143 (298)
++.-...+++.++|+|+...+.+.... ....+|+|++ +.||.+.+..+. +...... ..|+.|-
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~~ 91 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLHL 91 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cccccee
Confidence 344556788889999999999887643 4578899998 668888775543 2111111 1222221
Q ss_pred cCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCC
Q 022401 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (298)
Q Consensus 144 dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 223 (298)
|+ ++..| -++... .... .+++||||+|.++.++.-|...+..
T Consensus 92 -----~~---------~~~td-~~~t~~------~~~~-----------------~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 92 -----NI---------IYITD-HFLTKY------PSPI-----------------GPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred -----hh---------hhccc-cccccC------CCCC-----------------CcchhhhhHHHHHHHHHHhhHHHHH
Confidence 12 22222 010100 0000 1259999999999999888766544
Q ss_pred CCCchhHHHHHHHHhhcCCCCC----------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 224 PDEPKDFRKTIQRILSVQYSVP----------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
....+ ..+.+..-..... ..-.++..+..+...|+...|..||...+..++.
T Consensus 134 ~~~s~----~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~ 195 (725)
T KOG1093|consen 134 LTESE----YLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRC 195 (725)
T ss_pred HHHHH----HHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCc
Confidence 33221 1122111111000 0012467788999999999999999776665543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.0078 Score=48.81 Aligned_cols=55 Identities=16% Similarity=0.109 Sum_probs=33.6
Q ss_pred CcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 48 KELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 48 ~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
++.|++++........-....|..+++.+...++ .++++.+ .+ . .|.+|+++.+|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~-~~-g--~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFF-EN-G--RVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEE-TT-E--EEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEc-CC-C--cEEEEeccccc
Confidence 4578999888776566667788888888865555 3444443 22 2 35588876654
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.14 Score=43.98 Aligned_cols=29 Identities=31% Similarity=0.615 Sum_probs=24.2
Q ss_pred cCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 138 ~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
.+++|||+++.||+++. +. +.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 57899999999999986 44 8899998543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.044 Score=48.69 Aligned_cols=78 Identities=10% Similarity=0.024 Sum_probs=44.8
Q ss_pred CeeEEeeeccCCeEEEEEEEEccC-CcE-----EEEEEeecCCcchHHHHHHHHHHhcCCCCCee-eeeEEEEeCCeEEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVT-KEL-----VAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAI 96 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~-~~~-----~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~l 96 (298)
..++ +.+..|-...+|++..... +.. |.++.........-.-.+|..+++.+...++- ++++.+. -++
T Consensus 52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~ 126 (383)
T PTZ00384 52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFT 126 (383)
T ss_pred cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEE
Confidence 3444 4555577789998875432 122 44443322222222335688888888665554 4555542 257
Q ss_pred EEeccCCCCH
Q 022401 97 VMEYASGGEL 106 (298)
Q Consensus 97 v~~~~~~~sL 106 (298)
+.+|++|.++
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 8899988766
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.14 Score=44.11 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=25.6
Q ss_pred CcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 139 ~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+++|+|+.++|+++++++. +.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 6999999999999988776 8999998654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.0015 Score=65.80 Aligned_cols=202 Identities=13% Similarity=0.072 Sum_probs=123.5
Q ss_pred HHHHHhcCCCCCeeeeeEEEEeC--CeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---
Q 022401 69 EIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ--- 139 (298)
Q Consensus 69 e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~~~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~Lh~~~--- 139 (298)
|..-.+...|+++.....-.... ...+..+.++.+|.+.+.+-++ +..+..-+....++.+....-.|+..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 33444556788876654444332 2457788888888888887543 33444444444444455555545321
Q ss_pred --cEEecCCCCceEeeCCCCCCEEEeecCccc-cccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh
Q 022401 140 --VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216 (298)
Q Consensus 140 --i~H~dl~p~nilv~~~~~~~~~l~d~~~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~ 216 (298)
-+|.++++.|.++..+.. ++++++|+.+ ........+...+++.|+.+++...-.++.+ +|+|..|+.+|..-.
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSD 1435 (2724)
T ss_pred ccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhc
Confidence 689999999999987766 9999999987 3333344456667888999998877777666 999999999988776
Q ss_pred CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 217 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 217 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
|..+|..- .....+.+..........-..|.+.......+|-..-..||.-..++.+
T Consensus 1436 ~n~~fi~f-----lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~ 1492 (2724)
T KOG1826|consen 1436 GNAYFIFF-----LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSR 1492 (2724)
T ss_pred ccHHHHHH-----HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccc
Confidence 66554321 1112222211111111111134555555555666666677755444443
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.043 Score=47.81 Aligned_cols=83 Identities=25% Similarity=0.283 Sum_probs=57.7
Q ss_pred CCeeeeeEEEEeC-CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCC
Q 022401 79 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSP 156 (298)
Q Consensus 79 ~~i~~~~~~~~~~-~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~ 156 (298)
++..+..-+-.++ ...|++|++- |+++.. + .--...++..++++.+..+.-+.. -.+-|+|+...||+++ .|
T Consensus 285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 285 VFLETLKVVSLDETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred hhhhcceEEecCCceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 4444433333233 3567788775 445432 1 112567888899988888877764 3689999999999999 77
Q ss_pred CCCEEEeecCccc
Q 022401 157 APRLKICDFGYSK 169 (298)
Q Consensus 157 ~~~~~l~d~~~~~ 169 (298)
+ +.|+||.+++
T Consensus 359 n--vtLIDfklsR 369 (488)
T COG5072 359 N--VTLIDFKLSR 369 (488)
T ss_pred c--eEEEEeeeee
Confidence 7 9999999987
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.13 Score=44.61 Aligned_cols=131 Identities=16% Similarity=0.178 Sum_probs=75.2
Q ss_pred CeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCC------eeeeeEEEE--eCC--eEEEEEeccCCC
Q 022401 35 NFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVIL--TPT--HLAIVMEYASGG 104 (298)
Q Consensus 35 ~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~--~~~--~~~lv~~~~~~~ 104 (298)
....+|.+... +|+ +++|+.... .....+..|+..++-|.-.+ +...-|-.. -.. ..+.+++|++|.
T Consensus 37 ~eN~~f~~~~~-~g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTE-DGR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEec-CCC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 44577888775 333 599998887 66677777887777663211 122211111 123 778899999988
Q ss_pred CHHH-H----H----------H----hCC----C-C---CHH----H---------HHHHHHHHHHHHHHHh--------
Q 022401 105 ELFE-R----I----------C----NAG----R-F---SED----E---------ARFFFQQLISGVSYCH-------- 136 (298)
Q Consensus 105 sL~~-~----l----------~----~~~----~-~---~~~----~---------~~~i~~~l~~~l~~Lh-------- 136 (298)
.+.. . + + ..+ . . ... . -.....++...+..+.
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7762 1 1 0 000 0 0 000 0 0012223333333333
Q ss_pred hcC--cEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 137 AMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 137 ~~~--i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+.+ ++|+|+.|.||+++.+.. .+-+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 233 899999999999987763 36789998654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.13 Score=41.83 Aligned_cols=86 Identities=17% Similarity=0.134 Sum_probs=55.7
Q ss_pred hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh--hcCc
Q 022401 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--AMQV 140 (298)
Q Consensus 63 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh--~~~i 140 (298)
..-+.++..++.++ -+|+++..- ....+.++.|+|..-.. . +. -++..=+.+|...| +.+.
T Consensus 102 ~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i---~------~~----N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 102 DALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKI---N------FS----NFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCccc---c------hh----HHHHHhHHHHHHhhccCCCe
Confidence 34566676766644 356666532 33467899998854211 0 01 11112245566778 3569
Q ss_pred EEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 141 CHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 141 ~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
.|||..|+||+.|..|. +||.|-+.
T Consensus 165 lHGD~np~NiM~D~~G~--lKlVDP~~ 189 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKFGY--LKLVDPVC 189 (308)
T ss_pred ecCCCChhheeecCCCC--EEecChhh
Confidence 99999999999999999 99999763
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.31 Score=44.28 Aligned_cols=79 Identities=16% Similarity=0.042 Sum_probs=47.7
Q ss_pred CCeeEEeeeccCCeEEEEEEEEcc--------CCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCee-eeeEEEEeCCe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKV--------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTH 93 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~ 93 (298)
++. -++.|..|=.-.+|++.... .++.|+++++-.+....-...+|..+++.+...++- ++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 344 56666666667888887542 145789998766544333456677777777544443 3444431
Q ss_pred EEEEEeccCCCCH
Q 022401 94 LAIVMEYASGGEL 106 (298)
Q Consensus 94 ~~lv~~~~~~~sL 106 (298)
-+.+.+|.+|.+|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2346788877644
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.14 Score=42.70 Aligned_cols=79 Identities=15% Similarity=0.123 Sum_probs=53.9
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc-CCCCH
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA-SGGEL 106 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~-~~~sL 106 (298)
...+..|..+.|+.++.. +|+.+++|+.........+...+ ..|+...-.+.+++++. +...-.+++|+. ++.+|
T Consensus 7 ~~~~~~g~~s~V~pv~~~-dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~--d~~~~AlLLErl~~g~~L 82 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRA-DGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAA--DPERGALLLERLDPGRSL 82 (253)
T ss_pred CCCCCCCcceEEEEEEcC-CCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeecc--ccccchhhhhhccCCCch
Confidence 345667888999999865 68899999877655433332222 34777788888899886 344566688888 55677
Q ss_pred HHHH
Q 022401 107 FERI 110 (298)
Q Consensus 107 ~~~l 110 (298)
.+..
T Consensus 83 ~~~~ 86 (253)
T PF04655_consen 83 ASLP 86 (253)
T ss_pred hhcc
Confidence 5443
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.64 E-value=1 Score=45.57 Aligned_cols=32 Identities=34% Similarity=0.484 Sum_probs=25.6
Q ss_pred cCcEEecCCCCceEeeCCCCCCEE-EeecCccc
Q 022401 138 MQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSK 169 (298)
Q Consensus 138 ~~i~H~dl~p~nilv~~~~~~~~~-l~d~~~~~ 169 (298)
.+++|+|+++.||+++.++..++. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 569999999999999877532355 99999765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 298 | ||||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-142 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-138 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-138 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-137 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-137 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-135 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-46 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-44 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-44 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-44 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-44 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-44 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-44 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-44 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-43 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-43 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-42 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-42 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-42 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-41 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-40 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-40 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-40 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-40 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-38 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-37 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-37 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-37 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-37 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-37 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-37 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-37 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-37 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-37 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-37 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-37 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-37 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-37 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-37 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-37 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-37 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-37 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-37 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-37 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-37 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-36 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-36 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-36 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-36 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-36 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-36 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-35 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-35 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-35 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-35 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-35 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-35 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-35 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-35 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-35 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-35 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-35 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-35 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-35 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-35 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-35 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-35 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-35 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-35 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-35 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-35 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-35 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-35 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-35 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-35 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-35 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-35 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-34 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-34 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-34 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-34 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-33 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-33 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-33 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-33 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-33 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-33 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-33 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-33 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-33 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-33 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-33 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-33 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-33 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-33 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-33 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-33 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-33 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-33 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-33 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-33 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-33 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-33 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-33 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-33 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-33 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-33 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-33 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-33 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-33 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-33 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-33 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-33 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-33 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-33 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-33 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-33 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-33 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-32 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-32 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-32 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-32 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-32 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-32 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-32 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-32 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-32 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-32 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-32 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-32 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-32 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-32 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-32 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-31 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-31 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-31 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-31 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-31 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-31 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-31 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-31 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-31 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-31 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-31 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-30 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-30 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-30 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-30 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-30 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-30 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-30 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-30 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-30 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-30 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-30 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-29 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-29 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-29 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-29 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-29 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-29 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-29 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-29 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-28 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-28 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-28 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-28 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-28 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-28 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-28 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-28 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-28 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-28 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-28 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-28 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-27 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-27 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-27 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-27 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-27 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-27 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-27 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-27 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-27 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-27 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-27 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-27 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-27 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-27 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-27 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-27 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-27 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-27 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-27 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-27 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-27 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-27 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-27 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-27 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-27 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-27 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-26 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-26 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-26 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-26 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-26 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-26 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-26 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-26 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-26 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-26 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-26 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-26 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-26 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-25 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-25 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-25 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-25 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-25 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-25 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-25 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-25 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-25 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-25 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-25 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-25 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-25 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-25 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-25 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-25 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-24 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-24 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-24 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-24 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-24 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-24 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-24 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-24 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-24 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-24 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-24 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-24 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-24 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-24 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-24 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-24 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-24 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-24 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-24 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-24 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-24 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-23 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-23 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-23 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-23 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-23 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-23 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-20 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-20 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-20 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-19 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-18 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-18 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-18 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-18 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-18 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-18 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-18 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-18 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-18 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-18 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-18 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-18 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-18 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-18 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-18 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-18 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-18 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-18 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-18 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-18 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-18 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-17 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-17 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-16 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-16 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-16 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-16 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-15 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-12 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 9e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 4e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 5e-05 |
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 471 bits (1214), Expect = e-169
Identities = 238/265 (89%), Positives = 252/265 (95%), Gaps = 1/265 (0%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERG I
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQRILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 243 SVPDTNPISQECRDLISRIFVADPA 267
S+PD IS EC LISRIFVADPA
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPA 264
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-132
Identities = 86/259 (33%), Positives = 136/259 (52%), Gaps = 13/259 (5%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
M +P + + +D V+ +G G +G +L ++VT+E VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 188
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
PE+L R E+ + DVWSCG+ L ML G P++ P + + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKEKKTYLNPWK 232
Query: 249 PISQECRDLISRIFVADPA 267
I L+ +I V +P+
Sbjct: 233 KIDSAPLALLHKILVENPS 251
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-131
Identities = 86/260 (33%), Positives = 140/260 (53%), Gaps = 15/260 (5%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
M +P + + +D V+ +G G +G +L ++VT+E VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 188
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSVQYSVPDT 247
PE+L R E+ + DVWSCG+ L ML G P++ P + +++ ++ + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPW 231
Query: 248 NPISQECRDLISRIFVADPA 267
I L+ +I V +P+
Sbjct: 232 KKIDSAPLALLHKILVENPS 251
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = e-101
Identities = 99/248 (39%), Positives = 133/248 (53%), Gaps = 14/248 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
Y +G G FG ++ ++T VAVK + R KI ++REI N + RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P+I++ +VI TPT +VMEY SGGELF+ IC GR E EAR FQQ++S V YCH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ Y
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
G D+WSCGV LY +L G PF+D P F+K I + +P+ +++ L+
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATLL 242
Query: 259 SRIFVADP 266
+ DP
Sbjct: 243 MHMLQVDP 250
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = e-101
Identities = 93/247 (37%), Positives = 139/247 (56%), Gaps = 13/247 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
Y ++ IG GNF +L R +T VA+K I++ +++ + + RE+ + L HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV+ EVI T L ++MEYASGGE+F+ + GR E EAR F+Q++S V YCH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ HRDLK EN LLD +KI DFG+S + + + G P Y APE+ +YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
DVWS GV LY ++ G PF+ + + + +L +Y +P +S +C +L+
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFY--MSTDCENLLK 246
Query: 260 RIFVADP 266
R V +P
Sbjct: 247 RFLVLNP 253
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 3e-99
Identities = 80/250 (32%), Positives = 116/250 (46%), Gaps = 14/250 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
RY R +G G F + D TKE+ A K + + E + EI HRSL H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEY 197
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL + +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
+ DVWS G +Y +LVG PFE + + + I +YS+P I+ L
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLR----IKKNEYSIPKH--INPVAASL 245
Query: 258 ISRIFVADPA 267
I ++ DP
Sbjct: 246 IQKMLQTDPT 255
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 2e-98
Identities = 97/249 (38%), Positives = 132/249 (53%), Gaps = 14/249 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
Y +G G FG ++ + ++T VAVK + R KI ++REI N + RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P+I++ +VI TP+ + +VMEY SGGELF+ IC GR E E+R FQQ++SGV YCH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ Y
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
G D+WS GV LY +L G PF+D P F+K I + P ++ L+
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQY--LNPSVISLL 247
Query: 259 SRIFVADPA 267
+ DP
Sbjct: 248 KHMLQVDPM 256
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 3e-98
Identities = 82/250 (32%), Positives = 117/250 (46%), Gaps = 14/250 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
RY R +G G F + D TKE+ A K + + E + EI HRSL H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEY 197
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL + +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
+ DVWS G +Y +LVG PFE ++T RI +YS+P I+ L
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKH--INPVAASL 271
Query: 258 ISRIFVADPA 267
I ++ DP
Sbjct: 272 IQKMLQTDPT 281
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 7e-98
Identities = 106/249 (42%), Positives = 144/249 (57%), Gaps = 15/249 (6%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
Y +G G+FG +L T++ VA+K+I R + V+REI + LRH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P+I++ +VI TPT + +V+EYA GGELF+ I R +EDE R FFQQ+I + YCH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
++ HRDLK EN LLD + +KI DFG S + K++ G+P Y APEV+ Y
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
G DVWSCG+ LYVMLVG PF+D P F+K + S Y +PD +S + LI
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQSLI 239
Query: 259 SRIFVADPA 267
R+ VADP
Sbjct: 240 RRMIVADPM 248
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 5e-96
Identities = 75/251 (29%), Positives = 122/251 (48%), Gaps = 15/251 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
+ + +G G+F T VA+K I++ + + VQ E+ H L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA 137
P+I+ ++ +V+E GE+ + N FSE+EAR F Q+I+G+ Y H+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHE 196
+ HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ R
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
+ + +DVWS G Y +L+G PF+ K ++ Y +P +S E +D
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----VVLADYEMPSF--LSIEAKD 241
Query: 257 LISRIFVADPA 267
LI ++ +PA
Sbjct: 242 LIHQLLRRNPA 252
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 7e-96
Identities = 74/258 (28%), Positives = 123/258 (47%), Gaps = 24/258 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------DENVQREIINHRSLR 77
+Y +G G++G + + D T AVK +++ K+ + NV++EI R LR
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64
Query: 78 HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 133
H N+++ +V+ + +VMEY G E+ + + RF +A +F QLI G+
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 190
Y H+ + H+D+K N LL LKI G +++ + +++ G+PA+ PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
+ + G D+WS GVTLY + G YPFE + K F I Y++P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN----IGKGSYAIPGD-- 235
Query: 250 ISQECRDLISRIFVADPA 267
DL+ + +PA
Sbjct: 236 CGPPLSDLLKGMLEYEPA 253
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 2e-95
Identities = 89/280 (31%), Positives = 131/280 (46%), Gaps = 47/280 (16%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER------------------------- 58
+Y +IG G++GV +L ++ A+K + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 59 --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 114
E V +EI + L HPN+V+ EV+ P HL +V E + G + E +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 169
SED+ARF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190
Query: 170 SSVLHSQPKSTVGTPAYIAPEVL--LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
++L +TVGTPA++APE L R + GK DVW+ GVTLY + G PF D
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
K I S PD I+++ +DLI+R+ +P
Sbjct: 247 CLHSK----IKSQALEFPDQPDIAEDLKDLITRMLDKNPE 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 5e-94
Identities = 80/249 (32%), Positives = 127/249 (51%), Gaps = 14/249 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH 78
D +D R +G G FG L R+K K ++A+K + + ++ ++REI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI+R + +++E+A GEL++ + GRF E + F ++L + YCH
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+V HRD+K EN L+ LKI DFG+S + + ++ GT Y+ PE++ +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
K D+W GV Y LVG PF+ P + R+ I++V P +S +DLI
Sbjct: 191 EK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLKFPPF--LSDGSKDLI 243
Query: 259 SRIFVADPA 267
S++ P
Sbjct: 244 SKLLRYHPP 252
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 2e-93
Identities = 81/249 (32%), Positives = 132/249 (53%), Gaps = 14/249 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH 78
+ ++ R +G G FG L R+K +K ++A+K + + ++ ++RE+ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI+R T + +++EYA G ++ + +F E + +L + +SYCH+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+V HRD+K EN LL + LKI DFG+S S+ GT Y+ PE++ +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
K D+WS GV Y LVG PFE +T +RI V+++ PD +++ RDLI
Sbjct: 186 EK-VDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFPDF--VTEGARDLI 238
Query: 259 SRIFVADPA 267
SR+ +P+
Sbjct: 239 SRLLKHNPS 247
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 4e-93
Identities = 74/259 (28%), Positives = 112/259 (43%), Gaps = 32/259 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--------VQREIINHR 74
+Y +GSG FG VA+K++E+ D+I + V E++ +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101
Query: 75 SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 131
+ ++R + P +++E +LF+ I G E+ AR FF Q++
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 188
V +CH V HRD+K EN L+D + LK+ DFG K +V GT Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
PE + H Y G+ A VWS G+ LY M+ G PFE + I+ Q
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQR- 265
Query: 249 PISQECRDLISRIFVADPA 267
+S EC+ LI P+
Sbjct: 266 -VSSECQHLIRWCLALRPS 283
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 7e-93
Identities = 72/254 (28%), Positives = 111/254 (43%), Gaps = 24/254 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIINHR 74
+Y + +GSG FG DK + V VK+I++ D V EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 75 SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ H NI++ ++ +VME + SG +LF I R E A + F+QL+S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y + HRD+K EN ++ +K+ DFG + + GT Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
+ Y G ++WS GVTLY ++ PF + +E + P +S+E
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPP--YLVSKE 250
Query: 254 CRDLISRIFVADPA 267
L+S + P
Sbjct: 251 LMSLVSGLLQPVPE 264
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 4e-92
Identities = 71/261 (27%), Positives = 104/261 (39%), Gaps = 34/261 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--------NVQREIINHR 74
Y +G G FG + VA+K I R +++ E+
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89
Query: 75 SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 129
+ HP ++R + T +V+E +LF+ I G E +R FF Q++
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 186
+ + +CH+ V HRD+K EN L+D K+ DFG GT Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
PE + RH+Y A VWS G+ LY M+ G PFE Q IL + P
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFP- 253
Query: 247 TNPISQECRDLISRIFVADPA 267
+S +C LI R P+
Sbjct: 254 -AHVSPDCCALIRRCLAPKPS 273
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 2e-87
Identities = 85/251 (33%), Positives = 127/251 (50%), Gaps = 12/251 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHP 79
+ Y IG G++G ++ K T+ A K I + ++ + ++EI +SL HP
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NI+R E T + +VME +GGELFER+ + F E +A + ++S V+YCH +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 140 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+VL Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y- 184
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRD 256
G D WS GV +YV+L G PF P + + K I ++ P+ +S +
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAES 240
Query: 257 LISRIFVADPA 267
LI R+ P
Sbjct: 241 LIRRLLTKSPK 251
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 1e-86
Identities = 84/252 (33%), Positives = 127/252 (50%), Gaps = 11/252 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
SD YD ++G G F V R K T A K I + + ++RE R L+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCH+
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL + Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECR 255
K D+W+CGV LY++LVG PF D D+ + + + I + Y P + ++ E +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 239
Query: 256 DLISRIFVADPA 267
LI + +P
Sbjct: 240 SLIDSMLTVNPK 251
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 8e-86
Identities = 85/251 (33%), Positives = 130/251 (51%), Gaps = 12/251 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 80
+ F+ +GSG F L++ ++T +L A+K I++ + +++ EI + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV +++ + TH +VM+ SGGELF+RI G ++E +A QQ++S V Y H +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 141 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYD 198
HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL + Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRD 256
K D WS GV Y++L G PF + E K F K I Y + IS+ +D
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKD 240
Query: 257 LISRIFVADPA 267
I + DP
Sbjct: 241 FICHLLEKDPN 251
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-85
Identities = 81/259 (31%), Positives = 122/259 (47%), Gaps = 18/259 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIIN 72
D Y + +GSG G +L ++ T + VA+K I + NV+ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 133 SYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 192 LLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT-- 247
L+ + D WS GV L++ L G PF + +I S +Y+
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVW 244
Query: 248 NPISQECRDLISRIFVADP 266
+S++ DL+ ++ V DP
Sbjct: 245 AEVSEKALDLVKKLLVVDP 263
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 2e-85
Identities = 77/254 (30%), Positives = 122/254 (48%), Gaps = 14/254 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 79
D + F R +GSG FG L+ ++ + +K I ++ E ++ EI +SL HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 135
NI++ EV ++ IVME GGEL ERI SE +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 136 HAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
H+ V H+DLK EN L SP +KI DFG ++ + GT Y+APEV +
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDTNPISQE 253
+ K D+WS GV +Y +L G PF + +K + + + P++ +
Sbjct: 200 RDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQ 254
Query: 254 CRDLISRIFVADPA 267
DL+ ++ DP
Sbjct: 255 AVDLLKQMLTKDPE 268
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 1e-84
Identities = 53/293 (18%), Positives = 97/293 (33%), Gaps = 59/293 (20%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER------------------GDKIDE 64
+ Y +R + G F L + A+K E+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 65 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 116
+ + E+ +++ + + +I + I+ EY + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 117 SEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
+ + +++ SY H +CHRD+K N L+D + R+K+ DFG S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
+ + GT ++ PE Y+G D+WS G+ LYVM PF
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SLV 259
Query: 232 KTIQRILSVQYSVPDTNP-----------------ISQECRDLISRIFVADPA 267
+ I + P +S E D + +PA
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-84
Identities = 84/256 (32%), Positives = 132/256 (51%), Gaps = 16/256 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D Y+ ++GSG F + R R K T + A K+I R E ++RE+ R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+RHPNI+ ++ T + +++E SGGELF+ + +EDEA F +Q++ GV Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H+ ++ H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPI 250
G AD+WS GV Y++L G PF + + I +V Y + +
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNT 238
Query: 251 SQECRDLISRIFVADP 266
S+ +D I R+ V DP
Sbjct: 239 SELAKDFIRRLLVKDP 254
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 3e-84
Identities = 60/285 (21%), Positives = 110/285 (38%), Gaps = 39/285 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+ + +G G R K T +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 80 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 134
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 193 LRHEYD-------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-- 243
R G D+WS GVT Y G PF + P+ ++ + +I++ + S
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 244 -----------------VPDTNPISQECRD----LISRIFVADPA 267
+P + +S+ + +++ I AD
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 3e-84
Identities = 80/259 (30%), Positives = 123/259 (47%), Gaps = 18/259 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIIN 72
D Y + +GSG G +L ++ T + VA++ I + NV+ EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 133 SYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 192 LLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT-- 247
L+ + D WS GV L++ L G PF + + +I S +Y+
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVW 369
Query: 248 NPISQECRDLISRIFVADP 266
+S++ DL+ ++ V DP
Sbjct: 370 AEVSEKALDLVKKLLVVDP 388
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 6e-84
Identities = 89/252 (35%), Positives = 137/252 (54%), Gaps = 12/252 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
++RY+ V +G G+FG +D++T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECR 255
D K DVWS GV LY++L G PF +E ++ + + +Y+ IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK 254
Query: 256 DLISRIFVADPA 267
DLI ++ P+
Sbjct: 255 DLIRKMLTFHPS 266
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 1e-83
Identities = 79/262 (30%), Positives = 120/262 (45%), Gaps = 23/262 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREI-I 71
+YD IG G V R + T AVK +E +++ E +RE I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
+ HP+I+ + + + + +V + GELF+ + SE E R + L+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
VS+ HA + HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDN-MQ-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 192 LLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
L + GK D+W+CGV L+ +L G PF + R I+ QY
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSS 326
Query: 247 T--NPISQECRDLISRIFVADP 266
+ S +DLISR+ DP
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDP 348
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 1e-83
Identities = 91/253 (35%), Positives = 124/253 (49%), Gaps = 13/253 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
+D Y+ DIG G++ V + K T AVK I DK + EI I R +HPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
I+ K+V ++ +V E GGEL ++I FSE EA + V Y HA V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 141 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
HRDLK N L ++ICDFG++K + T T ++APEVL R Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI-QRILSVQYSVPDT--NPISQEC 254
D D+WS GV LY ML G PF + P D + I RI S ++S+ N +S
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPFA--NGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 255 RDLISRIFVADPA 267
+DL+S++ DP
Sbjct: 255 KDLVSKMLHVDPH 267
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-83
Identities = 85/252 (33%), Positives = 128/252 (50%), Gaps = 11/252 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKID-ENVQREIINHRSLRH 78
SD YD ++G G F V R K T A K I + D + ++RE R L+H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCH+
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL + Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECR 255
K D+W+CGV LY++LVG PF D D+ + + + I + Y P + ++ E +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 262
Query: 256 DLISRIFVADPA 267
LI + +P
Sbjct: 263 SLIDSMLTVNPK 274
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 3e-83
Identities = 60/285 (21%), Positives = 110/285 (38%), Gaps = 39/285 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+ + +G G R K T +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 80 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 134
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 193 LRHEYD-------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-- 243
R G D+WS GVT Y G PF + P+ ++ + +I++ + S
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 244 -----------------VPDTNPISQECRD----LISRIFVADPA 267
+P + +S+ + +++ I AD
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 5e-83
Identities = 85/256 (33%), Positives = 137/256 (53%), Gaps = 16/256 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 135 CHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H++Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPI 250
G AD+WS GV Y++L G PF + ++T+ + +V Y D +
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNT 244
Query: 251 SQECRDLISRIFVADP 266
S +D I R+ V DP
Sbjct: 245 SALAKDFIRRLLVKDP 260
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 6e-83
Identities = 79/264 (29%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREI- 70
+ Y+ +G G V R K T + AVK I E ++ E +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 71 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 130
I + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 191 VLLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
++ D GK D+WS GV +Y +L G PF + R I+S Y
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFG 249
Query: 246 DT--NPISQECRDLISRIFVADPA 267
+ S +DL+SR V P
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQ 273
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 1e-82
Identities = 81/256 (31%), Positives = 131/256 (51%), Gaps = 16/256 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+ HPNI+ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPI 250
G AD+WS GV Y++L G PF + ++T+ I +V Y + +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQT 245
Query: 251 SQECRDLISRIFVADP 266
S+ +D I ++ V +
Sbjct: 246 SELAKDFIRKLLVKET 261
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 1e-82
Identities = 80/256 (31%), Positives = 130/256 (50%), Gaps = 16/256 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+ H N++ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPI 250
G AD+WS GV Y++L G PF + ++T+ I SV Y + +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHT 245
Query: 251 SQECRDLISRIFVADP 266
S+ +D I ++ V +
Sbjct: 246 SELAKDFIRKLLVKET 261
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 2e-82
Identities = 61/248 (24%), Positives = 111/248 (44%), Gaps = 8/248 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
++Y D+G G FG+ + +K+ K+++ V++EI RH NI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQV 140
+ E + L ++ E+ SG ++FERI + +E E + Q+ + + H+ +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLI 258
D+WS G +YV+L G PF ++ I+ I++ +Y+ + IS E D +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 259 SRIFVADP 266
R+ V +
Sbjct: 239 DRLLVKER 246
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 6e-82
Identities = 70/266 (26%), Positives = 104/266 (39%), Gaps = 27/266 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPN 80
++ +G+G FG + T E VA+K + K E EI + L HPN
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 81 IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 131
+V +EV LA + MEY GG+L + + N E R + S
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 132 VSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
+ Y H ++ HRDLK EN +L G KI D GY+K VGT Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR-------------- 236
+L + +Y D WS G + + G PF +P + ++
Sbjct: 194 LLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 237 ILSVQYSVPDTNPISQECRDLISRIF 262
+ +P N +S + R
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWL 278
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 7e-82
Identities = 86/249 (34%), Positives = 133/249 (53%), Gaps = 8/249 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
SD ++ ++G G + + K T++ A+K +++ + V+ EI L HPNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
++ KE+ TPT +++V+E +GGELF+RI G +SE +A +Q++ V+Y H +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 142 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y G
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLI 258
D+WS G+ Y++L G PF D + +RIL+ +Y + +S +DL+
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNCEYYFISPWWDEVSLNAKDLV 286
Query: 259 SRIFVADPA 267
++ V DP
Sbjct: 287 RKLIVLDPK 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 1e-81
Identities = 93/257 (36%), Positives = 133/257 (51%), Gaps = 14/257 (5%)
Query: 22 SDRYDF---VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLR 77
YD + +G G+F + R K + + AVK I + +++ N Q+EI
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HPNIV+ EV H +VME +GGELFERI FSE EA + ++L+S VS+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 138 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRH 195
+ V HRDLK EN L D + +KI DFG+++ +QP K+ T Y APE+L ++
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI---QRILSVQYSVPDT--NPI 250
YD + D+WS GV LY ML G PF+ D + ++I +S +
Sbjct: 185 GYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 251 SQECRDLISRIFVADPA 267
SQE +DLI + DP
Sbjct: 244 SQEAKDLIQGLLTVDPN 260
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 1e-81
Identities = 72/249 (28%), Positives = 117/249 (46%), Gaps = 9/249 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
D YD + ++GSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQ 139
++ + + +++E+ SGGELF+RI + SE E + +Q G+ + H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ H D+K EN + + A +KI DFG + K T T + APE++ R G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDL 257
D+W+ GV YV+L G PF D+ +T+Q + + + + +S E +D
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 258 ISRIFVADP 266
I + +P
Sbjct: 285 IKNLLQKEP 293
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 3e-81
Identities = 89/250 (35%), Positives = 137/250 (54%), Gaps = 8/250 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
++RY+ V +G G+FG +D++T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
D K DVWS GV LY++L G PF +E ++ ++ + +P IS + +DL
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR-VETG-KYAFDLPQWRTISDDAKDL 256
Query: 258 ISRIFVADPA 267
I ++ P+
Sbjct: 257 IRKMLTFHPS 266
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 5e-81
Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 18/256 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
++ Y ++G G F V R + + A I D + ++RE R L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNIVR + I H ++ + +GGELFE I +SE +A QQ++ V +CH M
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 139 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 193
V HR+LK EN LL G+ +K+ DFG + Q GTP Y++PEVL
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
+ Y GK D+W+CGV LY++LVG PF D D+ + +++ I + Y P + ++
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVT 241
Query: 252 QECRDLISRIFVADPA 267
E +DLI+++ +P+
Sbjct: 242 PEAKDLINKMLTINPS 257
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 6e-81
Identities = 87/250 (34%), Positives = 131/250 (52%), Gaps = 8/250 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
S+ Y V+ +GSG +G L RDKVT A+K I + + + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI++ + + +VME GGELF+ I + +F+E +A +Q++SGV+Y H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK EN LL +KI DFG S + K +GT YIAPEVL + Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-Y 214
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
D K DVWS GV L+++L G PF + + RK +++ + P+ +S+ +DL
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK-VEKG-KYTFDSPEWKNVSEGAKDL 271
Query: 258 ISRIFVADPA 267
I ++ D
Sbjct: 272 IKQMLQFDSQ 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 1e-80
Identities = 55/261 (21%), Positives = 103/261 (39%), Gaps = 26/261 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
Y ++ IGSG + ++ K++ A+KY+ + + ++ + EI L+ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRH 195
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 196 EYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
+DVWS G LY M G PF+ + I+ + +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIE 260
Query: 246 DTNPISQECRDLISRIFVADP 266
+ ++ +D++ DP
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDP 281
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 1e-80
Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 58/300 (19%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKID-ENVQREIINHRS 75
+Y IG G++GV R+ + T+ + A+K + + + D E ++ E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 115
L HPNI R EV ++ +VME GG L +++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 116 --------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155
E +Q+ S + Y H +CHRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 156 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLRHEYD-GKIADVWSCGV 209
+ +K+ DFG SK + + GTP ++APEVL G D WS GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 210 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPA 267
L+++L+G PF ++ + +L+ + + N +S RDL+S + +
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 1e-80
Identities = 93/253 (36%), Positives = 138/253 (54%), Gaps = 13/253 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKID-ENVQREIINHRSLR 77
SDRY R +G G+FG L +DK+T + AVK I + K D E++ RE+ + L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HPNI++ E + +V E +GGELF+ I + RFSE +A +Q++SG++Y H
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 138 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ HRDLK EN LL+ S ++I DFG S + K +GT YIAPEVL
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 203
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQEC 254
YD K DVWS GV LY++L G PF +E ++++ +Y+ +S+
Sbjct: 204 YDEK-CDVWSTGVILYILLSGCPPFNGANE----YDILKKVEKGKYTFELPQWKKVSESA 258
Query: 255 RDLISRIFVADPA 267
+DLI ++ P+
Sbjct: 259 KDLIRKMLTYVPS 271
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 3e-80
Identities = 76/251 (30%), Positives = 128/251 (50%), Gaps = 11/251 (4%)
Query: 22 SDRYDFVR--DIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRH 78
+ Y + +G G FG + T +A K I+ RG K E V+ EI L H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHA 137
N+++ + + + +VMEY GGELF+RI + +E + F +Q+ G+ + H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
M + H DLK EN L A ++KI DFG ++ + K GTP ++APEV + +++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDF 264
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECR 255
D+WS GV Y++L G PF ++ +T+ IL+ ++ + D IS+E +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACRWDLEDEEFQDISEEAK 320
Query: 256 DLISRIFVADP 266
+ IS++ + +
Sbjct: 321 EFISKLLIKEK 331
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 7e-80
Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 39/277 (14%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ ++ + +G G FG R+ + A+K I ++ + E++ SL H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 82 VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 127
VR+ L + L I MEY G L++ I + DE F+Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 172
++ +SY H+ + HRDLK N +D S +KI DFG +K+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
S +GT Y+A EVL + + D++S G+ + M+ YPF E
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERV---N 236
Query: 233 TIQRILSVQYSVPDT--NPISQECRDLISRIFVADPA 267
++++ SV P + + + +I + DP
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 8e-80
Identities = 77/249 (30%), Positives = 128/249 (51%), Gaps = 9/249 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
D YD ++G+G FGV + ++ T A K++ + D E V++EI LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQ 139
+V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G+ + H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
H DLK EN + + LK+ DFG + K T GT + APEV G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDL 257
D+WS GV Y++L G PF ++ +T++ + S +++ D+ + IS++ +D
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 258 ISRIFVADP 266
I ++ +ADP
Sbjct: 391 IRKLLLADP 399
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 8e-80
Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 15/255 (5%)
Query: 22 SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREI-INHRSL 76
++ Y +++G G F V R K T + A K+++ RG + EI + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 134
P ++ EV + + +++EYA+GGE+F A SE++ +Q++ GV Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 135 CHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
H + H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
D+W+ G+ Y++L PF D + + I V + + +S
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVS 261
Query: 252 QECRDLISRIFVADP 266
Q D I + V +P
Sbjct: 262 QLATDFIQSLLVKNP 276
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 1e-79
Identities = 86/263 (32%), Positives = 133/263 (50%), Gaps = 23/263 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--------------GDKIDENVQ 67
+ Y VR +GSG +G L ++K A+K I++ +K E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 68 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 127
EI +SL HPNI++ +V + +V E+ GGELFE+I N +F E +A +Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 128 LISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
++SG+ Y H + HRD+K EN LL + + +KI DFG S + + +GT Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSV 244
IAPEVL + Y+ K DVWSCGV +Y++L G PF ++ + I+++ +
Sbjct: 215 IAPEVLKKK-YNEK-CDVWSCGVIMYILLCGYPPFGGQND----QDIIKKVEKGKYYFDF 268
Query: 245 PDTNPISQECRDLISRIFVADPA 267
D IS E ++LI + D
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYN 291
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-79
Identities = 55/261 (21%), Positives = 103/261 (39%), Gaps = 26/261 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
Y ++ IGSG + ++ K++ A+KY+ + + ++ + EI L+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRH 195
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 196 EYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
+DVWS G LY M G PF+ + I+ + +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIE 241
Query: 246 DTNPISQECRDLISRIFVADP 266
+ ++ +D++ DP
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDP 262
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 1e-78
Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 22/279 (7%)
Query: 5 RASLTVGPAMDMPIMHDS--DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE----- 57
S G +DM D Y+ IG G F V R ++ T + AVK ++
Sbjct: 4 GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 63
Query: 58 -RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR- 115
E+++RE L+HP+IV E + L +V E+ G +L I
Sbjct: 64 SSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA 123
Query: 116 ---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 171
+SE A + +Q++ + YCH + HRD+K LL + +K+ FG +
Sbjct: 124 GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 172 VLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230
VGTP ++APEV+ R Y GK DVW CGV L+++L G PF E
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE---- 238
Query: 231 RKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPA 267
+ + I+ +Y + + IS+ +DL+ R+ + DPA
Sbjct: 239 -RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPA 276
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 1e-78
Identities = 54/261 (20%), Positives = 103/261 (39%), Gaps = 26/261 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
Y ++ IGSG + ++ K++ A+KY+ + + ++ + EI L+ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRH 195
+ H DLK N L+ LK+ DFG + + S VG Y+ PE +
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 196 EYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
+DVWS G LY M G PF+ + I+ + +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIE 288
Query: 246 DTNPISQECRDLISRIFVADP 266
+ ++ +D++ DP
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDP 309
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 6e-78
Identities = 84/274 (30%), Positives = 130/274 (47%), Gaps = 16/274 (5%)
Query: 5 RASLTVGPAMDMPIMHDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
V + + D Y + +G G G + +K T+E A+K ++
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98
Query: 64 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 116
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 175
+E EA + + + Y H++ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+ TP Y+APEVL +YD K D+WS GV +Y++L G PF
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
Query: 236 RILSVQYSVPDT--NPISQECRDLISRIFVADPA 267
RI QY P+ + +S+E + LI + +P
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-77
Identities = 74/258 (28%), Positives = 118/258 (45%), Gaps = 19/258 (7%)
Query: 22 SDRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHP 79
+D Y + +G G G + T + A+K + ++E+ + ++ P
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82
Query: 80 NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 133
+IV +V H I+ME GGELF RI G F+E EA + + + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 134 YCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 191
+ H+ + HRD+K EN L LK+ DFG++K ++ TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NP 249
L +YD K D+WS GV +Y++L G PF +RI QY P+ +
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 250 ISQECRDLISRIFVADPA 267
+S++ + LI + DP
Sbjct: 260 VSEDAKQLIRLLLKTDPT 277
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 5e-76
Identities = 75/276 (27%), Positives = 112/276 (40%), Gaps = 31/276 (11%)
Query: 22 SDRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREI-INHRSLRH 78
D Y D +G G + + +T + AVK IE + I V RE+ + ++ H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
N++ E +V E GG + I F+E EA Q + S + + H
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 139 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 188
+ HRDLK EN L + +P +KICDF S + + + G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 189 PEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI---------- 234
PEV+ + K D+WS GV LY++L G PF
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 235 -QRILSVQYSVPDT--NPISQECRDLISRIFVADPA 267
+ I +Y PD IS +DLIS++ V D
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK 285
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 9e-74
Identities = 66/268 (24%), Positives = 106/268 (39%), Gaps = 26/268 (9%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHP 79
D+ Y F++ +G G F L+ A+K I ++ D E QRE HR HP
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 80 NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 131
NI+R L +++ + G L+ I +ED+ + + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 181
+ HA HRDLK N LL + + D G + +H +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 182 GTPAYIAPEV--LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
T +Y APE+ + H + DVWS G LY M+ G P++ + D ++ +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQ 261
Query: 240 VQYSVPDTNPISQECRDLISRIFVADPA 267
Q S+P + S L++ + DP
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPH 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 4e-73
Identities = 69/251 (27%), Positives = 126/251 (50%), Gaps = 14/251 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHP 79
++Y ++ IG G+FG A L++ +K I E +RE+ +++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV+++E L IVM+Y GG+LF+RI F ED+ +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
Y+ K +D+W+ G LY + + FE + + +I+S + P + S + R
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFP-PVSLHYSYDLRS 255
Query: 257 LISRIFVADPA 267
L+S++F +P
Sbjct: 256 LVSQLFKRNPR 266
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-72
Identities = 74/260 (28%), Positives = 121/260 (46%), Gaps = 23/260 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHP 79
+ Y+ + IG+G++G + +R K +++ K ++ G + + + E+ R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 80 NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
NIVR+ + I+ T L IVMEY GG+L I + E+ QL +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 134 YCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 187
CH V HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
+PE + R Y+ K +D+WS G LY + PF ++ +I ++
Sbjct: 184 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFR-RIP 237
Query: 248 NPISQECRDLISRIFVADPA 267
S E ++I+R+
Sbjct: 238 YRYSDELNEIITRMLNLKDY 257
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-71
Identities = 55/263 (20%), Positives = 102/263 (38%), Gaps = 34/263 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+ + IGSG FG + ++ + +K + +E +RE+ L H NIV
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67
Query: 83 RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 124
+ + L I ME+ G L + I + + A
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
F+Q+ GV Y H+ ++ +RDLK N L + ++KI DFG S + + GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
Y++PE + +Y + D+++ G+ L +L + K + S
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDT------AFETSKFFTDLRDGIIS- 237
Query: 245 PDTNPISQECRDLISRIFVADPA 267
+ ++ + L+ ++ P
Sbjct: 238 ---DIFDKKEKTLLQKLLSKKPE 257
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-69
Identities = 74/256 (28%), Positives = 112/256 (43%), Gaps = 36/256 (14%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
D + +G G G + +K T+E A+K ++ +RE+ ++ R+ + P+
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72
Query: 81 IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 134
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 135 CHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
H++ + HRD+K EN L P LK+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET-T 171
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
+YD K D+WS GV +Y++L G PF RI QY P+ + +S
Sbjct: 172 GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230
Query: 252 QECRDLISRIFVADPA 267
+E + LI + +P
Sbjct: 231 EEVKMLIRNLLKTEPT 246
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 4e-69
Identities = 66/273 (24%), Positives = 108/273 (39%), Gaps = 39/273 (14%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 81
R R + G F +D + A+K + ++ + +E+ + L HPNI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 82 VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 131
V+F KE T +++ G+L E + G S D F Q
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 132 VSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 180
V + H + + HRDLK+EN LL +K+CDFG + + + +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 181 ----VGTPAYIAPEV--LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
TP Y PE+ L + G+ D+W+ G LY++ +PFED
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AK 258
Query: 235 QRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
RI++ +YS+P + LI + +P
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPE 291
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 7e-69
Identities = 69/284 (24%), Positives = 119/284 (41%), Gaps = 21/284 (7%)
Query: 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQ 67
P M + + + IG G F + VA+K ++ D +D +
Sbjct: 24 PDMGYNTL---ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80
Query: 68 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARF 123
+EI + L HPN++++ + L IV+E A G+L I + + E
Sbjct: 81 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 182
+F QL S + + H+ +V HRD+K N + + +K+ D G + S + S VG
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
TP Y++PE + + Y+ K +D+WS G LY M PF + + ++I Y
Sbjct: 199 TPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEQCDY 255
Query: 243 SVPDTNPISQECRDLISRIFVADPA----AVSIFFFPLNMSCLL 282
++ S+E R L++ DP ++ M
Sbjct: 256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-68
Identities = 59/250 (23%), Positives = 102/250 (40%), Gaps = 17/250 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSL-RH 78
+ + +G G++G +R K L AVK RG K E+ +H + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHA 137
P VR ++ L + E G L + G E + + + + +++ H+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ H D+K N L P R K+ DFG + G P Y+APE+ L+ Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSY 232
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
ADV+S G+T+ + P + +++ Q L ++ T +S E R +
Sbjct: 233 GTA-ADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYLPPEF----TAGLSSELRSV 284
Query: 258 ISRIFVADPA 267
+ + DP
Sbjct: 285 LVMMLEPDPK 294
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 3e-65
Identities = 64/281 (22%), Positives = 106/281 (37%), Gaps = 46/281 (16%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 81
+ + +G G+ G + VAVK + + EI + S HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 134
+R+ T L I +E L + + + E+ +Q+ SGV++
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 135 CHAMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 178
H++++ HRDLK +N L+ S R+ I DFG K S +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 179 STVGTPAYIAPEVLLRHEYD------GKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFR 231
+ GT + APE+L + D++S G Y +L G PF D
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----- 245
Query: 232 KTIQRILSVQYSVPDTNP-----ISQECRDLISRIFVADPA 267
I+ +S+ + + E DLIS++ DP
Sbjct: 246 -RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPL 285
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 2e-63
Identities = 60/275 (21%), Positives = 103/275 (37%), Gaps = 40/275 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
++ ++ +G G FGV ++KV A+K I + E V RE+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 81 IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 125
IVR+ L +L I M+ L + + C F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 172
Q+ V + H+ + HRDLK N +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+++ VGT Y++PE + + Y K D++S G+ L+ +L YPF E +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV---R 235
Query: 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
T+ + ++++ P ++ + P
Sbjct: 236 TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPM 269
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 5e-63
Identities = 71/252 (28%), Positives = 119/252 (47%), Gaps = 20/252 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 78
+ F + +G G+F L R+ T A+K +I + +K+ +R++++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRH 195
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
K +D+W+ G +Y ++ G PF +E Q+I+ ++Y P+ + R
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEK--FFPKAR 260
Query: 256 DLISRIFVADPA 267
DL+ ++ V D
Sbjct: 261 DLVEKLLVLDAT 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-62
Identities = 59/258 (22%), Positives = 93/258 (36%), Gaps = 21/258 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 82
+ +G G G R VAVK I + RE+ + S HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVC 141
R+ I +E L E + E QQ SG+++ H++ +
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 142 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLR 194
HRDLK N L+ + + I DFG K S+ GT +IAPE+L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 195 HEYD--GKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRKTIQRILSVQYSVPDTNP-I 250
+ D++S G Y ++ G PF + R+ + +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQANILLGACSLDCLHPEKHE 256
Query: 251 SQECRDLISRIFVADPAA 268
R+LI ++ DP
Sbjct: 257 DVIARELIEKMIAMDPQK 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 6e-60
Identities = 47/279 (16%), Positives = 92/279 (32%), Gaps = 40/279 (14%)
Query: 21 DSDRYDFVRDIGSGNFGVARL-----MRDKVTKELVAVKYIERGDKIDENVQREIIN-HR 74
S +G G F + D K+ +K + + + + +++ +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 129
++F L +V E S G L I + F +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 180
+ H ++ H D+K +N +L + L + D G S + PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240
Query: 181 V-----GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEPKDFRKTI 234
+ T + E+L ++ +I D + T+Y ML G Y ++
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 235 QR---------ILSVQYSVPDTN--PISQECRDLISRIF 262
+R V ++PD + P R + ++F
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-58
Identities = 62/272 (22%), Positives = 106/272 (38%), Gaps = 38/272 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREIINHRSL-R 77
+ + + IGSG FG ++ + A+K + G ++N RE+ H L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
H ++VR+ H+ I EY +GG L + I R F E E + Q+ G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 134 YCHAMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 176
Y H+M + H D+K N + S KI D G+ S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186
Query: 177 PKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
P+ G ++A EVL + + K AD+++ +T+ + D+ + R+
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRL 245
Query: 236 RILSVQYSVPDTNPISQECRDLISRIFVADPA 267
+ SQE +L+ + DP
Sbjct: 246 PRIPQVL--------SQEFTELLKVMIHPDPE 269
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-58
Identities = 72/255 (28%), Positives = 132/255 (51%), Gaps = 22/255 (8%)
Query: 23 DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----S 75
+++ ++ +G G+FG + + + ++L A+K + + + + R
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
+ HP IV+ T L +++++ GG+LF R+ F+E++ +F+ +L + +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 136 HAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 192
H++ + +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
R + + AD WS GV ++ ML G PF+ D ++T+ IL + +P +S
Sbjct: 199 NRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDR----KETMTMILKAKLGMPQF--LSP 251
Query: 253 ECRDLISRIFVADPA 267
E + L+ +F +PA
Sbjct: 252 EAQSLLRMLFKRNPA 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-56
Identities = 35/291 (12%), Positives = 69/291 (23%), Gaps = 62/291 (21%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR-- 77
+G + D+ T E V ++ + ++ E++ R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 78 -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 106
++R + L+ Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
Q+I ++ H + H L+ + +LD + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251
Query: 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHE----------YDGKIADVWSCGVTLYVMLV 216
V + + + PE+ R D W+ G+ +Y +
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 217 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
P + + I Q R L+
Sbjct: 309 ADLPITKDAALGGSEWIFRSCKN----------IPQPVRALLEGFLRYPKE 349
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 2e-56
Identities = 77/253 (30%), Positives = 126/253 (49%), Gaps = 27/253 (10%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
+ +R +G+G+FG L+R + A+K + K + V+ + + H +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
HP I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 137 AMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
+ + +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
Y K D WS G+ +Y ML G PF D + KT ++IL+ + P +++
Sbjct: 178 KPY-NKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNAELRFPPF--FNEDV 230
Query: 255 RDLISRIFVADPA 267
+DL+SR+ D +
Sbjct: 231 KDLLSRLITRDLS 243
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-56
Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 15/250 (6%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 81
+ +R IG G+FG +++ TK++ A+KY+ + ++ N R + L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V + +V++ GG+L + F E+ + F +L+ + Y ++
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 142 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
HRD+K +N LLD G + I DF + +Q + GT Y+APE+ + G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 200 --KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
D WS GVT Y +L G P+ ++ + + + P SQE L
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPSA--WSQEMVSL 250
Query: 258 ISRIFVADPA 267
+ ++ +P
Sbjct: 251 LKKLLEPNPD 260
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-56
Identities = 40/285 (14%), Positives = 72/285 (25%), Gaps = 46/285 (16%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
+ V + G+ V L+RD E A+K G + E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 80 NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 107
+ ++ + ++M AS L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 108 ERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167
G QLI + + + H +N + RL + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239
Query: 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPD 225
+ P AP L + W G+++Y + PF
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 226 EPKDF---RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
R +++ + + P+ + LI R D
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-56
Identities = 75/256 (29%), Positives = 126/256 (49%), Gaps = 22/256 (8%)
Query: 23 DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQRE-IINHR---- 74
+ ++ +R +G G +G R + T ++ A+K +++ + R
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++HP IV T L +++EY SGGELF ++ G F ED A F+ ++ + +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 191
H + +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
L+R + + D WS G +Y ML G PF + +KTI +IL + ++P ++
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENR----KKTIDKILKCKLNLPPY--LT 245
Query: 252 QECRDLISRIFVADPA 267
QE RDL+ ++ + A
Sbjct: 246 QEARDLLKKLLKRNAA 261
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-56
Identities = 72/251 (28%), Positives = 129/251 (51%), Gaps = 19/251 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
D++D ++ +G+G+FG L++ K + A+K +++ + +N + ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
+ +RDLK EN L+D G +++ DFG++K + + + GTP +APE++L
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
Y K D W+ GV +Y M G PF + + K I+S + P S + +D
Sbjct: 215 Y-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKD 267
Query: 257 LISRIFVADPA 267
L+ + D
Sbjct: 268 LLRNLLQVDLT 278
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-55
Identities = 84/254 (33%), Positives = 132/254 (51%), Gaps = 22/254 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------R 74
+ +D+++ +G G FG L+R+K T A+K + R + I + ++ + H +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+ RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 193
H+ V +RD+KLEN +LD +KI DFG K + T GTP Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
++Y G+ D W GV +Y M+ G PF + D + + IL + P T +S E
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPRT--LSPE 231
Query: 254 CRDLISRIFVADPA 267
+ L++ + DP
Sbjct: 232 AKSLLAGLLKKDPK 245
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-55
Identities = 83/255 (32%), Positives = 124/255 (48%), Gaps = 23/255 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
D ++F+R +G G+FG L R K T +L AVK + + D I +Q + +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ HP + + TP L VME+ +GG+L I + RF E ARF+ ++IS +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
+ H + +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
Y G D W+ GV LY ML G PFE +E F IL+ + P + +
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTW--LHE 249
Query: 253 ECRDLISRIFVADPA 267
+ ++ +P
Sbjct: 250 DATGILKSFMTKNPT 264
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-55
Identities = 80/257 (31%), Positives = 122/257 (47%), Gaps = 27/257 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+ + + +G G+FG L K T + A+K + K D + + +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ HP + T +L VMEY +GG+L I + +F A F+ ++I G+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
+ H+ + +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
+LL +Y D WS GV LY ML+G PF DE + I P +
Sbjct: 189 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNPFYPRW--L 241
Query: 251 SQECRDLISRIFVADPA 267
+E +DL+ ++FV +P
Sbjct: 242 EKEAKDLLVKLFVREPE 258
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-55
Identities = 81/257 (31%), Positives = 119/257 (46%), Gaps = 27/257 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
++F+ +G G+FG L K T EL AVK + K D +Q + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLA 75
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
+ + + +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
++ Y GK D W+ GV LY ML G PFE DE + Q I+ + P + +
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPKS--M 244
Query: 251 SQECRDLISRIFVADPA 267
S+E + + P
Sbjct: 245 SKEAVAICKGLMTKHPG 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-55
Identities = 77/257 (29%), Positives = 120/257 (46%), Gaps = 27/257 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+ F++ IG G+FG L R K + AVK + + I ++++ H
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
Y H++ + +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
VL + Y + D W G LY ML G PF + + IL+ + I
Sbjct: 210 VLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNKPLQLKPN--I 262
Query: 251 SQECRDLISRIFVADPA 267
+ R L+ + D
Sbjct: 263 TNSARHLLEGLLQKDRT 279
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 8e-55
Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 28/260 (10%)
Query: 26 DFVRDIGSGNFG---VARLMRDKVTKELVAVK-----YIERGDKIDENVQRE-----IIN 72
+ ++ +G+G +G + R + T +L A+K I + K E+ + E I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 133 SYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 188
+ H + + +RD+KLEN LLD G + + DFG SK V ++ GT Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 189 PEVLLRHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
P+++ + K D WS GV +Y +L G PF E + +RIL + P
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288
Query: 248 NPISQECRDLISRIFVADPA 267
+S +DLI R+ + DP
Sbjct: 289 --MSALAKDLIQRLLMKDPK 306
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-54
Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 28/262 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+D +R IG G++ L+R K T + A+K + + + + E I+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----KDFRKTIQRILSVQYSVP 245
+L +Y G D W+ GV ++ M+ G PF+ Q IL Q +P
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 246 DTNPISQECRDLISRIFVADPA 267
+ +S + ++ DP
Sbjct: 240 RS--LSVKAASVLKSFLNKDPK 259
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 5e-54
Identities = 84/251 (33%), Positives = 129/251 (51%), Gaps = 15/251 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
+ +++++ +G G FG L+++K T A+K +++ + ++ + + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + K T L VMEYA+GGELF + FSED ARF+ +++S + Y H+
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 139 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHE 196
+ V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL ++
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
Y G+ D W GV +Y M+ G PF + D K F IL + P T + E +
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEAKS 378
Query: 257 LISRIFVADPA 267
L+S + DP
Sbjct: 379 LLSGLLKKDPK 389
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-53
Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 17/244 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
+G G+FG M+DK T AVK + ++ E++ L P IV +
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150
+ I ME GG L + I G ED A ++ Q + G+ Y H ++ H D+K +N
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 151 LLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
LL R +CDFG++ GT ++APEV++ D K D+
Sbjct: 182 LLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDI 239
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDLISRIFV 263
WS + ML G +P+ +I S + + P + I
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRG----PLCLKIASEPPPIREIPPSCAPLTAQAIQEGLR 295
Query: 264 ADPA 267
+P
Sbjct: 296 KEPV 299
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-53
Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 28/262 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+D +R IG G++ L+R K T + A++ + + + + E I+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----KDFRKTIQRILSVQYSVP 245
+L +Y G D W+ GV ++ M+ G PF+ Q IL Q +P
Sbjct: 224 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282
Query: 246 DTNPISQECRDLISRIFVADPA 267
+ +S + ++ DP
Sbjct: 283 RS--LSVKAASVLKSFLNKDPK 302
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 6e-53
Identities = 81/251 (32%), Positives = 119/251 (47%), Gaps = 26/251 (10%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
Y+ V+ IG G FG +L+R K T+++ A+K + E ++R
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
P +V+ +L +VMEY GG+L + + E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 194
+M HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 195 HEYD---GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNP 249
D G+ D WS GV LY MLVG PF T +I++ + S+ PD N
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDND 299
Query: 250 ISQECRDLISR 260
IS+E ++LI
Sbjct: 300 ISKEAKNLICA 310
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 7e-53
Identities = 71/249 (28%), Positives = 115/249 (46%), Gaps = 13/249 (5%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-------SLRH 78
R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ + H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL +
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
AD +S G L+ +L G PF + KD + + L++ +PD+ S E R L+
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLL 425
Query: 259 SRIFVADPA 267
+ D
Sbjct: 426 EGLLQRDVN 434
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-52
Identities = 79/252 (31%), Positives = 122/252 (48%), Gaps = 17/252 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
++F+ +G G+FG L K T EL AVK +++ I ++ V++ ++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+ +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRH 195
+ + +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
Y GK D W+ GV LY ML G PFE DE + Q I+ + P + +S+E
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPKS--MSKEAV 570
Query: 256 DLISRIFVADPA 267
+ + P
Sbjct: 571 AICKGLMTKHPG 582
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-52
Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 11/251 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRH 78
+ + R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 136
+V T L +V+ +GG+L I + G+ F E A F+ ++ G+ H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ +RDLK EN LLD ++I D G + K VGT Y+APEV+
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
Y D W+ G LY M+ G PF+ + + + + V + S + R
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARS 418
Query: 257 LISRIFVADPA 267
L S++ DPA
Sbjct: 419 LCSQLLCKDPA 429
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-52
Identities = 72/256 (28%), Positives = 109/256 (42%), Gaps = 18/256 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
D + R +G G FG + K T +L A K + + + + + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 134
IV T T L +VM +GG++ I N F E A F+ Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 191
H + +RDLK EN LLD G ++I D G + GTP ++APE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
LL EY D ++ GVTLY M+ PF E + ++ QR+L + PD S
Sbjct: 361 LLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FS 417
Query: 252 QECRDLISRIFVADPA 267
+D + DP
Sbjct: 418 PASKDFCEALLQKDPE 433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 6e-52
Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 28/260 (10%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
++ ++ IG G FG +++ K ++ A+K + E ++R +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 135
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 193
H + HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 194 RHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP---D 246
E G D WS GV +Y ML G PF +T +I++ +
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKERFQFPTQ 305
Query: 247 TNPISQECRDLISRIFVADP 266
+S+ +DLI R+ +
Sbjct: 306 VTDVSENAKDLIRRLICSRE 325
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-51
Identities = 63/262 (24%), Positives = 110/262 (41%), Gaps = 25/262 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------R 74
D ++ ++ IG G F +++ K T ++ A+K + + ++R ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 133
+ I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 191
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 192 LLRHEYD------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
L G D W+ GV Y M G PF + + K + + +
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294
Query: 246 DTNPISQECRDLISRIFVADPA 267
D + +E RD I R + P
Sbjct: 295 DEG-VPEEARDFIQR-LLCPPE 314
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-50
Identities = 36/288 (12%), Positives = 71/288 (24%), Gaps = 55/288 (19%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR-- 77
+G + D+ T E V ++ + ++ E++ R LR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 78 --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 106
P + V L + ++ + G L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
Q+I ++ H + H L+ + +LD + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256
Query: 167 YSKS--SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI----ADVWSCGVTLYVMLVGGYP 220
+ + S P A +L ++ + D W+ G+ +Y + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 221 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 268
D I Q R L+
Sbjct: 317 NTDDAALGGSEWI----------FRSCKNIPQPVRALLEGFLRYPKED 354
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-49
Identities = 70/251 (27%), Positives = 114/251 (45%), Gaps = 26/251 (10%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 89
+G G +G+ RD + +A+K I D + + EI H+ L+H NIV++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 90 TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+ I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 147 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHE--YDGKIAD 203
+N L++ + + LKI DFG SK + ++ ++ GT Y+APE++ + Y AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-AD 207
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------ISQECRD 256
+WS G T+ M G PF + EP + + V +S E +
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEP----------QAAMFKVGMFKVHPEIPESMSAEAKA 257
Query: 257 LISRIFVADPA 267
I + F DP
Sbjct: 258 FILKCFEPDPD 268
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-45
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 7/205 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
+ + + IG G+FG D T+++VA+K I E + E++Q+EI P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ ++ L T L I+MEY GG + + G E + ++++ G+ Y H+ +
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
HRD+K N LL +K+ DFG + ++T VGTP ++APEV+ + YD
Sbjct: 140 KIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 199 GKIADVWSCGVTLYVMLVGGYPFED 223
K AD+WS G+T + G P +
Sbjct: 198 SK-ADIWSLGITAIELARGEPPHSE 221
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-45
Identities = 66/237 (27%), Positives = 107/237 (45%), Gaps = 9/237 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--VQREI-INHRSLR 77
D ++ + ++G+GN GV + K + ++A K I K + RE+ + H
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 138 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ HRD+K N L++ +K+CDFG S + S S VGT +Y++PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
Y + +D+WS G++L M VG YP PD + ++ P
Sbjct: 207 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-44
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ +D + +G G++G K T ++VA+K + + E + +EI + P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V++ T L IVMEY G + + I +EDE Q + G+ Y H M+
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K N LL +G K+ DFG + + + ++ + +GTP ++APEV+ Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFED 223
+ AD+WS G+T M G P+ D
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYAD 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 59/249 (23%), Positives = 101/249 (40%), Gaps = 22/249 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 84
IG G+F D T VA ++ QR E + L+HPNIVRF
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 85 -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VC 141
+ + + +V E + G L + R + +Q++ G+ + H +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +YD
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDES- 209
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSVQYSVPDTNP--ISQECRDLI 258
DV++ G+ + M YP+ + +R+ + P + E +++I
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------PASFDKVAIPEVKEII 263
Query: 259 SRIFVADPA 267
+
Sbjct: 264 EGCIRQNKD 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-43
Identities = 60/257 (23%), Positives = 111/257 (43%), Gaps = 18/257 (7%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREI-INHRSLR 77
+ + + + ++GSG G MR + T ++AVK + + ++ + ++ + +S
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P IV+ +T T + I ME + G E ++ + Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 138 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL--- 192
V HRD+K N LLD ++K+CDFG S V + K G AY+APE +
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERIDPP 199
Query: 193 --LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTNP 249
+ +YD + ADVWS G++L + G +P+++ + + ++L + +P
Sbjct: 200 DPTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTD---FEVLTKVLQEEPPLLPGHMG 255
Query: 250 ISQECRDLISRIFVADP 266
S + + + D
Sbjct: 256 FSGDFQSFVKDCLTKDH 272
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-43
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D + +G G FGV + + K + VA+K I + + E+ + HPN
Sbjct: 6 DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHA 137
IV+ L P + +VMEYA GG L+ + A A + GV+Y H+
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 138 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
MQ + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
Y K DV+S G+ L+ ++ PF++ P
Sbjct: 178 SNYSEK-CDVFSWGIILWEVITRRKPFDEIGGP 209
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-43
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
+Y IG G G D T + VA++ + ++ K + + EI+ R ++P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV + + L L +VMEY +GG L + + E + ++ + + + H+ Q
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
V HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV+ R
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFED 223
Y K D+WS G+ M+ G P+ +
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLN 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-43
Identities = 58/260 (22%), Positives = 114/260 (43%), Gaps = 23/260 (8%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--VQREI-INHRSLR 77
+D + + ++G G +GV MR + +++AVK I E + ++ I+ R++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 134
P V F + + I ME + ++++ + ED ++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 135 CHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
H+ + V HRD+K N L++ ++K+CDFG S V K G Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 193 L----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--D 246
+ Y K +D+WS G+T+ + + +P++ P ++++ V+ P
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQ---QLKQV--VEEPSPQLP 235
Query: 247 TNPISQECRDLISRIFVADP 266
+ S E D S+ +
Sbjct: 236 ADKFSAEFVDFTSQCLKKNS 255
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-43
Identities = 77/258 (29%), Positives = 126/258 (48%), Gaps = 29/258 (11%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 80
D IG G+ G+ L R+K + VAVK ++ R + E + E++ R +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V + L L ++ME+ GG L + I + R +E++ + ++ ++Y HA V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+ R Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------- 249
+ D+WS G+ + M+ G P+ D P + + D+ P
Sbjct: 219 ATE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMKRLRDSPPPKLKNSHK 266
Query: 250 ISQECRDLISRIFVADPA 267
+S RD + R+ V DP
Sbjct: 267 VSPVLRDFLERMLVRDPQ 284
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-42
Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 18/242 (7%)
Query: 1 MKMDR-ASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--E 57
M ++ L + P ++ + +IG G +G M K + +++AVK I
Sbjct: 1 MSIESSGKLKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 58 RGDKIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA- 113
+K + + ++ + RS P IV+F + I ME S + ++ + +
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 114 -GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171
E+ + +++ +++ HRD+K N LLD S +K+CDFG S
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQL 176
Query: 172 VLHSQPKSTVGTPAYIAPEVL----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
V G Y+APE + R YD + +DVWS G+TLY + G +P+ +
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSV 235
Query: 228 KD 229
D
Sbjct: 236 FD 237
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-42
Identities = 75/270 (27%), Positives = 113/270 (41%), Gaps = 28/270 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRH 78
+ D Y+ IGSG V + KE VA+K I E+ + + +EI H
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 130
PNIV + + L +VM+ SGG + + +G E ++++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 131 GVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS------KSSVLHSQPKSTVG 182
G+ Y H HRD+K N LL DGS ++I DFG S + K+ VG
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 183 TPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ----RI 237
TP ++APEV+ + YD K AD+WS G+T + G P+ K T+Q +
Sbjct: 189 TPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 238 LSVQYSVPDTNPISQECRDLISRIFVADPA 267
+ + R +IS DP
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPE 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-41
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 17/213 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
++ ++ V ++G G FG ++K T L A K I + +++++ EI + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAM 138
IV+ L I++E+ GG + + +E + + +Q++ +++ H+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRH 195
++ HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV++
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 196 E-----YDGKIADVWSCGVTLYVMLVGGYPFED 223
YD K AD+WS G+TL M P +
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 20/220 (9%)
Query: 21 DSDRYDFVRDIGSG--NFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRS 75
+ Y+ + IG G + L R K T E V V+ I +++ +Q E+ +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 133
HPNIV ++ + L +V + + G + IC +E + Q ++ +
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 185
Y H M HR +K + L+ + + + + V+H PK +V
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 186 YIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFED 223
+++PEVL + YD K +D++S G+T + G PF+D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-41
Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
IG+G+FG + R + VAVK + D E V RE+ + LRHPNIV F
Sbjct: 45 IGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAM--QVCH 142
+ P +L+IV EY S G L+ + +G E + G++Y H + H
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDG 199
R+LK N L+D +K+CDFG S+ + S KS GTP ++APEVL +
Sbjct: 163 RNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 200 KIADVWSCGVTLYVMLVGGYPFED 223
K +DV+S GV L+ + P+ +
Sbjct: 219 K-SDVYSFGVILWELATLQQPWGN 241
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPN 80
+ ++ V +G+G +G R T +L A+K ++ +E +++EI + H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 81 IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 132
I + K L +VME+ G + + + E+ + ++++ G+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 133 SYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 189
S+ H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 190 EVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFED 223
EV+ E YD K +D+WS G+T M G P D
Sbjct: 199 EVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-40
Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 80
IG G FG ++ R + VAVK D ENV++E L+HPN
Sbjct: 10 TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-- 138
I+ + V L +L +VME+A GG L + R D + Q+ G++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 139 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ HRDLK N L+ LKI DFG ++ + S G A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
+ + +DVWS GV L+ +L G PF
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRG 216
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-40
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSL 76
+ +R+IG G+FG RD E+VA+K + + +K + + +E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
RHPN ++++ L +VMEY G + E E + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 137 AMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 193
+ + HRD+K N LL G +K+ DFG + + S VGTP ++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224
Query: 194 --RHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
+YDGK DVWS G+T + P +
Sbjct: 225 MDEGQYDGK-VDVWSLGITCIELAERKPPLFN 255
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 6e-40
Identities = 40/224 (17%), Positives = 77/224 (34%), Gaps = 26/224 (11%)
Query: 60 DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 116
+ +I N V + +L I M+ L + + C+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176
F Q+ V + H+ + HRDLK N +K+ DFG + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219
Query: 177 PKST-------------VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
++ VGT Y++PE + + Y K D++S G+ L+ +L Y F
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275
Query: 224 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
E + I + ++++ + ++ + P
Sbjct: 276 QMERV---RIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPT 315
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPN 80
++ ++ +G G FGV ++KV A+K I ++ E V RE+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 81 IVRFKE 86
IVR+
Sbjct: 66 IVRYFN 71
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-39
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV--------QREIINHRSLR 77
++ + IG G FG+ R K +VA+K + GD E QRE+ +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 136
HPNIV+ ++ P +VME+ G+L+ R+ + + G+ Y
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 137 AM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ HRDL+ N L + K+ DFG S+ +G ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 192 LL-RHE-YDGKIADVWSCGVTLYVMLVGGYPFED 223
+ E Y K AD +S + LY +L G PF++
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDE 230
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 31 IGSGNFGVARLMRDKVTKEL----VAVKYIERGDKIDENVQ---REIINHRSLRHPNIVR 83
IG G FG +V VA++ I+ ++ ++ RE++ +R RH N+V
Sbjct: 41 IGKGRFG-------QVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCH 142
F ++P HLAI+ G L+ + +A ++ R Q+++ G+ Y HA + H
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL---- 192
+DLK +N D ++ I DFG + + + G ++APE++
Sbjct: 154 KDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 193 -----LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
+ + +DV++ G Y + +PF+
Sbjct: 211 PDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKT 245
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-38
Identities = 77/278 (27%), Positives = 120/278 (43%), Gaps = 36/278 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
DRY + +G G +G D VT E VA+K I R + +E V RE+ + L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
NI+ K VI L ++ EYA +L + + S + F QLI+GV++CH+
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 139 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 193
+ HRDLK +N LL S A LKI DFG +++ + + + + T Y PE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 194 RHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED--PDEPK--D 229
Y + D+WS ML+ G P + P D
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270
Query: 230 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
++++ + + E DL++ + DP
Sbjct: 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-38
Identities = 63/250 (25%), Positives = 107/250 (42%), Gaps = 25/250 (10%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
IGSG+FG + + K + VAVK + + +Q E+ R RH NI+ F
Sbjct: 32 IGSGSFG--TVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 88 ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T LAIV ++ G L+ + + +F + +Q G+ Y HA + HRDLK
Sbjct: 89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 147 LENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGK 200
N L +KI DFG + Q + G+ ++APEV+ + Y +
Sbjct: 148 SNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC----RD 256
+DV++ G+ LY ++ G P+ + + + + R PD + + C +
Sbjct: 206 -SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----GSLSPDLSKVRSNCPKRMKR 260
Query: 257 LISRIFVADP 266
L++
Sbjct: 261 LMAECLKKKR 270
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-38
Identities = 69/286 (24%), Positives = 116/286 (40%), Gaps = 40/286 (13%)
Query: 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSL 76
M S ++ + +G+G + +K T VA+K + + + REI + L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 77 RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 131
+H NIVR +VI T L +V E+ + + ++F QL+ G
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 190
+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED------ 223
VL+ Y I D+WSCG L M+ G G P E
Sbjct: 179 VLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237
Query: 224 --PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
P + ++ R L P+ D + + +P
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 5 RASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE 64
S V + ++Y+ + +G G++G+ R+K T +VA+K D+
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65
Query: 65 NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 118
V REI + LRH N+V EV +V E+ + E N
Sbjct: 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123
Query: 119 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178
+ + Q+I+G+ +CH+ + HRD+K EN L+ S +K+CDFG++++ +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181
Query: 179 ST-VGTPAYIAPEVLLRHEYDGKIADVWSCG 208
V T Y APE+L+ GK DVW+ G
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIG 212
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-37
Identities = 40/204 (19%), Positives = 79/204 (38%), Gaps = 19/204 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEV 87
+ + G L + + + VK ++ D + + E R HPN++
Sbjct: 18 LNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 88 ILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQ--VC 141
+P H ++ + G L+ + F D+++ F + G+++ H ++ +
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIP 135
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
L + ++D +I S Q + PA++APE L + D
Sbjct: 136 RHALNSRSVMIDED--MTARISMADVKFS----FQSPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 202 --ADVWSCGVTLYVMLVGGYPFED 223
AD+WS V L+ ++ PF D
Sbjct: 190 RSADMWSFAVLLWELVTREVPFAD 213
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP 79
Y + IG+G+FGV + + ELVA+K + DK +N RE+ R L H
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--RELQIMRKLDHC 107
Query: 80 NIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLIS 130
NIVR + + +L +V++Y + + QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 188
++Y H+ +CHRD+K +N LLD A LK+CDFG +K L + + + Y A
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPNVSYICSRYYRA 224
Query: 189 PEVLLR-HEYDGKIADVWSCG 208
PE++ +Y I DVWS G
Sbjct: 225 PELIFGATDYTSSI-DVWSAG 244
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
+Y+ + IG G +G +++ T E+VA+K + R D DE V REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
NIVR +V+ + L +V E+ + F+ G + + F QL+ G+ +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-R 194
+ V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPF 221
Y I D+WS G + G P
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPL 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 16/195 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
++Y+ + IG G++GV R++ T ++VA+K + D ++ REI + L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 79 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
PN+V EV L +V EY +R E + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 193
HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175
Query: 194 RHEYDGKIADVWSCG 208
G DVW+ G
Sbjct: 176 GDTQYGPPVDVWAIG 190
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 48/281 (17%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
++Y + IG G +GV ++ E A+K I R +K DE + REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 79 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
NIV+ +VI T L +V E+ +L + G A+ F QL++G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-R 194
+V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 195 HEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED--------PDE 226
+Y I D+WS G M+ G G P P
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
+F + + DL+S++ DP
Sbjct: 235 DPNFTVYEPLPWESFLK-----GLDESGIDLLSKMLKLDPN 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G FG A + + T E++ +K + R ++ +E+ R L HPN+++F V+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 90 TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L + EY GG L I + + + F + + SG++Y H+M + HRDL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 149 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 193
N L+ + + + DFG ++ + + VG P ++APE++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225
YD K DV+S G+ L ++ D
Sbjct: 196 GRSYDEK-VDVFSFGIVLCEIIGRVNADPDYL 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-35
Identities = 65/280 (23%), Positives = 114/280 (40%), Gaps = 45/280 (16%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+ Y + +G G + + K+T LVA+K I E + RE+ + L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 81 IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
IV ++I T L +V EY + + + + F QL+ G++YCH
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHE 196
+V HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++LL +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 197 YDGKIADVWSCGVTLYVMLVG--------------------GYPFED--------PD-EP 227
Y +I D+W G Y M G G P E+ + +
Sbjct: 178 YSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
++ K L + + DL++++ +
Sbjct: 237 YNYPKYRAEALLSHAP-----RLDSDGADLLTKLLQFEGR 271
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 74/302 (24%), Positives = 125/302 (41%), Gaps = 49/302 (16%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
M ++ ++Y + +G G +GV +D +VA+K I R D
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58
Query: 63 DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 116
DE + REI + L HPNIV +VI + L +V E+ ++ + N
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176
+ + + + QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174
Query: 177 PKST-VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG----------------- 217
+ V T Y AP+VL+ +Y + D+WS G M+ G
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233
Query: 218 ---GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
G P P + + F+ ++ S QE DL+S + D
Sbjct: 234 SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIP-----GFCQEGIDLLSNMLCFD 288
Query: 266 PA 267
P
Sbjct: 289 PN 290
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------ 67
M + + + RY+ + +G G F RDK T ++VA+K I + E
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59
Query: 68 -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 124
REI + L HPNI+ + +++++V ++ + + N+ + + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 181
+ G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ + V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173
Query: 182 GTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVG 217
T Y APE+L R Y + D+W+ G L +L+
Sbjct: 174 VTRWYRAPELLFGARM-YGVGV-DMWAVGCILAELLLR 209
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 67/305 (21%), Positives = 112/305 (36%), Gaps = 58/305 (19%)
Query: 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----Q 67
+++ P + +Y+ + IG G FG R + T + VA+K + + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64
Query: 68 REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 117
REI + L+H N+V E+ T +V ++ L + +F+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122
Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 173
E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180
Query: 174 HSQP-KSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-------------- 217
+ V T Y PE+LL +Y I D+W G + M
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239
Query: 218 ------GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
G + E + K +R + + DLI ++
Sbjct: 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK---AYVRDPYALDLIDKLL 296
Query: 263 VADPA 267
V DPA
Sbjct: 297 VLDPA 301
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
Y + IG+G+FGV + + E VA+K + DK +N RE+ R ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94
Query: 82 VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 132
V K + L +V+EY + + QL+ +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
+Y H++ +CHRD+K +N LLD LK+ DFG +K +L + + + + Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211
Query: 191 VLLR-HEYDGKIADVWSCGVTLYVMLVG 217
++ Y I D+WS G + ++ G
Sbjct: 212 LIFGATNYTTNI-DIWSTGCVMAELMQG 238
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 51/221 (23%), Positives = 86/221 (38%), Gaps = 29/221 (13%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
+G G +G + R E VAVK D+ + E+ N LRH NI+ F
Sbjct: 16 VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ------- 139
+ T L ++ Y G L++ + + SG+++ H
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 140 -VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL- 192
+ HRDLK +N L+ + + I D G + ++ L VGT Y+APEVL
Sbjct: 133 AIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 193 -----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
+ + D+W+ G+ L+ + ++ K
Sbjct: 191 ETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 23 DRYDFVRD-IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH 78
D +++ +G G +G A+ +D + A+K IE I + REI R L+H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77
Query: 79 PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 128
PN++ ++V L+ + + +YA + + + Q+
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 182
+ G+ Y HA V HRDLK N L+ G R +KI D G ++ + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 183 TPAYIAPEVLL--RHEYDGKIADVWSCG 208
T Y APE+LL RH Y I D+W+ G
Sbjct: 198 TFWYRAPELLLGARH-YTKAI-DIWAIG 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN 80
D Y VR +G G + + E V VK ++ K + ++REI +LR PN
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+ +++ P A+V E+ + + + ++ + RF+ +++ + YCH+M
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR-H 195
+ HRD+K N ++D +L++ D+G ++ H + V + + PE+L+
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPF 221
YD + D+WS G L M+ PF
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPF 231
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 55/247 (22%), Positives = 99/247 (40%), Gaps = 30/247 (12%)
Query: 7 SLTVGPAMDMPIMH---DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
S + G +P++ + + V+ IG G +G + K E VAVK ++
Sbjct: 18 SQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEAS 75
Query: 64 ENVQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSED 119
+ EI +RH NI+ F + + T L ++ +Y G L++ + +
Sbjct: 76 WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAK 134
Query: 120 EARFFFQQLISGVSYCHAMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 169
+SG+ + H + HRDLK +N L+ + I D G +
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKF 192
Query: 170 ---SSVLHSQPKSTVGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
++ + P + VGT Y+ PEVL H +AD++S G+ L+ +
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 222 EDPDEPK 228
+E +
Sbjct: 253 GIVEEYQ 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-33
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
IG G FG + R K E VAVK ++ + EI LRH NI+ F +
Sbjct: 50 IGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------M 138
T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL- 192
+ HRDLK +N L+ + I D G + + + P VGT Y+APEVL
Sbjct: 167 AIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224
Query: 193 ----LRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
++H E + AD+++ G+ + + ++ +
Sbjct: 225 DSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQ 264
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 28/206 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ-------REIINHRS 75
RY+ V +IG G +G RD + VA+K + R RE+ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67
Query: 76 LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 125
L HPN+VR +V T + +V E+ ++ + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 182
+Q + G+ + HA + HRDLK EN L+ +K+ DFG ++ +S V
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCG 208
T Y APEVLL+ Y + D+WS G
Sbjct: 182 TLWYRAPEVLLQSTYATPV-DMWSVG 206
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-33
Identities = 71/207 (34%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLR 77
++RY V +G G L D + VA+K I + E +RE+ N L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
H NIV +V +VMEY G L E I + G S D A F Q++ G+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRH 195
M++ HRD+K +N L+D LKI DFG +K S +Q +GT Y +PE
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFE 222
D D++S G+ LY MLVG PF
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 7 SLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN- 65
SL A D + DR+ R G G FG +L ++K T VA+K + D N
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNR 65
Query: 66 VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR--- 115
+ + + L HPNIV+ + T L +VMEY L N R
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQV 124
Query: 116 -FSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172
+ F QLI + H ++ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLS 183
Query: 173 LHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG 217
+ + + Y APE++ Y + D+WS G M++G
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG 228
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 61/214 (28%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
RY ++ +G G G+ D + VA+K I D ++ REI R L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 81 IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 128
IV+ E++ + E E + G E+ AR F QL
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 184
+ G+ Y H+ V HRDLK N ++ + LKI DFG ++ H K + T
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 185 AYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG 217
Y +P +LL + Y I D+W+ G ML G
Sbjct: 189 WYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTG 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 66/250 (26%), Positives = 97/250 (38%), Gaps = 30/250 (12%)
Query: 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV---- 66
G M P DRY+ +G G L RD VAVK + D +
Sbjct: 1 GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59
Query: 67 QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
+RE N +L HP IV + IVMEY G L + + G + A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 178
+++ H + HRD+K N ++ S +K+ DFG + S +Q
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--------------EDP 224
+ +GT Y++PE D + +DV+S G LY +L G PF EDP
Sbjct: 178 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 225 DEPKDFRKTI 234
P + +
Sbjct: 237 IPPSARHEGL 246
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-31
Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 9/205 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLRHP 79
Y R +G G G D V + +VA+K + D QRE L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
++V + L + M +G +L + G + A +Q+ S + HA
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K EN L+ S + DFG + + +Q +TVGT Y+APE
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFE 222
+ AD+++ LY L G P++
Sbjct: 213 TYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYIERGDKIDENVQ----REI---INHR 74
+Y+ V +IG G +G RD K VA+K + R +E + RE+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 75 SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 127
+ HPN+VR +V T L +V E+ ++ + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 185
L+ G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ Q T V T
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184
Query: 186 YIAPEVLLRHEYDGKIADVWSCG 208
Y APEVLL+ Y + D+WS G
Sbjct: 185 YRAPEVLLQSSYATPV-DLWSVG 206
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 49/240 (20%), Positives = 86/240 (35%), Gaps = 34/240 (14%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGDKIDENVQ----REIINHRSL 76
+ +Y+ I G G L D+ V V +K + D Q E +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136
Query: 77 RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
HP+IV+ + IVMEY G L + EA + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+SY H++ + + DLK EN +L +LK+ D G + GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFE------------DPDEPKDFRKTIQRILS 239
+ D+++ G TL + + + + ++R +
Sbjct: 249 VRTGPTVA--TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAID 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 51/229 (22%), Positives = 90/229 (39%), Gaps = 28/229 (12%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
S + G FG + + ++ E VAVK DK + E+ + ++H N
Sbjct: 22 QSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHEN 79
Query: 81 IVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
I++F K L ++ + G L + + A S +E + + G++Y H
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLH 138
Query: 137 AMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 183
+ HRD+K +N LL + I DFG + T VGT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 184 PAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
Y+APEVL + + + D+++ G+ L+ + + P +
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 58/251 (23%), Positives = 99/251 (39%), Gaps = 21/251 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
RY ++ IGSG G+ D + + VA+K + R ++ + RE++ + + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
NI+ V L IVME L ++ + + Q++ G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+ H+ + HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--QYSVPDTNPI 250
L Y + D+WS G + M+ GG F D +++ +
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPG----TDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 251 SQECRDLISRI 261
R +
Sbjct: 254 QPTVRTYVENR 264
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 53/238 (22%), Positives = 85/238 (35%), Gaps = 37/238 (15%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D D + IG G +G + + + + VAVK ++ + ++ I + H N
Sbjct: 11 DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 81 IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
I RF + +VMEY G L + + + + + G++Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 136 HAM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 177
H + HRDL N L+ I DFG S +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 178 KSTVGTPAYIAPEVL------LRHEYDGKIADVWSCGVTLYVML---VGGYPFEDPDE 226
S VGT Y+APEVL E K D+++ G+ + + +P E E
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
+RY + +GSG +G D T VAVK + R I + RE+ + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
N++ +V L +V G +L I + ++D +F Q++ G+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
Y H+ + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199
Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVG 217
++L Y+ + D+WS G + +L G
Sbjct: 200 IMLNWMHYNQTV-DIWSVGCIMAELLTG 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
Y ++ +GSG +G D T VA+K + R ++ + RE+ + +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
N++ +V L +VM + G +L ++ + ED +F Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
Y HA + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195
Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVG 217
V+L Y + D+WS G + M+ G
Sbjct: 196 VILNWMRYTQTV-DIWSVGCIMAEMITG 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 25/253 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
RY ++ IGSG G+ D V VA+K + R ++ + RE++ + + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
NI+ V L +VME L + I + + Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
+ H+ + HRDLK N ++ LKI DFG +++ + T V T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--QYSVPDTN 248
V+L Y + D+WS G + M+ F +D+ +++
Sbjct: 234 VILGMGYKENV-DIWSVGCIMGEMVRHKILFPG----RDYIDQWNKVIEQLGTPCPEFMK 288
Query: 249 PISQECRDLISRI 261
+ R+ +
Sbjct: 289 KLQPTVRNYVENR 301
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-29
Identities = 66/214 (30%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQ------REIINH 73
RY + IG G +G+ D + K VA+K KI E+ REI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79
Query: 74 RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 128
RH NI+ ++I PT + IV + +L ++ S D +F Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 184
+ G+ Y H+ V HRDLK N LL+ + LKICDFG ++ + V T
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 185 AYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG 217
Y APE++L Y I D+WS G L ML
Sbjct: 196 WYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSN 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQ------REII 71
+ S + +G G +GV K T E+VA+K KI+ + REI
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61
Query: 72 NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 126
+ +H NI+ + + I+ E +L R+ + S+D ++F
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 180
Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 181 -----VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG 217
V T Y APEV+L +Y + DVWSCG L + +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLR 219
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
Y +GSG +G DK + E VA+K + R +I + RE++ + ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
N++ +V + L +VM + +L + + +FSE++ ++ Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
Y H+ V HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193
Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVG 217
V+L Y+ + D+WS G + ML G
Sbjct: 194 VILSWMHYNQTV-DIWSVGCIMAEMLTG 220
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 51/238 (21%), Positives = 91/238 (38%), Gaps = 47/238 (19%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
S +Y + +G+G+FG+ + D + + A+K + + D +N RE+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 114
++ + T N G
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 115 --------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160
+ + QL V + H++ +CHRD+K +N L++ L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181
Query: 161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG 217
K+CDFG +K + + + + Y APE++L EY I D+WS G +++G
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 53/241 (21%), Positives = 85/241 (35%), Gaps = 30/241 (12%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------------ 67
Y R I SG++G D VA+K + V
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 68 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 121
REI HPNI+ +++ + L +V E +L + I S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 182 GTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILS 239
Y APE+++ + + D+WS G + M F F + +I+
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALF-----RGSTFYNQLNKIVE 248
Query: 240 V 240
V
Sbjct: 249 V 249
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSL 76
DRY+ IG+G++G DK+ K +VA+K I R D ID + + REI L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 77 RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
H ++V+ ++++ L +V+E A + + +E + L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 185
V Y H+ + HRDLK N L++ +K+CDFG +++ S +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 186 ----------------------YIAPEVLLR-HEYDGKIADVWSCG 208
Y APE++L Y I DVWS G
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIG 271
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 26/234 (11%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHR 74
+ RY VR +G G+F L +D V VA+K + E + EI +N
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 75 SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 122
+I++ + H+ +V E G L + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 123 FFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 177
+QL+ G+ Y H + H D+K EN L++ +P +KI D G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
+++ T Y +PEVLL + D+WS ++ ++ G + FE + +
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTK 245
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 36/239 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
D Y IG G++G L DK T++ VA+K + R D ID + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 79 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
I+R ++I+ L IV+E A +L + +E+ + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 185
+ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 186 ---------------YIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
Y APE++L + Y I D+WS G +L + +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLR- 77
+Y+ V+ +G G +G+ D+ T E+VAVK I + D + REI+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 78 HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
H NIV V+ + +V +Y +L + A ++ QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 180
H+ + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 181 -------VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG 217
V T Y APE+LL +Y I D+WS G L +L G
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCG 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 20 HDSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH 78
H + RY+ ++ IG G+FG V + D + VA+K + + EI R L H
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149
Query: 79 ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 127
N++ E H+ + E S L+E I FS R F
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 186
++ + H ++ H DLK EN LL +K+ DFG SS Q T + + Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
APEV+L Y I D+WS G L +L G
Sbjct: 266 RAPEVILGARYGMPI-DMWSLGCILAELLTG 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 64/206 (31%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP--- 79
DRY+ IG G+FG D+V +E VA+K I+ Q E+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 80 ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 134
IV K + HL +V E S L++ + N S + R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 135 CHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 191
+ + H DLK EN LL +KI DFG SS Q + + Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVG 217
LL YD I D+WS G L M G
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTG 254
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-24
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
F++ +G GNFG ++D T E+VAVK + ++ + +REI +SL+H N
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K V + L ++MEY G L + + + R + + Q+ G+ Y
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
+ HRDL N L+ + R+KI DFG +K + + V P APE L
Sbjct: 133 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 193 LRHEYDGKIADVWSCGVTLY 212
++ +DVWS GV LY
Sbjct: 190 TESKFSVA-SDVWSFGVVLY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
F++ +G GNFG ++D T E+VAVK + ++ + +REI +SL+H N
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K V + L ++MEY G L + + + R + + Q+ G+ Y
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
+ HRDL N L+ + R+KI DFG +K + + V P APE L
Sbjct: 164 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 193 LRHEYDGKIADVWSCGVTLY 212
++ +DVWS GV LY
Sbjct: 221 TESKFSVA-SDVWSFGVVLY 239
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-24
Identities = 36/251 (14%), Positives = 66/251 (26%), Gaps = 36/251 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRH 78
RY + G D VA+ +++ + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + R +V+ T +V E+ GG L E S A Q L + H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V + S + + PA +
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA-------- 179
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDL 257
D+ G +LY +LV +P + + D + I + +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239
Query: 258 ISRIFVADPAA 268
+R D
Sbjct: 240 AARSVQGDGGI 250
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 57/206 (27%), Positives = 78/206 (37%), Gaps = 14/206 (6%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 84
IG GNFG R + LVAVK D + +E + HPNIVR
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 85 KEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
V + IVME GG+ + R +G+ Y + HR
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYD 198
DL N L+ LKI DFG S+ + G + APE L Y
Sbjct: 238 DLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 199 GKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS G+ L+ +G P+ +
Sbjct: 294 SE-SDVWSFGILLWETFSLGASPYPN 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-24
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 20/230 (8%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
++ +G GNFG + D T LVAVK + G + QREI ++L
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDN-TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV+++ V P L +VMEY G L + + + R + Q+ G+ Y +
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
+ HRDL N L+ S A +KI DFG +K + + V P APE L
Sbjct: 146 RRCVHRDLAARNILV-ESEA-HVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 193 LRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241
+ + + +DVWS GV LY + E + + ++
Sbjct: 203 SDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-23
Identities = 55/212 (25%), Positives = 82/212 (38%), Gaps = 21/212 (9%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHP 79
+ +G G+FGV VAVK ++ + I SL H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
N++R V+LTP + +V E A G L +R+ + G F + Q+ G+ Y +
Sbjct: 82 NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVL 192
+ HRDL N LL + +KI DFG + L APE L
Sbjct: 141 RFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 193 LRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +D W GVTL+ + G P+
Sbjct: 197 KTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
+RD+G G+FG D T E VAVK + E G ++++EI R+L H
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 80 NIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 136
NIV++K + + ++ME+ G L E + N + + + + Q+ G+ Y
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI-----APE 190
+ Q HRDL N L+ S ++KI DFG +K + + + TV APE
Sbjct: 144 SRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 191 VLLRHEYDGKIADVWSCGVTLY 212
L++ ++ +DVWS GVTL+
Sbjct: 200 CLMQSKFYIA-SDVWSFGVTLH 220
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 27 FVRDIGSGNFGVARL----MRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+RD+G G+FG L + T E+VAVK + + G + ++EI R+L H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+++K L +VMEY G L + + + F QQ+ G++Y HA
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 193
HRDL N LL + +KI DFG +K +V V APE L
Sbjct: 154 HYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 194 RHEYDGKIADVWSCGVTLY 212
+++ +DVWS GVTLY
Sbjct: 211 EYKFYYA-SDVWSFGVTLY 228
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 6e-22
Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 8/208 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G +G K VAVK ++ E +E + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHE 196
HR+L N L+ + +K+ DFG S+ + APE L ++
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ K +DVW+ GV L+ + G P+
Sbjct: 396 FSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-22
Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 38/227 (16%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSL 76
+ + +R +G G FG V + K+ AVK + K + + E I + +
Sbjct: 35 NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 134
+ NIV++ + H+ ++ E G L+E I F ++ + + +++ ++Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 135 CHAMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 171
M + H DLK EN LLD +K+ DFG +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209
Query: 172 VLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
S + + T Y APEV+L +D D+WS G L + G
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-22
Identities = 56/222 (25%), Positives = 82/222 (36%), Gaps = 32/222 (14%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP-- 79
+RY+ V ++G G FG V + K VA+K I K E + EI + ++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 80 ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 133
V + H+ I E G FE + + R QL +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 134 YCHAMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 176
+ H Q+ H DLK EN L S +++ DFG S+ +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194
Query: 177 PKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+T V T Y PEV+L + DVWS G L+ G
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRG 235
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-22
Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERGDKIDENVQREIINH----RSLRH 78
++ +GSG FG + + ++ VA+K + +EI++ S+ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDN 76
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 77 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLR 194
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L
Sbjct: 136 RRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
Y + +DVWS GVT++ +M G P++
Sbjct: 194 RIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-22
Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 10/203 (4%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
+G G +G K VAVK ++ E +E + ++HPN+V+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 87 VILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
V I+ E+ + G L + R CN S + Q+ S + Y HRD
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLRHEYDGKI 201
L N L+ + +K+ DFG S+ + + G P + APE L +++ K
Sbjct: 137 LAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK- 192
Query: 202 ADVWSCGVTLY-VMLVGGYPFED 223
+DVW+ GV L+ + G P+
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPG 215
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-21
Identities = 64/223 (28%), Positives = 90/223 (40%), Gaps = 34/223 (15%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHR-- 74
RY+ V +G G FG V + K VAVK ++ D+ E + EI +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 132
+ V+ E H+ IV E G ++ I G F D R Q+ V
Sbjct: 74 NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 175
++ H+ ++ H DLK EN L S P +K+ DFG S+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 176 QPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+ ST V T Y APEV+L + DVWS G L +G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLG 230
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 7e-21
Identities = 57/271 (21%), Positives = 94/271 (34%), Gaps = 66/271 (24%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLR 77
RY +R +G G+F L D K+ VA+K ++ + E EI + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 78 HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 128
PN +V+ FK + TH+ +V E + + N + QQ+
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155
Query: 129 ISGVSYCHA-MQVCHRDLKLENTLLD---------------------------------- 153
+ G+ Y H ++ H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 154 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
+ ++KI D G + +H + T Y + EVL+ Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
AD+WS + + G Y FE + R
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTR 303
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 8e-21
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 10/208 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHE 196
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ K +DVWS G+ L + G P+
Sbjct: 358 FTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 9e-21
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 10/208 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHE 196
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ K +DVWS G+ L + G P+
Sbjct: 441 FTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-20
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
FV++IGSG FG+ +K VA+K I G +E+ E L HP +V+
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDK---VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V L + +V E+ G L + R G F+ + + G++Y V H
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
RDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV Y
Sbjct: 128 RDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
K +DVWS GV ++ V G P+E+
Sbjct: 185 K-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
+ IGSG+ G RL VA+K ++ G ++ + E HPNI
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+R + V+ IV EY G L F R + G+F+ + + + +G+ Y +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLLRH 195
HRDL N L+D + K+ DFG S+ +T G I APE +
Sbjct: 172 YVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS GV ++ V+ G P+ +
Sbjct: 230 TFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 29 RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNI 81
+++GSGNFG KV K VAVK + + + D ++ E++ + L +P I
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKT-VAVKIL-KNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 81 VRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLLRH 195
HRDL N LL + KI DFG SK L + K+ P + APE + +
Sbjct: 140 HRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFED 223
++ K +DVWS GV ++ G P+
Sbjct: 196 KFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-20
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPN 80
++ +GSG FG + + ++ VA+K + K ++ + E S+ +P+
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ R + LT T + ++ + G L + + + + Q+ G++Y +
Sbjct: 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLRHE 196
+ HRDL N L+ +P +KI DFG +K + G P ++A E +L
Sbjct: 138 LVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
Y + +DVWS GVT++ +M G P++
Sbjct: 196 YTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-20
Identities = 56/204 (27%), Positives = 81/204 (39%), Gaps = 18/204 (8%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
++ IG G FG L + K VAVK I + D + E LRH N+V+
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 87 VILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
VI+ L IV EY + G L + R D F + + Y HR
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGK 200
DL N L+ K+ DFG +K + + + APE L ++ K
Sbjct: 314 DLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTK 366
Query: 201 IADVWSCGVTLY-VMLVGGYPFED 223
+DVWS G+ L+ + G P+
Sbjct: 367 -SDVWSFGILLWEIYSFGRVPYPR 389
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-20
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
++ +GSG FG + + + ++ V +K I + G + + V ++ SL H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
IVR + + L +V +Y G L + + + G + Q+ G+ Y
Sbjct: 77 IVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLR 194
+ HR+L N LL SP+ ++++ DFG + +L K + + A A E +
Sbjct: 136 MVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+Y + +DVWS GVT++ +M G P+
Sbjct: 192 GKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
+ +G+G FG RL + VA+K ++ G +K + E HPNI
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+R + V+ + IV EY G L F R + +F+ + + + SG+ Y M
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLL 193
HRDL N L++ + K+ DFG + VL P +T G I +PE +
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
++ +DVWS G+ L+ VM G P+ +
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-19
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
++++GSG FGV + + + VAVK I+ G ++ +E L HP +V+F
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYD---VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V + IV EY S G L + R + + + G+++ + Q H
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
RDL N L+D +K+ DFG ++ VL Q S+VGT + APEV +Y
Sbjct: 128 RDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
K +DVW+ G+ ++ V +G P++
Sbjct: 185 K-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-19
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
+ +G+G FG + + VAVK ++ G E E ++L+H +V+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 87 VILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
V+ T + I+ E+ + G L F + + + F Q+ G+++ HRD
Sbjct: 251 VV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKI 201
L+ N L+ S KI DFG ++ + ++ + G I APE + + K
Sbjct: 310 LRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK- 365
Query: 202 ADVWSCGVTLY-VMLVGGYPFED 223
+DVWS G+ L ++ G P+
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPG 388
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 31 IGSGNFG-VAR-LMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKE 86
+G GNFG V + + R + + VA+K +++G E + RE L +P IVR
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 87 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V + +VME A GG L + + Q+ G+ Y HRDL
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLLRHEYDG 199
N LL + KI DFG SK L + + P + APE + ++
Sbjct: 137 AARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS GVT++ + G P++
Sbjct: 193 R-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
V +G+G FG VAVK +++G + E + L+H +VR
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V+ T + I+ EY G L F + + + + ++ Q+ G+++ H
Sbjct: 74 YAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
RDL+ N L+ + + KI DFG ++ + ++ + G I APE + +
Sbjct: 133 RDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
K +DVWS G+ L ++ G P+
Sbjct: 190 K-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 57/210 (27%), Positives = 83/210 (39%), Gaps = 18/210 (8%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ ++ IG G FG L + K VAVK I + D + E LRH N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75
Query: 81 IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHA 137
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLR 194
HRDL N L+ S K+ DFG +K + + + APE L
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 188
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
++ K +DVWS G+ L+ + G P+
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 2e-19
Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 20/206 (9%)
Query: 31 IGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
+G GNFG K + VA+K +++G E + RE L +P IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 86 EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
V + +VME A GG L + + Q+ G+ Y HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLRHEYD 198
L N LL + KI DFG SK L + + + APE + ++
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 199 GKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS GVT++ + G P++
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
F++++G+G FGV + R + VA+K I+ G ++ E +L H +V+
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYD---VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V + I+ EY + G L + R RF + + + + Y + Q H
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
RDL N L++ +K+ DFG S+ VL + S+VG+ + PEVL+ ++
Sbjct: 144 RDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
K +D+W+ GV ++ + +G P+E
Sbjct: 201 K-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPN 80
+ IG+G FG L KE+ VA+K ++ G +K + E H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + VI + I+ EY G L F R G FS + + + +G+ Y M
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLLR 194
HRDL N L++ + K+ DFG S+ + +T G I APE +
Sbjct: 167 NYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
++ +DVWS G+ ++ VM G P+ +
Sbjct: 225 RKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 15/207 (7%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
R +G G FG K K VAVK ++ E E + ++L HP+I
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V+ +I I+ME GEL + N + Q+ ++Y ++
Sbjct: 76 VKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEY 197
HRD+ + N L+ +K+ DFG S+ + T I +PE + +
Sbjct: 135 VHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFED 223
+DVW V ++ ++ G PF
Sbjct: 192 TTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-18
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
R IG G FG M + VA+K + D + E +E + R HP+I
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
V+ VI I+ME + GEL F + + QL + ++Y + +
Sbjct: 79 VKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLRHE 196
HRD+ N L+ + +K+ DFG S+ + S P ++APE +
Sbjct: 137 FVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVW GV ++ +++ G PF+
Sbjct: 194 FTSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 52/216 (24%), Positives = 79/216 (36%), Gaps = 24/216 (11%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
+R +G G FG M + + VAVK + + + E + H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
NIVR V L I+ME +GG+L + + L+ G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI---- 187
Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 211
Query: 188 -APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
PE + + K D WS GV L+ + +G P+
Sbjct: 212 MPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 6e-18
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
R IG G FG M + VA+K + D + E +E + R HP+I
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V+ VI I+ME + GEL + + QL + ++Y + +
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLLRHE 196
HRD+ N L+ + +K+ DFG S+ + K++ G P ++APE +
Sbjct: 513 VHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVW GV ++ +++ G PF+
Sbjct: 569 FTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-18
Identities = 50/228 (21%), Positives = 90/228 (39%), Gaps = 35/228 (15%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHR 74
++ R +G G FG A+L ++ + VAVK ++ +++ RE +
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 75 SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
HP++ + +++ + G+L F A R E+ Q
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137
Query: 127 QLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
L+ G+ Y + HRDL N +L + + DFG S+ ++S
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYY 193
Query: 180 TVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
G + + A E L + Y +DVW+ GVT++ +M G P+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 51/216 (23%), Positives = 79/216 (36%), Gaps = 24/216 (11%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
+R +G G FG M + + VAVK + + + E + H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
NIVR V L I++E +GG+L + + L+ G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI---- 187
Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKW 252
Query: 188 -APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
PE + + K D WS GV L+ + +G P+
Sbjct: 253 MPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 50/227 (22%), Positives = 84/227 (37%), Gaps = 34/227 (14%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHR 74
D + + +G G FG L ++ T VAVK ++ + ++ E +
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 75 SLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQ 127
HPN++R + +++ + G+L + R Q
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQT 148
Query: 128 LI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180
L+ G+ Y HRDL N +L + + DFG SK ++S
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYR 204
Query: 181 VGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
G A + A E L Y K +DVW+ GVT++ + G P+
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 33/223 (14%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLRHPN 80
R++G G FG + K LVAVK ++ QRE +L+H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQLI-- 129
IV+F V L +V EY G+L + I G+ + + Q++
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 130 -----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
SG+ Y + HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYRVGGH 194
Query: 185 AYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ PE ++ ++ + +DVWS GV L+ + G P+
Sbjct: 195 TMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 236
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-17
Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 20/222 (9%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
+ I S F IG G+FG L+ + K AVK + R I E Q E
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 70 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 185
Q+ G+ Y + + HRDL N +LD +K+ DFG ++ + + S
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR-DMYDKEYYSVHNKTGA 192
Query: 186 -----YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++A E L ++ K +DVWS GV L+ +M G P+
Sbjct: 193 KLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-17
Identities = 37/218 (16%), Positives = 74/218 (33%), Gaps = 29/218 (13%)
Query: 27 FVRDIGSGNFGV-------ARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRH 78
F +G G F ++ + V +K +++ E+ L H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 136
++V V + +V E+ G L + + N + +QL + + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 137 AMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
+ H ++ +N LL + K+ D G S + + + + ++ PE
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPPE 187
Query: 191 VLLRHEYDGKI----ADVWSCGVTLY-VMLVGGYPFED 223
+ + K D WS G TL+ + G P
Sbjct: 188 CIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 59/222 (26%), Positives = 88/222 (39%), Gaps = 32/222 (14%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLRHPN 80
++G G FG + + K LVAVK ++ + QRE L+H +
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQLI--- 129
IVRF V L +V EY G+L AG QL+
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 130 ----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
+G+ Y + HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRVGGRT 220
Query: 186 YI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ PE +L ++ + +DVWS GV L+ + G P+
Sbjct: 221 MLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
+ I S F IG G+FG L+ + K AVK + R I E Q E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 70 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
Q+ G+ + + + HRDL N +LD +K+ DFG ++ T A
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 187 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ A E L ++ K +DVWS GV L+ +M G P+
Sbjct: 258 LPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 45/218 (20%), Positives = 87/218 (39%), Gaps = 28/218 (12%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
R++G G+FG VA+ + + VA+K + + E + E +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFFQQLI 129
++VR V+ ++ME + G+L + R + ++
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-- 187
G++Y +A + HRDL N ++ + +KI DFG ++ ++ G +
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 204
Query: 188 ---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+PE L + +DVWS GV L+ + + P+
Sbjct: 205 RWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-16
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 20/222 (9%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
D+ I H+ R IG G+FGV + + A+K + R ++ + RE
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 70 IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 125
+ R L HPN++ ++L +++ Y G+L F R + + F
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 182
Q+ G+ Y + HRDL N +LD S +K+ DFG ++ +S +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHA 188
Query: 183 T-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
P + A E L + + K +DVWS GV L+ ++ G P+
Sbjct: 189 RLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPY 229
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-15
Identities = 44/224 (19%), Positives = 87/224 (38%), Gaps = 34/224 (15%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
F+ ++G FG + VA+K ++ + E + E + L+HP
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQLI- 129
N+V V+ L+++ Y S G+L + + ++ +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 130 ------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
+G+ Y + V H+DL N L+ +KI D G + +++ +
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAADYYKLLG 188
Query: 184 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ + APE ++ ++ +D+WS GV L+ V G P+
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 54/231 (23%), Positives = 84/231 (36%), Gaps = 47/231 (20%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQREIINH 73
F + +G+G FG A + VAVK + ER + E V +
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL--- 83
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSEDEAR 122
H NIV ++ EY G+L + +DE
Sbjct: 84 --GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
+ L+S G+++ + HRDL N LL KICDFG ++ + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKN 197
Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
V A + APE + Y + +DVWS G+ L+ + +G P
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 60/233 (25%), Positives = 89/233 (38%), Gaps = 47/233 (20%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQRE 69
D + F IG GNFG AR+ +D + + A+K + + D E V +
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 120
+ HPNI+ +L + +EYA G L E +
Sbjct: 82 L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 121 ARFFFQQLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
+ QQL+ G+ Y Q HRDL N L+ + KI DFG S+ +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEV 194
Query: 174 HSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
+ T + A E L Y +DVWS GV L+ ++ +GG P
Sbjct: 195 Y-----VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 22/213 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 81
+++ R IGSG+FG L + T E VA+K E + E +R L+ I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 82 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + + +VM+ S +LF C+ + S Q+I+ V + H+
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 140 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 190
HRD+K +N L+ G A ++ I DFG +K S+ H + K+ GT Y +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 191 VLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
L E D D+ S G L L G P
Sbjct: 184 THLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 42/232 (18%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+VRDIG G FG A + +VAVK ++ + + QRE +P
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSEDEAR 122
NIV+ V + ++ EY + G+L + A S
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 123 FFFQQLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
+ + +G++Y + HRDL N L+ +KI DFG S++ ++S
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN--IYS 226
Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
I PE + + Y + +DVW+ GV L+ + G P+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-14
Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 24/215 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
Y R IG G+FGV + + + VA+K+ E ++ E ++ L I
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 82 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
H +V++ S +L +C +FS +Q+++ V H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 140 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIA 188
+ +RD+K +N L+ + A + + DFG K + H + K+ GT Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 189 PEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
L E D D+ + G L G P
Sbjct: 187 INTHLGREQSRRD----DLEALGHVFMYFLRGSLP 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 48/231 (20%), Positives = 86/231 (37%), Gaps = 43/231 (18%)
Query: 23 DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVK-------YIERGDKIDE-NVQRE 69
+ F + +G+G FG A + + VAVK E+ + E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 122
+ +H NIV + ++ EY G+L + F+ +
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
+ L+ G+++ + HRD+ N LL + KI DFG ++ + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMN 216
Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
V A + APE + Y + +DVWS G+ L+ + +G P
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNP 266
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 82
+ + IG GNFG RL ++ T E VA+K +E + E ++ L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 83 RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+ + A+V+E S +LF +C+ FS QLIS + Y H+ +
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 141 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAYIAP 189
+RD+K EN L+ ++ DF +K + H + KS GT Y++
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 190 EVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
L E D D+ + G L G P
Sbjct: 187 NTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 54/232 (23%), Positives = 91/232 (39%), Gaps = 42/232 (18%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+ +G G FG A ++ + VAVK ++ ++ E + + HP
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSEDEAR 122
++++ L +++EYA G L ++ DE
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
LIS G+ Y M++ HRDL N L+ +KI DFG S+ ++
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD--VYE 202
Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ + I A E L H Y + +DVWS GV L+ ++ +GG P+
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-14
Identities = 58/213 (27%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
+RY R IGSG+FG L D E VA+K E + E ++ ++ I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 82 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + +VME S +LF C+ +FS Q+IS + Y H+
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 140 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 190
HRD+K +N L+ G + I DFG +K + H + K+ GT Y +
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 191 VLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
L E D D+ S G L +G P
Sbjct: 186 THLGIEQSRRD----DLESLGYVLMYFNLGSLP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 37/226 (16%)
Query: 27 FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYIERGDKIDENV--QREIINHRSL- 76
+ +G G FG + +DK + + VAVK ++ + E+ + +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 127
+H NI+ L +++EYAS G L + E + F+
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 128 LIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180
L+S G+ Y + + HRDL N L+ + +KI DFG ++ +++
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNIDYYK 214
Query: 181 VGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
T + APE L Y + +DVWS GV ++ + +GG P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 54/235 (22%), Positives = 84/235 (35%), Gaps = 46/235 (19%)
Query: 23 DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQRE 69
DR + +G G FG A + T VAVK + E + E +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 70 IINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL---------FERICNAGRFSED 119
I H N+V P L +++E+ G L
Sbjct: 87 I-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 120 EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172
+ + LI G+ + + + HRDL N LL +KICDFG ++
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLAR--D 197
Query: 173 LHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++ P A + APE + Y + +DVWS GV L+ + +G P+
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 37/227 (16%)
Query: 27 FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYIERGDKIDENV--QREIINHRSL- 76
+ +G G FG + +DK + + VAVK ++ + E+ + +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 127
+H NI+ L +++EYAS G L + E + F+
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 128 LIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180
L+S G+ Y + + HRDL N L+ + +KI DFG ++ +++
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYK 260
Query: 181 VGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
T + APE L Y + +DVWS GV ++ + +GG P+
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 47/231 (20%)
Query: 27 FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYI-------ERGDKIDE-NVQREII 71
+ +G G FG L +DK + VAVK + + D I E + + I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEAR 122
+H NI+ L +++EYAS G L + E +
Sbjct: 133 -----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
+ L+S G+ Y + + HRDL N L+ + +KI DFG ++ +H
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DIHH 243
Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
T + APE L Y + +DVWS GV L+ + +GG P
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSP 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-13
Identities = 56/236 (23%), Positives = 83/236 (35%), Gaps = 52/236 (22%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQREIINH 73
F + +GSG FG A + VAVK + ER + E + ++
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL--- 105
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNAGRFS 117
H NIV + ++ EY G+L
Sbjct: 106 --GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 118 EDEARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
ED F+ L+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARD 221
Query: 171 SVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
+ S V A + APE L Y K +DVWS G+ L+ + +G P
Sbjct: 222 --IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 3e-11
Identities = 37/196 (18%), Positives = 57/196 (29%), Gaps = 52/196 (26%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---------VQREIIN 72
+++ IG G FG VA+K I N + EII
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 73 HRSL---------RHPNIVRFKEVIL------------------------------TPTH 93
+ L R + V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLL 152
L IV+E+ GG E++ S A+ QL + ++ +++ HRDL N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 153 DGSPAPRLKICDFGYS 168
+ +L G S
Sbjct: 196 KKTSLKKLHYTLNGKS 211
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-10
Identities = 62/214 (28%), Positives = 84/214 (39%), Gaps = 50/214 (23%)
Query: 31 IGSGNFGVARLMRDKVTK------ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIV 82
IG G FG KV K VA+K I+E + EI RHP++V
Sbjct: 47 IGHGVFG-------KVYKGVLRDGAKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLV 98
Query: 83 RF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQ 126
E + ++ +Y G L + + + AR
Sbjct: 99 SLIGFCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR---- 150
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GT 183
G+ Y H + HRD+K N LLD + P KI DFG SK Q STV GT
Sbjct: 151 ----GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGT 204
Query: 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
YI PE ++ K +DV+S GV L+ +L
Sbjct: 205 LGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCA 237
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 9e-09
Identities = 55/217 (25%), Positives = 78/217 (35%), Gaps = 55/217 (25%)
Query: 31 IGSGNFGVARLMRDKVTK-----ELVAVKYIERGDKI-----DENVQREIINHRSLRHPN 80
+G G FG V K VAVK + I + +EI +H N
Sbjct: 39 MGEGGFG-------VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91
Query: 81 IVRFKEVILTPTHLAIVMEYASGG----ELFER-------------ICNAGRFSEDEARF 123
+V L +V Y G L I + A
Sbjct: 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA------QGAAN- 144
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST-- 180
G+++ H HRD+K N LLD + KI DFG ++ S ++
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRI 195
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
VGT AY+APE L K +D++S GV L ++ G
Sbjct: 196 VGTTAYMAPEALRGEITP-K-SDIYSFGVVLLEIITG 230
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 58/216 (26%), Positives = 83/216 (38%), Gaps = 63/216 (29%)
Query: 31 IGSGNFGVARLMRDKVTK------ELVAVKYIERGDKIDENVQRE------IINHRSLRH 78
+G G FG KV K LVAVK ++ + + + +I+ H
Sbjct: 38 LGRGGFG-------KVYKGRLADGTLVAVKRLKEERT--QGGELQFQTEVEMISM--AVH 86
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQ 126
N++R + +TPT +V Y + G L ER + AR
Sbjct: 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR---- 142
Query: 127 QLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-- 181
G++Y H ++ HRD+K N LLD + DFG +K L + V
Sbjct: 143 ----GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTT 193
Query: 182 ---GTPAYIAPEVLLRHEYDGKI---ADVWSCGVTL 211
GT +IAPE L GK DV+ GV L
Sbjct: 194 AVRGTIGHIAPEYLST----GKSSEKTDVFGYGVML 225
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 29/167 (17%), Positives = 59/167 (35%), Gaps = 24/167 (14%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 83
++ + IGSG FG+ L E A ++ + + + E+ ++ + + ++
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 84 FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 122
+L I VME ++ N G F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 8e-08
Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 11/119 (9%)
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
+ Q+ G+ + + + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 184 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQR 236
A + APE + Y + +DVWS GV L+ + +G P+ ++F + ++
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 26/197 (13%), Positives = 60/197 (30%), Gaps = 37/197 (18%)
Query: 24 RYDFVRDIGSGNFGV--------ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS 75
++ N G+ K+ ++K ++ D N Q R+
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99
Query: 76 LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 118
+ + ++K++ TP + +V+ S + SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158
Query: 119 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH- 174
+L+ + + H + H ++ EN +D ++ + +G++ S H
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
Query: 175 ----SQPKSTVGTPAYI 187
G +I
Sbjct: 219 AYVEGSRSPHEGDLEFI 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 2e-07
Identities = 45/284 (15%), Positives = 100/284 (35%), Gaps = 66/284 (23%)
Query: 25 YDFVRDIGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
FV ++ N+ ++ + ++ ++ YIE+ D++ + Q + S R +
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138
Query: 83 RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 133
+ ++ + L P ++ + G + +C + + + + F+ ++ +
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190
Query: 134 YCH-------AMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
C+ +Q + ++ + D S +L+I +L S+P
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242
Query: 186 YIAPEVL--LRHEYDGKIADVW--SC---------GVTLYVMLVGGYPFE--------DP 224
Y L L + + K + + SC VT ++ P
Sbjct: 243 Y--ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 225 DEPKD-FRKTI-QRILSVQYSVPDTNP-----ISQECRDLISRI 261
DE K K + R + V TNP I++ RD ++
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 26/169 (15%), Positives = 50/169 (29%), Gaps = 25/169 (14%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKV-----TKELVAVK---------------YIERGDKID 63
+ IG G FG L + VK Y
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 64 ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 120
+ L P ++ ++M+ + +++E RFS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153
Query: 121 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 298 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.57 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.32 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.56 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.19 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.12 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.96 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.64 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.6 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.85 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.98 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.89 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.23 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-62 Score=414.91 Aligned_cols=262 Identities=27% Similarity=0.446 Sum_probs=231.2
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++++.||+|+||.||+|+++.+++.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3456899999999999999999999999999999999753 334567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+||||++||+|.+++.+.+.+++.++..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|.......
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPES 186 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCC
Confidence 99999999999999999899999999999999999999999999999999999999998887 9999999997543322
Q ss_pred ---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 176 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 176 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
......||+.|+|||++.+..++.+ +||||+||++|+|++|..||...+. .+...++....+.++. .+++
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~ 259 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNE----GLIFAKIIKLEYDFPE--KFFP 259 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT--TCCH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCc--ccCH
Confidence 2345579999999999988888665 9999999999999999999987554 4556666677666554 4899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++.+||.+||+.||.+|||+.|++++. .+++|||+.+.
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~--~i~~Hp~F~~i 297 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYG--PLKAHPFFESV 297 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHH--HHHTSGGGTTC
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCH--HHHCCCCcCCC
Confidence 999999999999999999999998654 46899999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=406.54 Aligned_cols=263 Identities=37% Similarity=0.624 Sum_probs=208.7
Q ss_pred CCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEE
Q 022401 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEV 87 (298)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~ 87 (298)
|+..++.....++|++++.||+|+||.||+|+++.+|+.||+|++.+.. .....+.+|+.++++++||||++++++
T Consensus 2 P~~~l~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~ 81 (275)
T 3hyh_A 2 PKSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 81 (275)
T ss_dssp ------------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 3444444455689999999999999999999999999999999987542 334568899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 88 ~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
+.+++.+|+||||+ +++|.+.+.+.+++++.++..++.||+.||+|||++||+||||||+||+++.++. +||+|||+
T Consensus 82 ~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGl 158 (275)
T 3hyh_A 82 IKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGL 158 (275)
T ss_dssp EECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSC
T ss_pred EEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCC
Confidence 99999999999999 5699999999999999999999999999999999999999999999999998887 99999999
Q ss_pred cccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCC
Q 022401 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247 (298)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
|.............||+.|+|||++.+..++..++||||+||++|+|++|..||...+. ....+.+.......+
T Consensus 159 a~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----~~~~~~i~~~~~~~p-- 232 (275)
T 3hyh_A 159 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----PVLFKNISNGVYTLP-- 232 (275)
T ss_dssp C---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCC--
T ss_pred CeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCCCC--
Confidence 97655555556678999999999999888876669999999999999999999987543 445556666665544
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..+|+++.+||.+||+.||.+|||+ .++++|||++.
T Consensus 233 ~~~s~~~~~li~~~L~~dP~~R~s~--------~eil~hpw~k~ 268 (275)
T 3hyh_A 233 KFLSPGAAGLIKRMLIVNPLNRISI--------HEIMQDDWFKV 268 (275)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCH--------HHHHHCHHHHT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCH--------HHHHcCccccc
Confidence 4489999999999999999999987 56668999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-60 Score=407.92 Aligned_cols=258 Identities=27% Similarity=0.480 Sum_probs=213.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
...++|++++.||+|+||.||+|+++.+|+.||||++.+.. ...+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999997653 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
||||++|++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNST 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCC
Confidence 99999999999999654 35799999999999999999999999999999999999998887 999999999754322
Q ss_pred C-CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 175 S-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 175 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
. ......|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+. .+...++....+. +.+..+|++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~-~~~~~~s~~ 252 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSM----KNLVLKIISGSFP-PVSLHYSYD 252 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHTCCC-CCCTTSCHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHcCCCC-CCCccCCHH
Confidence 1 1123469999999999988888665 9999999999999999999987654 3445555555543 334558999
Q ss_pred HHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+.+||.+||+.||.+|||+ .++++|||++...
T Consensus 253 ~~~li~~~L~~dP~~R~s~--------~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSV--------NSILEKGFIAKRI 284 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCH--------HHHHTSHHHHTTG
T ss_pred HHHHHHHHccCChhHCcCH--------HHHhcCHHhhcCC
Confidence 9999999999999999987 4556788887543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-60 Score=401.46 Aligned_cols=259 Identities=28% Similarity=0.476 Sum_probs=217.5
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEc---cCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
.++|++++.||+|+||.||+|++. .+++.||+|++.+.. .....+.+|+.++++++||||+++++++.+++.+|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 367999999999999999999974 467899999986532 23346788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-C
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~ 174 (298)
+||||++|++|.+++.+.+.+++.++..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+.... .
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999887 99999999975433 2
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
.......||+.|+|||++.+..++.+ +||||+||++|+|++|..||.+.+. .+....+.......+ ..+|+++
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~~p--~~~s~~~ 253 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDR----KETMTMILKAKLGMP--QFLSPEA 253 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCC--TTSCHHH
T ss_pred ccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCH----HHHHHHHHcCCCCCC--CcCCHHH
Confidence 33455679999999999988888765 9999999999999999999987554 445555666665544 4589999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+||.+||+.||.+|||+... ...++++|||+++.
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~---~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPD---GVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTT---THHHHHTSGGGTTC
T ss_pred HHHHHHHcccCHHHCCCCCcC---CHHHHHcCccccCC
Confidence 999999999999999997432 24688999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-59 Score=402.32 Aligned_cols=253 Identities=26% Similarity=0.437 Sum_probs=218.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
++|++++.||+|+||.||+|+++.+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+++.+|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999997543 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCCC
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~~ 180 (298)
+|++|.+++.+ ..+++.++..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|...... ......
T Consensus 154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence 99999998865 56999999999999999999999999999999999999998887 999999999755433 233456
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-CCCCCCCCCCCHHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 259 (298)
.|++.|+|||++.+..++.+ +|||||||++|||++|..||...+.. +....+... ....+....+++++.+||.
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 79999999999988888665 99999999999999999999876543 333333332 2334444568999999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+||+.||.+|||+ .++++|||++.
T Consensus 306 ~~L~~dP~~R~ta--------~e~l~Hp~~~~ 329 (346)
T 4fih_A 306 RLLVRDPAQRATA--------AELLKHPFLAK 329 (346)
T ss_dssp HHSCSSTTTSCCH--------HHHTTCGGGGG
T ss_pred HHcCCChhHCcCH--------HHHhcCHhhcC
Confidence 9999999999987 55668999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-58 Score=389.20 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=211.8
Q ss_pred CCCe-eEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCe
Q 022401 22 SDRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTH 93 (298)
Q Consensus 22 ~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 93 (298)
.++| ++.+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ +..
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 4566 78889999999999999999999999999987543 234568899999999999999999999875 356
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEeeC-CCCCCEEEeecCcccc
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKS 170 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~~ 170 (298)
+|+||||+++++|.+++.....+++..+..++.||+.||+|||++| |+||||||+|||++. ++. +||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEe
Confidence 8999999999999999999899999999999999999999999998 999999999999974 566 99999999964
Q ss_pred ccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
.. ........||+.|+|||++.+ .++.+ +|||||||++|+|+||..||....... .....+.........+...
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~~~---~~~~~i~~~~~~~~~~~~~ 255 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAA---QIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHHHTTTCCCGGGGGCC
T ss_pred CC-CCccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcHH---HHHHHHHcCCCCCCCCccC
Confidence 32 223345579999999998864 56554 999999999999999999998755433 3344444443333334457
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++++.+||.+||+.||.+|||+ .++++|||+++.
T Consensus 256 ~~~~~~li~~~L~~dP~~R~s~--------~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 256 IPEVKEIIEGCIRQNKDERYSI--------KDLLNHAFFQEE 289 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGC--
T ss_pred CHHHHHHHHHHccCChhHCcCH--------HHHhcCccccCC
Confidence 8999999999999999999987 566789999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-59 Score=399.45 Aligned_cols=263 Identities=24% Similarity=0.303 Sum_probs=222.3
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
...+.|++.++||+|+||.||+|+++.+|+.||||++...... .+|+.++++++||||+++++++.++..+|+|||
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3457899999999999999999999999999999999865432 469999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC---
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 176 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~--- 176 (298)
|++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++. ++||+|||+|........
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC--------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccc
Confidence 9999999999998889999999999999999999999999999999999999998763 399999999975433221
Q ss_pred ---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCC-CCCCCCCH
Q 022401 177 ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV-PDTNPISQ 252 (298)
Q Consensus 177 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 252 (298)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+.. +....... ..+..+++
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~s~ 284 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK----IASEPPPIREIPPSCAP 284 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH----HHHSCCGGGGSCTTSCH
T ss_pred eecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HHcCCCCchhcCccCCH
Confidence 123469999999999988888766 9999999999999999999988765444333 33333322 23456899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHH-----Hhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLL-----LFSFVWMFDA 292 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~-----~~~hp~~~~~ 292 (298)
++.+||.+||+.||.+|||+.|++++.... .+.|||+.+.
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 999999999999999999999998875433 3789998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-58 Score=403.78 Aligned_cols=253 Identities=26% Similarity=0.437 Sum_probs=218.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
++|++++.||+|+||.||+|+++.+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+++.+|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999999999999999997643 33466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCCC
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~~ 180 (298)
+||+|.+++.. ..+++.++..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|...... ......
T Consensus 231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence 99999998865 46999999999999999999999999999999999999999887 999999998755433 233456
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-CCCCCCCCCCCHHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 259 (298)
.|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+.. +....+... .........+++++.+||.
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 79999999999988888665 99999999999999999999876543 333333333 2344455568999999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+||+.||.+|||+ .++++|||++.
T Consensus 383 ~~L~~dP~~R~ta--------~ell~Hp~~~~ 406 (423)
T 4fie_A 383 RLLVRDPAQRATA--------AELLKHPFLAK 406 (423)
T ss_dssp HHSCSSTTTSCCH--------HHHTTCGGGGG
T ss_pred HHcCCChhHCcCH--------HHHhcCHHhcC
Confidence 9999999999987 55668999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=378.69 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=210.2
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
+.++.+++++.+.||+|+||.||+|+.+. .+|||++.... ...+.+.+|+.++++++||||+++++++.+ +.+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 34567899999999999999999998753 48999886433 334668899999999999999999998854 568
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++||||+++|+|.+++... .++++.++..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceeccc
Confidence 9999999999999999654 57999999999999999999999999999999999999998887 99999999974432
Q ss_pred C---CCCCCCCCCCcccCccccccc---cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCC
Q 022401 174 H---SQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247 (298)
Q Consensus 174 ~---~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
. .......|++.|+|||++.+. .++. ++|||||||++|||+||..||...+....+...+.+....+......
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~-ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF-QSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCH-HHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCc-HHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence 2 223445799999999998643 3444 49999999999999999999987665443333332211111111234
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.++|+++.+|+.+||+.||++|||+.+++. .++.++||+-
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~--~Le~l~~~lp 303 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILS--SIELLQHSLP 303 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHH--HHHHHHTTCC
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHHhccCC
Confidence 568999999999999999999999999995 4577889873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-55 Score=385.03 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=213.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEe------CC
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT------PT 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 92 (298)
.++|++++.||+|+||.||+|+++.+|+.||||++...... ...+.+|+.+++.++||||+++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36899999999999999999999999999999999764332 3457789999999999999999999764 36
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+|+||||++ ++|.+++...+++++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecc
Confidence 7899999996 579999988889999999999999999999999999999999999999998887 9999999997443
Q ss_pred CC-----CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC----
Q 022401 173 LH-----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS---- 243 (298)
Q Consensus 173 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 243 (298)
.. .......||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+..+.+.............
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 223456799999999998887776666999999999999999999999877655554444332221110
Q ss_pred ------------CCC---------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 244 ------------VPD---------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 244 ------------~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+. ...+++++.+||.+||+.||.+|||+ .++++|||++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta--------~e~L~Hp~f~~ 350 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA--------AAALRHPFLAK 350 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH--------HHHTTSGGGTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH--------HHHhcCHhhCc
Confidence 000 12468999999999999999999988 55567888874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-56 Score=376.37 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=208.4
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
+..++|.+.+.||+|+||.||+|++. .++..||||++.... ...+.+.+|+.++++++||||+++++++.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 44578999999999999999999864 357889999987643 334678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCE
Q 022401 94 LAIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~-------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~ 160 (298)
+++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++++||||||+|||++.++. +
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--E
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--E
Confidence 99999999999999999653 35899999999999999999999999999999999999998887 9
Q ss_pred EEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 022401 161 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR 236 (298)
Q Consensus 161 ~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~ 236 (298)
||+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|||+| |..||...+.. +....
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~ 242 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIEC 242 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH
Confidence 999999996433222 2233457899999999988888766 999999999999998 89999886542 33444
Q ss_pred HhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 237 ILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+..+. ..+.+..+|+++.+|+.+||+.||++|||+.++..
T Consensus 243 i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 243 ITQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp HHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 44433 23445568999999999999999999999988753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-55 Score=373.52 Aligned_cols=252 Identities=20% Similarity=0.320 Sum_probs=212.0
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
.+..+++++.+.||+|+||.||+|+.. .+++.||||++... ....+.|.+|+.++++++||||++++|++.++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 456678999999999999999999863 35788999998653 23457799999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC
Q 022401 92 THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~ 155 (298)
..+++|+||+++|+|.+++... ..+++.++..++.|++.||+|||+++++||||||+|||++.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 9999999999999999999643 358999999999999999999999999999999999999988
Q ss_pred CCCCEEEeecCccccccCC---CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHH
Q 022401 156 PAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 231 (298)
Q Consensus 156 ~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~ 231 (298)
+. +||+|||+++..... .......+++.|+|||++.+..++.+ +|||||||++|||+| |..||.+.+. .
T Consensus 182 ~~--~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~----~ 254 (308)
T 4gt4_A 182 LN--VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSN----Q 254 (308)
T ss_dssp GC--EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCH----H
T ss_pred CC--EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCH----H
Confidence 87 999999998744322 22344568899999999988888766 999999999999998 8999987654 2
Q ss_pred HHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 232 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
+....+..+. ..+.+..+|+++.+++.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 255 DVVEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3334444333 345566789999999999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=374.20 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=206.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
+..++|.+.+.||+|+||.||+|+.+ .+++.||||++..... ..+.|.+|+.++++++||||+++++++.+++.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 44578999999999999999999864 3688999999875433 34678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC
Q 022401 94 LAIVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~ 158 (298)
+++||||+++|+|.+++... .++++.++..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~- 196 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV- 196 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE-
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc-
Confidence 99999999999999998653 35899999999999999999999999999999999999998887
Q ss_pred CEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 022401 159 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTI 234 (298)
Q Consensus 159 ~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~ 234 (298)
+||+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|||+| |..||...+.. +..
T Consensus 197 -~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~ 270 (329)
T 4aoj_A 197 -VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNT----EAI 270 (329)
T ss_dssp -EEECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHH----HHH
T ss_pred -EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHH----HHH
Confidence 9999999987443222 2234568999999999988888666 999999999999999 89999876543 333
Q ss_pred HHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
..+..+ .+.+.+..+|+++.+|+.+||+.||++|||+.+++.+.
T Consensus 271 ~~i~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 314 (329)
T 4aoj_A 271 DCITQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314 (329)
T ss_dssp HHHHHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred HHHHcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 334333 23445566899999999999999999999999998654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-54 Score=375.70 Aligned_cols=279 Identities=86% Similarity=1.371 Sum_probs=231.8
Q ss_pred cCCCCCccCCCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCee
Q 022401 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82 (298)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 82 (298)
|++++...+| ...|.....++|++++.||+|+||.||++++..+++.||+|++.......+.+.+|+.++++++||||+
T Consensus 1 m~~~~~~~~p-~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCCC-CCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence 4455555554 567888999999999999999999999999999999999999988777778899999999999999999
Q ss_pred eeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEE
Q 022401 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (298)
Q Consensus 83 ~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l 162 (298)
++++++.....+++|+||+.+++|.+.+...+.+++..++.++.|++.||.|||++|++||||||+||+++.++..++||
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999999999999999998888899999999999999999999999999999999999998877767999
Q ss_pred eecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 163 ~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
+|||++.............+++.|+|||.+.+..++.+++||||||+++|+|++|..||...............+.....
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239 (361)
T ss_dssp CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence 99999875555555556678999999999988888777689999999999999999999988877778888888888888
Q ss_pred CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 243 SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 243 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
..+....+++++.+||.+||+.||.+|||+ .++++|||+.
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--------~ell~hp~f~ 279 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISI--------PEIKTHSWFL 279 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCH--------HHHHTSHHHH
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCH--------HHHHhCcchh
Confidence 777777789999999999999999999987 5566788874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=369.34 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=196.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--------
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 92 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 92 (298)
++|++++.||+|+||.||+|+++.+|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999999999999999999876543 2356889999999999999999999987543
Q ss_pred ----eEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 93 ----HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 93 ----~~~lv~~~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
.+|+||||+++++|.+++..... .+...++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence 47999999999999999987654 345668899999999999999999999999999999998887 999999
Q ss_pred CccccccCCCCC-------------CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 022401 166 GYSKSSVLHSQP-------------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (298)
Q Consensus 166 ~~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 232 (298)
|+|+........ ....||+.|+|||++.+..++.+ +|||||||++|||++ ||... .....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~---~~~~~ 235 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQ---MERVR 235 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSH---HHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCc---cHHHH
Confidence 998754332211 22358999999999988888665 999999999999995 77542 12223
Q ss_pred HHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
....+....+. +.....++++.+||.+||+.||.+|||+ .++++|||+.+.
T Consensus 236 ~~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~--------~eil~h~~~~~~ 286 (299)
T 4g31_A 236 TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEA--------INIIENAVFEDL 286 (299)
T ss_dssp HHHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCH--------HHHHTSGGGCCC
T ss_pred HHHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCH--------HHHhcCHhhCCC
Confidence 33333333321 1112245678899999999999999987 555678888754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=371.93 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=205.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEc---cCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 97 (298)
.++|++.+.||+|+||.||+|+++ .+++.||+|.+.... ...++.+|+++++.+ +||||+++++++.+++.+|+|
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 468999999999999999999875 457889999887654 345678899999988 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC-CCCCEEEeecCccccccCCC-
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS- 175 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~-~~~~~~l~d~~~~~~~~~~~- 175 (298)
|||+++++|.+.+. .+++.+++.++.|++.||+|||++||+||||||+|||++.+ +. +||+|||+|+......
T Consensus 99 mE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~--~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 99 MPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKK--YALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEECTTCSC
T ss_pred EeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCe--EEECcCCCCcccCCccc
Confidence 99999999999883 48999999999999999999999999999999999999876 44 9999999986332211
Q ss_pred ----------------------------CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc
Q 022401 176 ----------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227 (298)
Q Consensus 176 ----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 227 (298)
......||+.|+|||++.+....+.++||||+||++|+|++|..||....+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 1123458999999999988765566699999999999999999999766543
Q ss_pred hhHHHHHHHHhh-----------------------------------cC--------------CCCCCCCCCCHHHHHHH
Q 022401 228 KDFRKTIQRILS-----------------------------------VQ--------------YSVPDTNPISQECRDLI 258 (298)
Q Consensus 228 ~~~~~~~~~~~~-----------------------------------~~--------------~~~~~~~~~~~~l~~li 258 (298)
......+..+.+ .. ........+++++.+||
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 322222211110 00 01112235789999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++||+.||.+|||+ .++++|||+++.
T Consensus 334 ~~lL~~dP~~R~ta--------~eaL~Hp~f~~i 359 (361)
T 4f9c_A 334 DKLLDLNPASRITA--------EEALLHPFFKDM 359 (361)
T ss_dssp HHHTCSCTTTSCCH--------HHHHTSGGGTTC
T ss_pred HHHCcCChhHCcCH--------HHHhcCcccCCC
Confidence 99999999999988 566699999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=392.86 Aligned_cols=265 Identities=25% Similarity=0.347 Sum_probs=222.3
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHH---HHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENV---QREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
....++|+++++||+|+||.||+|+++.+|+.||+|++.+.. ...... +.++.+++.++||||+++++++.++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 345689999999999999999999999999999999987531 222223 3446777888999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|+ +||+|||+|...
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~ 342 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDF 342 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeec
Confidence 999999999999999999999999999999999999999999999999999999999999999998 999999999754
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
... ......|++.|+|||++..+..+..++|+|||||++|+|++|..||...+..+ .......+.......+ ..++
T Consensus 343 ~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p--~~~S 418 (689)
T 3v5w_A 343 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELP--DSFS 418 (689)
T ss_dssp SSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCC--TTSC
T ss_pred CCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCC--ccCC
Confidence 332 33456799999999999755433445999999999999999999998754432 3445566666665554 4489
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+++.+||.+||+.||.+|++... ....++++|||+.+.
T Consensus 419 ~~a~dLI~~lL~~dP~~Rl~~~~---~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 419 PELRSLLEGLLQRDVNRRLGCLG---RGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHHHHTCSCGGGCTTCSS---STHHHHTTSGGGTTC
T ss_pred HHHHHHHHHHccCCHhHCCCCCC---CCHHHHhcCccccCC
Confidence 99999999999999999998521 235788899999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=390.72 Aligned_cols=258 Identities=29% Similarity=0.525 Sum_probs=222.2
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
..++|++++.||+|+||.||+|+++.+|+.||+|++...... .+.+.+|+.+|+.++||||+++++++.++..+|+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 347899999999999999999999999999999998765433 4567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
|++|++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+||+++.+....+||+|||++..........
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 9999999998864 457999999999999999999999999999999999999987644459999999998665544445
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCCCCCHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRD 256 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 256 (298)
...|++.|+|||++.+..++.+ +||||+||++|+|++|..||.+.+. .+....+.......+ ....+++++.+
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred eeEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 5679999999999988888655 9999999999999999999987654 344555555554433 23468999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
||++||+.||.+|||+ .++++|||++.
T Consensus 390 li~~~L~~dp~~R~t~--------~e~l~Hpw~~~ 416 (573)
T 3uto_A 390 FIRKLLLADPNTRMTI--------HQALEHPWLTP 416 (573)
T ss_dssp HHHTTSCSSGGGSCCH--------HHHHHSTTTSC
T ss_pred HHHHHccCChhHCcCH--------HHHhcCcCcCC
Confidence 9999999999999987 45568899874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=366.33 Aligned_cols=253 Identities=21% Similarity=0.334 Sum_probs=210.1
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccC-----CcEEEEEEeecCCc--chHHHHHHHHHHhcCCC-CCeeeeeEEEEeC
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSLRH-PNIVRFKEVILTP 91 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 91 (298)
+..++|++++.||+|+||.||+|.+... ++.||+|.+..... ....+.+|+.++.++.| |||++++++|..+
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 4557999999999999999999997643 36799999876533 23568899999999965 9999999998764
Q ss_pred -CeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC
Q 022401 92 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (298)
Q Consensus 92 -~~~~lv~~~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~ 154 (298)
+.+++|||||++|+|.+++... ..+++.++..++.||+.||+|||+++++||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 5789999999999999999643 34889999999999999999999999999999999999998
Q ss_pred CCCCCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhH
Q 022401 155 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 230 (298)
Q Consensus 155 ~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~ 230 (298)
++. +||+|||+|+....... .....+++.|+|||.+.+..++.+ +|||||||++|||+| |..||.+....+.+
T Consensus 221 ~~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 221 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp GGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 887 99999999975433222 233457889999999988888766 999999999999998 89999886654444
Q ss_pred HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
...+. ...+.+.+..+++++.+++.+||+.||.+|||+.+++++.
T Consensus 298 ~~~i~----~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 298 CRRLK----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp HHHHH----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHH----cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 33332 2334455566899999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=354.72 Aligned_cols=255 Identities=37% Similarity=0.674 Sum_probs=222.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.+++.++||||+++++++..++.+++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3578999999999999999999999999999999987643 2345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
+||+++++|.+++...+.+++..++.++.|++.||+|||+.|++||||||+||+++.++. +||+|||++.........
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCcc
Confidence 999999999999988889999999999999999999999999999999999999998887 999999998765555555
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||.+.+..+.+.++||||+|+++|+|++|..||...+. ......+..+....+. .+++++.+|
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l 244 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----KELRERVLRGKYRIPF--YMSTDCENL 244 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCC--CCCHHHHHH
Confidence 5667899999999998888876679999999999999999999987553 4445555556555444 379999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+++||+.||.+|||+. ++++|||+..
T Consensus 245 i~~~L~~dP~~R~t~~--------eil~h~~~~~ 270 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLE--------QIMKDRWINA 270 (328)
T ss_dssp HHHHCCSSTTTSCCHH--------HHTTCTTTTT
T ss_pred HHHHCCCChhHCcCHH--------HHhcCHhhcC
Confidence 9999999999999884 5557888764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=351.43 Aligned_cols=257 Identities=31% Similarity=0.555 Sum_probs=220.7
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
.++|++++.||+|+||.||++++..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999999976432 246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC--CCEEEeecCcccccc
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 172 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~--~~~~l~d~~~~~~~~ 172 (298)
++|+||+.+++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ..++|+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 999999999999999988889999999999999999999999999999999999999987662 249999999987655
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--CCCC
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPI 250 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 250 (298)
.........|++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+. .+....+.......+. ...+
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHTTCCCCCHHHHTTS
T ss_pred CCCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCchhccCC
Confidence 5444556679999999999987777655 9999999999999999999987654 3344445554443331 2457
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 246 s~~~~~li~~~L~~dP~~R~t~--------~e~l~hp~~~~ 278 (361)
T 2yab_A 246 SELAKDFIRKLLVKETRKRLTI--------QEALRHPWITP 278 (361)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCH--------HHHHTSTTTSC
T ss_pred CHHHHHHHHHHCCCChhHCcCH--------HHHhcCcCcCC
Confidence 8999999999999999999987 56668899874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=346.04 Aligned_cols=260 Identities=31% Similarity=0.528 Sum_probs=220.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
..++|++++.||+|+||.||++++..+++.||+|++.+. ......+.+|..+++.++||||+++++++.+.+.+++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 457899999999999999999999999999999998753 3344668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 175 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~ 175 (298)
|+||+++++|...+.....+++..++.++.||+.||+|||++|++||||||+||+++.++. ++|+|||++..... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCC
Confidence 9999999999999988889999999999999999999999999999999999999998887 99999999874332 22
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
......+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+. ......+.......+ ..+++++.
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~s~~~~ 233 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFP--RTLSPEAK 233 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred cccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCC--CCCCHHHH
Confidence 3345568999999999988877665 9999999999999999999987554 334444555555444 34899999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++|.+||+.||.+||+.. .....++++|||+.+.
T Consensus 234 ~li~~lL~~dP~~R~g~~---~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGG---PSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHTCSSTTTSTTCS---TTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhcCHHHhcCCC---CCCHHHHHcCCCcCCC
Confidence 999999999999999321 0123677788888754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=349.32 Aligned_cols=252 Identities=22% Similarity=0.222 Sum_probs=193.7
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----eEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 98 (298)
.+|.+.+.||+|+||.||+|++ +|+.||||++............|+..+.+++||||+++++++.+++ .+|+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5799999999999999999987 5889999998765443333445666677899999999999998653 689999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc--------CcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~--------~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
||+++++|.+++... ++++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence 999999999999654 589999999999999999999987 8999999999999999887 99999999874
Q ss_pred ccCCC-----CCCCCCCCCcccCccccccccC-----CCCccchHHHHHHHHHHHhCCCCCCCCCC-----------chh
Q 022401 171 SVLHS-----QPKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------PKD 229 (298)
Q Consensus 171 ~~~~~-----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----------~~~ 229 (298)
..... ......|++.|+|||++.+... .+.++|||||||++|||+||..||..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 43322 2233468999999999875421 23349999999999999999776543221 112
Q ss_pred HHHHHHHHhhcCCCCCCCC-----CCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 230 FRKTIQRILSVQYSVPDTN-----PISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.......+.....+...+. ..+..+.+++.+||+.||.+|||+.+++++.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 292 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 2333333443333322221 1235789999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=349.55 Aligned_cols=260 Identities=24% Similarity=0.438 Sum_probs=221.4
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
.++|++.+.||+|+||.||++.+..+++.+|+|.+.........+.+|+.+++.++||||+++++++.+...+++|+||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 47899999999999999999999999999999999877666677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCC
Q 022401 102 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 180 (298)
++++|.+.+.... .+++.+++.++.|++.||.|||+.|++|+||||+||+++.++...++|+|||++............
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 9999999997654 799999999999999999999999999999999999998743445999999998755444433445
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--CCCCCHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLI 258 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 258 (298)
.+++.|+|||.+.+..++.+ +||||||+++|+|++|..||..... ......+.......+. ...+++++.+||
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 68999999999987766555 9999999999999999999987654 3344444444443332 235799999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.+||+.||.+|||+ .++++|||+.+..+
T Consensus 239 ~~~L~~dp~~Rpt~--------~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 239 DRLLVKERKSRMTA--------SEALQHPWLKQKIE 266 (321)
T ss_dssp HTTSCSSGGGSCCH--------HHHHHSHHHHSCGG
T ss_pred HHHcCCChhHCcCH--------HHHhcChhhccCcc
Confidence 99999999999987 55668999986544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=348.28 Aligned_cols=263 Identities=30% Similarity=0.477 Sum_probs=218.6
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (298)
....++|++++.||+|+||.||+++++.+++.||+|++.+. ......+.+|..+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45668999999999999999999999999999999998753 23345677899999988 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+||||+++++|..++.....+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeeccc
Confidence 9999999999999999998889999999999999999999999999999999999999998887 99999999874332
Q ss_pred -CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
........+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+. .+....+.......+. .+++
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~~~ 249 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAILNDEVVYPT--WLHE 249 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCH
Confidence 233345568999999999988777665 9999999999999999999987654 3445555566555443 4799
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++.++|++||+.||.+||++.+.- ...++++|||+.+.
T Consensus 250 ~~~~li~~lL~~dP~~R~~~~~~~--~~~~il~hp~f~~~ 287 (353)
T 3txo_A 250 DATGILKSFMTKNPTMRLGSLTQG--GEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHHHHTCSSGGGSTTSGGGT--CTHHHHTSGGGTTC
T ss_pred HHHHHHHHHhhhCHHHccCCcccC--CHHHHhhCCcccCC
Confidence 999999999999999999873211 23678899999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=340.20 Aligned_cols=259 Identities=29% Similarity=0.504 Sum_probs=222.4
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++++.||+|+||.||++++..+|+.||+|++.+. ....+.+.+|..+++.++||||+++++++.+...++
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 3457899999999999999999999999999999998753 234466788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+|+||+++++|.+++.....+++..++.++.|++.||+|||++|++||||||+||+++.++. ++|+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--
Confidence 99999999999999998889999999999999999999999999999999999999998887 99999999874432
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
......+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+. .....++.......+ ..+++++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~p--~~~~~~~~ 231 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNAELRFP--PFFNEDVK 231 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred ccccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCC--CCCCHHHH
Confidence 2345568999999999988877666 9999999999999999999987654 344455555555444 44899999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++|.+||+.||.+||+..+ ....++++|||+.+.
T Consensus 232 ~li~~lL~~dp~~R~~~~~---~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQ---NGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHHHTCSCTTTCTTSST---TTTHHHHTSGGGSSC
T ss_pred HHHHHHhccCHHHcCCCcC---CCHHHHhcCccccCC
Confidence 9999999999999995421 234778899999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=334.47 Aligned_cols=259 Identities=25% Similarity=0.418 Sum_probs=210.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++++.||+|+||.||+|++..+++.||+|++..... ....+.+|+.++++++||||+++++++.+++.+++|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 689999999999999999999999999999999975433 23667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~ 178 (298)
+++++.+.........+++..++.++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++...... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccccc
Confidence 9987544444455678999999999999999999999999999999999999998887 999999998754322 3334
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC---------------
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--------------- 243 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------- 243 (298)
...+++.|+|||.+.+....+.++||||+|+++|+|++|..||............+.+.......
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence 45678999999999877754556999999999999999888865544433333333332211110
Q ss_pred ---------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 244 ---------VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 244 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
......+++++.+||.+||+.||.+|||+ .++++|||+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--------~e~l~hp~f~~ 288 (292)
T 3o0g_A 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA--------EEALQHPYFSD 288 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGTT
T ss_pred ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH--------HHHhcCccccc
Confidence 01112478999999999999999999987 66668999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=349.41 Aligned_cols=268 Identities=26% Similarity=0.413 Sum_probs=223.2
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (298)
.....++|++++.||+|+||.||+++++.+++.||+|++.+.. .....+.+|..++.++ +||||+++++++.+++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 3456689999999999999999999999999999999987642 2334577888888876 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc-
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS- 171 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~- 171 (298)
.+++|+||+++++|..++.....+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~ 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecc
Confidence 99999999999999999988889999999999999999999999999999999999999999887 999999998753
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch-----hHHHHHHHHhhcCCCCCC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----DFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~ 246 (298)
..........|++.|+|||++.+..++.+ +|+||||+++|+|++|..||......+ ......+.+.......+.
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 23333455678999999999988887655 999999999999999999997543211 223344555555555444
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+++++.+||++||+.||.+||++... ....++++|||+.+.
T Consensus 284 --~~s~~~~~li~~lL~~dP~~R~~~~~~--~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 284 --SLSVKAASVLKSFLNKDPKERLGCHPQ--TGFADIQGHPFFRNV 325 (396)
T ss_dssp --TSCHHHHHHHHHHTCSCTTTSTTCSTT--THHHHHHHSTTTTTC
T ss_pred --cCCHHHHHHHHHHhcCCHhHcCCCCCC--CCHHHHhcCccccCC
Confidence 489999999999999999999997422 135788899999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=347.34 Aligned_cols=254 Identities=41% Similarity=0.672 Sum_probs=216.4
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++..+..+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999999999999999998753 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
+||+ +++|.+.+.....+++.+++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||++.........
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCccc
Confidence 9999 6789999888888999999999999999999999999999999999999998887 999999998766555555
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||.+.+..+...++||||+|+++|+|++|..||......... ..+.... ...+..+++++.+|
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~--~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVNSCV--YVMPDFLSPGAQSL 238 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCCSSC--CCCCTTSCHHHHHH
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCC--CCCcccCCHHHHHH
Confidence 66779999999999988877666699999999999999999999875442211 1111222 22344579999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
|++||+.||.+|||+ .++++|||+...
T Consensus 239 i~~~L~~dP~~Rpt~--------~eil~hp~~~~~ 265 (336)
T 3h4j_B 239 IRRMIVADPMQRITI--------QEIRRDPWFNVN 265 (336)
T ss_dssp HHTTSCSSGGGSCCH--------HHHTTCHHHHTT
T ss_pred HHHHcCCChhHCcCH--------HHHHhChhhccC
Confidence 999999999999988 455578887643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=346.58 Aligned_cols=265 Identities=25% Similarity=0.417 Sum_probs=225.9
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
........++|++++.||+|+||.||++++..+++.||+|++... ......+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 7 DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp -CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 344556678999999999999999999999999999999998753 2334678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
...+++|+||+.+++|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~ 164 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAM 164 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeee
Confidence 9999999999999999999998889999999999999999999999999999999999999998887 99999999976
Q ss_pred ccCCCCCCCCCCCCcccCccccccc---cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCC
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
...........|++.|+|||++... .++.+ +|||||||++|+|++|..||...... ........+.......+
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~p-- 240 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFETTVVTYP-- 240 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHHCCCCCC--
T ss_pred ccCCCceeccCCCccccCCeeeccCCCCCCCcc-ceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhhcccCCC--
Confidence 6555555667799999999998643 35444 99999999999999999999865442 23444445444444433
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..+++++.+||.+||+.||.+||+. ..++.+|||+.+.
T Consensus 241 ~~~s~~~~~li~~lL~~dP~~R~s~-------~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 241 SAWSQEMVSLLKKLLEPNPDQRFSQ-------LSDVQNFPYMNDI 278 (384)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCS-------HHHHHTSGGGTTC
T ss_pred CcCCHHHHHHHHHHhcCCHhHhccc-------HHHHHcChhhhcC
Confidence 4489999999999999999999984 4677899999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=336.39 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=216.1
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++.+++|+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 3468999999999999999999999999999999987543 334668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~ 178 (298)
|+.+++|.+++... .+++..++.++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++....... ...
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBC
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccC
Confidence 99999999999665 6899999999999999999999999999999999999998887 9999999986444332 234
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
...+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+....... ...........+..+++.+.+||
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFL 250 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHHCSCCCSCGGGSCHHHHHHH
T ss_pred CccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhCCCCCCCCccccCHHHHHHH
Confidence 4568999999999988877665 9999999999999999999987654332222 12223334444556899999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+||+.||.+|||+ .++++|||+..
T Consensus 251 ~~~l~~dp~~Rps~--------~ell~h~~~~~ 275 (297)
T 3fxz_A 251 NRCLEMDVEKRGSA--------KELLQHQFLKI 275 (297)
T ss_dssp HHHSCSSTTTSCCH--------HHHTTCGGGGG
T ss_pred HHHccCChhHCcCH--------HHHhhChhhcc
Confidence 99999999999988 55557888764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=342.90 Aligned_cols=259 Identities=31% Similarity=0.481 Sum_probs=218.4
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (298)
.....++|++.+.||+|+||.||+|+++.+++.||+|++.+. ......+..|..++..+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345678999999999999999999999999999999999764 23345677888888876 9999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+|+|+||+++++|.+++.....+++..++.++.|++.||+|||++|++||||||+||+++.++. ++|+|||++....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENM 169 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcc
Confidence 99999999999999999988888999999999999999999999999999999999999998887 9999999987433
Q ss_pred C-CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 173 L-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 173 ~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
. ........|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+. ......+.......+ ..++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~s 242 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNPFYP--RWLE 242 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCC--TTSC
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHhCCCCCC--cccC
Confidence 2 223345568999999999988777655 9999999999999999999987554 344445555554443 3489
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+++.++|.+||+.||.+||++.+ ++++|||+.+.
T Consensus 243 ~~~~~li~~lL~~dp~~R~~~~~-------~i~~hp~f~~~ 276 (345)
T 1xjd_A 243 KEAKDLLVKLFVREPEKRLGVRG-------DIRQHPLFREI 276 (345)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBS-------CGGGSGGGTTC
T ss_pred HHHHHHHHHHhcCCHhHcCCChH-------HHHcCccccCC
Confidence 99999999999999999999851 45578888754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=340.64 Aligned_cols=266 Identities=26% Similarity=0.423 Sum_probs=222.0
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (298)
...++|++++.||+|+||.||+++++.+++.||+|++.+... ....+.+|..+++++ +||||+++++++.+++.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 345789999999999999999999999999999999986432 234577899999887 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~- 173 (298)
|+|+||+++++|.+++.....+++..++.++.|++.||+|||++|++||||||+||+++.++. ++|+|||++.....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCC
Confidence 999999999999999988888999999999999999999999999999999999999998887 99999999874322
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc-----hhHHHHHHHHhhcCCCCCCCC
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----KDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 248 (298)
........+++.|+|||++.+..++.+ +|+|||||++|+|++|..||...... .......+.+.......+ .
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~ 240 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--R 240 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC--T
T ss_pred CCcccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC--C
Confidence 233345578999999999988777555 99999999999999999999753221 122334445555555444 4
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.++.++.++|.+||+.||.+||++... ....++++|||+.+.
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~--~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQ--TGFADIQGHPFFRNV 282 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTT--THHHHHHTSGGGTTC
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCc--CCHHHHhcCCccCCC
Confidence 589999999999999999999997431 134788899999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=341.03 Aligned_cols=257 Identities=32% Similarity=0.574 Sum_probs=218.1
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+...+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3679999999999999999999999999999999876432 346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC--CCEEEeecCcccccc
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 172 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~--~~~~l~d~~~~~~~~ 172 (298)
++|+|++++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ..++|+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 999999999999999988888999999999999999999999999999999999999987662 249999999987665
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCCCC
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPI 250 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 250 (298)
.........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .....+.......+ ....+
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 244 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQ----ETLANVSAVNYEFEDEYFSNT 244 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHHTCCCCCHHHHTTS
T ss_pred CCCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHHhcCCCcCccccccC
Confidence 4444556678999999999977777655 99999999999999999999875543 23333333333222 12357
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
++++.+||.+||+.||.+|||+ .++++|||+..
T Consensus 245 ~~~~~~li~~~L~~dP~~Rpt~--------~e~l~hp~~~~ 277 (326)
T 2y0a_A 245 SALAKDFIRRLLVKDPKKRMTI--------QDSLQHPWIKP 277 (326)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCH--------HHHHHSTTTSC
T ss_pred CHHHHHHHHHHccCChhhCCCH--------HHHhcCCCccC
Confidence 8999999999999999999987 56668888864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=337.50 Aligned_cols=267 Identities=26% Similarity=0.396 Sum_probs=214.6
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
.......++|++++.||+|+||.||++++. +++.||+|++..... ....+.+|+.++++++||||+++++++.++.
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 344556689999999999999999999986 588999999875432 2356789999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
.+++|+||+++ +|.+.+... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~ 169 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAF 169 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEET
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceec
Confidence 99999999976 777777554 45999999999999999999999999999999999999998887 999999998754
Q ss_pred cCC-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC-CC----
Q 022401 172 VLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VP---- 245 (298)
Q Consensus 172 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~---- 245 (298)
... .......+++.|+|||.+.+....+.++||||||+++|+|++|..||......+.+............. ++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 322 233445679999999998775544556999999999999999999999877766655554433222110 00
Q ss_pred -------------------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 246 -------------------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 246 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
....+++++.+||.+||+.||.+|||+ .++++|||+.+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~ell~hp~f~~~~~ 309 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA--------RDAMNHPYFKDLDP 309 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH--------HHHHTSGGGTTSCT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH--------HHHhcCcccccCCc
Confidence 012367899999999999999999987 66678999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=344.67 Aligned_cols=257 Identities=33% Similarity=0.570 Sum_probs=218.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3579999999999999999999999999999999976432 3356789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC-CCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~-~~~~l~d~~~~~~~~~~~~~ 177 (298)
|++.+++|.+.+.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ..+||+|||++.........
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 99999999999988888999999999999999999999999999999999999976542 35999999998765544444
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--CCCCCHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECR 255 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 255 (298)
....+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+. ......+..+....+. ...+++++.
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred ccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 55678999999999987777655 9999999999999999999987554 3344444455444332 245799999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+||.+||+.||.+|||+ .++++|||+.+
T Consensus 263 ~li~~~L~~dP~~R~t~--------~e~l~hp~~~~ 290 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITA--------DQALKVPWICN 290 (362)
T ss_dssp HHHHHHSCSSGGGSCCH--------HHHTTSHHHHT
T ss_pred HHHHHHcCCChhhCcCH--------HHHhcCcccCC
Confidence 99999999999999987 55567888864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=341.05 Aligned_cols=262 Identities=30% Similarity=0.450 Sum_probs=222.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (298)
....++|++++.||+|+||.||++++..+++.||+|++.+. ....+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 34568999999999999999999999989999999998763 23446678899999888 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+|+||+++++|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++. ++|+|||++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCccccccc
Confidence 9999999999999999988888999999999999999999999999999999999999998887 99999999875332
Q ss_pred -CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
........|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+. ......+.......+ ..+++
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~s~ 246 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYP--KSMSK 246 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCC--TTSCH
T ss_pred CCcccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCH----HHHHHHHHhCCCCCC--CCCCH
Confidence 223345568999999999988777655 9999999999999999999987554 344555555555544 35899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++.+||.+||+.||.+||++.. ....++++|||+.+.
T Consensus 247 ~~~~li~~lL~~dP~~R~~~~~---~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 247 EAVAICKGLMTKHPGKRLGCGP---EGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHHHHHTCSCTTSCTTCST---THHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhhcCHHHcCCCCC---CCHHHHhcCccccCC
Confidence 9999999999999999997632 245788899999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=341.97 Aligned_cols=260 Identities=28% Similarity=0.482 Sum_probs=223.2
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
....++|++++.||+|+||.||++++..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 456689999999999999999999999999999999987532 3446788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
|+|+||+++++|.+++.....+++..++.++.|++.||+|||++|++||||||+||+++.++. ++|+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC-
Confidence 999999999999999988888999999999999999999999999999999999999998887 99999999874432
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
......+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+. ......+.......+ ..+++++
T Consensus 194 -~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~~~~~ 265 (350)
T 1rdq_E 194 -RTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFP--SHFSSDL 265 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCC--TTCCHHH
T ss_pred -CcccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCH----HHHHHHHHcCCCCCC--CCCCHHH
Confidence 2334568999999999988777655 9999999999999999999987554 344555555555444 4589999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.++|.+||+.||.+||+.. .....++++|||+.+.
T Consensus 266 ~~li~~lL~~dp~~R~~~~---~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNL---KNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSS---TTTTHHHHTSGGGTTC
T ss_pred HHHHHHHhhcCHHhccCCc---cCCHHHHHhCcCcCCC
Confidence 9999999999999999832 1124678899998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=335.76 Aligned_cols=257 Identities=33% Similarity=0.545 Sum_probs=210.8
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---------------------------chHHHHHHHH
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------------------------IDENVQREII 71 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---------------------------~~~~~~~e~~ 71 (298)
....++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 3456899999999999999999999999999999999875431 1246789999
Q ss_pred HHhcCCCCCeeeeeEEEEe--CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCc
Q 022401 72 NHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149 (298)
Q Consensus 72 ~l~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~n 149 (298)
++++++||||+++++++.+ ...+++|+||+++++|.+.+ ...++++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999999987 56899999999999998755 44578999999999999999999999999999999999
Q ss_pred eEeeCCCCCCEEEeecCccccccCCC-CCCCCCCCCcccCccccccccC--CCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 022401 150 TLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (298)
Q Consensus 150 ilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 226 (298)
|+++.++. ++|+|||++....... ......+++.|+|||.+.+... ...++||||||+++|+|++|..||.....
T Consensus 168 il~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99998887 9999999987443322 2234568999999999876543 34558999999999999999999987543
Q ss_pred chhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
......+.......+....+++++.++|.+||+.||.+|||+ .++++|||++
T Consensus 246 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~--------~e~l~hp~~~ 297 (298)
T 2zv2_A 246 ----MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV--------PEIKLHPWVT 297 (298)
T ss_dssp ----HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH--------HHHTTCHHHH
T ss_pred ----HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCH--------HHHhcCcccc
Confidence 333444455555556556789999999999999999999987 5566899985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=350.80 Aligned_cols=258 Identities=32% Similarity=0.569 Sum_probs=216.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.++|++.+.||+|+||.||++.+..+|+.+|+|++..... ....+.+|+.++++++||||+++++++.+++..++|+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 3689999999999999999999999999999999876542 2355789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC-CCCCEEEeecCccccccCCCC-
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ- 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~-~~~~~~l~d~~~~~~~~~~~~- 176 (298)
|++.+++|.+.+.....+++..+..++.|++.||.|||++|++||||||+||+++.+ ....+||+|||++........
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 999999999999998999999999999999999999999999999999999999853 223599999999865443322
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCCCCCHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQEC 254 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 254 (298)
.....+++.|+|||++.+..++.+ +||||+|+++|+|++|..||...+. ......+..+....+ ....+++++
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQ----HRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred eecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCCCCCCccccccCCHHH
Confidence 234568999999999988777665 9999999999999999999987654 334444555544433 334689999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+||.+||+.||.+|||+ .++++|||+...
T Consensus 245 ~~li~~~L~~dP~~Rpta--------~e~L~hp~~~~~ 274 (444)
T 3soa_A 245 KDLINKMLTINPSKRITA--------AEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHSCSSTTTSCCH--------HHHHHSCTTHHH
T ss_pred HHHHHHHcCCChhHCCCH--------HHHhcCccccCC
Confidence 999999999999999987 566688998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=344.16 Aligned_cols=262 Identities=29% Similarity=0.470 Sum_probs=217.4
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHH-HhcCCCCCeeeeeEEEEeCC
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIIN-HRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~ 92 (298)
.....++|++++.||+|+||.||+++++.+++.||+|++.+... ....+.+|..+ ++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 34566899999999999999999999999999999999976432 22345566665 56789999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+|+||||+++++|.+++.....+++..++.++.+++.||+|||++|++||||||+||+++.++. +||+|||++....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGB
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999998887 9999999987432
Q ss_pred -CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 173 -LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 173 -~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
.........|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+. .+....+.......+ ..++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~~--~~~~ 263 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNKPLQLK--PNIT 263 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBH----HHHHHHHHHSCCCCC--SSSC
T ss_pred cCCCccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhcccCCC--CCCC
Confidence 2334455678999999999988777655 9999999999999999999987554 344455555554443 4589
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.++.++|.+||+.||.+||++.+. ..+++.|||+.+.
T Consensus 264 ~~~~~li~~lL~~dp~~R~~~~~~----~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 264 NSARHLLEGLLQKDRTKRLGAKDD----FMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSTTTTTT----HHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHhCCCCCCC----HHHHhCCccccCC
Confidence 999999999999999999998644 3689999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=354.12 Aligned_cols=259 Identities=36% Similarity=0.629 Sum_probs=223.7
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
......++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34556689999999999999999999999999999999987532 23467889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+++|+||+++++|.+++...+.+++..++.++.|++.||+|||+.|++||||||+||+++.++. +||+|||++....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~ 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhcc
Confidence 99999999999999999988888999999999999999999999999999999999999998887 9999999987655
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
.........+++.|+|||.+.+..+...++||||||+++|+|++|..||...+.. ....++..+.... +..+++
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~--p~~~s~ 241 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFKKICDGIFYT--PQYLNP 241 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHHHHHTTCCCC--CTTCCH
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHHHHhcCCcCC--CccCCH
Confidence 4444456678999999999988877666699999999999999999999876653 3444455554433 344799
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
++.+||.+||+.||.+|||+ .++++|||+..
T Consensus 242 ~~~~Li~~~L~~dP~~Rpt~--------~eil~hp~~~~ 272 (476)
T 2y94_A 242 SVISLLKHMLQVDPMKRATI--------KDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHHHHTCSSTTTSCCH--------HHHHTCHHHHT
T ss_pred HHHHHHHHHcCCCchhCcCH--------HHHHhCHHhhh
Confidence 99999999999999999988 45557788764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=333.26 Aligned_cols=264 Identities=25% Similarity=0.377 Sum_probs=210.7
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC------cchHHHHHHHHHHhcCC---CCCeeeeeEEEEe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLR---HPNIVRFKEVILT 90 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 90 (298)
...++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34679999999999999999999999999999999987432 22346677887777664 9999999999987
Q ss_pred CC-----eEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEe
Q 022401 91 PT-----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (298)
Q Consensus 91 ~~-----~~~lv~~~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~ 163 (298)
.. .+++|+|++. ++|.+++..... +++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEe
Confidence 65 5899999997 499999977654 899999999999999999999999999999999999998887 9999
Q ss_pred ecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 022401 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243 (298)
Q Consensus 164 d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
|||++.............+++.|+|||++.+..++.+ +||||||+++|+|++|..||......+...............
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9999876655555556678999999999988887666 999999999999999999998877655554444433221110
Q ss_pred -CC--------------------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhh
Q 022401 244 -VP--------------------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATEN 295 (298)
Q Consensus 244 -~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~ 295 (298)
++ ....+++++.+||.+||+.||.+|||+ .++++|||++....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--------~e~l~h~~~~~~~~~ 306 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA--------FRALQHSYLHKDEGN 306 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH--------HHHHTSTTC------
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH--------HHHhcCccccCCCCC
Confidence 10 012478999999999999999999987 566689999876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=340.67 Aligned_cols=259 Identities=33% Similarity=0.533 Sum_probs=215.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
-.++|++++.||+|+||.||++++..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 35799999999999999999999999999999999865432 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC---C
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---S 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~---~ 175 (298)
||+++++|.+.+.....+++.+++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++...... .
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRER 162 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEEC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCccc
Confidence 99999999999988888999999999999999999999999999999999999998887 999999998643222 2
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
......+++.|+|||.+.+..+.+.++||||||+++|+|++|..||.......... ..........+....+++++.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH---HHHHTTCTTSTTGGGSCHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHHhcccccCCccccCCHHHH
Confidence 22345689999999999887775666999999999999999999998765533222 222223333333445899999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+||.+||+.||.+|||+ .++++|||+...
T Consensus 240 ~li~~~L~~dP~~R~t~--------~eil~h~~~~~~ 268 (323)
T 3tki_A 240 ALLHKILVENPSARITI--------PDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHSCSSTTTSCCH--------HHHTTCTTTTCC
T ss_pred HHHHHHccCChhhCcCH--------HHHhhChhhccc
Confidence 99999999999999987 555688888753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=327.72 Aligned_cols=261 Identities=32% Similarity=0.556 Sum_probs=220.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
-.++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 35799999999999999999999999999999999876432 235677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC-CCEEEeecCccccccCCCC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~-~~~~l~d~~~~~~~~~~~~ 176 (298)
+|++.+++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ..++|+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999988888999999999999999999999999999999999999976543 3599999999876555554
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCC--CCCCCCCHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQEC 254 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 254 (298)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .....+....... +....+++++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQH----RLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchh----HHHHHHHhccccCCchhhcccCHHH
Confidence 455678999999999988777655 99999999999999999999876543 2333333333332 3334689999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.+++.+||+.||.+|||+ .++++|||+.+..+
T Consensus 239 ~~li~~~l~~dp~~Rps~--------~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITA--------DQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHSCSSTTTSCCH--------HHHTTSHHHHSCCC
T ss_pred HHHHHHHcccChhhCCCH--------HHHhcCccccCChh
Confidence 999999999999999987 55668999986543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=328.89 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=207.8
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++++.||+|+||.||+|++ .+++.+|+|++..... ....+.+|+.++++++||||+++++++..++.+++|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999998 5788999999865432 23678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCC
Q 022401 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~ 177 (298)
++++ +|.+.+... +.+++..++.++.|++.||+|||++|++|+||||+||+++.++. +||+|||++...... ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence 9976 888888654 57899999999999999999999999999999999999998887 999999998644322 222
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC-C------------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-V------------ 244 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~------------ 244 (298)
....+++.|+|||.+.+....+.++||||||+++|+|++|..||......+.+............. +
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 344678999999998766544556999999999999999999998876555444443332211100 0
Q ss_pred ----------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 245 ----------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 245 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.....+++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA--------KQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH--------HHHHTSGGGGC
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH--------HHHhcCcchhh
Confidence 0113478999999999999999999987 56668999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=345.94 Aligned_cols=259 Identities=27% Similarity=0.467 Sum_probs=218.1
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
..++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.++++++||||+++++++.+...+++|+|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 34789999999999999999999999999999999876532 33568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
|+.+++|.+.+.... .+++.+++.++.|++.||+|||+.|++|+||||+||+++.++...++|+|||++..........
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 999999999887554 6999999999999999999999999999999999999986554569999999987654444444
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCC--CCCCCCCHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRD 256 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 256 (298)
...+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+.. .....+....... .....+++++.+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred eeccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCccccccCCHHHHH
Confidence 5568999999999987777655 99999999999999999999876543 3333444443322 233458999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
||.+||+.||.+|||+ .++++|||+.+.
T Consensus 284 li~~~L~~dP~~Rpt~--------~ell~hp~~~~~ 311 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTV--------HDALEHPWLKGD 311 (387)
T ss_dssp HHHTTSCSSGGGSCCH--------HHHHTSTTTSSC
T ss_pred HHHHHcCCChhHCcCH--------HHHhhCccccCC
Confidence 9999999999999987 556688888754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=340.50 Aligned_cols=262 Identities=34% Similarity=0.560 Sum_probs=205.2
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
.++|++.+.||+|+||.||++++..+++.||+|++.... ..+.+.+|+.++++++||||+++++++.....+++|+||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 467999999999999999999999899999999987653 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-CCCCCEEEeecCccccccCCCCCCCC
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~~~~~~~~~~~~ 180 (298)
++++|.+.+.....+++.+++.++.|++.||.|||+.|++|+||||+||+++. +....++|+|||++............
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence 99999999988888999999999999999999999999999999999999975 22334999999998755444444456
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCC--CCCCCCCHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRDLI 258 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 258 (298)
.+++.|+|||.+.+..++.+ +||||||+++|+|++|..||....... .....+....... +....++.++.+||
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 211 CGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQ---FMFRRILNCEYYFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp --CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHH---HHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred cCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccH---HHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence 68999999999987777655 999999999999999999998765533 2334444444332 22345899999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
.+||+.||.+|||+ .++++|||+.+...+.
T Consensus 287 ~~~L~~dP~~Rpt~--------~e~l~hp~~~~~~~~~ 316 (349)
T 2w4o_A 287 RKLIVLDPKKRLTT--------FQALQHPWVTGKAANF 316 (349)
T ss_dssp HTTSCSSGGGSCCH--------HHHHHSTTTTSTTCCC
T ss_pred HHHccCChhhCcCH--------HHHhcCcccCCCccch
Confidence 99999999999987 5666899998766543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=333.99 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=197.9
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
.+.++|++++.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++++..++.+++|
T Consensus 2 s~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp -----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred CcccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 35679999999999999999999999999999999987543 3346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 98 MEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
+||+++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++...
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAF 158 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEET
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceec
Confidence 999974 898888643 35899999999999999999999999999999999999998887 999999998754
Q ss_pred cCC-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC-------
Q 022401 172 VLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS------- 243 (298)
Q Consensus 172 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------- 243 (298)
... .......+++.|+|||.+.+......++||||||+++|+|++|..||...+..+.+.............
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 322 223445678999999998775544555999999999999999999998876655444433322111000
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 244 ---------------------VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 244 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
......+++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~--------~e~l~hp~f~~ 299 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA--------KQALHHPWFAE 299 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH--------HHHTTSGGGGG
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH--------HHHhCChhhhc
Confidence 00112478899999999999999999988 55557888865
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=326.24 Aligned_cols=255 Identities=33% Similarity=0.556 Sum_probs=217.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC-CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.++|++.+.||+|+||.||++.+..++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+....++|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 35799999999999999999999999999999998764 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe---eCCCCCCEEEeecCccccccCCCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv---~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
+++++|.+.+.....+++..++.++.|++.||+|||++|++|+||+|+||++ +.++. ++|+|||++.........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~--~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP--LKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC--EEECCCTTCEECCTTSCB
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc--EEEEecccceeccCccch
Confidence 9999999999888889999999999999999999999999999999999999 55555 999999998766555555
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--CCCCCHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECR 255 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 255 (298)
....+++.|+|||.+.+. ++.+ +||||||+++|+|++|..||...... .....+.......+. ...+++++.
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDS----EVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTT-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred hccCCCCCccChHHhccc-CCch-hhehhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 666789999999988654 5454 99999999999999999999876543 333444444443332 124789999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++|.+||+.||.+|||+ .++++|||+++.
T Consensus 240 ~li~~~l~~dp~~R~s~--------~~~l~h~~~~~~ 268 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITS--------LQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHTCSSTTTSCCH--------HHHTTSHHHHHH
T ss_pred HHHHHHccCChhhCcCH--------HHHhcCHHHhcc
Confidence 99999999999999987 556689998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=341.90 Aligned_cols=266 Identities=22% Similarity=0.375 Sum_probs=212.9
Q ss_pred CCCCCCCCeeEEeeeccC--CeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 17 PIMHDSDRYDFVRDIGSG--NFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g--~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
+.....++|++++.||+| +||.||++++..+++.||+|++.... .....+.+|+.++++++||||+++++++.++
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 456677899999999999 99999999999999999999997653 2335677899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 92 THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+.+++|+||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++. ++|+|||.+.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~ 176 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNL 176 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGGGCE
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccccce
Confidence 9999999999999999999765 67999999999999999999999999999999999999998887 9999999874
Q ss_pred cccC--------CCCCCCCCCCCcccCcccccc--ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 022401 170 SSVL--------HSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239 (298)
Q Consensus 170 ~~~~--------~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 239 (298)
.... ........+++.|+|||.+.+ ..++. ++|||||||++|+|++|..||...+..............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 2211 112233467888999999877 34544 499999999999999999999887665544332221110
Q ss_pred c----------------------------------------CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 240 V----------------------------------------QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 240 ~----------------------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
. ....+....+++++.+||.+||+.||.+|||+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta------- 328 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA------- 328 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH-------
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH-------
Confidence 0 00112233478999999999999999999988
Q ss_pred hHHHhhhhhhhhhh
Q 022401 280 CLLLFSFVWMFDAT 293 (298)
Q Consensus 280 ~~~~~~hp~~~~~~ 293 (298)
.++++|||+.+..
T Consensus 329 -~ell~hp~f~~~~ 341 (389)
T 3gni_B 329 -STLLNHSFFKQIK 341 (389)
T ss_dssp -HHHTTSGGGGGC-
T ss_pred -HHHhcCHHHHHHh
Confidence 4555788887543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=334.23 Aligned_cols=257 Identities=30% Similarity=0.540 Sum_probs=218.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
.++|++.+.||+|+||.||++++..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4679999999999999999999999999999999876432 246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC--CEEEeecCcccccc
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--RLKICDFGYSKSSV 172 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~--~~~l~d~~~~~~~~ 172 (298)
++|+|++++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.. .++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 9999999999999999888889999999999999999999999999999999999999877621 49999999987655
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--CCCC
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPI 250 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 250 (298)
.........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .....+.......+. ...+
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~ 245 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQ----ETLANITSVSYDFDEEFFSHT 245 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHTTCCCCCHHHHTTC
T ss_pred ccccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcccccChhhhccc
Confidence 5444455678999999999977777555 99999999999999999999875542 333344443333221 2357
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
++++.++|.+||+.||.+|||+ .++++|||+.+
T Consensus 246 ~~~~~~li~~~l~~dp~~Rps~--------~e~l~hp~~~~ 278 (321)
T 2a2a_A 246 SELAKDFIRKLLVKETRKRLTI--------QEALRHPWITP 278 (321)
T ss_dssp CHHHHHHHHTTSCSSTTTSCCH--------HHHHHSTTTSC
T ss_pred CHHHHHHHHHHcCCChhhCcCH--------HHHhcCccccC
Confidence 8999999999999999999987 56667888874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=330.01 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=210.2
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.++|++++.||+|+||.||++++..+++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999999999999999988665432 355778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~ 177 (298)
|++++++|..++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCccccc
Confidence 99999999999888888999999999999999999999999999999999999998887 999999998644322 222
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------CC
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------QY 242 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~ 242 (298)
....+++.|+|||.+.+....+.++||||||+++|+|++|..||......+............ ..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 445678899999998775554556999999999999999999998876655443333221110 01
Q ss_pred CCCC----------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 243 SVPD----------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 243 ~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..+. ...+++++.+|+.+||+.||.+|||+ .++++|||+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~ell~hp~f~~~ 291 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC--------EQLLHHPYFENI 291 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH--------HHHHTSGGGTTC
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH--------HHHhcChHHHhc
Confidence 1111 12478899999999999999999987 566688998864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=334.02 Aligned_cols=263 Identities=28% Similarity=0.446 Sum_probs=212.5
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEc---cCCcEEEEEEeecCC-----cchHHHHHHHHHHhcCCCCCeeeeeEEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVIL 89 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (298)
.....++|++.+.||+|+||.||++++. .+++.||+|++.... .....+.+|+.++++++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3455689999999999999999999985 578999999987542 23345778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 90 ~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
..+.+++|+||+++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~ 169 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCK 169 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC-
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCccc
Confidence 99999999999999999999988888999999999999999999999999999999999999998887 9999999986
Q ss_pred cccCC-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 170 SSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 170 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
..... .......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+. ......+.......+ .
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~p--~ 242 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENR----KKTIDKILKCKLNLP--P 242 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHTCCCCC--T
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhCCCCCC--C
Confidence 43322 22344568999999999987777555 9999999999999999999987654 333444445444443 3
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+++++.++|.+||+.||.+||++.. ....++++|||+.+.
T Consensus 243 ~~~~~~~~li~~~L~~dp~~R~~~~~---~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 243 YLTQEARDLLKKLLKRNAASRLGAGP---GDAGEVQAHPFFRHI 283 (327)
T ss_dssp TSCHHHHHHHHHHSCSCGGGSTTSST---TTHHHHHHSGGGSSC
T ss_pred CCCHHHHHHHHHHHhcCHhhccCCCC---CCHHHHHcCCcccCC
Confidence 47999999999999999999996532 134788899999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=325.13 Aligned_cols=260 Identities=36% Similarity=0.615 Sum_probs=211.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
+....++|++.+.||+|++|.||.+++..+++.||+|++... ......+.+|+.++++++||||+++++++.....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 344568999999999999999999999989999999998753 2334678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
.++|+|++.+++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCC
Confidence 9999999999999999988888999999999999999999999999999999999999998887 99999999875544
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
........+++.|+|||.+.+..+.+.++||||||+++|+|++|..||..... ......+....... +..++.+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~--~~~~~~~ 237 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----PTLFKKIRGGVFYI--PEYLNRS 237 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCC--CTTSCHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhcCcccC--chhcCHH
Confidence 44444556889999999988776655569999999999999999999987543 23333444443333 3447899
Q ss_pred HHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+.++|.+||+.||.+|||+ .++++|||+.+..
T Consensus 238 l~~li~~~l~~~p~~Rps~--------~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATI--------KDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCH--------HHHHHSHHHHTTC
T ss_pred HHHHHHHHccCChhhCCCH--------HHHHhChhhccCc
Confidence 9999999999999999987 5566789987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=324.77 Aligned_cols=257 Identities=31% Similarity=0.588 Sum_probs=215.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++.+.||+|+||.||++.+..++..+|+|++.... .....+.+|+.++++++||||+++++++.+....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 34578999999999999999999999999999999986532 23456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+|+||+++++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS- 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC----
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCcc-
Confidence 99999999999999988888999999999999999999999999999999999999998887 999999987543322
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||..... ......+.......+ ..+++++.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~ 235 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRVEFTFP--DFVTEGAR 235 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCC--TTSCHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcH----HHHHHHHHhCCCCCC--CcCCHHHH
Confidence 2234568899999999987777655 9999999999999999999987553 333344444444433 34799999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
+||.+||+.||.+|||+ .++++|||+.+...
T Consensus 236 ~li~~~l~~~p~~Rps~--------~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 236 DLISRLLKHNPSQRPML--------REVLEHPWITANSS 266 (279)
T ss_dssp HHHHHHCCSSGGGSCCH--------HHHHHCHHHHHHCS
T ss_pred HHHHHHhccChhhCCCH--------HHHhhCccccCCcc
Confidence 99999999999999987 66668999986543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=345.18 Aligned_cols=262 Identities=30% Similarity=0.429 Sum_probs=217.3
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++++.||+|+||.||+++++.+++.||+|++.+. ......+.+|..+++.++||||+++++++.++..+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 4567999999999999999999999999999999998752 223345788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+||||+++++|.+++.. ..+++..++.++.|++.||+|||+.|++||||||+||+++.++. +||+|||++.......
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCC
Confidence 99999999999999865 46899999999999999999999999999999999999998887 9999999986443332
Q ss_pred --CCCCCCCCCcccCccccccccC---CCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 176 --QPKSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
......|++.|+|||++.+... .+.++||||||+++|+|++|..||...+............. ....+....+
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~ 300 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--SLTFPDDNDI 300 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCTTCCC
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--cccCCCcccc
Confidence 2235678999999999876551 23459999999999999999999987665333333332211 2334444568
Q ss_pred CHHHHHHHHHhhhhCCCC--cccccccchhhhHHHhhhhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAA--VSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~--Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
++++.+||.+||+.+|.+ ||++ .++++|||+.+..-
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~--------~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGV--------EEIKRHLFFKNDQW 338 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCH--------HHHHTSGGGCCSSC
T ss_pred cHHHHHHHHHHccChhhhCCCCCH--------HHHhcCccccCCCH
Confidence 999999999999988888 9977 66668999987643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=348.94 Aligned_cols=257 Identities=32% Similarity=0.536 Sum_probs=211.2
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
....++|++++.||+|+||.||++++..+++.||+|++... ......+.+|+.+++.++||||+++++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34568899999999999999999999999999999998753 23335567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++||||+++++|...+.....+++..+..++.|++.||+|||+ .|++||||||+||+++.++. ++|+|||++.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIK 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccC
Confidence 9999999999999999888899999999999999999999998 99999999999999998887 99999999874322
Q ss_pred -CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
........+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+. ......+.......+ ..+++
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~~~ 374 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILMEEIRFP--RTLGP 374 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCC--TTSCH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHHHhCCCCCC--ccCCH
Confidence 233345678999999999988777655 9999999999999999999987654 333444444544443 34899
Q ss_pred HHHHHHHHhhhhCCCCcc-----cccccchhhhHHHhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVS-----IFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rp-----s~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++.+||.+||+.||.+|| ++ .++++|||+.+.
T Consensus 375 ~~~~li~~~L~~dP~~R~~~~~~t~--------~ell~hp~f~~~ 411 (446)
T 4ejn_A 375 EAKSLLSGLLKKDPKQRLGGGSEDA--------KEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTH--------HHHHTSGGGTTC
T ss_pred HHHHHHHHHcccCHHHhCCCCCCCH--------HHHHhCccccCC
Confidence 999999999999999999 66 666789998865
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=351.41 Aligned_cols=260 Identities=33% Similarity=0.552 Sum_probs=217.8
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--------------cchHHHHHHHHHHhcCCCCCeeee
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNIVRF 84 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~ 84 (298)
....++|++++.||+|+||.||+|++..+++.+|+|++.... ...+.+.+|+.++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 345688999999999999999999999999999999987543 234678899999999999999999
Q ss_pred eEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC-CCEEEe
Q 022401 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKIC 163 (298)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~-~~~~l~ 163 (298)
++++.+...+++|+||+++++|.+.+.....+++..++.++.|++.||.|||+.|++||||||+||+++.++. ..++|+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999999999988889999999999999999999999999999999999999987653 259999
Q ss_pred ecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 022401 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243 (298)
Q Consensus 164 d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
|||++.............+++.|+|||.+.+ .++. ++||||+|+++|+|++|..||...+.. .....+..+...
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~ 265 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNE-KCDVWSCGVIMYILLCGYPPFGGQNDQ----DIIKKVEKGKYY 265 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCC
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCc-hHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCC
Confidence 9999976655555556679999999998763 4544 499999999999999999999886543 344444444443
Q ss_pred CC--CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 244 VP--DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 244 ~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+ ....+++++.+||++||+.||.+|||+ .++++|||+...
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~--------~e~l~h~~~~~~ 308 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTA--------EEALNSRWIKKY 308 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH--------HHHHTSHHHHHT
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCH--------HHHhcCHhhhhc
Confidence 22 224579999999999999999999987 555678888754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=350.96 Aligned_cols=266 Identities=30% Similarity=0.384 Sum_probs=227.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
....++|++.+.||+|+||.||+++++.+|+.||+|++.+.. .....+.+|..++++++||||+++++++.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 345689999999999999999999999999999999987532 3345678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 95 AIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
|+||||++|++|..++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++. +||+|||++..
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~ 338 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVE 338 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeee
Confidence 9999999999999998763 36999999999999999999999999999999999999999887 99999999875
Q ss_pred ccCCCCC-CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 171 SVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 171 ~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
....... ....|++.|+|||++.+..++.+ +|+|||||++|+|++|..||...............+.......+ ..
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~ 415 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DK 415 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TT
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cc
Confidence 4433322 33478999999999988777665 99999999999999999999887654444556666666655444 45
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+++++.+||.+||+.||.+||++.+. ...++++|||+.+.
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~---~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDG---SCDGLRTHPLFRDI 455 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTT---BSHHHHTSGGGTTC
T ss_pred cCHHHHHHHHHhccCCHhHCCCCccc---CHHHHHcCccccCC
Confidence 89999999999999999999987543 35788899999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=336.87 Aligned_cols=257 Identities=29% Similarity=0.524 Sum_probs=212.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC------CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
.++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++.++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 36899999999999999999999999999999998642 123567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC-CCEEEeecCcccc
Q 022401 96 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKS 170 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~-~~~~l~d~~~~~~ 170 (298)
+|+||+++++|.+.+... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++. ..++|+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998877432 35899999999999999999999999999999999999976543 3599999999875
Q ss_pred ccCCCC-CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--C
Q 022401 171 SVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--T 247 (298)
Q Consensus 171 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 247 (298)
...... .....+++.|+|||++.+..++.+ +||||||+++|+|++|..||.... ......+......... .
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-----ERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHHHHTCCCCCHHHH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHHHcCCCCCCcccc
Confidence 443322 334568999999999988777655 999999999999999999998742 2333444444433221 2
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..+++++.+||.+||+.||.+|||+ .++++|||+.+.
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~--------~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITV--------YEALNHPWLKER 293 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCH--------HHHHTSHHHHTH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCH--------HHHhcChhhcCC
Confidence 3579999999999999999999987 556678888754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=336.29 Aligned_cols=270 Identities=28% Similarity=0.373 Sum_probs=209.4
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
..+.....++|++.+.||+|+||.||++++..+++.||+|++...... ...+.+|+.++++++||||+++++++.++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 26 AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp ------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred cCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 345666778999999999999999999999999999999998754322 34567899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC---CCCEEEeecCcc
Q 022401 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFGYS 168 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~---~~~~~l~d~~~~ 168 (298)
..+++|+||+++ +|.+++.....+++..++.++.|++.||+|||++|++|+||||+||+++.++ ...++|+|||++
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999999999975 9999999888999999999999999999999999999999999999995433 234999999998
Q ss_pred ccccCC-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC-C--
Q 022401 169 KSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-V-- 244 (298)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-- 244 (298)
...... .......+++.|+|||.+.+....+.++||||||+++|+|++|..||......+.+............. +
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 644322 223344578999999999876644556999999999999999999998876655554444432211110 0
Q ss_pred -----------CC----------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 245 -----------PD----------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 245 -----------~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+. ...+++++.+||.+||+.||.+|||+ .++++|||+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--------~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA--------KNALEHPYFSHND 326 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH--------HHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH--------HHHhCCcccCCCC
Confidence 00 00167899999999999999999987 6667899998653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=348.90 Aligned_cols=256 Identities=33% Similarity=0.552 Sum_probs=214.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++++.||+|+||.||+|++..++..+|+|++... ......+.+|+.+++.++||||+++++++.+...+++|+|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4799999999999999999999999999999998754 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
|+.+++|.+.+.....+++..++.++.|++.||.|||++|++||||||+||+++..+ ...+||+|||++..........
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 196 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence 999999999998888899999999999999999999999999999999999997643 2359999999987665555555
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCCCCCHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRD 256 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 256 (298)
...+++.|+|||++. ..++. ++||||+|+++|+|++|..||...... +....+..+....+ ....+++++.+
T Consensus 197 ~~~gt~~y~aPE~l~-~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 197 ERLGTAYYIAPEVLR-KKYDE-KCDVWSIGVILFILLAGYPPFGGQTDQ----EILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp CCCSCTTTCCHHHHT-TCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred ccCCCcCeeCHHHHc-ccCCC-chhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 667999999999875 44555 499999999999999999999886543 33444444444332 23458999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
||.+||+.||.+|||+ .++++|||+.+.
T Consensus 271 li~~~L~~dp~~R~s~--------~e~l~hp~~~~~ 298 (494)
T 3lij_A 271 LIKQMLQFDSQRRISA--------QQALEHPWIKEM 298 (494)
T ss_dssp HHHHHTCSSTTTSCCH--------HHHHTCHHHHHH
T ss_pred HHHHHCCCChhhCccH--------HHHhcCcccccC
Confidence 9999999999999987 556688888764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=352.21 Aligned_cols=265 Identities=25% Similarity=0.338 Sum_probs=224.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++.+.||+|+||.||++++..+|+.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 5568899999999999999999999999999999998753 233456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 96 IVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+||||++|++|.+++..... +++..++.++.||+.||+|||+.|++||||||+||+++.++. +||+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceeccc
Confidence 99999999999999976543 999999999999999999999999999999999999998887 99999999875544
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
........|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...............+.......+ ..++++
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~ 415 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQ 415 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHH
T ss_pred CccccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHH
Confidence 433345578999999999988777655 99999999999999999999886654444455555555554443 458999
Q ss_pred HHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.+||.+||+.||.+||++. .....++++|||+.+.
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~---~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCR---GGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCS---SSHHHHHHTSGGGTTC
T ss_pred HHHHHHHhccCCHHHcCCCC---CCCHHHHHhChhhccC
Confidence 99999999999999999542 1134778899999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=333.73 Aligned_cols=258 Identities=33% Similarity=0.521 Sum_probs=215.2
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
..++|++.+.||+|+||.||++.++.+++.||+|++...... ..+|++++.++ +||||+++++++.++..+|+|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 356899999999999999999999999999999999765432 34677778777 79999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-C-CCEEEeecCccccccCC-CC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-A-PRLKICDFGYSKSSVLH-SQ 176 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~-~~~~l~d~~~~~~~~~~-~~ 176 (298)
|+.+++|.+.+.....+++..+..++.|++.||+|||+.|++||||||+||++.++. . ..++|+|||++...... ..
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 176 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence 999999999998888999999999999999999999999999999999999985432 2 24999999998744332 23
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--CCCCCHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQEC 254 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 254 (298)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||..... +...+....+..+....+. ...+++++
T Consensus 177 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 177 LMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp BCCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred eeccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHH
Confidence 345568999999999887766555 9999999999999999999986533 2334556666666554432 34589999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+||++||+.||.+|||+ .++++|||+.+
T Consensus 255 ~~li~~~L~~dP~~R~t~--------~~il~hp~~~~ 283 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTA--------ALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHTCSSTTTSCCH--------HHHTTSHHHHT
T ss_pred HHHHHHHCCCChhHCcCH--------HHHhcCCeecC
Confidence 999999999999999987 55667888854
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=336.95 Aligned_cols=248 Identities=29% Similarity=0.452 Sum_probs=213.4
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
.++|++.+.||+|+||.||++++..+++.||+|++..... ....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3689999999999999999999999999999999876532 2235678999999999999999999999999
Q ss_pred eEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 HLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~~-sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
.+++|+|++.++ +|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceEC
Confidence 999999998655 99999998889999999999999999999999999999999999999998887 999999998765
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
..........+++.|+|||.+.+..+...++||||||+++|+|++|..||..... ... .....+..++
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~--~~~~~~~~~~ 248 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVE--AAIHPPYLVS 248 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTT--TCCCCSSCCC
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHh--hccCCCcccC
Confidence 5544445566899999999998888766669999999999999999999976332 111 1223344479
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~--------~ell~hp~~~~ 280 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTL--------EKLVTDPWVTQ 280 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCH--------HHHHHCTTTTC
T ss_pred HHHHHHHHHHccCChhhCcCH--------HHHhcCccccC
Confidence 999999999999999999987 56668899875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=344.38 Aligned_cols=260 Identities=23% Similarity=0.425 Sum_probs=214.4
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++++.||+|+||.||+++++.+++.||+|++.+. ......+.+|..++..++||||+++++++.+++.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 4567999999999999999999999999999999998752 222334788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+||||+.+++|.+++.. ...+++..++.++.|++.||+|||+.|++||||||+||+++.++. +||+|||++......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMED 228 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccC
Confidence 99999999999999987 568999999999999999999999999999999999999998887 999999998644332
Q ss_pred CC--CCCCCCCCcccCccccc-----cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC-
Q 022401 175 SQ--PKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD- 246 (298)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 246 (298)
.. .....|++.|+|||++. ...++. ++||||||+++|+|++|..||...+..+........... ...+.
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~-~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~ 305 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--FQFPTQ 305 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCCSS
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCC-cCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc--ccCCcc
Confidence 22 23356899999999987 334544 599999999999999999999886654443333322211 22222
Q ss_pred CCCCCHHHHHHHHHhhhhCCCC--cccccccchhhhHHHhhhhhhhhh
Q 022401 247 TNPISQECRDLISRIFVADPAA--VSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...+++++.+||++||..+|++ |+++ .++++|||+.+.
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~--------~eil~Hpff~~i 345 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGI--------EDFKKHPFFSGI 345 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTT--------HHHHTSGGGTTC
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCH--------HHHhCCCccCCC
Confidence 2348999999999999888887 8876 666789999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=353.80 Aligned_cols=261 Identities=35% Similarity=0.557 Sum_probs=218.9
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
....++|++.+.||+|+||.||++++..+++.||+|++... ......+.+|+.++++++||||+++++++.+...+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34457899999999999999999999999999999998754 23456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC-CCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~-~~~~~~l~d~~~~~~~~~ 173 (298)
++|+|++.+++|.+.+.....+++..++.++.|++.||.|||++|++||||||+||+++.. ....++|+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999999999888899999999999999999999999999999999999999532 223499999999875544
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--CCCCCCCC
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPIS 251 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 251 (298)
........+++.|+|||.+.+ .++. ++||||+|+++|+|++|..||...+.. .....+..+... .+....++
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s 255 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDE-KCDVWSTGVILYILLSGCPPFNGANEY----DILKKVEKGKYTFELPQWKKVS 255 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCSGGGGGSC
T ss_pred ccccccCCCCccccCceeecC-CCCC-cceeHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCCCCCCCcccccCC
Confidence 444445568999999999865 4544 499999999999999999999886653 334444444433 23334689
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+++.+||++||+.||.+|||+ .++++|||++...
T Consensus 256 ~~~~~li~~~L~~dp~~R~s~--------~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 256 ESAKDLIRKMLTYVPSMRISA--------RDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHHHTCSSGGGSCCH--------HHHHTSHHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCH--------HHHhhChhhcccc
Confidence 999999999999999999987 5566788887543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=322.80 Aligned_cols=258 Identities=31% Similarity=0.573 Sum_probs=219.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
....++|++.+.||+|++|.||.+++..++..||+|++... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 34557999999999999999999999989999999998653 22346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++|+|++++++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCccc
Confidence 999999999999999988888999999999999999999999999999999999999998887 999999988644322
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .....+....... +..+++++
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~--~~~~~~~~ 239 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHT----ETHRRIVNVDLKF--PPFLSDGS 239 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCC--CTTSCHHH
T ss_pred -ccccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHh----HHHHHHhccccCC--CCcCCHHH
Confidence 2234568899999999988777665 99999999999999999999876542 3334444444433 34579999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.++|.+||+.||.+|||+ .++++|||+.+..+
T Consensus 240 ~~li~~~l~~~p~~Rps~--------~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPL--------KGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHHHSCSSGGGSCCH--------HHHHTCHHHHHHCC
T ss_pred HHHHHHHhhcCHhhCCCH--------HHHhhCHHHHhhcc
Confidence 999999999999999987 56668999986543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=323.90 Aligned_cols=259 Identities=32% Similarity=0.582 Sum_probs=214.6
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
++|++.+.||+|+||.||++++..+++.+|+|++..... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999998999999999876422 3467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC--CCCEEEeecCccccccC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVL 173 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~--~~~~~l~d~~~~~~~~~ 173 (298)
+|+|++++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ ...++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888899999999999999999999999999999999999998766 22499999999875544
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCCCCC
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPIS 251 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 251 (298)
........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .....+.......+ ....++
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQ----ETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCCHHHHTTCC
T ss_pred CCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchH----HHHHHhHhcccCCcchhcccCC
Confidence 444445568899999999877777555 99999999999999999999876542 23333333333222 123578
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
+++.+++.+||+.||.+|||+ .++++|||+....+
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~--------~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTI--------AQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCH--------HHHHHCHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCH--------HHHHhCHHHHHHHH
Confidence 999999999999999999987 56668999887643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=337.57 Aligned_cols=258 Identities=29% Similarity=0.496 Sum_probs=210.0
Q ss_pred CCeeE--EeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDF--VRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~--~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
+.|++ .+.||+|+||.||++++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+.+++|+|
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34555 678999999999999999999999999988654 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCC
Q 022401 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~ 178 (298)
|+++++|.+.+... ..+++..++.++.|++.||+|||+.|++|+||||+||++..++...++|+|||++..........
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99999998888654 46899999999999999999999999999999999999964444459999999987655554445
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--CCCCCHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRD 256 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ 256 (298)
...+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+..+ ....+....+..+. ...+++++.+
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~ 321 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAE----TLNNILACRWDLEDEEFQDISEEAKE 321 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCSCSGGGTTSCHHHHH
T ss_pred cccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccCCCChhhhccCCHHHHH
Confidence 5678999999999877666555 999999999999999999998866533 33444444433322 2457999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
||.+||+.||.+|||+ .++++|||+.+.+
T Consensus 322 li~~~L~~dp~~Rps~--------~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 322 FISKLLIKEKSWRISA--------SEALKHPWLSDHK 350 (373)
T ss_dssp HHHTTSCSSGGGSCCH--------HHHHHSHHHHCHH
T ss_pred HHHHHcCCChhhCCCH--------HHHhcCcCcCCCc
Confidence 9999999999999987 5666888887653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=348.96 Aligned_cols=257 Identities=35% Similarity=0.600 Sum_probs=215.3
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
..++|++++.||+|+||.||++++..+++.||+|++... ......+.+|+.++++++||||+++++++.+...+++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 347899999999999999999999999999999998642 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCccccccCCCC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~~~~~~~~ 176 (298)
+|++.+++|.+.+.....+++..++.++.|++.||.|||+.|++||||||+||+++..+ ...+||+|||++........
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 99999999999998888999999999999999999999999999999999999996432 23599999999876655555
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--CCCCCCCCHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQEC 254 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 254 (298)
.....+++.|+|||++.+ .++. ++||||+|+++|+|++|..||...+.. .....+..+... .+....+++++
T Consensus 180 ~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG-TYDE-KCDVWSAGVILYILLSGTPPFYGKNEY----DILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp --CCTTGGGGCCGGGGGS-CCCH-HHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred cCCCcCCCCCCCHHHhCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCCcccCCCCHHH
Confidence 556678999999999865 3544 599999999999999999999876543 334444444433 33334589999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+||.+||+.||.+|||+ .++++|||++.
T Consensus 254 ~~li~~~L~~dp~~R~t~--------~~~l~hp~~~~ 282 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITA--------TQCLEHPWIQK 282 (486)
T ss_dssp HHHHHHHTCSSTTTSCCH--------HHHHHCHHHHH
T ss_pred HHHHHHHcCCChhhCcCH--------HHHhcCHhhcc
Confidence 999999999999999988 55557888764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=332.67 Aligned_cols=262 Identities=23% Similarity=0.379 Sum_probs=206.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch--HHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
++|++++.||+|+||.||++++..+++.||+|++....... ..+.+|+.++++++||||+++++++..++..++|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999999999999999986543221 2345799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCC
Q 022401 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 178 (298)
Q Consensus 101 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~ 178 (298)
+++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence 975 888887654 45899999999999999999999999999999999999998887 999999998644322 2223
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC-C-------------
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-V------------- 244 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~------------- 244 (298)
...+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+............... +
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 44678999999998775554556999999999999999999998876655444433322211110 0
Q ss_pred ----------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhh
Q 022401 245 ----------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATEN 295 (298)
Q Consensus 245 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~ 295 (298)
.....+++++.+||.+||+.||.+|||+ .++++|||+.+..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--------~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA--------EDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH--------HHHTTSGGGGGGCST
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH--------HHHhcChhhhhcccc
Confidence 0112468899999999999999999987 566689999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=332.32 Aligned_cols=259 Identities=36% Similarity=0.565 Sum_probs=198.1
Q ss_pred CCeeEE---eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFV---RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~---~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++. +.||+|+||.||++.+..+++.||+|++... ....+.+|+.+++.+. ||||+++++++.++...++|+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 357775 7899999999999999999999999998753 3467788999999997 999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCccccccCC-CC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH-SQ 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~~~~~~-~~ 176 (298)
|++++++|.+.+.....+++.+++.++.|++.||+|||++|++||||||+||+++.++ ...++|+|||++...... ..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999999999999988999999999999999999999999999999999999997655 224999999998744332 22
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc---hhHHHHHHHHhhcCCCCCCC--CCCC
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQYSVPDT--NPIS 251 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~--~~~~ 251 (298)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.. ....+....+..+....+.. ..++
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp ------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred ccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 244557899999999987777655 99999999999999999999875432 22345566666655543321 2479
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+++.+||.+||+.||.+|||+.+++ +|||+++.
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell--------~h~w~~~~ 277 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLR--------YNEWLQDG 277 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTST--------TCGGGCTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHh--------cChhhccC
Confidence 9999999999999999999996666 78888753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=324.41 Aligned_cols=258 Identities=29% Similarity=0.508 Sum_probs=207.5
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
...++|++.+.||+|+||.||++++..++..+|+|++.... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 34578999999999999999999999999999999987643 3347788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC-CCCCEEEeecCcccccc
Q 022401 98 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSV 172 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~-~~~~~~l~d~~~~~~~~ 172 (298)
+|++++++|.+.+.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ ....++|+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999988853 3679999999999999999999999999999999999999542 22349999999987655
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC-CCCCCC
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPIS 251 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 251 (298)
.........+++.|+|||.+. ..++ .++||||||+++|+|++|..||...... .............. ....++
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~-~~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFK-RDVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLE----EVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCC--CCCC
T ss_pred CcccCcCcccccCcCChHHhc-cCCC-cccCeehHHHHHHHHHhCCCCCCCCCHH----HHHhhhccCCcccccccCcCC
Confidence 555555667899999999875 3444 4599999999999999999999875532 22333333333222 223478
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+++.+++.+||+.||.+|||+ .++++|||++.
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~--------~e~l~hp~f~~ 284 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSA--------AQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCH--------HHHHTSGGGGC
T ss_pred HHHHHHHHHHccCChhhCcCH--------HHHhcCHHhhc
Confidence 999999999999999999987 66668999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=340.53 Aligned_cols=265 Identities=24% Similarity=0.403 Sum_probs=215.1
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++++.||+|+||.||+++++.+++.||+|++.+.. .....+.+|..++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 45689999999999999999999999999999999987532 22345788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+||||+++++|.+++... ..+++..++.++.+++.||+|||+.|++||||||+||+++.+++ +||+|||++......
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRAD 215 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCC
Confidence 999999999999999765 47999999999999999999999999999999999999998887 999999998754433
Q ss_pred CC--CCCCCCCCcccCcccccc-------ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 175 SQ--PKSTVGTPAYIAPEVLLR-------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
.. .....|++.|+|||++.. ..++ .++|+||||+++|+|++|..||...+..+.......... ....+
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p 292 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE--HLSLP 292 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCC
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCC-hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CcCCC
Confidence 22 234578999999999873 3444 459999999999999999999988665333333322111 12222
Q ss_pred C-CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcC
Q 022401 246 D-TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYH 297 (298)
Q Consensus 246 ~-~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~ 297 (298)
. ...+++++.+||++||+ +|.+|+.. ....++++|||+.+. +|+
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr-----~~~~ei~~Hpff~~i--~w~ 337 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGR-----GGAGDFRTHPFFFGL--DWD 337 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTT-----TTHHHHHTSGGGTTC--CST
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCC-----CCHHHHhcCCCcCCC--CHH
Confidence 1 24589999999999998 99999631 134777899999865 454
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=340.14 Aligned_cols=260 Identities=32% Similarity=0.512 Sum_probs=204.1
Q ss_pred CCCCCeeEE-eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHH-hcCCCCCeeeeeEEEEe----CCe
Q 022401 20 HDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT----PTH 93 (298)
Q Consensus 20 ~~~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~ 93 (298)
...++|.+. +.||+|+||.||++.+..+++.||+|++... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 345678887 7899999999999999999999999998643 4567788876 45589999999999875 567
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCcccc
Q 022401 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 170 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~~ 170 (298)
+|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++ ...+||+|||++..
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 899999999999999997654 599999999999999999999999999999999999998732 23499999999875
Q ss_pred ccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCC
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTN 248 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 248 (298)
...........+++.|+|||++.+..++.+ +|||||||++|+|++|..||...............+..+....+ ...
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 292 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTT
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccc
Confidence 554444455678999999999977777655 99999999999999999999876543321222333444444333 234
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+++++.+||++||+.||.+|||+ .++++|||+...
T Consensus 293 ~~s~~~~~li~~~L~~dP~~Rpt~--------~eil~hp~~~~~ 328 (400)
T 1nxk_A 293 EVSEEVKMLIRNLLKTEPTQRMTI--------TEFMNHPWIMQS 328 (400)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCH--------HHHHHSHHHHTT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCH--------HHHhcCccccCC
Confidence 589999999999999999999987 556678888643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=332.65 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=215.0
Q ss_pred CCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-----CCCeeeeeE
Q 022401 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKE 86 (298)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~ 86 (298)
.....++....++|++++.||+|+||.||++++..+++.||+|++.........+..|+.+++.++ ||||+++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 334455666788999999999999999999999989999999999876666677888999999886 999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC---------
Q 022401 87 VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--------- 155 (298)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~--------- 155 (298)
++......++|+|++ +++|.+++.... .+++..++.++.|++.||+|||+.|++||||||+||+++.+
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 889999997654 58999999999999999999999999999999999999751
Q ss_pred --------------CCCCEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCC
Q 022401 156 --------------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221 (298)
Q Consensus 156 --------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 221 (298)
....++|+|||++.... .......+++.|+|||++.+..++.+ +||||||+++|+|++|..||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCC
Confidence 12349999999987433 23345668999999999988887766 99999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhhcCC-----------------------CCCCCC------------------CCCHHHHHHHHH
Q 022401 222 EDPDEPKDFRKTIQRILSVQY-----------------------SVPDTN------------------PISQECRDLISR 260 (298)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~------------------~~~~~l~~li~~ 260 (298)
...+..+..... ........ .++... ..++++.+||.+
T Consensus 260 ~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 260 RTHEHMEHLAMM-ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCSSHHHHHHHH-HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCcHHHHHHHH-HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 886654433322 22211100 001100 123778899999
Q ss_pred hhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 261 IFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 261 ~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
||+.||.+|||+ .++++|||++
T Consensus 339 ~L~~dP~~Rpta--------~elL~hp~f~ 360 (360)
T 3llt_A 339 ILQIDPTLRPSP--------AELLKHKFLE 360 (360)
T ss_dssp HCCSSGGGSCCH--------HHHTTSGGGC
T ss_pred HhcCChhhCCCH--------HHHhcCcccC
Confidence 999999999988 5556888874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=336.84 Aligned_cols=261 Identities=22% Similarity=0.368 Sum_probs=209.1
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe---------
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--------- 90 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 90 (298)
...++|++++.||+|+||.||+|++..+++.||+|++..+... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 4467999999999999999999999999999999998765433 2469999999999999999999843
Q ss_pred -----------------------------CCeEEEEEeccCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHhh
Q 022401 91 -----------------------------PTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHA 137 (298)
Q Consensus 91 -----------------------------~~~~~lv~~~~~~~sL~~~l----~~~~~~~~~~~~~i~~~l~~~l~~Lh~ 137 (298)
...+++||||+++ +|.+.+ .....+++..++.++.|++.||.|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3458999999975 666555 346789999999999999999999999
Q ss_pred cCcEEecCCCCceEee-CCCCCCEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh
Q 022401 138 MQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216 (298)
Q Consensus 138 ~~i~H~dl~p~nilv~-~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~ 216 (298)
.|++||||||+||+++ .++. ++|+|||++.............+++.|+|||.+.+....+.++||||+||++|+|++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTE--EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCc--EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999998 4555 999999999866555555666789999999998876644555999999999999999
Q ss_pred CCCCCCCCCCchhHHHHHHHHhhcC-------------CCCC----------CCCCCCHHHHHHHHHhhhhCCCCccccc
Q 022401 217 GGYPFEDPDEPKDFRKTIQRILSVQ-------------YSVP----------DTNPISQECRDLISRIFVADPAAVSIFF 273 (298)
Q Consensus 217 g~~pf~~~~~~~~~~~~~~~~~~~~-------------~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ 273 (298)
|..||......+.+...++...... ...+ .+..+++++.+||.+||+.||.+|||+
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~- 316 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP- 316 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH-
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH-
Confidence 9999998776555555443221110 0001 123478999999999999999999988
Q ss_pred ccchhhhHHHhhhhhhhhhhh
Q 022401 274 FPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 274 ~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.++++|||+.+...
T Consensus 317 -------~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 317 -------YEAMAHPFFDHLRN 330 (383)
T ss_dssp -------HHHHTSGGGHHHHH
T ss_pred -------HHHhcCHHHHHHHh
Confidence 55667888876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=321.75 Aligned_cols=255 Identities=33% Similarity=0.471 Sum_probs=216.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++.+.||+|+||.||++.+..+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45589999999999999999999999999999999987542 23456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~- 174 (298)
+|+|++++++|.+++.....+++.+++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCc
Confidence 99999999999999988888999999999999999999999999999999999999998887 999999998754322
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
.......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... +....+....... +..+++++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~ 242 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIKKNEYSI--PKHINPVA 242 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCC--CTTSCHHH
T ss_pred cccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhhccCCC--ccccCHHH
Confidence 22334568889999999877777555 99999999999999999999875542 3333344444333 34579999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+++.+||+.||.+|||+.+++ +|||+.+
T Consensus 243 ~~li~~~l~~~p~~Rps~~~ll--------~~~~~~~ 271 (294)
T 2rku_A 243 ASLIQKMLQTDPTARPTINELL--------NDEFFTS 271 (294)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGG--------GSHHHHT
T ss_pred HHHHHHHcccChhhCcCHHHHh--------hChheec
Confidence 9999999999999999985555 6788764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=333.64 Aligned_cols=264 Identities=27% Similarity=0.418 Sum_probs=217.5
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
.....++|++.+.||+|+||.||++++..++..||+|++.... .....+.+|+.++++++||||+++++++.+++.++
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 3455689999999999999999999999999999999987653 23456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc-CcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+|+||+++++|.+++.....+++..+..++.+++.||.|||+. |++|+||+|+||+++.++. ++|+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccccc
Confidence 9999999999999998888899999999999999999999986 9999999999999998887 999999988533221
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchh-------------------------
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------------- 229 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~------------------------- 229 (298)
......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+....
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2234568899999999987777655 9999999999999999999987543221
Q ss_pred -------------HHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 230 -------------FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 230 -------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
..+....+............++.++.+||.+||+.||.+|||+ .++++|||+.+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~ell~hp~~~~~~ 332 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL--------KQLMVHAFIKRSD 332 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCH--------HHHHTSHHHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCH--------HHHhhChHhhcch
Confidence 1122223333333333334478999999999999999999987 5666899998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=332.32 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=210.2
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEe--
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-- 90 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 90 (298)
.|.+-..++|++++.||+|+||.||+|++..+++.||+|++.... .....+.+|+.++++++||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 10 CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp CTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 445556789999999999999999999999999999999886543 234567899999999999999999999987
Q ss_pred ------CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEe
Q 022401 91 ------PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (298)
Q Consensus 91 ------~~~~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~ 163 (298)
.+.+++|+||+++ +|.+.+.. ...+++.+++.++.|++.||+|||++|++|+||||+||+++.++. ++|+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~ 166 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLA 166 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEEC
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEc
Confidence 3468999999976 66666654 357999999999999999999999999999999999999998887 9999
Q ss_pred ecCccccccC-----CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 022401 164 DFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 238 (298)
Q Consensus 164 d~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 238 (298)
|||++..... ........+++.|+|||.+.+....+.++||||||+++|+|++|..||.................
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999864432 12223445789999999987765545569999999999999999999998665444333332222
Q ss_pred hcCCCC-CCCC-------------------------CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 239 SVQYSV-PDTN-------------------------PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 239 ~~~~~~-~~~~-------------------------~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...... +... ..++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--------~e~l~hp~f~~ 317 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS--------DDALNHDFFWS 317 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGGS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH--------HHHhCCCCcCC
Confidence 111111 0000 026789999999999999999987 56668999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=322.86 Aligned_cols=260 Identities=33% Similarity=0.538 Sum_probs=217.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.++|++.+.||+|++|.||.+.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 368999999999999999999999899999999987543 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC---CC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 176 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~---~~ 176 (298)
++++++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhc
Confidence 9999999999987778999999999999999999999999999999999999998887 999999998643222 12
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....+++.|+|||.+.+..+...++||||||+++|+|++|..||.......... ..+.......+....+++++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH---HHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHhhhcccccCchhhcCHHHHH
Confidence 2345678899999999877765556999999999999999999998766433222 2222222233333457999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
+|.+||+.||.+|||+ .++++|||++++.+
T Consensus 241 li~~~l~~~p~~Rps~--------~~il~~~~~~~~~~ 270 (276)
T 2yex_A 241 LLHKILVENPSARITI--------PDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHHSCSSTTTSCCH--------HHHTTCTTTTCCCC
T ss_pred HHHHHCCCCchhCCCH--------HHHhcCccccChhh
Confidence 9999999999999987 55668999986644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=325.70 Aligned_cols=262 Identities=29% Similarity=0.448 Sum_probs=210.7
Q ss_pred CCCeeEE-eeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEE
Q 022401 22 SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 22 ~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.++|++. +.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++.++ +||||+++++++.+++.+++|+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4689995 78999999999999999899999999997654 3356788999999885 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC-CCEEEeecCccccccCCC--
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS-- 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~-~~~~l~d~~~~~~~~~~~-- 175 (298)
|++++++|.+++.....+++..++.++.|++.||+|||++|++|+||||+||+++.++. ..++|+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99999999999988888999999999999999999999999999999999999986654 348999999886433211
Q ss_pred ------CCCCCCCCCcccCcccccc-----ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch-----------hHHHH
Q 022401 176 ------QPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------DFRKT 233 (298)
Q Consensus 176 ------~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-----------~~~~~ 233 (298)
......+++.|+|||.+.. ..++.+ +||||||+++|+|++|..||......+ .....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 1123348899999999865 345454 999999999999999999998764321 12233
Q ss_pred HHHHhhcCCCCCCC--CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 234 IQRILSVQYSVPDT--NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 234 ~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...+.......+.. ..+++++.+||.+||+.||.+|||+ .++++|||+++.
T Consensus 250 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~--------~e~l~hp~~~~~ 302 (316)
T 2ac3_A 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA--------AQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH--------HHHHHSTTCC--
T ss_pred HHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH--------HHHhcChhhcCC
Confidence 44455554444321 3478999999999999999999987 666689999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=325.29 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=211.6
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEe---
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT--- 90 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--- 90 (298)
........++|++.+.||+|+||.||++++..+++.||+|++.........+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33445567899999999999999999999998999999999988777778899999999998 79999999999987
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 91 ---PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 91 ---~~~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
...+++|+||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Df 173 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDF 173 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeC
Confidence 46899999999999999999764 46899999999999999999999999999999999999998887 999999
Q ss_pred CccccccCC-CCCCCCCCCCcccCccccc-----cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 022401 166 GYSKSSVLH-SQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239 (298)
Q Consensus 166 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 239 (298)
|++...... .......+++.|+|||.+. +..++.+ +||||||+++|+|++|..||........ ...+..
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~ 248 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRA----LFLIPR 248 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC--------CCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHH
T ss_pred cCceecCcCccccccccCCccccChhhhccccccCcCCCcc-chHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHhhc
Confidence 988644322 2233456889999999986 3344444 9999999999999999999977554222 222223
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 240 VQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..........+++++.++|.+||+.||.+|||+ .++++|||+.+.
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--------~~ll~hp~~~~~ 293 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT--------EQLMKHPFIRDQ 293 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCH--------HHHHTSHHHHCC
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCH--------HHHhhChHHhhC
Confidence 333223345589999999999999999999987 556678888753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=334.70 Aligned_cols=261 Identities=29% Similarity=0.500 Sum_probs=210.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC------CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
.++|++.+.||+|+||.||++.+..++..+|+|++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 46899999999999999999999999999999998653 344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 022401 96 IVMEYASGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVSYC 135 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~----------------------------------------~~~~~~~~~~~i~~~l~~~l~~L 135 (298)
+|+||+++++|.+.+.. ...+++..++.++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998842 11235778899999999999999
Q ss_pred hhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-----CCCCCCCCCcccCccccccc-cCCCCccchHHHHH
Q 022401 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGV 209 (298)
Q Consensus 136 h~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ 209 (298)
|+.|++|+||+|+||+++.++...++|+|||++....... ......+++.|+|||.+.+. ...+.++||||||+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 9999999999999999987775569999999986433221 22345688999999998652 33344599999999
Q ss_pred HHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCC--CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhh
Q 022401 210 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFV 287 (298)
Q Consensus 210 ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp 287 (298)
++|+|++|..||......+. ...+....... +....+++++.++|.+||+.||.+|||+ .++++||
T Consensus 265 il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--------~~~l~hp 332 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADT----ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA--------MRALQHP 332 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH--------HHHHHSH
T ss_pred HHHHHHHCCCCCCCCChHHH----HHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH--------HHHhcCh
Confidence 99999999999988665433 33333333332 2233478999999999999999999987 6667899
Q ss_pred hhhhhhh
Q 022401 288 WMFDATE 294 (298)
Q Consensus 288 ~~~~~~~ 294 (298)
|+.+...
T Consensus 333 ~~~~~~~ 339 (345)
T 3hko_A 333 WISQFSD 339 (345)
T ss_dssp HHHTTSS
T ss_pred hhccChH
Confidence 9987543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=327.48 Aligned_cols=256 Identities=32% Similarity=0.470 Sum_probs=217.3
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++.+.||+|+||.||++++..+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34578999999999999999999999999999999987542 23456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~- 174 (298)
+|+||+.+++|.+++.....+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCc
Confidence 99999999999999988888999999999999999999999999999999999999998887 999999998754322
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
.......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .....+....... +..+++++
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~--~~~~~~~~ 268 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIKKNEYSI--PKHINPVA 268 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCCC--CTTSCHHH
T ss_pred ccccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHhcCCCCC--CccCCHHH
Confidence 22334568899999999987777555 99999999999999999999875542 3333344444433 33479999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.++|.+||+.||.+|||+.+++ +|||+.+.
T Consensus 269 ~~li~~~l~~dp~~Rps~~ell--------~~~~~~~~ 298 (335)
T 2owb_A 269 ASLIQKMLQTDPTARPTINELL--------NDEFFTSG 298 (335)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGG--------GSHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHh--------cCccccCC
Confidence 9999999999999999885555 78887753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=322.37 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=216.5
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----------cchHHHHHHHHHHhcCC-CCCeeeeeEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----------KIDENVQREIINHRSLR-HPNIVRFKEVIL 89 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 89 (298)
-.++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3579999999999999999999999999999999987643 12345778999999995 999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 90 ~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
.+...++|+|++++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~ 172 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSC 172 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCE
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchh
Confidence 99999999999999999999988888999999999999999999999999999999999999998887 9999999987
Q ss_pred cccCCCCCCCCCCCCcccCcccccc------ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 022401 170 SSVLHSQPKSTVGTPAYIAPEVLLR------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243 (298)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
............+++.|+|||.+.+ ..+ +.++||||||+++|+|++|..||...... .....+......
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~ 247 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQM----LMLRMIMSGNYQ 247 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCC
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHH----HHHHHHhcCCcc
Confidence 6554444455678899999998752 233 44599999999999999999999876542 233334444433
Q ss_pred CC--CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 244 VP--DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 244 ~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+ ....+++++.+++.+||+.||.+|||+ .++++|||+++.
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--------~~ll~h~~~~~~ 290 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA--------EEALAHPFFQQY 290 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH--------HHHTTSGGGCTT
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCH--------HHHHhChHhhhc
Confidence 32 234589999999999999999999987 556689998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=326.89 Aligned_cols=263 Identities=25% Similarity=0.386 Sum_probs=212.1
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
...++|++.+.||+|+||.||++++..+++.||+|++...... ...+.+|+.++++++||||+++++++.+....++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 3567999999999999999999999999999999998654332 3456789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-C
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 175 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~ 175 (298)
|+|++++++|..++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCcc
Confidence 9999999999888877788999999999999999999999999999999999999998887 999999998643332 2
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh---------------c
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS---------------V 240 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~ 240 (298)
......+++.|+|||.+.+....+.++||||||+++|+|++|..||......+........... .
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 2344568899999999877644455699999999999999999999887665544433322111 0
Q ss_pred CCCCCC----------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 241 QYSVPD----------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 241 ~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
....+. ...+++++.+||.+||+.||.+|||+.++| +|||++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell--------~hp~f~~~ 313 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL--------HHDFFQMD 313 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGG--------GSHHHHGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHh--------cCchhccC
Confidence 011111 124689999999999999999999986655 68888754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=321.65 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=193.5
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
.++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 368999999999999999999998899999999987532 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-C
Q 022401 98 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 175 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~ 175 (298)
+|++++++|.+++... .++++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCC
Confidence 9999999999999765 57899999999999999999999999999999999999998887 999999998754322 2
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||........ ..++..... ..+..++.++.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~~ 240 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNT----LNKVVLADY--EMPSFLSIEAK 240 (278)
T ss_dssp ------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCC--CCCTTSCHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHH----HHHHhhccc--CCccccCHHHH
Confidence 2234567889999999887777655 9999999999999999999987654322 222222222 33445799999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
++|.+||+.||.+|||+ .++++|||+.+..
T Consensus 241 ~li~~~l~~dp~~Rps~--------~~~l~h~~~~~~~ 270 (278)
T 3cok_A 241 DLIHQLLRRNPADRLSL--------SSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHSCSSGGGSCCH--------HHHTTSTTTC---
T ss_pred HHHHHHcccCHhhCCCH--------HHHhcCccccCCC
Confidence 99999999999999987 5666899998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=323.07 Aligned_cols=254 Identities=34% Similarity=0.578 Sum_probs=211.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.++|++.+.||+|+||.||++++..+++.||+|++..... ....+.+|+.++++++||||+++++++.+....++|+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 4689999999999999999999998999999999886533 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe---eCCCCCCEEEeecCccccccCCCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv---~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
+++++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++. ++|+|||++...... ..
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~-~~ 164 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSK--IMITDFGLSKMEQNG-IM 164 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCC--EEBCSCSTTCCCCCB-TT
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCC--EEEccCCcceecCCC-cc
Confidence 9999999999888889999999999999999999999999999999999999 44554 999999987643221 22
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--CCCCCCCCHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECR 255 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~ 255 (298)
....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .....+...... .+....+++++.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEETES----KLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred ccccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCCCCCCccccccCCHHHH
Confidence 33457899999999987776555 99999999999999999999876542 333344444332 233356899999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
++|.+||+.||.+|||+ .++++|||+.+
T Consensus 240 ~li~~~l~~dp~~Rps~--------~~~l~h~~~~~ 267 (304)
T 2jam_A 240 DFICHLLEKDPNERYTC--------EKALSHPWIDG 267 (304)
T ss_dssp HHHHHHHCSSTTTSCCH--------HHHHTSHHHHS
T ss_pred HHHHHHcCCChhHCcCH--------HHHhcCccccC
Confidence 99999999999999987 55567888864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=326.47 Aligned_cols=261 Identities=21% Similarity=0.391 Sum_probs=211.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-CCCeeeeeEEEEe--CCeEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAIV 97 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv 97 (298)
..++|++++.||+|+||.||++++..+++.||+|++... ....+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 457899999999999999999999999999999998743 3467889999999997 9999999999987 5688999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
+|++.+++|.+.+.. +++.+++.++.|++.||+|||+.|++|+||||+||+++.++. .++|+|||++.........
T Consensus 112 ~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp EECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCC
T ss_pred EeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCcc
Confidence 999999999888743 789999999999999999999999999999999999987662 3999999999765555555
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh----------cCC-----
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS----------VQY----- 242 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~----- 242 (298)
....++..|+|||.+.+....+.++||||||+++|+|++|..||............+..... ...
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence 66678899999999877554455699999999999999999999665443222211111110 000
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhh
Q 022401 243 -----------------SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATEN 295 (298)
Q Consensus 243 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~ 295 (298)
.......+++++.+||.+||+.||.+|||+ .++++|||+++..|+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta--------~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA--------REAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH--------HHHHTSGGGTTCC--
T ss_pred hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH--------HHHhcCccHhhhccC
Confidence 011112268999999999999999999987 666799999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=322.85 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=211.8
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
.|+..+.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++...+..++|+||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 48899999999999999999998999999999876543 34668899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCCCCC
Q 022401 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 181 (298)
Q Consensus 103 ~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 181 (298)
+++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence 9999998854 56899999999999999999999999999999999999998887 9999999986544332 234456
Q ss_pred CCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CCCCCCCCCHHHHHHHHH
Q 022401 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTNPISQECRDLISR 260 (298)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 260 (298)
+++.|+|||.+.+..++.+ +||||||+++|+|++|..||....... ....+..... .......+++++.+++.+
T Consensus 203 gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQ----AMKRLRDSPPPKLKNSHKVSPVLRDFLER 277 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred CCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence 8999999999987777665 999999999999999999998755422 2333333322 233344578999999999
Q ss_pred hhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 261 IFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 261 ~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
||+.||.+|||+ .++++|||+..
T Consensus 278 ~l~~dp~~Rps~--------~ell~hp~~~~ 300 (321)
T 2c30_A 278 MLVRDPQERATA--------QELLDHPFLLQ 300 (321)
T ss_dssp HSCSSTTTSCCH--------HHHHTSGGGGG
T ss_pred HccCChhhCcCH--------HHHhcChhhcc
Confidence 999999999987 55567888763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=325.24 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=213.2
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--eEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 95 (298)
...++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 45679999999999999999999999999999999987543 33466789999999999999999999988765 789
Q ss_pred EEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe----eCCCCCCEEEeecCcc
Q 022401 96 IVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICDFGYS 168 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv----~~~~~~~~~l~d~~~~ 168 (298)
+|+||+++++|.+++..... +++.+++.++.|++.||+|||+.|++|+||||+||++ +.++ .+||+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCc
Confidence 99999999999999976443 8999999999999999999999999999999999998 4444 4999999999
Q ss_pred ccccCCCCCCCCCCCCcccCccccc--------cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 022401 169 KSSVLHSQPKSTVGTPAYIAPEVLL--------RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240 (298)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (298)
.............+++.|+|||.+. +..++.+ +||||||+++|+|++|..||..........+.+.++..+
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 7655555545567899999999876 3445444 999999999999999999998766655556666666554
Q ss_pred CC-------------------CCCCC----CCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 241 QY-------------------SVPDT----NPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 241 ~~-------------------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
.. ..+.. ..+++.+.++|++||+.||++|||+.++|++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 33 11111 1234679999999999999999999888766543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=327.28 Aligned_cols=270 Identities=20% Similarity=0.325 Sum_probs=202.1
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCc---EEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEE
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVI 88 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (298)
........++|++.+.||+|+||.||++++..++. .||+|++... ....+.+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 34556677899999999999999999999876664 7999998754 33446788999999999999999999999
Q ss_pred EeCCeE------EEEEeccCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC
Q 022401 89 LTPTHL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156 (298)
Q Consensus 89 ~~~~~~------~lv~~~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~ 156 (298)
...... ++|+||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 877654 99999999999999985432 589999999999999999999999999999999999999887
Q ss_pred CCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 022401 157 APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRK 232 (298)
Q Consensus 157 ~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~ 232 (298)
. ++|+|||++....... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+...
T Consensus 175 ~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~- 250 (323)
T 3qup_A 175 T--VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYN- 250 (323)
T ss_dssp C--EEECCCCC-----------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-
T ss_pred C--EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHH-
Confidence 7 9999999986443322 2223345678999999887777655 999999999999999 899998876544322
Q ss_pred HHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.+.... ....+..+++++.+++.+||+.||.+|||+.++++ ....++.|||+.+..
T Consensus 251 ---~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~-~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 251 ---YLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM-ELENILGHLSVLSTS 306 (323)
T ss_dssp ---HHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH-HHHHHHHC-------
T ss_pred ---HHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHH-HHHHHHHHhhhcCCC
Confidence 222222 33444568999999999999999999999999987 678899999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=324.55 Aligned_cols=259 Identities=30% Similarity=0.381 Sum_probs=209.8
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
+....++|++++.||+|+||.||++++..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++..++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 34456899999999999999999999999999999999865432 23567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+++|+||+++++|.+++...+++++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC--
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCcccccc
Confidence 9999999999999999998889999999999999999999999999999999999999998887 99999999875433
Q ss_pred CC--CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--CCCCCC
Q 022401 174 HS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNP 249 (298)
Q Consensus 174 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 249 (298)
.. ......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||......... ...+...... ......
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 239 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIA---IKHIQDSVPNVTTDVRKD 239 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHH---HHHHSSCCCCHHHHSCTT
T ss_pred ccccccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHhhccCCCcchhcccC
Confidence 22 2233458999999999988777665 99999999999999999999876543222 2222222111 122345
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhhhHH
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMSCLL 282 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~ 282 (298)
+|+++.++|.+||+.||.+||+..+.+...+..
T Consensus 240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 899999999999999999999766655444433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=329.61 Aligned_cols=253 Identities=31% Similarity=0.489 Sum_probs=213.8
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---------hHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------DENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (298)
++|++.+.||.|++|.||+|++..+|+.||||++...... .+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999989999999998765321 34577899999998 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
..++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence 99999999999999999988888999999999999999999999999999999999999998887 9999999987655
Q ss_pred CCCCCCCCCCCCcccCccccccc------cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC-
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP- 245 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 245 (298)
.........+++.|+|||.+.+. .++. ++||||||+++|+|++|..||...... .....+.......+
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGK-EVDLWACGVILFTLLAGSPPFWHRRQI----LMLRMIMEGQYQFSS 326 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCH
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCc-hhhHHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCCC
Confidence 55444566789999999987633 3444 499999999999999999999875542 23333434433322
Q ss_pred -CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 246 -DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 246 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
....++.++.++|.+||+.||.+|||+ .++++|||++
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~--------~ell~hp~f~ 364 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTA--------EQALQHPFFE 364 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCH--------HHHHHSGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCH--------HHHhcCcccC
Confidence 223578999999999999999999987 6666899985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=318.78 Aligned_cols=260 Identities=21% Similarity=0.311 Sum_probs=196.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch---HHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
...++|++.+.||+|+||.||++++..+++.||+|++....... ..+.++...++.++||||+++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 45579999999999999999999999999999999987643222 223455556788899999999999999999999
Q ss_pred EEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhc-CcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 97 VMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 97 v~~~~~~~sL~~~l~----~~~~~~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
|+|++++ +|.+++. ....+++..++.++.|++.||+|||++ |++|+||||+||+++.++. ++|+|||++...
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccc
Confidence 9999975 7766654 456799999999999999999999998 9999999999999998887 999999998765
Q ss_pred cCCCCCCCCCCCCcccCccccc---cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
..........+++.|+|||.+. .....+.++||||+|+++|+|++|..||....... .................
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF---QQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH---HHHHHHHHSCCCCCCTT
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH---HHHHHHhccCCCCcccc
Confidence 5555555567899999999962 23333445999999999999999999998644322 22222223333223334
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.+++++.+++.+||+.||.+|||+ .++++|||++...
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~--------~e~l~hp~f~~~~ 274 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTY--------PELMQHPFFTLHE 274 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCH--------HHHTTSHHHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCH--------HHHHhCcccccCc
Confidence 589999999999999999999987 5556899988543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=324.96 Aligned_cols=250 Identities=21% Similarity=0.250 Sum_probs=198.6
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch---HHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||+|++..+++.||+|++....... .....|+..+.++ +||||+++++++.+++.+++|+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 68999999999999999999999899999999876543222 2344455554444 8999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|++ +++|.+.+.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence 999 5588777755 446999999999999999999999999999999999999998887 999999998766555555
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||++.+ .++. ++||||||+++|+|++|..|+.... ....+............+++++.++
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~el~~g~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGT-AADVFSLGLTILEVACNMELPHGGE-------GWQQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCST-HHHHHHHHHHHHHHHHTCCCCSSHH-------HHHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred cccCCCccccCHhHhcC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHhccCCCcccccCCCHHHHHH
Confidence 56678999999998865 5544 4999999999999999977665422 1222222222222233578999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
|.+||+.||.+|||+ .++++|||++.+
T Consensus 285 i~~~L~~dP~~Rpt~--------~ell~hp~~~~p 311 (311)
T 3p1a_A 285 LVMMLEPDPKLRATA--------EALLALPVLRQP 311 (311)
T ss_dssp HHHHSCSSTTTSCCH--------HHHHTSGGGSCC
T ss_pred HHHHcCCChhhCcCH--------HHHHhCccccCC
Confidence 999999999999987 666689998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=322.56 Aligned_cols=254 Identities=27% Similarity=0.406 Sum_probs=204.9
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
.......++|++.+.||+|+||.||++++ +++.||+|++...... ...+.+|+.++++++||||+++++++.+..
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34455668999999999999999999987 4788999998765432 346788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 93 HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
.+++|+||+++++|.+++..... +++..++.++.|++.||+|||+.| ++||||||+||+++.++. ++|+|||+
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~ 185 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGL 185 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC-
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCC
Confidence 99999999999999999977653 899999999999999999999999 999999999999998887 99999999
Q ss_pred cccccCC-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 168 SKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
+...... .......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.. .....+.........
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~~~~ 260 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPA----QVVAAVGFKCKRLEI 260 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHHHSCCCCCC
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCCC
Confidence 8643322 22344568999999999988877666 99999999999999999999876542 223333333334445
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
+..+++++.++|.+||+.||.+|||+.++++.
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 292 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 56689999999999999999999999988864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=352.29 Aligned_cols=262 Identities=30% Similarity=0.450 Sum_probs=223.9
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (298)
....++|++++.||+|+||.||++++..+++.||+|++.+. ....+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34568999999999999999999999999999999998753 33446678899999887 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+||||+++++|..++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++.....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIW 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeecccc
Confidence 9999999999999999998889999999999999999999999999999999999999999887 99999999874322
Q ss_pred -CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
........|++.|+|||++.+..++.+ +||||||+++|||++|..||...+. .+....+.......+. .+++
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~ 567 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPK--SMSK 567 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHSSCCCCCT--TSCH
T ss_pred CCcccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCH----HHHHHHHHhCCCCCCc--cCCH
Confidence 233345678999999999988887665 9999999999999999999987654 4555666666655543 4899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++.+||++||+.||.+||++.. ....++++|||+.+.
T Consensus 568 ~~~~li~~lL~~dP~~R~~~~~---~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 568 EAVAICKGLMTKHPGKRLGCGP---EGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHHHHHSCSSSTTCTTCST---THHHHHHSSGGGSSC
T ss_pred HHHHHHHHHccCCHHHCCCCCC---CcHHHHhcCccccCC
Confidence 9999999999999999998732 234788899999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=340.48 Aligned_cols=260 Identities=32% Similarity=0.511 Sum_probs=204.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 478999999999999999999999999999999987532 11224788999999999999999999974 55
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~~~ 171 (298)
.+++|+||+.+++|.+.+.....+++.+++.++.|++.||+|||++|++||||||+||+++.++ ...+||+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6899999999999999998888999999999999999999999999999999999999997543 235999999999865
Q ss_pred cCCCCCCCCCCCCcccCcccccc--ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DT 247 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~ 247 (298)
..........+++.|+|||++.+ ....+.++||||||+++|+|++|..||........+...+. ....... ..
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---~~~~~~~~~~~ 369 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVW 369 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---TTCCCCCHHHH
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---cCCCCCCchhh
Confidence 54444455678999999999864 22223459999999999999999999987655444433332 2222211 12
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
..+++++.+||.+||+.||.+|||+ .++++|||+++..
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~--------~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTT--------EEALRHPWLQDED 407 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCH--------HHHHHSGGGCCHH
T ss_pred cccCHHHHHHHHHHccCChhHCcCH--------HHHhCCcccCChh
Confidence 3478999999999999999999987 5667899998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=329.66 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=206.6
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
....++|++++.||+|+||.||.+.+..+|+.||+|++..... ....+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 3456789999999999999999999998999999999875322 2346789999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
..++|+|++++ +|...+... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSF 162 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTT
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceec
Confidence 99999999976 788877654 36899999999999999999999999999999999999998887 999999998754
Q ss_pred cCC-CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CCCC---
Q 022401 172 VLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPD--- 246 (298)
Q Consensus 172 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~--- 246 (298)
... .......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+.+............ .++.
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 332 23344568999999999876654455699999999999999999999887665555444443322111 0100
Q ss_pred ------------------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 247 ------------------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 247 ------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...+++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~ell~h~~f~~ 297 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA--------TQALKMKYFSN 297 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH--------HHHHTSGGGTS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH--------HHHhcChhhhc
Confidence 13467999999999999999999988 55667888864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=337.44 Aligned_cols=267 Identities=24% Similarity=0.310 Sum_probs=217.0
Q ss_pred CcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC------CCCCeeeeeEE
Q 022401 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEV 87 (298)
Q Consensus 14 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~ 87 (298)
...+......+|++++.||+|+||.||+|.+..+++.||+|++.........+.+|+.+++.+ .|+||++++++
T Consensus 88 ~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 88 VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp CCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred cccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 345566677899999999999999999999999999999999987766666777888888776 57799999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 88 ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 88 ~~~~~~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
+.....+++|+|++. ++|.+++.... .+++..++.++.|++.||+|||+.|++||||||+||+++.++...+||+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999996 58888887654 489999999999999999999999999999999999999887666999999
Q ss_pred CccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--
Q 022401 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-- 243 (298)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 243 (298)
|++.... .......+++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+.+.............
T Consensus 247 G~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 247 GSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp TTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccceecC--CcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 9986432 23345578899999999988887665 999999999999999999998877655544443321110000
Q ss_pred --------------C-----------------------------C--------CCCCCCHHHHHHHHHhhhhCCCCcccc
Q 022401 244 --------------V-----------------------------P--------DTNPISQECRDLISRIFVADPAAVSIF 272 (298)
Q Consensus 244 --------------~-----------------------------~--------~~~~~~~~l~~li~~~l~~dp~~Rps~ 272 (298)
. + .....++++.+||.+||+.||.+|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 0 0 011237889999999999999999988
Q ss_pred cccchhhhHHHhhhhhhhhh
Q 022401 273 FFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 273 ~~~l~~~~~~~~~hp~~~~~ 292 (298)
.++++|||+...
T Consensus 404 --------~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 404 --------GQALRHPWLRRR 415 (429)
T ss_dssp --------HHHHTSTTTC--
T ss_pred --------HHHhCChhhccC
Confidence 566689999854
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=328.73 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=205.1
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----hHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT- 92 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 92 (298)
+....++|++.+.||+|+||.||++++..+++.||+|++...... ...+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 344568999999999999999999999989999999998764322 246789999999999999999999987654
Q ss_pred ---eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 93 ---HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 93 ---~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
..++|+||+++++|.+++...+++++.+++.++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++.
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~ 164 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIAR 164 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC-
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcc
Confidence 35999999999999999988889999999999999999999999999999999999999998887 9999999986
Q ss_pred cccCCC----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--
Q 022401 170 SSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-- 243 (298)
Q Consensus 170 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 243 (298)
...... ......+++.|+|||++.+..++.+ +||||||+++|+|++|..||......... .........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~----~~~~~~~~~~~ 239 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVA----YQHVREDPIPP 239 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHCCCCCH
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHhcCCCCCc
Confidence 443322 2223457999999999987777655 99999999999999999999876543222 222222211
Q ss_pred CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHH
Q 022401 244 VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLL 282 (298)
Q Consensus 244 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~ 282 (298)
......+++++.++|.+||+.||.+||++.+++.+.+..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 112334799999999999999999999886666544443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=342.64 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=201.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------C
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------T 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 92 (298)
.++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999999999999999998753 23345678999999999999999999999654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+|+|+||++++ +.+.+.. .+++..++.++.|++.||+|||+.|++||||||+||+++.++. +||+|||++....
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC----
T ss_pred eEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecC
Confidence 679999999764 6565533 4899999999999999999999999999999999999998887 9999999997665
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC----------
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY---------- 242 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------- 242 (298)
.........+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+.+......+.....
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 5444555678999999999988887766 99999999999999999999987765555444433221100
Q ss_pred -----CCCCCCC---------------------CCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 243 -----SVPDTNP---------------------ISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 243 -----~~~~~~~---------------------~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
..+.... .++++.+||.+||+.||.+|||+ .++++|||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta--------~e~L~Hp~~~ 360 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV--------DDALQHPYIN 360 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH--------HHHHTSTTTG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH--------HHHhcChhhh
Confidence 0000000 14679999999999999999988 5555788876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=316.40 Aligned_cols=257 Identities=22% Similarity=0.341 Sum_probs=210.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CC
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PT 92 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 92 (298)
.....|++.+.||+|+||.||++.+..++..|++|.+.... .....+.+|+.++++++||||+++++++.. ..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 44566999999999999999999999999999999987543 234567899999999999999999999875 45
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEee-CCCCCCEEEeecCccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGYSK 169 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~-~~~~~~~~l~d~~~~~ 169 (298)
.+++|+||+++++|.+++.....+++..++.++.+++.||.|||+.| ++|+||+|+||+++ .++. ++|+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCcc
Confidence 78999999999999999988888999999999999999999999999 99999999999997 5665 9999999986
Q ss_pred cccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
..... ......+++.|+|||.+.+ .++. ++||||||+++|+|++|..||........ ....+............
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGT-CCCT-HHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCGGGGGC
T ss_pred ccccc-ccccccCCcCcCCHHHHhc-cCCC-cchHHHHHHHHHHHHhCCCCCCCcCcHHH---HHHHHhccCCccccCCC
Confidence 33222 2234458899999998754 3544 59999999999999999999987655333 23333333333233344
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.++++.++|.+||+.||.+|||+ .++++|||+++.
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~--------~ell~h~~f~~~ 289 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSI--------KDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhhCCCH--------HHHhhCcccccC
Confidence 67999999999999999999987 667789999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=333.50 Aligned_cols=257 Identities=26% Similarity=0.354 Sum_probs=197.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCC--eEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~ 95 (298)
.++|++++.||+|+||.||+|.+..+++.||+|++... ........+|+.+++.+. ||||+++++++..++ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46899999999999999999999999999999998643 223355678999999997 999999999997554 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~- 174 (298)
+|+||+++ +|...+.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++. +||+|||+++.....
T Consensus 88 lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred EEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence 99999974 88888865 47899999999999999999999999999999999999998887 999999998643221
Q ss_pred ---------------------CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 022401 175 ---------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (298)
Q Consensus 175 ---------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 233 (298)
.......+++.|+|||.+.+....+.++||||+||++|+|++|..||.+.+..+.+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 11122358889999999987554455699999999999999999999887665554444
Q ss_pred HHHHhhcCC-----------------------------------------CCCCCCCCCHHHHHHHHHhhhhCCCCcccc
Q 022401 234 IQRILSVQY-----------------------------------------SVPDTNPISQECRDLISRIFVADPAAVSIF 272 (298)
Q Consensus 234 ~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 272 (298)
...+..... .......+++++.+||.+||+.||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 322111100 001112468999999999999999999988
Q ss_pred cccchhhhHHHhhhhhhh
Q 022401 273 FFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 273 ~~~l~~~~~~~~~hp~~~ 290 (298)
.++++|||+.
T Consensus 324 --------~e~l~Hp~~~ 333 (388)
T 3oz6_A 324 --------NDALKHPFVS 333 (388)
T ss_dssp --------HHHTTSTTTT
T ss_pred --------HHHhCCHHHH
Confidence 4555788875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=319.57 Aligned_cols=274 Identities=19% Similarity=0.255 Sum_probs=226.4
Q ss_pred CcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 14 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
....+....++|++.+.||+|+||.||.+.+..++..+|+|++..+....+.+.+|+.++++++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 33456667889999999999999999999999999999999998877777889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 94 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
+++|+|++.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLM 161 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceec
Confidence 99999999999999999764 35899999999999999999999999999999999999988887 999999998744
Q ss_pred cCCCC--CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 172 VLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 172 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
..... .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..... .. .........+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~-~~----~~~~~~~~~~~ 235 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY-EL----LEKDYRMERPE 235 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HH----HHTTCCCCCCT
T ss_pred cCCccccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH----HhccCCCCCCC
Confidence 33221 122335678999999987777555 999999999999999 88999876643322 22 22233344455
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATEN 295 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~ 295 (298)
.+++++.+++.+||+.||.+|||+.++++..-....+...-.+..+.
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~~~~~~~ 282 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 282 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccccchhhcc
Confidence 68999999999999999999999999998665555554444444433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=324.28 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=207.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+|+.++++++||||+++++++..++..++|+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999999989999999998765322 245789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
||+.| +|.+.+. ...++++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++..... .
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~---~ 207 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---A 207 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---B
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCC---C
Confidence 99975 7777764 4567999999999999999999999999999999999999998887 99999999864432 2
Q ss_pred CCCCCCCcccCccccc---cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 178 KSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
....+++.|+|||.+. ...++. ++||||||+++|+|++|..||...+.... ...+............+++++
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~-~~DiwslG~il~ell~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPALQSGHWSEYF 282 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCCCCCCTTSCHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhcCCCCCCCCCCCHHH
Confidence 3456899999999985 344544 49999999999999999999987654332 233333333333345689999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+||.+||+.||.+|||+ .++++|||+..
T Consensus 283 ~~li~~~l~~dP~~Rps~--------~~ll~h~~~~~ 311 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTS--------EVLLKHRFVLR 311 (348)
T ss_dssp HHHHHHHTCSSGGGSCCH--------HHHTTCHHHHS
T ss_pred HHHHHHHcccChhhCcCH--------HHHhhChhhhc
Confidence 999999999999999988 45557788764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=336.32 Aligned_cols=268 Identities=25% Similarity=0.324 Sum_probs=206.4
Q ss_pred CcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 14 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
+........++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.++++++||||+++++++..
T Consensus 17 Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 17 QGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96 (432)
T ss_dssp TCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred cCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEec
Confidence 34445556789999999999999999999999999999999987542 223567899999999999999999999976
Q ss_pred C-----CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 91 P-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 91 ~-----~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
. ..+|+|+|+++ ++|.+.+.....+++..++.++.||+.||.|||+.|++||||||+||+++.++. +||+||
T Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DF 173 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDF 173 (432)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccC
Confidence 6 57999999986 499999988888999999999999999999999999999999999999998887 999999
Q ss_pred CccccccCCCC-----------------------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCC-
Q 022401 166 GYSKSSVLHSQ-----------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF- 221 (298)
Q Consensus 166 ~~~~~~~~~~~-----------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf- 221 (298)
|+++....... .....+++.|+|||.+......+.++||||+||++|+|++|..||
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 99874433211 234567899999998755554455699999999999999854443
Q ss_pred ----------CCCCC-----------------chhHHHHHHH--------------------HhhcCCCCCC-----CCC
Q 022401 222 ----------EDPDE-----------------PKDFRKTIQR--------------------ILSVQYSVPD-----TNP 249 (298)
Q Consensus 222 ----------~~~~~-----------------~~~~~~~~~~--------------------~~~~~~~~~~-----~~~ 249 (298)
.+.+. .+.+...... +.......+. ...
T Consensus 254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (432)
T 3n9x_A 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333 (432)
T ss_dssp SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 33220 0111111110 0001111110 134
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+++++.+||++||+.||.+|||+ .++++|||+.+.
T Consensus 334 ~s~~~~dLl~~mL~~dP~~R~ta--------~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 334 ISDDGINLLESMLKFNPNKRITI--------DQALDHPYLKDV 368 (432)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCH--------HHHHTCGGGTTT
T ss_pred CCHHHHHHHHHHhcCCcccCCCH--------HHHhcChhhhhc
Confidence 78999999999999999999987 566688998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=317.99 Aligned_cols=257 Identities=35% Similarity=0.606 Sum_probs=215.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.++|++.+.||+|++|.||++++..+++.||+|++... ......+.+|+.++++++||||+++++++.+....++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 36899999999999999999999989999999998653 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|++.+++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|||++.........
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 9999999999998888899999999999999999999999999999999999997644 335999999998755444444
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--CCCCCCCCHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECR 255 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~ 255 (298)
....+++.|+|||.+.+. ++ .++||||||+++|+|++|..||...+.. .....+..+... .+....+++++.
T Consensus 181 ~~~~~~~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEY----DILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp SCHHHHHTTCCHHHHTTC-CC-THHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred ccccCcccccChHHhcCC-CC-CchhhHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 444577889999988654 44 4599999999999999999999876542 333344444332 233345899999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++|.+||+.||.+|||+ .++++|||+++.
T Consensus 255 ~li~~~l~~dp~~Rps~--------~ell~hp~~~~~ 283 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITA--------TQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHTCSSGGGSCCH--------HHHHHSHHHHHH
T ss_pred HHHHHHcccChhhCcCH--------HHHhcCHHHhcc
Confidence 99999999999999987 666689998754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=318.16 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=210.0
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
..++|++.+.||+|+||.||.+.+..+|+.||+|.+.... ....+.+|+.++++++||||+++++++...+.+++|+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 4578999999999999999999999899999999987654 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCC
Q 022401 101 ASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 178 (298)
Q Consensus 101 ~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~ 178 (298)
+++++|.+++. ....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccC
Confidence 99999999986 4567999999999999999999999999999999999999998887 999999998644332 2233
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (298)
...+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.......... ...............+++++.++|
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIF---MIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred ccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhcCCCcccCCcccCCHHHHHHH
Confidence 4567889999999988777666 999999999999999999998755422211 111122223333445789999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+||+.||.+|||+ .++++|||+.+.
T Consensus 260 ~~~l~~dp~~Rpt~--------~~ll~~~~~~~~ 285 (314)
T 3com_A 260 KQCLVKSPEQRATA--------TQLLQHPFVRSA 285 (314)
T ss_dssp HHHTCSCTTTSCCH--------HHHTTSHHHHTC
T ss_pred HHHccCChhhCcCH--------HHHHhCHHHhcC
Confidence 99999999999987 555678888754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=325.27 Aligned_cols=271 Identities=27% Similarity=0.365 Sum_probs=192.6
Q ss_pred CCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
+...|+....++|++.+.||+|++|.||.+.+..+++.||+|++... ......+.+|+.++++++||||+++++++..
T Consensus 5 s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 5 SSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp --------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred ccccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 44667888899999999999999999999999888999999988654 2334567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEE
Q 022401 91 PTHLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~--------~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l 162 (298)
.+..++|+||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl 162 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQI 162 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEE
Confidence 9999999999999999999863 456899999999999999999999999999999999999998887 999
Q ss_pred eecCccccccCCC------CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 022401 163 CDFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 236 (298)
Q Consensus 163 ~d~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~ 236 (298)
+|||++....... ......+++.|+|||.+.+....+.++||||||+++|+|++|..||...............
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 9999876433221 1233458889999999876443345599999999999999999999887654433222211
Q ss_pred HhhcC----CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 237 ILSVQ----YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 237 ~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
..... ........++.++.+++.+||+.||.+|||+ .++++|||+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--------~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA--------AELLRHKFFQKAK 295 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCH--------HHHHTSTTC----
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCH--------HHHhhChhhhcCC
Confidence 10000 0111224578999999999999999999987 5666888887543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=313.22 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=213.4
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.+..++|++.+.||+|+||.||++.+. +++.||+|++.......+.+.+|+.++++++||||+++++++.++...++|+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 455678999999999999999999987 5677999999987777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC--C
Q 022401 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~--~ 175 (298)
||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEeccccccccccccccc
Confidence 999999999999654 46899999999999999999999999999999999999988877 999999998643222 1
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
......+++.|+|||.+.+..++.+ +||||+|+++|+|++ |..||......+ ....+... .....+...++++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~ 236 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSE----VVEDISTG-FRLYKPRLASTHV 236 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTT-CCCCCCTTSCHHH
T ss_pred cccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHH----HHHHHhcC-ccCCCCCcCCHHH
Confidence 2233445678999999977777655 999999999999999 899998765432 23333332 3334445579999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
.+++.+||+.||.+|||+.+++++..
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHH
Confidence 99999999999999999999987544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=328.71 Aligned_cols=265 Identities=27% Similarity=0.459 Sum_probs=217.2
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEc---cCCcEEEEEEeecCC-----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 91 (298)
..++|++.+.||+|+||.||++++. .+++.||+|++.... ...+.+.+|+.+++.+ +||||+++++++..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 4479999999999999999999984 478999999986432 2345567899999999 699999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
..+++|+||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++...
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~ 209 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEF 209 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEEC
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeec
Confidence 999999999999999999988888999999999999999999999999999999999999998887 999999998643
Q ss_pred cCC--CCCCCCCCCCcccCcccccccc-CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 172 VLH--SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 172 ~~~--~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
... .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||...............+.......+ .
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~ 287 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--Q 287 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--T
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--c
Confidence 222 1223346899999999987532 2344599999999999999999999876655555555666555544433 4
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+++.+.+||.+||+.||.+||++.. ....++++|||+...
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~---~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGP---RDADEIKEHLFFQKI 328 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSST---TTHHHHHTSGGGTTC
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCC---CCHHHHHcCcchhcC
Confidence 47999999999999999999994321 123677788888753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=316.14 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=204.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+..+.++ +||||+++++++.+++..++|+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 6899999999999999999999989999999998764 23345677899999988 9999999999999999999999
Q ss_pred eccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-----------------C
Q 022401 99 EYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-----------------A 157 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-----------------~ 157 (298)
||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 999999999999764 6789999999999999999999999999999999999998543 2
Q ss_pred CCEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 022401 158 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 237 (298)
Q Consensus 158 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 237 (298)
..++|+|||.+...... ....+++.|+|||.+.+....+.++||||||+++++|++|..|+.... . ...+
T Consensus 171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~----~~~~ 240 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q----WHEI 240 (289)
T ss_dssp CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H----HHHH
T ss_pred eEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H----HHHH
Confidence 24999999988644332 334588999999998776444456999999999999999987765432 1 2222
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
..... ...+..+++++.++|.+||+.||.+|||+ .++++|||+.+..+
T Consensus 241 ~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~--------~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 241 RQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSA--------MALVKHSVLLSASR 288 (289)
T ss_dssp HTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCH--------HHHHTCTTC-----
T ss_pred HcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCH--------HHHhhChHhhhhcc
Confidence 22222 12334589999999999999999999987 66779999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=328.50 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=202.7
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-------
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------- 92 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 92 (298)
...++|++.+.||+|+||.||++++..+++.||+|++..+........+++..+..++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 4457899999999999999999999999999999999877666677888888899999999999999986533
Q ss_pred eEEEEEeccCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHh--hcCcEEecCCCCceEeeC-CCCCCEEEeec
Q 022401 93 HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDG-SPAPRLKICDF 165 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l----~~~~~~~~~~~~~i~~~l~~~l~~Lh--~~~i~H~dl~p~nilv~~-~~~~~~~l~d~ 165 (298)
.+++|+||+++ +|...+ .....+++..++.++.|++.||.||| +.|++|+||||+||+++. ++. ++|+||
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~--~kl~Df 176 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDF 176 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--EEECCC
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--EEEeeC
Confidence 38899999977 444333 35567899999999999999999999 999999999999999986 665 999999
Q ss_pred CccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC----
Q 022401 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---- 241 (298)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 241 (298)
|++.............+++.|+|||.+.+....+.++||||||+++|+|++|..||...+....+...........
T Consensus 177 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp TTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 9998666555555667899999999987766445569999999999999999999998776555444443221110
Q ss_pred ---------CC-------------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 242 ---------YS-------------VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 242 ---------~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.. .......++++.+||.+||+.||.+|||+ .++++|||+.+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP--------YEALCHPYFDELH 322 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH--------HHHTTSGGGGGGG
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH--------HHHhcCccccccC
Confidence 00 00111246889999999999999999987 5566899998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=328.73 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=202.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 92 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 92 (298)
..++|++.+.||+|+||.||.|.+..+|+.||+|++..... ....+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 35789999999999999999999999999999999865322 2356789999999999999999999997653
Q ss_pred -eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 -~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
.+|+|+|++ +++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++. +||+|||++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccccc
Confidence 469999999 7799998865 57899999999999999999999999999999999999998887 999999998754
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC----------
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------- 241 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 241 (298)
.. ......+++.|+|||.+.+....+.++||||+||++++|++|..||.+.+..+.+...........
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 32 233456789999999988744344459999999999999999999998766554444332211100
Q ss_pred ---------CCC------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 242 ---------YSV------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 242 ---------~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
... ......++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~--------~e~l~hp~f~~ 313 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA--------GEALAHPYFES 313 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH--------HHHHHSGGGTT
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH--------HHHhcChHHHh
Confidence 000 1123468999999999999999999988 55667888874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=326.15 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=200.8
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--------
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 92 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 92 (298)
++|++++.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 57999999999999999999999999999999987543 34467889999999999999999999986543
Q ss_pred -------------------------------------------------eEEEEEeccCCCCHHHHHHhCCC---CCHHH
Q 022401 93 -------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSEDE 120 (298)
Q Consensus 93 -------------------------------------------------~~~lv~~~~~~~sL~~~l~~~~~---~~~~~ 120 (298)
.+++|+||+++++|.+++..... .+...
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999977653 45667
Q ss_pred HHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-------------CCCCCCCCCccc
Q 022401 121 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAYI 187 (298)
Q Consensus 121 ~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-------------~~~~~~~~~~~~ 187 (298)
++.++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++....... ......+++.|+
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 8999999999999999999999999999999998887 9999999987544332 223346899999
Q ss_pred CccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCC
Q 022401 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267 (298)
Q Consensus 188 aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 267 (298)
|||.+.+..++.+ +||||||+++|+|++|..|+.. ............... .....++++.++|.+||+.||.
T Consensus 244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQME------RVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHHCSSGG
T ss_pred ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhccCCCc-ccccCChhHHHHHHHHccCCCC
Confidence 9999988777655 9999999999999998765321 122233322222211 1122467899999999999999
Q ss_pred CcccccccchhhhHHHhhhhhhhh
Q 022401 268 AVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 268 ~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+|||+ .++++|||+.+
T Consensus 316 ~Rps~--------~~~l~~~~f~~ 331 (332)
T 3qd2_B 316 ERPEA--------TDIIENAIFEN 331 (332)
T ss_dssp GSCCH--------HHHHHSTTCCC
T ss_pred cCCCH--------HHHhhchhhhc
Confidence 99987 66668999865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=324.52 Aligned_cols=255 Identities=27% Similarity=0.498 Sum_probs=208.3
Q ss_pred CCCeeEE-eeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEE
Q 022401 22 SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 22 ~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (298)
.++|.+. +.||+|+||.||++.+..+++.||+|++... ......+.+|+.+++++ +||||+++++++.+...+++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3568888 8999999999999999999999999998753 23346788999999999 46999999999999999999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC---CCCCCEEEeecCccccc
Q 022401 97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSS 171 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~---~~~~~~~l~d~~~~~~~ 171 (298)
|+||+.+++|.+++... ..+++.+++.++.|++.||+|||+.|++||||+|+||+++. ++. ++|+|||++...
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~--~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGD--IKIVDFGMSRKI 184 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCC--EEECCGGGCEEC
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCc--EEEeeCcccccc
Confidence 99999999999988543 57999999999999999999999999999999999999986 444 999999998766
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC--CCCCCCCC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPDTNP 249 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 249 (298)
..........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||......+.. ..+.... ........
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 185 GHACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETY----LNISQVNVDYSEETFSS 259 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCTTTTTT
T ss_pred CCccccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHH----HHHHhcccccCchhhcc
Confidence 55544455678999999999987777655 99999999999999999999876543332 2222222 23333446
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+++++.++|.+||+.||.+|||+ .++++|||+++
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~--------~~ll~h~~~~~ 293 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTA--------EICLSHSWLQQ 293 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCH--------HHHTTCGGGCC
T ss_pred cCHHHHHHHHHHcCCChhhCcCH--------HHHhCCHhhcc
Confidence 89999999999999999999987 55568888864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=322.10 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=204.1
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCC--CCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRH--PNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~ 94 (298)
...++|++++.||+|+||.||++.+. +++.||+|++...... .+.+.+|+.++++++| |||+++++++..+..+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 45678999999999999999999985 5888999998764332 3567899999999976 9999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++|||+ .+++|.+++.....+++.+++.++.|++.||.|||+.|++||||||+||+++ ++. +||+|||++......
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~--~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE--EEECCCSSSCCC---
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCc--EEEeecccccccCcc
Confidence 999994 5779999999988999999999999999999999999999999999999997 444 999999998754332
Q ss_pred CC---CCCCCCCCcccCcccccc-----------ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 022401 175 SQ---PKSTVGTPAYIAPEVLLR-----------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240 (298)
Q Consensus 175 ~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (298)
.. .....+++.|+|||.+.+ ..+ +.++||||||+++|+|++|..||...... ......+...
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~ 236 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDP 236 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHHHHHCT
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhH---HHHHHHHhcC
Confidence 22 234568999999999864 333 44599999999999999999999865432 2233344444
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 241 QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 241 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
......+...+.++.+|+.+||+.||.+|||+.+++ +|||++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l--------~hp~~~ 278 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL--------AHPYVQ 278 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH--------TSHHHH
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHH--------hCcccc
Confidence 444444555789999999999999999999885555 566665
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=312.30 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=212.1
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.+..++|++.+.||+|+||.||++++. ++..||+|++.......+.+.+|+.++++++||||+++++++.++...++|+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 456689999999999999999999876 5667999999887777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--
Q 022401 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-- 175 (298)
|++++++|.+++.... .+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhh
Confidence 9999999999997654 5999999999999999999999999999999999999998887 9999999986433222
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||....... ....+.... ....+...++++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~l 234 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSE----VVLKVSQGH-RLYRPHLASDTI 234 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHHHHTTC-CCCCCTTSCHHH
T ss_pred cccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHH----HHHHHHcCC-CCCCCCcChHHH
Confidence 1223345667999999987777666 999999999999999 999998765432 222222222 233344579999
Q ss_pred HHHHHHhhhhCCCCcccccccchhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.+++.+||+.||.+|||+.+++++.
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L 259 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSSI 259 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999999888643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=324.42 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=209.4
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CeE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 94 (298)
.++|++++.||+|+||.||++.+..++..||+|++.... .....+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 469999999999999999999999999999999987533 2236678999999999999999999998754 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++|++++.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++. ++|+|||++......
T Consensus 106 ~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPD 181 (364)
T ss_dssp EEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGG
T ss_pred EEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCC
Confidence 999999975 89888855 46899999999999999999999999999999999999998887 999999998644332
Q ss_pred CC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC--------
Q 022401 175 SQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-------- 242 (298)
Q Consensus 175 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 242 (298)
.. .....+++.|+|||.+.+....+.++||||||+++|+|++|..||......+.+............
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 21 234468999999998766654455599999999999999999999887766655444332211100
Q ss_pred --------CCC---------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 243 --------SVP---------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 243 --------~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..+ ....+++++.+||.+||+.||.+|||+ .++++|||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--------~e~l~hp~~~~ 319 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV--------EQALAHPYLEQ 319 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH--------HHHHTSGGGTT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH--------HHHhcCcchhh
Confidence 000 013468999999999999999999987 55567888864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=314.82 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=214.1
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
...+.|++++.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++++.++...++|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 34467999999999999999999999899999999987653 3457788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-C
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~ 176 (298)
+||+++++|.+++.. .++++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBCC
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCccccc
Confidence 999999999998854 57899999999999999999999999999999999999998887 9999999986443322 2
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||........ ...+.... .......++.++.+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~l~~ 249 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKV----LFLIPKNN-PPTLEGNYSKPLKE 249 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSC-CCCCCSSCCHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHH----HHHhhcCC-CCCCccccCHHHHH
Confidence 234568889999999988777665 9999999999999999999987554222 22222222 22234458999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
++.+||+.||.+|||+ .++++|||+....
T Consensus 250 li~~~l~~dp~~Rps~--------~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTA--------KELLKHKFILRNA 278 (303)
T ss_dssp HHHHHCCSSGGGSCCH--------HHHTTCHHHHHHC
T ss_pred HHHHHcCCChhhCcCH--------HHHhhChhhhcCC
Confidence 9999999999999988 5555788876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=337.40 Aligned_cols=260 Identities=26% Similarity=0.380 Sum_probs=191.5
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----C
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-----T 92 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 92 (298)
..++|++++.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++.++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 35789999999999999999999999999999999875422 235678999999999999999999998543 5
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+|+|+|++ +++|.+++.....+++..++.++.||+.||+|||+.|++||||||+||+++.++. +||+|||++....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhcc
Confidence 799999998 5689999988888999999999999999999999999999999999999998887 9999999987543
Q ss_pred CCCC----------------------------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh--------
Q 022401 173 LHSQ----------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-------- 216 (298)
Q Consensus 173 ~~~~----------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-------- 216 (298)
.... .....+++.|+|||++......+.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 2211 1223468899999987555444555999999999999998
Q ss_pred ---CCCCCCCCCC--------------------chhHHHHHHHHhhcCC--------------------C------CCCC
Q 022401 217 ---GGYPFEDPDE--------------------PKDFRKTIQRILSVQY--------------------S------VPDT 247 (298)
Q Consensus 217 ---g~~pf~~~~~--------------------~~~~~~~~~~~~~~~~--------------------~------~~~~ 247 (298)
|..+|.+... .+.+. .+..+.+... . ....
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLN-VIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHH-HHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHH-HHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 5666654321 01111 1111111000 0 0011
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...++++.+||++||+.||.+|||+ .++++|||+.+.
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~--------~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITI--------NECLAHPFFKEV 403 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCH--------HHHHHSGGGTTT
T ss_pred CCCCHHHHHHHHHHhccCccccCCH--------HHHhcCHhhhhc
Confidence 2358999999999999999999987 566688888754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=321.37 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=208.4
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC-CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
...++|++.+.||+|+||.||++.+..+++.+|+|.+... ......+.+|+.++++++||||+++++++.++...++|+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 4567999999999999999999999999999999987653 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
||+++++|.+++.. ...+++.+++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++.........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceeccccccc
Confidence 99999999999977 567999999999999999999999999999999999999998887 999999998644322211
Q ss_pred ---------------CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchh-HHHHHHHHhhcC
Q 022401 178 ---------------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSVQ 241 (298)
Q Consensus 178 ---------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 241 (298)
....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||........ ...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 13468899999999988777665 9999999999999999998866432111 00011111111
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 242 YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
..+..+|+++.+++.+||+.||++|||+.++++..
T Consensus 243 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 243 ---YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp ---TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 12344788999999999999999999999998643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=321.31 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=210.3
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCc---EEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
......++|++.+.||+|+||.||.+++..++. .||+|++.... .....+.+|+.++++++||||+++++++.++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 445677899999999999999999999975444 59999987642 3345688999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
+..++|+||+++++|.+++... ..+++.+++.++.+++.||.|||+.|++|+||||+||+++.++. ++|+|||++..
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 200 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRV 200 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccc
Confidence 9999999999999999999654 57999999999999999999999999999999999999998887 99999999874
Q ss_pred ccCCCCC----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 171 SVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 171 ~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
....... ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+ ....+.. ....+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~~-~~~~~ 274 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRD----VISSVEE-GYRLP 274 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHH----HHHHHHT-TCCCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHH----HHHHHHc-CCCCC
Confidence 4332211 22234668999999987777665 999999999999999 999998765432 2222222 23445
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.+..+++++.+++.+||+.||.+|||+.++++..
T Consensus 275 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 5566899999999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=324.94 Aligned_cols=259 Identities=32% Similarity=0.510 Sum_probs=207.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
.++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 368999999999999999999999999999999986532 12234788999999999999999999986655
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~~~ 171 (298)
.++|+|++++++|.+.+.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ ...++|+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 899999999999999998888899999999999999999999999999999999999997654 235999999998754
Q ss_pred cCCCCCCCCCCCCcccCcccccc--ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DT 247 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~ 247 (298)
..........+++.|+|||.+.. ......++||||||+++|+|++|..||........+...+.. ...... ..
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~ 244 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEVW 244 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCCCCHHHH
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---CccccCchhh
Confidence 33222223457899999998742 233344599999999999999999999876654444333322 222211 12
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..+++++.++|.+||+.||.+|||+ .++++|||+++.
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~--------~~~l~h~~~~~~ 281 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTT--------EEALRHPWLQDE 281 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCH--------HHHHTSGGGCCH
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCH--------HHHhhCcCcCCH
Confidence 3478999999999999999999987 566689998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=322.27 Aligned_cols=264 Identities=28% Similarity=0.351 Sum_probs=212.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEE-ccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCC------CeeeeeEEEEe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILT 90 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~ 90 (298)
+....++|++.+.||+|+||.||++.+ ..+++.||+|++.......+.+.+|+.+++.++|+ +++++++++..
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 344567999999999999999999998 56789999999987666667788999999888654 59999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC------------
Q 022401 91 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP------------ 156 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~------------ 156 (298)
.+.+++|+|++ +++|.+++.... ++++..++.++.|++.||+|||++|++|+||||+||+++.++
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999 789999987665 689999999999999999999999999999999999998743
Q ss_pred -----CCCEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 022401 157 -----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231 (298)
Q Consensus 157 -----~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~ 231 (298)
...++|+|||++.... .......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+..+...
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred cccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 3349999999986432 23345568999999999988777665 999999999999999999998766544332
Q ss_pred HHHHHHhhcCC------------------C---------------------CCCCCCCCHHHHHHHHHhhhhCCCCcccc
Q 022401 232 KTIQRILSVQY------------------S---------------------VPDTNPISQECRDLISRIFVADPAAVSIF 272 (298)
Q Consensus 232 ~~~~~~~~~~~------------------~---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 272 (298)
. +.++..... . .......++++.+||.+||+.||.+|||+
T Consensus 245 ~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 245 M-MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp H-HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred H-HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 2 222221100 0 01111235789999999999999999987
Q ss_pred cccchhhhHHHhhhhhhhhhhh
Q 022401 273 FFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 273 ~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.++++|||+.+.++
T Consensus 324 --------~ell~hp~f~~~~~ 337 (339)
T 1z57_A 324 --------REALKHPFFDLLKK 337 (339)
T ss_dssp --------HHHTTSGGGGGGGC
T ss_pred --------HHHhcCHHHHHHhc
Confidence 56668999988765
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=325.92 Aligned_cols=258 Identities=22% Similarity=0.364 Sum_probs=214.8
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----h--------------HHHHHHHHHHhcCCCCC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----D--------------ENVQREIINHRSLRHPN 80 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~--------------~~~~~e~~~l~~l~h~~ 80 (298)
....++|++.+.||+|+||.||.+.+ +++.||+|++...... . +.+.+|+.++++++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34457999999999999999999999 8899999998753211 1 78899999999999999
Q ss_pred eeeeeEEEEeCCeEEEEEeccCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceE
Q 022401 81 IVRFKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTL 151 (298)
Q Consensus 81 i~~~~~~~~~~~~~~lv~~~~~~~sL~~~------l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nil 151 (298)
|+++++++.+.+..++|+||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999988 655 5679999999999999999999999 99999999999999
Q ss_pred eeCCCCCCEEEeecCccccccCCCCCCCCCCCCcccCccccccc-cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhH
Q 022401 152 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230 (298)
Q Consensus 152 v~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 230 (298)
++.++. ++|+|||++...... ......+++.|+|||.+.+. .++..++||||||+++|+|++|..||.......
T Consensus 185 ~~~~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 259 (348)
T 2pml_X 185 MDKNGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-- 259 (348)
T ss_dssp ECTTSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred EcCCCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence 998887 999999998754332 23445688999999998877 444435999999999999999999998766532
Q ss_pred HHHHHHHhhcCCCCCCC-----------------CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 231 RKTIQRILSVQYSVPDT-----------------NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 231 ~~~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.....+.......+.. ..+++++.+||.+||+.||.+|||+ .++++|||+.+.
T Consensus 260 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~--------~e~l~hp~f~~~ 329 (348)
T 2pml_X 260 -ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS--------EDALKHEWLADT 329 (348)
T ss_dssp -HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH--------HHHHTSGGGTTC
T ss_pred -HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH--------HHHhcCccccCC
Confidence 3334444444443321 4589999999999999999999987 566678888754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=313.45 Aligned_cols=257 Identities=21% Similarity=0.347 Sum_probs=213.1
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
..+....++|++++.||+|+||.||.+.+. ++..||+|++.......+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 345667789999999999999999999887 5678999999887777788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
+|+|++++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEcccccccccccc
Confidence 99999999999999976 457999999999999999999999999999999999999998887 999999998643222
Q ss_pred --CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 175 --SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 175 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
.......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||........ ...+... .....+...+
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~ 247 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSET----AEHIAQG-LRLYRPHLAS 247 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHHHTT-CCCCCCTTCC
T ss_pred ccccccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccChhHH----HHHHhcc-cCCCCCCcCC
Confidence 12233345678999999987776555 999999999999998 9999987664322 2222222 2333444578
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
+++.+++.+||+.||.+|||+.+++++...
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 999999999999999999999999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=331.78 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=206.4
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------Ce
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 93 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 93 (298)
....+|++.+.||+|+||.||++++..+++.||||++...... ..+|+.++++++||||+++++++... ..
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---HHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 3445799999999999999999999989999999998765322 34699999999999999999998542 24
Q ss_pred EEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 94 LAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+++|+||+++ ++.+.+. ....+++..++.++.||+.||.|||+.|++||||||+||+++.++. .+||+|||++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~ 205 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 205 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhh
Confidence 7899999976 5555543 3567999999999999999999999999999999999999986543 38999999997
Q ss_pred cccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------
Q 022401 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------- 240 (298)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 240 (298)
............+++.|+|||++.+......++|||||||++|+|++|..||...+..+.+.+.++.+...
T Consensus 206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 65544444556789999999998776444555999999999999999999999877655555544432110
Q ss_pred ----CCCCC----------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 241 ----QYSVP----------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 241 ----~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+..+ ....+++++.+||++||+.||.+|||+ .+++.|||+.+.
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~--------~e~l~hp~f~~~ 343 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP--------LEACAHSFFDEL 343 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGGGG
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH--------HHHhCCHhhccc
Confidence 01111 123468999999999999999999988 555578887643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=328.49 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=196.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC------
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 92 (298)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999999999999999987643 22356778999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+++|+|++++ +|.+.+. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++. +||+|||++....
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 178 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-----
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccc
Confidence 78999999975 7877775 35899999999999999999999999999999999999998887 9999999987554
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh-------------
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS------------- 239 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 239 (298)
.........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+..+.+.........
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred cccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 4433445678899999999988777666 99999999999999999999887654433333221100
Q ss_pred -----cCCCCCC------------CC------CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 240 -----VQYSVPD------------TN------PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 240 -----~~~~~~~------------~~------~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
....... +. ..++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~--------~e~l~hp~~~~ 324 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV--------DEALQHPYINV 324 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH--------HHHHHSHHHHT
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH--------HHHhCCcchhh
Confidence 0000000 00 014679999999999999999988 55567888763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=314.44 Aligned_cols=275 Identities=19% Similarity=0.196 Sum_probs=220.8
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 97 (298)
....++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+.+|+.+++++ +|+|++++++++......++|
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 344578999999999999999999998899999999886543 345678899999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC---CCEEEeecCccccccC
Q 022401 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVL 173 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~---~~~~l~d~~~~~~~~~ 173 (298)
+|++ +++|.+++.... ++++..++.++.|++.||+|||+.|++|+||||+||+++.++. ..++|+|||++.....
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999 889999997654 5999999999999999999999999999999999999976543 2499999999874433
Q ss_pred CCC--------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC---C
Q 022401 174 HSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---Y 242 (298)
Q Consensus 174 ~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~ 242 (298)
... .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||........ ......+.... .
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEKKQSTP 241 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHHHHHHHHSC
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhcccc-HHHHHHHHhhccCcc
Confidence 222 234568899999999987777555 9999999999999999999988653322 12222221111 1
Q ss_pred CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcC
Q 022401 243 SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYH 297 (298)
Q Consensus 243 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~ 297 (298)
.......+|+++.+++.+||+.||.+|||+.++++......-...+-.+..-+|+
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 242 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 1111234799999999999999999999999999876666555555556666665
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=316.29 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=207.9
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEE----EccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~----~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
|.....++|++++.||+|+||.||+++ +..+++.||+|++..... ....+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345677899999999999999999998 566889999999876433 235688999999999999999999998653
Q ss_pred --CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 92 --THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 92 --~~~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
..+++|+||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCccc
Confidence 56899999999999999997654 4999999999999999999999999999999999999998887 999999998
Q ss_pred ccccCCC----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCC-----------chhHHHH
Q 022401 169 KSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------PKDFRKT 233 (298)
Q Consensus 169 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----------~~~~~~~ 233 (298)
....... ......++..|+|||.+.+..++.+ +||||||+++|+|++|..||..... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 7443322 1223345667999999988777655 9999999999999999999865321 1111112
Q ss_pred HHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 234 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
...........+.+..+|+++.+++.+||+.||.+|||+.++++..-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 22223334445556678999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=322.94 Aligned_cols=272 Identities=22% Similarity=0.239 Sum_probs=218.7
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
..++|++.+.||+|+||.||++++..+++.||+|++.... ..+.+.+|+.+++++ +||||+++++++......++|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3578999999999999999999999999999999887653 345688999999999 99999999999999999999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC---CCEEEeecCccccccCCC
Q 022401 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 100 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~---~~~~l~d~~~~~~~~~~~ 175 (298)
++ +++|.+++.. ...+++..++.++.|++.||+|||+.|++||||||+||+++.++. ..++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 8899999976 467999999999999999999999999999999999999986653 239999999987443322
Q ss_pred C--------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC-
Q 022401 176 Q--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD- 246 (298)
Q Consensus 176 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 246 (298)
. .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||....... ..+....+.......+.
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADT-LKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSS-HHHHHHHHHHHHHHSCHH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCcccccccc-HHHHHHHHHhhhccCCHH
Confidence 1 235568999999999988777555 999999999999999999998865432 23333333322221111
Q ss_pred --CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcC
Q 022401 247 --TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYH 297 (298)
Q Consensus 247 --~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~ 297 (298)
....| ++.+++..||+.||.+||++.++++......-...+..+...+|+
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 12245 999999999999999999999999866655555555555555664
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=325.85 Aligned_cols=254 Identities=22% Similarity=0.333 Sum_probs=205.2
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCC--CCCeeeeeEEEEeCCeEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 95 (298)
...+|++++.||+|+||.||++.+.. ++.||+|++..... ..+.+.+|+.++++++ ||||+++++++..+..++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34569999999999999999999874 88999999876432 3356889999999996 599999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+||| +.+++|.+++.....+++.+++.++.|++.||.|||+.|++||||||+||+++ ++. +||+|||++.......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~--~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSC--EEECCCSSSCCC----
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCe--EEEEecCccccccCCC
Confidence 9999 56789999999888999999999999999999999999999999999999995 444 9999999987543322
Q ss_pred ---CCCCCCCCCcccCccccccc----------cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 176 ---QPKSTVGTPAYIAPEVLLRH----------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 176 ---~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
......+++.|+|||++.+. ...+.++||||||+++|+|++|..||...... ......+.....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~~~~~~~~ 285 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPNH 285 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHCTTS
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---HHHHHHHhCccc
Confidence 12345689999999998652 22344599999999999999999999865432 233444455444
Q ss_pred CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 243 SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 243 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
....+...+.++.+||.+||+.||.+|||+. ++++|||++
T Consensus 286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~--------ell~hp~~~ 325 (390)
T 2zmd_A 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIP--------ELLAHPYVQ 325 (390)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHH--------HHHTSHHHH
T ss_pred cCCCCccchHHHHHHHHHHcccChhhCCCHH--------HHhhCcCcc
Confidence 4444555689999999999999999999884 555677775
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=318.30 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=208.9
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
...++|++++.||+|+||.||.+.+..+++.+|+|++.... .....+.+|+.++++++||||+++++++.+++..++|+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34578999999999999999999999899999999987543 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC-CCC
Q 022401 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 176 (298)
Q Consensus 99 ~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-~~~ 176 (298)
|++++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccc
Confidence 99999999998865 456999999999999999999999999999999999999998887 99999998642211 122
Q ss_pred CCCCCCCCcccCccccc-----cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-CCCCCCCCC
Q 022401 177 PKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVPDTNPI 250 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 250 (298)
.....+++.|+|||.+. ...+ +.++||||||+++|+|++|..||...+.... ...+.... .....+..+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 248 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRV----LLKIAKSDPPTLLTPSKW 248 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCCCCSSGGGS
T ss_pred cccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHH----HHHHhccCCcccCCcccc
Confidence 23456889999999874 3344 4459999999999999999999987654322 22222222 223334558
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
+.++.++|.+||+.||.+|||+ .++++|||+.+..
T Consensus 249 ~~~l~~li~~~l~~dp~~Rps~--------~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNPETRPSA--------AQLLEHPFVSSIT 283 (302)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCH--------HHHTTSTTTTTCC
T ss_pred CHHHHHHHHHHcccChhhCCCH--------HHHhcChHHhhhc
Confidence 9999999999999999999987 5666899988654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=324.07 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=209.2
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEc-------cCCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 88 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 88 (298)
....++|++++.||+|+||.||+|++. .++..||+|++..... ..+.+.+|+.+++++ +||||+++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 445689999999999999999999974 3456799999876533 235688999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe
Q 022401 89 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (298)
Q Consensus 89 ~~~~~~~lv~~~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv 152 (298)
.+.+.+++|+||+.+++|.+++.... .++..+++.++.|++.||+|||++|++||||||+||++
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 99999999999999999999997643 47899999999999999999999999999999999999
Q ss_pred eCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCch
Q 022401 153 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (298)
Q Consensus 153 ~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~ 228 (298)
+.++. +||+|||++....... ......+++.|+|||++.+..++.+ +||||||+++|+|++ |..||......+
T Consensus 237 ~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 237 TENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp CTTCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CCCCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 98887 9999999987433221 2233345678999999987777655 999999999999999 999998766533
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
... .+.. ......+..+++++.+++.+||+.||.+|||+.++++..
T Consensus 314 ~~~----~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 314 LFK----LLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp HHH----HHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHH----HHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 222 2222 223334456899999999999999999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=329.76 Aligned_cols=256 Identities=24% Similarity=0.335 Sum_probs=212.3
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
.+....++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.++++++||||+++++++..++.+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 455667899999999999999999999998899999999875432 234577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++|+||+++++|.+++...+ .++...++.++.|++.||+|||+.|++||||+|+||+++.++. +||+|||++.....
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEAD 265 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCC
Confidence 99999999999999987644 6899999999999999999999999999999999999998887 99999999864322
Q ss_pred CC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 174 HS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 174 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
.. ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||....... . ..........+.+..
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~----~-~~~~~~~~~~~~~~~ 339 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQ----T-REFVEKGGRLPCPEL 339 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHH----H-HHHHHTTCCCCCCTT
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHH----H-HHHHHcCCCCCCCCC
Confidence 11 1112234567999999987777655 999999999999998 999998765422 1 222233344455666
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
+|+++.+++.+||+.||.+|||+.++++...
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 8999999999999999999999999986543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=328.37 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=205.5
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC------
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 92 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 92 (298)
.....+|++.+.||+|+||.||+|++..++. +|+|.+...... ..+|+.+++.++||||+++++++....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3345689999999999999999999986665 888877654332 236899999999999999999986433
Q ss_pred eEEEEEeccCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEee-CCCCCCEEEeecCcc
Q 022401 93 HLAIVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYS 168 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l---~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~-~~~~~~~~l~d~~~~ 168 (298)
.+++|+||++++.+.... .....+++..++.++.|++.||.|||+.|++||||||+||+++ .++. +||+|||++
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a 189 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSA 189 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTC
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCc
Confidence 488999999875443322 2356799999999999999999999999999999999999998 5665 999999999
Q ss_pred ccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-------
Q 022401 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------- 241 (298)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 241 (298)
.............+++.|+|||.+.+....+.++||||+||++|+|++|..||.+.+..+.+....+......
T Consensus 190 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 190 KILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp EECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 7665555555667899999999987765445569999999999999999999998776655555444321100
Q ss_pred ------CCCC----------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 242 ------YSVP----------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 242 ------~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...+ ....+++++.+||.+||+.||.+|||+ .+++.|||+.+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--------~e~l~hp~f~~~ 328 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA--------IEALCHPFFDEL 328 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH--------HHHHTSGGGSTT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH--------HHHhcChhhhhh
Confidence 0111 122378999999999999999999987 566688988754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=317.83 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=213.7
Q ss_pred CCCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEE--EEEEeecC--CcchHHHHHHHHHHhcC-CCCCeeeee
Q 022401 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELV--AVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFK 85 (298)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~--aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~ 85 (298)
++....-+..+.++|++.+.||+|+||.||++++..++..+ ++|.+... ......+.+|+.+++++ +||||++++
T Consensus 13 ~~~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 13 NPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp ---CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred CCCCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhc
Confidence 34444445567789999999999999999999998888765 99988653 23345688999999999 899999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCc
Q 022401 86 EVILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149 (298)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~n 149 (298)
+++.+.+..++|+|++++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 172 (327)
T 1fvr_A 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172 (327)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence 99999999999999999999999997654 68999999999999999999999999999999999
Q ss_pred eEeeCCCCCCEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCch
Q 022401 150 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (298)
Q Consensus 150 ilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~ 228 (298)
|+++.++. ++|+|||++.............+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......
T Consensus 173 Il~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~- 248 (327)
T 1fvr_A 173 ILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCA- 248 (327)
T ss_dssp EEECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred EEEcCCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHH-
Confidence 99998887 99999999875444444445567788999999877776655 999999999999998 99999876542
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
.....+.. ......+..+++++.++|.+||+.||.+|||+.+++++...
T Consensus 249 ---~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 249 ---ELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp ---HHHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHhhc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 23333332 23334455689999999999999999999999999976543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=325.95 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=199.2
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc------------hHHHHHHHHHHhcCCCCCeeeeeEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRFKEVI 88 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (298)
..++|++.+.||+|+||.||++.+.. ++.||+|++...... .+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45789999999999999999999864 889999988643211 26788999999999999999999998
Q ss_pred Ee-----CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEE
Q 022401 89 LT-----PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (298)
Q Consensus 89 ~~-----~~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l 162 (298)
.. ...+++|+|++.+ +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl 175 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITI 175 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEE
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEE
Confidence 54 3478999999975 777777544 46999999999999999999999999999999999999998887 999
Q ss_pred eecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-
Q 022401 163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ- 241 (298)
Q Consensus 163 ~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~- 241 (298)
+|||++.............+++.|+|||.+.+....+.++||||||+++|+|++|..||......+.............
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 9999987555555555567889999999987744445569999999999999999999988765444444333221110
Q ss_pred -------------------CCCC------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 242 -------------------YSVP------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 242 -------------------~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...+ .....++.+.+||.+||+.||.+|||+ .++++|||+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~ell~hp~f~~~ 323 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST--------EQALRHPYFESL 323 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH--------HHHHTSGGGTTT
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH--------HHHHcCchhhhc
Confidence 0000 112468899999999999999999987 556688888754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=318.74 Aligned_cols=268 Identities=28% Similarity=0.366 Sum_probs=202.9
Q ss_pred CCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEE--
Q 022401 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL-- 89 (298)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-- 89 (298)
||.++.....++|++++.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 1 sm~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 1 SMNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp -----CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCccccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 345566667789999999999999999999999899999999987654 33466889999999999999999999873
Q ss_pred ------------eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC
Q 022401 90 ------------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (298)
Q Consensus 90 ------------~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~ 157 (298)
+....++|+|++. ++|.+.+. ..++++..++.++.|++.||+|||+.|++|+||+|+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 3468899999997 58998885 457899999999999999999999999999999999999974432
Q ss_pred CCEEEeecCccccccCC----CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 022401 158 PRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (298)
Q Consensus 158 ~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 233 (298)
.++|+|||++...... .......++..|+|||.+.+....+.++||||||+++|+|++|..||......+.....
T Consensus 159 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 159 -VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp -EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3999999998744322 12233456888999998876444455699999999999999999999887654433333
Q ss_pred HHHHhh------------------cCCCCC------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 234 IQRILS------------------VQYSVP------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 234 ~~~~~~------------------~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
...... .....+ ....+++++.+||.+||+.||.+|||+ .++++|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~ell~hp~~ 309 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA--------EEALSHPYM 309 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH--------HHHHTSHHH
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH--------HHHhCCccc
Confidence 222100 000000 113478999999999999999999987 566688888
Q ss_pred hh
Q 022401 290 FD 291 (298)
Q Consensus 290 ~~ 291 (298)
++
T Consensus 310 ~~ 311 (320)
T 2i6l_A 310 SI 311 (320)
T ss_dssp HT
T ss_pred cc
Confidence 74
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=316.54 Aligned_cols=261 Identities=26% Similarity=0.372 Sum_probs=210.0
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEc-cCCcEEEEEEeecCC---cchHHHHHHHHHHhcC---CCCCeeeeeEEEE-----
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL----- 89 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~----- 89 (298)
.++|++.+.||+|+||.||++++. .+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999995 678899999986532 2223556777776655 8999999999987
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 90 TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 90 ~~~~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
....+++|+|++. ++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcc
Confidence 4567899999997 59999987654 4899999999999999999999999999999999999998887 99999999
Q ss_pred cccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CC--
Q 022401 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SV-- 244 (298)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-- 244 (298)
+.............+++.|+|||.+.+..++.+ +||||||+++|+|++|..||......+.+............ .+
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 875544444445668899999999987777655 99999999999999999999987765544444433211100 00
Q ss_pred ------------------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 245 ------------------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 245 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.....+++++.+||.+||+.||.+|||+ .++++|||+.+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA--------YSALSHPYFQDLER 305 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH--------HHHHTSGGGTTCCC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH--------HHHhcCccccccch
Confidence 1123578999999999999999999987 56668999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=326.46 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=190.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeC------C
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------T 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 92 (298)
.++|++++.||+|+||.||+|.+..+|+.||+|++..... ....+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999999999999999865432 335677999999999999999999998654 5
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+++|++++ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||++....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccc
Confidence 679999999 6788888754 67999999999999999999999999999999999999998887 9999999987433
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-----------
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------- 241 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 241 (298)
. ......+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+.+....+.+....
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 184 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred c--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2 223456889999999987744444559999999999999999999988766554444333211100
Q ss_pred --------CCCCC------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 242 --------YSVPD------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 242 --------~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...+. ....++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~--------~e~L~hp~~~~ 317 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA--------AQALAHAYFAQ 317 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGTT
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH--------HHHhcChhhhh
Confidence 00000 12468899999999999999999988 55557888763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=318.71 Aligned_cols=261 Identities=27% Similarity=0.365 Sum_probs=206.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----C
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----T 92 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 92 (298)
...++|++.+.||+|+||.||++.+..+|+.||+|++..... ....+.+|+.++++++||||+++++++... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 346799999999999999999999998999999999865432 235677999999999999999999998654 6
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
..++|+|++. ++|.+.+.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccc
Confidence 7899999997 489888865 56899999999999999999999999999999999999998887 9999999986443
Q ss_pred CCCC-----------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC
Q 022401 173 LHSQ-----------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241 (298)
Q Consensus 173 ~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (298)
.... .....+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+.+...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 2211 12235788999999876644445569999999999999999999988765443332222111110
Q ss_pred --------------------CCCC------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 242 --------------------YSVP------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 242 --------------------~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...+ ....+++++.+||.+||+.||.+|||+ .++++|||+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~ell~hp~~~~~ 312 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA--------KEALEHPYLQTY 312 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGTTT
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH--------HHHhcCcccccc
Confidence 0000 012478999999999999999999987 556678888753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=332.06 Aligned_cols=249 Identities=13% Similarity=0.070 Sum_probs=195.8
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHH---HHHhcCCCCCeeeee-------E
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREI---INHRSLRHPNIVRFK-------E 86 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~ 86 (298)
..++|++.+.||+|+||.||+|++..+|+.||+|++... ....+.+.+|+ .++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999999888999999998743 23346788999 455566899999988 6
Q ss_pred EEEeCC-----------------eEEEEEeccCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHhhcCcEE
Q 022401 87 VILTPT-----------------HLAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHAMQVCH 142 (298)
Q Consensus 87 ~~~~~~-----------------~~~lv~~~~~~~sL~~~l~~~~~~~~-------~~~~~i~~~l~~~l~~Lh~~~i~H 142 (298)
++.+++ ..++||||+ +++|.+++.....+++ ..++.++.|++.||+|||+.|++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 665543 278999999 5799999976554554 788889999999999999999999
Q ss_pred ecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCCcccCccccccc-----------cCCCCccchHHHHHHH
Q 022401 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-----------EYDGKIADVWSCGVTL 211 (298)
Q Consensus 143 ~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~Di~slG~ll 211 (298)
|||||+||+++.++. +||+|||++..... ......+ +.|+|||++.+. .++. ++||||||+++
T Consensus 230 rDikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~-~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVLDQRGG--VFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF-SFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEECTTCC--EEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH-HHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCC--EEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCCh-hhhHHHHHHHH
Confidence 999999999998887 99999999874322 2233446 999999999877 5654 49999999999
Q ss_pred HHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 212 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 212 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
|+|++|..||.......... . .......+++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 304 ~elltg~~Pf~~~~~~~~~~----~------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~--------~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSE----W------IFRSCKNIPQPVRALLEGFLRYPKEDRLLP--------LQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSG----G------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCH--------HHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchh----h------hhhhccCCCHHHHHHHHHHcCCCchhCCCH--------HHHhhChHHHH
Confidence 99999999997754322111 1 111224579999999999999999999987 56668899886
Q ss_pred hhh
Q 022401 292 ATE 294 (298)
Q Consensus 292 ~~~ 294 (298)
...
T Consensus 366 ~~~ 368 (377)
T 3byv_A 366 LRT 368 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=309.19 Aligned_cols=251 Identities=29% Similarity=0.399 Sum_probs=200.0
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
+..++|++.+.||+|+||.||++.+. ++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45689999999999999999999985 7889999986542 2236788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---cEEecCCCCceEeeCCC------CCCEEEeec
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSP------APRLKICDF 165 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~---i~H~dl~p~nilv~~~~------~~~~~l~d~ 165 (298)
++|+||+++++|.+++. ...+++..++.++.|++.||.|||+.| ++|+||+|+||+++.+. ...++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999998884 557899999999999999999999999 89999999999997521 234999999
Q ss_pred CccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
|++....... .....+++.|+|||.+.+..++.+ +||||||+++++|++|..||...... .............+
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~ 234 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGL----AVAYGVAMNKLALP 234 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHHTSCCCCC
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHhhhcCCCCCC
Confidence 9986443322 234568899999999887776555 99999999999999999999876542 23333444444555
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.+..+++++.+++.+||+.||.+|||+.+++++.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 5667899999999999999999999999988653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=321.04 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=211.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEcc-------CCcEEEEEEeecCCcc--hHHHHHHHHHHhcC-CCCCeeeeeEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEV 87 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~ 87 (298)
+.+..++|++.+.||+|+||.||+|++.. .+..||+|++...... ...+.+|+.+++++ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 45566899999999999999999999753 3357999998765332 35688999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceE
Q 022401 88 ILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (298)
Q Consensus 88 ~~~~~~~~lv~~~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nil 151 (298)
+..++..++|+|++++++|.+++.... .+++.+++.++.|++.||+|||+.|++||||||+||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 999999999999999999999997653 4899999999999999999999999999999999999
Q ss_pred eeCCCCCCEEEeecCccccccCC---CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 022401 152 LDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP 227 (298)
Q Consensus 152 v~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~ 227 (298)
++.++. +||+|||++...... .......+++.|+|||++.+..++.+ +||||||+++++|++ |..||......
T Consensus 224 l~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 224 VTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp ECTTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EcCCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 998887 999999998744332 22233445678999999987777655 999999999999999 99999876532
Q ss_pred hhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHH
Q 022401 228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLL 282 (298)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~ 282 (298)
+....+.. ......+..+++++.+++.+||+.||.+|||+.+++++.-..
T Consensus 301 ----~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 301 ----ELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ----HHHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHc-CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22222222 223344556899999999999999999999999999865433
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=315.07 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=201.9
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe------------
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT------------ 90 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------ 90 (298)
++|++++.||+|+||.||.+++..+++.||+|++.......+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 57999999999999999999999899999999997766566778899999999999999999998865
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 91 -PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 91 -~~~~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
....++|+|++++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~ 163 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLA 163 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcch
Confidence 357899999999999999997544 5788999999999999999999999999999999999998887 999999998
Q ss_pred ccccCC---------------CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 022401 169 KSSVLH---------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (298)
Q Consensus 169 ~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 233 (298)
...... .......+++.|+|||.+.+....+.++||||||+++|+|++ ||..... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---~~~~ 237 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---RVNI 237 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---HHHH
Confidence 644321 112334578899999998766444556999999999999997 5543222 2233
Q ss_pred HHHHhhcCCCCC--CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 234 IQRILSVQYSVP--DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 234 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...+.......+ .....+..+.++|.+||+.||.+|||+ .++++|||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--------~~ll~h~~~~~ 289 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA--------RTLLNSGWLPV 289 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH--------HHHHHSSCSCC
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCH--------HHHhCCCCcCC
Confidence 334433333222 334567889999999999999999987 56668999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=329.38 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=206.1
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC--------CCCeeeeeEEE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVI 88 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~ 88 (298)
......++|++.+.||+|+||.||+|++..+++.||+|++.......+.+.+|+.++++++ |+||+++++++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3344568999999999999999999999999999999999876666677889999999885 78899999998
Q ss_pred E----eCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhc-CcEEecCCCCceEeeCCCC----
Q 022401 89 L----TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPA---- 157 (298)
Q Consensus 89 ~----~~~~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~p~nilv~~~~~---- 157 (298)
. ....+++|+|++. +++.+.+... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.
T Consensus 111 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 7 4568999999995 4565555443 4699999999999999999999998 9999999999999986641
Q ss_pred -------------------------------------------CCEEEeecCccccccCCCCCCCCCCCCcccCcccccc
Q 022401 158 -------------------------------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194 (298)
Q Consensus 158 -------------------------------------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 194 (298)
..++|+|||++..... ......+++.|+|||++.+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHT
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcC
Confidence 2499999999874432 2344568999999999988
Q ss_pred ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchh-----HHHHHHHHhhcC---------CC-----------------
Q 022401 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-----FRKTIQRILSVQ---------YS----------------- 243 (298)
Q Consensus 195 ~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~---------~~----------------- 243 (298)
..++.+ +|||||||++|+|++|..||........ ....+....... ..
T Consensus 268 ~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp SCCCTH-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCcH-HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 877665 9999999999999999999987553221 111111111110 00
Q ss_pred -----------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 244 -----------VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 244 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.......++++.+||.+||+.||.+|||+ .++++|||+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~e~l~hp~~~~ 397 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA--------AECLRHPWLNS 397 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH--------HHHHTSGGGGC
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH--------HHHhhCccccC
Confidence 00111234678999999999999999987 66668999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=312.91 Aligned_cols=254 Identities=28% Similarity=0.455 Sum_probs=206.4
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC-----CcchHHHHHHHHHHhcCCCCCeeeeeEEEE--eCCeE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 94 (298)
.++|++.+.||+|+||.||.+.+..+++.+|+|++... ......+.+|+.++++++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999999989999999998753 234567889999999999999999999984 45688
Q ss_pred EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 95 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
++|+||+.++ |.+.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence 9999999876 7676654 446899999999999999999999999999999999999998887 9999999986443
Q ss_pred CC---CCCCCCCCCCcccCccccccccC-CCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 173 LH---SQPKSTVGTPAYIAPEVLLRHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 173 ~~---~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
.. .......+++.|+|||.+.+... .+.++||||||+++|+|++|..||...+. ......+....... +.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~--~~ 234 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI----YKLFENIGKGSYAI--PG 234 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHCCCCC--CS
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHHHhcCCCCC--CC
Confidence 22 12234458899999999875432 24459999999999999999999987543 33344444444433 34
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+++++.++|.+||+.||.+|||+ .++++|||+.+.
T Consensus 235 ~~~~~l~~li~~~l~~dp~~Rps~--------~~ll~~~~~~~~ 270 (305)
T 2wtk_C 235 DCGPPLSDLLKGMLEYEPAKRFSI--------RQIRQHSWFRKK 270 (305)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSCCH--------HHHHHSHHHHSC
T ss_pred ccCHHHHHHHHHHccCChhhCCCH--------HHHhcCcccccC
Confidence 589999999999999999999987 566688998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=307.77 Aligned_cols=249 Identities=19% Similarity=0.288 Sum_probs=208.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--C
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--T 92 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 92 (298)
.....++|++.+.||+|+||.||++++. ++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+. .
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 4456689999999999999999999985 7889999987653 2335688999999999999999999999877 7
Q ss_pred eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 93 HLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
..++|+||+++++|.+++.... .+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++. +++.||++.
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~ 160 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVK 160 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSC
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccce
Confidence 8899999999999999998765 4899999999999999999999999 999999999999998887 888888875
Q ss_pred ccccCCCCCCCCCCCCcccCccccccccCCCC--ccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK--IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~--~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
.. .......+++.|+|||.+.+...... ++||||||+++|+|++|..||...... ...............
T Consensus 161 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~ 232 (271)
T 3kmu_A 161 FS----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----EIGMKVALEGLRPTI 232 (271)
T ss_dssp CT----TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH----HHHHHHHHSCCCCCC
T ss_pred ee----ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH----HHHHHHHhcCCCCCC
Confidence 43 22234567899999999887655442 599999999999999999999876543 233334444444455
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
+..+++++.+++.+||+.||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56689999999999999999999999998864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=322.61 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=202.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE----
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL---- 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---- 94 (298)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ...+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 36899999999999999999999999999999998764322 35677999999999999999999999876654
Q ss_pred --EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 95 --AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 95 --~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
++|+|++. ++|.+.+. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc
Confidence 99999997 47777663 34899999999999999999999999999999999999998887 9999999987443
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-----------
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------- 241 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 241 (298)
. ......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+.+...........
T Consensus 196 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 196 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred c--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 2 233456789999999988744444459999999999999999999988765444443332211100
Q ss_pred --------CCCC------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 242 --------YSVP------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 242 --------~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...+ ....+++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~ell~hp~f~~ 329 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA--------AQALTHPFFEP 329 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH--------HHHHTSGGGTT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH--------HHHhcCccccc
Confidence 0000 012468999999999999999999987 56668888874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=314.36 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=210.1
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
.....++|++.+.||+|+||.||++.+. .++..||+|++..... ....+.+|+.++++++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3455689999999999999999999983 3458899999875432 33567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHhhcCcEEecCC
Q 022401 91 PTHLAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~~------------------------~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~ 146 (298)
.+..++|+||+++++|.+++..... +++.+++.++.|++.||.|||+.|++|+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 9999999999999999999976543 8899999999999999999999999999999
Q ss_pred CCceEeeCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCC
Q 022401 147 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFE 222 (298)
Q Consensus 147 p~nilv~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~ 222 (298)
|+||+++.++. ++|+|||++....... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.
T Consensus 178 p~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 178 ARNILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGGEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred hheEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCCCCCCC
Confidence 99999998887 9999999986443221 2233446678999999987777655 999999999999999 999998
Q ss_pred CCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
........ . .+. .......+..+++++.+++.+||+.||.+|||+.+++++.
T Consensus 255 ~~~~~~~~-~---~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 255 GIPPERLF-N---LLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp TCCGGGHH-H---HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHH-H---Hhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 76653322 2 222 2223344456899999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=324.98 Aligned_cols=258 Identities=21% Similarity=0.338 Sum_probs=211.5
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEE-----EccCCcEEEEEEeecCCcc--hHHHHHHHHHHhcC-CCCCeeeeeEEE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVI 88 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~-----~~~~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~ 88 (298)
.+....++|++++.||+|+||.||+++ +..+++.||+|++...... .+.+.+|+.++.++ +||||+++++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 344567899999999999999999999 4556789999999764332 34688999999999 789999999999
Q ss_pred EeCC-eEEEEEeccCCCCHHHHHHhCCC----------------------------------------------------
Q 022401 89 LTPT-HLAIVMEYASGGELFERICNAGR---------------------------------------------------- 115 (298)
Q Consensus 89 ~~~~-~~~lv~~~~~~~sL~~~l~~~~~---------------------------------------------------- 115 (298)
.+.. .+++|+||+++++|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8765 58999999999999999976532
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---CCC
Q 022401 116 --------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPK 178 (298)
Q Consensus 116 --------------~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~---~~~ 178 (298)
+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++....... ...
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhcc
Confidence 889999999999999999999999999999999999998887 9999999987443222 223
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
...+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||............... ......+..+++++.++
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHH
T ss_pred ccCCCceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CCCCCCCCCCCHHHHHH
Confidence 3446778999999987777655 999999999999998 99999887654443333322 22334445589999999
Q ss_pred HHHhhhhCCCCcccccccchhhhH
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
+.+||+.||.+|||+.+++++.-.
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHH
Confidence 999999999999999999976543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=318.29 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=187.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc--hHHHHHHHH-HHhcCCCCCeeeeeEEEEeCCeE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREII-NHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
.....++|++++.||+|+||.||++.+..+++.||+|++...... ...+..|+. +++.++||||+++++++..++..
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 345678999999999999999999999989999999998765322 234445555 77888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhc-CcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 95 AIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
++|+|++.+ +|.+++.. ...+++..+..++.+++.||.|||+. |++|+||+|+||+++.++. +||+|||++
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~ 173 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGIS 173 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSS
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCc
Confidence 999999976 78777753 56789999999999999999999998 9999999999999998887 999999998
Q ss_pred ccccCCCCCCCCCCCCcccCccccc----cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-C
Q 022401 169 KSSVLHSQPKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-S 243 (298)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~ 243 (298)
.............+++.|+|||.+. +..++. ++||||||+++|+|++|..||....... .....+..... .
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 249 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDV-RSDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQ 249 (327)
T ss_dssp CC------------------------------CCS-HHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCC
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCc-hhhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCC
Confidence 7554444444456889999999984 334444 5999999999999999999998644211 11111111111 1
Q ss_pred C--CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 244 V--PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 244 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
. .....+++++.+++.+||+.||.+|||+ .++++|||+.+..
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--------~ell~hp~~~~~~ 293 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKY--------KELLKHPFILMYE 293 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH--------HHHTTSHHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCH--------HHHHhChHHHHhH
Confidence 1 1223578999999999999999999987 5556788887654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=309.77 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=211.0
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEE----EccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEE
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVI 88 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~----~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (298)
..+......+|++++.||+|+||.||.++ +..+++.||+|++.... .....+.+|+.++++++||||+++++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 33445566789999999999999999999 56689999999987543 3346788999999999999999999999
Q ss_pred EeC--CeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 89 LTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 89 ~~~--~~~~lv~~~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
.+. ..+++|+|++++++|.+++. ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+||
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Df 170 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDF 170 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCC
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECcc
Confidence 876 67899999999999999994 4457999999999999999999999999999999999999998887 999999
Q ss_pred CccccccCCC----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCC-----------CCchhH
Q 022401 166 GYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-----------DEPKDF 230 (298)
Q Consensus 166 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-----------~~~~~~ 230 (298)
|++....... ......++..|+|||.+.+..++.+ +||||||+++|+|++|..|+... .....
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 248 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT- 248 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH-
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC-
Confidence 9986443332 2234457778999999988777655 99999999999999999886432 11112
Q ss_pred HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
..............+.+..+++++.+++.+||+.||.+|||+.++++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 2222233333444555667899999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=306.28 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=212.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.++.++|++.+.||+|+||.||.+.+. +++.+|+|++.......+.+.+|+.++++++||||+++++++.+++..++|+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 345678999999999999999999987 5678999999887777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC--C
Q 022401 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~--~ 175 (298)
|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccc
Confidence 999999999999765 46899999999999999999999999999999999999988887 999999988643221 1
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...... .....+... .....+...++++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~i~~~-~~~~~~~~~~~~l 234 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTG-FRLYKPRLASTHV 234 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTT-CCCCCCTTSCHHH
T ss_pred ccccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCCCCHH----HHHHHHhcC-CcCCCCccCcHHH
Confidence 2233446678999999877776554 999999999999999 89999876542 223333332 2333444579999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
.+++.+||+.||.+|||+.+++++..
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQLA 260 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999999987543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=323.55 Aligned_cols=257 Identities=19% Similarity=0.284 Sum_probs=208.5
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEE-----EccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~-----~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
....++|++++.||+|+||.||+|+ +..++..||+|++.... .....+.+|+.++++++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3456789999999999999999999 44567889999986532 2334678899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC-CCEEEe
Q 022401 92 THLAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKIC 163 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~-~~~~l~ 163 (298)
...++|+||+.+++|.+++... ..++..+++.++.|++.||+|||++|++||||||+||+++.++. ..+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999999999754 34899999999999999999999999999999999999985442 249999
Q ss_pred ecCcccccc---CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 022401 164 DFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS 239 (298)
Q Consensus 164 d~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 239 (298)
|||++.... .........+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...... +....+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~----~~~~~i~~ 301 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTS 301 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHc
Confidence 999986322 2233344557889999999987777655 999999999999998 99999876542 23333333
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 240 VQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
.. ....+..+++++.+++.+||+.||.+|||+.+++++...
T Consensus 302 ~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 302 GG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 32 333445589999999999999999999999888876544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=306.31 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=207.8
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch--------HHHHHHHHHHhcCCCCCeeeeeEEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVIL 89 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (298)
+....++|++.+.||+|+||.||++++..+++.||+|++....... ..+.+|+.++++++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 3466789999999999999999999999899999999986543221 56889999999999999999999986
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEeeCCCC---CCEEEe
Q 022401 90 TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPA---PRLKIC 163 (298)
Q Consensus 90 ~~~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~~~~~---~~~~l~ 163 (298)
+.. ++|+||+++++|.+.+... ..+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++. ..++|+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 665 6899999999998887654 46999999999999999999999999 999999999999976543 238999
Q ss_pred ecCccccccCCCCCCCCCCCCcccCcccccc--ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC
Q 022401 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241 (298)
Q Consensus 164 d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (298)
|||++..... ......+++.|+|||.+.. ..+ +.++||||||+++|+|++|..||........ ..........
T Consensus 172 Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIREEG 246 (287)
T ss_dssp CCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHHHHHHSC
T ss_pred CCCccccccc--cccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHHHHhccC
Confidence 9999873332 2344568899999999843 333 3459999999999999999999987664332 2233333444
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 242 YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.....+..+++++.+++.+||+.||.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 4445556689999999999999999999999998864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=318.86 Aligned_cols=262 Identities=29% Similarity=0.441 Sum_probs=182.9
Q ss_pred CCCCCCCCeeEEe-eeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe----C
Q 022401 17 PIMHDSDRYDFVR-DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----P 91 (298)
Q Consensus 17 ~~~~~~~~y~~~~-~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 91 (298)
+.....++|++.+ .||+|+||.||++.+..+++.||+|++...... ..+....++.++||||+++++++.. .
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA---RQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 3445678999965 699999999999999999999999998764322 2223344567799999999999876 4
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCcc
Q 022401 92 THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYS 168 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~ 168 (298)
..+++|+||+++++|.+++.... .+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++ ...++|+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56899999999999999997664 699999999999999999999999999999999999997643 335999999998
Q ss_pred ccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--CCC
Q 022401 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPD 246 (298)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~ 246 (298)
..... .......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...............+...... .+.
T Consensus 179 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 179 KETTQ-NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp EEC-----------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred eeccc-cccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence 64432 22234567899999999877777555 999999999999999999997765433322223333333322 223
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...+++++.+||.+||+.||.+|||+ .++++|||+.+
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~--------~ell~hp~~~~ 293 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTI--------TQFMNHPWINQ 293 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCH--------HHHHHSHHHHT
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCH--------HHHhcCccccc
Confidence 34689999999999999999999987 55567888865
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=320.83 Aligned_cols=270 Identities=13% Similarity=0.097 Sum_probs=216.1
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEcc--------CCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeee----------
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKV--------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR---------- 83 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------- 83 (298)
.++|++.+.||+|+||.||++++.. .++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 5899999999999999999999986 4789999998755 46788999999999999887
Q ss_pred -----eeEEEEe-CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC
Q 022401 84 -----FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155 (298)
Q Consensus 84 -----~~~~~~~-~~~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~ 155 (298)
+++++.. +...++|+||+ +++|.+++... ..+++.+++.++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 6777776 67899999999 89999999876 689999999999999999999999999999999999999988
Q ss_pred CCCCEEEeecCccccccCCCC--------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCC-C
Q 022401 156 PAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-E 226 (298)
Q Consensus 156 ~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-~ 226 (298)
+...++|+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.... .
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 733499999999864432221 133468899999999987776555 999999999999999999998765 3
Q ss_pred chhHHHHHHHHhhcCCCCCC----CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcC
Q 022401 227 PKDFRKTIQRILSVQYSVPD----TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYH 297 (298)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~ 297 (298)
..........+......... ...+++++.+++.+||+.||.+|||+.++++..-..+-....-.+..-+|+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~ 349 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLP 349 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence 34444444444333332222 124689999999999999999999999999876655555554445555564
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=316.01 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=209.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-------chHHHHHHHHHHhcCC--CCCeeeeeEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVI 88 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~--h~~i~~~~~~~ 88 (298)
.....++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.++++++ |+|++++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34567899999999999999999999999999999999876432 1245667899999986 59999999999
Q ss_pred EeCCeEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEee-CCCCCCEEEeecC
Q 022401 89 LTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFG 166 (298)
Q Consensus 89 ~~~~~~~lv~~~~~~-~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~-~~~~~~~~l~d~~ 166 (298)
..++..++|++++.+ ++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++ .++. ++|+|||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg 195 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG 195 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCc
Confidence 999999999999975 89999998888999999999999999999999999999999999999998 5565 9999999
Q ss_pred ccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
++...... ......+++.|+|||.+.+..+.+.++||||||+++|+|++|..||.... .+..... ..
T Consensus 196 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~~~~~~~--~~ 262 (320)
T 3a99_A 196 SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQV--FF 262 (320)
T ss_dssp TCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCC--CC
T ss_pred cccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------hhhcccc--cc
Confidence 98644322 22345688999999998877776666899999999999999999997521 1122222 23
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
...+++++.++|.+||+.||.+|||+ .++++|||+++.
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~--------~~ll~hp~~~~~ 300 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTF--------EEIQNHPWMQDV 300 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCH--------HHHHTSGGGSSC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCH--------HHHhcCHhhcCc
Confidence 34589999999999999999999987 556688888754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=313.63 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=213.0
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEE-----ccCCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEEEe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 90 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (298)
....++|++.+.||+|+||.||++.+ ..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 44558999999999999999999985 45678999999876543 346688999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe
Q 022401 91 PTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~------------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv 152 (298)
++..++|+|++++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 999999999999999999997654 48999999999999999999999999999999999999
Q ss_pred eCCCCCCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCch
Q 022401 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (298)
Q Consensus 153 ~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~ 228 (298)
+.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.......
T Consensus 179 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 THGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cCCCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 98887 99999999875443322 123345678999999887776555 999999999999998 999998876654
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
........ .........+++++.+++.+||+.||.+|||+.+++++.-.
T Consensus 256 ~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 256 KFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 44433332 23334445689999999999999999999999999975543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=309.63 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=201.0
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
...++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 35578999999999999999999998899999999987532 23456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 96 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
+|+|++++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFF 186 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeee
Confidence 99999999999998864 456899999999999999999999999999999999999998887 999999988644
Q ss_pred cCCC-CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 172 VLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 172 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
.... ......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .......+............+
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTS
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCccccc
Confidence 3322 2233457889999999887777655 99999999999999999999764422 233334444444433334568
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
++++.+++.+||+.||.+|||+.++++..
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999999999999999999999988643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=318.84 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=210.8
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecC--CcchHHHHHHHHHHhcC-CCCCeeeeeEEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVIL 89 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 89 (298)
+....++|++.+.||+|+||.||++.+. .++..||+|++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4456689999999999999999999973 35678999998753 23456788999999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCC
Q 022401 90 TPTHLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146 (298)
Q Consensus 90 ~~~~~~lv~~~~~~~sL~~~l~~~~-----------------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~ 146 (298)
..+..++|+||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999997643 27899999999999999999999999999999
Q ss_pred CCceEeeCCCCCCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCC
Q 022401 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFE 222 (298)
Q Consensus 147 p~nilv~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~ 222 (298)
|+||+++.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.
T Consensus 200 p~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 200 ARNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp GGGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSST
T ss_pred hhhEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCCCcc
Confidence 99999998887 99999999874433222 123345678999999887776555 999999999999998 999998
Q ss_pred CCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
.......+.... ........+..+++++.+++.+||+.||.+|||+.+++++...
T Consensus 277 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 277 GIPVDANFYKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp TCCCSHHHHHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCcHHHHHHHH----hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 876544433332 3333444455689999999999999999999999888865543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=308.44 Aligned_cols=262 Identities=28% Similarity=0.408 Sum_probs=206.7
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
...++|.....||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 33445555569999999999999999899999999987643 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-CCCCCEEEeecCccccccCC
Q 022401 99 EYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~~~~~~ 174 (298)
|++++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++. ++|+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGI 176 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC-
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCCC
Confidence 9999999999997652 4678999999999999999999999999999999999987 665 999999998644322
Q ss_pred -CCCCCCCCCCcccCcccccccc-CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 175 -SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 175 -~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
.......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||......... .............+..+++
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHHHHCCCCCCCTTSCH
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhccccccccccccCCH
Confidence 2233456889999999987643 2344599999999999999999999765443221 1111111222233445899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
++.++|.+||+.||.+|||+ .++++|||+....+
T Consensus 254 ~~~~li~~~l~~dp~~Rps~--------~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACA--------NDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCH--------HHHHTSGGGCC---
T ss_pred HHHHHHHHHccCChhhCCCH--------HHHhcChhhhhccc
Confidence 99999999999999999987 66668999986554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=334.91 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=216.5
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
+....++|++.+.||+|+||.||++.+..++..||+|++.......+.+.+|+.++++++||||+++++++.+...+++|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 45566789999999999999999999998899999999987776778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-
Q 022401 98 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~- 174 (298)
+||+.+++|.+++... ..++...++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDT 372 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCc
Confidence 9999999999999764 45899999999999999999999999999999999999998887 999999998744322
Q ss_pred -CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 175 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 175 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
.......++..|+|||.+....++.+ +||||||+++|+|++ |..||...+..... . ........+.+..+++
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~----~~~~~~~~~~~~~~~~ 446 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY-E----LLEKDYRMERPEGCPE 446 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-H----HHHTTCCCCCCTTCCH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-H----HHHcCCCCCCCCCCCH
Confidence 12223345678999999987777665 999999999999999 89999876643322 2 2233444455666899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
++.+++.+||+.||.+|||+.++++..
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 999999999999999999999998644
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=319.12 Aligned_cols=274 Identities=15% Similarity=0.147 Sum_probs=206.1
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccC-----CcEEEEEEeecCCcch------------HHHHHHHHHHhcCCCCCeee
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDKID------------ENVQREIINHRSLRHPNIVR 83 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~aiK~~~~~~~~~------------~~~~~e~~~l~~l~h~~i~~ 83 (298)
..++|++.+.||+|+||.||++.+..+ ++.||+|++....... .....|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345999999999999999999998754 5789999987654211 22334566677889999999
Q ss_pred eeEEEEeC----CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC
Q 022401 84 FKEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (298)
Q Consensus 84 ~~~~~~~~----~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~ 158 (298)
+++++... ...++||||+ +++|.+++... ..+++..++.++.|++.||+|||+.|++||||||+||+++.+...
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 4689999999 99999999765 579999999999999999999999999999999999999833333
Q ss_pred CEEEeecCccccccCCCCC--------CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhH
Q 022401 159 RLKICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230 (298)
Q Consensus 159 ~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 230 (298)
.+||+|||++......... ....+++.|+|||++.+..++.+ +||||||+++|+|++|..||.........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 4999999998643322211 23348999999999988777555 99999999999999999999864433332
Q ss_pred HHHHHHHhhcCC-----CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 231 RKTIQRILSVQY-----SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 231 ~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
............ .......+|+++.+++..||+.||.+||++.++++..-..+-..-+-.+..-+|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 222221111110 001123479999999999999999999999999876544444433333344444
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=329.21 Aligned_cols=259 Identities=15% Similarity=0.140 Sum_probs=189.4
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHH---HHHhcCCCCCeeeee-------EEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREI---INHRSLRHPNIVRFK-------EVI 88 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~ 88 (298)
.+|++.+.||+|+||.||++++..+++.||+|++..... ..+.+.+|+ ..++. +|||+++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 459999999999999999999999999999999987543 234566774 45555 799987755 444
Q ss_pred EeC-----------------CeEEEEEeccCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHhhcCcEEec
Q 022401 89 LTP-----------------THLAIVMEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHAMQVCHRD 144 (298)
Q Consensus 89 ~~~-----------------~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~------~~i~~~l~~~l~~Lh~~~i~H~d 144 (298)
..+ ..+++||||++ ++|.+++... ..++.... +.++.|++.||+|||++|++|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 332 34899999998 7999999753 23444445 67779999999999999999999
Q ss_pred CCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCCcccCcccccc--ccCCCCccchHHHHHHHHHHHhCCCCCC
Q 022401 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (298)
Q Consensus 145 l~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~ 222 (298)
|||+||+++.++. +||+|||++....... ....+++.|+|||.+.+ ..++. ++||||||+++|+|++|..||.
T Consensus 220 ikp~NIll~~~~~--~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~-~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGR--LMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTH-ALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSC--EEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCH-HHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCC--EEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCc-cccHHHHHHHHHHHHhCCCCCC
Confidence 9999999998887 9999999987443221 14456699999999976 45544 4999999999999999999998
Q ss_pred CCCCchhH--HH-HHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 223 DPDEPKDF--RK-TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 223 ~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
........ .. ............+....+++++.+||.+||+.||.+|||+ .++++|||+.+..+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--------~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP--------LEAMETPEFLQLQNEI 363 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH--------HHHTTSHHHHHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH--------HHHhcCHHHHHHHHHH
Confidence 76321100 00 0000011223334445689999999999999999999987 5666899998776543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=320.88 Aligned_cols=263 Identities=27% Similarity=0.342 Sum_probs=209.3
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-CC-----CeeeeeEEEEeC
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTP 91 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~ 91 (298)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.........+..|+.+++.++ |+ +++++.+++...
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344568999999999999999999999999999999999876555567778888888774 44 499999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHh--hcCcEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 92 THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh--~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
..+++|+|++++ +|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++...+||+|||+
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999999965 999988765 45899999999999999999999 5799999999999999764444599999999
Q ss_pred cccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-----
Q 022401 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----- 242 (298)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 242 (298)
+.... .......+++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+.+............
T Consensus 208 a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (382)
T 2vx3_A 208 SCQLG--QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284 (382)
T ss_dssp CEETT--CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ceecc--cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 87443 22345668899999999988877655 99999999999999999999987765554444432211000
Q ss_pred ---------CCC-----------------CC--C---------------------C----CCHHHHHHHHHhhhhCCCCc
Q 022401 243 ---------SVP-----------------DT--N---------------------P----ISQECRDLISRIFVADPAAV 269 (298)
Q Consensus 243 ---------~~~-----------------~~--~---------------------~----~~~~l~~li~~~l~~dp~~R 269 (298)
..+ .+ . . .++++.+||.+||+.||.+|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 000 00 0 0 01478999999999999999
Q ss_pred ccccccchhhhHHHhhhhhhhhh
Q 022401 270 SIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 270 ps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
||+ .++++|||+++.
T Consensus 365 pta--------~e~L~hp~f~~~ 379 (382)
T 2vx3_A 365 IQP--------YYALQHSFFKKT 379 (382)
T ss_dssp CCH--------HHHTTSGGGCC-
T ss_pred CCH--------HHHhcCcccccC
Confidence 988 556689999754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=311.47 Aligned_cols=259 Identities=28% Similarity=0.466 Sum_probs=210.7
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCeEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 95 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 95 (298)
..++|++.+.||+|+||.||++++..+++.+|+|.+.... ...+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 3578999999999999999999999999999999997643 234568899999999999999999998854 56899
Q ss_pred EEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC-----cEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 96 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~Lh~~~-----i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
+|+||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++. ++|+|||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg 161 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFG 161 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCc
Confidence 999999999999998643 34899999999999999999999999 999999999999998887 9999999
Q ss_pred ccccccCCCC-CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 167 YSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 167 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+. ......+...... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~i~~~~~~-~ 235 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKFR-R 235 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCC-C
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCH----HHHHHHHhhcccc-c
Confidence 8864332211 122357889999999887776554 9999999999999999999987653 2233333333332 2
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATEN 295 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~ 295 (298)
.+..+++++.++|.+||+.||.+|||+ .++++|||...+...
T Consensus 236 ~~~~~~~~l~~li~~~l~~~p~~Rps~--------~~ll~~~~~~~~~~~ 277 (279)
T 2w5a_A 236 IPYRYSDELNEIITRMLNLKDYHRPSV--------EEILENPLILEHHHH 277 (279)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCH--------HHHHTSTTCCGGGSC
T ss_pred CCcccCHHHHHHHHHHcCCCcccCCCH--------HHHHhChhhhhhccc
Confidence 334589999999999999999999987 666689998877643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=317.73 Aligned_cols=261 Identities=20% Similarity=0.204 Sum_probs=205.9
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-- 92 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 92 (298)
.....+..++|++.+.||+|+||.||++++. ++.||+|++............|+.++++++||||+++++++....
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 3445577789999999999999999999875 789999999876666666777999999999999999999998743
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc----------CcEEecCCCCceEeeCCCCCCE
Q 022401 93 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM----------QVCHRDLKLENTLLDGSPAPRL 160 (298)
Q Consensus 93 --~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~----------~i~H~dl~p~nilv~~~~~~~~ 160 (298)
.+++|+||+++++|.+++... .+++..++.++.|++.||+|||+. |++|+||||+||+++.++. +
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~ 170 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--A 170 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--E
T ss_pred CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--E
Confidence 479999999999999999664 589999999999999999999999 9999999999999998887 9
Q ss_pred EEeecCccccccCCCC---CCCCCCCCcccCccccccccC----CCCccchHHHHHHHHHHHhCCCCCCCCCCch-----
Q 022401 161 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEY----DGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----- 228 (298)
Q Consensus 161 ~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~----- 228 (298)
||+|||++........ .....+++.|+|||++.+... .+.++||||||+++|+|++|..||.......
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 9999999864433222 233468999999999876322 1234899999999999999999997654321
Q ss_pred -------hHHHHHHHHhhcCCCCCCCC-----CCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 229 -------DFRKTIQRILSVQYSVPDTN-----PISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 229 -------~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
.................... ..++++.++|.+||+.||.+|||+.++++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 314 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11222222222222111111 12456999999999999999999999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=316.82 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=208.0
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCC-cEEEEEEeecCCcchHHHHHHHHHHhcCCCCC------eeeeeEEEE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVIL 89 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~ 89 (298)
.+....++|++.+.||+|+||.||++.+..++ ..||+|++.......+.+.+|+.++++++|++ ++.+.+++.
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 34445689999999999999999999997766 78999999876666677888999999887655 899999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEee--------------
Q 022401 90 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-------------- 153 (298)
Q Consensus 90 ~~~~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~-------------- 153 (298)
....+++|+|++ ++++.+.+... ..+++..++.++.|++.||.|||+.|++|+||||+||+++
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999 55666666544 3699999999999999999999999999999999999993
Q ss_pred -----CCCCCCEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch
Q 022401 154 -----GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (298)
Q Consensus 154 -----~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 228 (298)
.++ .++|+|||++.... .......+++.|+|||++.+..++.+ +||||||+++|+|++|..||......+
T Consensus 172 ~~~~~~~~--~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNT--SIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCC--CEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCC--cEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 344 49999999986432 23345568999999999988777665 999999999999999999998866544
Q ss_pred hHHHHHHHHhhcCC------------------C---------------------CCCCCCCCHHHHHHHHHhhhhCCCCc
Q 022401 229 DFRKTIQRILSVQY------------------S---------------------VPDTNPISQECRDLISRIFVADPAAV 269 (298)
Q Consensus 229 ~~~~~~~~~~~~~~------------------~---------------------~~~~~~~~~~l~~li~~~l~~dp~~R 269 (298)
.... +.++..... . .......+.++.+||.+||+.||.+|
T Consensus 247 ~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 HLVM-MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHH-HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHH-HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 3332 222221100 0 00111124589999999999999999
Q ss_pred ccccccchhhhHHHhhhhhhhhhh
Q 022401 270 SIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 270 ps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
||+ .++++|||+.+..
T Consensus 326 pt~--------~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 326 ITL--------AEALLHPFFAGLT 341 (355)
T ss_dssp CCH--------HHHTTSGGGGGCC
T ss_pred cCH--------HHHhcChhhcCCC
Confidence 987 5666899998643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=317.55 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=209.2
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
.....++|++++.||+|+||.||++++. .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3556789999999999999999999997 345889999987643 234568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCC
Q 022401 91 PTHLAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~ 146 (298)
.+..++|+||+++++|.+++... ..+++.+++.++.|++.||.|||+.|++|+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 99999999999999999999763 568999999999999999999999999999999
Q ss_pred CCceEeeCCCCCCEEEeecCccccccCC---CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCC
Q 022401 147 LENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFE 222 (298)
Q Consensus 147 p~nilv~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~ 222 (298)
|+||+++.++. ++|+|||++...... .......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.
T Consensus 202 p~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 202 TRNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp GGGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCCCcCC
Confidence 99999998887 999999998643222 22234456788999999887777655 999999999999999 999998
Q ss_pred CCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
..... +....+..... ...+..+++++.+++.+||+.||.+|||+.+++++
T Consensus 279 ~~~~~----~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 279 GMAHE----EVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TSCHH----HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCChH----HHHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 76542 23333333332 23345589999999999999999999999888853
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=306.96 Aligned_cols=270 Identities=21% Similarity=0.229 Sum_probs=212.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEE-EeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~~~ 100 (298)
.++|++.+.||+|+||.||++++..+++.||+|++..... .+.+.+|+.++++++|++++..+..+ ......++|+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4789999999999999999999998999999998876543 35688999999999987766555554 567788999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEee---CCCCCCEEEeecCccccccCCCC
Q 022401 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 101 ~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~---~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
+ +++|.+++.. ...+++..++.++.|++.||+|||++|++|+||+|+||+++ .++. ++|+|||++........
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCccccccccc
Confidence 9 8899999973 55799999999999999999999999999999999999994 5555 99999999874433322
Q ss_pred --------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc---hhHHHHHHHHhhcCCCCC
Q 022401 177 --------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 177 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~ 245 (298)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... ..+............. .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~ 241 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-V 241 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-H
T ss_pred ccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-H
Confidence 234568899999999988776555 99999999999999999999875432 2222222222221111 1
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcC
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYH 297 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~ 297 (298)
....+|+++.+++.+||+.||.+|||+.++++..-...-....-.+..-+|+
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 1234789999999999999999999999999866555555544445556665
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=325.59 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=209.0
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-eEE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLA 95 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 95 (298)
.+.+..++|++.+.||+|+||.||++... ++.||+|++.... ..+.+.+|+.++++++||||+++++++.... .++
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 34566789999999999999999999885 6789999987654 5678899999999999999999999987765 799
Q ss_pred EEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 96 IVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+||+++++|.+++...+. ++...++.++.|++.||+|||++|++||||+|+||+++.++. +||+|||++.....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS 341 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC-
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCcccccc
Confidence 99999999999999976543 799999999999999999999999999999999999998887 99999999874332
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
. .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+... .+. .....+.+..+|+
T Consensus 342 ~--~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----~i~-~~~~~~~p~~~~~ 413 (450)
T 1k9a_A 342 T--QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----RVE-KGYKMDAPDGCPP 413 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH----HHH-TTCCCCCCTTCCH
T ss_pred c--ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCcCCH
Confidence 2 223356788999999988777665 999999999999998 999998766543322 222 2234455566899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
++.+++.+||+.||.+|||+.++++.
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~~ 439 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLREQ 439 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=315.80 Aligned_cols=256 Identities=20% Similarity=0.314 Sum_probs=203.8
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcE----EEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEE
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL----VAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVIL 89 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~----~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (298)
....+..++|++.+.||+|+||.||++++..+++. +++|.+... ......+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp SSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred HHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 34456678999999999999999999998777665 477766432 234567889999999999999999999998
Q ss_pred eCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 90 TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 90 ~~~~~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
.+. .+++++++.+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||++
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a 164 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLA 164 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHH
T ss_pred cCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcce
Confidence 765 7788999999999999876 457999999999999999999999999999999999999998887 999999998
Q ss_pred ccccCCCCC---CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCC
Q 022401 169 KSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSV 244 (298)
Q Consensus 169 ~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
......... ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||........ .. ........
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~-~~----~~~~~~~~ 238 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEI-SS----ILEKGERL 238 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HH----HHHTTCCC
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHH-HH----HHHcCCCC
Confidence 644332221 23345678999999988777655 999999999999999 9999987665332 22 22233344
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 245 PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 245 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
+.+..++.++.+++.+||+.||.+|||+.+++++..
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 274 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 455568999999999999999999999999997643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=308.10 Aligned_cols=258 Identities=23% Similarity=0.341 Sum_probs=191.6
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch---HHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
....++|++++.||+|+||.||++++..+++.||+|++....... ..+.++..+++.++||||+++++++..+..++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 345689999999999999999999999899999999997654332 23344556778889999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhc-CcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+|++ ++.+..+... ...+++..++.++.+++.||.|||+. |++|+||+|+||+++.++. ++|+|||++.....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVD 177 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC-----
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccC
Confidence 999999 5566555543 56799999999999999999999995 9999999999999998887 99999999875544
Q ss_pred CCCCCCCCCCCcccCcccccc-----ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-CCCCCCC
Q 022401 174 HSQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDT 247 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 247 (298)
........+++.|+|||.+.. ..+ ..++||||||+++|+|++|..||....... .....+... ....+..
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 253 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDF---EVLTKVLQEEPPLLPGH 253 (318)
T ss_dssp ---------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHHSCCCCCCSS
T ss_pred CccccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccH---HHHHHHhccCCCCCCcc
Confidence 444445568899999999852 334 445999999999999999999998754432 222233332 2334444
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..+++++.+++.+||+.||.+|||+.++ ++|||+.+
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~l--------l~h~~~~~ 289 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKL--------LEHSFIKR 289 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHH--------TTSHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHH--------hhCHHHHh
Confidence 5689999999999999999999988554 56777764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=306.14 Aligned_cols=252 Identities=23% Similarity=0.282 Sum_probs=205.9
Q ss_pred CCCCCCeeEEe-eeccCCeEEEEEEEE--ccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 19 MHDSDRYDFVR-DIGSGNFGVARLMRD--KVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 19 ~~~~~~y~~~~-~lg~g~~~~vy~~~~--~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
..+.++|++.+ .||+|+||.||++.+ ..+++.||+|++.... ...+.+.+|+.++++++||||+++++++ ...
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 45567899999 999999999999954 5567899999987543 2246788999999999999999999999 667
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
..++|+|++.+++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALR 168 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECC
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcceeec
Confidence 78999999999999999998888999999999999999999999999999999999999998887 9999999986443
Q ss_pred CCCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCC
Q 022401 173 LHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247 (298)
Q Consensus 173 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
.... .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||....... ....+... .....+
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~ 242 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKG-ERMGCP 242 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHHTT-CCCCCC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHHcC-CCCCCC
Confidence 3221 122335678999999877776555 999999999999999 999998765422 22222222 223344
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
..+++++.+++.+||+.||.+|||+.++++..
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 56899999999999999999999999888644
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=326.83 Aligned_cols=253 Identities=21% Similarity=0.355 Sum_probs=211.8
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
..+.+..++|++.+.||+|+||.||++.+. ++..||+|++.......+.+.+|+.++++++||||+++++++. .+.++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 345667789999999999999999999986 4677999999887777788999999999999999999999986 66789
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 96 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+||+.+++|.+++... ..++...++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++.....
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIED 336 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCC
Confidence 999999999999999754 36889999999999999999999999999999999999998887 99999999874432
Q ss_pred C--CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 174 H--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 174 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
. .......++..|+|||.+....++.+ +||||||+++|+|++ |..||......+. ...+. .....+.+..+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~----~~~i~-~~~~~~~~~~~ 410 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEV----IRALE-RGYRMPRPENC 410 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHHH-HTCCCCCCTTS
T ss_pred CceeccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHH----HHHHH-cCCCCCCCCCC
Confidence 1 11223345678999999987777655 999999999999999 9999987654332 22222 23444556678
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
|+++.+++.+||+.||.+|||+.++++.
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~ 438 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQSV 438 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999999888753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=307.65 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=198.7
Q ss_pred CCCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEE
Q 022401 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEV 87 (298)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~ 87 (298)
.+.-..++.+..++|++.+.||+|+||.||++++.. .+|+|++..... ..+.+.+|+.++++++||||++++++
T Consensus 12 ~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 12 SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp ------CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence 334445667788999999999999999999998753 499998875432 23568899999999999999999996
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 88 ILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 88 ~~~~~~~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
. .....++|++++.+++|.+.+.. ...+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg 165 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFG 165 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC
T ss_pred c-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccce
Confidence 5 55678999999999999999854 446899999999999999999999999999999999999998887 9999999
Q ss_pred ccccccC---CCCCCCCCCCCcccCccccc---cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 022401 167 YSKSSVL---HSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240 (298)
Q Consensus 167 ~~~~~~~---~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (298)
++..... ........+++.|+|||.+. +..++. ++||||||+++|+|++|..||......+............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF-QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCH-HHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCc-ccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence 9864332 12223446899999999986 333433 4999999999999999999998877655544444332211
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 241 QYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 241 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.........+|+++.+++.+||+.||.+|||+.+++++.
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 111122345889999999999999999999999988643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=314.90 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=201.3
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc-------hHHHHHHHHHHhcC----CCCCeeeeeEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-------DENVQREIINHRSL----RHPNIVRFKEV 87 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~e~~~l~~l----~h~~i~~~~~~ 87 (298)
..-.++|++.+.||+|+||.||++++..+++.||+|++...... ...+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34467899999999999999999999989999999998754321 22345688888888 89999999999
Q ss_pred EEeCCeEEEEEec-cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEee-CCCCCCEEEeec
Q 022401 88 ILTPTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDF 165 (298)
Q Consensus 88 ~~~~~~~~lv~~~-~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~-~~~~~~~~l~d~ 165 (298)
+...+..++|+++ +.+++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++ .++. ++|+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~df 184 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDF 184 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECCC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEEc
Confidence 9999999999999 78899999998888899999999999999999999999999999999999998 6665 999999
Q ss_pred CccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
|++...... ......++..|+|||.+.+..+...++||||||+++|+|++|..||.... .+......
T Consensus 185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~~~~~~~~-- 251 (312)
T 2iwi_A 185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EILEAELH-- 251 (312)
T ss_dssp SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHTCCC--
T ss_pred chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------HHhhhccC--
Confidence 998644332 22345588999999998877776656999999999999999999997521 12222222
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATEN 295 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~ 295 (298)
....++.++.++|.+||+.||.+|||+ .++++|||+++..++
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~--------~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSL--------EEILLDPWMQTPAED 293 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCH--------HHHHHSTTTCC----
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCH--------HHHhcChhhcCchhc
Confidence 334589999999999999999999987 666689999876654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=319.50 Aligned_cols=257 Identities=18% Similarity=0.198 Sum_probs=200.1
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEcc---CCcEEEEEEeecCCcc------------hHHHHHHHHHHhcCCCCCeeee
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRF 84 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~ 84 (298)
...++|++.+.||+|+||.||+|.+.. ++..+|+|+....... ...+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 445789999999999999999999986 7889999998765321 1335678888999999999999
Q ss_pred eEEEEe----CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCE
Q 022401 85 KEVILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (298)
Q Consensus 85 ~~~~~~----~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~ 160 (298)
++++.. ....++|+|++ +++|.+++.....+++.+++.++.|++.||+|||+.|++|+||||+||+++.++...+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999988 67899999999 9999999987778999999999999999999999999999999999999998874459
Q ss_pred EEeecCccccccCCCC--------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCC-CchhHH
Q 022401 161 KICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-EPKDFR 231 (298)
Q Consensus 161 ~l~d~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-~~~~~~ 231 (298)
+|+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.... ......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999864432211 133468899999999887766555 999999999999999999996533 222222
Q ss_pred HHHHHHhhcCC----CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 232 KTIQRILSVQY----SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 232 ~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
........... .......+++++.+++.+||+.||.+|||+.++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 22222222111 011122579999999999999999999999998853
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=311.98 Aligned_cols=254 Identities=21% Similarity=0.312 Sum_probs=208.3
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEc-------cCCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 88 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 88 (298)
....++|++.+.||+|+||.||++++. .++..||+|++..... ....+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 455689999999999999999999975 3567899999876432 335688999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe
Q 022401 89 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (298)
Q Consensus 89 ~~~~~~~lv~~~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv 152 (298)
.+.+.+++|+||+++++|.+++.... .+++.+++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999997654 38999999999999999999999999999999999999
Q ss_pred eCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCch
Q 022401 153 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (298)
Q Consensus 153 ~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~ 228 (298)
+.++. ++|+|||++....... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+
T Consensus 191 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 191 TENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp CTTCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 98887 9999999986443321 2233446678999999887777555 999999999999999 999998765422
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
....+... .....+..++.++.+++.+||+.||.+|||+.++++..-
T Consensus 268 ----~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 268 ----LFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp ----HHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----HHHHHhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22222222 223344568999999999999999999999999997653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=314.77 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=201.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe-----
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 93 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 93 (298)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3689999999999999999999999999999999876432 23567889999999999999999999987653
Q ss_pred -EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 -~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
+++|+|++.+ +|.+.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--
T ss_pred eEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC
Confidence 5999999974 7877663 35899999999999999999999999999999999999998887 9999999987433
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc------------
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------ 240 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 240 (298)
. ......+++.|+|||.+.+......++||||||+++|+|++|..||...+..+.+..........
T Consensus 178 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 178 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred C--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 2 22345678999999998774444455999999999999999999998876544433333221100
Q ss_pred ------------CCCC-CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 241 ------------QYSV-PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 241 ------------~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
...+ .....+++++.+||.+||+.||.+|||+ .++++|||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~--------~e~l~hp~f~~ 311 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA--------AQALTHPFFEP 311 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH--------HHHHTSGGGTT
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH--------HHHhcCcchhh
Confidence 0001 1123578999999999999999999987 56667888864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=309.43 Aligned_cols=254 Identities=22% Similarity=0.255 Sum_probs=199.1
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----hHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
......++|++.+.||+|+||.||++++..+++.||+|++...... .+.+.+|+.++++++||||+++++++..++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 4455678999999999999999999999989999999998754322 356789999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
..++|+|++++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATT 185 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC-----
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcccc
Confidence 99999999999999999988888999999999999999999999999999999999999998887 9999999886443
Q ss_pred CCC--CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-CCCCCCC
Q 022401 173 LHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTNP 249 (298)
Q Consensus 173 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 249 (298)
... ......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .....+..... .......
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 260 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIPRPSTVRPG 260 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCCCGGGTSTT
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCCCccccCCC
Confidence 322 2234468899999999987777665 99999999999999999999875431 11122222111 1123445
Q ss_pred CCHHHHHHHHHhhhhCCCCcc-cccccch
Q 022401 250 ISQECRDLISRIFVADPAAVS-IFFFPLN 277 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rp-s~~~~l~ 277 (298)
+|+++.++|.+||+.||.+|| ++.++++
T Consensus 261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 899999999999999999999 6655553
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=306.68 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=199.5
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
.....++|++.+.||+|+||.||++.+..+ +..+|+|.+.... ...+.+.+|+.++++++||||+++++++ .++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TEN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccC
Confidence 345668999999999999999999998643 4579999876532 2345688999999999999999999997 456
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
..++|+|++++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYM 166 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECcccccccc
Confidence 7889999999999999997654 6899999999999999999999999999999999999998887 999999998644
Q ss_pred cCCC--CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 172 VLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 172 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
.... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+... .+... ...+.+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~----~i~~~-~~~~~~~ 240 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIG----RIENG-ERLPMPP 240 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----HHHTT-CCCCCCT
T ss_pred CcccccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHH----HHHcC-CCCCCCC
Confidence 3322 1223345678999999877776555 999999999999996 899998876544322 22222 2234455
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
.+++++.+++.+||+.||.+|||+.+++++...
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 689999999999999999999999998875443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=323.44 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=210.4
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--eEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLA 95 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 95 (298)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 44679999999999999999999999999999999987543 33466789999999999999999999998765 789
Q ss_pred EEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEee--CCCCCCEEEeecCcccc
Q 022401 96 IVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKS 170 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~--~~~~~~~~l~d~~~~~~ 170 (298)
+|+||+++++|.+++.... .+++..++.++.|++.||+|||+.|++||||||+||++. .++...+||+|||++..
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999999986543 389999999999999999999999999999999999982 22223499999999976
Q ss_pred ccCCCCCCCCCCCCcccCcccccc--------ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLR--------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
...........+++.|+|||.+.+ ..++. ++||||||+++|+|++|..||..........+.+.++..+..
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGA-TVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHH-HHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 555544455678999999998765 33333 499999999999999999999876554444555555554432
Q ss_pred C-------------------CCCC----CCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 243 S-------------------VPDT----NPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 243 ~-------------------~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
. .+.. ..++..+.+++.+||+.||++|||+.++++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 1 1111 12346789999999999999999999988755
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=312.62 Aligned_cols=258 Identities=20% Similarity=0.312 Sum_probs=204.7
Q ss_pred CcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEE----EEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEE
Q 022401 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEV 87 (298)
Q Consensus 14 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~----aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 87 (298)
......+..++|++++.||+|+||.||++++..+++.+ ++|.+... ......+.+|+.++++++||||++++++
T Consensus 6 ~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (327)
T 3lzb_A 6 QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp --CCEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred hhhhcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence 34445567789999999999999999999998777655 56655432 3445778999999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 88 ILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 88 ~~~~~~~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
+..+. .+++++++.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||
T Consensus 86 ~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG 162 (327)
T 3lzb_A 86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFG 162 (327)
T ss_dssp EESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTT
T ss_pred EecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCc
Confidence 98765 7888999999999999876 456999999999999999999999999999999999999998887 9999999
Q ss_pred ccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 167 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 167 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||........ .. ......
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~-~~----~~~~~~ 236 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEI-SS----ILEKGE 236 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HH----HHHTTC
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HH----HHHcCC
Confidence 9874433222 122345678999999987777655 999999999999999 9999988665332 22 222333
Q ss_pred CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 243 SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 243 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
..+.+..++.++.+++.+||+.||.+|||+.++++...
T Consensus 237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 274 (327)
T 3lzb_A 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 44455568999999999999999999999999997543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=319.75 Aligned_cols=257 Identities=22% Similarity=0.337 Sum_probs=202.4
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEc---cCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
.......++|++.+.||+|+||.||++++. .++..||+|++.... .....+.+|+.++++++||||+++++++.+
T Consensus 38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 344556679999999999999999999986 457789999987643 234568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 91 PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
....++|+||+++++|.+++.... .+++.+++.++.|++.||+|||+.|++||||||+||+++.++. +||+|||++.
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~ 195 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR 195 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC----
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCcccc
Confidence 999999999999999999997654 6999999999999999999999999999999999999998887 9999999987
Q ss_pred cccCCCCC----CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCC
Q 022401 170 SSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSV 244 (298)
Q Consensus 170 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
........ ....+++.|+|||.+.+..++.+ +||||||+++|++++ |..||......+ ....+ ......
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~----~~~~i-~~~~~~ 269 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAV-DEGYRL 269 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHH----HHHHH-HTTEEC
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH-HcCCCC
Confidence 44332211 12234568999999987777665 999999999999998 999998765422 22222 223334
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 245 PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 245 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
+....++.++.+++.+||+.||.+||++.++++..-
T Consensus 270 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305 (373)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence 445568999999999999999999999999987543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=310.42 Aligned_cols=269 Identities=17% Similarity=0.243 Sum_probs=216.6
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
+....++|++.+.||+|+||.||+|.+. .+++.||+|.+..... ....+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3455689999999999999999999886 4578899999876433 23457899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCE
Q 022401 91 PTHLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~ 160 (298)
.+..++|+|++++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. +
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~ 177 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--V 177 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--E
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--E
Confidence 99999999999999999998642 45689999999999999999999999999999999999998887 9
Q ss_pred EEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 022401 161 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR 236 (298)
Q Consensus 161 ~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~ 236 (298)
+|+|||++....... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...... .....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~ 252 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNE----QVLRF 252 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHH----HHHHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHH----HHHHH
Confidence 999999986433222 1123345778999999887776555 999999999999999 88999876542 22333
Q ss_pred HhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 237 ILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
+..... ......+++++.+++.+||+.||.+|||+.+++++. .-...||+.+....|
T Consensus 253 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L--~~~~~~~~~~~~~~~ 309 (322)
T 1p4o_A 253 VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI--KEEMEPGFREVSFYY 309 (322)
T ss_dssp HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH--GGGSCTTHHHHCSTT
T ss_pred HHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH--HHhhccCCccccccc
Confidence 333322 233455899999999999999999999999999643 233347776665544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=305.45 Aligned_cols=271 Identities=21% Similarity=0.223 Sum_probs=209.5
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEE-EeCCeEEEEEe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVME 99 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~~ 99 (298)
..++|++.+.||+|+||.||++++..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ......++|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 34789999999999999999999998999999998665432 34578899999999887766655554 66778999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe---eCCCCCCEEEeecCccccccCCC
Q 022401 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 100 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv---~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
++ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||++ +.++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCcc
Confidence 99 8899999874 4579999999999999999999999999999999999999 56665 9999999987443332
Q ss_pred C--------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch---hHHHHHHHHhhcCCCC
Q 022401 176 Q--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---DFRKTIQRILSVQYSV 244 (298)
Q Consensus 176 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 244 (298)
. .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||....... ...............
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh-
Confidence 2 234568899999999987776555 999999999999999999998754322 222222222221111
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcC
Q 022401 245 PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYH 297 (298)
Q Consensus 245 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~ 297 (298)
.....+|+++.+++.+||+.||.+|||+.++++..-...-.+.+-.+...+|+
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 11234789999999999999999999999999866655555555445556675
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=302.80 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=208.5
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
+....++|++.+.||+|+||.||.+.+. ++..+|+|.+.......+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 3445689999999999999999999976 5678999999877767788999999999999999999999986 4568899
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 98 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
+|++.+++|.+++.... .+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNE 163 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSC
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCcc
Confidence 99999999999986543 6899999999999999999999999999999999999998877 9999999986443221
Q ss_pred --CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 176 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
......++..|+|||.+.+..++.+ +||||||+++++|++ |..||......+ ....+.. ......+..+++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~ 237 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNLER-GYRMVRPDNCPE 237 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHHT-TCCCCCCTTCCH
T ss_pred cccccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHH----HHHHHhc-ccCCCCcccccH
Confidence 2233345678999999877776555 999999999999999 899998765432 2222222 223344456899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
++.+++.+||+.||.+|||+.++++..
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 999999999999999999998888643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=303.80 Aligned_cols=259 Identities=25% Similarity=0.336 Sum_probs=210.4
Q ss_pred CCCCCCCeeEEe-eeccCCeEEEEEEEEc--cCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 18 IMHDSDRYDFVR-DIGSGNFGVARLMRDK--VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 18 ~~~~~~~y~~~~-~lg~g~~~~vy~~~~~--~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
..+..++|.+.+ .||+|+||.||++.+. .++..||+|++.... ...+.+.+|+.++++++||||+++++++ ..+
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 345668899988 9999999999999864 467889999987643 3346688999999999999999999999 566
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
..++|+|++.+++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~ 160 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKAL 160 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeee
Confidence 799999999999999998644 46999999999999999999999999999999999999998886 999999998644
Q ss_pred cCCC----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 172 VLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 172 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
.... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+. ...+... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~i~~~-~~~~~ 234 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEV----MAFIEQG-KRMEC 234 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHH----HHHHHTT-CCCCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHH----HHHHhcC-CcCCC
Confidence 3222 2233345788999999877777655 999999999999998 9999988665332 2222222 22334
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFS 285 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~ 285 (298)
+..+++++.++|.+||+.||.+|||+.+++++......+
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 456899999999999999999999999998765554443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=313.02 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=205.5
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcE----EEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~----~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
......++|++.+.||+|+||.||++.+..++.. +++|.+.... .....+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 3456678999999999999999999999877765 6777664432 22355678999999999999999999985
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 91 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+...++|++|+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~ 163 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVAD 163 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCccc
Confidence 45688999999999999998764 57899999999999999999999999999999999999998887 9999999987
Q ss_pred cccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 170 SSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 170 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
....... .....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||........ . ..+ .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~-~---~~~-~~~~~~~ 237 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEV-P---DLL-EKGERLA 237 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHH-H---HHH-HTTCBCC
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHH-H---HHH-HcCCCCC
Confidence 5433322 233456778999999987777655 999999999999999 9999987664332 1 222 2222334
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
.+..++.++.+++.+||+.||.+|||+.+++++..
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 44457889999999999999999999999998653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=307.39 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=204.5
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCC--CCCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLR--HPNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 94 (298)
...++|++.+.||+|+||.||++.+. +++.||+|++.... .....+.+|+.++++++ ||||+++++++..+...
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34568999999999999999999986 58889999987543 23466789999999997 59999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++|+| +.+++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||++++ +. ++|+|||++......
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~--~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM--LKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE--EEECCCSSSCC----
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-Ce--EEEeeccccccccCc
Confidence 99999 557899999998889999999999999999999999999999999999999964 44 999999998744332
Q ss_pred CC---CCCCCCCCcccCccccccc----------cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC
Q 022401 175 SQ---PKSTVGTPAYIAPEVLLRH----------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241 (298)
Q Consensus 175 ~~---~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (298)
.. .....+++.|+|||.+.+. .....++||||||+++|+|++|..||...... ......+....
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~ 256 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPN 256 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHHHHHCTT
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---HHHHHHHHhcc
Confidence 21 2344588999999998652 22344599999999999999999999875432 22333444444
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 242 YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.....+...+.++.+++.+||+.||.+|||+ .++++|||++....
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--------~ell~h~~~~~~~~ 301 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISI--------PELLAHPYVQIQTH 301 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH--------HHHHTSHHHHCC--
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCH--------HHHhcCccccCCCC
Confidence 4444455578999999999999999999987 55557777775443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=312.67 Aligned_cols=255 Identities=21% Similarity=0.318 Sum_probs=210.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCc-----EEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 89 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 89 (298)
.....++|++.+.||+|+||.||.+.+..++. .+|+|.+..... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 45667899999999999999999999876554 799999876532 345688999999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC
Q 022401 90 TPTHLAIVMEYASGGELFERICN--------------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155 (298)
Q Consensus 90 ~~~~~~lv~~~~~~~sL~~~l~~--------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~ 155 (298)
+.+.+++|+|++++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 99999999999999999999864 3457999999999999999999999999999999999999988
Q ss_pred CCCCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHH
Q 022401 156 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 231 (298)
Q Consensus 156 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~ 231 (298)
+. ++|+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||..........
T Consensus 201 ~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 201 HV--AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GE--EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred Ce--EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 87 99999999874433222 223345678999999887777655 999999999999998 889998876544443
Q ss_pred HHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 232 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.... .......+...++++.+++.+||+.||.+|||+.+++++.
T Consensus 278 ~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 278 KLVK----DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp HHHH----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHh----cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 3332 2333344555799999999999999999999999988643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=319.57 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=204.4
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-----------CCCeeeeeEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVI 88 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~ 88 (298)
...++|++.+.||+|+||.||+|++..+++.||+|++.......+.+.+|+.+++++. ||||+++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3567999999999999999999999989999999999876666677889999998876 89999999998
Q ss_pred EeCC----eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhc-CcEEecCCCCceEeeCCC----C
Q 022401 89 LTPT----HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSP----A 157 (298)
Q Consensus 89 ~~~~----~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~p~nilv~~~~----~ 157 (298)
.... .+++++|++ +++|.+++... ..+++..++.++.|++.||+|||++ |++|+||||+||+++.++ .
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 8654 789999999 88999998763 4589999999999999999999998 999999999999996433 2
Q ss_pred CCEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc------hhHH
Q 022401 158 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------KDFR 231 (298)
Q Consensus 158 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~------~~~~ 231 (298)
..++|+|||++..... ......+++.|+|||++.+..++.+ +||||||+++|+|++|..||...... +.+.
T Consensus 175 ~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 175 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred ceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 2599999999864432 2344568999999999988777655 99999999999999999999865421 1111
Q ss_pred HHHHHHhhcCC------------------------------------CCCCCCCCCHHHHHHHHHhhhhCCCCccccccc
Q 022401 232 KTIQRILSVQY------------------------------------SVPDTNPISQECRDLISRIFVADPAAVSIFFFP 275 (298)
Q Consensus 232 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~ 275 (298)
.....+..... ....+...++++.+||.+||+.||.+|||+
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--- 328 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA--- 328 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH---
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH---
Confidence 22111100000 001112245789999999999999999987
Q ss_pred chhhhHHHhhhhhhhhh
Q 022401 276 LNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 276 l~~~~~~~~~hp~~~~~ 292 (298)
.++++|||+.+.
T Consensus 329 -----~ell~hp~f~~~ 340 (373)
T 1q8y_A 329 -----GGLVNHPWLKDT 340 (373)
T ss_dssp -----HHHHTCGGGTTC
T ss_pred -----HHHhhChhhhcc
Confidence 566689999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=311.91 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=212.4
Q ss_pred CcCCCCCCCCCeeEEeeeccCCeEEEEEEE----EccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEE
Q 022401 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVI 88 (298)
Q Consensus 14 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~----~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (298)
-.+.-.+..++|++.+.||+|+||.||+++ +..+++.||+|++..... ..+.+.+|+.++++++||||+++++++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 14 CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp ---CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 344455677899999999999999999999 466889999999876543 335688999999999999999999998
Q ss_pred E--eCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 89 L--TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 89 ~--~~~~~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
. +...+++|+||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Df 171 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADF 171 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEccc
Confidence 7 45679999999999999999976 456999999999999999999999999999999999999998887 999999
Q ss_pred CccccccCCC----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch----------hHH
Q 022401 166 GYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------DFR 231 (298)
Q Consensus 166 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~----------~~~ 231 (298)
|++....... ......++..|+|||.+.+..++.+ +||||||+++|+|++|..||....... ...
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 9987443322 2233456778999999887777555 999999999999999999986532210 111
Q ss_pred HHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 232 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.............+.+..+++++.+++.+||+.||.+|||+.+++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 222233333444555667899999999999999999999999998644
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=307.68 Aligned_cols=251 Identities=16% Similarity=0.154 Sum_probs=202.7
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCC-------cEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTK-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-------~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
...++|++.+.||+|+||.||++.+..++ ..||+|++.... ...+.+.+|+.++++++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 45679999999999999999999998776 469999986543 3456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC------CEEEee
Q 022401 92 THLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP------RLKICD 164 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~------~~~l~d 164 (298)
+..++|+||+++++|.+++..... +++..++.++.|++.||.|||++|++|+||||+||+++.++.. .++|+|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999999977654 8999999999999999999999999999999999999877642 289999
Q ss_pred cCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCC
Q 022401 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244 (298)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
||++..... .....+++.|+|||.+.+....+.++||||||+++|+|++|..|+.......... .........
T Consensus 165 fg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~----~~~~~~~~~ 237 (289)
T 4fvq_A 165 PGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL----QFYEDRHQL 237 (289)
T ss_dssp CCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----HHHHTTCCC
T ss_pred CcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH----HHhhccCCC
Confidence 998753321 1223467789999999874444555999999999999999655544433322211 222222222
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 245 PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 245 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
+...++++.+++.+||+.||.+|||+.+++++.
T Consensus 238 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 238 --PAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp --CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 233578899999999999999999999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=321.27 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=187.8
Q ss_pred CCeeE-EeeeccCCeEEEEEEEEc--cCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCeEEEE
Q 022401 23 DRYDF-VRDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIV 97 (298)
Q Consensus 23 ~~y~~-~~~lg~g~~~~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 97 (298)
+.|++ +++||+|+||.||+|+++ .+++.||+|++.... ....+.+|+.++++++||||+++++++.. ...+++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 45777 568999999999999976 468899999987543 34678899999999999999999999965 6789999
Q ss_pred EeccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe----eCCCCCCEEEee
Q 022401 98 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICD 164 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv----~~~~~~~~~l~d 164 (298)
+||+.+ +|.+.+... ..+++..++.++.||+.||.|||+.|++||||||+||++ +.++. +||+|
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~--~kl~D 175 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR--VKIAD 175 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC--EEECC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc--EEEEE
Confidence 999965 777776421 248999999999999999999999999999999999999 34444 99999
Q ss_pred cCccccccCC----CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc---------hhHH
Q 022401 165 FGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------KDFR 231 (298)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---------~~~~ 231 (298)
||++...... .......+++.|+|||.+.+....+.++|||||||++|+|++|..||...... +.+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9998754332 22234567999999999987665556699999999999999999999765432 2222
Q ss_pred HHHHHHhhcCCC-C-------------------------------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 232 KTIQRILSVQYS-V-------------------------------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 232 ~~~~~~~~~~~~-~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.....+...... + ......++++.+||.+||+.||.+|||+
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta------- 328 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS------- 328 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH-------
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH-------
Confidence 222211110000 0 0011126789999999999999999988
Q ss_pred hHHHhhhhhhhhh
Q 022401 280 CLLLFSFVWMFDA 292 (298)
Q Consensus 280 ~~~~~~hp~~~~~ 292 (298)
.++++|||+.+.
T Consensus 329 -~e~L~hp~f~~~ 340 (405)
T 3rgf_A 329 -EQAMQDPYFLED 340 (405)
T ss_dssp -HHHHTSGGGTSS
T ss_pred -HHHhcChhhccC
Confidence 566689998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=307.82 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=206.2
Q ss_pred cCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCC----cEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEE
Q 022401 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI 88 (298)
Q Consensus 15 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (298)
.....+..++|++.+.||+|+||.||++.+..++ ..||+|++..... ....+.+|+.++++++||||+++++++
T Consensus 36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3444567789999999999999999999986543 3599999876432 234678999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 89 LTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 89 ~~~~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
...+..++|+|++++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~ 193 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGL 193 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCc
Confidence 9999999999999999999999764 57999999999999999999999999999999999999998877 99999999
Q ss_pred cccccCCCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCC
Q 022401 168 SKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY 242 (298)
Q Consensus 168 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (298)
+........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...... .....+.. ..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~----~~~~~~~~-~~ 267 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNH----EVMKAIND-GF 267 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHT-TC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHHC-CC
Confidence 864432211 122234678999999877777655 999999999999999 99999876542 22333332 23
Q ss_pred CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 243 SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 243 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
..+.+..+++++.+++.+||+.||.+||++.+++++...
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 344455689999999999999999999999999875533
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=306.05 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=202.4
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEcc---CCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEE
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVIL 89 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (298)
.......++|++.+.||+|+||.||++.... ++..||+|++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 4455677899999999999999999998764 455899999875432 2356789999999999999999999998
Q ss_pred eCC-----eEEEEEeccCCCCHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC
Q 022401 90 TPT-----HLAIVMEYASGGELFERIC------NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (298)
Q Consensus 90 ~~~-----~~~lv~~~~~~~sL~~~l~------~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~ 158 (298)
+.. ..++|++++.+++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~- 185 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT- 185 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC-
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc-
Confidence 754 3599999999999999984 3356999999999999999999999999999999999999998887
Q ss_pred CEEEeecCccccccCC---CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 022401 159 RLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTI 234 (298)
Q Consensus 159 ~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~ 234 (298)
++|+|||++...... .......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||..........
T Consensus 186 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~--- 260 (313)
T 3brb_A 186 -VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYD--- 260 (313)
T ss_dssp -EEECSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---
T ss_pred -EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHH---
Confidence 999999998644322 22233446778999999977776555 999999999999999 889998766543322
Q ss_pred HHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHH
Q 022401 235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLL 283 (298)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~ 283 (298)
.+... .....+..+++++.+++.+||+.||.+|||+.+++++.-..+
T Consensus 261 -~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 261 -YLLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp -HHHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22222 223344558999999999999999999999999997655443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=310.55 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=209.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEE-----ccCCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 89 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 89 (298)
+....++|++.+.||+|+||.||++.+ ..+++.||+|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 345678999999999999999999985 34678999999876543 234678999999999 7899999999987
Q ss_pred eCC-eEEEEEeccCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe
Q 022401 90 TPT-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (298)
Q Consensus 90 ~~~-~~~lv~~~~~~~sL~~~l~~~~~----------------~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv 152 (298)
..+ .+++|+||+++++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 754 58999999999999999976654 7899999999999999999999999999999999999
Q ss_pred eCCCCCCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCch
Q 022401 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (298)
Q Consensus 153 ~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~ 228 (298)
+.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.......
T Consensus 182 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 182 SEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp CGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 98887 99999999874433222 123345778999999987777655 999999999999998 999998876544
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
.+...... ......+..+++++.+++.+||+.||.+|||+.+++++...
T Consensus 259 ~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 259 EFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp HHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcc----CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 43333322 22233344579999999999999999999999999976543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=301.59 Aligned_cols=241 Identities=23% Similarity=0.322 Sum_probs=203.3
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe------------
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT------------ 90 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------ 90 (298)
++|++.+.||+|+||.||++.+..+++.||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 57999999999999999999999899999999987654 456789999999999999999998864
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEee
Q 022401 91 ----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (298)
Q Consensus 91 ----~~~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d 164 (298)
...+++|+||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~D 165 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGD 165 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECc
Confidence 34689999999999999999654 57899999999999999999999999999999999999998887 99999
Q ss_pred cCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCC
Q 022401 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244 (298)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
||++.............+++.|+|||.+.+..++.+ +||||||+++|+|++|..|+... ......+....
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~~--- 235 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET------SKFFTDLRDGI--- 235 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTTC---
T ss_pred chhheeccccccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhccc---
Confidence 999876555555556678999999999987777555 99999999999999999886431 12222222221
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 245 PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 245 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
....++.++.++|.+||+.||.+|||+.+++++.
T Consensus 236 -~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 236 -ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2334789999999999999999999997777544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=320.83 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=206.1
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
.+.+..++|++.+.||+|+||.||++.+.. +..||+|++.......+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 345667889999999999999999999874 4569999998776667789999999999999999999999865 67899
Q ss_pred EEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 97 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
|+||+.+++|.+++.. ...+++..++.++.|++.||+|||++|++||||+|+||+++.++. +||+|||++......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDN 333 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCC
Confidence 9999999999999964 356899999999999999999999999999999999999998877 999999998744322
Q ss_pred C--CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 175 S--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 175 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
. ......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+ ....+. .....+.+..+|
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~~i~-~~~~~~~~~~~~ 407 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVE-RGYRMPCPPECP 407 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHH-TTCCCCCCTTSC
T ss_pred ceecccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH-cCCCCCCCCCCC
Confidence 1 1223345678999999987777655 999999999999999 899998765422 222222 233445556689
Q ss_pred HHHHHHHHHhhhhCCCCcccccccch
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+++.+++.+||+.||.+|||+.++++
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999988875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=307.06 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=196.3
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhc--CCCCCeeeeeEEEEeC----Ce
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----TH 93 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~ 93 (298)
...++|++.+.||+|+||.||++++ +++.||+|++.... ...+..|.+++.. ++||||+++++++... ..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 3457999999999999999999987 58899999987543 3445556666655 7999999999997543 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh--------hcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------AMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh--------~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
+++|+||+++++|.+++. ...+++..++.++.|++.||+||| +.|++|+||||+||+++.++. +||+||
T Consensus 81 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Df 157 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADL 157 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCC
T ss_pred eEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeC
Confidence 899999999999999994 457899999999999999999999 999999999999999998887 999999
Q ss_pred CccccccCCCC-----CCCCCCCCcccCccccccccCC-----CCccchHHHHHHHHHHHhC----------CCCCCCCC
Q 022401 166 GYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVG----------GYPFEDPD 225 (298)
Q Consensus 166 ~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~ll~~l~~g----------~~pf~~~~ 225 (298)
|++........ .....+++.|+|||.+.+.... +.++||||||+++|+|++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99863332221 2334689999999998766322 1359999999999999999 88886654
Q ss_pred CchhHHHHHHHHhhcCCCCC-CC-----CCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 226 EPKDFRKTIQRILSVQYSVP-DT-----NPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
...................+ .+ ...++++.+++.+||+.||.+|||+.++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 33322233333322222111 11 12457899999999999999999999998643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=306.27 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=203.2
Q ss_pred CCCCcCCCCCCCCCeeEEeeeccCCeEEEEEEEEcc-CC--cEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeee
Q 022401 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKV-TK--ELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVR 83 (298)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-~~--~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~ 83 (298)
+|..........++|++.+.||+|+||.||++++.. ++ ..||+|++... ....+.+.+|+.++++++||||++
T Consensus 6 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 85 (291)
T 1u46_A 6 GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85 (291)
T ss_dssp -----CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCccc
Confidence 555566667788999999999999999999998643 33 36899988653 234467889999999999999999
Q ss_pred eeEEEEeCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEE
Q 022401 84 FKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (298)
Q Consensus 84 ~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l 162 (298)
+++++..+. .++|+|++.+++|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|
T Consensus 86 ~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl 162 (291)
T 1u46_A 86 LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKI 162 (291)
T ss_dssp EEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEE
T ss_pred EEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEE
Confidence 999997665 88999999999999998654 56899999999999999999999999999999999999998887 999
Q ss_pred eecCccccccCCCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 022401 163 CDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 237 (298)
Q Consensus 163 ~d~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~ 237 (298)
+|||++........ .....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+. ......+
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~ 237 (291)
T 1u46_A 163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNG----SQILHKI 237 (291)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHH
T ss_pred ccccccccccccccchhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCCH----HHHHHHH
Confidence 99999864433221 223346678999999877776555 999999999999999 9999987654 3344444
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
.......+....+++++.+++.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 238 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 45555555666789999999999999999999999988863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=303.18 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=200.6
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-CeEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAI 96 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 96 (298)
+....++|++.+.||+|++|.||++.+. ++.+|+|++.... ..+.+.+|+.++++++||||+++++++... ...++
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 3456789999999999999999999874 7889999987643 457788999999999999999999997654 47899
Q ss_pred EEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 97 VMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
|+|++++++|.+++..... +++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST 170 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccccc
Confidence 9999999999999976543 889999999999999999999999999999999999998887 999999988643322
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+.. ..+.. ......+..++++
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~ 242 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRVEK-GYKMDAPDGCPPA 242 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHH----HHHTT-TCCCCCCTTCCHH
T ss_pred --ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHhc-CCCCCCcccCCHH
Confidence 233456788999999877776555 999999999999998 99999876643322 22222 2233445568999
Q ss_pred HHHHHHHhhhhCCCCcccccccchhh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
+.+++.+||+.||.+|||+.++++..
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 99999999999999999999988643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=308.99 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=204.7
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEE-----EccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~-----~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
.....++|++.+.||+|+||.||+++ +..++..||+|.+.... .....+.+|+.++++++||||+++++++.+
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 34567899999999999999999999 55678899999986432 334567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEE
Q 022401 91 PTHLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKI 162 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l 162 (298)
....++|+|++++++|.+++.... .++...++.++.|++.||.|||+.|++|+||+|+||+++.++ ...++|
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999997653 489999999999999999999999999999999999998543 234999
Q ss_pred eecCccccccCC---CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 022401 163 CDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRIL 238 (298)
Q Consensus 163 ~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 238 (298)
+|||++...... .......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...... .....+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~ 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVT 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHH----HHHHHHh
Confidence 999988633221 22234456889999999877776555 999999999999998 88999875532 2233333
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 239 SVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
... .......+++++.++|.+||+.||.+|||+.+++++...
T Consensus 260 ~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 260 SGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 322 233345589999999999999999999999888876543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=313.53 Aligned_cols=258 Identities=22% Similarity=0.223 Sum_probs=206.0
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
....++|++.+.||+|+||.||++++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 345689999999999999999999975 68899999887543 3456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 98 MEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTE 191 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeeccccccccc
Confidence 99999999999886543 5899999999999999999999999999999999999998887 99999999864332
Q ss_pred CCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhH--HHH-HHHHhhcCCC----
Q 022401 174 HSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--RKT-IQRILSVQYS---- 243 (298)
Q Consensus 174 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~--~~~-~~~~~~~~~~---- 243 (298)
... .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||......+.. ... ..........
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 221 123347889999999887777655 99999999999999999999765432211 111 1111111110
Q ss_pred ----CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 244 ----VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 244 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
.......+.++.+++.+||+.||.+|||+.+++++..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 0111224567999999999999999999999887553
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=306.21 Aligned_cols=254 Identities=27% Similarity=0.371 Sum_probs=204.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEE----ccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--C
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRD----KVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--T 92 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~----~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 92 (298)
....|++++.||+|+||.||++.. ..+++.||+|++.... .....+.+|+.++++++||||+++++++.+. .
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 333459999999999999987754 4578899999987653 2345688999999999999999999999874 6
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+++|+||+++++|.+++... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECC
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCcccccccc
Confidence 889999999999999998655 4899999999999999999999999999999999999998887 9999999987543
Q ss_pred CCC----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCc----------hhHHHHHHHHh
Q 022401 173 LHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------KDFRKTIQRIL 238 (298)
Q Consensus 173 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~----------~~~~~~~~~~~ 238 (298)
... ......++..|+|||.+.+..++.+ +||||||+++|+|++|..||...... ...........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 322 2234456778999999987777655 99999999999999999998753211 11111223333
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchh
Q 022401 239 SVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 278 (298)
......+.+..+++++.++|.+||+.||.+|||+.++++.
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 304 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3444555566789999999999999999999999999853
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=309.53 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=202.9
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILT----PTH 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 93 (298)
.+..++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 345689999999999999999999998899999999886543 334668899999999999999999999873 347
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 94 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
.++|+||+.+++|.+++.. ...+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~ 182 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMN 182 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCE
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcch
Confidence 8999999999999998865 467999999999999999999999999999999999999998887 9999999876
Q ss_pred cccCCCCC----------CCCCCCCcccCccccccccC--CCCccchHHHHHHHHHHHhCCCCCCCCCC-chhHHHHHHH
Q 022401 170 SSVLHSQP----------KSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDE-PKDFRKTIQR 236 (298)
Q Consensus 170 ~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~ 236 (298)
........ ....+++.|+|||.+..... ...++||||||+++|+|++|..||..... ......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---- 258 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---- 258 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----
Confidence 43221111 12236889999999865431 23459999999999999999999954211 011111
Q ss_pred HhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 237 ILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
........+....+++++.++|.+||+.||.+|||+.+++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 1122334455556899999999999999999999999998643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=305.45 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=208.4
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEE----EccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~----~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
+.....++|++++.||+|+||.||+++ +..+++.||+|++.... .....+.+|+.++++++||||+++++++...
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 445667889999999999999999998 45678999999987643 3346788999999999999999999998765
Q ss_pred C--eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcc
Q 022401 92 T--HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (298)
Q Consensus 92 ~--~~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~ 168 (298)
. .+++|+|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcch
Confidence 4 789999999999999999775 45899999999999999999999999999999999999998887 999999998
Q ss_pred ccccCCCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCC-----------chhHHHH
Q 022401 169 KSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------PKDFRKT 233 (298)
Q Consensus 169 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----------~~~~~~~ 233 (298)
........ .....++..|+|||.+.+..++.+ +||||||+++|+|++|..||..... .......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 75433221 223446677999999887776555 9999999999999999998764210 0111112
Q ss_pred HHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 234 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
...........+.+..+++++.++|.+||+.||.+|||+.++++..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2222333334455566899999999999999999999999998644
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=302.68 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=199.5
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.++.++|++.+.||+|+||.||++++. ++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++|+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 345679999999999999999999885 678999998654 345678899999999999999999998763 478999
Q ss_pred eccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhh---cCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 99 EYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l~~~l~~Lh~---~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
||+++++|.+++.... .++...++.++.|++.||.|||+ +|++|+||||+||+++.++. .+||+|||++....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQ 157 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC-----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccc
Confidence 9999999999997665 37899999999999999999999 89999999999999987764 37999999986433
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
. ......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||....... ......... ....+....+++
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~ 231 (307)
T 2eva_A 158 T--HMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWAVHN-GTRPPLIKNLPK 231 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHHHHHT-TCCCCCBTTCCH
T ss_pred c--ccccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccH--HHHHHHHhc-CCCCCcccccCH
Confidence 2 2234458999999999987777655 999999999999999999998754432 112222222 222334455899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
++.+++.+||+.||.+|||+.+++++..
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 9999999999999999999999997543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=300.62 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=204.1
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEcc---CCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
....++|++.+.||+|+||.||++.+.. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ ..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 3456899999999999999999998753 34469999987653 234678899999999999999999999865 45
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.++|+|++.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIE 164 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC-
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccc
Confidence 68999999999999999664 45899999999999999999999999999999999999998887 9999999987443
Q ss_pred CCC--CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 173 LHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 173 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+... ... . ....+.+..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~-~~~---~-~~~~~~~~~ 238 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIG-VLE---K-GDRLPKPDL 238 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-HHH---H-TCCCCCCTT
T ss_pred cccccccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCChHHHHH-HHh---c-CCCCCCCCC
Confidence 322 1233446778999999877776555 999999999999998 999998766543322 221 1 223344555
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
+++++.+++.+||+.||.+|||+.+++++..
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence 8999999999999999999999999987543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=300.35 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=202.9
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCc---EEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE-EE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL-AI 96 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~l 96 (298)
-.|++.+.||+|+||.||++.+..++. .+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 367888999999999999999765444 799998875433 336688999999999999999999999876654 99
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC--
Q 022401 97 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 173 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~-- 173 (298)
+++++.+++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCc
Confidence 9999999999999976 456899999999999999999999999999999999999998887 99999999863322
Q ss_pred ---CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 174 ---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 174 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
........+++.|+|||.+.+..++.+ +||||||+++|+|++|..|+.............. .....+.+..+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 253 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----QGRRLPQPEYC 253 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----TTCCCCCCTTC
T ss_pred ccccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----cCCCCCCCccc
Confidence 122234456788999999987777655 9999999999999996665544444333333222 22233445568
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
++++.+++.+||+.||.+|||+.++++..-
T Consensus 254 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 254 PDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999999999999999999999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=306.61 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=197.0
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhc--CCCCCeeeeeEEEEeC----CeE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----THL 94 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~ 94 (298)
..++|++.+.||+|+||.||++++. ++.||+|++..... .....|.+++.. ++||||+++++++... ..+
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3468999999999999999999885 88999999875433 344455555554 4899999999999887 789
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc--------CcEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~--------~i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
++|+||+++++|.+++... .+++..++.++.|++.||.|||+. |++|+||||+||+++.++. +||+|||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg 187 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLG 187 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCT
T ss_pred EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCC
Confidence 9999999999999999654 689999999999999999999998 9999999999999998887 9999999
Q ss_pred ccccccCCCC-----CCCCCCCCcccCccccccccCCCC-----ccchHHHHHHHHHHHhC----------CCCCCCCCC
Q 022401 167 YSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGK-----IADVWSCGVTLYVMLVG----------GYPFEDPDE 226 (298)
Q Consensus 167 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~-----~~Di~slG~ll~~l~~g----------~~pf~~~~~ 226 (298)
++........ .....+++.|+|||++.+...... ++||||||+++|+|++| ..||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 9864333222 124468999999999876655443 38999999999999999 777765433
Q ss_pred chhHHHHHHHHh-hcCCCCCCC-----CCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 227 PKDFRKTIQRIL-SVQYSVPDT-----NPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 227 ~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
............ ........+ ..+++++.+++.+||+.||.+|||+.+++++.-
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 222222222222 222221111 135678999999999999999999999987553
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=309.85 Aligned_cols=263 Identities=22% Similarity=0.233 Sum_probs=205.6
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
....++|++.+.||+|+||.||++++. +++.||+|++.... .....+.+|+.+++.++||||+++++++......++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 345689999999999999999999865 68889999987543 223468899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 97 VMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~~l~~Lh~~---~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
|+||+.+++|.+++.... .+++..++.++.|++.||+|||+. |++|+||+|+||+++.++. ++|+|||++.
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~ 182 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAK 182 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCE
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCcccc
Confidence 999999999999997543 489999999999999999999999 9999999999999998887 9999999987
Q ss_pred cccCCCC--CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCC----CCCchhHHHHHHHHhhcCC-
Q 022401 170 SSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED----PDEPKDFRKTIQRILSVQY- 242 (298)
Q Consensus 170 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~----~~~~~~~~~~~~~~~~~~~- 242 (298)
....... .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.. ...................
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred ccCcccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 4433222 233448999999999877777555 9999999999999999999952 1111122222221111110
Q ss_pred ----C----CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhh
Q 022401 243 ----S----VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFS 285 (298)
Q Consensus 243 ----~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~ 285 (298)
. .......+.++.+++.+||+.||.+|||+.+++++.....+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 0 001111236799999999999999999998888765544333
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=301.72 Aligned_cols=245 Identities=31% Similarity=0.499 Sum_probs=189.9
Q ss_pred CCCCCCCCCeeEE-eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHH-hcCCCCCeeeeeEEEEe---
Q 022401 16 MPIMHDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT--- 90 (298)
Q Consensus 16 ~~~~~~~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~--- 90 (298)
+......++|.+. +.||+|+||.||.+.+..+++.||+|++... ....+|+.++ +..+||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 3344556789988 7899999999999999999999999998643 4567788887 66699999999999887
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecC
Q 022401 91 -PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFG 166 (298)
Q Consensus 91 -~~~~~lv~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~ 166 (298)
...+++|+||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ ...++|+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 678999999999999999997754 699999999999999999999999999999999999998732 2349999999
Q ss_pred ccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
++.... +..++ .++||||||+++|+|++|..||...............+.......+.
T Consensus 166 ~a~~~~---------------------~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 166 FAKETT---------------------GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp TCEECT---------------------TCGGG-GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred cccccc---------------------cccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 875221 12233 34999999999999999999997654322111111111111111111
Q ss_pred --CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 247 --TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 247 --~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
...+++++.++|.+||+.||.+|||+ .++++|||+.+..+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~--------~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTI--------TEFMNHPWIMQSTK 265 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCH--------HHHHTSHHHHTGGG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCH--------HHHhcChhhccccc
Confidence 13578999999999999999999987 56668999986654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=323.47 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=209.6
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
.+.+..++|++.+.||+|+||.||++.+.. +..||||++.......+.+.+|+.++++++||||+++++++.+ +.+++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 445667899999999999999999999874 4569999998776667889999999999999999999999865 67899
Q ss_pred EEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 97 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
|+||+.+++|.+++.. ...+++.+++.++.|++.||+|||++|++||||+|+||+++.++. +||+|||++......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDN 416 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCC
Confidence 9999999999999964 356899999999999999999999999999999999999988877 999999998744321
Q ss_pred --CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 175 --SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 175 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
.......++..|+|||.+....++.+ +||||||+++|+|++ |..||......+ ....+. .....+.+..++
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~----~~~~i~-~~~~~~~~~~~~ 490 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVE-RGYRMPCPPECP 490 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHH----HHHHHH-TTCCCCCCTTCC
T ss_pred ceecccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH-cCCCCCCCCCCC
Confidence 11223345678999999887777655 999999999999999 899998765422 222222 233445556689
Q ss_pred HHHHHHHHHhhhhCCCCcccccccch
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+++.+||.+||+.||++|||+.++++
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999988875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=306.86 Aligned_cols=267 Identities=21% Similarity=0.238 Sum_probs=196.3
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe-----CCe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PTH 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 93 (298)
....++|++.+.||+|+||.||+++. +++.||+|++............++..+..++||||+++++.+.. ...
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 45678999999999999999999976 57899999987654332223334444556899999999986542 336
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---------CcEEecCCCCceEeeCCCCCCEEEee
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---------QVCHRDLKLENTLLDGSPAPRLKICD 164 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~---------~i~H~dl~p~nilv~~~~~~~~~l~d 164 (298)
+++|+||+++++|.+++.... .+...++.++.|++.||+|||+. |++|+||||+||+++.++. +||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECC
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEee
Confidence 799999999999999996654 48899999999999999999999 9999999999999998887 99999
Q ss_pred cCccccccCC---------CCCCCCCCCCcccCccccccc------cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchh
Q 022401 165 FGYSKSSVLH---------SQPKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 229 (298)
Q Consensus 165 ~~~~~~~~~~---------~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 229 (298)
||++...... .......+++.|+|||++.+. ...+.++||||||+++|+|++|..||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 9998644321 112234588999999998762 1223349999999999999999776644322111
Q ss_pred --------------HHHHHHHHhhcCCCCCCC------CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 230 --------------FRKTIQRILSVQYSVPDT------NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 230 --------------~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
.................+ ...++++.++|.+||+.||.+|||+.++++ .+.-+.++|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~--~L~~ll~~~~ 321 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE--RMAELMMIWE 321 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH--HHHHHHHCCC
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH--HHHHHHHHHH
Confidence 111111111111111111 123458999999999999999999999995 4566667876
Q ss_pred hhh
Q 022401 290 FDA 292 (298)
Q Consensus 290 ~~~ 292 (298)
.+-
T Consensus 322 ~~~ 324 (336)
T 3g2f_A 322 RNK 324 (336)
T ss_dssp C--
T ss_pred hcc
Confidence 643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=315.63 Aligned_cols=253 Identities=21% Similarity=0.234 Sum_probs=204.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCC-CCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.++|++++.||+|+||.||++++..+++.||||++..... ...+.+|+.+++.++| +++..+..++......++|+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 4789999999999999999999998999999998775443 3457889999999977 5666677777788899999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe---eCCCCCCEEEeecCccccccCCCC
Q 022401 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 101 ~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv---~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
+ +++|.+++.. ...+++.+++.++.||+.||.|||+.|++|+||||+||++ +.++. +||+|||++........
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCcc
Confidence 9 8899999975 5579999999999999999999999999999999999999 45665 99999999874433222
Q ss_pred --------CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCC---C
Q 022401 177 --------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV---P 245 (298)
Q Consensus 177 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~ 245 (298)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||......... ....++....... .
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVATSIEA 239 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHH-HHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHH-HHHHHHhhccccccHHH
Confidence 225568999999999988777655 99999999999999999999886543221 2222222111110 1
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
....+++++.+++..||+.||.+||++.++++..-
T Consensus 240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~ 274 (483)
T 3sv0_A 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274 (483)
T ss_dssp HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 11347899999999999999999999999987553
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=308.10 Aligned_cols=275 Identities=22% Similarity=0.281 Sum_probs=206.5
Q ss_pred CcCCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 022401 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (298)
Q Consensus 14 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (298)
......+..++|++.+.||+|+||.||++.+.. .+++|++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 345566778999999999999999999998853 38999886532 233557789999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 91 PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
...+++|+|++++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++ ++. ++|+|||++.
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~--~~l~Dfg~~~ 177 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK--VVITDFGLFS 177 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C--CEECCCSCCC
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC--EEEeecCCcc
Confidence 999999999999999999997655 689999999999999999999999999999999999998 444 9999999876
Q ss_pred cccC------CCCCCCCCCCCcccCccccccc--------cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 022401 170 SSVL------HSQPKSTVGTPAYIAPEVLLRH--------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235 (298)
Q Consensus 170 ~~~~------~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 235 (298)
.... ........+++.|+|||.+... ...+.++||||||+++|+|++|..||...... ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~ 253 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE----AIIW 253 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----HHHH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH
Confidence 3321 1122233477889999998652 22344599999999999999999999876542 2233
Q ss_pred HHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcCC
Q 022401 236 RILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYHS 298 (298)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~~ 298 (298)
.+............++.++.+++.+||+.||.+|||+.+++++.-...-...-+.++...|+|
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~ 316 (319)
T 2y4i_B 254 QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316 (319)
T ss_dssp HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence 333333332333357899999999999999999999999998766555555555666666654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=304.02 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=186.6
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCC-CCCeeeeeEEEE--------
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVIL-------- 89 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-------- 89 (298)
....+|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 44568999999999999999999999899999999886543 33456789999999996 999999999984
Q ss_pred eCCeEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEeeCCCCCCEEEee
Q 022401 90 TPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICD 164 (298)
Q Consensus 90 ~~~~~~lv~~~~~~~sL~~~l~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~~~~~~~~~l~d 164 (298)
....++++++++. ++|.+++.. ..++++.+++.++.|++.||.|||+.| ++|+||||+||+++.++. ++|+|
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~D 181 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCD 181 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEec
Confidence 3346899999996 588887754 567999999999999999999999999 999999999999998887 99999
Q ss_pred cCccccccCCCCC-------------CCCCCCCcccCccccc---cccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch
Q 022401 165 FGYSKSSVLHSQP-------------KSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (298)
Q Consensus 165 ~~~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 228 (298)
||++......... ....+++.|+|||.+. +..+ +.++||||||+++|+|++|..||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 9998754332211 1344788999999983 3344 345999999999999999999997644321
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHH
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLL 282 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~ 282 (298)
+.......+.....+..+.+++.+||+.||.+|||+.+++++....
T Consensus 261 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 261 --------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred --------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2223334444555788999999999999999999999998765443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=296.49 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=199.4
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEE-eCCeE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL-TPTHL 94 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 94 (298)
...+|++.+.||+|+||.||++.+..+ +..+++|.+..... ..+.+.+|+.++++++||||+++++++. .++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 346899999999999999999997533 34589998875432 3356889999999999999999999865 45688
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++|+|++++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccccccc
Confidence 999999999999999975 446899999999999999999999999999999999999998887 99999999864432
Q ss_pred CC-----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCC
Q 022401 174 HS-----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247 (298)
Q Consensus 174 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
.. ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..+.... +.... ....+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~ 254 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQGR-RLLQP 254 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH----HHTTC-CCCCC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH----HhcCC-CCCCC
Confidence 21 1223345678999999987777655 999999999999999 5566666554332222 22222 22334
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
..+++++.+++.+||+.||.+|||+.++++..-
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 287 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 457999999999999999999999999997543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.84 Aligned_cols=252 Identities=16% Similarity=0.135 Sum_probs=201.2
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEE-----EEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC---CCCeeeeeEEEEe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLM-----RDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILT 90 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~-----~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 90 (298)
....++|++.+.||+|+||.||+| .+..+++.||+|++... ....+..|..++++++ |+|++++++++..
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345688999999999999999999 46678899999998754 3456778888888886 8999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-----------
Q 022401 91 PTHLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG----------- 154 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~----------- 154 (298)
.+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++||||||+||+++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999999973 457999999999999999999999999999999999999987
Q ss_pred CCCCCEEEeecCcccccc---CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 022401 155 SPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231 (298)
Q Consensus 155 ~~~~~~~l~d~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~ 231 (298)
++. +||+|||++.... .........+++.|+|||++.+..++.+ +||||||+++|+|++|..||........
T Consensus 219 ~~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 219 SAG--LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp CTT--EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred cCC--EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 555 9999999985332 2222344568999999999988887665 9999999999999999999965432110
Q ss_pred HHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhh
Q 022401 232 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFS 285 (298)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~ 285 (298)
....... ....++.+.+++..||+.+|.+|++..+.+.......+.
T Consensus 294 -------~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 -------KPEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -------EECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -------eechhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0011111 112467899999999999999998776666555444443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=323.78 Aligned_cols=247 Identities=23% Similarity=0.286 Sum_probs=200.2
Q ss_pred CeeEE-eeeccCCeEEEEEEEE--ccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 24 RYDFV-RDIGSGNFGVARLMRD--KVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 24 ~y~~~-~~lg~g~~~~vy~~~~--~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
.+.+. +.||+|+||.||++.+ ..+++.||||++.... ...+.+.+|+.++++++||||+++++++.. +.+++|
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 34443 4899999999999955 4567889999987543 234678999999999999999999999864 568899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 175 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-- 175 (298)
|||+.+++|.+++.....+++..++.++.||+.||+|||+.|++||||||+||+++.++. +||+|||++.......
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENY 525 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC----
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccc
Confidence 999999999999998889999999999999999999999999999999999999998887 9999999986443222
Q ss_pred --CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 176 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
......+++.|+|||++.+..++.+ +||||||+++|+|++ |..||......+ ....+.. ......+..+|+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~~i~~-~~~~~~p~~~~~ 599 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK-GERMGCPAGCPR 599 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHHT-TCCCCCCTTCCH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHc-CCCCCCCCCCCH
Confidence 1222345678999999987777665 999999999999998 999998765432 2222222 223344556899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
++.++|.+||+.||++|||+.++++..
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999999999888643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=320.31 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=201.9
Q ss_pred CCCCCeeEEe-eeccCCeEEEEEEEEc--cCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVR-DIGSGNFGVARLMRDK--VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~-~lg~g~~~~vy~~~~~--~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
...+++.+.+ .||+|+||.||++..+ .++..||||++.... ...+.+.+|+.++++++||||+++++++.. +.+
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 3455667777 8999999999999875 345679999987643 345778999999999999999999999876 568
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++|+||+.+++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++.....
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGA 488 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC-
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccC
Confidence 9999999999999998654 45999999999999999999999999999999999999998887 99999999875432
Q ss_pred CCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 174 HSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 174 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
... .....+++.|+|||++.+..++.+ +||||||+++|||++ |..||......+ ....+..+ ...+.+.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~~i~~~-~~~~~p~ 562 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAFIEQG-KRMECPP 562 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHH----HHHHHHTT-CCCCCCT
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHHcC-CCCCCCC
Confidence 221 122334578999999987777665 999999999999998 999998876533 22333222 3344455
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
.+|+++.+++.+||+.||.+||++.++++
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 68999999999999999999999988875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.34 Aligned_cols=254 Identities=21% Similarity=0.261 Sum_probs=196.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEe-CCe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTH 93 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 93 (298)
....+|++.+.||+|+||.||++....+ +..+|+|.+.... ...+.+.+|+.++++++||||+++++++.. ++.
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 3445689999999999999999997543 3468999886532 334678899999999999999999998754 457
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.++|+||+++++|.+++.... .+++..++.++.|++.||+|||+.|++||||||+||+++.++. +||+|||++....
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMY 243 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccccc
Confidence 899999999999999997653 5889999999999999999999999999999999999998887 9999999986432
Q ss_pred CCC-----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 173 LHS-----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 173 ~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..+... .+..+. ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~----~~~~~~-~~~~ 317 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITV----YLLQGR-RLLQ 317 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH----HHHTTC-CCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH----HHHcCC-CCCC
Confidence 221 1122345678999999987777655 999999999999999 677887765543322 222222 2334
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
+..+|+++.+++.+||+.||.+|||+.+++++...
T Consensus 318 p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 318 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 45589999999999999999999999999975543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=297.80 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=201.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC-----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
..|..++.||+|+||.||++.. +++.+|+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 3456669999999999999987 5778999998653 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 98 MEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++++++++|.+++.. ..++++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKF 186 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSC
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccccc
Confidence 999999999999863 346899999999999999999999999999999999999998877 999999998644332
Q ss_pred CC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC--------C
Q 022401 175 SQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------S 243 (298)
Q Consensus 175 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~ 243 (298)
.. .....+++.|+|||.+.+ .++. ++||||||+++|+|++|..||...............+..... .
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG-EITP-KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT-EECT-HHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred cccccccccCCCcCcCChHHhcC-CCCc-cchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 21 233467899999998765 3444 499999999999999999999876654443333333322211 0
Q ss_pred C-CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 244 V-PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 244 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
. ......++.+.+++.+||+.||.+|||+.+++++.
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0 11122457799999999999999999999888643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=313.36 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=189.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
+.|.+.+.||+|+||+||.+. ..+|+.||+|++..+ ..+.+.+|+.+++++ +||||+++++++.+++.+++|+|++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 567778999999999998654 457899999998754 245678899999876 8999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-----------CCCEEEe
Q 022401 102 SGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-----------APRLKIC 163 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~-------~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-----------~~~~~l~ 163 (298)
+ ++|.+++...... ++..++.++.|++.||+|||+.|++||||||+||+++.++ ...++|+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 6 5999999765432 2234577999999999999999999999999999997643 3359999
Q ss_pred ecCccccccCCCC-----CCCCCCCCcccCccccccc------cCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHH
Q 022401 164 DFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 231 (298)
Q Consensus 164 d~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~ 231 (298)
|||++........ .....+++.|+|||++.+. ...+.++|||||||++|+|++ |..||.......
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--- 247 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--- 247 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---
Confidence 9999875433221 2234689999999998651 233455999999999999999 899997654322
Q ss_pred HHHHHHhhcCCCCCC-----CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 232 KTIQRILSVQYSVPD-----TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 232 ~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
..+.......+. ...+++++.++|.+||+.||.+|||+ .++++|||+.+..
T Consensus 248 ---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~--------~eil~hp~f~~~~ 303 (434)
T 2rio_A 248 ---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA--------MKVLRHPLFWPKS 303 (434)
T ss_dssp ---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH--------HHHHTSGGGSCHH
T ss_pred ---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH--------HHHHhCCccCCcH
Confidence 122222222221 11245789999999999999999988 4556788886544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=330.10 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=203.2
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEe------C
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT------P 91 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 91 (298)
...++|++.+.||+|+||.||++.+..+|+.||+|++... ....+.+.+|+.++++++||||+++++++.. +
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 3458999999999999999999999989999999988654 2334568899999999999999999999765 6
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC-CEEEeecCc
Q 022401 92 THLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGY 167 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~-~~~l~d~~~ 167 (298)
+..++|+||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.. .++|+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 67899999999999999997654 58999999999999999999999999999999999999876542 489999999
Q ss_pred cccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHH-----HHHHHH-----
Q 022401 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR-----KTIQRI----- 237 (298)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~-----~~~~~~----- 237 (298)
+.............+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.......... ......
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred ccccccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 986655555556678999999999988777666 999999999999999999997643211100 000000
Q ss_pred hhcCC----CCC----CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 238 LSVQY----SVP----DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 238 ~~~~~----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..+.. ..+ ....+++++.++|.+||+.||.+|||+.+++ +|||+..
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL--------~hp~F~~ 303 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP--------NVGCFQA 303 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC--------CCTTHHH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh--------cCHHHHH
Confidence 00111 111 1123568899999999999999999997777 5666654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=297.18 Aligned_cols=252 Identities=22% Similarity=0.245 Sum_probs=201.4
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhc--CCCCCeeeeeEEEEeCC----eEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~ 95 (298)
.++|++.+.||+|+||.||++++ +++.||+|++... ....+.+|.+++.. ++||||+++++++.... .++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 46899999999999999999988 4889999998643 34567778888876 79999999999998775 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh--------hcCcEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------AMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh--------~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
+|+||+++++|.+++.. ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++. ++|+|||+
T Consensus 117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~ 193 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 193 (342)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTT
T ss_pred EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCC
Confidence 99999999999999965 46899999999999999999999 899999999999999998887 99999999
Q ss_pred cccccCCC-----CCCCCCCCCcccCccccccccCCC-----CccchHHHHHHHHHHHhC----------CCCCCCCCCc
Q 022401 168 SKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEYDG-----KIADVWSCGVTLYVMLVG----------GYPFEDPDEP 227 (298)
Q Consensus 168 ~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~ll~~l~~g----------~~pf~~~~~~ 227 (298)
+....... ......+++.|+|||.+.+..... .++||||||+++|+|++| ..||......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 86443332 234456889999999987653221 359999999999999999 7888765432
Q ss_pred h-hHHHHHHHHhhcCCCCCCC-----CCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 228 K-DFRKTIQRILSVQYSVPDT-----NPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 228 ~-~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
. ........+.........+ ...++.+.+++.+||+.||.+|||+.+++++..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 2 2233333333333222221 123468999999999999999999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=309.08 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=192.2
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
....+|++.+.||+|+||.||. ....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++|+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3445799999999999998763 4445788999999875432 3356899999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC---CCCCCEEEeecCccccccCC
Q 022401 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~---~~~~~~~l~d~~~~~~~~~~ 174 (298)
|++.+ +|.+++.... ..+...++.++.|++.||.|||+.|++||||||+||+++. ++..+++|+|||++......
T Consensus 98 E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99965 8999887654 4555677899999999999999999999999999999953 44445889999998754432
Q ss_pred ----CCCCCCCCCCcccCccccccc--cCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh-cCCC-CC
Q 022401 175 ----SQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS-VQYS-VP 245 (298)
Q Consensus 175 ----~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~-~~ 245 (298)
.......+++.|+|||++.+. ...+.++|||||||++|+|++ |..||....... ...... .... ..
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----~~~~~~~~~~~~~~ 251 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----ANILLGACSLDCLH 251 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----HHHHTTCCCCTTSC
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----HHHHhccCCccccC
Confidence 222345689999999998742 222345999999999999999 889996644321 111111 1111 11
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.....+..+.+||.+||+.||.+|||+ .++++|||+.+..
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~--------~evl~hp~f~~~~ 291 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSA--------KHVLKHPFFWSLE 291 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCH--------HHHHTSTTTCCHH
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCH--------HHHHhCccccChH
Confidence 122235668999999999999999987 5555788876544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=316.29 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=204.8
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
.....++|++.+.||+|+||.||++.+..+ +..+|+|...... ...+.+.+|+.++++++||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 345567899999999999999999998643 4579999876533 23367889999999999999999999984 55
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
..++|+||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~ 541 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYM 541 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeec
Confidence 6899999999999999997554 6899999999999999999999999999999999999998887 999999998754
Q ss_pred cCCCC--CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 172 VLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 172 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
..... .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+ ....+... ...+.+.
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~~~i~~~-~~~~~~~ 615 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENG-ERLPMPP 615 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHHT-CCCCCCT
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHcC-CCCCCCc
Confidence 33221 123345678999999977776555 999999999999997 899998765433 22333222 2234455
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
.+|+++.+++.+||+.||.+|||+.+++++..
T Consensus 616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647 (656)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 68999999999999999999999999987543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=290.21 Aligned_cols=236 Identities=15% Similarity=0.115 Sum_probs=188.6
Q ss_pred CCCCcCCCC-CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcch----HHHHHHHHHHhcCCCCCeeeee
Q 022401 11 GPAMDMPIM-HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFK 85 (298)
Q Consensus 11 ~~~~~~~~~-~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~ 85 (298)
.+....++. ...++|++.+.||+|+||.||++++..+++.||+|++....... ..+.+|+..+.+++||||++++
T Consensus 18 ~~~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~ 97 (286)
T 3uqc_A 18 DDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97 (286)
T ss_dssp --CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceee
Confidence 344445555 66789999999999999999999999889999999998654332 6788999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
+++.+++..|+||||+++++|.+++..+ ....++..++.|++.||+|||++|++|+||||+||+++.++. ++|+++
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~ 173 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYP 173 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSC
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEec
Confidence 9999999999999999999999999543 366688999999999999999999999999999999998887 888754
Q ss_pred CccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--
Q 022401 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-- 243 (298)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 243 (298)
+. ++| + +.++||||||+++|+|++|..||...+....+....+.+ .....
T Consensus 174 ~~-------------------~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~ 225 (286)
T 3uqc_A 174 AT-------------------MPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEP 225 (286)
T ss_dssp CC-------------------CTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBCCH
T ss_pred cc-------------------cCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCCCh
Confidence 32 222 2 445999999999999999999998765432110000000 11110
Q ss_pred CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 244 VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 244 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
......+|+++.++|.+||+.||.+| |+.++++..
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L 260 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLM 260 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence 01123589999999999999999999 999998754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=300.08 Aligned_cols=248 Identities=14% Similarity=0.074 Sum_probs=186.2
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCC-CCe---------ee----
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH-PNI---------VR---- 83 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h-~~i---------~~---- 83 (298)
..+|++.+.||+|+||.||+|.+..+|+.||||++... ....+.+.+|+.+++.++| ++. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34699999999999999999999999999999988732 2234678899999999977 321 11
Q ss_pred --------eeEEEEe-----CCeEEEEEeccCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEe
Q 022401 84 --------FKEVILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143 (298)
Q Consensus 84 --------~~~~~~~-----~~~~~lv~~~~~~~sL~~~l~~-------~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~ 143 (298)
+..++.. ...++++++.+ +++|.+++.. ...+++..++.++.|++.||+|||++|++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 12467777766 5689888741 2346778899999999999999999999999
Q ss_pred cCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCCcccCccccc----------cccCCCCccchHHHHHHHHH
Q 022401 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----------RHEYDGKIADVWSCGVTLYV 213 (298)
Q Consensus 144 dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----------~~~~~~~~~Di~slG~ll~~ 213 (298)
||||+||+++.++. +||+|||++...... .....+ +.|+|||++. ...++. ++|||||||++|+
T Consensus 236 DiKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF-AFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH-HHHHHHHHHHHHH
T ss_pred CcccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCc-hhhHHHHHHHHHH
Confidence 99999999999888 999999998644333 234456 9999999983 334444 4999999999999
Q ss_pred HHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 214 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 214 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
|++|..||.......... ........+|+++.+||.+||+.||.+|||+. ++++|||+....
T Consensus 310 lltg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~--------~~l~~~~~~~~~ 371 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSE----------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPL--------QAMETPEYEQLR 371 (413)
T ss_dssp HHHSSCCCCTTGGGSCSG----------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHH--------HHTTSHHHHHHH
T ss_pred HHHCCCCCCCcchhhhHH----------HHHhhcccCCHHHHHHHHHHccCChhhCcCHH--------HHHhCHHHHHHH
Confidence 999999998754322111 11222335799999999999999999999884 455677777654
Q ss_pred h
Q 022401 294 E 294 (298)
Q Consensus 294 ~ 294 (298)
+
T Consensus 372 ~ 372 (413)
T 3dzo_A 372 T 372 (413)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=314.35 Aligned_cols=244 Identities=20% Similarity=0.211 Sum_probs=196.1
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEcc-CCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe--
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-- 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 93 (298)
....++|++.+.||+|+||.||++.+.. +++.||+|++.... .....+.+|+.++++++||||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 3455899999999999999999999976 68999999886543 233567899999999999999999999987654
Q ss_pred ---EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccc
Q 022401 94 ---LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (298)
Q Consensus 94 ---~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~ 170 (298)
.|+||||+++++|.+.+.. .+++.+++.++.|++.||.|||+.|++|+||||+||+++.+ . +||+|||++..
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~--~kl~DFG~a~~ 230 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q--LKLIDLGAVSR 230 (681)
T ss_dssp CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-C--EEECCCTTCEE
T ss_pred CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-c--EEEEecccchh
Confidence 7999999999999887754 78999999999999999999999999999999999999875 3 99999999875
Q ss_pred ccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
.... ....+++.|+|||++.+.. +.++||||||+++++|++|..||........ .........
T Consensus 231 ~~~~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------~~~~~~~~~ 293 (681)
T 2pzi_A 231 INSF---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------PEDDPVLKT 293 (681)
T ss_dssp TTCC---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------CTTCHHHHH
T ss_pred cccC---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc------------ccccccccc
Confidence 4332 4556899999999986543 4459999999999999999988765321100 000000113
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLF 284 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~ 284 (298)
++++.++|.+||+.||.+||+..+.+.+.+..++
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 5789999999999999999999888776665554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=293.87 Aligned_cols=246 Identities=17% Similarity=0.181 Sum_probs=186.2
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---------chHHHHHHHHHHhcCC---------CCCe
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPNI 81 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~~i 81 (298)
...++|++++.||+|+||.||+|++ +|+.||+|++..... ..+.+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4457899999999999999999998 679999999986532 2267888999888885 7777
Q ss_pred eeeeEEEE-----------------e-------------CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHH
Q 022401 82 VRFKEVIL-----------------T-------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131 (298)
Q Consensus 82 ~~~~~~~~-----------------~-------------~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~ 131 (298)
+++.+++. + ...+++||||+.++++.+.+.. ..+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 77666542 2 6789999999998876666633 568999999999999999
Q ss_pred HHHHh-hcCcEEecCCCCceEeeCCCC------------------CCEEEeecCccccccCCCCCCCCCCCCcccCcccc
Q 022401 132 VSYCH-AMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192 (298)
Q Consensus 132 l~~Lh-~~~i~H~dl~p~nilv~~~~~------------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 192 (298)
|+||| +.|++||||||+||+++.++. ..+||+|||+++.... ....+++.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhh
Confidence 99999 999999999999999988761 1499999999874432 244789999999998
Q ss_pred ccccCCCCccchHHHHHH-HHHHHhCCCCCCCCCCchhHHHHHHHHhhc-CCCCCC----CCCCCHHHHHHHHHhhhhCC
Q 022401 193 LRHEYDGKIADVWSCGVT-LYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPD----TNPISQECRDLISRIFVADP 266 (298)
Q Consensus 193 ~~~~~~~~~~Di~slG~l-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~l~~li~~~l~~dp 266 (298)
.+.. ..++||||+|++ .+++++|..||.... ........+... ...... ...+++++.+||++||+.|
T Consensus 250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d- 323 (336)
T 2vuw_A 250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS- 323 (336)
T ss_dssp CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred cCCC--ccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence 7665 445999998766 777888888885311 001122222211 111111 1236789999999999976
Q ss_pred CCcccccccchhhhHHHh-hhhhhh
Q 022401 267 AAVSIFFFPLNMSCLLLF-SFVWMF 290 (298)
Q Consensus 267 ~~Rps~~~~l~~~~~~~~-~hp~~~ 290 (298)
|+ .+++ +|||++
T Consensus 324 ----sa--------~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ----SA--------TDLLCQHSLFK 336 (336)
T ss_dssp ----SH--------HHHHHHCGGGC
T ss_pred ----CH--------HHHHhcCCCcC
Confidence 44 7788 899984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=246.57 Aligned_cols=181 Identities=14% Similarity=0.054 Sum_probs=131.2
Q ss_pred eeccCCeEEEEEEEEccCCcEEEEEEeecCC-----------cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeEEEE
Q 022401 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 30 ~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 97 (298)
..+.|+.|.+..+++...|..+++|++.++. ...+++.+|+++|+++ .|+||+++++++++++.+|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3556777788888888889999999987642 2224588999999999 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~ 176 (298)
|||++|++|.+.+...+++++. .|+.||+.||+|+|++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence 9999999999999999888875 47899999999999999999999999999998887 999999998744332 22
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhC
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g 217 (298)
.....|++.|+|||++.+.. .. .+|+||+|++.+++.++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~-~~-~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK-SW-NGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred ccCceechhhccHHHhCCCC-CC-cccccccccchhhhccc
Confidence 23345889999999987643 33 48999999987766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=213.15 Aligned_cols=182 Identities=20% Similarity=0.109 Sum_probs=139.0
Q ss_pred eEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 26 ~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
...+.||+|+||.||++.. .++.+++|....... ..+.+.+|+.++++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3467999999999999944 467789997654221 12347899999999999999977777777778899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
||||+++++|.+++.. +..++.|++.+|+|||++|++||||||+||+++. . +||+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~--~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D--LYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S--EEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e--EEEEECccCEECCCccc
Confidence 9999999999998865 6689999999999999999999999999999987 4 99999999875533211
Q ss_pred --------CCCCCCCCcccCcccccc--ccCCCCccchHHHHHHHHHHHhCCCCCC
Q 022401 177 --------PKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (298)
Q Consensus 177 --------~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~ 222 (298)
.....+++.|+|||++.. ..|... .|+|+..+-..+-+.+..+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence 123458899999999876 455444 899999988888777666653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-24 Score=180.70 Aligned_cols=142 Identities=18% Similarity=0.154 Sum_probs=112.6
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-------------------chHHHHHHHHHHhcCCCCCeeeee
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFK 85 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~i~~~~ 85 (298)
|++++.||+|+||.||.+.+ .+|+.||+|++..... ....+.+|+.++++++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 33449999999999999999 7899999999864321 2345789999999998 4 6666
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
+++.. +..++||||++|++|.+ +. ......++.|++.|+.+||+.|++|+||||+||+++ ++. ++|+||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vkl~DF 236 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IWIIDF 236 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EEECCC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EEEEEC
Confidence 65533 55699999999999987 42 123557999999999999999999999999999999 666 999999
Q ss_pred CccccccCCCCCCCCCCCCcccCccccc
Q 022401 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLL 193 (298)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 193 (298)
|++.. ...+.|||.+.
T Consensus 237 G~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE------------TTSTTHHHHHH
T ss_pred CCCeE------------CCCCCHHHHHH
Confidence 98762 23356788763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1e-20 Score=157.83 Aligned_cols=137 Identities=15% Similarity=0.095 Sum_probs=105.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcE--EEEEEeecCCcc-------------------------hHHHHHHHHHHhcC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKI-------------------------DENVQREIINHRSL 76 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~--~aiK~~~~~~~~-------------------------~~~~~~e~~~l~~l 76 (298)
-|++.+.||+|+||.||.|.+..+|+. ||+|++...... ...+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999999778888 999987543111 12577899999999
Q ss_pred CCCCeeeeeEEEEeCCeEEEEEeccCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh-hcCcEEecCCCCce
Q 022401 77 RHPNIVRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENT 150 (298)
Q Consensus 77 ~h~~i~~~~~~~~~~~~~~lv~~~~~~-~----sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh-~~~i~H~dl~p~ni 150 (298)
.|+++.....+.. ...++||||+.+ + +|.+.... .++..+..++.|++.++.+|| +.|++||||||+||
T Consensus 128 ~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 128 KEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred HhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 8776422222211 356899999942 3 66665432 234567889999999999999 99999999999999
Q ss_pred EeeCCCCCCEEEeecCccc
Q 022401 151 LLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 151 lv~~~~~~~~~l~d~~~~~ 169 (298)
+++. . ++|+|||++.
T Consensus 203 Ll~~--~--~~liDFG~a~ 217 (258)
T 1zth_A 203 MYID--K--VYFIDMGQAV 217 (258)
T ss_dssp EESS--S--EEECCCTTCE
T ss_pred EEcC--c--EEEEECcccc
Confidence 9987 4 9999999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=6.9e-18 Score=146.73 Aligned_cols=135 Identities=15% Similarity=0.122 Sum_probs=96.6
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---------------chHH--------HHHHHHHHhcCCCCCe
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------------IDEN--------VQREIINHRSLRHPNI 81 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---------------~~~~--------~~~e~~~l~~l~h~~i 81 (298)
|++++.||.|++|.||.|.+. +|+.||||++..... .... ..+|...+.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999986 688999998753210 0011 1245566666644444
Q ss_pred eeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC---
Q 022401 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--- 158 (298)
Q Consensus 82 ~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~--- 158 (298)
....-+.... .++||||++|.+|..+.. ......++.|++.+|.+||+.|++||||||.|||++.++..
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 3222222222 268999999988865432 22346788999999999999999999999999999876632
Q ss_pred -----CEEEeecCcc
Q 022401 159 -----RLKICDFGYS 168 (298)
Q Consensus 159 -----~~~l~d~~~~ 168 (298)
.++++||+-+
T Consensus 248 ~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 248 SSITLTPIIIXFPQM 262 (397)
T ss_dssp TSEEEEEEECCCTTC
T ss_pred cccccceEEEEeCCc
Confidence 2789999843
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=2.1e-12 Score=107.47 Aligned_cols=138 Identities=16% Similarity=0.126 Sum_probs=108.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+.|++...++.|+.+.||.+... ++.+++|+..... .....+.+|..+++.+. +..+.++++++.+.+..++||++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 56999999999999999999754 5689999886521 22345788999998884 56777899988888899999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA------------------------------------------- 137 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~------------------------------------------- 137 (298)
++|.++.+.+. +......++.+++.++..||+
T Consensus 92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99999876531 122345778899999999998
Q ss_pred ----------------cCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 138 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 138 ----------------~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
..++|||++|.||++++++. +.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcE--EEEEEchhcc
Confidence 45899999999999976432 5699998543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=4.8e-11 Score=98.87 Aligned_cols=135 Identities=14% Similarity=0.119 Sum_probs=97.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCC--eeeeeEEEEeCCeEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~~ 99 (298)
...+.+....+.|..+.||.+.. .+|+.+++|+.... ....+..|..+++.+.+.+ +.+++++...++..++|++
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 35677766555666789999965 35677999987654 2345778888888885444 4558888877778999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---------------------------------------- 139 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~---------------------------------------- 139 (298)
+++|.++. .. ..+ ...++.+++..+..||+..
T Consensus 96 ~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 96 EVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred ecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 99998873 21 112 2356677777788887643
Q ss_pred ------------------cEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 140 ------------------VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 140 ------------------i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
++|+|++|.||++++++. +.|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRF--SGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcE--EEEEcchhcc
Confidence 999999999999976543 5699998654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.6e-10 Score=100.64 Aligned_cols=141 Identities=14% Similarity=0.205 Sum_probs=104.6
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEee--cCC--cchHHHHHHHHHHhcCCC--CCeeeeeEEEEeC---CeEE
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGD--KIDENVQREIINHRSLRH--PNIVRFKEVILTP---THLA 95 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~--~~~--~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~ 95 (298)
..-++.++.|.++.+|.+... +..+++|+.. ... .....+.+|..+++.+.. ..+.+++.++.+. +..+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 345778899999999998875 3578899776 432 223467789999988864 4577888887666 4578
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------
Q 022401 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-------------------------------------- 137 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-------------------------------------- 137 (298)
+||++++|.++.+. ....++..+...++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999777431 12346788888999999999999997
Q ss_pred --------------------cCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 138 --------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 138 --------------------~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
.+++|||+++.||+++.++...+.|+||+.+.
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999987654335899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=6.7e-10 Score=94.35 Aligned_cols=186 Identities=16% Similarity=0.125 Sum_probs=116.5
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-CCCC--eeeeeEEEEeCC---eEEEEEecc
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPN--IVRFKEVILTPT---HLAIVMEYA 101 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~~~~ 101 (298)
++.++.|....||.+. ..+++|+.... .....+.+|...++.+ .+.. +.+++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3458899999999764 35899975432 3456788899999877 3333 334444433333 347899999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------------
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-------------------------------------------- 137 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-------------------------------------------- 137 (298)
+|.++..... ..++..+...++.+++..+..||+
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988865332 235677778888888888888885
Q ss_pred --------------cCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCCCCCCcccCcccccc--ccCCCC-
Q 022401 138 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGK- 200 (298)
Q Consensus 138 --------------~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~- 200 (298)
..++|+|++|.||+++.+....+.++||+.+.................-.+|+.... ..|...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 136999999999999874222378999998753322111000000000012221110 011111
Q ss_pred ----------ccchHHHHHHHHHHHhCCCCC
Q 022401 201 ----------IADVWSCGVTLYVMLVGGYPF 221 (298)
Q Consensus 201 ----------~~Di~slG~ll~~l~~g~~pf 221 (298)
..+.|++|.+++.+.+|..+|
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 158899999999999998664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=5.6e-07 Score=74.74 Aligned_cols=137 Identities=18% Similarity=0.228 Sum_probs=95.3
Q ss_pred CeeEEeeeccCCeE-EEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEEEecc
Q 022401 24 RYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 24 ~y~~~~~lg~g~~~-~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
.|+.. .+..|..+ .||.......+..+++|+.... ....+..|...++.+. +--+.+++.++.+.+..++||+++
T Consensus 26 g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 26 GYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp TCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred CCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 34433 33445544 7898888777778999986643 3456778888888774 223667888888889999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 022401 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM------------------------------------------- 138 (298)
Q Consensus 102 ~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~------------------------------------------- 138 (298)
+|.++.+..... ......+..++...+..||+.
T Consensus 103 ~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 103 PGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp CSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred CCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 998887665332 122334555666666666641
Q ss_pred ---------------CcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 139 ---------------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 139 ---------------~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
.++|||+++.||++++++. +-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence 1589999999999986553 5699998654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=8.2e-07 Score=75.33 Aligned_cols=133 Identities=19% Similarity=0.134 Sum_probs=88.5
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCC---CeeeeeEEEE-eCCeEEEEEeccCC
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG 103 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~~~~~~ 103 (298)
++.++.|....||.+ +..+++|+.. .......+.+|..+++.+.+. .+.+.+.+.. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 455788888899988 4568999743 233456788999999988642 2455665553 34567899999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------------
Q 022401 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHA---------------------------------------------- 137 (298)
Q Consensus 104 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~---------------------------------------------- 137 (298)
.++....- ..++..+...++.++...+..||+
T Consensus 98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 88865321 123444444445555555544443
Q ss_pred --------------cCcEEecCCCCceEeeC---CCCCCEEEeecCccc
Q 022401 138 --------------MQVCHRDLKLENTLLDG---SPAPRLKICDFGYSK 169 (298)
Q Consensus 138 --------------~~i~H~dl~p~nilv~~---~~~~~~~l~d~~~~~ 169 (298)
..++|+|++|.||+++. ++. .+.|+||+.+.
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~ 223 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcC
Confidence 13599999999999986 232 24799999765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.5e-06 Score=74.99 Aligned_cols=76 Identities=17% Similarity=0.085 Sum_probs=49.2
Q ss_pred EEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--------cchHHHHHHHHHHhcCCC--CCe-eeeeEEEEeCCeEE
Q 022401 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------KIDENVQREIINHRSLRH--PNI-VRFKEVILTPTHLA 95 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~e~~~l~~l~h--~~i-~~~~~~~~~~~~~~ 95 (298)
-.+.+|.|..+.||.+....+++.+++|...... .....+..|..+++.+.. +.. .+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 4678999999999999776567789999764321 123456778888877632 333 345443 444567
Q ss_pred EEEeccCCC
Q 022401 96 IVMEYASGG 104 (298)
Q Consensus 96 lv~~~~~~~ 104 (298)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=4.2e-06 Score=72.41 Aligned_cols=83 Identities=8% Similarity=0.071 Sum_probs=55.0
Q ss_pred eeEEeee-ccCCeEEEEEEEEc--c----CCcEEEEEEeecCC---c-chHHHHHHHHHHhcCCC---CCeeeeeEEEEe
Q 022401 25 YDFVRDI-GSGNFGVARLMRDK--V----TKELVAVKYIERGD---K-IDENVQREIINHRSLRH---PNIVRFKEVILT 90 (298)
Q Consensus 25 y~~~~~l-g~g~~~~vy~~~~~--~----~~~~~aiK~~~~~~---~-~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~ 90 (298)
....+.| +.|....+|.+... . +++.+++|+..... . ....+..|..+++.+.. -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 88888999988753 1 15678999765432 1 12456778888877732 345667776655
Q ss_pred C---CeEEEEEeccCCCCHH
Q 022401 91 P---THLAIVMEYASGGELF 107 (298)
Q Consensus 91 ~---~~~~lv~~~~~~~sL~ 107 (298)
. ...++||++++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3467899999886643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=5.5e-05 Score=64.70 Aligned_cols=74 Identities=18% Similarity=0.246 Sum_probs=41.3
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcC-----CCCCeeeee-E--EEEeCCeEEEEEe
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK-E--VILTPTHLAIVME 99 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~-~--~~~~~~~~~lv~~ 99 (298)
++.|+.|..+.+|.+... +..+++|+..... ..+..|..+++.+ ..|.++... + +....+..+++++
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 455666678899998764 3358999887632 3333444444433 234444311 1 1234667899999
Q ss_pred ccCCCCH
Q 022401 100 YASGGEL 106 (298)
Q Consensus 100 ~~~~~sL 106 (298)
+++|.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.84 E-value=3.9e-05 Score=64.67 Aligned_cols=71 Identities=13% Similarity=0.113 Sum_probs=43.9
Q ss_pred EeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCeEEEEEecc-CCCC
Q 022401 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE 105 (298)
Q Consensus 28 ~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~-~~~s 105 (298)
++.|+.|....+|.+ ..+++|+........-...+|...++.+...++ .+++.. +...-+++++|+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 788989999999998 358999876543222223567777766633222 344443 343446789999 7655
Q ss_pred H
Q 022401 106 L 106 (298)
Q Consensus 106 L 106 (298)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.82 E-value=9.2e-05 Score=58.55 Aligned_cols=146 Identities=15% Similarity=0.081 Sum_probs=91.4
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCC
Q 022401 103 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (298)
Q Consensus 103 ~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 180 (298)
..||.+.|.. +.++++.++|.++.|.+.+|.-+-. +.-...=+.|..|++..+|. |-+.+ .. ..
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~-----------s~ 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AA-----------DD 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cc-----------cc
Confidence 4578888864 5589999999999999999877621 12123344568899998988 54442 10 00
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 260 (298)
.....+.+||... ...+.+.=|||||+++|..+--..|-+. ...+++.|.+||..
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~e-----------------------E~eLS~~LE~LL~~ 152 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKENE-----------------------ERELSPPLEQLIDH 152 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTTE-----------------------EECCCHHHHHHHHH
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCccc-----------------------chhhCHHHHHHHHH
Confidence 1123456777652 2223347899999999999864444222 22278999999999
Q ss_pred hhhh-------------------------CCCCcccccccchhhhHHHhhhhh
Q 022401 261 IFVA-------------------------DPAAVSIFFFPLNMSCLLLFSFVW 288 (298)
Q Consensus 261 ~l~~-------------------------dp~~Rps~~~~l~~~~~~~~~hp~ 288 (298)
|.+. .+..|+++.++++ .|..-+.-|+
T Consensus 153 Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~-~C~~hl~~ps 204 (229)
T 2yle_A 153 MANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK-LCAAHLPTES 204 (229)
T ss_dssp HTTCCC--------------------CCSCCCCCCSHHHHHH-HHHTTSSSGG
T ss_pred HHhcccccccccccccccccccccccccccccCcCCHHHHHH-HHHhhccCcc
Confidence 9865 2468888888875 4444444443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00028 Score=62.33 Aligned_cols=73 Identities=14% Similarity=0.234 Sum_probs=43.4
Q ss_pred EEeeeccCCeEEEEEEEEccCCcEEEEEEeec-----CCc-----chHHHHHHHHHHh-cCCCCCeeeeeEEEEeCCeEE
Q 022401 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDK-----IDENVQREIINHR-SLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~-----~~~-----~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 95 (298)
-.+.+|.|..+.||.+.. +++.+++|.... ... ....+..|+..+. ......+.+++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 457789999999999964 456799994321 111 1122333333222 11223455666554 56678
Q ss_pred EEEecc-CC
Q 022401 96 IVMEYA-SG 103 (298)
Q Consensus 96 lv~~~~-~~ 103 (298)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0041 Score=51.75 Aligned_cols=79 Identities=11% Similarity=0.047 Sum_probs=54.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCC---CeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHP---NIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~lv~ 98 (298)
.+..-++.+|.|..+.||++... +|+.+++|+..... .....+..|...|+.|... -+.+++.+ +.. ++|+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~--~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDR--TLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETT--EEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCc--eEEE
Confidence 45677889999999999999865 67889999876443 2335678888888877421 23334333 332 5688
Q ss_pred eccCCCCH
Q 022401 99 EYASGGEL 106 (298)
Q Consensus 99 ~~~~~~sL 106 (298)
|+..+...
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 98876543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00073 Score=58.78 Aligned_cols=141 Identities=16% Similarity=0.149 Sum_probs=78.9
Q ss_pred CeeEEeeeccCCeEEEEEEEEcc-------CCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCeEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLA 95 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~ 95 (298)
..+ ++.+..|-...+|++.... +++.+++|+............+|..+++.+...++ .++++++. + .
T Consensus 52 ~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g 126 (379)
T 3feg_A 52 ELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--G 126 (379)
T ss_dssp GCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred ceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--c
Confidence 344 3456667777889888642 34679999874433344566688888887743222 44555543 3 2
Q ss_pred EEEeccCCCCHHH----------H-------HHhCC-----CCC--HHHHHHHHHHHHH-------------------HH
Q 022401 96 IVMEYASGGELFE----------R-------ICNAG-----RFS--EDEARFFFQQLIS-------------------GV 132 (298)
Q Consensus 96 lv~~~~~~~sL~~----------~-------l~~~~-----~~~--~~~~~~i~~~l~~-------------------~l 132 (298)
+|++|++|.++.. . ++... ... ..++..+..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998855521 0 11111 111 2344545443321 22
Q ss_pred HHHh----h----cCcEEecCCCCceEeeCCC--CCCEEEeecCccc
Q 022401 133 SYCH----A----MQVCHRDLKLENTLLDGSP--APRLKICDFGYSK 169 (298)
Q Consensus 133 ~~Lh----~----~~i~H~dl~p~nilv~~~~--~~~~~l~d~~~~~ 169 (298)
+.|. + ..++|+|+.+.||+++.+. ...+.++||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3332 2 3489999999999998761 1248999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0037 Score=52.94 Aligned_cols=75 Identities=9% Similarity=0.058 Sum_probs=46.6
Q ss_pred eeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCC--eeeeeEE-----EEeCCeEEEEEecc
Q 022401 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYA 101 (298)
Q Consensus 29 ~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~lv~~~~ 101 (298)
+.++ |....||.+... +|+.+++|...........+..|..+++.+...+ +.+++.. ....+..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3455 777789987653 4557999988754334456667777776663212 2333332 12345678899999
Q ss_pred CCCC
Q 022401 102 SGGE 105 (298)
Q Consensus 102 ~~~s 105 (298)
+|.+
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0011 Score=56.20 Aligned_cols=141 Identities=16% Similarity=0.145 Sum_probs=76.1
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-----CCCeeeee-E--EEEeCCeEE
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFK-E--VILTPTHLA 95 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~-~--~~~~~~~~~ 95 (298)
...-.+.|+.|....+|.+... ++ .+++|+.... ...+.+..|..+++.+. .|.++... + +....+..+
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 3445667788888899998764 33 5899988752 12234556666665552 23333211 1 112345678
Q ss_pred EEEeccCCCCHHH-----------H---HHhC----C-C----CCHHHHHHH---------------HHHHHHHHHHHhh
Q 022401 96 IVMEYASGGELFE-----------R---ICNA----G-R----FSEDEARFF---------------FQQLISGVSYCHA 137 (298)
Q Consensus 96 lv~~~~~~~sL~~-----------~---l~~~----~-~----~~~~~~~~i---------------~~~l~~~l~~Lh~ 137 (298)
+++++.+|.++.. . ++.. . + ......... ...+...++.+.+
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999998865310 0 1110 0 0 111111110 0113334455542
Q ss_pred -------cCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 138 -------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 138 -------~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
.+++|+|+++.||+++.++. +.++||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 46899999999999986543 5799998654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0026 Score=54.12 Aligned_cols=32 Identities=31% Similarity=0.414 Sum_probs=25.4
Q ss_pred cCcEEecCCCCceEeeCCC--CCCEEEeecCccc
Q 022401 138 MQVCHRDLKLENTLLDGSP--APRLKICDFGYSK 169 (298)
Q Consensus 138 ~~i~H~dl~p~nilv~~~~--~~~~~l~d~~~~~ 169 (298)
..++|||+++.||+++.+. ...+.|+||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 4699999999999997641 1248999999765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00091 Score=59.25 Aligned_cols=75 Identities=13% Similarity=0.117 Sum_probs=48.5
Q ss_pred EEeeeccCCeEEEEEEEEcc-------CCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCeEEEEE
Q 022401 27 FVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 98 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 98 (298)
-++.|+.|....+|.+.... .+..+++|+.... ...+.+..|..+++.+...++ .++++.+. + .+|+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 45678888889999998642 2467999987432 222455678888887743333 45555442 2 2788
Q ss_pred eccCCCCH
Q 022401 99 EYASGGEL 106 (298)
Q Consensus 99 ~~~~~~sL 106 (298)
+|++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0019 Score=55.83 Aligned_cols=76 Identities=16% Similarity=0.051 Sum_probs=43.3
Q ss_pred EEeeeccCCeEEEEEEEEccC--------CcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCeEEEE
Q 022401 27 FVRDIGSGNFGVARLMRDKVT--------KELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIV 97 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~--------~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv 97 (298)
-.+.++.|....+|.+..... ++.+++|+.............|..+++.+...++ .++++.. ++ ++|
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 355677777789999986531 2578999876543222223567777776643333 3444433 22 578
Q ss_pred EeccCCCCH
Q 022401 98 MEYASGGEL 106 (298)
Q Consensus 98 ~~~~~~~sL 106 (298)
+++++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.014 Score=51.94 Aligned_cols=76 Identities=16% Similarity=0.085 Sum_probs=47.7
Q ss_pred EEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCeEEEEEeccCCCC
Q 022401 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 105 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~s 105 (298)
-++.|+.|-...+|++.....+..+++|+........-....|..+++.|...++ .++++.+ .+. .|++|++|.+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCCcc
Confidence 3567788888899999875434778999875432222122578888888865444 4566655 333 4999998744
Q ss_pred H
Q 022401 106 L 106 (298)
Q Consensus 106 L 106 (298)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.015 Score=49.06 Aligned_cols=96 Identities=18% Similarity=0.128 Sum_probs=72.6
Q ss_pred eEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCeEEEEEeccC
Q 022401 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS 102 (298)
Q Consensus 26 ~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (298)
.-.+.++.|....+|.+.. ++..+++|+.... ....+..|...++.|. ...+.+++.+....+..++|+++++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 4467789999999999876 3567899987653 3466788888888773 3557778777777788999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 022401 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139 (298)
Q Consensus 103 ~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~ 139 (298)
+.++.. ....++...|..||+.+
T Consensus 115 G~~~~~--------------~~~~~lG~~LA~LH~~~ 137 (312)
T 3jr1_A 115 KSKNKQ--------------SSFTIFAEKIAQLHQIQ 137 (312)
T ss_dssp CCCCCT--------------THHHHHHHHHHHHHHCC
T ss_pred CCCCCc--------------hhHHHHHHHHHHHHcCC
Confidence 876421 24567888899999864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.034 Score=47.40 Aligned_cols=30 Identities=23% Similarity=0.475 Sum_probs=25.6
Q ss_pred cCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 138 ~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
..++|+|+.+.||+++.++. +.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES--IYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC--EEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCe--EEEEECCCCe
Confidence 45899999999999987665 8999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.021 Score=50.33 Aligned_cols=76 Identities=17% Similarity=0.080 Sum_probs=46.5
Q ss_pred EEeeeccCCeEEEEEEEEccC-------CcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCeEEEEE
Q 022401 27 FVRDIGSGNFGVARLMRDKVT-------KELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 98 (298)
Q Consensus 27 ~~~~lg~g~~~~vy~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 98 (298)
-++.+..|-...+|.+..... +..+++|+........-...+|..+++.+...++ .++++.+ .+ +.|+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 345666677779999887521 5679999875543322234567777777643233 3444432 33 6789
Q ss_pred eccCCCCH
Q 022401 99 EYASGGEL 106 (298)
Q Consensus 99 ~~~~~~sL 106 (298)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99988654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.98 E-value=0.19 Score=43.83 Aligned_cols=30 Identities=40% Similarity=0.606 Sum_probs=23.6
Q ss_pred cEEecCCCCceEeeC----CCCCCEEEeecCccc
Q 022401 140 VCHRDLKLENTLLDG----SPAPRLKICDFGYSK 169 (298)
Q Consensus 140 i~H~dl~p~nilv~~----~~~~~~~l~d~~~~~ 169 (298)
++|+|+.+.||++.. +....+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 689999999999943 222359999999875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.89 E-value=0.13 Score=40.49 Aligned_cols=115 Identities=9% Similarity=0.035 Sum_probs=77.2
Q ss_pred CCCCCeeeeeEEEEeCCeEEEEEeccC-CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC
Q 022401 76 LRHPNIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (298)
Q Consensus 76 l~h~~i~~~~~~~~~~~~~~lv~~~~~-~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~ 154 (298)
..+|++++. .+-.+++.+.+.++.-+ +.++.. + ...+....++++.+|+....+++++ +|--++|+|++++.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~r--~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRTR--YTFVLAPDELFFTR 114 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGSS--EECCCSGGGEEECT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcCc--eEEEEecceEEEcC
Confidence 368999977 56667777777777654 223322 2 2468899999999999977555444 89999999999999
Q ss_pred CCCCCEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCC
Q 022401 155 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221 (298)
Q Consensus 155 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 221 (298)
++. +++.-.|+-.. ++|.. . ....=+-++=+++..++++...|
T Consensus 115 ~~~--p~i~~RGik~~----------------l~P~~-----~-~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 115 DGL--PIAKTRGLQNV----------------VDPLP-----V-SEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp TSC--EEESCCEETTT----------------BSCCC-----C-CHHHHHHHHHHHHHHHHCTTCCH
T ss_pred CCC--EEEEEccCccC----------------CCCCC-----C-CHHHHHHHHHHHHHHHHcCCCCH
Confidence 987 88887764221 11221 1 11123445667888888877665
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.23 E-value=1.1 Score=35.23 Aligned_cols=82 Identities=15% Similarity=0.071 Sum_probs=60.5
Q ss_pred CCCCeeeeeEEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHhhcCcEEecCCCCceEeeCC
Q 022401 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS-YCHAMQVCHRDLKLENTLLDGS 155 (298)
Q Consensus 77 ~h~~i~~~~~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~-~Lh~~~i~H~dl~p~nilv~~~ 155 (298)
.||++ -..+-.+++.+.+.++.-+++.-...+ ...+..+.++++.+|+.... ++ ..-+|--++|+|++++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 67888 444556778888888776433222333 24688999999999998766 44 445899999999999998
Q ss_pred CCCCEEEeecCc
Q 022401 156 PAPRLKICDFGY 167 (298)
Q Consensus 156 ~~~~~~l~d~~~ 167 (298)
+. +++...|+
T Consensus 121 ~~--p~i~hRGi 130 (219)
T 4ano_A 121 LE--PFFLHVGV 130 (219)
T ss_dssp CC--EEESCCEE
T ss_pred Cc--EEEEEcCC
Confidence 88 88888774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 298 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-74 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-72 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-72 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-71 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-70 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-69 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-68 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-67 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-65 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-62 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-61 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-60 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-60 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-59 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-53 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-53 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-53 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-50 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-50 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-49 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-41 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-40 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-33 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-14 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 228 bits (583), Expect = 6e-74
Identities = 71/249 (28%), Positives = 115/249 (46%), Gaps = 9/249 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 81
D YD + ++GSG FGV +K T + K+I +D V+ EI L HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQV 140
+ + + +++E+ SGGELF+RI + SE E + +Q G+ + H +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
H D+K EN + + A +KI DFG + K T T + APE++ R
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLI 258
D+W+ GV YV+L G PF D+ +T+Q + + + +S E +D I
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 259 SRIFVADPA 267
+ +P
Sbjct: 264 KNLLQKEPR 272
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 225 bits (574), Expect = 1e-72
Identities = 77/258 (29%), Positives = 130/258 (50%), Gaps = 9/258 (3%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIIN 72
+++ H D YD ++G+G FGV + ++ T A K++ + D E V++EI
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 131
LRHP +V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ + H H DLK EN + + LK+ DFG + K T GT + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-- 249
D+WS GV Y++L G PF ++ +T++ + S +++ D+
Sbjct: 197 AEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSG 251
Query: 250 ISQECRDLISRIFVADPA 267
IS++ +D I ++ +ADP
Sbjct: 252 ISEDGKDFIRKLLLADPN 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-72
Identities = 86/250 (34%), Positives = 133/250 (53%), Gaps = 10/250 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+ +D V+ +G G +G +L ++VT+E VAVK + +R EN+++EI ++ L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V+F + +EY SGGELF+RI E +A+ FF QL++GV Y H + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHEY 197
HRD+K EN LLD LKI DFG + +++ + GT Y+APE+L R E+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
+ DVWSCG+ L ML G P+ D+P D + + + I L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 258 ISRIFVADPA 267
+ +I V +P+
Sbjct: 240 LHKILVENPS 249
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 1e-71
Identities = 82/249 (32%), Positives = 134/249 (53%), Gaps = 14/249 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLRH 78
+ ++ R +G G FG L R+K +K ++A+K + + V +RE+ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI+R T + +++EYA G ++ + +F E + +L + +SYCH+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+V HRD+K EN LL + LKI DFG+S + S+ + GT Y+ PE++ +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
K D+WS GV Y LVG PFE +++T +RI V+++ PD +++ RDLI
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPDF--VTEGARDLI 235
Query: 259 SRIFVADPA 267
SR+ +P+
Sbjct: 236 SRLLKHNPS 244
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 3e-70
Identities = 62/248 (25%), Positives = 112/248 (45%), Gaps = 8/248 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
++Y D+G G FG+ + +K+ K+++ V++EI RH NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
E + L ++ E+ SG ++FERI +A +E E + Q+ + + H+ +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLIS 259
D+WS G +YV+L G PF ++ I+ I++ +Y+ + IS E D +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 260 RIFVADPA 267
R+ V +
Sbjct: 240 RLLVKERK 247
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 215 bits (549), Expect = 2e-69
Identities = 87/251 (34%), Positives = 128/251 (50%), Gaps = 10/251 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
D YDF +G+G F L DK T++LVA+K I + + + +++ EI ++HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV ++ + HL ++M+ SGGELF+RI G ++E +A Q++ V Y H +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 140 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ HRDLK EN L ++ I DFG SK S + GTP Y+APEVL + Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRD 256
D WS GV Y++L G PF D ++ K ++IL +Y IS +D
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYDENDA----KLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 257 LISRIFVADPA 267
I + DP
Sbjct: 243 FIRHLMEKDPE 253
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 1e-68
Identities = 71/252 (28%), Positives = 114/252 (45%), Gaps = 16/252 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRH 78
+ + F + +G G+F L R+ T A+K +E+ I EN + L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRH 195
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
+D+W+ G +Y ++ G PF +E Q+I+ ++Y P+ + R
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRAGNEY----LIFQKIIKLEYDFPEK--FFPKAR 238
Query: 256 DLISRIFVADPA 267
DL+ ++ V D
Sbjct: 239 DLVEKLLVLDAT 250
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 5e-68
Identities = 64/253 (25%), Positives = 116/253 (45%), Gaps = 12/253 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
D ++ + ++G G FG ++K T L A K I+ + + E+ EI S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
IV+ + +L I++E+ +GG + + R +E + + +Q + ++Y H +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
+ HRDLK N L +K+ DFG S + Q + + +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 199 GKI----ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
+ ADVWS G+TL M P + + + K + S ++ + S
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNF 245
Query: 255 RDLISRIFVADPA 267
+D + + +
Sbjct: 246 KDFLKKCLEKNVD 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-67
Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 45/286 (15%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
D ++ + ++G+GN GV + K + ++A K I E I + RE+ P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ- 139
IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------------- 226
+ +D+WS G++L M VG YP PD
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 227 -----PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
P + + I++ + S E +D +++ + +PA
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-67
Identities = 66/248 (26%), Positives = 110/248 (44%), Gaps = 9/248 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
+Y IG G G D T + VA++ + + E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV + + L L +VMEY +GG L + + E + ++ + + + H+ QV
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
K D+WS G+ M+ G P+ + + + + + +S RD ++
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG---TPELQNPEKLSAIFRDFLN 251
Query: 260 RIFVADPA 267
R D
Sbjct: 252 RCLDMDVE 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (533), Expect = 5e-67
Identities = 66/253 (26%), Positives = 110/253 (43%), Gaps = 17/253 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR 77
+ +R+IG G+FG RD E+VA+K + K +++ +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HPN ++++ L +VMEY G + E E + G++Y H+
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-- 195
+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+L
Sbjct: 134 HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188
Query: 196 -EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
+YDGK DVWS G+T + P + + + I + + S+
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPALQSGHWSEYF 243
Query: 255 RDLISRIFVADPA 267
R+ + P
Sbjct: 244 RNFVDSCLQKIPQ 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 204 bits (520), Expect = 2e-65
Identities = 78/261 (29%), Positives = 119/261 (45%), Gaps = 20/261 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREIIN 72
+ Y+ +G G V R K T + AVK I E ++ E +E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 73 HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
R + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 192 LLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
+ D GK D+WS GV +Y +L G PF + R + + Q+ P+
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 238
Query: 247 TNPISQECRDLISRIFVADPA 267
+ S +DL+SR V P
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQ 259
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-64
Identities = 84/257 (32%), Positives = 134/257 (52%), Gaps = 16/257 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H++Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--I 250
AD+WS GV Y++L G PF + +T+ + +V Y D
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQ----ETLANVSAVNYEFEDEYFSNT 243
Query: 251 SQECRDLISRIFVADPA 267
S +D I R+ V DP
Sbjct: 244 SALAKDFIRRLLVKDPK 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-64
Identities = 83/256 (32%), Positives = 125/256 (48%), Gaps = 16/256 (6%)
Query: 23 DRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
D Y +G G G + +K T+E A+K ++ K +RE+ ++ R+ + P+
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQCPH 66
Query: 81 IVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 134
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 135 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
H++ + HRD+K EN L P LK+ DFG++K + H+ + TP Y+APEVL
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--IS 251
+YD D+WS GV +Y++L G PF RI QY P+ +S
Sbjct: 187 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 252 QECRDLISRIFVADPA 267
+E + LI + +P
Sbjct: 246 EEVKMLIRNLLKTEPT 261
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-62
Identities = 72/260 (27%), Positives = 117/260 (45%), Gaps = 23/260 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
+ Y+ + IG+G++G + +R K +++ K ++ G + Q E+ R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 80 NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
NIVR+ + I+ T T L IVMEY GG+L I + E+ QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 134 YCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYI 187
CH V HRDLK N LDG +K+ DFG ++ + TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
+PE + R Y+ K +D+WS G LY + PF + ++ +I ++
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKFRRIPY 236
Query: 248 NPISQECRDLISRIFVADPA 267
S E ++I+R+
Sbjct: 237 R-YSDELNEIITRMLNLKDY 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-61
Identities = 78/251 (31%), Positives = 125/251 (49%), Gaps = 15/251 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----DKIDENVQREIINHRSLR 77
+ + + +G G+FG L K T + A+K +++ D ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HP + T +L VMEY +GG+L I + +F A F+ ++I G+ + H+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE 196
+ +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+LL +
Sbjct: 122 KGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
Y+ D WS GV LY ML+G PF DE + I P + +E +D
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMDNPFYPRW--LEKEAKD 232
Query: 257 LISRIFVADPA 267
L+ ++FV +P
Sbjct: 233 LLVKLFVREPE 243
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 194 bits (495), Expect = 1e-61
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 13/258 (5%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRS 75
H SDRY+ +G G L RD VAVK + R +RE N +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 76 LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
L HP IV + T IVMEY G L + + G + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 189
+++ H + HRD+K N ++ + A ++ + S +Q + +GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
E D + +DV+S G LY +L G PF + ++ + +
Sbjct: 184 EQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG-- 240
Query: 250 ISQECRDLISRIFVADPA 267
+S + ++ + +P
Sbjct: 241 LSADLDAVVLKALAKNPE 258
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-60
Identities = 59/259 (22%), Positives = 104/259 (40%), Gaps = 16/259 (6%)
Query: 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHR 74
+ +D F +IG G+F D T VA ++ + + E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 75 SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 130
L+HPNIVRF + + + +V E + G L + R + +Q++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 131 GVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
G+ + H + HRDLK +N + G P +KI D G + S K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
PE+ +YD DV++ G+ + M YP+ + +R+ S
Sbjct: 182 PEM-YEEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASFDK 236
Query: 249 PISQECRDLISRIFVADPA 267
E +++I +
Sbjct: 237 VAIPEVKEIIEGCIRQNKD 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 193 bits (492), Expect = 4e-60
Identities = 71/252 (28%), Positives = 117/252 (46%), Gaps = 13/252 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-------S 75
+ + R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
H V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL +
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
AD +S G L+ +L G PF + KD + + L++ +PD+ S E R
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDS--FSPELR 237
Query: 256 DLISRIFVADPA 267
L+ + D
Sbjct: 238 SLLEGLLQRDVN 249
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 8e-59
Identities = 72/255 (28%), Positives = 109/255 (42%), Gaps = 24/255 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-------VQREIINHRS 75
+Y +GSG FG VA+K++E+ D V E++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 76 LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 132
+ ++R + P +++E +LF+ I G E+ AR FF Q++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+CH V HRD+K EN L+D + LK+ DFG + + GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWI 181
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
H Y G+ A VWS G+ LY M+ G PFE +E I+ Q +S
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSS 229
Query: 253 ECRDLISRIFVADPA 267
EC+ LI P+
Sbjct: 230 ECQHLIRWCLALRPS 244
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 186 bits (474), Expect = 5e-58
Identities = 74/249 (29%), Positives = 126/249 (50%), Gaps = 15/249 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
+ +R +G+G+FG L+R + A+K +++ + E+ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+ Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
D WS G+ +Y ML G PF D + KT ++IL+ + P +++ +DL+
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNAELRFPPF--FNEDVKDLL 232
Query: 259 SRIFVADPA 267
SR+ D +
Sbjct: 233 SRLITRDLS 241
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-57
Identities = 58/256 (22%), Positives = 100/256 (39%), Gaps = 15/256 (5%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLR 77
+ + IGSG+FG + VAVK + + +Q E+ R R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 136
H NI+ F T LAIV ++ G L+ + +F + +Q G+ Y H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
A + HRDLK N L +KI DFG + Q + G+ ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 194 RHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
+ + +DV++ G+ LY ++ G P+ + + + R +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 252 QECRDLISRIFVADPA 267
+ + L++
Sbjct: 240 KAMKRLMAECLKKKRD 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-55
Identities = 61/250 (24%), Positives = 96/250 (38%), Gaps = 15/250 (6%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ ++ IG G FG L + VAVK I + D + E LRH N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-KNDATAQAFLAEASVMTQLRHSN 61
Query: 81 IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
+V+ VI+ L IV EY + G L + + + GR D F + + Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRDL N L+ K+ DFG +K S + + APE L ++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
K +DVWS G+ L+ + G KD +++ Y + + ++
Sbjct: 178 STK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPPAVYEV 232
Query: 258 ISRIFVADPA 267
+ + D A
Sbjct: 233 MKNCWHLDAA 242
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-55
Identities = 82/250 (32%), Positives = 128/250 (51%), Gaps = 14/250 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRH 78
+ +D+++ +G G FG L+R+K T A+K + + I ++ E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y H+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEY 197
V +RD+KLEN +LD +KI DFG K + K+ GTP Y+APEVL ++Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
D W GV +Y M+ G PF + D + + IL + P T +S E + L
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPRT--LSPEAKSL 235
Query: 258 ISRIFVADPA 267
++ + DP
Sbjct: 236 LAGLLKKDPK 245
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-54
Identities = 53/250 (21%), Positives = 103/250 (41%), Gaps = 11/250 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D F++++G+G FGV + + + + VA+K I+ G ++ E +L H
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQ 139
+V+ V + I+ EY + G L + RF + + + + Y + Q
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEY 197
HRDL N L++ +K+ DFG S+ + S + PEVL+ ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
K +D+W+ GV ++ + G P E +T + I + + S++ +
Sbjct: 179 SSK-SDIWAFGVLMWEIYSLGKM---PYERFTNSETAEHIAQG-LRLYRPHLASEKVYTI 233
Query: 258 ISRIFVADPA 267
+ +
Sbjct: 234 MYSCWHEKAD 243
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-53
Identities = 59/250 (23%), Positives = 100/250 (40%), Gaps = 11/250 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D FV++IGSG FG+ L K+ VA+K I G +E+ E L HP
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+V+ V L + +V E+ G L + G F+ + + G++Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
V HRDL N L+ + +K+ DFG ++ ++ T + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
K +DVWS GV ++ + G + + + I + + S +
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYKPRLASTHVYQI 234
Query: 258 ISRIFVADPA 267
++ + P
Sbjct: 235 MNHCWKERPE 244
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 5e-53
Identities = 70/249 (28%), Positives = 128/249 (51%), Gaps = 15/249 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
D++D ++ +G+G+FG L++ K + A+K +++ + E+ E +++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ +RDLK EN L+D +++ DFG++K + + GTP +APE++L Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
D W+ GV +Y M G PF + ++I+S + P S + +DL+
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFPS--HFSSDLKDLL 269
Query: 259 SRIFVADPA 267
+ D
Sbjct: 270 RNLLQVDLT 278
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 173 bits (440), Expect = 6e-53
Identities = 57/280 (20%), Positives = 113/280 (40%), Gaps = 41/280 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 81
D Y VR +G G + + E V VK ++ K + ++REI +LR PNI
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 82 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ +++ P A+V E+ + + + ++ + RF+ +++ + YCH+M
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ HRD+K N ++D +L++ D+G ++ + V + + PE+L+ ++
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----------------- 242
D+WS G L M+ PF + D I ++L +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 243 ---------------SVPDTNPISQECRDLISRIFVADPA 267
+ + +S E D + ++ D
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 9e-53
Identities = 61/266 (22%), Positives = 103/266 (38%), Gaps = 31/266 (11%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRF 84
+G G F RDK T ++VA+K I+ G D I+ REI + L HPNI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
+ +++++V ++ N+ + + + + G+ Y H + HRD
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
LK N LLD + LK+ DFG +KS + V T Y APE+L G D
Sbjct: 126 LKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT---------------- 247
+W+ G L +L+ + + + + +
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243
Query: 248 ------NPISQECRDLISRIFVADPA 267
+ + DLI +F+ +P
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPC 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-52
Identities = 70/291 (24%), Positives = 108/291 (37%), Gaps = 39/291 (13%)
Query: 9 TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR 68
T G D P Y + IG+G+FGV + + ELVA+K + + R
Sbjct: 9 TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62
Query: 69 EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 119
E+ R L H NIVR + + +L +V++Y
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
+ + QL ++Y H+ +CHRD+K +N LLD A K+CDFG +K V S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181
Query: 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
+ + Y APE++ DVWS G L +L+G F + I+ + +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 240 -------------VQYSVPDTNP----------ISQECRDLISRIFVADPA 267
++ P E L SR+ P
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (435), Expect = 1e-52
Identities = 50/251 (19%), Positives = 98/251 (39%), Gaps = 11/251 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G +G K VAVK ++ E +E + ++HPN
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM 138
+V+ V I+ E+ + G L + + R S + Q+ S + Y
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHE 196
HRDL N L+ + +K+ DFG S+ + ++ + APE L ++
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
+ K +DVW+ GV L+ + G + + +++ Y + ++ +
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEKVYE 247
Query: 257 LISRIFVADPA 267
L+ + +P+
Sbjct: 248 LMRACWQWNPS 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-52
Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 13/251 (5%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V+ + + IV EY S G L + + + Q+ SG++Y M
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHE 196
HRDL+ N L+ + K+ DFG ++ ++ + + APE L
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
+ K +DVWS G+ L + G ++ ++R Y +P + D
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHD 245
Query: 257 LISRIFVADPA 267
L+ + + +P
Sbjct: 246 LMCQCWRKEPE 256
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-51
Identities = 59/263 (22%), Positives = 100/263 (38%), Gaps = 17/263 (6%)
Query: 16 MPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKID----ENVQR 68
+ + + +G G+FGV VAVK ++ ++ R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 69 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 127
E+ SL H N++R V+LTP + +V E A G L +R+ + G F + Q
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 184
+ G+ Y + + HRDL N LL +KI DFG + + H + P
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
L+ +D W GVTL+ M G P + + + +I +
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHKIDKEGERL 234
Query: 245 PDTNPISQECRDLISRIFVADPA 267
P Q+ +++ + + P
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPE 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-51
Identities = 51/251 (20%), Positives = 97/251 (38%), Gaps = 13/251 (5%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ V +G+G FG + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAM 138
+VR V+ T + I+ EY G L + + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHE 196
HRDL+ N L+ KI DFG ++ + + APE +
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
+ K +DVWS G+ L ++ G + + ++R Y + + +E
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQ 241
Query: 257 LISRIFVADPA 267
L+ + P
Sbjct: 242 LMRLCWKERPE 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-50
Identities = 70/280 (25%), Positives = 107/280 (38%), Gaps = 38/280 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
RY + IG G +G+ D V K VA+K I + REI RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 81 IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
I+ ++I PT ++ + G +L++ + S D +F Q++ G+ Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 192
+ V HRDLK N LL+ + LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ----------------R 236
L + K D+WS G L ML F + +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 237 ILSVQYSVPDTNP---------ISQECRDLISRIFVADPA 267
+ S+P N + DL+ ++ +P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-50
Identities = 60/255 (23%), Positives = 107/255 (41%), Gaps = 16/255 (6%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRS 75
+R + R IG G FG M + VA+K + D + E +E + R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 134
HP+IV+ VI T + I+ME + GEL + + QL + ++Y
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
+ + HRD+ N L+ + +K+ DFG S+ + K++ ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
+ +DVW GV ++ +L+ G P + I RI + + +P
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPP 236
Query: 253 ECRDLISRIFVADPA 267
L+++ + DP+
Sbjct: 237 TLYSLMTKCWAYDPS 251
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 4e-50
Identities = 59/267 (22%), Positives = 99/267 (37%), Gaps = 19/267 (7%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH 73
M++ + +RY R IGSG+FG L D E VA+K +E + E +
Sbjct: 1 MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56
Query: 74 RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ ++ I + + +VME + +FS Q+IS +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 133 SYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 183
Y H+ HRD+K +N L+ G + I DFG +K + + + K+ GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243
Y + L E + D+ S G L +G P++ +K +RI + S
Sbjct: 177 ARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMS 234
Query: 244 VPD---TNPISQECRDLISRIFVADPA 267
P E ++
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFD 261
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-50
Identities = 66/255 (25%), Positives = 119/255 (46%), Gaps = 12/255 (4%)
Query: 23 DRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGD-----KIDENVQREIINHR 74
+ ++ ++ +G+G +G R + T +L A+K +++ K E+ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 75 SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+R P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
+ H + + +RD+KLEN LLD + L + + GT Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 194 RHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
+ K D WS GV +Y +L G PF E + +RIL + P +S
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSA 261
Query: 253 ECRDLISRIFVADPA 267
+DLI R+ + DP
Sbjct: 262 LAKDLIQRLLMKDPK 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-50
Identities = 63/296 (21%), Positives = 106/296 (35%), Gaps = 44/296 (14%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREI 70
++ P + +Y+ + IG G FG R + T + VA+K + + REI
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 71 INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 122
+ L+H N+V E+ T + +V ++ +F+ E +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 177
Q L++G+ Y H ++ HRD+K N L+ LK+ DFG ++ + ++
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRY 178
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 237
+ V T Y PE+LL G D+W G + M + E Q
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 238 LSVQYSVPD--------------------------TNPISQECRDLISRIFVADPA 267
S+ V DLI ++ V DPA
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-50
Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 30/273 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
+ + V IG G +GV R+K+T E+VA+K I + + REI + L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
NIV+ +VI T L +V E+ + F + + QL+ G+++CH+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
+V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE+LL +Y
Sbjct: 122 RVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ-------RILSVQYSVPDTNP- 249
D+WS G M+ F E + + + S+PD P
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 250 ---------------ISQECRDLISRIFVADPA 267
+ ++ R L+S++ DP
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (416), Expect = 1e-49
Identities = 55/259 (21%), Positives = 101/259 (38%), Gaps = 19/259 (7%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERG--DKIDENVQREIINHRS 75
D + IG+G FG K+ + VA+K ++ G +K + E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 134
HPN++ + V+ T + I+ E+ G L N G+F+ + + + +G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 188
M HRDL N L++ + K+ DFG S+ S ++ + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
PE + ++ +DVWS G+ ++ ++ G +D I++ Y +P
Sbjct: 202 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ----DYRLPPPM 256
Query: 249 PISQECRDLISRIFVADPA 267
L+ + D
Sbjct: 257 DCPSALHQLMLDCWQKDRN 275
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-49
Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 40/279 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
Y ++ +GSG +G D T VA+K + R + + RE+ + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 80 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
N++ +V T +VM + G ++ + ED +F Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y HA + HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQRILS 239
+ D+WS G + M+ G F+ D P +F + +Q +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 240 VQY--SVPDTNP---------ISQECRDLISRIFVADPA 267
Y +P+ S +L+ ++ V D
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-49
Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 30/273 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
+Y+ + IG G +G +++ T E+VA+K + + + + + REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIVR +V+ + L +V E+ G + + F QL+ G+ +CH+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRHEYD 198
V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL--------SVQYSVPDTNP- 249
D+WS G + G P ++ D K I R+L +PD P
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 250 ---------------ISQECRDLISRIFVADPA 267
++ RDL+ + +P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-49
Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 20/257 (7%)
Query: 23 DRYDFV---RDIGSGNFGVARLMRDKVTKE--LVAVKYIERGDKID--ENVQREIINHRS 75
R + + ++G GNFG R ++ K+ VA+K +++G + E + RE
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSY 134
L +P IVR V L +VME A GG L + + Q+ G+ Y
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 190
HRDL N LL + I DFG SK ++ + + APE
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
+ ++ + +DVWS GVT++ L G P + + + I + +
Sbjct: 183 CINFRKFSSR-SDVWSYGVTMWEALSYGQK---PYKKMKGPEVMAFIEQGKR-MECPPEC 237
Query: 251 SQECRDLISRIFVADPA 267
E L+S ++
Sbjct: 238 PPELYALMSDCWIYKWE 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-49
Identities = 53/281 (18%), Positives = 96/281 (34%), Gaps = 40/281 (14%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKEL-----VAVKYI--ERGDKIDENVQREIINH 73
+ +F + +GSG FG + VAVK + + E + E+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 74 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 110
L H NIV + ++ EY G+L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 111 -CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ + ++ F Q+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212
Query: 170 ---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
S + + ++APE L Y K +DVWS G+ L+ + G P
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVN---PYP 268
Query: 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
+++ + + ++E ++ + D
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSR 309
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-48
Identities = 57/257 (22%), Positives = 99/257 (38%), Gaps = 20/257 (7%)
Query: 23 DRYDFV---RDIGSGNFGVARL--MRDKVTKELVAVKYIERG---DKIDENVQREIINHR 74
DR +++GSGNFG + + K + VAVK ++ + + + E +
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
L +P IVR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 64 QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 190
HRDL N LL KI DFG SK+ + + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
+ +++ K +DVWS GV ++ G + + +++ +
Sbjct: 181 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGC 235
Query: 251 SQECRDLISRIFVADPA 267
+E DL++ + D
Sbjct: 236 PREMYDLMNLCWTYDVE 252
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 52/261 (19%), Positives = 100/261 (38%), Gaps = 17/261 (6%)
Query: 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI------ERGDKIDENVQRE 69
+ I+ +++ + ++ +GSG FG E V + K ++ + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
S+ +P++ R + LT T I G L + + Q+
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 186
G++Y ++ HRDL N L+ +KI DFG +K + + +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
+A E +L Y + +DVWS GVT++ ++ G D + I IL +P
Sbjct: 180 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQ 234
Query: 247 TNPISQECRDLISRIFVADPA 267
+ + ++ + ++ D
Sbjct: 235 PPICTIDVYMIMVKCWMIDAD 255
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 159 bits (403), Expect = 8e-48
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 30/272 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
++Y + IG G +GV ++ E A+K I + + I REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV+ +VI T L +V E+ G A+ F QL++G++YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------YSVPDTNP-- 249
D+WS G M+ G F E + + + + +P +P
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 250 --------------ISQECRDLISRIFVADPA 267
+ + DL+S++ DP
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPN 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (402), Expect = 1e-47
Identities = 48/259 (18%), Positives = 91/259 (35%), Gaps = 18/259 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
Y R IG G+FGV + + + VA+K+ R ++ E ++ L I
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
H +V++ +FS +Q+++ V H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 142 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 190
+RD+K +N L+ + + + DFG K + + + K+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP- 249
L E + D+ + G L G P++ + +K +RI + S P
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTPLRELC 241
Query: 250 --ISQECRDLISRIFVADP 266
+E +
Sbjct: 242 AGFPEEFYKYMHYARNLAF 260
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-47
Identities = 60/268 (22%), Positives = 95/268 (35%), Gaps = 28/268 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKID--ENVQREIINHRSL 76
D + F IG GNFG R K A+K ++ D + E+ L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 77 -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 119
HPNI+ +L + +EYA G L + + A S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
+ F + G+ Y Q HRDL N L+ + KI DFG S+ ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185
Query: 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
++A E L Y +DVWS GV L+ ++ G + + + +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--- 241
Query: 240 VQYSVPDTNPISQECRDLISRIFVADPA 267
Y + E DL+ + + P
Sbjct: 242 -GYRLEKPLNCDDEVYDLMRQCWREKPY 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 3e-47
Identities = 62/279 (22%), Positives = 105/279 (37%), Gaps = 41/279 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYI--ERGDKIDENVQREIINHRS 75
+ ++VRDIG G FG R +VAVK + E + + QRE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 115
+PNIV+ V + ++ EY + G+L E + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 116 ----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 169
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190
Query: 170 -SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
S+ + + ++ PE + + Y + +DVW+ GV L+ + G P
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGM 246
Query: 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
+ I + N E +L+ + PA
Sbjct: 247 AHEEVIYYVRDGNILACPEN-CPLELYNLMRLCWSKLPA 284
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-47
Identities = 54/265 (20%), Positives = 95/265 (35%), Gaps = 19/265 (7%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDE--NVQRE 69
+ I S F IG G+FG L+ + K AVK + R I E E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 70 IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 127
I + HPN++ + L + +V+ Y G+L + + F Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 182
+ G+ + + + HRDL N +LD +K+ DFG ++
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
++A E L ++ K +DVWS GV L+ ++ G P D + +
Sbjct: 197 PVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GR 251
Query: 243 SVPDTNPISQECRDLISRIFVADPA 267
+ +++ + +
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAE 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-46
Identities = 68/279 (24%), Positives = 106/279 (37%), Gaps = 37/279 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYI---ERGDKIDENVQREIINHRSL-- 76
+Y+ V +IG G +G RD VA+K + + + + RE+ R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 77 -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 129
HPN+VR +V T L +V E+ + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL----------- 238
EVLL+ Y D+WS G M F + K + I
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 239 ----------SVQYSVPDTNPISQECRDLISRIFVADPA 267
S Q I + +DL+ + +PA
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 282
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 8e-46
Identities = 55/276 (19%), Positives = 95/276 (34%), Gaps = 35/276 (12%)
Query: 21 DSDRYDFVRDIGSGNFGV-----ARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
+R F + +G+G FG A + VAVK ++ + E + E+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 74 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 114
L H NIV ++ EY G+L + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174
++ F Q+ G+++ + HRDL N LL KICDFG ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198
Query: 175 SQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
S ++APE + Y + +DVWS G+ L+ + G
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255
Query: 232 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
+++ + + E D++ + ADP
Sbjct: 256 -KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-45
Identities = 54/258 (20%), Positives = 95/258 (36%), Gaps = 18/258 (6%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG--DKIDENVQREIINHR 74
+ IG+G FG K + VA+K ++ G +K + E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 133
H NI+R + VI + I+ EY G L + + G FS + + + +G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 189
Y M HRDL N L++ + K+ DFG S+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
E + ++ +DVWS G+ ++ ++ G + K I + +P
Sbjct: 183 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMD 237
Query: 250 ISQECRDLISRIFVADPA 267
L+ + + + A
Sbjct: 238 CPSAIYQLMMQCWQQERA 255
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-45
Identities = 58/279 (20%), Positives = 106/279 (37%), Gaps = 38/279 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRH 78
+RY + +GSG +G D T VAVK + R + + RE+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 79 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
N++ +V L ++ + G I + ++D +F Q++ G+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y H+ + HRDLK N ++ LKI DFG ++ + V T Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP---- 249
+ + D+WS G + +L G F D + ++ + + +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 250 ---------------------ISQECRDLISRIFVADPA 267
+ DL+ ++ V D
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-42
Identities = 51/274 (18%), Positives = 98/274 (35%), Gaps = 32/274 (11%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE-------LVAVKYI--ERGDKIDENVQREII 71
DR + +G G FG L + VAVK + + +K ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 72 NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 114
+ + +H NI+ L +++EYAS G L E +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 173
+ S + Q+ G+ Y + + HRDL N L+ ++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233
+ + + ++APE L Y + +DVWS GV L+ + G ++ K
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 234 IQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
++ + + + + E ++ + A P+
Sbjct: 250 LKE----GHRMDKPSNCTNELYMMMRDCWHAVPS 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-41
Identities = 61/284 (21%), Positives = 102/284 (35%), Gaps = 43/284 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ IG G FG + E VAVK ++ + EI LRH NI
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 82 VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
+ F T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 138 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 184
+ HRDLK +N L+ + I D G S + + P VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 185 AYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFE---------------DP 224
Y+APEVL ++H K AD+++ G+ + + DP
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 225 DEPKDFRKTIQRILSVQY-SVPDTNPISQECRDLISRIFVADPA 267
+ + ++ L + + + ++ + A+ A
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 6e-41
Identities = 65/290 (22%), Positives = 108/290 (37%), Gaps = 51/290 (17%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
RY ++ IGSG G+ D V VA+K + R + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 80 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
NI+ V + +VME + + Q++ G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
+ H+ + HRDLK N ++ LKI DFG ++++ V T Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-------------- 239
Y + D+WS G + M+ F D + K I+++ +
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 240 ---------VQYSVPDTNP-------------ISQECRDLISRIFVADPA 267
+ P P + + RDL+S++ V DPA
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-40
Identities = 45/267 (16%), Positives = 99/267 (37%), Gaps = 27/267 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKIDE--NVQREIINH 73
++ R++G G+FG+ K + VA+K + + E E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 123
+ ++VR V+ ++ME + G+L + + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 180
++ G++Y +A + HRDL N ++ +KI DFG ++ + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
+ +++PE L + DVWS GV L+ + P + + ++ ++
Sbjct: 196 LLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEG 251
Query: 241 QYSVPDTNPISQECRDLISRIFVADPA 267
+ + +L+ + +P
Sbjct: 252 GL-LDKPDNCPDMLFELMRMCWQYNPK 277
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-40
Identities = 55/275 (20%), Positives = 97/275 (35%), Gaps = 34/275 (12%)
Query: 21 DSDRYDFVRDIGSGNFGV-----ARLMRDKVTKELVAVKYIERGDKIDEN---VQREIIN 72
DR + +G G FG A + T VAVK ++ G E+ + I
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 73 HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 115
H N+V P L +++E+ G L + +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 116 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
+ + + Q+ G+ + + + HRDL N LL +KICDFG ++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+ + ++APE + Y + +DVWS GV L+ + G P +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDE 244
Query: 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 267
R L + + + E + + +P+
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 279
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (307), Expect = 4e-33
Identities = 52/244 (21%), Positives = 93/244 (38%), Gaps = 22/244 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 83
RY VR +G G+F L +D V VA+K + E + EI + + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 84 ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 127
F H+ +V E L + + +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 128 LISGVSYCHAMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
L+ G+ Y H + H D+K EN L++ SP ++I + +++ T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK--TIQRILSVQY 242
Y +PEVLL + AD+WS ++ ++ G + FE + + I +I+ +
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 243 SVPD 246
+P
Sbjct: 253 ELPS 256
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.3 bits (161), Expect = 9e-14
Identities = 22/155 (14%), Positives = 43/155 (27%), Gaps = 26/155 (16%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERG-----------DKIDENVQREIINHRSLRHP 79
+G G + VK+ + G D D + I
Sbjct: 8 MGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 80 NIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
+ + + + + + A++ME R + ++ V+
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
+ + H DL N L+ + I DF S
Sbjct: 120 YHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 298 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.23 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.34 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.86 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.6 | |
| d1kq8a_ | 75 | HFH-1 (HNF-3 forkhead homolog-1) {Rat (Rattus norv | 80.15 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-59 Score=389.77 Aligned_cols=253 Identities=32% Similarity=0.596 Sum_probs=221.2
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
.++|++++.||+|+||.||+|+++.+++.||+|++.+. ......+.+|+.++++++||||+++++++.+++.+++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999998743 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|||+++++|.+.+.....+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||++...... ..
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~~-~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-RR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCCC-CC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCCC-cc
Confidence 999999999999998889999999999999999999999999999999999999998887 999999998644332 23
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+. .+....+.......+ ..+|+++.+|
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~s~~~~~l 234 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRVEFTFP--DFVTEGARDL 234 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTTCCCCC--TTSCHHHHHH
T ss_pred cccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCC--ccCCHHHHHH
Confidence 45568999999999988887665 9999999999999999999977543 344555556555544 4489999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
|.+||+.||.+|||+ .++++|||+++.
T Consensus 235 i~~~L~~dp~~R~t~--------~eil~hp~~~~~ 261 (263)
T d2j4za1 235 ISRLLKHNPSQRPML--------REVLEHPWITAN 261 (263)
T ss_dssp HHHHTCSSGGGSCCH--------HHHHTCHHHHHH
T ss_pred HHHHccCCHhHCcCH--------HHHHcCcCcCCc
Confidence 999999999999987 566689999853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-59 Score=395.09 Aligned_cols=259 Identities=28% Similarity=0.445 Sum_probs=225.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
++|++++.||+|+||.||+|+++.+++.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999998753 334467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC---
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--- 175 (298)
||+++++|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++.......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999998887 9999999987544322
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
......|++.|+|||++.+..++.+ +||||+||++|+|++|..||...+. .....++.......+ ..+++++.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~s~~~~ 238 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFP--EKFFPKAR 238 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHTTCCCCC--TTCCHHHH
T ss_pred ccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCH----HHHHHHHHcCCCCCC--ccCCHHHH
Confidence 2234568999999999988877655 9999999999999999999987654 344555666665544 45899999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+||.+||+.||.+|||+.|++.+ ..+++|||+.+.
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~--~~i~~Hpff~~i 273 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGY--GPLKAHPFFESV 273 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCH--HHHHTSGGGTTC
T ss_pred HHHHHHccCCHhHCcCHHHHcCC--HHHHcCCccCCC
Confidence 99999999999999999999865 446899999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-59 Score=392.45 Aligned_cols=259 Identities=33% Similarity=0.539 Sum_probs=218.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.++|++++.||+|+||.||+|+++.+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 478999999999999999999999999999999987643 233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC---CC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 176 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~---~~ 176 (298)
|+++++|.+++.....+++.+++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++...... ..
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcccc
Confidence 9999999999988888999999999999999999999999999999999999998887 999999998754322 22
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....|++.|+|||++.+..++++++||||+||++|+|++|..||.......... ...............+++++.+
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH---HHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCCCCCccccCCHHHHH
Confidence 2445689999999999888877666999999999999999999998765433222 2222333333334458999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
||.+||+.||.+|||+ .++++|||++.+-
T Consensus 239 li~~~L~~dP~~R~t~--------~eil~hpwf~~~l 267 (271)
T d1nvra_ 239 LLHKILVENPSARITI--------PDIKKDRWYNKPL 267 (271)
T ss_dssp HHHHHSCSSTTTSCCH--------HHHTTCTTTTCCC
T ss_pred HHHHHcCCChhHCcCH--------HHHhcCHhhCcCC
Confidence 9999999999999987 5556899998554
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=385.62 Aligned_cols=255 Identities=26% Similarity=0.409 Sum_probs=217.7
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.++|++++.||+|+||.||+|+++.+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 358999999999999999999999999999999987643 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~ 179 (298)
+++++|.+++.. ..+++.+++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++...... .....
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccccc
Confidence 999999988765 46899999999999999999999999999999999999998887 999999999755433 33345
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 259 (298)
..|++.|+|||++.+..++.+ +||||+||++|+|++|..||...+..+.+. ............+..+++++.+||.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred cccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHH---HHHhCCCCCCCCcccCCHHHHHHHH
Confidence 569999999999988877665 999999999999999999998765433222 2222334445555668999999999
Q ss_pred HhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 260 RIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 260 ~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+||+.||.+|||+. ++++|||++.
T Consensus 252 ~~L~~dP~~R~s~~--------eil~Hp~~~~ 275 (293)
T d1yhwa1 252 RCLDMDVEKRGSAK--------ELLQHQFLKI 275 (293)
T ss_dssp HHTCSSTTTSCCHH--------HHTTCGGGGG
T ss_pred HHccCChhHCcCHH--------HHhcCHhhCC
Confidence 99999999999884 5557888863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=388.77 Aligned_cols=262 Identities=27% Similarity=0.430 Sum_probs=216.5
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
-.++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.++++++||||+++++++.++..+|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999999999999999987643 33467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
||+++++|.+++.+.+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++. +||+|||+|..... ...
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~~ 160 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 160 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HTC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-Ccc
Confidence 999999999999988899999999999999999999997 59999999999999998887 99999999874432 223
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHH--------------------------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR-------------------------- 231 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~-------------------------- 231 (298)
....|++.|+|||++.+..++.+ +||||+||++|||++|..||...+......
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred ccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 35579999999999998888776 999999999999999999998765432111
Q ss_pred ------------HHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 232 ------------KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 232 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
+....+............++.++.+||.+||..||.+|||+ .++++|||++..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta--------~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL--------KQLMVHAFIKRSDA 306 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH--------HHHHTSHHHHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCH--------HHHhhCHhhCcCCc
Confidence 01111111111111222368899999999999999999988 56668999986543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-57 Score=388.14 Aligned_cols=256 Identities=35% Similarity=0.598 Sum_probs=204.1
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
++|++.+.||+|+||.||+|+++.+++.||+|++.... .....+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56999999999999999999999999999999987643 2235577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC-CCCCCEEEeecCccccccCCCCCCC
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~~~~~~~~~~~ 179 (298)
++|++|.+++...+.+++.++..++.|++.||+|||++|++||||||+||++.. +....+||+|||++...........
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 168 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 168 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence 999999999998889999999999999999999999999999999999999954 2223499999999976655555556
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCC--CCCCCCCHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRDL 257 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 257 (298)
..|++.|+|||++.+..++.+ +||||+||++|+|++|..||..... ......+....... +....+|+++.+|
T Consensus 169 ~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 169 ACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDEND----AKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ----CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred eeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 679999999999988877665 9999999999999999999987554 33445555554433 3445689999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
|.+||+.||.+|||+ .++++|||+++
T Consensus 244 i~~~L~~dP~~R~s~--------~eil~hp~~~~ 269 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTC--------EQALQHPWIAG 269 (307)
T ss_dssp HHHHSCSSGGGSCCH--------HHHHHSTTTTS
T ss_pred HHHHccCCHhHCcCH--------HHHhcCHhhCC
Confidence 999999999999987 56668999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.9e-57 Score=391.60 Aligned_cols=260 Identities=30% Similarity=0.530 Sum_probs=222.7
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
....++|++++.||+|+||.||+|+++.+|+.||+|++...... .+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34567999999999999999999999999999999998765433 45678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 98 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 98 ~~~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
|||++|++|.+.+. ..+.+++.++..++.||+.||+|||++|++||||||+||+++.+....+||+|||++........
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 99999999999985 45579999999999999999999999999999999999999765445699999999986655555
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--CCCCCHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQEC 254 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 254 (298)
.....|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+. .+....+.......+. ...+++++
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred cceecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCcccccCCCHHH
Confidence 556778999999999988888655 9999999999999999999987554 3444555555544332 34589999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.+||.+||+.||.+|||+ .++++|||+++
T Consensus 257 ~~li~~~L~~dP~~R~t~--------~eil~hp~~~~ 285 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTI--------HQALEHPWLTP 285 (350)
T ss_dssp HHHHHHHCCSSGGGSCCH--------HHHHHSTTTSC
T ss_pred HHHHHHHccCChhHCcCH--------HHHhcCcccCC
Confidence 999999999999999987 55668899874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=380.05 Aligned_cols=257 Identities=32% Similarity=0.574 Sum_probs=222.4
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ...+.+.+|+.++++++||||+++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999999999999999987532 2346789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCC--CCEEEeecCcccccc
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 172 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~--~~~~l~d~~~~~~~~ 172 (298)
|+||||+++++|.+++...+.+++..++.++.|++.||+|||+.|++||||||+||+++.++. ..+|++|||++....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999999999998889999999999999999999999999999999999999987663 249999999998666
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCCCC
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPI 250 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 250 (298)
.........+++.|+|||++.+..++.+ +||||+||++|+|++|..||.+.+. .+....+.......+ ....+
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHTTCCCCCHHHHTTS
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCH----HHHHHHHHhcCCCCCchhcCCC
Confidence 5555666778999999999988777665 9999999999999999999987554 334445555544333 23458
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
|+++.+||++||+.||.+|||+ .++++|||+++
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~--------~eil~hp~~~~ 276 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTI--------QDSLQHPWIKP 276 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCH--------HHHHHSTTTCC
T ss_pred CHHHHHHHHHHccCChhHCcCH--------HHHhcCcccCC
Confidence 9999999999999999999987 55668999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-57 Score=380.91 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=214.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC-CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
+.|++++.||+|+||.||+|+++.+++.||+|++... ....+.+.+|++++++++||||+++++++.+++.+++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4699999999999999999999999999999998764 344577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCCC
Q 022401 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (298)
Q Consensus 102 ~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~~ 179 (298)
++++|.+++.+ ...+++.++..++.|++.||+|||++|++||||||+||+++.++. +||+|||++...... .....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence 99999998765 457999999999999999999999999999999999999998887 999999998643222 22235
Q ss_pred CCCCCcccCcccccc-----ccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC-CCCCCCCCCCHH
Q 022401 180 TVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVPDTNPISQE 253 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 253 (298)
..|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...+..+.+ .++.... .....+..+|++
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVL----LKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH----HHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCCCCCccccCCHH
Confidence 678999999999853 234 44599999999999999999999887664433 3333333 234445568999
Q ss_pred HHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+.+||.+||+.||.+|||+ .++++|||++.
T Consensus 245 ~~~li~~~L~~dp~~R~t~--------~ell~hp~~~~ 274 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTT--------SQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCH--------HHHTTSGGGCC
T ss_pred HHHHHHHHccCChhHCcCH--------HHHhcCcccCC
Confidence 9999999999999999987 45568999873
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=372.49 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=210.4
Q ss_pred CCCCe-eEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CC
Q 022401 21 DSDRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PT 92 (298)
Q Consensus 21 ~~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 92 (298)
..++| ++.+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +.
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 34566 78889999999999999999999999999987543 233568899999999999999999999875 35
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--cEEecCCCCceEeeC-CCCCCEEEeecCccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSK 169 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~p~nilv~~-~~~~~~~l~d~~~~~ 169 (298)
.+++||||+++++|.+++.+...+++.+++.++.|++.||+|||+++ ++||||||+||++++ ++. +||+|||++.
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~ 163 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLAT 163 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGG
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcce
Confidence 68999999999999999998889999999999999999999999999 999999999999964 565 9999999986
Q ss_pred cccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
.... .......|++.|+|||++.+ .++. ++|||||||++|+|++|..||....... ...+.+.........+..
T Consensus 164 ~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~-~~DIwSlGvilyel~~g~~Pf~~~~~~~---~~~~~i~~~~~~~~~~~~ 237 (270)
T d1t4ha_ 164 LKRA-SFAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAA---QIYRRVTSGVKPASFDKV 237 (270)
T ss_dssp GCCT-TSBEESCSSCCCCCGGGGGT-CCCT-HHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHHHTTTCCCGGGGGC
T ss_pred eccC-CccCCcccCccccCHHHhCC-CCCC-cCchhhHHHHHHHHHHCCCCCCCcccHH---HHHHHHHcCCCCcccCcc
Confidence 4322 22345578999999998865 4655 4999999999999999999998755433 334444444333333445
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
.++++.+||.+||+.||++|||+ .++++|||++
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~--------~ell~Hp~fk 270 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSI--------KDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGC
T ss_pred CCHHHHHHHHHHccCCHhHCcCH--------HHHhCCcccC
Confidence 78999999999999999999987 5666889974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-56 Score=389.28 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=221.8
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.++|++++.||+|+||.||+|++..+|+.||+|++..... ....+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4679999999999999999999999999999999876543 335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCC
Q 022401 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (298)
Q Consensus 101 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~ 179 (298)
++|++|.+.+... .++++.+++.++.||+.||+|||++|++||||||+|||++......+||+|||++...........
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~ 187 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence 9999998877554 469999999999999999999999999999999999999854444599999999987665555566
Q ss_pred CCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCC--CCCCCCHHHHHH
Q 022401 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDL 257 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 257 (298)
..+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+. ......+.......+ ....+++++.+|
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 188 TTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred ccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 778999999999988888666 9999999999999999999987654 334445555554433 345689999999
Q ss_pred HHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
|++||+.||.+|||+ .++++|||+++..
T Consensus 263 i~~~L~~dp~~R~s~--------~eil~Hp~~~~~~ 290 (352)
T d1koba_ 263 IKNLLQKEPRKRLTV--------HDALEHPWLKGDH 290 (352)
T ss_dssp HHTTSCSSGGGSCCH--------HHHHTSTTTSSCC
T ss_pred HHHHccCChhHCcCH--------HHHhcCHhhCCCc
Confidence 999999999999987 5566899987543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=375.40 Aligned_cols=252 Identities=29% Similarity=0.468 Sum_probs=202.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCeEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 96 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 96 (298)
.++|++++.||+|+||.||+|+++.+|+.||+|.+...... .+.+.+|+.++++++||||+++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36899999999999999999999999999999998765332 3457899999999999999999999865 457899
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC-----cEEecCCCCceEeeCCCCCCEEEeecCc
Q 022401 97 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGY 167 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~-----i~H~dl~p~nilv~~~~~~~~~l~d~~~ 167 (298)
||||+++++|.+++.. ...+++..++.++.|++.||+|||+.| ++||||||+||+++.++. +||+|||+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~ 160 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL 160 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccc
Confidence 9999999999998853 467999999999999999999999976 999999999999998887 99999999
Q ss_pred cccccCCC-CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 168 SKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 168 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
+....... ......+++.|+|||++.+..++.+ +|||||||++|+|++|..||...+. .+....+..+... +.
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~----~~~~~~i~~~~~~-~~ 234 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKFR-RI 234 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHTCCC-CC
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCH----HHHHHHHHcCCCC-CC
Confidence 87544332 2345678999999999988777655 9999999999999999999987554 3344455555443 23
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhh
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWM 289 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~ 289 (298)
+..+|+++.+||++||+.||.+|||+ .++++|||+
T Consensus 235 ~~~~s~~l~~li~~~L~~dp~~Rps~--------~ell~hp~i 269 (269)
T d2java1 235 PYRYSDELNEIITRMLNLKDYHRPSV--------EEILENPLI 269 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCH--------HHHHTSTTC
T ss_pred CcccCHHHHHHHHHHcCCChhHCcCH--------HHHHhCCcC
Confidence 44589999999999999999999987 566689985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-56 Score=380.60 Aligned_cols=260 Identities=31% Similarity=0.529 Sum_probs=225.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
..++|++++.||+|+||.||+|+++.+|+.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 457899999999999999999999999999999998753 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-C
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 175 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~ 175 (298)
||||+++++|..++.....+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++...... .
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCc
Confidence 9999999999999999999999999999999999999999999999999999999999887 999999999754433 3
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
......|++.|+|||++.+..++.+ +||||+||++|+|++|..||...+. .+..+.+.......+ ..+++++.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~----~~~~~~i~~~~~~~p--~~~s~~~~ 233 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFP--RTLSPEAK 233 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCH----HHHHHHHhcCCCCCC--ccCCHHHH
Confidence 3345668999999999999888766 9999999999999999999988654 344555666665554 44899999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+||.+||+.||.+|++.... ...++++|||+.+.
T Consensus 234 dli~~~L~~dP~~R~~~~~~---~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 234 SLLAGLLKKDPKQRLGGGPS---DAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTT---THHHHHTSGGGTTC
T ss_pred HHHHhhccCCchhhcccccc---cHHHHHcCcccccC
Confidence 99999999999999974221 13678899998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=384.68 Aligned_cols=258 Identities=24% Similarity=0.437 Sum_probs=224.5
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (298)
-++|++++.||+|+||.||+|.++.+++.||+|++.........+.+|+.++++++||||+++++++.+++.+|+||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 36899999999999999999999999999999999887766677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCCC
Q 022401 102 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (298)
Q Consensus 102 ~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 180 (298)
+|++|.+.+...+ ++++.+++.++.||+.||+|||+.|++||||||+||+++.++...++|+|||++............
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~ 163 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence 9999999997665 799999999999999999999999999999999999998777667999999998765554445556
Q ss_pred CCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCC--CCCCCHHHHHHH
Q 022401 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLI 258 (298)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 258 (298)
.+++.|+|||...+..++.+ +||||+||++|+|++|..||...+. ......+.......+. ...+++++.+||
T Consensus 164 ~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 78999999999988877665 9999999999999999999988654 3445555555554432 235799999999
Q ss_pred HHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 259 SRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 259 ~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+||..||.+|||+ .++++|||++..
T Consensus 239 ~~~L~~dp~~R~s~--------~eil~hp~~~~~ 264 (321)
T d1tkia_ 239 DRLLVKERKSRMTA--------SEALQHPWLKQK 264 (321)
T ss_dssp HTTSCSSGGGSCCH--------HHHHHSHHHHSC
T ss_pred HHHccCChhHCcCH--------HHHhcCHhhccC
Confidence 99999999999987 555688998743
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.8e-56 Score=378.03 Aligned_cols=258 Identities=30% Similarity=0.515 Sum_probs=223.5
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
+.++|++++.||+|+||.||+|+++.+|+.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 346899999999999999999999999999999998753 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
||||+.|++|...+.....+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++..... .
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--~ 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--V 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--C
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--c
Confidence 9999999999999999999999999999999999999999999999999999999998887 99999999875433 2
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+. .+...++.......+ ..+++++.+
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~s~~~~~ 230 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNAELRFP--PFFNEDVKD 230 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHCCCCCC--TTSCHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCH----HHHHHHHHcCCCCCC--CCCCHHHHH
Confidence 345679999999999988888765 9999999999999999999987554 444555666655444 448999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
++.+||+.||.+|++. .+-+..++++|||+.+.
T Consensus 231 li~~~L~~dp~~R~~~---~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 231 LLSRLITRDLSQRLGN---LQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHHTCSCTTTCTTS---STTTTHHHHTSGGGSSC
T ss_pred HHHHHhhhCHHhcccc---chhhHHHHHcCcccccC
Confidence 9999999999999742 11234777899999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-56 Score=377.76 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=213.0
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc----hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
.|++++.||+|+||.||+|++..+++.||||++...... .+.+.+|+.++++++||||+++++++.+++.+|+|+|
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 599999999999999999999999999999998765432 2457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCCCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~~~ 179 (298)
|+.+++|...+....++++.+++.++.||+.||.|||++|++||||||+||+++.++. +||+|||++..... ...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~~ 170 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANS 170 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CCc
Confidence 9999999888888888999999999999999999999999999999999999998887 99999999874432 345
Q ss_pred CCCCCcccCccccccc---cCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 180 TVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 180 ~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
..|++.|+|||++.+. .++. ++|||||||++|+|++|..||...+.. ....++............+|+++.+
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~-~~DiwSlGvilyel~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred cccCccccCHHHHhccCCCCcCc-hhhhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 5799999999998643 3444 499999999999999999999876543 3344444444444445568999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
||.+||+.||.+|||+.+ +++|||+.
T Consensus 246 li~~~L~~dP~~Rpt~~e--------ll~Hp~~~ 271 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEV--------LLKHRFVL 271 (309)
T ss_dssp HHHHHTCSSGGGSCCHHH--------HTTCHHHH
T ss_pred HHHHHCcCChhHCcCHHH--------HHhCHHhc
Confidence 999999999999998855 45777775
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-55 Score=370.12 Aligned_cols=254 Identities=30% Similarity=0.466 Sum_probs=218.0
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----------chHHHHHHHHHHhcCC-CCCeeeeeEEEEeC
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----------IDENVQREIINHRSLR-HPNIVRFKEVILTP 91 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----------~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 91 (298)
++|++.+.||+|+||.||+|++..+++.||+|++.+... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 689999999999999999999999999999999876432 1235778999999997 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
+.+|+||||+++++|.+++...+++++.+++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++...
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEc
Confidence 999999999999999999998899999999999999999999999999999999999999998887 999999999866
Q ss_pred cCCCCCCCCCCCCcccCcccccccc-----CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--C
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--V 244 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 244 (298)
..........|++.|+|||.+.+.. ..+.++||||+||++|+|++|..||...+. ......+...... .
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLMLRMIMSGNYQFGS 236 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----HHHHHHHHhCCCCCCC
Confidence 6555556667899999999986432 224459999999999999999999987654 3334445555443 3
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 245 PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 245 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
+...++|+++.+||.+||+.||.+|||+ .++++|||+.
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~--------~eil~h~~~~ 274 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTA--------EEALAHPFFQ 274 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCH--------HHHTTSGGGC
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCH--------HHHHcCHHHH
Confidence 3344689999999999999999999987 5566888885
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-55 Score=378.56 Aligned_cols=258 Identities=28% Similarity=0.484 Sum_probs=221.9
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
..++|++++.||+|+||.||+|+++.+|+.||+|++.+. ....+.+.+|+.++++++||||+++++++.+...+++
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 357999999999999999999999999999999998743 3344678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~ 176 (298)
|++++.+++|...+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||++..... .
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~--~ 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--R 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--C
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeeccc--c
Confidence 9999999999999998889999999999999999999999999999999999999998887 99999999975432 2
Q ss_pred CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
.....|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+. .....++.......+ ..+++++.+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~~~~~~~p--~~~s~~~~~ 267 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFP--SHFSSDLKD 267 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCC--TTCCHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCH----HHHHHHHhcCCCCCC--ccCCHHHHH
Confidence 345678999999999988888665 9999999999999999999987543 445555666655444 458999999
Q ss_pred HHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 257 LISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
||++||+.||.+|+.. ++....++++|||+.+.
T Consensus 268 li~~~L~~dP~kR~~~---~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 268 LLRNLLQVDLTKRFGN---LKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHSCSCTTTCTTS---STTTTHHHHTSGGGTTC
T ss_pred HHHHHhhhCHHhcccc---ccccHHHHHcCccccCC
Confidence 9999999999999521 11133677789999765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.8e-55 Score=378.90 Aligned_cols=263 Identities=25% Similarity=0.337 Sum_probs=218.2
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC----cchHHH---HHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENV---QREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
+.++|++++.||+|+||.||+|++..+|+.||+|++.+.. .....+ .+++.+++.++||||+++++++.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 4679999999999999999999999999999999986432 112223 345777888899999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+||||+++++|.+++.....+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC
Confidence 9999999999999999999899999999999999999999999999999999999999998887 99999999875443
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
. ......|++.|+|||++......+.++|||||||++|+|++|..||......+ ............. ..+..++++
T Consensus 160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~~--~~~~~~s~~ 235 (364)
T d1omwa3 160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAV--ELPDSFSPE 235 (364)
T ss_dssp S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHHHHHHSSSCCC--CCCSSSCHH
T ss_pred C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCCC--CCCCCCCHH
Confidence 2 33456799999999998765544555999999999999999999998765433 2333434333333 334458999
Q ss_pred HHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+.+||.+||+.||.+|||..+. ...++++|||+.+.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~~~---~a~eil~Hp~f~~i 271 (364)
T d1omwa3 236 LRSLLEGLLQRDVNRRLGCLGR---GAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHHHTCSSTTTSTTTSSS---THHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHHhCCCccc---CHHHHHcCccccCC
Confidence 9999999999999999985332 24788899999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=369.72 Aligned_cols=254 Identities=31% Similarity=0.489 Sum_probs=215.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC----CcchHHHHHHHHHH-hcCCCCCeeeeeEEEEeCCeEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
.++|++++.||+|+||+||+|+++.+++.||+|++.++ ....+.+..|..++ +.++||||+++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 36899999999999999999999999999999999753 22334555666655 46899999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-
Q 022401 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~- 175 (298)
||||+++++|.+++.....+++.+++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++.......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhcccccc
Confidence 9999999999999999999999999999999999999999999999999999999998887 9999999987544332
Q ss_pred CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHH
Q 022401 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255 (298)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (298)
......|++.|+|||++.+..++.+ +||||+||++|+|++|..||.+.+. .....++....+..+ ..+|+++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~~p--~~~s~~~~ 231 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNPFYP--RWLEKEAK 231 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCC--ccCCHHHH
Confidence 3344568999999999998888765 9999999999999999999987554 344455555555444 44899999
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+||.+||+.||.+|||+.+ ++++|||+.+
T Consensus 232 dli~~~L~~dP~~R~s~~~-------~l~~hpff~~ 260 (320)
T d1xjda_ 232 DLLVKLFVREPEKRLGVRG-------DIRQHPLFRE 260 (320)
T ss_dssp HHHHHHSCSSGGGSBTTBS-------CGGGSGGGTT
T ss_pred HHHHHhcccCCCCCcCHHH-------HHHhCchhcc
Confidence 9999999999999999852 2357888865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-55 Score=368.19 Aligned_cols=253 Identities=20% Similarity=0.273 Sum_probs=216.9
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
+.++.++|++.+.||+|+||.||+|+++.+++.||||++..+....+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 45566899999999999999999999999999999999988777778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC
Q 022401 98 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~ 175 (298)
|||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++. +||+|||+++......
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDT 169 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCC
Confidence 9999999999998654 46899999999999999999999999999999999999998887 9999999987543322
Q ss_pred CC--CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 176 QP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 176 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
.. ....+++.|+|||.+.+..++.+ +||||||+++|||++|..||.......... +........+.+..+|++
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~----~~i~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY----ELLEKDYRMERPEGCPEK 244 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----HHHHTTCCCCCCTTCCHH
T ss_pred ceeeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHH----HHHhcCCCCCCCccchHH
Confidence 21 22346788999999988887655 999999999999999887766555433332 233334455556678999
Q ss_pred HHHHHHHhhhhCCCCcccccccch
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+.+|+.+||+.||.+|||+.++++
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999998875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-55 Score=375.14 Aligned_cols=261 Identities=31% Similarity=0.488 Sum_probs=213.7
Q ss_pred CCCCCCeeEEe-eeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhc-CCCCCeeeeeEEEEe----CC
Q 022401 19 MHDSDRYDFVR-DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILT----PT 92 (298)
Q Consensus 19 ~~~~~~y~~~~-~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~ 92 (298)
....++|++++ .||+|+||.||+|++..+++.||||++.. ...+.+|+.++.+ .+||||+++++++.+ +.
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 34457899875 59999999999999999999999999864 3567789988654 589999999999875 46
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCccc
Q 022401 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 169 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~ 169 (298)
.+|+||||++|++|.+++... ..+++.+++.++.||+.||+|||++|++||||||+||+++.++ ...+||+|||++.
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 789999999999999999764 3699999999999999999999999999999999999997633 3459999999998
Q ss_pred cccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCC--
Q 022401 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT-- 247 (298)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 247 (298)
............|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+...........+.......+..
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred eccCCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence 6666666667789999999999988888665 9999999999999999999987665554444444555455444432
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..+|+++.+||.+||+.||.+|||+ .++++|||+...
T Consensus 242 ~~~s~~~~~li~~~L~~dP~~R~s~--------~eil~hp~~~~~ 278 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPTQRMTI--------TEFMNHPWIMQS 278 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTTTSCCH--------HHHHHSHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCH--------HHHHcCHHhhCC
Confidence 2478999999999999999999987 556688888643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=362.91 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=213.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++++.||+|+||.||+|++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.++..+|+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999999999999999986543 235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCC
Q 022401 100 YASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (298)
Q Consensus 100 ~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~ 177 (298)
++.++.+..... ....+++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||++...... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccc
Confidence 997654443333 3456999999999999999999999999999999999999998887 999999998754332 333
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--------------
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-------------- 243 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------- 243 (298)
....+++.|+|||.+....+.+.++||||+|+++|+|++|..||...+..+.+.............
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 455789999999998888877777999999999999999999998876555444443332211100
Q ss_pred CCC---------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 244 VPD---------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 244 ~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.+. ...+++++.+||++||+.||.+|||+ .++++|||+++..+
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~--------~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA--------KAALAHPFFQDVTK 291 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH--------HHHHTSGGGTTCCC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH--------HHHhCCHhhccCCC
Confidence 000 11467899999999999999999987 56668999987543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=357.07 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=203.0
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+.++|++++.||+|+||.||+|++. +++.||||++..+....+.+.+|+.++++++||||+++++++.+++.+++|+||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 4568999999999999999999986 567899999988777778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCC--C
Q 022401 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 177 (298)
Q Consensus 101 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~--~ 177 (298)
+++++|.+++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++. +||+|||+++....... .
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC-------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceee
Confidence 9999999988654 56889999999999999999999999999999999999998887 99999999874433322 2
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 257 (298)
....+++.|+|||.+.+..++.+ +||||||+++|||+|+..|+....... +....+.. ......+..+++++.++
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~~-~~~~~~p~~~~~~l~~l 234 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIST-GFRLYKPRLASTHVYQI 234 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHHH-TCCCCCCTTSCHHHHHH
T ss_pred cceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHHh-cCCCCCccccCHHHHHH
Confidence 33457899999999988888665 999999999999999654443333322 22333333 23334455689999999
Q ss_pred HHHhhhhCCCCcccccccchhh
Q 022401 258 ISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 258 i~~~l~~dp~~Rps~~~~l~~~ 279 (298)
+.+||+.||.+|||+.+++++.
T Consensus 235 i~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 235 MNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHHH
Confidence 9999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-54 Score=360.27 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=203.7
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (298)
+..++|++++.||+|+||.||+|+.+ ..||||++... ....+.+.+|+.++++++||||+++++++. +..+++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 45688999999999999999999764 24999998653 334467889999999999999999999875 456899
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-
Q 022401 97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~- 174 (298)
|+||+++++|.+++... .++++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||++......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC-----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccC
Confidence 99999999999999654 56999999999999999999999999999999999999998887 999999998644332
Q ss_pred --CCCCCCCCCCcccCcccccccc--CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 175 --SQPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 175 --~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
.......+++.|+|||++.+.. ..+.++|||||||++|||+||..||..............+.............+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 2223456899999999986532 224459999999999999999999988766554444433322111112234558
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
|+++.+|+.+||+.||.+|||+.+++.+.
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 99999999999999999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-54 Score=364.68 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=209.2
Q ss_pred eEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 26 ~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
+.+++||+|+||+||+|+++.+|+.||+|++..... ....+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 357899999999999999999999999999865422 23468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-CCCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~-~~~~ 178 (298)
|+.++++......+..+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||++...... ....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCccccc
Confidence 9998888777776778999999999999999999999999999999999999998887 999999998754433 2334
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC-C-------------
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-V------------- 244 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~------------- 244 (298)
...+++.|+|||.+......+.++||||+||++|+|++|..||...+..+.+....+........ +
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 45689999999998776655556999999999999999999998877655544444332211100 0
Q ss_pred --CC------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 245 --PD------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 245 --~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
+. ...+++++.+||.+||+.||++|||+ .++++|||+++.
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa--------~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA--------TQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH--------HHHHTSGGGTSS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH--------HHHhCCHhhCCC
Confidence 00 12467899999999999999999988 555689999854
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=361.04 Aligned_cols=248 Identities=30% Similarity=0.475 Sum_probs=209.4
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc-------chHHHHHHHHHHhcCC--CCCeeeeeEEEEeCC
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTPT 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 92 (298)
.++|++.+.||+|+||.||+|++..+|+.||+|++.+... ...++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 5789999999999999999999999999999999875321 1233568999999886 899999999999999
Q ss_pred eEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~-~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
.+++|+|++.+ +++.+.+.....+++.+++.++.|++.||+|||++|++||||||+||+++.+.. .+||+|||++...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~-~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEEC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC-eEEECccccceec
Confidence 99999999975 678888888889999999999999999999999999999999999999986532 3999999998643
Q ss_pred cCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCC
Q 022401 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251 (298)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
.. .......|++.|+|||++.+..+.++++||||+||++|+|++|..||...+ .+....... +..+|
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~--~~~~s 228 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFF--RQRVS 228 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCC--SSCCC
T ss_pred cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcccCC--CCCCC
Confidence 32 223455689999999999888877666899999999999999999997521 233333333 34589
Q ss_pred HHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 252 QECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 252 ~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
+++.+||++||+.||.+|||+ .++++|||+++
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~--------~eil~hp~~~~ 260 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTF--------EEIQNHPWMQD 260 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCH--------HHHHTSGGGSS
T ss_pred HHHHHHHHHHccCCHhHCcCH--------HHHhcCHhhCC
Confidence 999999999999999999987 55668999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=354.14 Aligned_cols=249 Identities=22% Similarity=0.384 Sum_probs=214.9
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEec
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+.++|++++.||+|+||.||+++++ +++.||||++..+....+.+.+|+.++++++||||+++++++.+++.+++|+||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 3468999999999999999999986 677899999998888888999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--CC
Q 022401 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 177 (298)
Q Consensus 101 ~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~--~~ 177 (298)
+++++|..++.. ...+++..++.++.|+++||+|||+.|++||||||+||+++.++. +||+|||+++...... ..
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceee
Confidence 999999888654 457899999999999999999999999999999999999998887 9999999986443322 22
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHHHH
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (298)
....+++.|+|||.+.+..++.+ +||||||+++|||+| |..||...+.. +....+.. ....+.+...++++.+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~----~~~~~i~~-~~~~~~p~~~~~~l~~ 232 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEHIAQ-GLRLYRPHLASEKVYT 232 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHHHHT-TCCCCCCTTCCHHHHH
T ss_pred cccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHH----HHHHHHHh-CCCCCCcccccHHHHH
Confidence 33557889999999988888665 999999999999998 78999876643 33344443 3345556678999999
Q ss_pred HHHHhhhhCCCCcccccccchh
Q 022401 257 LISRIFVADPAAVSIFFFPLNM 278 (298)
Q Consensus 257 li~~~l~~dp~~Rps~~~~l~~ 278 (298)
|+++||+.||.+|||+.+++++
T Consensus 233 li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 233 IMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999988875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-53 Score=360.55 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=205.0
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCc---EEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (298)
..+.++|++.+.||+|+||.||+|+++.+++ .+|+|.+.... ...+.+.+|+.++++++||||+++++++.+++.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 4556789999999999999999999876554 58888876543 234568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
+++||||+++++|.+++... +.+++.++..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLE 179 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEcc
Confidence 99999999999999988764 56999999999999999999999999999999999999998887 9999999987443
Q ss_pred CCCCC------CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCC
Q 022401 173 LHSQP------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP 245 (298)
Q Consensus 173 ~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
..... ....+++.|+|||.+.+..++.+ +|||||||++|||+| |..||...... +....+.. ....+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~----~~~~~i~~-~~~~~ 253 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQ----DVINAIEQ-DYRLP 253 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHT-TCCCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHH----HHHHHHHc-CCCCC
Confidence 32211 12346789999999988777665 999999999999998 89999876542 23333332 34445
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhh
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFV 287 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp 287 (298)
.+..+|+++.+++.+||+.||.+|||+.+++++. ..++++|
T Consensus 254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L-~~~l~~p 294 (299)
T d1jpaa_ 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL-DKMIRNP 294 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH-HHHHHSG
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH-HHHhcCh
Confidence 5666899999999999999999999999998743 3445555
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=354.43 Aligned_cols=259 Identities=22% Similarity=0.277 Sum_probs=209.8
Q ss_pred CeeEE-eeeccCCeEEEEEEEEc--cCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 24 RYDFV-RDIGSGNFGVARLMRDK--VTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 24 ~y~~~-~~lg~g~~~~vy~~~~~--~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
.+.+. +.||+|+||.||+|.++ .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEE
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEE
Confidence 34444 46999999999999864 345789999986532 234678899999999999999999999865 467899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 175 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-- 175 (298)
|||+++++|.+++....++++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENY 163 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSE
T ss_pred EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccc
Confidence 999999999999999999999999999999999999999999999999999999998887 9999999987443222
Q ss_pred --CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 176 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
......+++.|+|||.+.+..++.+ +||||||+++|||++ |..||...+.. +....+.. ....+.+..+|+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~~~i~~-~~~~~~p~~~~~ 237 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAMLEK-GERMGCPAGCPR 237 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHHT-TCCCCCCTTCCH
T ss_pred cccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHH----HHHHHHHc-CCCCCCCcccCH
Confidence 2233457889999999988877665 999999999999998 89999876542 22333333 234445566899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
++.+|+.+||+.||.+|||+.+++ ..++|+|.+-..++.
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~~i~-----~~L~~~~~~~~~e~~ 276 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFAAVE-----LRLRNYYYDVVNEGH 276 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHH-----HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHH-----HHhhCHHhhcCCCCC
Confidence 999999999999999999998775 357888887666654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-52 Score=354.96 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=211.2
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++++.||+|+||.||+|+++ +|+.||+|++.... .....+.+|+.++++++||||+++++++.+++..+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 69999999999999999999986 77899999987643 234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~ 178 (298)
++.++.+.........+++..+..++.||+.||+|||+.||+||||||+||+++.++. +|++|||.+....... ...
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccc
Confidence 9988777777777888999999999999999999999999999999999999998887 9999999987543332 233
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC---------------
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--------------- 243 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------- 243 (298)
...+++.|+|||.+.+..+.+.++||||+|+++|+|++|..||...+..+.+.............
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 44588899999999877776667999999999999999999998876554444433322111000
Q ss_pred --------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 244 --------VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 244 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
......+++++.+||++||+.||++|||+ .++++|||+++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~--------~ell~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA--------KQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH--------HHHHTSGGGGC
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH--------HHHhcCcccCc
Confidence 01123468899999999999999999987 56668999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=353.58 Aligned_cols=251 Identities=21% Similarity=0.298 Sum_probs=207.4
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (298)
+.+..++|++++.||+|+||.||+|.++ +++.||||++.......+.+.+|+.++++++||||+++++++.+ +.+++|
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 3445579999999999999999999986 56789999998877777889999999999999999999998754 567899
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC-
Q 022401 98 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~- 174 (298)
|||+++++|.+.+... .++++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||+++.....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNE 163 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCc
Confidence 9999999998876433 36899999999999999999999999999999999999998887 999999999754332
Q ss_pred -CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 175 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 175 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
.......+++.|+|||.+.+..++.+ +||||||+++|||+||..|+....... +....+.. ....+.+..+|++
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~i~~-~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLER-GYRMVRPDNCPEE 238 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHT-TCCCCCCTTCCHH
T ss_pred cccccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh-cCCCCCcccChHH
Confidence 22234567889999999988877655 999999999999999766554443322 23333333 3344455668999
Q ss_pred HHHHHHHhhhhCCCCcccccccch
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+.+|+.+||+.||.+|||+.++++
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999977764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-53 Score=362.96 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=211.5
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCc-----EEEEEEeecC--CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 91 (298)
+..++|++++.||+|+||.||+|++..+++ .||+|.+... ......+.+|+.++.++ +||||+++++++.++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 455799999999999999999999875443 6899987543 34456788999999988 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCC
Q 022401 92 THLAIVMEYASGGELFERICNA-----------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~-----------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~ 148 (298)
+.+++||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 9999999999999999999654 24789999999999999999999999999999999
Q ss_pred ceEeeCCCCCCEEEeecCccccccCCCCC---CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 022401 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDP 224 (298)
Q Consensus 149 nilv~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~ 224 (298)
||+++.++. +||+|||+++........ ....+++.|+|||.+.+..++.+ +|||||||++|||++ |..||...
T Consensus 194 Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCC
Confidence 999998887 999999999754433322 23446889999999988887665 999999999999997 89999887
Q ss_pred CCchhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 225 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
+....+.+ +.......+.+..+|+++.+||.+||+.||.+|||+.+++++.-
T Consensus 271 ~~~~~~~~----~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDANFYK----LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHHHHH----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHH----HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 66444433 33444555566678999999999999999999999999997653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=352.11 Aligned_cols=257 Identities=25% Similarity=0.330 Sum_probs=211.2
Q ss_pred CCCCCeeEEee-eccCCeEEEEEEEEcc--CCcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVRD-IGSGNFGVARLMRDKV--TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~~-lg~g~~~~vy~~~~~~--~~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
+..++|.+.+. ||+|+||.||+|.++. ++..||||++.... ...+.+.+|+.++++++||||+++++++.+ +.+
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 44578999995 9999999999998753 45579999987543 334678899999999999999999999865 468
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++||||+++++|.+++.. ...+++.++..++.|++.||+|||++|++||||||+||+++.++. +||+|||+++....
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGA 161 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhcccc
Confidence 899999999999998754 457999999999999999999999999999999999999998887 99999999874433
Q ss_pred C----CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 174 H----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 174 ~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
. .......+++.|+|||.+.+..++.+ +|||||||++|||+| |..||......+ ....+.. ..+.+.+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~----~~~~i~~-~~~~~~p~ 235 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAFIEQ-GKRMECPP 235 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHHHHHT-TCCCCCCT
T ss_pred cccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHH----HHHHHHc-CCCCCCCC
Confidence 2 22234457889999999988877666 999999999999998 899998866532 2233333 23344556
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
.+|+++.+|+.+||+.||++|||+.+++ +.++|+|..
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~-----~~L~~~~~~ 272 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVE-----QRMRACYYS 272 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHH-----HHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHH-----HHHHHHHHH
Confidence 6899999999999999999999998776 456788875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-52 Score=353.63 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=202.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----e
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPT----H 93 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 93 (298)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ....+.+|+.++++++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4789999999999999999999999999999999875432 2346889999999999999999999987643 4
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
+|+||||++|++|...+...+++++.+++.++.|++.||+|||++|++||||||+||+++.++. .+++|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcc
Confidence 8999999999999999988889999999999999999999999999999999999999998887 99999998753322
Q ss_pred CC----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCC--CCCC
Q 022401 174 HS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDT 247 (298)
Q Consensus 174 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~ 247 (298)
.. ......|++.|+|||++.+..++.+ +||||+|+++|+|++|..||...+..+ ...++...... ....
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVS----VAYQHVREDPIPPSARH 238 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHCCCCCGGGTS
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHH----HHHHHHhcCCCCCchhc
Confidence 22 2334468999999999988777665 999999999999999999998755432 23333333322 2234
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
..+|+++.+||.+||+.||.+||+..+.+.+.+
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 568999999999999999999995544443333
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=357.03 Aligned_cols=265 Identities=26% Similarity=0.340 Sum_probs=211.6
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccC-CcEEEEEEeecCC---cchHHHHHHHHHHhcC---CCCCeeeeeEEEEe-
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT- 90 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~-~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~- 90 (298)
+-..++|++++.||+|+||.||+|++..+ ++.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 34468999999999999999999999655 6779999986532 2233456777776655 79999999999853
Q ss_pred ----CCeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 91 ----PTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 91 ----~~~~~lv~~~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
...+++++|+++++++..... ....+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~df 160 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADF 160 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSC
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecch
Confidence 347899999998876654443 3456899999999999999999999999999999999999998887 999999
Q ss_pred CccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC---
Q 022401 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--- 242 (298)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 242 (298)
|++.............|++.|+|||++.+..++.+ +||||+||++|+|++|..||...+..+.+............
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 99876665566667789999999999988888766 99999999999999999999887665554444333211100
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 243 ------------------SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 243 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
.......+++++.+||++||+.||.+|||+ .++++|||+++..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa--------~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA--------YSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH--------HHHHTSGGGTTCCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH--------HHHhcChhhcCchh
Confidence 001123478999999999999999999987 56679999987643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=358.05 Aligned_cols=266 Identities=26% Similarity=0.353 Sum_probs=212.0
Q ss_pred CCCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe-----
Q 022401 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----- 90 (298)
Q Consensus 16 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 90 (298)
.|...+.-+|+.+++||+|+||+||+|++..+|+.||||++..+... ..+|+.++++++||||+++++++..
T Consensus 13 ~p~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 13 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp SSCCCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred CCCCcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence 34445555899999999999999999999999999999999765433 3479999999999999999999854
Q ss_pred -CCeEEEEEeccCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecC
Q 022401 91 -PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (298)
Q Consensus 91 -~~~~~lv~~~~~~~sL~~~l---~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~ 166 (298)
..++++||||++++++..+. .....+++.+++.++.||+.||+|||++||+||||||+||+++.++. .+||+|||
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG 168 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFG 168 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCT
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEeccc
Confidence 23589999999876443332 35567999999999999999999999999999999999999987763 39999999
Q ss_pred ccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc------
Q 022401 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------ 240 (298)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 240 (298)
++.............+++.|+|||.+.+......++||||+||++|+|++|..||...+..+.+....+.....
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 99866666666667899999999998776555556999999999999999999998876655444433221100
Q ss_pred -------CCCC----------CCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhh
Q 022401 241 -------QYSV----------PDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDAT 293 (298)
Q Consensus 241 -------~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~ 293 (298)
.... ......++++.+||.+||+.||.+|||+ .++++|||+++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta--------~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP--------LEACAHSFFDELR 310 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH--------HHHhcCHhhcccc
Confidence 0001 1123468999999999999999999988 4566888887653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=347.82 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=210.2
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEE
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (298)
.++.++|++.+.||+|+||.||+|+++.+ +.||||++.......+.+.+|+.++++++||||+++++++. ++.+++|+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 34568999999999999999999998744 57999999887777788999999999999999999999985 45678999
Q ss_pred eccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-
Q 022401 99 EYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~- 175 (298)
||+++|+|..++.. ...+++.+++.++.||+.||+|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCc
Confidence 99999999888743 456899999999999999999999999999999999999998887 9999999987543222
Q ss_pred -CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHHH
Q 022401 176 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254 (298)
Q Consensus 176 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (298)
......+++.|+|||.+....++.+ +||||||+++|||++|..|+......... ...+.. ....+.+..+|+++
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~---~~~i~~-~~~~~~~~~~~~~l 243 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVER-GYRMPCPPECPESL 243 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHT-TCCCCCCTTSCHHH
T ss_pred eeeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHH---HHHHHh-cCCCCCCcccCHHH
Confidence 2233557899999999988888665 99999999999999977666554443333 222222 23444566689999
Q ss_pred HHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhc
Q 022401 255 RDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENY 296 (298)
Q Consensus 255 ~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~ 296 (298)
.+++.+||+.||++|||+.+++. ..++|+++...+|
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~------~L~~~~~~~~p~~ 279 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQA------FLEDYFTSTEPQY 279 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH------HHHTTTSCSCCCC
T ss_pred HHHHHHHcccCHhHCcCHHHHHH------HHhhhhcCCCCCC
Confidence 99999999999999999977653 3356666544443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-51 Score=345.49 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=215.8
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEEEEEe
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (298)
++|++++.||+|+||+||+|++..+++.||||++.... ....++.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999999999999999986543 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC-CCC
Q 022401 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (298)
Q Consensus 100 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-~~~ 178 (298)
++.++++..++.....+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||.+....... ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence 9999999998888889999999999999999999999999999999999999998887 9999999997554433 333
Q ss_pred CCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC----------------
Q 022401 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY---------------- 242 (298)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------- 242 (298)
...+++.|.|||.+....+.+.++||||+||++|+|++|..||-...+.......+........
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 4456778999998877776566699999999999999999997665554443333333322110
Q ss_pred --------CCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 243 --------SVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 243 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
.......+++++.+||++||+.||.+|||+ .++++|||+++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa--------~e~L~Hp~f~~ 288 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA--------EEALQHPYFSD 288 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH--------HHHTTSGGGSS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH--------HHHhcChhhcC
Confidence 011122467899999999999999999988 56668999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-51 Score=354.06 Aligned_cols=260 Identities=22% Similarity=0.400 Sum_probs=214.0
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-CCCeeeeeEEEEeC--CeEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIV 97 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv 97 (298)
..++|++++.||+|+||+||+|++..+|+.||+|++... ..+++.+|+.++++++ ||||+++++++... ..+++|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 457899999999999999999999999999999998754 3467889999999995 99999999999743 579999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCCCC
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~~~ 177 (298)
|||+.+++|... ...+++..++.++.||+.||+|||++||+||||||+||+++.++. .++|+|||++.........
T Consensus 111 ~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence 999999998765 346899999999999999999999999999999999999986653 4899999999866665666
Q ss_pred CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc------------C----
Q 022401 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------Q---- 241 (298)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------~---- 241 (298)
....+++.|+|||.+.+....+.++||||+||+++++++|..||............+.+.... .
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 677789999999998877655566999999999999999999998876544333333222210 0
Q ss_pred ----------------CCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhh
Q 022401 242 ----------------YSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATE 294 (298)
Q Consensus 242 ----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~ 294 (298)
........+++++.+||++||+.||.+|||+ .++++|||+++..|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta--------~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA--------REAMEHPYFYTVVK 327 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGTTSCC
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH--------HHHhcCcccCCCCC
Confidence 0011112368899999999999999999988 56668999998655
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=345.83 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=201.6
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCC----cEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
..++|++.++||+|+||.||+|.++.++ ..||||++..... ....+.+|+.++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 3467999999999999999999987544 4699999865432 334688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++|+|++.++++.+.+... ..+++.++..++.|++.|++|||+++++||||||+||+++.++. +||+|||+++....
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLED 162 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccC
Confidence 9999999999998877654 57999999999999999999999999999999999999998887 99999999875433
Q ss_pred CCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCC
Q 022401 174 HSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249 (298)
Q Consensus 174 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
... .....+++.|+|||.+.+..++.+ +||||||+++|||++|..|+........ ....+ ....+.+.+..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~---~~~~i-~~~~~~~~~~~ 237 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAI-NDGFRLPTPMD 237 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH-HTTCCCCCCTT
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHH---HHHHH-hccCCCCCchh
Confidence 221 123357889999999988877665 9999999999999997666554443332 22333 23344555667
Q ss_pred CCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 250 ISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 250 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
+|+++.+++.+||+.||++|||+.+++++.
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 899999999999999999999999998743
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=351.32 Aligned_cols=265 Identities=24% Similarity=0.308 Sum_probs=209.6
Q ss_pred CCCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC---CcchHHHHHHHHHHhcCCCCCeeeeeEEEEe---
Q 022401 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT--- 90 (298)
Q Consensus 17 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 90 (298)
|.+.+.++|++++.||+|+||+||+|++..+|+.||||++... ......+.+|+.++++++|||++++++++..
T Consensus 4 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp TTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred CCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 4566679999999999999999999999999999999998653 2334678899999999999999999999865
Q ss_pred -----CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 91 -----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 91 -----~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
+..+++|+|++.++++.........+++..++.++.|++.||.|||++|++||||||+||+++.++. +|++||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~df 161 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADF 161 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCC
T ss_pred cccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeec
Confidence 3468999999988777766666778999999999999999999999999999999999999998887 999999
Q ss_pred CccccccC-----CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 022401 166 GYSKSSVL-----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240 (298)
Q Consensus 166 ~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (298)
|++..... ........+++.|+|||.+.+....+.++||||+||++|+|++|..||...+....+....+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99864332 1222334589999999998877554556999999999999999999998765544333333222211
Q ss_pred CCCCCCCC--------------------------CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 241 QYSVPDTN--------------------------PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 241 ~~~~~~~~--------------------------~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
........ ..++++.+||.+||+.||++|||+ .++++|||+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa--------~elL~Hpff~~ 310 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS--------DDALNHDFFWS 310 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH--------HHHHHSGGGSS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH--------HHHHcChhhcc
Confidence 11100000 125678899999999999999988 56669999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=350.16 Aligned_cols=265 Identities=27% Similarity=0.463 Sum_probs=222.5
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEE---ccCCcEEEEEEeecC-----CcchHHHHHHHHHHhcCCC-CCeeeeeEEEEeC
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRD---KVTKELVAVKYIERG-----DKIDENVQREIINHRSLRH-PNIVRFKEVILTP 91 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~---~~~~~~~aiK~~~~~-----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 91 (298)
..++|++++.||+|+||.||+|++ +.+|+.||+|++.+. ....+.+.+|+.++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 348899999999999999999987 346889999998643 2334567899999999966 8999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
..+++++|++.+++|.+.+.....+++..+..++.|++.|++|||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEF 179 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEEC
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhh
Confidence 999999999999999999999989999999999999999999999999999999999999998887 999999998643
Q ss_pred cC--CCCCCCCCCCCcccCcccccccc-CCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCC
Q 022401 172 VL--HSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248 (298)
Q Consensus 172 ~~--~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
.. ........+++.|++||.+.+.. ....++||||+||++|+|++|..||...+..+......+.........+ .
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~--~ 257 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--Q 257 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--T
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc--c
Confidence 22 23334566899999999987654 3344599999999999999999999888777776776666666555443 3
Q ss_pred CCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 249 PISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 249 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
.+++++.+||++||+.||.+|||+...- ..++++|||+++.
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t---~~eil~Hpff~~i 298 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRD---ADEIKEHLFFQKI 298 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTT---HHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCccc---HHHHHcCHhhcCC
Confidence 5899999999999999999999752211 3677899999763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=340.39 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=201.1
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEe-CCeEEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAI 96 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 96 (298)
+.++.++|++++.||+|+||.||+|+.+ |+.||+|++..+ ...+.+.+|+.++++++||||+++++++.+ ++.+++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 3456789999999999999999999985 678999998654 455779999999999999999999999865 457899
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 97 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 97 v~~~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
|+||+++++|.+++.... .+++..++.++.||+.||.|||+.+++||||+|+||+++.++. ++++|||++.....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS- 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC-
Confidence 999999999999986543 4899999999999999999999999999999999999999887 99999999874332
Q ss_pred CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCHH
Q 022401 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253 (298)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
......++..|+|||.+.+..++.+ +||||||+++|||+| |..||...+..+. ...+.. ....+.+..++++
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~~~~~~~~~----~~~i~~-~~~~~~~~~~~~~ 228 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDV----VPRVEK-GYKMDAPDGCPPA 228 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGH----HHHHTT-TCCCCCCTTCCHH
T ss_pred -CCccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCCCCCCHHHH----HHHHHc-CCCCCCCccCCHH
Confidence 2334567889999999988877655 999999999999998 6777776554332 223322 2344455568999
Q ss_pred HHHHHHHhhhhCCCCcccccccchhh
Q 022401 254 CRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 254 l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
+.+||++||+.||.+|||+.+++++.
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 99999999999999999999998753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=351.01 Aligned_cols=257 Identities=24% Similarity=0.352 Sum_probs=203.5
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC------
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------ 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 92 (298)
.++|++++.||+|+||.||+|.++.+|+.||||++..... ..+.+.+|+.++++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4789999999999999999999999999999999875432 2356789999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+|+||||+ +.+|.... ....+++..++.++.|++.||+|||++|++||||||+||+++.++. ++++|||++....
T Consensus 97 ~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD 172 (346)
T ss_dssp CCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred eEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccC
Confidence 579999999 55676665 4567999999999999999999999999999999999999998887 9999999987443
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc------------
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------ 240 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 240 (298)
.......+++.|+|||.+.+..+.+.++||||+||++|+|++|..||...+..+.+..........
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 173 --SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp --SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred --CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 333456789999999998877666666999999999999999999998876544433322211100
Q ss_pred -------CCC------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 241 -------QYS------VPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 241 -------~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
... .....+.++++.+||.+||..||.+|||+ .++++|||+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta--------~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA--------GEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH--------HHHHHSGGGTTT
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH--------HHHhcChhhCcC
Confidence 000 01123478999999999999999999988 555689998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=343.68 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=209.0
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccCCcE--EEEEEeecC--CcchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~--~aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (298)
++-++|++.+.||+|+||.||+|.++.++.. ||||.+... ....+.+.+|+.++.++ +||||+++++++.+++.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 3557999999999999999999999887764 667776532 33446789999999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCC
Q 022401 95 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~ 158 (298)
++|+||+++++|.+++... ..+++..+..++.|++.|+.|||+.|++||||||+|||++.++.
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~- 165 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 165 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-
Confidence 9999999999999998644 56899999999999999999999999999999999999998887
Q ss_pred CEEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCC-CCCCCCCCchhHHHHHHHH
Q 022401 159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRI 237 (298)
Q Consensus 159 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~~~~~~~~~~~~~~~~ 237 (298)
+||+|||+++............++..|+|||.+.+..++.+ +||||||+++|||++|. .||...+. .+....+
T Consensus 166 -~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~----~~~~~~i 239 (309)
T d1fvra_ 166 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKL 239 (309)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHG
T ss_pred -eEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCH----HHHHHHH
Confidence 99999999976655555556678999999999988888665 99999999999999976 46765443 3334444
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
..+ .+.+.+..+++++.+||.+||+.||++|||+.+++++.
T Consensus 240 ~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 240 PQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp GGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred Hhc-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 433 34455566899999999999999999999999999763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=341.67 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=200.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecC----CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (298)
+..++|++.+.||+|+||.||+|+.... ...||||++... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4457899999999999999999987533 236899988653 3334678899999999999999999999965 4
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccc
Q 022401 93 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~ 171 (298)
.+++|+||++++++.+.+.. ..++++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhc
Confidence 67899999999999887654 456999999999999999999999999999999999999998887 999999998754
Q ss_pred cCCCC----CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCC
Q 022401 172 VLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246 (298)
Q Consensus 172 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
..... .....++..|+|||.+.+..++.+ +||||||+++|||++ |..||...+. .+...++.......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~----~~~~~~i~~~~~~~~~ 236 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNG----SQILHKIDKEGERLPR 236 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTSCCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCH----HHHHHHHHhCCCCCCC
Confidence 33322 223346778999999988777655 999999999999998 8999987654 3445566666666677
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 247 TNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 247 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
+..+|+++.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7789999999999999999999999988875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=339.62 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=197.8
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecCC--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
+..++|++++.||+|+||.||+|++..+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++. ++.+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 3447899999999999999999998643 3568888876432 22456889999999999999999999985 5678
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 95 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
++|+||+++++|..++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+++....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED 160 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC---------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccC
Confidence 999999999999988654 457899999999999999999999999999999999999998887 99999999875433
Q ss_pred C--CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 174 H--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 174 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
. .......+++.|+|||.+.+..++.+ +||||||+++|||++ |..||...+..+. ...+..+ ...+.+.++
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~----~~~i~~~-~~~~~~~~~ 234 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDV----IGRIENG-ERLPMPPNC 234 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGH----HHHHHTT-CCCCCCTTC
T ss_pred CcceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHH----HHHHHcC-CCCCCCCCC
Confidence 2 22234457889999999988777665 999999999999998 8889987665433 2233333 233556678
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
|+++.+||.+||+.||.+|||+.+++++.
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 99999999999999999999999988753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=348.38 Aligned_cols=257 Identities=28% Similarity=0.401 Sum_probs=201.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----eE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-----HL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 94 (298)
+++|++++.||+|+||.||+|.+..+|+.||||++..... ..+.+.+|+.++++++|||++++++++..+. .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4689999999999999999999999999999999875432 2356789999999999999999999987643 35
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++++ ++.+++|.+++... .+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++......
T Consensus 87 ~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPD 162 (345)
T ss_dssp EEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGG
T ss_pred EEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCC
Confidence 5555 56688999998654 6899999999999999999999999999999999999998887 999999998644332
Q ss_pred C----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcC---------
Q 022401 175 S----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------- 241 (298)
Q Consensus 175 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 241 (298)
. ......+++.|+|||.+........++||||+||++|+|++|..||...+..+.............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 234456889999999987766666669999999999999999999987665443333222111110
Q ss_pred -------CCCC---------CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 242 -------YSVP---------DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 242 -------~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
...+ ....+++++.+||.+||+.||.+|||+ .++++|||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta--------~e~L~hpf~~ 299 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV--------EQALAHPYLE 299 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH--------HHHHTSGGGT
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH--------HHHhcCHhhc
Confidence 0000 122467899999999999999999987 5556788887
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=342.28 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=200.3
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCc----EEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (298)
.++|++++.||+|+||.||+|.+..+|+ .||+|.+... ....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 3579999999999999999999987765 5788877543 34456789999999999999999999999765 456
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCC
Q 022401 96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (298)
Q Consensus 96 lv~~~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~ 174 (298)
++++++.+++|.+.+.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||+++.....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecccc
Confidence 77788888899887755 457999999999999999999999999999999999999998887 999999998754332
Q ss_pred CCC---CCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCC
Q 022401 175 SQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250 (298)
Q Consensus 175 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
... ....+++.|+|||.+.+..++.+ +||||||+++|||+| |..||...+..+ +...+. .....+.+..+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~-~~~~i~----~~~~~~~p~~~ 238 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILE----KGERLPQPPIC 238 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGG-HHHHHH----HTCCCCCCTTB
T ss_pred cccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHH-HHHHHH----cCCCCCCCccc
Confidence 222 23357899999999988877655 999999999999998 788888765433 222222 23344555668
Q ss_pred CHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 251 SQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 251 ~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
|+++.+++.+||+.||.+|||+.+++.+.
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-50 Score=339.29 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=205.8
Q ss_pred CCCCCCCeeEEeeeccCCeEEEEEEEEccCC-------cEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEE
Q 022401 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTK-------ELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEV 87 (298)
Q Consensus 18 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-------~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~ 87 (298)
+.+..++|++++.||+|+||.||+|+...++ ..||+|++..+.. ....+.+|...+.++ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 3455689999999999999999999976443 4799999876543 335677888888888 79999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceE
Q 022401 88 ILTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (298)
Q Consensus 88 ~~~~~~~~lv~~~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nil 151 (298)
+.++..+++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+++||||||+||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999999644 34899999999999999999999999999999999999
Q ss_pred eeCCCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 022401 152 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP 227 (298)
Q Consensus 152 v~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~ 227 (298)
++.++. +||+|||++....... ......+++.|+|||.+.+..++.+ +||||||+++|||++ |..||...+..
T Consensus 168 l~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 168 VTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp ECTTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ecCCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 999887 9999999987443332 2344567889999999988888665 999999999999998 68888765542
Q ss_pred hhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
.....+ ......+.+..+++++.+||.+||+.||.+|||+.+++++.
T Consensus 245 ----~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 245 ----ELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp ----HHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ----HHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 222232 23344455667899999999999999999999999999755
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-50 Score=340.41 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=205.6
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCcc--hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCeE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (298)
.++|++++.||+|+||.||+|+.+. +++.||||++...... .+.+.+|+.++++++|||++++++++...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 4689999999999999999999753 5678999998764332 45689999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCce
Q 022401 95 AIVMEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (298)
Q Consensus 95 ~lv~~~~~~~sL~~~l~~~~------------------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~ni 150 (298)
+++++++.+++|.+++.... .++...++.++.|++.||+|||+.+++||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 99999999999999986432 378899999999999999999999999999999999
Q ss_pred EeeCCCCCCEEEeecCccccccCC---CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCC-CCCCCCCC
Q 022401 151 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDE 226 (298)
Q Consensus 151 lv~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~~~~~ 226 (298)
+++.++. +||+|||++...... .......+++.|+|||.+.+..++.+ +||||||+++|||++|. .||...+.
T Consensus 172 Lld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 172 LVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCCCCCCCCH
Confidence 9998887 999999998643222 22234557789999999988887765 99999999999999986 56776554
Q ss_pred chhHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccch
Q 022401 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLN 277 (298)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 277 (298)
. +....+..+. ..+.+..+|+++.+|+.+||+.||.+|||+.++++
T Consensus 249 ~----e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 E----EVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp H----HHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H----HHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3 3333444443 33445568999999999999999999999998875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=347.71 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=196.2
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCc---chHHHHHHHHHHhcCCCCCeeeeeEEEEe------CC
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT------PT 92 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 92 (298)
.++|++++.||+|+||+||+|++..+|+.||||++..... ...++.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3689999999999999999999999999999999976532 23457899999999999999999999864 36
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCcccccc
Q 022401 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (298)
Q Consensus 93 ~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~ 172 (298)
.+|+|+||+.++++ +.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++. ++++|||++....
T Consensus 96 ~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~ 170 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 170 (355)
T ss_dssp EEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred eeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccc
Confidence 88999999977544 444 346899999999999999999999999999999999999998887 9999999987666
Q ss_pred CCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh-------------
Q 022401 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS------------- 239 (298)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 239 (298)
.........+++.|+|||.+.+..++.+ +||||+||++++|++|..||.+.+..............
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 6666666778999999999988877776 99999999999999999999887654444433332211
Q ss_pred -----cCCCCCCC------------------CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 240 -----VQYSVPDT------------------NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 240 -----~~~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
........ ...++++.+||++||..||++|||+ .++++|||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta--------~elL~Hpw~~~ 316 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV--------DDALQHPYINV 316 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH--------HHHHTSTTTGG
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH--------HHHhcCcccCC
Confidence 11000000 0134678999999999999999988 55558888874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=339.71 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=210.8
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEc-----cCCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEEEe
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 90 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (298)
....++|++++.||+|+||.||+|+.. .+++.||||++..... ....+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 355689999999999999999999863 4677899999876543 334578999999999 69999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEe
Q 022401 91 PTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (298)
Q Consensus 91 ~~~~~lv~~~~~~~sL~~~l~~~~------------------~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv 152 (298)
+..+++||||+++++|.+++.... .+++..+..++.||+.|++|||++|++||||||+||++
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 999999999999999999986543 58899999999999999999999999999999999999
Q ss_pred eCCCCCCEEEeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHh-CCCCCCCCCCch
Q 022401 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (298)
Q Consensus 153 ~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~ 228 (298)
+.++. ++++|||.++....... .....+++.|+|||.+.+..++.+ +||||||+++|||+| |..||...+..+
T Consensus 179 ~~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 179 THGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp ETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 98887 99999999875443222 233457889999999987777665 999999999999999 555566655544
Q ss_pred hHHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhh
Q 022401 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSC 280 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~ 280 (298)
.+.+.+ ........+..+|+++.+||.+||+.||.+|||+.+++++.-
T Consensus 256 ~~~~~i----~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 256 KFYKMI----KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp HHHHHH----HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHH----hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 433333 334444555568999999999999999999999999997543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=339.92 Aligned_cols=255 Identities=21% Similarity=0.328 Sum_probs=198.3
Q ss_pred CCCCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCc--chHHHHHHHHHHhcC-CCCCeeeeeEEEEeC
Q 022401 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (298)
Q Consensus 20 ~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 91 (298)
+..++|++++.||+|+||.||+|.+.. +++.||+|++..... ....+.+|...+.++ +|+||+.+.+++..+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 445789999999999999999999753 446899999875432 234566777777666 689999999998664
Q ss_pred -CeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeC
Q 022401 92 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (298)
Q Consensus 92 -~~~~lv~~~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~ 154 (298)
..+++||||+++++|.+++... ..+++.+++.++.|++.||+|||++|++||||||+||+++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 5789999999999999998643 24789999999999999999999999999999999999998
Q ss_pred CCCCCEEEeecCccccccCCC---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCC-CCCCCCCCchhH
Q 022401 155 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDF 230 (298)
Q Consensus 155 ~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~~~~~~~~~ 230 (298)
++. +||+|||+++...... ......|++.|+|||.+.+..++.+ +||||+||++|||++|. .||........+
T Consensus 170 ~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 170 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp GGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 887 9999999986443322 2234568899999999988777655 99999999999999875 678776654444
Q ss_pred HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhH
Q 022401 231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCL 281 (298)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~ 281 (298)
...+.. ....+.+..+++++.+++.+||+.||.+|||+.+++++...
T Consensus 247 ~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 247 CRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhc----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 333332 33344455689999999999999999999999999987543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=346.87 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=204.0
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc---hHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----Ce
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP-----TH 93 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 93 (298)
.++|++++.||+|+||+||+|++..+|+.||||++.+.... .+.+.+|+.++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999999999999999998765332 34577999999999999999999998643 23
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccC
Q 022401 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (298)
Q Consensus 94 ~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~ 173 (298)
.+++++++.+++|.+++. ..++++.+++.++.||+.||+|||++|++||||||+||+++.++. ++++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT-
T ss_pred eEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC-
Confidence 355566777899999884 457999999999999999999999999999999999999999887 9999999886433
Q ss_pred CCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCC-----------
Q 022401 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----------- 242 (298)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 242 (298)
.......+++.|+|||...+..+.+.++||||+||++|+|++|..||.+.+.................
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 23345567889999999888776666699999999999999999999887654444333332211110
Q ss_pred --------CCCC------CCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhh
Q 022401 243 --------SVPD------TNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFD 291 (298)
Q Consensus 243 --------~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~ 291 (298)
..+. ...+++++.+||++||+.||.+|||+ .++++|||++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta--------~elL~Hp~f~~ 306 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA--------AQALAHAYFAQ 306 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH--------HHHHTSGGGTT
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH--------HHHhcCHhhCC
Confidence 0000 12478999999999999999999988 55668888874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=331.33 Aligned_cols=264 Identities=17% Similarity=0.245 Sum_probs=214.5
Q ss_pred CCCCCCeeEEeeeccCCeEEEEEEEEcc-----CCcEEEEEEeecCCcch--HHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 022401 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILTP 91 (298)
Q Consensus 19 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (298)
.++.++|++++.||+|+||.||+|.++. +++.||||++....... ..+.+|+.++++++||||+++++++..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 4455899999999999999999998853 35789999987543322 3578999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEE
Q 022401 92 THLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (298)
Q Consensus 92 ~~~~lv~~~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~ 161 (298)
...++|+||+.+++|.+++... ..++...+..++.+++.||.|||+++++||||||+||+++.++. +|
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~K 173 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VK 173 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EE
Confidence 9999999999999999987532 24688999999999999999999999999999999999998887 99
Q ss_pred EeecCccccccCCCC---CCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCC-CCCCCCCCchhHHHHHHHH
Q 022401 162 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRI 237 (298)
Q Consensus 162 l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~~~~~~~~~~~~~~~~ 237 (298)
|+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|||++|. .||...+.. +....+
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~----~~~~~i 248 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNE----QVLRFV 248 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHH----HHHHHH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHH----HHHHHH
Confidence 999999864433222 233457899999999988877655 99999999999999985 777765442 333333
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhh
Q 022401 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDA 292 (298)
Q Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~ 292 (298)
..+. ..+.+..+|+++.+++.+||+.||.+|||+.+++++ ++-..+|++.+.
T Consensus 249 ~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~--L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 249 MEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS--IKEEMEPGFREV 300 (308)
T ss_dssp HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HGGGSCTTHHHH
T ss_pred HhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcCCCCcCC
Confidence 3333 334455689999999999999999999999999964 344456777654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=328.37 Aligned_cols=248 Identities=21% Similarity=0.252 Sum_probs=199.0
Q ss_pred eeEEeeeccCCeEEEEEEEEccC---CcEEEEEEeecC--CcchHHHHHHHHHHhcCCCCCeeeeeEEEEe-CCeEEEEE
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVM 98 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~---~~~~aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 98 (298)
+.+.++||+|+||.||+|++..+ ...||||.+... ....+++.+|+.++++++||||+++++++.+ +..+++|+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 34578999999999999998643 236899998643 3334678999999999999999999999876 46899999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeecCccccccCCC--
Q 022401 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 175 (298)
Q Consensus 99 ~~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~~~~~~~-- 175 (298)
||+++++|.+++.... ..+...+..++.|++.||.|||+.+++||||||+||++++++. +||+|||++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFD 186 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccc
Confidence 9999999999887544 5778899999999999999999999999999999999998887 9999999987443322
Q ss_pred ---CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcCCCCCCCCCCCH
Q 022401 176 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252 (298)
Q Consensus 176 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
......+++.|+|||.+....++.+ +||||||+++|||++|..||........ ....+..+ .....+..+++
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~---~~~~i~~g-~~~~~p~~~~~ 261 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG-RRLLQPEYCPD 261 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC---------CHHHHHTT-CCCCCCTTCCH
T ss_pred cceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcC-CCCCCcccCcH
Confidence 2223457889999999988877665 9999999999999998888766443222 22233333 23345556899
Q ss_pred HHHHHHHHhhhhCCCCcccccccchhh
Q 022401 253 ECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 253 ~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
++.+|+.+||+.||.+|||+.+++++.
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999999999999763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-48 Score=327.23 Aligned_cols=260 Identities=22% Similarity=0.216 Sum_probs=200.0
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCC-eeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~~~ 100 (298)
.++|++++.||+|+||.||+|++..+|+.||||++.... ..+.+..|++++++++|++ ++.+.+++.+....++|+|+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 368999999999999999999999999999999877653 3356788999999998765 55566666778899999999
Q ss_pred cCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCC-CCCEEEeecCccccccCCC---
Q 022401 101 ASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS--- 175 (298)
Q Consensus 101 ~~~~sL~~~l-~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~-~~~~~l~d~~~~~~~~~~~--- 175 (298)
+++ ++...+ .....+++..+..++.|++.||+|||++|++||||||+||+++..+ ...++|+|||++.......
T Consensus 85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 85 LGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred cCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 955 554544 4566899999999999999999999999999999999999985432 3359999999987443322
Q ss_pred -----CCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHH---HHHhhcCCCCCCC
Q 022401 176 -----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI---QRILSVQYSVPDT 247 (298)
Q Consensus 176 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~ 247 (298)
......|++.|+|||.+.+..++.+ +|||||||++|+|++|..||............. ......... ...
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 241 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-VLC 241 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH-HHT
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh-Hhc
Confidence 2234468999999999988777655 999999999999999999998765433322211 111111111 123
Q ss_pred CCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhh
Q 022401 248 NPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMF 290 (298)
Q Consensus 248 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~ 290 (298)
.++|+++.+++..||+.||.+||++.++. ++++|+|..
T Consensus 242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~-----~~l~~~~~~ 279 (299)
T d1ckia_ 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLR-----QLFRNLFHR 279 (299)
T ss_dssp TTSCHHHHHHHHHHHHSCTTCCCCHHHHH-----HHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHH-----HHHHHHHHH
Confidence 35899999999999999999999986654 456676653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5e-47 Score=321.15 Aligned_cols=272 Identities=19% Similarity=0.198 Sum_probs=209.9
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCC-CCeeeeeEEEEeCCeEEEEEec
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
.++|++++.||+|+||.||+|++..+|+.||+|+..... ..+.+.+|++.++.++| +|++.+++++..+...++|+|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 579999999999999999999999999999999876543 33557788899999965 8999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCC---CCCCEEEeecCccccccCC--
Q 022401 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLH-- 174 (298)
Q Consensus 101 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~---~~~~~~l~d~~~~~~~~~~-- 174 (298)
+ +++|.+.+... ..++..++..++.|++.||+|||++|++||||||+||+++.+ ....++|+|||+++.....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9 67898888654 469999999999999999999999999999999999999752 2234999999999743322
Q ss_pred ------CCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---CCCCC
Q 022401 175 ------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---QYSVP 245 (298)
Q Consensus 175 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~ 245 (298)
.......||+.|+|||++.+..++.+ +||||||+++|+|++|..||........... ..++... .....
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~-~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTPLRE 239 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-HHHHHHHHHHSCHHH
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHH-HHHHHhccCCCChHH
Confidence 12234468999999999988777655 9999999999999999999987654333221 1122111 11111
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcC
Q 022401 246 DTNPISQECRDLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYH 297 (298)
Q Consensus 246 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~ 297 (298)
...++|+++.+++..|++.+|.+||++..+.+.....+-..-+-.+...+|+
T Consensus 240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~ 291 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 291 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence 1234799999999999999999999987665432222222222234455675
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=320.76 Aligned_cols=253 Identities=22% Similarity=0.219 Sum_probs=192.7
Q ss_pred CCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----eEEEE
Q 022401 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIV 97 (298)
Q Consensus 22 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 97 (298)
..+|.+.+.||+|+||.||+|+. +|+.||||++............|+..+.+++||||+++++++.+++ .+++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35799999999999999999986 5789999998765443333444556666789999999999998653 68999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh--------cCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 98 ~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~--------~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
+||+++++|.+++... +++...++.++.+++.|+.|||+ +|++||||||+||+++.++. +||+|||++.
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCccc
Confidence 9999999999999765 68999999999999999999996 59999999999999998887 9999999987
Q ss_pred cccCCC-----CCCCCCCCCcccCccccccccC-----CCCccchHHHHHHHHHHHhCCCCCCCCCCc-----------h
Q 022401 170 SSVLHS-----QPKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------K 228 (298)
Q Consensus 170 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-----------~ 228 (298)
...... ......|++.|+|||++.+... .+.++|||||||++|||++|..||...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 443322 2234568999999999865432 133489999999999999998877443211 1
Q ss_pred hHHHHHHHHhhcCCCCCCCC-----CCCHHHHHHHHHhhhhCCCCcccccccchhh
Q 022401 229 DFRKTIQRILSVQYSVPDTN-----PISQECRDLISRIFVADPAAVSIFFFPLNMS 279 (298)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~~l~~~ 279 (298)
..............+...+. ..+.++.+++.+||+.||.+|||+.|++++.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 12222223333232211111 1234699999999999999999999998754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-43 Score=308.29 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=193.0
Q ss_pred CCCCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-----------CCCeeeeeEEEE
Q 022401 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVIL 89 (298)
Q Consensus 21 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~ 89 (298)
..++|++++.||+|+||+||+|++..+|+.||||++.......+.+.+|+.+++.+. |+||+++++++.
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 346799999999999999999999999999999999877655677788998888774 578999999876
Q ss_pred e--CCeEEEEEeccCCCC-HHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHhh-cCcEEecCCCCceEeeCCCCC----C
Q 022401 90 T--PTHLAIVMEYASGGE-LFERI--CNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP----R 159 (298)
Q Consensus 90 ~--~~~~~lv~~~~~~~s-L~~~l--~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~p~nilv~~~~~~----~ 159 (298)
. ....++++.++.... ..... .....+++..++.++.|++.|++|||+ .||+||||||+||+++.++.. .
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 4 345566666554333 22222 234578999999999999999999997 899999999999999765542 4
Q ss_pred EEEeecCccccccCCCCCCCCCCCCcccCccccccccCCCCccchHHHHHHHHHHHhCCCCCCCCCCch------hHHHH
Q 022401 160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------DFRKT 233 (298)
Q Consensus 160 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~------~~~~~ 233 (298)
++++|||.+.... .......+++.|+|||++....++.+ +||||+||++++|++|..||...+... .....
T Consensus 171 ~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 171 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eeEeecccccccc--cccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 8999999886433 33456678999999999988888765 999999999999999999997654321 11111
Q ss_pred HHHHhhcC---------------------CC----------------CCCCCCCCHHHHHHHHHhhhhCCCCcccccccc
Q 022401 234 IQRILSVQ---------------------YS----------------VPDTNPISQECRDLISRIFVADPAAVSIFFFPL 276 (298)
Q Consensus 234 ~~~~~~~~---------------------~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l 276 (298)
. +..... .. .......++++.+||.+||+.||.+|||+
T Consensus 248 ~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta---- 322 (362)
T d1q8ya_ 248 I-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA---- 322 (362)
T ss_dssp H-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH----
T ss_pred H-HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH----
Confidence 1 111000 00 00111235789999999999999999988
Q ss_pred hhhhHHHhhhhhhhh
Q 022401 277 NMSCLLLFSFVWMFD 291 (298)
Q Consensus 277 ~~~~~~~~~hp~~~~ 291 (298)
.++++|||+++
T Consensus 323 ----~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 323 ----GGLVNHPWLKD 333 (362)
T ss_dssp ----HHHHTCGGGTT
T ss_pred ----HHHhcCcccCC
Confidence 55568999974
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=6.9e-24 Score=167.20 Aligned_cols=131 Identities=17% Similarity=0.158 Sum_probs=103.5
Q ss_pred eeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcc-------------------hHHHHHHHHHHhcCCCCCeeeee
Q 022401 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-------------------DENVQREIINHRSLRHPNIVRFK 85 (298)
Q Consensus 25 y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-------------------~~~~~~e~~~l~~l~h~~i~~~~ 85 (298)
+.+++.||+|+||.||+|++. +|+.||||++..+... .....+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999985 6889999986532110 12234678888999999998877
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCcEEecCCCCceEeeCCCCCCEEEeec
Q 022401 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (298)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~p~nilv~~~~~~~~~l~d~ 165 (298)
++. . .+++|+++++..+.. ++......++.|++.+++|||+.|++||||||+||++++++ ++|+||
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF 146 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF 146 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence 653 2 268999998765432 34455678999999999999999999999999999998654 899999
Q ss_pred Ccccc
Q 022401 166 GYSKS 170 (298)
Q Consensus 166 ~~~~~ 170 (298)
|.+..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 98753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=4.1e-07 Score=73.20 Aligned_cols=138 Identities=15% Similarity=0.118 Sum_probs=89.9
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCC-cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCeEEEEEec
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 100 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~ 100 (298)
+.|++.+..+.++.+.||.+.. ++..+++|+..... .....+.+|...++.+. +--+.+++.+..+++..++|+++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 4678877765555578998764 45567888776542 23345677887777663 32356677777788899999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 022401 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA------------------------------------------- 137 (298)
Q Consensus 101 ~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~Lh~------------------------------------------- 137 (298)
.+|.++....... .....++.+++..+..||+
T Consensus 92 l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 92 ADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred ccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 9998875543211 1122233444444444442
Q ss_pred ----------------cCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 138 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 138 ----------------~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
..++|+|+.|.||++++++. +-|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCce--EEEeechhcc
Confidence 12589999999999986653 5699998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.23 E-value=2.9e-06 Score=72.36 Aligned_cols=80 Identities=16% Similarity=0.096 Sum_probs=49.4
Q ss_pred CeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecC--------CcchHHHHHHHHHHhcCC--CCC-eeeeeEEEEeCC
Q 022401 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--------DKIDENVQREIINHRSLR--HPN-IVRFKEVILTPT 92 (298)
Q Consensus 24 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~--------~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~ 92 (298)
..+ .+.+|.|....||.+....+++.+++|..... .....+...|...++.+. .|. +.+++.+ ++.
T Consensus 28 ~l~-~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~ 104 (392)
T d2pula1 28 TLT-CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 104 (392)
T ss_dssp CCE-EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred Cee-EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC
Confidence 344 55689999999999998777888999975421 112344556777776552 233 4445443 455
Q ss_pred eEEEEEeccCCCCH
Q 022401 93 HLAIVMEYASGGEL 106 (298)
Q Consensus 93 ~~~lv~~~~~~~sL 106 (298)
..++|||+.++..+
T Consensus 105 ~~~lvmE~L~~~~~ 118 (392)
T d2pula1 105 MAVTVMEDLSHLKI 118 (392)
T ss_dssp TTEEEECCCTTSEE
T ss_pred CCEEEEeccCCccc
Confidence 56789999976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=1.8e-05 Score=62.83 Aligned_cols=74 Identities=14% Similarity=0.075 Sum_probs=50.2
Q ss_pred eeccCCe-EEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCC--CCeeeeeEEEEeCCeEEEEEeccCCCCH
Q 022401 30 DIGSGNF-GVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGGEL 106 (298)
Q Consensus 30 ~lg~g~~-~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~~~~~~~sL 106 (298)
.+..|.. +.||.+... ++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++|+++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444544 578988765 45568889766543 2346667777766632 2356677777788889999999988665
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.34 E-value=0.00032 Score=57.69 Aligned_cols=69 Identities=13% Similarity=0.144 Sum_probs=46.4
Q ss_pred eEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCe-----eeee--EEEEeCCeEEEEEeccCCCC
Q 022401 36 FGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-----VRFK--EVILTPTHLAIVMEYASGGE 105 (298)
Q Consensus 36 ~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~--~~~~~~~~~~lv~~~~~~~s 105 (298)
.-.||.++.. +|+.|++|+...+....+++..|...+..|...++ +..- ..+......+.++++..|..
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 3589988875 67789999987776667788888888877632221 1111 11234567888999987644
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.86 E-value=0.0014 Score=55.17 Aligned_cols=78 Identities=13% Similarity=0.134 Sum_probs=50.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEcc-------CCcEEEEEEeecCCcchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCeE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHL 94 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~ 94 (298)
+..++ +.|+.|-.-.+|++.... .++.++++++.. ....-...+|..+++.+.-.++ .++++++. +
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~-- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--
Confidence 44555 567778888999988642 345677777663 3334456678888887753344 45666653 2
Q ss_pred EEEEeccCCCCH
Q 022401 95 AIVMEYASGGEL 106 (298)
Q Consensus 95 ~lv~~~~~~~sL 106 (298)
..|++|++|.++
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 568888887544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.60 E-value=0.0033 Score=51.00 Aligned_cols=142 Identities=15% Similarity=0.069 Sum_probs=71.5
Q ss_pred CCeeEEeeeccCCeEEEEEEEEccCCcEEEEEEeecCCcchHHHHHHHHHHhcCC-----CCCeeeee-E--EEEeCCeE
Q 022401 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFK-E--VILTPTHL 94 (298)
Q Consensus 23 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~-~--~~~~~~~~ 94 (298)
++..-.+.|..|-.-+.|.+... +| .|++|++... ...+.+..|+.++..|. .|..+.-. | +.......
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~ 94 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 94 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred CCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeeccc
Confidence 34444555667777788998865 34 4899988653 23344455555555442 22222110 0 01123445
Q ss_pred EEEEeccCCCCHH-----HH---------HHh---CC------CC------------------CHHHHHHHHHHHHHHHH
Q 022401 95 AIVMEYASGGELF-----ER---------ICN---AG------RF------------------SEDEARFFFQQLISGVS 133 (298)
Q Consensus 95 ~lv~~~~~~~sL~-----~~---------l~~---~~------~~------------------~~~~~~~i~~~l~~~l~ 133 (298)
..++.+..+.... .. ++. .. .. ........+......+.
T Consensus 95 ~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (316)
T d2ppqa1 95 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 174 (316)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred ceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhh
Confidence 5666666543221 00 000 00 00 01111222333333333
Q ss_pred HHh----hcCcEEecCCCCceEeeCCCCCCEEEeecCccc
Q 022401 134 YCH----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (298)
Q Consensus 134 ~Lh----~~~i~H~dl~p~nilv~~~~~~~~~l~d~~~~~ 169 (298)
... ..|++|+|+.+.||+++.+.. .-+.||+.++
T Consensus 175 ~~~~~~L~~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 175 AHWPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred ccCccccccccccCCcchhhhhcccccc--eeEecccccc
Confidence 333 256999999999999987664 6899999764
|
| >d1kq8a_ a.4.5.14 (A:) HFH-1 (HNF-3 forkhead homolog-1) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: DNA/RNA-binding 3-helical bundle superfamily: "Winged helix" DNA-binding domain family: Forkhead DNA-binding domain domain: HFH-1 (HNF-3 forkhead homolog-1) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=80.15 E-value=0.44 Score=29.03 Aligned_cols=39 Identities=10% Similarity=0.060 Sum_probs=33.2
Q ss_pred HHHHHhhhhCCCCcccccccchhhhHHHhhhhhhhhhhhhcC
Q 022401 256 DLISRIFVADPAAVSIFFFPLNMSCLLLFSFVWMFDATENYH 297 (298)
Q Consensus 256 ~li~~~l~~dp~~Rps~~~~l~~~~~~~~~hp~~~~~~~~~~ 297 (298)
.||...+...|..|.|..||.+ ...-..||+....++|.
T Consensus 3 ~LI~~Ai~~sp~~~ltL~eIy~---~i~~~fpy~r~~~~gWk 41 (75)
T d1kq8a_ 3 ALITMAIRDSAGGRLTLAEINE---YLMGKFPFFRGSYTGWR 41 (75)
T ss_dssp HHHHHHHTTSSSSCBCHHHHHH---HHHHHCTTGGGTCSCCH
T ss_pred HHHHHHHHhCCCCCccHHHHHH---HHHHhCcccccCCccch
Confidence 5788888889999999999997 55677899998888884
|